screen,dose,repurposing_target,MOA,IDs,Drug.Name,Synonyms
REP.300,2.5,,,BRD:BRD-K00104122-001-01-9,MRTX1133,MRTX1133
REP.300,2.5,,,BRD:BRD-K00104124-001-01-9,PEMIGATINIB,PEMIGATINIB
REP.300,2.5,,,BRD:BRD-K00085355-001-01-9,TELAVANCIN,TELAVANCIN
REP.300,2.5,,,BRD:BRD-K00075140-005-02-9,ECHOTHIOPHATE IODIDE,ECHOTHIOPHATE IODIDE
REP.300,2.5,,,BRD:BRD-K00080753-001-01-9,SPINOSAD,SPINOSAD
REP.300,2.5,,,BRD:BRD-K00085357-001-01-9,FLUCICLOVINE,FLUCICLOVINE
REP.300,2.5,,,BRD:BRD-K00108790-001-01-9,AMG-397,AMG-397
REP.300,2.5,,,BRD:BRD-K00104123-001-01-9,THZ531,THZ531
REP.PRIMARY,2.5,PRKG1,PKA ACTIVATOR,BRD:BRD-A00077618-236-07-6,8-BROMO-CGMP,8-BROMO-CGMP
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-A00100033-001-08-9,NIFURTIMOX,NIFURTIMOX
REP.PRIMARY,2.5,PPARG,"INSULIN SENSITIZER, PPAR RECEPTOR PARTIAL AGONIST",BRD:BRD-A00147595-001-01-5,BALAGLITAZONE,BALAGLITAZONE
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A00218260-001-03-4,FLUTRIMAZOLE,FLUTRIMAZOLE
REP.PRIMARY,2.5,MME,NEPRILYSIN INHIBITOR,BRD:BRD-A00376169-001-01-6,KBG,KBG
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A00520476-001-07-4,OTENZEPAD,OTENZEPAD
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A00546892-001-02-6,BIPERIDEN,BIPERIDEN
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A00578795-001-04-3,ZALTOPROFEN,ZALTOPROFEN
REP.PRIMARY,2.5,PGR,PROGESTOGEN HORMONE,BRD:BRD-A00758722-001-04-9,NORETYNODREL,NORETYNODREL
REP.PRIMARY,2.5,"ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B","ADENOSINE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-A00827783-001-24-6,DYPHYLLINE,DYPHYLLINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, HTR1A",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A00993607-003-24-6,ALPRENOLOL,ALPRENOLOL
REP.PRIMARY,2.5,CACNA1C,CALCIUM CHANNEL BLOCKER,BRD:BRD-A01098288-001-02-9,AZELNIDIPINE,AZELNIDIPINE
REP.PRIMARY,2.5,,,BRD:BRD-A01412266-001-01-0,HYDROXYPROPYL-BETA-CYCLODEXTRIN,HYDROXYPROPYL-BETA-CYCLODEXTRIN
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A01493904-003-12-1,WB-4101,WB-4101
REP.PRIMARY,2.5,"CACNA1C, CACNA1D, CACNA1F, CACNA1S",CALCIUM CHANNEL BLOCKER,BRD:BRD-A01563671-001-02-7,CLEVIPREX,CLEVIPREX
REP.PRIMARY,2.5,PGR,5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-A01593789-001-03-1,CHLORMADINONE-ACETATE,CHLORMADINONE-ACETATE
REP.PRIMARY,2.5,"KCNA5, PTGER1, SCN10A, SCN4A",SODIUM CHANNEL BLOCKER,BRD:BRD-A01636364-003-15-1,BUPIVACAINE,BUPIVACAINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A01643550-001-04-9,PREDNISOLONE-ACETATE,PREDNISOLONE-ACETATE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A01787639-003-16-9,NAFTOPIDIL,NAFTOPIDIL
REP.PRIMARY,2.5,OPRM1,OPIOID RECEPTOR AGONIST,BRD:BRD-A01907367-001-01-7,FK-33-824,FK-33-824
REP.PRIMARY,2.5,"CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4",CALCIUM CHANNEL BLOCKER,BRD:BRD-A02006392-001-16-4,NITRENDIPINE,NITRENDIPINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A02180903-001-04-5,BETAMETHASONE,BETAMETHASONE
REP.PRIMARY,2.5,BCHE,OPIOID RECEPTOR AGONIST,BRD:BRD-A02710418-003-11-8,MEPTAZINOL,MEPTAZINOL
REP.PRIMARY,2.5,CACNA1B,CALCIUM CHANNEL BLOCKER,BRD:BRD-A02743701-001-03-6,CILNIDIPINE,CILNIDIPINE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A02759312-003-24-5,BETAXOLOL,BETAXOLOL
REP.PRIMARY,2.5,ADRA2A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A02990301-003-06-6,LOFEXIDINE,LOFEXIDINE
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A03061970-003-07-3,ALIZAPRIDE,ALIZAPRIDE
REP.PRIMARY,2.5,SCN10A,"POTASSIUM CHANNEL BLOCKER, SODIUM CHANNEL BLOCKER",BRD:BRD-A03216249-003-24-3,MEPIVACAINE,MEPIVACAINE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A03359064-001-02-3,ICI-89406,ICI-89406
REP.PRIMARY,2.5,,HSP INHIBITOR,BRD:BRD-A03506276-001-01-5,XL888,XL888
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A03623303-045-09-5,METOPROLOL,METOPROLOL
REP.PRIMARY,2.5,,,BRD:BRD-A03880619-001-01-0,BISMUTH-SUBCITRATE-POTASSIUM,BISMUTH-SUBCITRATE-POTASSIUM
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A03932035-004-04-3,METHSCOPOLAMINE,METHSCOPOLAMINE
REP.PRIMARY,2.5,HTR2A,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A04203391-001-08-3,PIRICAPIRON,PIRICAPIRON
REP.PRIMARY,2.5,CYP2J2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A04252265-003-01-4,EPERISONE,EPERISONE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04322457-003-17-9,ISOPRENALINE,ISOPRENALINE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04327189-001-15-1,SYNEPHRINE,SYNEPHRINE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04327189-003-03-3,SYNEPHRINE,SYNEPHRINE
REP.PRIMARY,2.5,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-A04352665-001-05-3,MARAVIROC,MARAVIROC
REP.PRIMARY,2.5,"ESR1, ESR2, HSD3B1, HSD3B2",3BETA-HYDROXY-DELTA5-STEROID DEHYDROGENASE INHIBITOR,BRD:BRD-A04497688-001-04-2,TRILOSTANE,TRILOSTANE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-A04506385-001-01-2,STEPRONIN,STEPRONIN
REP.PRIMARY,2.5,"HRH1, SLC6A2, SLC6A3, SLC6A4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A04553218-050-16-2,CHLORPHENAMINE,CHLORPHENAMINE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A04661934-001-02-9,2-PMDQ,2-PMDQ
REP.PRIMARY,2.5,"CHRNA3, SLC6A2, SLC6A3",DOPAMINE UPTAKE INHIBITOR,BRD:BRD-A05186015-003-19-8,BUPROPION,BUPROPION
REP.PRIMARY,2.5,,"INTERLEUKIN RECEPTOR ANTAGONIST, STAT INHIBITOR",BRD:BRD-A05334458-001-02-8,LISOFYLLINE,LISOFYLLINE
REP.PRIMARY,2.5,,"L-TYPE CALCIUM CHANNEL ACTIVATOR, L-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-A05457250-001-08-4,BAY-K-8644-(+/-),BAY-K-8644-(+/-)
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-A05515753-001-03-2,ERDOSTEINE,ERDOSTEINE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-A05523972-001-01-5,TELMESTEINE,TELMESTEINE
REP.PRIMARY,2.5,,,BRD:BRD-A05674712-001-06-0,"MEVALONIC-D,-L-ACID-LACTONE","D,L-MEVALONIC-ACID-LACTONE, MEVALONIC-D,-L-ACID-LACTONE"
REP.PRIMARY,2.5,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A05729358-001-02-0,CPCCOET,CPCCOET
REP.PRIMARY,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-A05906449-004-01-1,LAPPACONITE,LAPPACONITE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A06352418-001-25-9,TERFENADINE,TERFENADINE
REP.PRIMARY,2.5,CHEK1,CHK INHIBITOR,BRD:BRD-A06352508-001-03-7,SB-218078,SB-218078
REP.PRIMARY,2.5,,ANTIARRHYTHMIC,BRD:BRD-A06390036-001-04-6,HYDROQUINIDINE,HYDROQUINIDINE
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-A06426627-001-03-5,DICLAZURIL,DICLAZURIL
REP.PRIMARY,2.5,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A06627858-236-03-0,MONENSIN,MONENSIN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A06771424-004-01-7,ANISOTROPINE,ANISOTROPINE
REP.PRIMARY,2.5,PDHA1,PYRUVATE DEHYDROGENASE INHIBITOR,BRD:BRD-A06916187-001-02-9,CPI-613,CPI-613
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A06935312-001-04-3,FUSIDIC-ACID,FUSIDIC-ACID
REP.PRIMARY,2.5,,,BRD:BRD-A07000685-001-04-4,HYDROCORTISONE-HEMISUCCINATE,HYDROCORTISONE-HEMISUCCINATE
REP.PRIMARY,2.5,,,BRD:BRD-A07164067-001-01-2,MELUADRINE,MELUADRINE
REP.PRIMARY,2.5,"PDE3A, PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A07207424-001-13-2,RO-20-1724,RO-20-1724
REP.PRIMARY,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-A07232941-001-02-7,8-M-PDOT,8-M-PDOT
REP.PRIMARY,2.5,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A07395371-003-10-0,ESMOLOL,ESMOLOL
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A07440155-003-25-4,LABETALOL,LABETALOL
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A07563059-035-01-3,BOPINDOLOL,BOPINDOLOL
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A07600638-060-05-2,MECLOCYCLINE-SULFOSALICYLATE,MECLOCYCLINE-SULFOSALICYLATE
REP.PRIMARY,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A07704283-001-01-3,ISOFLOXYTHEPIN,ISOFLOXYTHEPIN
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A07780951-001-08-9,METAPROTERENOL,METAPROTERENOL
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A07780951-065-10-0,METAPROTERENOL,METAPROTERENOL
REP.PRIMARY,2.5,,"GABA RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A07815743-001-01-1,KAKONEIN,KAKONEIN
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1",GABA RECEPTOR ANTAGONIST,BRD:BRD-A07870296-001-07-4,BICUCULLINE-(+),BICUCULLINE-(+)
REP.PRIMARY,2.5,"ABAT, GABBR1, SLC32A1",GABA AMINOTRANSFERASE INHIBITOR,BRD:BRD-A07893380-213-01-7,VIGABATRIN,VIGABATRIN
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",ANTI-HCVE2,BRD:BRD-A07932845-050-15-8,METITEPINE,METITEPINE
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-A07947329-001-01-4,BUPARVAQUONE,BUPARVAQUONE
REP.PRIMARY,2.5,"AR, CYP17A1",ANDROGEN RECEPTOR MODULATOR,BRD:BRD-A07986123-001-02-8,GALETERONE,GALETERONE
REP.PRIMARY,2.5,,,BRD:BRD-A08079565-001-01-8,CDBA,CDBA
REP.PRIMARY,2.5,MME,ENKEPHALINASE INHIBITOR,BRD:BRD-A08187463-001-12-9,RACECADOTRIL,RACECADOTRIL
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A08255417-001-14-7,FAMPROFAZONE,FAMPROFAZONE
REP.PRIMARY,2.5,"ESR1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A08302182-001-01-7,ETONOGESTREL,ETONOGESTREL
REP.PRIMARY,2.5,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-003-07-8,DOXYCYCLINE,DOXYCYCLINE
REP.PRIMARY,2.5,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-003-08-6,DOXYCYCLINE,DOXYCYCLINE
REP.PRIMARY,2.5,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-311-01-8,DOXYCYCLINE,DOXYCYCLINE
REP.PRIMARY,2.5,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-311-03-4,DOXYCYCLINE,DOXYCYCLINE
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A08660406-001-05-9,IODIXANOL,IODIXANOL
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A08715367-001-01-7,L-THEANINE,L-THEANINE
REP.PRIMARY,2.5,MAPK3,MAP KINASE PHOSPHATASE INHIBITOR,BRD:BRD-A08840375-001-01-3,CID-5458317,CID-5458317
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, KCNH2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A09056319-003-07-7,ALFUZOSIN,ALFUZOSIN
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-A09062839-003-10-0,AMYLEINE,AMYLEINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A09094913-065-01-0,STRYCHNINE,STRYCHNINE
REP.PRIMARY,2.5,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A09349126-001-10-7,NORETHINDRONE-ACETATE,NORETHINDRONE-ACETATE
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A09370961-001-01-0,IOXILAN,IOXILAN
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A09467419-003-22-4,MEBEVERINE,MEBEVERINE
REP.PRIMARY,2.5,"KCNA5, KCNA7, SCN4A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A09472452-015-23-4,FLECAINIDE,FLECAINIDE
REP.PRIMARY,2.5,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4",CALCIUM CHANNEL BLOCKER,BRD:BRD-A09533288-003-31-2,VERAPAMIL,VERAPAMIL
REP.PRIMARY,2.5,,PKA ACTIVATOR,BRD:BRD-A09554849-236-07-6,8-BROMO-CAMP,8-BROMO-CAMP
REP.PRIMARY,2.5,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7",DNA ALKYLATING AGENT,BRD:BRD-A09722536-002-18-0,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE
REP.PRIMARY,2.5,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS",HCV INHIBITOR,BRD:BRD-A09735281-001-02-5,BOCEPREVIR,BOCEPREVIR
REP.PRIMARY,2.5,"DRD1, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A09828896-004-11-0,SKF-81297,SKF-81297
REP.PRIMARY,2.5,"ADRA1A, ADRB1",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A09925278-003-05-6,ETILEFRINE,ETILEFRINE
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-A10039652-001-01-2,TIPRANAVIR,TIPRANAVIR
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10070317-003-28-3,PROPRANOLOL,PROPRANOLOL
REP.PRIMARY,2.5,"ACSL1, ACSS1, ACSS2, ADCY1, ADK, CREB1, FBP1, HINT1, PDE4B, PDE4D, PIM1, PRKAA1, PRKAB1, PRKAB2, PYGL, TRPM4",ADENOSINE RECEPTOR AGONIST,BRD:BRD-A10111329-001-04-6,ADENOSINE-PHOSPHATE,ADENOSINE-PHOSPHATE
REP.PRIMARY,2.5,ATP2A1,ATPASE INHIBITOR,BRD:BRD-A10420615-001-04-4,CYCLOPIAZONIC-ACID,CYCLOPIAZONIC-ACID
REP.PRIMARY,2.5,ROCK1,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-A10523515-001-07-9,GSK429286A,GSK429286A
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A10652366-238-04-1,FOSFOMYCIN,FOSFOMYCIN
REP.PRIMARY,2.5,"CALM1, MYLK2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A10662413-043-11-2,PRENYLAMINE,PRENYLAMINE
REP.PRIMARY,2.5,ADORA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10739734-003-10-6,EFAROXAN,EFAROXAN
REP.PRIMARY,2.5,"ADRA2A, ADRA2B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10903566-003-07-7,IMILOXAN,IMILOXAN
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A10967948-003-06-3,GRANISETRON,GRANISETRON
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10977446-001-12-1,CARVEDILOL,CARVEDILOL
REP.PRIMARY,2.5,,,BRD:BRD-A11070335-236-02-1,CARBAZOCHROME,CARBAZOCHROME
REP.PRIMARY,2.5,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2",ELECTRON ACCEPTOR,BRD:BRD-A11132253-001-08-2,NADIDE,NADIDE
REP.PRIMARY,2.5,,,BRD:BRD-A11551002-001-04-6,DEHYDROCHOLATE-ACID,DEHYDROCHOLATE-ACID
REP.PRIMARY,2.5,,,BRD:BRD-A11662333-001-03-3,MEPARFYLON,MEPARFYLON
REP.PRIMARY,2.5,,,BRD:BRD-A11731518-001-01-7,BAY-85-8050,BAY-85-8050
REP.PRIMARY,2.5,"CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2",STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A11776908-065-01-5,ENILCONAZOLE,ENILCONAZOLE
REP.PRIMARY,2.5,GRIN1,POTASSIUM CHANNEL BLOCKER,BRD:BRD-A11813248-003-02-4,AM-92016,AM-92016
REP.PRIMARY,2.5,,,BRD:BRD-A11815689-001-01-1,PROSCILLARIDIN-A,PROSCILLARIDIN-A
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A11990600-001-03-4,LORAZEPAM,LORAZEPAM
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A12077521-003-01-5,CEFEPIME,CEFEPIME
REP.PRIMARY,2.5,"MDM2, TP53",MDM INHIBITOR,BRD:BRD-A12230535-001-06-7,NUTLIN-3,NUTLIN-3
REP.PRIMARY,2.5,"ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6",NITRIC OXIDE STIMULANT,BRD:BRD-A12237696-001-04-2,L-CITRULLINE,L-CITRULLINE
REP.PRIMARY,2.5,PTPN1,MAP KINASE ACTIVATOR,BRD:BRD-A12417644-001-07-6,USNIACIN-(+),USNIACIN-(+)
REP.PRIMARY,2.5,,,BRD:BRD-A12454076-001-01-9,L-HYDROXYPROLINE,L-HYDROXYPROLINE
REP.PRIMARY,2.5,"HTR2A, HTR3A, HTR4, KCNH2",SEROTONIN RECEPTOR AGONIST,BRD:BRD-A12896037-001-04-3,CISAPRIDE,CISAPRIDE
REP.PRIMARY,2.5,"CRBN, PTGS2, TNF","ANGIOGENESIS INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-A12994259-001-02-1,POMALIDOMIDE,POMALIDOMIDE
REP.PRIMARY,2.5,"ACSL4, CYP2C8, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-A13084692-001-17-3,TROGLITAZONE,TROGLITAZONE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A13133631-001-04-0,FLUOROMETHOLONE,FLUOROMETHOLONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A13188892-066-21-5,DOXAZOSIN,DOXAZOSIN
REP.PRIMARY,2.5,FNTA,"APOPTOSIS STIMULANT, FARNESYLTRANSFERASE INHIBITOR",BRD:BRD-A13323580-001-04-8,PERILLYL-ALCOHOL,PERILLYL-ALCOHOL
REP.PRIMARY,2.5,"ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4",NFKB PATHWAY MODULATOR,BRD:BRD-A13561534-003-02-0,ORNITHINE,ORNITHINE
REP.PRIMARY,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-A13598753-001-01-2,5'-CHLORO-5'-DEOXY-ENBA-(+/-),5'-CHLORO-5'-DEOXY-ENBA-(+/-)
REP.PRIMARY,2.5,"AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A13946108-001-17-1,SULINDAC,SULINDAC
REP.PRIMARY,2.5,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-A13964793-001-02-6,TC1,TC1
REP.PRIMARY,2.5,"CHRM1, CHRM3",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A14208071-004-19-8,OXYPHENONIUM,OXYPHENONIUM
REP.PRIMARY,2.5,"F10, TAAR1",TRACE AMINE ASSOCIATED RECEPTOR AGONIST,BRD:BRD-A14240607-003-26-1,OCTOPAMINE,OCTOPAMINE
REP.PRIMARY,2.5,SLC6A2,ADRENERGIC INHIBITOR,BRD:BRD-A14262390-065-01-8,GUANADREL,GUANADREL
REP.PRIMARY,2.5,,SODIUM/CALCIUM EXCHANGE INHIBITOR,BRD:BRD-A14316475-001-02-3,SN-6,SN-6
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A14344385-001-03-2,IDRA-21,IDRA-21
REP.PRIMARY,2.5,"DRD2, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A14395271-074-17-8,MESORIDAZINE,MESORIDAZINE
REP.PRIMARY,2.5,"CHRNA3, CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A14574269-051-02-2,UB-165,UB-165
REP.PRIMARY,2.5,"AR, ESR1, PGR, SRD5A1",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A14886633-001-01-6,NORGESTREL,NORGESTREL
REP.PRIMARY,2.5,ABCB1,"MRP INHIBITOR, P GLYCOPROTEIN INHIBITOR",BRD:BRD-A14941520-051-01-0,DOFEQUIDAR,DOFEQUIDAR
REP.PRIMARY,2.5,SLC6A4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A14966924-003-07-7,ALAPROCLATE,ALAPROCLATE
REP.PRIMARY,2.5,"P2RY13, P2RY2",ADENOSINE KINASE INHIBITOR,BRD:BRD-A15035311-001-01-8,DIADENOSINE-TETRAPHOSPHATE,DIADENOSINE-TETRAPHOSPHATE
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4",SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),BRD:BRD-A15202882-003-02-7,MILNACIPRAN,MILNACIPRAN
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A15297126-001-04-3,FLUOCINOLONE-ACETONIDE,FLUOCINOLONE-ACETONIDE
REP.PRIMARY,2.5,"CTNS, SLC3A1, SLC7A11, SLC7A9",,BRD:BRD-A15397381-001-02-5,L-CYSTINE,L-CYSTINE
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A15415227-003-02-9,GW-1929,GW-1929
REP.PRIMARY,2.5,HTR1A,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-A15435692-003-02-3,BMY-14802,BMY-14802
REP.PRIMARY,2.5,"HTR1A, HTR1B","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A15530910-001-02-1,SDZ-21009,SDZ-21009
REP.PRIMARY,2.5,FPR1,FREE RADICAL SCAVENGER,BRD:BRD-A15909516-001-06-6,REBAMIPIDE,REBAMIPIDE
REP.PRIMARY,2.5,PRKACA,"ADENOSINE RECEPTOR AGONIST, CAMP STIMULANT",BRD:BRD-A15931911-001-03-8,BUCLADESINE,BUCLADESINE
REP.PRIMARY,2.5,"PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PLATELET AGGREGATION INHIBITOR",BRD:BRD-A16296925-001-01-3,INDOBUFEN,INDOBUFEN
REP.PRIMARY,2.5,"ACHE, LIAS, LIPT1, PTGS2, SLC5A6",REDUCING AGENT,BRD:BRD-A16347691-001-13-1,THIOCTIC-ACID,THIOCTIC-ACID
REP.PRIMARY,2.5,,,BRD:BRD-A16350940-001-01-9,DORAMECTIN,DORAMECTIN
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A16439188-001-01-1,QUINESTROL,QUINESTROL
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A16665823-001-02-0,BUTOCONAZOLE,BUTOCONAZOLE
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-A16694057-001-06-8,BADGE,BADGE
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A16700644-003-04-4,ISOXSUPRINE,ISOXSUPRINE
REP.PRIMARY,2.5,TRHR,THYROTROPIN RELEASING HORMONE RECEPTOR AGONIST,BRD:BRD-A16997652-001-02-3,PROTIRELIN,PROTIRELIN
REP.PRIMARY,2.5,,,BRD:BRD-A17300716-001-01-5,DEHYDROACETIC-ACID,DEHYDROACETIC-ACID
REP.PRIMARY,2.5,"CYP3A4, NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A17407635-001-04-0,ALCLOMETASONE-DIPROPIONATE,ALCLOMETASONE-DIPROPIONATE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A17411484-001-11-9,CARPROFEN,CARPROFEN
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-A17428743-003-09-0,BW-723C86,BW-723C86
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A17453586-003-02-3,MDL-72832,MDL-72832
REP.PRIMARY,2.5,"ADRB2, BCHE",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A17462676-003-11-6,BAMBUTEROL,BAMBUTEROL
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A17655518-001-24-4,IBUPROFEN,IBUPROFEN
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-A17846016-001-13-9,TROLOX,TROLOX
REP.PRIMARY,2.5,"CDH5, CRBN, PTGS2, TNF, TNFSF11",ANTICANCER AGENT,BRD:BRD-A17883755-001-06-1,LENALIDOMIDE,LENALIDOMIDE
REP.PRIMARY,2.5,"CACNA1G, CACNA1H, CACNA1I",SUCCINIMIDE ANTIEPILEPTIC,BRD:BRD-A18043272-001-09-9,PHENSUXIMIDE,PHENSUXIMIDE
REP.PRIMARY,2.5,"CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A18056626-003-22-3,METHACHOLINE,METHACHOLINE
REP.PRIMARY,2.5,NISCH,IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-A18074780-003-02-0,AGN-192403,AGN-192403
REP.PRIMARY,2.5,"ADRA1A, ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A18233884-003-02-7,BEVANTOLOL,BEVANTOLOL
REP.PRIMARY,2.5,"CS, ME2, PKD2L1",,BRD:BRD-A18396475-001-15-3,MALIC-ACID,MALIC-ACID
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-A18611368-001-01-5,TAZOBACTAM,TAZOBACTAM
REP.PRIMARY,2.5,"MMAA, MMACHC, MTHFR, MTR, MTRR, MUT","METHYLMALONYL COA MUTASE STIMULANT, VITAMIN B",BRD:BRD-A18627414-001-04-9,CYANOCOBALAMIN,CYANOCOBALAMIN
REP.PRIMARY,2.5,"ADRA2A, PTGS2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A18696154-003-22-6,IDAZOXAN,IDAZOXAN
REP.PRIMARY,2.5,BAX,CYTOCHROME C RELEASE INHIBITOR,BRD:BRD-A18763547-300-05-5,BAX-CHANNEL-BLOCKER,BAX-CHANNEL-BLOCKER
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A18795974-004-07-3,7-HYDROXY-DPAT,7-HYDROXY-DPAT
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A19102171-066-01-4,NALTRIBEN,NALTRIBEN
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4","NOREPINEPHRINE REPUTAKE INHIBITOR, TRICYCLIC ANTIDEPRESSANT",BRD:BRD-A19195498-050-14-1,TRIMIPRAMINE,TRIMIPRAMINE
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4",DOPAMINE-NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-A19585813-003-03-3,METHYLPHENIDATE,METHYLPHENIDATE
REP.PRIMARY,2.5,"CPT1A, CPT2",CARNITINE PALMITOYLTRANSFERASE INHIBITOR,BRD:BRD-A19633847-050-32-1,PERHEXILINE,PERHEXILINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A19661776-003-27-6,MIANSERIN,MIANSERIN
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A19736161-001-06-7,ONDANSETRON,ONDANSETRON
REP.PRIMARY,2.5,DHODH,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,BRD:BRD-A19795905-001-08-0,ATOVAQUONE,ATOVAQUONE
REP.PRIMARY,2.5,,"CHITINASE INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-A19952358-001-11-3,CLOSANTEL,CLOSANTEL
REP.PRIMARY,2.5,,,BRD:BRD-A19958636-065-04-4,TUAMINOHEPTANE,TUAMINOHEPTANE
REP.PRIMARY,2.5,"CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A20119038-003-07-8,MECAMYLAMINE,MECAMYLAMINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, LTF, PLA2G2E",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A20239487-001-24-9,ATENOLOL-(+/-),ATENOLOL-(+/-)
REP.PRIMARY,2.5,"GABRA1, TSPO",GABA RECEPTOR MODULATOR,BRD:BRD-A20348246-001-15-8,CHLORMEZANONE,CHLORMEZANONE
REP.PRIMARY,2.5,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A20550616-001-02-9,HALOTHANE,HALOTHANE
REP.PRIMARY,2.5,NR3C2,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-A20644369-001-08-6,CANRENONE,CANRENONE
REP.PRIMARY,2.5,,,BRD:BRD-A20758144-001-04-5,PRASTERONE-ACETATE,PRASTERONE-ACETATE
REP.PRIMARY,2.5,"TAT, TH, YARS, YARS2",,BRD:BRD-A20781140-001-01-7,PLOVAMER-ACETATE,PLOVAMER-ACETATE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A20839672-003-01-5,CEFMENOXIME,CEFMENOXIME
REP.PRIMARY,2.5,,,BRD:BRD-A21276153-001-01-1,"2,6-DIMETHYLPIPERIDINE","2,6-DIMETHYLPIPERIDINE"
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A21607826-003-05-1,MEDETOMIDINE,MEDETOMIDINE
REP.PRIMARY,2.5,,ANTHELMINTIC AGENT,BRD:BRD-A21858158-001-23-5,PRAZIQUANTEL,PRAZIQUANTEL
REP.PRIMARY,2.5,"CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A22032524-074-06-5,AMLODIPINE,AMLODIPINE
REP.PRIMARY,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A22081593-001-11-1,SULMAZOLE,SULMAZOLE
REP.PRIMARY,2.5,,,BRD:BRD-A22106989-001-05-0,PHENOTHRIN,PHENOTHRIN
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-A22143024-231-03-8,ESTROPIPATE,ESTROPIPATE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A22152765-003-10-0,TRIDIHEXETHYL,TRIDIHEXETHYL
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A22256192-003-22-7,TERAZOSIN,TERAZOSIN
REP.PRIMARY,2.5,,,BRD:BRD-A22267103-003-13-1,DROFENINE,DROFENINE
REP.PRIMARY,2.5,HMGCR,GLUCONEOGENESIS INHIBITOR,BRD:BRD-A22305049-003-13-6,BENFLUOREX,BENFLUOREX
REP.PRIMARY,2.5,ATP4A,ATPASE INHIBITOR,BRD:BRD-A22380646-236-05-8,PANTOPRAZOLE,PANTOPRAZOLE
REP.PRIMARY,2.5,SCN5A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-A22642447-001-01-9,LICARBAZEPINE,LICARBAZEPINE
REP.PRIMARY,2.5,"GABRA3, GABRA5, GABRA6",GABA RECEPTOR MODULATOR,BRD:BRD-A22707317-001-10-8,SB-205384,SB-205384
REP.PRIMARY,2.5,HRH1,ANTIHISTAMINE,BRD:BRD-A22769835-300-05-7,HOMOCHLORCYCLIZINE,HOMOCHLORCYCLIZINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A22844106-001-26-0,TENOXICAM,TENOXICAM
REP.PRIMARY,2.5,CYP51A1,CYTOCHROME P450 INHIBITOR,BRD:BRD-A23067620-300-01-3,ITRACONAZOLE,ITRACONAZOLE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A23072235-050-18-5,PHENIRAMINE,PHENIRAMINE
REP.PRIMARY,2.5,,,BRD:BRD-A23127772-001-02-3,SCLAREOL,SCLAREOL
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4",SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),BRD:BRD-A23359898-003-10-0,SIBUTRAMINE,SIBUTRAMINE
REP.PRIMARY,2.5,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3",RNA POLYMERASE INHIBITOR,BRD:BRD-A23603052-001-03-2,RIFAMPIN,RIFAMPIN
REP.PRIMARY,2.5,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",GABA RECEPTOR ANTAGONIST,BRD:BRD-A24122750-001-03-7,SACLOFEN,SACLOFEN
REP.PRIMARY,2.5,"GRIN1, GRIN2B","ADRENERGIC RECEPTOR ANTAGONIST, GLUTAMATE RECEPTOR ANTAGONIST",BRD:BRD-A24191444-046-02-1,IFENPRODIL,IFENPRODIL
REP.PRIMARY,2.5,"GRIN1, GRIN2B","ADRENERGIC RECEPTOR ANTAGONIST, GLUTAMATE RECEPTOR ANTAGONIST",BRD:BRD-A24191444-046-03-9,IFENPRODIL,IFENPRODIL
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A24228527-213-01-9,OFLOXACIN,OFLOXACIN
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A24284985-001-09-9,ANABASINE,ANABASINE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A24297246-001-03-9,TROLEANDOMYCIN,TROLEANDOMYCIN
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A24397426-001-10-4,NADIFLOXACIN,NADIFLOXACIN
REP.PRIMARY,2.5,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-A24514565-001-09-7,WARFARIN,WARFARIN
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A24543851-001-05-7,NORNICOTINE,NORNICOTINE
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A24560335-300-01-2,EFATUTAZONE,EFATUTAZONE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A24587114-066-22-5,ISOETHARINE,ISOETHARINE
REP.PRIMARY,2.5,VDAC2,ION CHANNEL ANTAGONIST,BRD:BRD-A25004090-001-08-4,ERASTIN,ERASTIN
REP.PRIMARY,2.5,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A25143711-001-02-2,HYDROCORTISONE-VALERATE,HYDROCORTISONE-VALERATE
REP.PRIMARY,2.5,"CYP11A1, CYP19A1",GLUCOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-A25234499-001-18-3,AMINOGLUTETHIMIDE,AMINOGLUTETHIMIDE
REP.PRIMARY,2.5,"LPAR1, LPAR3",LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-A25569250-001-03-3,KI-16425,KI-16425
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-A25608658-001-01-1,NARASIN,NARASIN
REP.PRIMARY,2.5,"CYP11B1, CYP19A1",AROMATASE INHIBITOR,BRD:BRD-A25619068-003-03-4,FADROZOLE,FADROZOLE
REP.PRIMARY,2.5,RPS2,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A25687296-300-04-3,EMETINE,EMETINE
REP.PRIMARY,2.5,"GRM1, GRM5, GSR, HMGCS2, PAPOLA, PRDX2",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A25800195-001-02-2,L-CYSTEINESULFINIC-ACID,L-CYSTEINESULFINIC-ACID
REP.PRIMARY,2.5,CALM1,CALMODULIN ANTAGONIST,BRD:BRD-A26032986-050-02-1,ZALDARIDE,ZALDARIDE
REP.PRIMARY,2.5,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A",ANTIARRHYTHMIC,BRD:BRD-A26334849-001-06-2,PROPAFENONE,PROPAFENONE
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA7, SLC12A1, SLC12A3",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-A26384407-001-25-1,CHLORTHALIDONE,CHLORTHALIDONE
REP.PRIMARY,2.5,"ADRA1A, HTR1E","ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-A26387268-050-04-4,ERGONOVINE,ERGONOVINE
REP.PRIMARY,2.5,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-A26503646-001-16-6,FORMESTANE,FORMESTANE
REP.PRIMARY,2.5,CYP3A4,HIV PROTEASE INHIBITOR,BRD:BRD-A26690767-066-01-9,SAQUINAVIR,SAQUINAVIR
REP.PRIMARY,2.5,"ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B",CALCIUM CHANNEL BLOCKER,BRD:BRD-A26711594-003-10-6,NICARDIPINE,NICARDIPINE
REP.PRIMARY,2.5,"HTR1A, HTR1B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A26845397-051-01-9,ISAMOLTANE,ISAMOLTANE
REP.PRIMARY,2.5,ESR2,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A27143604-001-02-0,DIARYLPROPIONITRILE,DIARYLPROPIONITRILE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A27290375-330-01-1,ATROPINE,ATROPINE
REP.PRIMARY,2.5,"CACNA2D1, CES1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A27370296-001-03-0,CYCLANDELATE,CYCLANDELATE
REP.PRIMARY,2.5,"FLT3, NTRK1","FLT3 INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR, JAK INHIBITOR",BRD:BRD-A27376179-001-01-3,LESTAURTINIB,LESTAURTINIB
REP.PRIMARY,2.5,"CYP2C19, CYP2D6",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-A27732521-003-08-3,TOLPERISONE,TOLPERISONE
REP.PRIMARY,2.5,PTPMT1,PHOSPHATIDYLGLYCEROPHOSPHATASE INHIBITOR,BRD:BRD-A27883417-300-01-6,ALEXIDINE,ALEXIDINE
REP.PRIMARY,2.5,"NR3C1, NR3C2, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A27887842-001-04-0,PREDNISOLONE,PREDNISOLONE
REP.PRIMARY,2.5,"GABBR1, GABBR2",GABA RECEPTOR ANTAGONIST,BRD:BRD-A27924917-001-03-3,2-HYDROXYSACLOFEN,2-HYDROXYSACLOFEN
REP.PRIMARY,2.5,ADRB3,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A28044053-001-01-7,AROTINOLOL,AROTINOLOL
REP.PRIMARY,2.5,,,BRD:BRD-A28301258-001-03-0,SALINOMYCIN,SALINOMYCIN
REP.PRIMARY,2.5,,,BRD:BRD-A28301258-001-04-8,SALINOMYCIN,SALINOMYCIN
REP.PRIMARY,2.5,NOS2,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-A28318179-003-08-5,AMINOMETHYLTRANSFERASE,AMINOMETHYLTRANSFERASE
REP.PRIMARY,2.5,"GRM2, GRM3",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A28329383-001-02-1,MTPG,MTPG
REP.PRIMARY,2.5,MTOR,"MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-A28467416-002-01-0,PKI-179,PKI-179
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A28545468-003-16-6,SELEGILINE,SELEGILINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A28856712-003-26-0,TETRAHYDROZOLINE,TETRAHYDROZOLINE
REP.PRIMARY,2.5,,,BRD:BRD-A28887267-001-19-3,PROXYPHYLLINE,PROXYPHYLLINE
REP.PRIMARY,2.5,"ATP1A1, CA1, CA2, CA4, PTGS1, PTGS2, SLC12A1, SLC12A3",CHLORIDE CHANNEL BLOCKER,BRD:BRD-A28940325-001-24-0,TRICHLORMETHIAZIDE,TRICHLORMETHIAZIDE
REP.PRIMARY,2.5,,INOSITOL MONOPHOSPHATASE INHIBITOR,BRD:BRD-A28958257-001-01-2,CENTPROPAZINE,CENTPROPAZINE
REP.PRIMARY,2.5,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A28970875-300-04-9,PUROMYCIN,PUROMYCIN
REP.PRIMARY,2.5,TYR,PROGESTOGEN HORMONE,BRD:BRD-A29111201-001-04-8,ETHISTERONE,ETHISTERONE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A29260609-003-26-0,ACEBUTOLOL,ACEBUTOLOL
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A29281099-003-03-2,CLORPRENALINE,CLORPRENALINE
REP.PRIMARY,2.5,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-A29289453-001-04-7,PCA-4248,PCA-4248
REP.PRIMARY,2.5,,ANTITUSSIVE,BRD:BRD-A29349577-001-23-0,DROPROPIZINE,DROPROPIZINE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A29426959-050-13-2,CARBINOXAMINE,CARBINOXAMINE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-A29485665-001-12-8,BICALUTAMIDE,BICALUTAMIDE
REP.PRIMARY,2.5,"HCAR2, HCAR3",CHOLESTEROL INHIBITOR,BRD:BRD-A29520968-001-02-7,ACIFRAN,ACIFRAN
REP.PRIMARY,2.5,ADRA1A,LIPID PEROXIDASE INHIBITOR,BRD:BRD-A29623586-001-01-3,ANISODAMINE,ANISODAMINE
REP.PRIMARY,2.5,"DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3","DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, NORADRENALINE UPTAKE INHIBITOR",BRD:BRD-A29644307-050-17-0,NOMIFENSINE,NOMIFENSINE
REP.PRIMARY,2.5,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3",11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-A29700858-304-01-8,CARBENOXOLONE,CARBENOXOLONE
REP.PRIMARY,2.5,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3",11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-A29700858-304-02-6,CARBENOXOLONE,CARBENOXOLONE
REP.PRIMARY,2.5,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A29731977-001-04-5,17-HYDROXYPROGESTERONE-CAPROATE,17-HYDROXYPROGESTERONE-CAPROATE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A29734509-011-13-6,DISOPYRAMIDE,DISOPYRAMIDE
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A29844814-300-01-5,ABT-202,ABT-202
REP.PRIMARY,2.5,"CCKAR, CCKBR",CCK RECEPTOR ANTAGONIST,BRD:BRD-A29854054-236-12-6,LORGLUMIDE,LORGLUMIDE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A29944538-003-08-3,PROXODOLOL,PROXODOLOL
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A30051119-002-01-8,AMIKACIN,AMIKACIN
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HYDANTOIN ANTIEPILEPTIC,BRD:BRD-A30205217-001-11-2,ETHOTOIN,ETHOTOIN
REP.PRIMARY,0.25,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-A30403214-001-03-3,EDELFOSINE,EDELFOSINE
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A30582499-003-05-1,TILETAMINE,TILETAMINE
REP.PRIMARY,2.5,,ACETYLCHOLINE RELEASE ENHANCER,BRD:BRD-A30590053-003-02-9,MR-16728,MR-16728
REP.PRIMARY,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-A30655177-001-14-0,LFM-A13,LFM-A13
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-A30693873-003-12-8,DIPERODON,DIPERODON
REP.PRIMARY,2.5,,,BRD:BRD-A30703952-201-01-2,GANGLIOSIDE-GM1,GANGLIOSIDE-GM1
REP.PRIMARY,2.5,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A30815329-001-10-5,FELODIPINE,FELODIPINE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A30886737-001-02-9,FLORFENICOL,FLORFENICOL
REP.PRIMARY,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-A30984645-001-01-5,GDC-0834,GDC-0834
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-A31095847-001-02-3,MOZAVAPTAN,MOZAVAPTAN
REP.PRIMARY,2.5,"ANO1, HTR2B, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-A31159102-003-30-4,FLUOXETINE,FLUOXETINE
REP.PRIMARY,2.5,,,BRD:BRD-A31454688-001-01-6,MONOSTEARIN,MONOSTEARIN
REP.PRIMARY,2.5,CA1,MUSCLE RELAXANT,BRD:BRD-A31521121-001-26-4,METHOCARBAMOL,METHOCARBAMOL
REP.PRIMARY,2.5,"ATP2C1, ATP5D, CALM1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9",INHALED ANAESTHETIC,BRD:BRD-A31564021-001-01-8,ISOFLURANE,ISOFLURANE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A31800922-003-25-1,PROCYCLIDINE,PROCYCLIDINE
REP.PRIMARY,2.5,PLA2G1B,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-A31811760-001-06-7,MILTEFOSINE,MILTEFOSINE
REP.PRIMARY,2.5,"ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7",ADENOSINE RECEPTOR AGONIST,BRD:BRD-A31990649-304-02-3,ADENOSINE-TRIPHOSPHATE,ADENOSINE-TRIPHOSPHATE
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-A32172948-001-07-6,METHIOPRIL,METHIOPRIL
REP.PRIMARY,2.5,TLR4,TUMOR NECROSIS FACTOR RECEPTOR ANTAGONIST,BRD:BRD-A32269193-001-01-5,VGX-1027,VGX-1027
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-A32505112-001-04-4,TRANDOLAPRIL,TRANDOLAPRIL
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-A32597168-001-03-6,LETOSTEINE,LETOSTEINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A32673558-003-03-9,ACECLIDINE,ACECLIDINE
REP.PRIMARY,2.5,,VASOCONSTRICTOR,BRD:BRD-A32988684-003-08-7,HEPTAMINOL,HEPTAMINOL
REP.PRIMARY,2.5,CYP51A1,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A33084557-001-06-6,TIOCONAZOLE,TIOCONAZOLE
REP.PRIMARY,2.5,"ADRB1, ADRB2, KCNH2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A33168282-003-18-0,SOTALOL,SOTALOL
REP.PRIMARY,2.5,,ANTHELMINTIC AGENT,BRD:BRD-A33447119-001-10-8,OXFENDAZOLE,OXFENDAZOLE
REP.PRIMARY,2.5,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A33514596-003-01-2,N-BENZYLNALTRINDOLE,N-BENZYLNALTRINDOLE
REP.PRIMARY,2.5,TERT,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-A33692381-001-01-9,ZIDOVUDINE,ZIDOVUDINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A33697453-008-02-4,FENTICONAZOLE,FENTICONAZOLE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A33711280-003-03-1,METIXENE,METIXENE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A34006693-001-15-4,SUPROFEN,SUPROFEN
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A34205397-001-04-5,SULOCTIDIL,SULOCTIDIL
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A34255068-001-34-5,ROLIPRAM,ROLIPRAM
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A34358106-003-01-6,SARPOGRELATE,SARPOGRELATE
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A34716233-004-03-5,AMPA-(RS),AMPA-(RS)
REP.PRIMARY,2.5,,HSP INDUCER,BRD:BRD-A34751532-001-06-9,HOMOSALATE,HOMOSALATE
REP.PRIMARY,2.5,GPR12,GENE EXPRESSION STIMULANT,BRD:BRD-A35379661-001-04-6,SPHINGOSYLPHOSPHORYLCHOLINE,SPHINGOSYLPHOSPHORYLCHOLINE
REP.PRIMARY,2.5,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-A35588707-001-05-5,TENIPOSIDE,TENIPOSIDE
REP.PRIMARY,2.5,SLC8A1,"MITOCHONDRIAL NA+/CA2+ EXCHANGER ANTAGONIST, SODIUM/CALCIUM EXCHANGE INHIBITOR",BRD:BRD-A35623999-001-05-7,CGP-37157,CGP-37157
REP.PRIMARY,2.5,,,BRD:BRD-A35868371-005-01-6,TROVENTOL,TROVENTOL
REP.PRIMARY,2.5,CYP17A1,GABA RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-A35912562-001-02-8,PREGNENOLONE-SUCCINATE,PREGNENOLONE-SUCCINATE
REP.PRIMARY,2.5,"NR3C1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A35989968-001-04-2,MEGESTROL-ACETATE,MEGESTROL-ACETATE
REP.PRIMARY,2.5,"ANXA1, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A36010170-001-04-0,AMCINONIDE,AMCINONIDE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A36057565-001-01-0,BRUCEANTIN,BRUCEANTIN
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A36074203-003-07-6,REMACEMIDE,REMACEMIDE
REP.PRIMARY,2.5,"ABCC1, ABCC2, FPR1, SLC22A12",URICOSURIC BLOCKER,BRD:BRD-A36217750-001-16-3,SULFINPYRAZONE,SULFINPYRAZONE
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A36267905-003-18-4,BUPHENINE,BUPHENINE
REP.PRIMARY,2.5,RIPK1,RIPK INHIBITOR,BRD:BRD-A36318220-001-08-8,NECROSTATIN-1,NECROSTATIN-1
REP.PRIMARY,2.5,,PROTEASOME INHIBITOR,BRD:BRD-A36331462-001-02-1,OPROZOMIB,OPROZOMIB
REP.PRIMARY,2.5,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A36456202-001-01-3,COLISTIN-B-SULFATE,COLISTIN-B-SULFATE
REP.PRIMARY,2.5,"SLC6A2, SLC6A3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A37288617-003-02-2,AMFEPRAMONE,AMFEPRAMONE
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-A37347161-003-02-6,BRL-52537,BRL-52537
REP.PRIMARY,2.5,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-A37390343-003-03-5,AMOROLFINE,AMOROLFINE
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A37441042-003-04-8,TULOBUTEROL,TULOBUTEROL
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A37492983-001-10-3,IOCETAMIC-ACID,IOCETAMIC-ACID
REP.PRIMARY,2.5,"AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF",P38 MAPK INHIBITOR,BRD:BRD-A37704979-001-10-7,SB-203580,SB-203580
REP.PRIMARY,2.5,CFTR,DELTAF508-CFTR CORRECTORS,BRD:BRD-A38076815-003-10-3,GLAFENINE,GLAFENINE
REP.PRIMARY,2.5,OPRD1,IMMUNOSTIMULANT,BRD:BRD-A38218502-001-01-2,METENKEPHALIN,METENKEPHALIN
REP.PRIMARY,2.5,"AR, CYP19A1, CYP21A2, KCNA10",STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A38350138-001-04-9,KETOCONAZOLE,KETOCONAZOLE
REP.PRIMARY,2.5,ANXA5,ANTIOXIDANT,BRD:BRD-A38592941-001-02-7,TIMONACIC,TIMONACIC
REP.PRIMARY,2.5,,IMIDAZOLINE RECEPTOR ANTAGONIST,BRD:BRD-A38747044-001-02-3,KU14R,KU14R
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A39052811-048-11-0,MOSAPRIDE,MOSAPRIDE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A39189014-003-22-7,METHOXAMINE,METHOXAMINE
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-A39230911-001-10-2,CHLORPHENSIN-CARBAMATE,CHLORPHENSIN-CARBAMATE
REP.PRIMARY,2.5,SLC1A2,"CHLORIDE CHANNEL BLOCKER, GAP JUNCTION MODULATOR, GLUTAMATE INHIBITOR",BRD:BRD-A39255369-001-03-1,DCPIB,DCPIB
REP.PRIMARY,2.5,ATP4A,"ATPASE INHIBITOR, GASTRIN INHIBITOR",BRD:BRD-A39390670-236-10-7,RABEPRAZOLE,RABEPRAZOLE
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A39791822-001-05-1,HYDROXYPROGESTERONE,HYDROXYPROGESTERONE
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-A39935389-001-05-9,TEROXIRONE,TEROXIRONE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A40084411-003-07-7,CGP-12177,CGP-12177
REP.PRIMARY,2.5,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-A40413915-003-01-2,NTNCB,NTNCB
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A40639672-234-18-0,KETOROLAC,KETOROLAC
REP.PRIMARY,2.5,,,BRD:BRD-A40777960-001-04-2,AMINOHYDROXYBUTYRIC-ACID,AMINOHYDROXYBUTYRIC-ACID
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A40787240-066-04-6,GEMIFLOXACIN,GEMIFLOXACIN
REP.PRIMARY,2.5,ALOX5,"CYCLOOXYGENASE INHIBITOR, PROSTAGLANDIN INHIBITOR",BRD:BRD-A40940854-001-01-1,IBUPROXAM,IBUPROXAM
REP.PRIMARY,2.5,,THIAZIDE DIURETIC,BRD:BRD-A41250306-001-11-7,CYCLOPENTHIAZIDE,CYCLOPENTHIAZIDE
REP.PRIMARY,2.5,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A41304429-001-14-8,PRACTOLOL,PRACTOLOL
REP.PRIMARY,2.5,,,BRD:BRD-A41385909-001-01-3,BORNYL-ACETATE,BORNYL-ACETATE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A41450521-075-10-8,TOSUFLOXACIN,TOSUFLOXACIN
REP.PRIMARY,2.5,TSPO,BENZODIAZEPINE RECEPTOR ANTAGONIST,BRD:BRD-A41451487-001-11-2,PK-11195,PK-11195
REP.PRIMARY,2.5,"PIK3CB, PIK3CD",PI3K INHIBITOR,BRD:BRD-A41692738-001-07-6,TGX-221,TGX-221
REP.PRIMARY,2.5,"GLRA1, GLRA2, GLRB, HTR3A, HTR3B",GABA RECEPTOR MODULATOR,BRD:BRD-A41714661-001-02-0,BILOBALIDE,BILOBALIDE
REP.PRIMARY,2.5,,,BRD:BRD-A41774846-001-01-4,ALGESTONE-ACETOPHENIDE,ALGESTONE-ACETOPHENIDE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",GLYCINE RECEPTOR ANTAGONIST,BRD:BRD-A41995253-001-04-5,BRUCINE,BRUCINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A42167015-003-10-2,CARTEOLOL,CARTEOLOL
REP.PRIMARY,2.5,IDO1,ATPASE INHIBITOR,BRD:BRD-A42270467-001-04-4,TENATOPRAZOLE,TENATOPRAZOLE
REP.PRIMARY,2.5,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-A42553870-001-14-3,L-152804,L-152804
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A42571354-300-12-0,CETIRIZINE,CETIRIZINE
REP.PRIMARY,2.5,,THYROID HORMONE INHIBITOR,BRD:BRD-A42628519-001-12-4,IOPANIC-ACID,IOPANIC-ACID
REP.PRIMARY,2.5,DHODH,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-A42699921-001-02-8,TERIFLUNOMIDE,TERIFLUNOMIDE
REP.PRIMARY,2.5,DHODH,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-A42699921-001-03-6,TERIFLUNOMIDE,TERIFLUNOMIDE
REP.PRIMARY,2.5,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A42746051-001-02-9,MELENGESTROL-ACETATE,MELENGESTROL-ACETATE
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-A42759514-001-20-5,ORNIDAZOLE,ORNIDAZOLE
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-A43082461-001-06-3,LINALOOL,LINALOOL
REP.PRIMARY,2.5,PTGS2,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-A43082555-001-01-1,LOXOPROFEN,LOXOPROFEN
REP.PRIMARY,2.5,PTGS2,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-A43082555-001-02-9,LOXOPROFEN,LOXOPROFEN
REP.PRIMARY,2.5,,,BRD:BRD-A43435802-001-02-0,MERCAPTOSUCCINIC-ACID,MERCAPTOSUCCINIC-ACID
REP.PRIMARY,2.5,"HSD17B11, IGHG2, SULT2A1",,BRD:BRD-A43598550-001-09-4,3-ALPHA-HYDROXY-5-BETA-ANDROSTAN-17-ONE,3-ALPHA-HYDROXY-5-BETA-ANDROSTAN-17-ONE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A43671941-003-11-9,OXPRENOLOL,OXPRENOLOL
REP.PRIMARY,2.5,,ANTITUSSIVE,BRD:BRD-A43809092-003-02-1,CLOBUTINOL,CLOBUTINOL
REP.PRIMARY,2.5,"ABCC8, ABCC9","ATP CHANNEL ACTIVATOR, POTASSIUM CHANNEL ACTIVATOR",BRD:BRD-A43882281-001-15-5,PINACIDIL,PINACIDIL
REP.PRIMARY,2.5,NR5A1,STEROIDOGENIC FACTOR ANTAGONIST,BRD:BRD-A43885598-001-08-1,SID-7969543,SID-7969543
REP.PRIMARY,2.5,"AVPR1A, AVPR2, OXTR",OXYTOCIN RECEPTOR ANTAGONIST,BRD:BRD-A43930669-003-02-8,L-368899,L-368899
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A43999749-004-04-1,HOMATROPINE-METHYLBROMIDE,HOMATROPINE-METHYLBROMIDE
REP.PRIMARY,2.5,"CHRM1, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A44008656-036-25-8,DOXYLAMINE,DOXYLAMINE
REP.PRIMARY,2.5,"CXCR1, CXCR2, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-A44090213-001-25-6,INDOPROFEN,INDOPROFEN
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A44133049-003-07-8,AZASETRON,AZASETRON
REP.PRIMARY,2.5,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B","BARBITURATE ANTIEPILEPTIC, GABA RECEPTOR MODULATOR",BRD:BRD-A44448661-001-04-8,PENTOBARBITAL,PENTOBARBITAL
REP.PRIMARY,2.5,,NOTCH SIGNALING INHIBITOR,BRD:BRD-A44500574-001-01-8,FLI-06,FLI-06
REP.PRIMARY,2.5,"HSD11B1, HSD11B2",LIPOXYGENASE INHIBITOR,BRD:BRD-A44696962-001-01-4,ACETYL-11-KETO-BETA-BOSWELLIC-ACID,ACETYL-11-KETO-BETA-BOSWELLIC-ACID
REP.PRIMARY,2.5,"CCKAR, CCKBR",CCK RECEPTOR ANTAGONIST,BRD:BRD-A44863528-001-13-2,PROGLUMIDE,PROGLUMIDE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A44936478-001-01-1,CEPHALOSPORIN-C-ZN,CEPHALOSPORIN-C-ZN
REP.PRIMARY,2.5,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A45044890-236-02-3,METHYLPREDNISOLONE-SODIUM-SUCCINATE,METHYLPREDNISOLONE-SODIUM-SUCCINATE
REP.PRIMARY,2.5,EIF2S1,EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR,BRD:BRD-A45107007-001-03-4,SALUBRINAL,SALUBRINAL
REP.PRIMARY,2.5,"AKR1C3, PTGER1, PTGER3, PTGFR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-A45153512-001-01-0,BIMATOPROST,BIMATOPROST
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-A45498368-001-07-1,WYE-125132,WYE-125132
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A45543382-001-10-0,METRIZAMIDE,METRIZAMIDE
REP.PRIMARY,2.5,EIF2A,EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR,BRD:BRD-A45869167-001-10-0,SAL003,SAL003
REP.PRIMARY,2.5,"PLA2G1B, PLA2G4A, PLA2G6, PLCL1","CYTOKINE PRODUCTION INHIBITOR, NFKB PATHWAY INHIBITOR, TP53 ACTIVATOR",BRD:BRD-A45889380-300-07-1,MEPACRINE,MEPACRINE
REP.PRIMARY,2.5,,,BRD:BRD-A45906415-001-01-9,K-MAP,K-MAP
REP.PRIMARY,2.5,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A46066006-004-22-6,CLIDINIUM,CLIDINIUM
REP.PRIMARY,2.5,"KCNK3, KCNK9",POTASSIUM CHANNEL BLOCKER,BRD:BRD-A46179541-311-02-0,DOXAPRAM,DOXAPRAM
REP.PRIMARY,2.5,"ANXA1, NOS2, NR3C1",,BRD:BRD-A46186775-369-02-0,HYDROCORTISONE-PHOSPHATE,HYDROCORTISONE-PHOSPHATE
REP.PRIMARY,2.5,"ALPPL2, CHRNA3",IMMUNOSTIMULANT,BRD:BRD-A46393198-003-16-6,TETRAMISOLE,TETRAMISOLE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A46717658-236-02-5,AZLOCILLIN,AZLOCILLIN
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A46813902-001-01-6,IODODEXETIMIDE,IODODEXETIMIDE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A46876182-003-02-8,LEVOBUNOLOL-(+/-),LEVOBUNOLOL-(+/-)
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A47342814-003-01-8,NALTRINDOLE,NALTRINDOLE
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-A47364545-003-02-6,SK&F-10047-(+),SK&F-10047-(+)
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A47449001-004-13-7,IPRATROPIUM,IPRATROPIUM
REP.PRIMARY,2.5,"ACHE, ADRA1A, ADRA2A, ADRB2, BCHE",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A47494775-003-11-3,DIPIVEFRINE,DIPIVEFRINE
REP.PRIMARY,2.5,"ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-A47598013-004-16-0,CITALOPRAM,CITALOPRAM
REP.PRIMARY,2.5,GCLM,GLUTATHIONE TRANSFERASE INHIBITOR,BRD:BRD-A47706533-001-02-6,BUTHIONINE-SULFOXIMINE,BUTHIONINE-SULFOXIMINE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A47790386-001-03-6,BALOFLOXACIN,BALOFLOXACIN
REP.PRIMARY,2.5,"ADRB1, HTR1A, HTR1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A47884604-051-01-2,CYANOPINDOLOL,CYANOPINDOLOL
REP.PRIMARY,2.5,,,BRD:BRD-A47953250-001-01-7,ECAMSULE-TRIETHANOLAMINE,ECAMSULE-TRIETHANOLAMINE
REP.PRIMARY,2.5,"CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG",SEROTONIN RECEPTOR AGONIST,BRD:BRD-A48015106-004-08-9,8-HYDROXY-DPAT,8-HYDROXY-DPAT
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A48180038-003-24-3,TRIHEXYPHENIDYL,TRIHEXYPHENIDYL
REP.PRIMARY,2.5,,"DNA ALKYLATING AGENT, DNA SYNTHESIS INHIBITOR",BRD:BRD-A48237631-001-04-8,MITOMYCIN-C,MITOMYCIN-C
REP.PRIMARY,2.5,F2,THROMBIN INHIBITOR,BRD:BRD-A48261811-001-08-1,ARGATROBAN,ARGATROBAN
REP.PRIMARY,2.5,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-A48300215-001-04-8,AJMALINE,AJMALINE
REP.PRIMARY,2.5,"PPARG, TRPM3","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-A48430263-003-17-2,PIOGLITAZONE,PIOGLITAZONE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-A48720949-001-04-0,TESTOSTERONE-PROPIONATE,TESTOSTERONE-PROPIONATE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A49035384-003-28-9,METHACYCLINE,METHACYCLINE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A49035384-003-30-5,METHACYCLINE,METHACYCLINE
REP.PRIMARY,2.5,SLC6A1,GABA UPTAKE INHIBITOR,BRD:BRD-A49046702-003-08-3,SKF-89976A,SKF-89976A
REP.PRIMARY,2.5,"ACHE, HTR2A",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-A49160188-003-12-7,DONEPEZIL,DONEPEZIL
REP.PRIMARY,2.5,"ATP4A, ATP4B",ATPASE INHIBITOR,BRD:BRD-A49172652-001-27-1,LANSOPRAZOLE,LANSOPRAZOLE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR AGONIST,BRD:BRD-A49225603-045-10-0,ALIMEMAZINE,ALIMEMAZINE
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-A49358627-001-14-6,CIPROFIBRATE,CIPROFIBRATE
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2, OXTR",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-A49399758-015-01-8,DESMOPRESSIN-ACETATE,DESMOPRESSIN-ACETATE
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A49447682-001-02-4,DESOXIMETASONE,DESOXIMETASONE
REP.PRIMARY,2.5,UTS2R,UROTENSIN RECEPTOR AGONIST,BRD:BRD-A49544621-003-02-8,AC-7954-(+/-),AC-7954-(+/-)
REP.PRIMARY,2.5,,LACTAMASE INHIBITOR,BRD:BRD-A49622760-001-01-9,FAROPENEM,FAROPENEM
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A49765801-001-04-1,FLUDROXYCORTIDE,FLUDROXYCORTIDE
REP.PRIMARY,2.5,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-A49838158-001-01-1,PHENPROCOUMON,PHENPROCOUMON
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A49906757-004-09-8,SCOPOLAMINE-N-OXIDE,SCOPOLAMINE-N-OXIDE
REP.PRIMARY,2.5,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-A50028488-001-01-6,TCS2002,TCS2002
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-A50049929-001-01-9,OXAZEPAM,OXAZEPAM
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A50064262-001-04-7,FLUMETHASONE-PIVALATE,FLUMETHASONE-PIVALATE
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A50157456-065-20-6,TERBUTALINE,TERBUTALINE
REP.PRIMARY,2.5,"HRH1, NR1I3",CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) AGONIST,BRD:BRD-A50311610-300-10-4,MECLIZINE,MECLIZINE
REP.PRIMARY,2.5,,"CHLORIDE CHANNEL BLOCKER, GABA GATED CHLORIDE CHANNEL BLOCKER",BRD:BRD-A50675702-001-07-1,FIPRONIL,FIPRONIL
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A50684349-003-02-9,FENOLDOPAM,FENOLDOPAM
REP.PRIMARY,2.5,"ATM, ATR","ATM KINASE INHIBITOR, ATR KINASE INHIBITOR",BRD:BRD-A50737080-001-03-0,CGK-733,CGK-733
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A50764878-003-02-8,MDL-73005EF,MDL-73005EF
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-A50922295-001-01-3,VALGANCICLOVIR,VALGANCICLOVIR
REP.PRIMARY,2.5,MTOR,"AKT INHIBITOR, MTOR INHIBITOR",BRD:BRD-A50998626-001-02-1,PALOMID-529,PALOMID-529
REP.PRIMARY,2.5,"DRD1, MAOA, MAOB",DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-A51078674-003-01-0,DICLOFENSINE,DICLOFENSINE
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A51355958-003-01-9,NEBRACETAM,NEBRACETAM
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-A51382177-236-03-0,FOSINOPRIL,FOSINOPRIL
REP.PRIMARY,2.5,,,BRD:BRD-A51407134-001-01-9,2-OCTYLDODECAN-1-OL,2-OCTYLDODECAN-1-OL
REP.PRIMARY,2.5,"IKBKB, IL1B, TNF",IKK INHIBITOR,BRD:BRD-A51571244-001-01-9,HYPOESTOXIDE,HYPOESTOXIDE
REP.PRIMARY,2.5,,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-A51713165-003-02-6,3-CPMT,3-CPMT
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4","ADRENERGIC INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",BRD:BRD-A51714012-003-13-6,VENLAFAXINE,VENLAFAXINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A51747092-003-03-0,MOPROLOL,MOPROLOL
REP.PRIMARY,2.5,"CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5","LANOSTEROL DEMETHYLASE INHIBITOR, STEROL DEMETHYLASE INHIBITOR",BRD:BRD-A51820102-008-28-9,ECONAZOLE,ECONAZOLE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A51829654-003-07-7,BRL-15572,BRL-15572
REP.PRIMARY,2.5,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4",MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-A51831848-001-01-7,ENFLURANE,ENFLURANE
REP.PRIMARY,2.5,"KCNH2, KCNN4",ANTIMALARIAL AGENT,BRD:BRD-A51964809-003-12-6,HALOFANTRINE,HALOFANTRINE
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A52460047-001-01-3,METHYLATROPINE-NITRATE,METHYLATROPINE-NITRATE
REP.PRIMARY,2.5,"DRD1, DRD5",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A52588987-004-08-2,SKF-83566,SKF-83566
REP.PRIMARY,2.5,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A52660433-066-02-1,TETRINDOLE,TETRINDOLE
REP.PRIMARY,2.5,ATP2A2,L-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-A52922642-001-03-7,GALLOPAMIL,GALLOPAMIL
REP.PRIMARY,2.5,,DPRE1 INHIBITOR,BRD:BRD-A53037217-001-02-0,BTZ043-RACEMATE,BTZ043-RACEMATE
REP.PRIMARY,2.5,LCT,,BRD:BRD-A53037300-001-01-0,2-FLUORO-2-DEOXY-D-GALACTOSE,2-FLUORO-2-DEOXY-D-GALACTOSE
REP.PRIMARY,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-A53134341-001-03-2,RO-106-9920,RO-106-9920
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-A53151380-001-01-2,PREDNISOLONE-TEBUTATE,PREDNISOLONE-TEBUTATE
REP.PRIMARY,2.5,,,BRD:BRD-A53539450-004-01-7,NEO-GILURYTMAL,NEO-GILURYTMAL
REP.PRIMARY,2.5,CHRM1,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A53561827-004-23-1,PIPENZOLATE,PIPENZOLATE
REP.PRIMARY,2.5,,ANGIOGENESIS INHIBITOR,BRD:BRD-A53566267-001-01-9,ANECORTAVE-ACETATE,ANECORTAVE-ACETATE
REP.PRIMARY,2.5,"GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A53576514-048-14-3,ORPHENADRINE,ORPHENADRINE
REP.PRIMARY,2.5,"MAPK10, MAPK8, MAPK9",JNK INHIBITOR,BRD:BRD-A53813595-001-01-8,PGL5001,PGL5001
REP.PRIMARY,2.5,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A53951045-004-01-6,BUTYLSCOPOLAMINE-BROMIDE,BUTYLSCOPOLAMINE-BROMIDE
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",LOCAL ANESTHETIC,BRD:BRD-A53952395-003-25-1,PRILOCAINE,PRILOCAINE
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRB1, ADRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, FOS, IL2, JDP2, JUN, NFATC1, SLC6A2, SLC6A3, SLC6A4, TNF",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A54236247-003-04-3,EPHEDRINE-(RACEMIC),EPHEDRINE-(RACEMIC)
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A54275602-001-01-0,LANOCONAZOLE,LANOCONAZOLE
REP.PRIMARY,2.5,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A54490543-066-11-9,PIRLINDOLE,PIRLINDOLE
REP.PRIMARY,2.5,SELP,P SELECTIN INHIBITOR,BRD:BRD-A54927599-001-16-9,KF-38789,KF-38789
REP.PRIMARY,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A55272860-001-14-6,SULPIRIDE,SULPIRIDE
REP.PRIMARY,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A55272860-001-15-3,SULPIRIDE,SULPIRIDE
REP.PRIMARY,1.24,ATP1A1,ATPASE INHIBITOR,BRD:BRD-A55312468-001-04-7,K-STROPHANTHIDIN,K-STROPHANTHIDIN
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-A55393291-001-09-9,TESTOSTERONE,TESTOSTERONE
REP.PRIMARY,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-A55424491-001-19-9,METHOTREXATE,METHOTREXATE
REP.PRIMARY,2.5,,,BRD:BRD-A55455283-001-01-3,"2-ETHYL-1,3-HEXANEDIOL","2-ETHYL-1,3-HEXANEDIOL"
REP.PRIMARY,2.5,,ENDOCRINE DISRUPTOR,BRD:BRD-A55464252-001-01-2,3-(4-METHYLBENZYLIDENE)CAMPHOR,3-(4-METHYLBENZYLIDENE)CAMPHOR
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-A55469827-001-07-4,MEPHENESIN,MEPHENESIN
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A55484088-050-02-5,BNTX,BNTX
REP.PRIMARY,2.5,"PROC, PROS1",,BRD:BRD-A55664972-236-02-6,SODIUM-TETRADECYL-SULFATE,SODIUM-TETRADECYL-SULFATE
REP.PRIMARY,2.5,"KRT7, NQO2","ANTIMALARIAL AGENT, DNA INHIBITOR",BRD:BRD-A55913614-316-09-6,PRIMAQUINE,PRIMAQUINE
REP.PRIMARY,2.5,"ATP4A, CLCN2",ATPASE INHIBITOR,BRD:BRD-A55962179-001-22-1,OMEPRAZOLE,OMEPRAZOLE
REP.PRIMARY,2.5,BRAF,RAF INHIBITOR,BRD:BRD-A56085258-001-01-8,LGX818,LGX818
REP.PRIMARY,2.5,,CHELATING AGENT,BRD:BRD-A56152450-001-02-0,DIMERCAPROL,DIMERCAPROL
REP.PRIMARY,2.5,ALOX5,"LEUKOTRIENE SYNTHESIS INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-A56359832-001-11-1,ZILEUTON,ZILEUTON
REP.PRIMARY,2.5,IDH1,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-A56371469-001-03-3,AGI-5198,AGI-5198
REP.PRIMARY,2.5,"CNR1, TXN, TXNRD1",THIOREDOXIN INHIBITOR,BRD:BRD-A56592690-001-04-3,PX-12,PX-12
REP.PRIMARY,2.5,,DIURETIC,BRD:BRD-A56675431-001-12-3,ALTHIAZIDE,ALTHIAZIDE
REP.PRIMARY,2.5,"SLC15A1, SLC15A2, SLC22A6, SLC22A8",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A56858165-001-04-4,CEFADROXIL,CEFADROXIL
REP.PRIMARY,2.5,ADCY1,ADENYLYL CYCLASE INHIBITOR,BRD:BRD-A56987319-001-12-9,SQ-22536,SQ-22536
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A57133233-003-11-0,CHLORCYCLIZINE,CHLORCYCLIZINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A57382968-001-29-0,PIROXICAM,PIROXICAM
REP.PRIMARY,2.5,"CACNA1G, CACNA1H, CACNA1I","T-TYPE CALCIUM CHANNEL BINDER, T-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-A57592049-001-01-6,METHSUXIMIDE,METHSUXIMIDE
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-A57798112-001-03-7,PD-318088,PD-318088
REP.PRIMARY,2.5,,GABA RECEPTOR ANTAGONIST,BRD:BRD-A57798559-004-02-3,BICUCULLINE-METHOCHLORIDE-(-),BICUCULLINE-METHOCHLORIDE-(-)
REP.PRIMARY,2.5,,,BRD:BRD-A57833392-001-01-7,OXYMATRINE,OXYMATRINE
REP.PRIMARY,2.5,GBF1,ARF INHIBITOR,BRD:BRD-A57886255-001-01-1,GOLGICIDE-A,GOLGICIDE-A
REP.PRIMARY,2.5,,HAEMOSTATIC AGENT,BRD:BRD-A57900429-003-05-8,HYDRASTININE,HYDRASTININE
REP.PRIMARY,2.5,,"LIPOTROPIC, MUCOLYTIC AGENT",BRD:BRD-A57957888-001-08-0,CITIOLONE,CITIOLONE
REP.PRIMARY,2.5,"AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A58048407-001-18-8,NIMODIPINE,NIMODIPINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A58193911-003-18-7,OXYPHENCYCLIMINE,OXYPHENCYCLIMINE
REP.PRIMARY,2.5,,NEMATOCIDE,BRD:BRD-A58564983-001-04-6,SELAMECTIN,SELAMECTIN
REP.PRIMARY,2.5,NFE2L2,"ANTICANCER AGENT, ARYL HYDROCARBON RECEPTOR ANTAGONIST",BRD:BRD-A58955223-001-03-8,SULFORAPHANE,SULFORAPHANE
REP.PRIMARY,2.5,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B",PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-A59001851-001-02-1,GINKGOLIDE-B,GINKGOLIDE-B
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A59174698-003-18-5,RITODRINE,RITODRINE
REP.PRIMARY,2.5,SLC6A2,NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-A59198242-003-02-9,VILOXAZINE,VILOXAZINE
REP.PRIMARY,2.5,"CA1, CA2, SLC12A1, SLC12A2, SLC12A3",THIAZIDE DIURETIC,BRD:BRD-A59303141-001-10-4,QUINETHAZONE,QUINETHAZONE
REP.PRIMARY,2.5,ADRB1,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A59337442-051-05-3,XAMOTEROL,XAMOTEROL
REP.PRIMARY,2.5,,,BRD:BRD-A59413292-001-08-2,DEXPANTHENOL,DEXPANTHENOL
REP.PRIMARY,2.5,"GRM1, GRM4",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A59709458-001-01-8,PHCCC,PHCCC
REP.PRIMARY,2.5,"DRD2, DRD3, HTR2A, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A60197193-001-14-6,AMISULPRIDE,AMISULPRIDE
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A60217728-001-11-2,IOHEXOL,IOHEXOL
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR LIGAND,BRD:BRD-A60594020-034-01-1,8-HYDROXY-PIPAT,8-HYDROXY-PIPAT
REP.PRIMARY,2.5,"PTPN6, TOP1",TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-A60786380-412-01-5,SODIUM-STIBOGLUCONATE,SODIUM-STIBOGLUCONATE
REP.PRIMARY,2.5,"ABCC8, VEGFA","ATP CHANNEL BLOCKER, INSULIN SECRETAGOGUE",BRD:BRD-A61154809-001-15-9,GLICLAZIDE,GLICLAZIDE
REP.PRIMARY,2.5,DDC,DOPA DECARBOXYLASE INHIBITOR,BRD:BRD-A61194565-003-27-0,BENSERAZIDE,BENSERAZIDE
REP.PRIMARY,2.5,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A61221616-001-04-3,MEDROXYPROGESTERONE-ACETATE,MEDROXYPROGESTERONE-ACETATE
REP.PRIMARY,2.5,"GRIN1, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A61392169-001-02-7,ELIPRODIL,ELIPRODIL
REP.PRIMARY,2.5,,ENZYME INDUCER,BRD:BRD-A61676498-001-06-6,CLIMBAZOLE,CLIMBAZOLE
REP.PRIMARY,2.5,SLC12A3,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-A61793559-001-15-6,METOLAZONE,METOLAZONE
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-A61850409-001-10-7,ALPHA-TOCHOPHERYL-ACETATE,ALPHA-TOCHOPHERYL-ACETATE
REP.PRIMARY,2.5,HTR2C,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A62021152-003-03-4,WAY-161503,WAY-161503
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A62057054-001-03-1,MDL-11939,MDL-11939
REP.PRIMARY,2.5,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A62071884-001-04-6,SIGUAZODAN,SIGUAZODAN
REP.PRIMARY,2.5,,KIR6 CHANNEL (KATP) ACTIVATOR,BRD:BRD-A62209527-001-04-5,ZM-226600,ZM-226600
REP.PRIMARY,2.5,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A62421304-004-18-9,MEPENZOLATE,MEPENZOLATE
REP.PRIMARY,2.5,HRH1,ANTIHISTAMINE,BRD:BRD-A62428732-300-06-3,HYDROXYZINE,HYDROXYZINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A62731508-001-05-8,CORTISONE,CORTISONE
REP.PRIMARY,2.5,"GAA, GANAB, GANC, MGAM",GLUCOSIDASE INHIBITOR,BRD:BRD-A63310107-001-04-8,MIGLITOL,MIGLITOL
REP.PRIMARY,2.5,PARP3,PARP INHIBITOR,BRD:BRD-A63444178-001-01-5,ME0328,ME0328
REP.PRIMARY,2.5,GRIN2B,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A63546914-003-02-0,RO-04-5595,RO-04-5595
REP.PRIMARY,2.5,,DNA DIRECTED DNA POLYMERASE INHIBITOR,BRD:BRD-A63675168-001-01-6,BRIVUDINE,BRIVUDINE
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A63752151-001-01-2,FIDARESTAT,FIDARESTAT
REP.PRIMARY,2.5,"ACE, AKR1B1",ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A63780829-001-11-4,HYPERIN,HYPERIN
REP.PRIMARY,2.5,,STEROID,BRD:BRD-A64011898-001-01-0,ANDROSTENONE,ANDROSTENONE
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-A64064900-001-02-3,SANGIVAMYCIN,SANGIVAMYCIN
REP.PRIMARY,2.5,"AHR, PLAU, SCN4A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A64092382-003-18-3,MEXILETINE,MEXILETINE
REP.PRIMARY,2.5,,,BRD:BRD-A64125466-236-04-6,DEHYDROCHOLATE,DEHYDROCHOLATE
REP.PRIMARY,2.5,DRD1,DOPAMINE RECEPTOR AGONIST,BRD:BRD-A64227845-004-09-3,SKF-77434,SKF-77434
REP.PRIMARY,2.5,,CARDIAC GLYCOSIDE,BRD:BRD-A64242993-001-05-6,LANATOSIDE-C,LANATOSIDE-C
REP.PRIMARY,2.5,LPL,"CHOLESTEROL INHIBITOR, LIPASE CLEARING FACTOR INHIBITOR",BRD:BRD-A64406146-001-01-2,TIMOFIBRATE,TIMOFIBRATE
REP.PRIMARY,2.5,ADRB2,SODIUM CHANNEL ACTIVATOR,BRD:BRD-A64553394-001-04-4,DPI-201106,DPI-201106
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A64610707-001-04-4,PRANOPROFEN,PRANOPROFEN
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A64698388-003-01-7,LEVO-PHENCYNONATE,LEVO-PHENCYNONATE
REP.PRIMARY,2.5,"ADRA1A, SLC18A2",,BRD:BRD-A64743628-001-01-5,ISOMETHEPTENE-MUCATE,ISOMETHEPTENE-MUCATE
REP.PRIMARY,2.5,ADRA1B,ADRENERGIC RECEPTOR LIGAND,BRD:BRD-A64808605-003-02-7,AH11110,AH11110
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A64977602-001-15-9,MIRTAZAPINE,MIRTAZAPINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A65013509-003-24-4,OXYBUTYNIN,OXYBUTYNIN
REP.PRIMARY,2.5,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-A65051990-001-12-9,ACENOCOUMAROL,ACENOCOUMAROL
REP.PRIMARY,2.5,"GRIA2, GRIK1",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A65145453-001-06-1,ATPA,ATPA
REP.PRIMARY,2.5,TNNC1,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A65248799-001-01-7,EMD-53998,EMD-53998
REP.PRIMARY,2.5,"CHRM1, DRD2, HRH1, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A65280694-003-13-7,MOLINDONE,MOLINDONE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A65440446-001-04-1,CIMATEROL,CIMATEROL
REP.PRIMARY,2.5,NR3C1,CYTOCHROME P450 INHIBITOR,BRD:BRD-A65449987-001-10-4,FLUNISOLIDE,FLUNISOLIDE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A65597028-003-07-3,RX-821002,RX-821002
REP.PRIMARY,2.5,"HTR3A, HTR3B, HTR4, HTR5A",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A65615053-003-02-2,ZACOPRIDE,ZACOPRIDE
REP.PRIMARY,2.5,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-A65671304-001-07-5,CANDESARTAN-CILEXTIL,"CANDESARTAN-CILEXETIL, CANDESARTAN-CILEXTIL"
REP.PRIMARY,2.5,"NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A65767837-001-04-4,HYDROCORTISONE-ACETATE,HYDROCORTISONE-ACETATE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A65797496-048-09-3,DEPTROPINE,DEPTROPINE
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A65818372-001-05-3,IOVERSOL,IOVERSOL
REP.PRIMARY,2.5,"CNR1, CNR2",CANNABINOID RECEPTOR AGONIST,BRD:BRD-A66116161-001-02-3,AM-1241,AM-1241
REP.PRIMARY,2.5,,PROTEASOME INHIBITOR,BRD:BRD-A66419424-001-02-4,IXAZOMIB-CITRATE,IXAZOMIB-CITRATE
REP.PRIMARY,2.5,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-A66435872-332-01-8,HTMT,HTMT
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A66869276-001-02-9,DIFLORASONE-DIACETATE,DIFLORASONE-DIACETATE
REP.PRIMARY,2.5,"GABBR1, GABBR2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A66920069-001-01-3,FENIGAM,FENIGAM
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-A66966115-001-01-0,NM107,NM107
REP.PRIMARY,2.5,PTPN1,NITRIC OXIDE DONOR,BRD:BRD-A67006024-001-04-8,SNAP,SNAP
REP.PRIMARY,2.5,,ANTHELMINTIC AGENT,BRD:BRD-A67060370-001-02-9,ALBENDAZOLE-OXIDE,ALBENDAZOLE-OXIDE
REP.PRIMARY,2.5,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1",DNA ALKYLATING AGENT,BRD:BRD-A67097164-001-18-7,IFOSFAMIDE,IFOSFAMIDE
REP.PRIMARY,2.5,,POLYPEPTIDE SYNTHESIS INHIBITOR,BRD:BRD-A67101513-001-03-7,HYGROMYCIN-B,HYGROMYCIN-B
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A67181951-001-01-2,GADOBUTROL,GADOBUTROL
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A67363467-001-01-3,DIHYDROSTREPTOMYCIN,DIHYDROSTREPTOMYCIN
REP.PRIMARY,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR ANTAGONIST,BRD:BRD-A67482312-001-02-6,4-P-PDOT,4-P-PDOT
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-A67514145-003-05-8,FURALTADONE,FURALTADONE
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A67516570-001-02-8,LAFUTIDINE,LAFUTIDINE
REP.PRIMARY,2.5,,,BRD:BRD-A67521319-001-01-6,PIMONIDAZOLE,PIMONIDAZOLE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A67616246-001-07-9,LEVOMEQUITAZINE,LEVOMEQUITAZINE
REP.PRIMARY,2.5,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-A67748489-001-10-0,K-858,K-858
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A67862938-034-14-9,NAFTIDROFURYL,NAFTIDROFURYL
REP.PRIMARY,2.5,MMP1,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-A67975844-001-01-8,NSC-405020,NSC-405020
REP.PRIMARY,2.5,CACNA1C,CALCIUM CHANNEL BLOCKER,BRD:BRD-A68083442-001-01-6,PRANIDIPINE,PRANIDIPINE
REP.PRIMARY,0.25,ALOX5,"LEUKOTRIENE RECEPTOR ANTAGONIST, LIPOXYGENASE INHIBITOR",BRD:BRD-A68281735-001-18-6,REV-5901,REV-5901
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4",DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-A68304895-003-02-2,BTS-54505,BTS-54505
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4","DOPAMINE REUPTAKE INHIBITOR, SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)",BRD:BRD-A68464583-001-02-5,MAZINDOL,MAZINDOL
REP.PRIMARY,2.5,"CYP1A2, CYP3A4",HCV INHIBITOR,BRD:BRD-A68493689-001-01-9,SIMEPREVIR,SIMEPREVIR
REP.PRIMARY,2.5,,BRONCHODILATOR,BRD:BRD-A68509429-003-03-9,ETHYLNOREPINEPHRINE,ETHYLNOREPINEPHRINE
REP.PRIMARY,2.5,,GLUCOSAMINE SYNTHETASE STIMULANT,BRD:BRD-A68589262-001-04-3,TROXIPIDE,TROXIPIDE
REP.PRIMARY,2.5,TRPV1,"ATPASE INHIBITOR, TRPV AGONIST",BRD:BRD-A68631409-001-05-4,EVODIAMINE,EVODIAMINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A68723818-050-32-5,BROMPHENIRAMINE,BROMPHENIRAMINE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A68888262-003-15-1,AZELASTINE,AZELASTINE
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4",SEROTONIN TRANSPORTER (SERT) INHIBITOR,BRD:BRD-A68942014-003-01-7,AMITIFADINE,AMITIFADINE
REP.PRIMARY,2.5,,DNA INTERCALATING AGENT,BRD:BRD-A68969091-001-12-7,ECHINOMYCIN,ECHINOMYCIN
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-A69275535-001-01-5,PINITOL,PINITOL
REP.PRIMARY,2.5,"CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5",CALCIUM CHANNEL BLOCKER,BRD:BRD-A69636825-003-04-7,DILTIAZEM,DILTIAZEM
REP.PRIMARY,2.5,"ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA",BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A69651145-003-07-2,MINOCYCLINE,MINOCYCLINE
REP.PRIMARY,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-A69777949-001-24-2,FLUMEQUINE,FLUMEQUINE
REP.PRIMARY,2.5,PPP3CA,CALCINEURIN INHIBITOR,BRD:BRD-A69815203-001-07-6,CYCLOSPORIN-A,CYCLOSPORIN-A
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A69917777-065-02-2,AMINOPENTAMIDE,AMINOPENTAMIDE
REP.PRIMARY,2.5,,"ACETYLCHOLINESTERASE INHIBITOR, MICROTUBULE INHIBITOR",BRD:BRD-A70083328-001-23-5,SECNIDAZOLE,SECNIDAZOLE
REP.PRIMARY,2.5,,"ACETYLCHOLINESTERASE INHIBITOR, MICROTUBULE INHIBITOR",BRD:BRD-A70083328-001-24-3,SECNIDAZOLE,SECNIDAZOLE
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A70268693-050-01-2,PG-9,PG-9
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A70407468-001-02-0,PSB-36,PSB-36
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-A70514680-003-11-2,ARTICAINE,ARTICAINE
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A70649075-008-30-8,SULCONAZOLE,SULCONAZOLE
REP.PRIMARY,2.5,"ESR1, ESR2, MAP1A, MAP2",DNA ALKYLATING AGENT,BRD:BRD-A70858459-001-01-7,ESTRAMUSTINE,ESTRAMUSTINE
REP.PRIMARY,2.5,CACNA1C,T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-A70998768-004-01-1,PINAVERIUM,PINAVERIUM
REP.PRIMARY,2.5,HTR2B,CALCIUM CHANNEL BLOCKER,BRD:BRD-A71033472-003-23-9,FENDILINE,FENDILINE
REP.PRIMARY,2.5,,VITAMIN B,BRD:BRD-A71157293-003-10-0,FURSULTIAMINE,FURSULTIAMINE
REP.PRIMARY,2.5,"DRD2, DRD3, HTR1A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A71262238-001-08-4,NAFADOTRIDE,NAFADOTRIDE
REP.PRIMARY,2.5,,OTHER ANTIFUNGAL,BRD:BRD-A71407503-001-01-8,INIMUR,INIMUR
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A71725768-001-01-3,METOXIBUTROPATE,METOXIBUTROPATE
REP.PRIMARY,2.5,,CHITIN INHIBITOR,BRD:BRD-A71774530-001-05-9,LUFENURON,LUFENURON
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-A72066420-001-04-5,MIFOBATE,MIFOBATE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-A72212290-300-01-4,EPRAZINONE,EPRAZINONE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A72309220-001-04-1,METERGOLINE,METERGOLINE
REP.PRIMARY,2.5,GM2A,ACETYLCHOLINE PRECURSOR,BRD:BRD-A72390365-001-15-2,CHOLINE-ALFOSCERATE,CHOLINE-ALFOSCERATE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A, HTR2B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A72483914-001-03-7,SPIROXATRINE,SPIROXATRINE
REP.PRIMARY,2.5,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A72703248-003-04-9,SKF-96365,SKF-96365
REP.PRIMARY,2.5,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A72711497-236-03-8,LASALOCID,LASALOCID
REP.PRIMARY,0.91,,CARDIAC GLYCOSIDE,BRD:BRD-A72716251-001-01-5,PERUVOSIDE,PERUVOSIDE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A72767275-003-01-6,NALMEFENE,NALMEFENE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A73368467-003-17-6,FEXOFENADINE,FEXOFENADINE
REP.PRIMARY,2.5,"AKR1B1, GPI, HK1, IGF2R, M6PR, PYGM",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-A73427433-240-01-3,ADAPREV,ADAPREV
REP.PRIMARY,2.5,PYGL,PHOSPHORYLASE INHIBITOR,BRD:BRD-A73556557-001-06-4,TAGATOSE,TAGATOSE
REP.PRIMARY,2.5,,PROTEIN PHOSPHATASE INHIBITOR,BRD:BRD-A73709786-001-01-3,LB-100,LB-100
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-A73871920-236-03-6,NANCHANGMYCIN,NANCHANGMYCIN
REP.PRIMARY,2.5,SIRT1,SIRT INHIBITOR,BRD:BRD-A73908300-001-06-7,EX-527,EX-527
REP.PRIMARY,2.5,"SLC36A1, SLC36A2",NEUROTRANSMITTER,BRD:BRD-A73930134-001-03-0,5-HYDROXYTRYPTOPHAN,5-HYDROXYTRYPTOPHAN
REP.PRIMARY,2.5,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",GABA RECEPTOR ANTAGONIST,BRD:BRD-A74208568-003-01-5,CGP-54626,CGP-54626
REP.PRIMARY,2.5,FOLH1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A74387232-001-02-5,PMPA,PMPA
REP.PRIMARY,2.5,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6",POTASSIUM CHANNEL BLOCKER,BRD:BRD-A74391928-051-01-3,IBUTILIDE,IBUTILIDE
REP.PRIMARY,2.5,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6",POTASSIUM CHANNEL BLOCKER,BRD:BRD-A74391928-051-02-1,IBUTILIDE,IBUTILIDE
REP.PRIMARY,2.5,"PTGS1, PTGS2, RXRA",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A74667430-001-23-6,ETODOLAC,ETODOLAC
REP.PRIMARY,2.5,ESR1,CONTRACEPTIVE AGENT,BRD:BRD-A74765037-001-01-1,ESTRADIOL-BENZOATE,ESTRADIOL-BENZOATE
REP.PRIMARY,2.5,"DHFR, TYMS",DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-A74914197-001-02-9,PRALATREXATE,PRALATREXATE
REP.PRIMARY,2.5,"CES1, CHRM1",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A74975734-004-10-7,HOMATROPINE,HOMATROPINE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A74980173-001-11-9,GATIFLOXACIN,GATIFLOXACIN
REP.PRIMARY,2.5,,,BRD:BRD-A75140635-003-10-9,"ISOQUINOLINE,-6,7-DIMETHOXY-1-METHYL-1,2,3,4-TETRAHYDRO,","ISOQUINOLINE,-6,7-DIMETHOXY-1-METHYL-1,2,3,4-TETRAHYDRO,"
REP.PRIMARY,2.5,,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-A75305484-001-01-3,ANIDULAFUNGIN,ANIDULAFUNGIN
REP.PRIMARY,2.5,,,BRD:BRD-A75369945-001-01-2,VITAMIN-B12,VITAMIN-B12
REP.PRIMARY,2.5,,"ANTIVIRAL, RNA SYNTHESIS INHIBITOR",BRD:BRD-A75479906-001-02-4,RIMANTADINE,RIMANTADINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A75552914-001-15-0,ISOXICAM,ISOXICAM
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3, NGF, TNF",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A75726477-003-21-3,CLENBUTEROL,CLENBUTEROL
REP.PRIMARY,2.5,OPRD1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A75769826-003-02-1,SDM25N,SDM25N
REP.PRIMARY,2.5,"MYH14, MYH2",ATPASE INHIBITOR,BRD:BRD-A75817871-001-06-7,BLEBBISTATIN-(+/-),BLEBBISTATIN-(+/-)
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A75850590-213-01-0,LOMEFLOXACIN,LOMEFLOXACIN
REP.PRIMARY,2.5,TYMS,FOLATE RECEPTOR LIGAND,BRD:BRD-A75919782-399-02-6,LEUCOVORIN,LEUCOVORIN
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A76672327-003-02-0,CLINDAMYCIN-PALMITATE,CLINDAMYCIN-PALMITATE
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A77218119-001-03-5,SYM-2206,SYM-2206
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A77291778-003-22-0,CYCLOPENTOLATE,CYCLOPENTOLATE
REP.PRIMARY,2.5,,PROTEIN KINASE INHIBITOR,BRD:BRD-A77577770-003-08-9,PALMITOYLCARNITINE,PALMITOYLCARNITINE
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-A78093359-001-06-3,MRS1845,"MRS-1845, MRS1845"
REP.PRIMARY,2.5,"RRM1, RRM2","APOPTOSIS STIMULANT, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-A78195072-001-06-2,IMEXON,IMEXON
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A78322124-003-14-0,DOBUTAMINE,DOBUTAMINE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-A78341343-001-01-6,REGADENOSON,REGADENOSON
REP.PRIMARY,2.5,KIF11,KINESIN INHIBITOR,BRD:BRD-A78377521-001-05-5,MONASTROL,MONASTROL
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A78391468-001-02-8,PREDNISOLONE-HEMISUCCINATE,PREDNISOLONE-HEMISUCCINATE
REP.PRIMARY,2.5,,,BRD:BRD-A78588743-001-03-4,EDITOL,EDITOL
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A78723049-001-01-2,CEFOTETAN,CEFOTETAN
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A78877355-001-03-0,NEFOPAM,NEFOPAM
REP.PRIMARY,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A78952587-001-01-5,A740003,A740003
REP.PRIMARY,2.5,AHCY,ADENOSYLHOMOCYSTEINASE INHIBITOR,BRD:BRD-A79431551-001-01-1,3-DEAZAADENOSINE,3-DEAZAADENOSINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A79672927-001-20-7,TROPICAMIDE,TROPICAMIDE
REP.PRIMARY,2.5,"FGF2, FKBP1A, MTOR",MTOR INHIBITOR,BRD:BRD-A79768653-001-12-0,SIROLIMUS,SIROLIMUS
REP.PRIMARY,2.5,"CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A79803969-003-16-1,MEMANTINE,MEMANTINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A79981887-003-16-4,MIDODRINE,MIDODRINE
REP.PRIMARY,2.5,"CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3",SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,BRD:BRD-A80017228-001-25-7,BENDROFLUMETHIAZIDE,BENDROFLUMETHIAZIDE
REP.PRIMARY,2.5,,RAS GTPASE INHIBITOR,BRD:BRD-A80213327-305-08-3,NSC-23766,NSC-23766
REP.PRIMARY,2.5,TAAR1,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,BRD:BRD-A80871782-004-06-9,HYDROXYAMPHETAMINE,HYDROXYAMPHETAMINE
REP.PRIMARY,2.5,,ANTITUSSIVE,BRD:BRD-A80908310-003-13-8,CLOPERASTINE,CLOPERASTINE
REP.PRIMARY,2.5,"PTGS1, PTGS2, SLC5A8",PROSTAGLANDIN INHIBITOR,BRD:BRD-A81129465-001-03-8,FENOPROFEN,FENOPROFEN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A81233518-004-16-1,GLYCOPYRROLATE,GLYCOPYRROLATE
REP.PRIMARY,2.5,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6",RIBOSOMAL PROTEIN INHIBITOR,BRD:BRD-A81370665-001-03-6,BI-D1870,BI-D1870
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A81513827-001-03-6,SAXAGLIPTIN,SAXAGLIPTIN
REP.PRIMARY,2.5,ATP5A1,"ATP SYNTHASE INHIBITOR, ATPASE INHIBITOR",BRD:BRD-A81541225-001-06-8,OLIGOMYCIN-A,OLIGOMYCIN-A
REP.PRIMARY,2.5,"PAH, TPH1, TPH2",TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-A81615860-003-01-7,FENCLONINE-(+/-),FENCLONINE-(+/-)
REP.PRIMARY,2.5,"AVPR1A, AVPR2",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-A82035391-001-02-7,TOLVAPTAN,TOLVAPTAN
REP.PRIMARY,2.5,"KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A82396632-008-29-0,MICONAZOLE,MICONAZOLE
REP.PRIMARY,2.5,ESR1,"ANDROGEN RECEPTOR AGONIST, ESTROGEN RECEPTOR AGONIST, PROGESTERONE RECEPTOR AGONIST",BRD:BRD-A82522119-001-01-7,TIBOLONE,TIBOLONE
REP.PRIMARY,2.5,MALT1,MALT1 INHIBITOR (JH),BRD:BRD-A82772293-001-03-2,MEPAZINE,MEPAZINE
REP.PRIMARY,2.5,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A83029242-001-05-3,PRASUGREL,PRASUGREL
REP.PRIMARY,2.5,"SERPINC1, SERPIND1",THROMBIN INHIBITOR,BRD:BRD-A83644949-236-01-6,ARDEPARIN,ARDEPARIN
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A83650191-004-02-8,A61603,A61603
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A83802939-304-04-2,DEXAMETHASONE-SODIUM-PHOSPHATE,DEXAMETHASONE-SODIUM-PHOSPHATE
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HYDANTOIN ANTIEPILEPTIC,BRD:BRD-A83937277-001-10-5,MEPHENYTOIN,MEPHENYTOIN
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A84174393-236-07-1,MELOXICAM,MELOXICAM
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A84389633-001-05-7,"TROPANYL-3,5-DIMETHYLBENZOATE","TROPANYL-3,5-DIMETHYLBENZOATE"
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCNH2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A84481105-003-31-3,THIORIDAZINE,THIORIDAZINE
REP.PRIMARY,2.5,PDE3A,"CALCIUM SENSITIZER, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-A84575140-001-02-4,PIMOBENDAN,PIMOBENDAN
REP.PRIMARY,2.5,"CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A84687895-001-03-2,NILVADIPINE,NILVADIPINE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRNA7",MUSCLE RELAXANT,BRD:BRD-A84907376-300-03-8,ALCURONIUM,ALCURONIUM
REP.PRIMARY,2.5,"GABBR1, GABBR2, SLC52A2",GABA RECEPTOR ANTAGONIST,BRD:BRD-A85025557-001-02-5,NCS-382,NCS-382
REP.PRIMARY,2.5,"CHRM1, SLC6A2, SLC6A3, SLC6A4",DOPAMINE UPTAKE INHIBITOR,BRD:BRD-A85216385-003-02-4,3-ALPHA-BIS-(4-FLUOROPHENYL)-METHOXYTROPANE,3-ALPHA-BIS-(4-FLUOROPHENYL)-METHOXYTROPANE
REP.PRIMARY,2.5,"ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE",ANTIOXIDANT,BRD:BRD-A85242401-001-12-3,ASCORBIC-ACID,ASCORBIC-ACID
REP.PRIMARY,2.5,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-A85472596-001-02-2,L-670596,L-670596
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A85548292-001-01-8,PIKETOPROFEN,PIKETOPROFEN
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A85587465-001-03-3,BEMESETRON,BEMESETRON
REP.PRIMARY,2.5,,SODIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-A85651701-001-19-7,CLOPAMIDE,CLOPAMIDE
REP.PRIMARY,2.5,"ESR1, ESR2, GPER1",ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-A85667082-001-12-7,FULVESTRANT,FULVESTRANT
REP.PRIMARY,2.5,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-A85876464-001-01-5,NIBENTAN,NIBENTAN
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A86044036-001-26-5,FLURBIPROFEN-(+/-),FLURBIPROFEN-(+/-)
REP.PRIMARY,2.5,"CHRNA3, CHRNA4, CHRNA6, CHRNA7",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A86216746-046-02-6,VARENICLINE,VARENICLINE
REP.PRIMARY,2.5,CDA,CYTIDINE DEAMINASE INHIBITOR,BRD:BRD-A86248581-001-01-4,TETRAHYDROURIDINE,TETRAHYDROURIDINE
REP.PRIMARY,2.5,,,BRD:BRD-A86354194-002-01-7,L-(+)-RHAMNOSE-MONOHYDRATE,L-(+)-RHAMNOSE-MONOHYDRATE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A86414188-003-01-5,RACTOPAMINE,RACTOPAMINE
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A86415025-050-01-0,"1-(1,2-DIPHENYLETHYL)PIPERIDINE-(+/-)","1-(1,2-DIPHENYLETHYL)PIPERIDINE-(+/-)"
REP.PRIMARY,2.5,NFKB1,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,BRD:BRD-A86619021-001-04-8,ANDROGRAPHOLIDE,ANDROGRAPHOLIDE
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-A86871940-001-01-9,NICARAVEN,NICARAVEN
REP.PRIMARY,2.5,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-A87130939-001-07-9,MASOPROCOL,MASOPROCOL
REP.PRIMARY,2.5,PDK1,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,BRD:BRD-A87435144-001-01-6,AZD7545,AZD7545
REP.PRIMARY,2.5,"KCNJ4, PTGS1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A87479750-001-02-7,TENIDAP,TENIDAP
REP.PRIMARY,2.5,,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,BRD:BRD-A87673115-001-04-1,MOGUISTEINE,MOGUISTEINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A87715314-003-14-4,PRONETHALOL,PRONETHALOL
REP.PRIMARY,2.5,"CCKAR, CCKBR",CCK RECEPTOR ANTAGONIST,BRD:BRD-A87983072-001-01-1,BENZOTRIPT,BENZOTRIPT
REP.PRIMARY,2.5,HSD17B1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A88080608-001-04-2,EQUILIN,EQUILIN
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A88138582-001-04-8,HALCINONIDE,HALCINONIDE
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A88369366-001-01-7,TRELAGLIPTIN,TRELAGLIPTIN
REP.PRIMARY,2.5,"CALY, DRD1, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A88548664-004-02-7,SKF-38393,SKF-38393
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-A88684804-001-04-3,BUCETIN,BUCETIN
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A89164055-001-03-3,SORBINIL,SORBINIL
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A89175223-051-14-8,BISOPROLOL,BISOPROLOL
REP.PRIMARY,2.5,OPRM1,OPIOID RECEPTOR AGONIST,BRD:BRD-A89196962-300-01-7,DALARGIN,DALARGIN
REP.PRIMARY,2.5,CHRM4,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A89337244-001-02-9,PD-102807,PD-102807
REP.PRIMARY,2.5,"ADORA2A, HBA1","ADENOSINE RECEPTOR ANTAGONIST, HEMOGLOBIN ANTAGONIST",BRD:BRD-A89585551-003-16-6,MEFLOQUINE,MEFLOQUINE
REP.PRIMARY,2.5,,,BRD:BRD-A89594340-003-11-5,CARNITINE-(D/L),CARNITINE-(D/L)
REP.PRIMARY,2.5,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",GABA RECEPTOR ANTAGONIST,BRD:BRD-A89672324-001-03-0,CGP-55845,CGP-55845
REP.PRIMARY,2.5,"GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A90272038-001-01-7,CGP-37849,CGP-37849
REP.PRIMARY,2.5,,EXPECTORANT,BRD:BRD-A90515964-001-16-5,GUAIFENESIN,GUAIFENESIN
REP.PRIMARY,2.5,"ITGA2B, ITGB3",PLATELET AGGREGATION INHIBITOR,BRD:BRD-A90547603-001-02-5,EPTIFIBATIDE,EPTIFIBATIDE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A90551241-001-10-8,LORNOXICAM,LORNOXICAM
REP.PRIMARY,2.5,LPL,LIPASE CLEARING FACTOR INHIBITOR,BRD:BRD-A90625545-001-02-0,CLINOFIBRATE,CLINOFIBRATE
REP.PRIMARY,2.5,"CACNA1C, CACNA1D",CALCIUM CHANNEL BLOCKER,BRD:BRD-A90695733-001-07-4,MANIDIPINE,MANIDIPINE
REP.PRIMARY,2.5,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A90799790-001-19-9,ISRADIPINE,ISRADIPINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A90926615-001-01-9,ADRAFINIL,ADRAFINIL
REP.PRIMARY,2.5,"ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A91008255-003-24-8,BEPRIDIL,BEPRIDIL
REP.PRIMARY,2.5,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A91366704-001-01-9,EPRINOMECTIN,EPRINOMECTIN
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A91452556-001-04-0,ESTRADIOL-CYPIONATE,ESTRADIOL-CYPIONATE
REP.PRIMARY,2.5,"GSTA2, MRGPRX1, TLR9, TNF",ANTIMALARIAL AGENT,BRD:BRD-A91699651-316-10-9,CHLOROQUINE,CHLOROQUINE
REP.PRIMARY,2.5,,,BRD:BRD-A91733352-300-04-5,CAMYLOFINE-CHLORHYDRATE,CAMYLOFINE-CHLORHYDRATE
REP.PRIMARY,2.5,"GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB",GABA RECEPTOR ANTAGONIST,BRD:BRD-A91822151-001-05-0,PICROTIN,PICROTIN
REP.PRIMARY,2.5,,,BRD:BRD-A91831168-003-02-5,TETRAHYDROPAPAVERINE,TETRAHYDROPAPAVERINE
REP.PRIMARY,2.5,,,BRD:BRD-A92096630-001-02-8,SHIKIMIC-ACID,SHIKIMIC-ACID
REP.PRIMARY,2.5,NR3C1,"GLUCOCORTICOID RECEPTOR AGONIST, IMMUNOSUPPRESSANT",BRD:BRD-A92439610-001-05-7,TRIAMCINOLONE-ACETONIDE,TRIAMCINOLONE-ACETONIDE
REP.PRIMARY,2.5,"AR, CCL2, ESR1, GNRHR, GNRHR2, PGR","ESTROGEN RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR AGONIST",BRD:BRD-A92537424-001-04-7,DANAZOL,DANAZOL
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-A92630576-050-24-1,TRIMEBUTINE,TRIMEBUTINE
REP.PRIMARY,2.5,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-A92670106-003-05-4,TOCAINIDE,TOCAINIDE
REP.PRIMARY,2.5,"KDR, MAPK14",TIE TYROSINE KINASE INHIBITOR,BRD:BRD-A92800748-001-05-5,TIE2-KINASE-INHIBITOR,TIE2-KINASE-INHIBITOR
REP.PRIMARY,2.5,INS,SODIUM CHANNEL BLOCKER,BRD:BRD-A92826379-001-01-5,LUPANINE,LUPANINE
REP.PRIMARY,2.5,CHIT1,,BRD:BRD-A92872453-001-01-8,N-ACETYLMANNOSAMINE,N-ACETYLMANNOSAMINE
REP.PRIMARY,2.5,PGRMC1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-A92933783-050-01-6,SM-21,SM-21
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A93000692-001-08-1,CIGLITAZONE,CIGLITAZONE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A93093700-001-02-9,TEMAZEPAM,TEMAZEPAM
REP.PRIMARY,2.5,ATP1A1,ATPASE INHIBITOR,BRD:BRD-A93236127-001-04-5,DIGITOXIN,DIGITOXIN
REP.PRIMARY,2.5,"CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF",TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,BRD:BRD-A93255169-001-28-3,THALIDOMIDE,THALIDOMIDE
REP.PRIMARY,2.5,CYP17A1,FUNGAL LANOSTEROL DEMETHYLASE INHIBITOR,BRD:BRD-A93353767-008-02-2,ISOCONAZOLE,ISOCONAZOLE
REP.PRIMARY,2.5,,"ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR",BRD:BRD-A93407926-001-01-1,ALLOPURINOL-RIBOSIDE,ALLOPURINOL-RIBOSIDE
REP.PRIMARY,2.5,CASP3,CASPASE ACTIVATOR,BRD:BRD-A93477898-001-04-2,PETCM,PETCM
REP.PRIMARY,2.5,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A93695607-322-02-5,NICOTINE,NICOTINE
REP.PRIMARY,2.5,,,BRD:BRD-A93699261-236-03-4,SODIUM-DANSHENSU,SODIUM-DANSHENSU
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A93964801-003-03-3,CLINAFLOXACIN,CLINAFLOXACIN
REP.PRIMARY,2.5,"CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7","BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR, BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR",BRD:BRD-A94008949-001-01-9,TELITHROMYCIN,TELITHROMYCIN
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A94033181-001-01-4,AZD6765,AZD6765
REP.PRIMARY,2.5,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A94276798-001-01-4,TALINOLOL,TALINOLOL
REP.PRIMARY,2.5,LPA,LIPOPROTEIN ANTAGONIST,BRD:BRD-A94323479-001-02-8,KI16198,KI16198
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A94523291-304-02-7,PREDNISOLONE-SODIUM-PHOSPHATE,PREDNISOLONE-SODIUM-PHOSPHATE
REP.PRIMARY,2.5,CYP2B6,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A94543220-001-24-7,BIFONAZOLE,BIFONAZOLE
REP.PRIMARY,2.5,PRKACA,"ADENOSINE RECEPTOR AGONIST, CAMP STIMULANT",BRD:BRD-A94624445-236-17-0,BUCLADESINE,BUCLADESINE
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-A94709349-001-08-3,METAXALONE,METAXALONE
REP.PRIMARY,2.5,ATP1A1,ATPASE INHIBITOR,BRD:BRD-A94756469-001-04-7,DIGOXIN,DIGOXIN
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A94993966-001-04-4,VILDAGLIPTIN,VILDAGLIPTIN
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A94993966-001-05-1,VILDAGLIPTIN,VILDAGLIPTIN
REP.PRIMARY,2.5,"GLRA1, GLRB",GABA RECEPTOR ANTAGONIST,BRD:BRD-A95121829-001-08-9,GINKGOLIDE-A,GINKGOLIDE-A
REP.PRIMARY,2.5,"CA1, CA2, CA4, SLC12A1, SLC12A3",CHLORIDE REABSORPTION INHIBITOR,BRD:BRD-A95340155-001-09-7,METHYCLOTHIAZIDE,METHYCLOTHIAZIDE
REP.PRIMARY,2.5,"ADRA2A, ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A95602221-003-02-1,CELIPROLOL,CELIPROLOL
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4",NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-A95696066-003-13-8,NISOXETINE,NISOXETINE
REP.PRIMARY,2.5,CYP26A1,CYTOCHROME P450 INHIBITOR,BRD:BRD-A95755460-001-01-3,TALAROZOLE,TALAROZOLE
REP.PRIMARY,2.5,"CA2, HTR3A, KCNE1, KCNQ1, SLC12A3",THIAZIDE DIURETIC,BRD:BRD-A95869247-001-26-9,INDAPAMIDE,INDAPAMIDE
REP.PRIMARY,2.5,,PULMONARY SURFACTANT,BRD:BRD-A95886749-001-03-5,COLFOSCERIL-PALMITATE,COLFOSCERIL-PALMITATE
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A95939040-001-01-2,SERTACONAZOLE,SERTACONAZOLE
REP.PRIMARY,2.5,"ARG2, ODC1",ORNITHINE DECARBOXYLASE INHIBITOR,BRD:BRD-A96292436-003-16-1,EFLORNITHINE,EFLORNITHINE
REP.PRIMARY,2.5,,COSMETIC,BRD:BRD-A96407378-001-15-1,ALLANTOIN,ALLANTOIN
REP.PRIMARY,2.5,,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-A96456596-001-02-2,FPL-55712,FPL-55712
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A96485169-001-14-3,EBPC,EBPC
REP.PRIMARY,2.5,,,BRD:BRD-A96529864-001-01-3,ISOSTEVIOL,ISOSTEVIOL
REP.PRIMARY,2.5,KCNQ1,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-A96977263-001-03-7,M-14157,M-14157
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A97104540-004-15-0,FENOTEROL,FENOTEROL
REP.PRIMARY,2.5,"ACSL4, FFAR1, PPARG, TRPC5, TRPM3","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-A97437073-050-14-5,ROSIGLITAZONE,ROSIGLITAZONE
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A97479839-003-13-3,PIPERIDOLATE,PIPERIDOLATE
REP.PRIMARY,2.5,"SCN10A, SCN4A, SCN5A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-A97674275-001-11-8,RANOLAZINE,RANOLAZINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A97701745-001-16-0,PINDOLOL,PINDOLOL
REP.PRIMARY,2.5,"SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A97730597-003-11-5,HEXYLCAINE,HEXYLCAINE
REP.PRIMARY,2.5,"CXCR1, PTGS1, PTGS2, SLC5A8",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A97739905-001-26-5,KETOPROFEN,KETOPROFEN
REP.PRIMARY,2.5,,,BRD:BRD-A98174560-001-02-1,CHLORALOSE,CHLORALOSE
REP.PRIMARY,2.5,ACHE,CHOLINESTERASE INHIBITOR,BRD:BRD-A98299281-050-09-6,"HYDROXYTACRINE-MALEATE-(R,S)","HYDROXYTACRINE-MALEATE-(R,S)"
REP.PRIMARY,2.5,CLCA1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A98378129-001-02-2,TALNIFLUMATE,TALNIFLUMATE
REP.PRIMARY,2.5,"SLC6A2, SLC6A3, SLC6A4",SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),BRD:BRD-A98845662-036-03-7,DESVENLAFAXINE,DESVENLAFAXINE
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A98990573-003-01-3,EPINASTINE,EPINASTINE
REP.PRIMARY,2.5,"TLR7, TLR9",ANTIMALARIAL AGENT,BRD:BRD-A99117172-065-04-0,HYDROXYCHLOROQUINE,HYDROXYCHLOROQUINE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A99388803-001-01-5,METIPRANOLOL,METIPRANOLOL
REP.PRIMARY,2.5,"CACNA1G, CACNA1H, CACNA1I",SUCCINIMIDE ANTIEPILEPTIC,BRD:BRD-A99633051-001-07-0,ETHOSUXIMIDE,ETHOSUXIMIDE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A99833829-003-27-1,BETHANECHOL,BETHANECHOL
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A99888680-001-03-8,PALIPERIDONE,PALIPERIDONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A99888680-001-04-6,PALIPERIDONE,PALIPERIDONE
REP.PRIMARY,2.5,CYP2C19,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A99939097-001-24-2,CARISOPRODOL,CARISOPRODOL
REP.PRIMARY,2.5,"ESR1, ESR2, MAP1A, MAP2","DNA SYNTHESIS INHIBITOR, MICROTUBULE INHIBITOR",BRD:BRD-K00077635-304-01-2,ESTRAMUSTINE-PHOSPHATE,ESTRAMUSTINE-PHOSPHATE
REP.PRIMARY,2.5,TLR7,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K00091711-001-01-2,RWJ-21757,RWJ-21757
REP.PRIMARY,2.5,"RARB, RARG",RETINOID RECEPTOR AGONIST,BRD:BRD-K00152668-001-01-5,ADAROTENE,ADAROTENE
REP.PRIMARY,2.5,"GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",MICROTUBULE INHIBITOR,BRD:BRD-K00259736-001-16-4,COLCHICINE,COLCHICINE
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K00312224-001-09-5,PPT,PPT
REP.PRIMARY,2.5,MDM2,MDM INHIBITOR,BRD:BRD-K00317371-001-06-1,RITA,RITA
REP.PRIMARY,2.5,PRKDC,DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K00337317-001-06-6,NU-7441,NU-7441
REP.PRIMARY,2.5,,,BRD:BRD-K00405906-001-01-9,PHLOROGLUCIN,PHLOROGLUCIN
REP.PRIMARY,2.5,"NGF, NGFR",NGF BINDING INHIBITOR,BRD:BRD-K00486786-001-02-2,RO-08-2750,RO-08-2750
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K00494077-066-01-9,TROVAFLOXACIN,TROVAFLOXACIN
REP.PRIMARY,2.5,,NEURAMINIDASE INHIBITOR,BRD:BRD-K00519864-341-03-3,PERAMIVIR,PERAMIVIR
REP.PRIMARY,2.5,"ITGA5, ITGAV, ITGB1, ITGB3",INTEGRIN ANTAGONIST,BRD:BRD-K00521308-019-01-9,ATN-161,ATN-161
REP.PRIMARY,2.5,,,BRD:BRD-K00535541-001-05-5,9-AMINOACRIDINE,9-AMINOACRIDINE
REP.PRIMARY,2.5,,,BRD:BRD-K00535541-001-06-3,9-AMINOACRIDINE,9-AMINOACRIDINE
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K00573984-003-01-5,DELAPRIL,DELAPRIL
REP.PRIMARY,2.5,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00603606-003-24-0,TICLOPIDINE,TICLOPIDINE
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00610438-003-02-5,ALTANSERIN,ALTANSERIN
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K00615600-001-12-9,AG-14361,AG-14361
REP.PRIMARY,2.5,HDAC6,HDAC INHIBITOR,BRD:BRD-K00627859-003-03-7,TUBASTATIN-A,TUBASTATIN-A
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K00662280-001-09-4,CL-218872,CL-218872
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00673382-001-18-9,FAMOTIDINE,FAMOTIDINE
REP.PRIMARY,2.5,CYP17A1,"ANDROGEN BIOSYNTHESIS INHIBITOR, ANDROGEN RECEPTOR ANTAGONIST, CYTOCHROME P450 INHIBITOR",BRD:BRD-K00674894-001-01-4,ORTERONEL,ORTERONEL
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR PARTIAL AGONIST,BRD:BRD-K00911143-001-01-9,BREXPIPRAZOLE,BREXPIPRAZOLE
REP.PRIMARY,2.5,"CCBL1, CRH, HCAR3",ENKEPHALINASE INHIBITOR,BRD:BRD-K00911807-003-01-2,D-PHENYLALANINE,D-PHENYLALANINE
REP.PRIMARY,2.5,,,BRD:BRD-K00926464-001-01-8,IMREG-1,IMREG-1
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K00938507-001-17-8,SULFAMETHOXYPYRIDAZINE,SULFAMETHOXYPYRIDAZINE
REP.PRIMARY,2.5,,"CHELATING AGENT, INSULIN SENSITIZER",BRD:BRD-K01029106-001-01-4,PICOLINIC-ACID,"CHROMIUM-PICOLINATE, PICOLINIC-ACID"
REP.PRIMARY,2.5,CBR1,MUCUS PROTECTING AGENT,BRD:BRD-K01039503-001-01-2,SOFALCONE,SOFALCONE
REP.PRIMARY,2.5,"AKR1D1, SRD5A1, SRD5A2",5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K01095011-001-15-9,FINASTERIDE,FINASTERIDE
REP.PRIMARY,2.5,HPD,HYDROXYPHENYLPYRUVATE DIOXYGENASE INHIBITOR,BRD:BRD-K01109406-001-03-7,NITISINONE,NITISINONE
REP.PRIMARY,2.5,GHSR,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K01174345-001-01-9,ANAMORELIN,ANAMORELIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K01244426-236-12-1,CLOXACILLIN,CLOXACILLIN
REP.PRIMARY,2.5,"CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K01292756-001-25-0,PIMOZIDE,PIMOZIDE
REP.PRIMARY,2.5,,,BRD:BRD-K01294196-001-01-5,SUCROSE-OCTAACETATE,SUCROSE-OCTAACETATE
REP.PRIMARY,2.5,PYGL,,BRD:BRD-K01295354-001-02-8,URIC-ACID,URIC-ACID
REP.PRIMARY,2.5,PIK3CG,PI3K INHIBITOR,BRD:BRD-K01377300-001-01-1,CZC24832,CZC24832
REP.PRIMARY,2.5,"AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1","CASEIN KINASE INHIBITOR, CELL PROLIFERATION INHIBITOR",BRD:BRD-K01493881-001-29-4,APIGENIN,APIGENIN
REP.PRIMARY,2.5,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3",RNA POLYMERASE INHIBITOR,BRD:BRD-K01507359-001-22-9,RIFAMPIN,RIFAMPIN
REP.PRIMARY,2.5,"MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK",JNK INHIBITOR,BRD:BRD-K01567962-001-23-0,PYRAZOLANTHRONE,PYRAZOLANTHRONE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K01577834-001-15-1,ADENOSINE,ADENOSINE
REP.PRIMARY,2.5,,,BRD:BRD-K01614093-001-02-6,DIHYDROMYRICETIN,DIHYDROMYRICETIN
REP.PRIMARY,2.5,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K01624185-001-05-7,MALTOBIONIC-ACID,MALTOBIONIC-ACID
REP.PRIMARY,2.5,"MAOA, MAOB",NOREPINEPHRINE TRANSPORTER INHIBITOR,BRD:BRD-K01649396-003-07-1,INDATRALINE,INDATRALINE
REP.PRIMARY,2.5,,,BRD:BRD-K01653460-001-01-1,CHLORINDANOL,CHLORINDANOL
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K01663662-003-20-2,DIPHENIDOL,DIPHENIDOL
REP.PRIMARY,2.5,"RRM1, RRM2",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K01669786-001-02-2,TRIAPINE,TRIAPINE
REP.PRIMARY,2.5,"HRH1, HRH2, HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K01674964-300-06-3,HISTAMINE,HISTAMINE
REP.PRIMARY,2.5,AURKB,AURORA KINASE INHIBITOR,BRD:BRD-K01683783-001-02-6,TAK-901,TAK-901
REP.PRIMARY,2.5,"ADRA2A, ADRA2C, HRH3, HRH4, HTR3A",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K01767299-050-02-1,CIPROXIFAN,CIPROXIFAN
REP.PRIMARY,2.5,MERTK,MER TYROSINE KINASE INHIBITOR,BRD:BRD-K01773560-001-02-4,UNC2250,UNC2250
REP.PRIMARY,2.5,AHR,"ARYL HYDROCARBON RECEPTOR AGONIST, INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K01815685-001-15-5,INDOLE-3-CARBINOL,INDOLE-3-CARBINOL
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K01824921-001-18-5,DPCPX,DPCPX
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K01868942-003-02-7,RS-23597-190,RS-23597-190
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K01902415-001-11-7,PIRINIXIC-ACID,PIRINIXIC-ACID
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K01942991-005-08-2,OXOTREMORINE-M,OXOTREMORINE-M
REP.PRIMARY,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K01950558-001-14-7,SUCCINYLSULFATHIAZOLE,SUCCINYLSULFATHIAZOLE
REP.PRIMARY,2.5,"SLC6A1, SLC6A11, SLC6A12, SLC6A13",GABA UPTAKE INHIBITOR,BRD:BRD-K01980392-003-11-6,GUVACINE,GUVACINE
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K01995783-001-01-6,AMG-9810,AMG-9810
REP.PRIMARY,2.5,JAK2,JAK INHIBITOR,BRD:BRD-K02017404-300-06-2,NVP-BSK805,NVP-BSK805
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K02079473-001-01-3,OXATOMIDE,OXATOMIDE
REP.PRIMARY,2.5,"PARP1, PARP2",PARP INHIBITOR,BRD:BRD-K02113016-001-15-4,OLAPARIB,OLAPARIB
REP.PRIMARY,2.5,MET,TYROSINE KINASE INHIBITOR,BRD:BRD-K02123250-001-06-7,JNJ-38877605,JNJ-38877605
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K02130563-001-11-4,PANOBINOSTAT,PANOBINOSTAT
REP.PRIMARY,2.5,CHEK1,CHK INHIBITOR,BRD:BRD-K02241333-001-02-7,CHIR-124,CHIR-124
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4",NOREPINEPHRINE REPUTAKE INHIBITOR,BRD:BRD-K02265150-001-26-5,AMOXAPINE,AMOXAPINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K02292852-001-02-1,CEFOPERAZONE,CEFOPERAZONE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K02314383-001-01-3,EPITIOSTANOL,EPITIOSTANOL
REP.PRIMARY,2.5,"HDAC1, HDAC3",HDAC INHIBITOR,BRD:BRD-K02389548-001-02-5,RG2833,RG2833
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3","ADENOSINE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K02404261-001-16-7,CAFFEINE,CAFFEINE
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K02407574-001-09-7,PARBENDAZOLE,PARBENDAZOLE
REP.PRIMARY,2.5,,,BRD:BRD-K02464583-001-02-2,ETHYL-PARABEN,ETHYL-PARABEN
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K02475039-001-01-0,ETHOPABATE,ETHOPABATE
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K02501528-001-01-1,S18986,S18986
REP.PRIMARY,2.5,"CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K02594908-001-16-4,SULFANILAMIDE,SULFANILAMIDE
REP.PRIMARY,2.5,"CA12, PDPK1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K02637541-001-18-0,CELECOXIB,CELECOXIB
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K02703275-001-07-5,GEDUNIN,GEDUNIN
REP.PRIMARY,2.5,,TYROSINE HYDROXYLASE INHIBITOR,BRD:BRD-K02715688-001-02-1,"HYDRASTINE-(1R,9S)","HYDRASTINE-(1R,-9S), HYDRASTINE-(1R,9S)"
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K02733959-236-07-7,CEFUROXIME,CEFUROXIME
REP.PRIMARY,2.5,,ANTHELMINTIC AGENT,BRD:BRD-K02764365-001-13-6,METHIAZOLE,METHIAZOLE
REP.PRIMARY,2.5,,,BRD:BRD-K02816415-001-01-9,CRT0044876,CRT0044876
REP.PRIMARY,2.5,"ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4",SEROTONIN REUPTAKE INHIBITOR,BRD:BRD-K02867583-300-08-9,MINAPRINE,MINAPRINE
REP.PRIMARY,2.5,"MAN1B1, MAN2A1",MANNOSIDASE INHIBITOR,BRD:BRD-K02898090-001-02-7,KIFUNENSINE,KIFUNENSINE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K02900412-001-11-3,CLOFOCTOL,CLOFOCTOL
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K02908048-003-06-4,PRECLAMOL,PRECLAMOL
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K02943813-001-01-9,DASABUVIR,DASABUVIR
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K02950022-001-02-9,BMS-299897,BMS-299897
REP.PRIMARY,2.5,SLCO1A2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K02953697-001-09-2,NARINGIN,NARINGIN
REP.PRIMARY,2.5,MET,"HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K02965346-001-07-5,SU11274,"SU-11274, SU11274"
REP.PRIMARY,0.25,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K02965577-001-03-4,SECALCIFEROL,SECALCIFEROL
REP.PRIMARY,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K02992638-001-11-8,LAMIVUDINE,LAMIVUDINE
REP.PRIMARY,2.5,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K03063480-001-05-8,PF-477736,PF-477736
REP.PRIMARY,2.5,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K03063480-001-06-6,PF-477736,PF-477736
REP.PRIMARY,2.5,"KCNJ11, KCNJ8, PDE3A, TNNC1",CALCIUM SENSITIZER,BRD:BRD-K03095347-001-06-1,LEVOSIMENDAN,LEVOSIMENDAN
REP.PRIMARY,2.5,"CDC25A, CDC25B, CDC25C",CDC INHIBITOR,BRD:BRD-K03109492-001-02-2,NSC-663284,NSC-663284
REP.PRIMARY,2.5,PPARD,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K03155172-001-02-2,GSK3787,GSK3787
REP.PRIMARY,2.5,,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K03164761-001-02-1,THIAZOVIVIN,THIAZOVIVIN
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K03194791-001-04-8,ROFLUMILAST,ROFLUMILAST
REP.PRIMARY,2.5,TYMS,"DNA DIRECTED DNA POLYMERASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K03243820-001-23-8,TRIFLURIDINE,TRIFLURIDINE
REP.PRIMARY,2.5,TYMS,"DNA DIRECTED DNA POLYMERASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K03243820-001-25-3,TRIFLURIDINE,TRIFLURIDINE
REP.PRIMARY,2.5,"CCNB1, CDK1, CDK5, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K03273112-001-01-8,1-AZAKENPAULLONE,1-AZAKENPAULLONE
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K03289018-001-02-7,CCT137690,CCT137690
REP.PRIMARY,2.5,,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K03289534-001-01-4,LERSIVIRINE,LERSIVIRINE
REP.PRIMARY,2.5,"CCNA2, CDK2",CDK INHIBITOR,BRD:BRD-K03294269-001-08-0,NU6027,"NU-6027, NU6027"
REP.PRIMARY,2.5,,CALMODULIN ANTAGONIST,BRD:BRD-K03301001-003-02-5,A-7,A-7
REP.PRIMARY,2.5,NOXO1,"GASTRIN INHIBITOR, UREASE INHIBITOR",BRD:BRD-K03353589-236-01-4,ECABET,ECABET
REP.PRIMARY,2.5,,"ANGIOGENESIS INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-K03384561-001-02-7,ROQUINIMEX,ROQUINIMEX
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-K03390685-001-01-7,COBIMETINIB,COBIMETINIB
REP.PRIMARY,2.5,"DNMT1, DNMT3A",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K03406345-001-27-8,AZACITIDINE,AZACITIDINE
REP.PRIMARY,2.5,"FLT1, FLT4, KDR, MET",VEGFR INHIBITOR,BRD:BRD-K03449891-001-08-6,FORETINIB,FORETINIB
REP.PRIMARY,2.5,CASP3,CASPASE ACTIVATOR,BRD:BRD-K03504028-001-07-6,AMYGDALIN,AMYGDALIN
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K03549949-001-01-0,XL388,XL388
REP.PRIMARY,2.5,,DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K03564313-001-03-3,DMNB,DMNB
REP.PRIMARY,2.5,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",MICROTUBULE STABILIZING AGENT,BRD:BRD-K03601870-001-01-2,IXABEPILONE,IXABEPILONE
REP.PRIMARY,2.5,PNP,PARP INHIBITOR,BRD:BRD-K03739921-001-06-8,HYPOXANTHINE,HYPOXANTHINE
REP.PRIMARY,2.5,"DRD2, DRD3, HTR1A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K04111260-001-10-0,RACLOPRIDE,RACLOPRIDE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K04112579-001-07-0,NEPAFENAC,NEPAFENAC
REP.PRIMARY,2.5,"IL1B, TNF",INTERLEUKIN INHIBITOR,BRD:BRD-K04176066-001-08-3,BERGENIN,BERGENIN
REP.PRIMARY,2.5,SCN10A,LOCAL ANESTHETIC,BRD:BRD-K04185004-003-11-9,OXYBUPROCAINE,OXYBUPROCAINE
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K04196797-001-24-4,OXCARBAZEPINE,OXCARBAZEPINE
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K04264130-001-01-4,FAVIPIRAVIR,FAVIPIRAVIR
REP.PRIMARY,2.5,"AR, NR3C2, PGR",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K04394237-001-03-7,DROSPIRENONE,DROSPIRENONE
REP.PRIMARY,2.5,"AR, NR3C2, PGR",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K04394237-001-06-0,DROSPIRENONE,DROSPIRENONE
REP.PRIMARY,2.5,TACR3,TACHYKININ ANTAGONIST,BRD:BRD-K04414442-001-08-3,SB-222200,SB-222200
REP.PRIMARY,2.5,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K04430056-001-17-7,7-NITROINDAZOLE,7-NITROINDAZOLE
REP.PRIMARY,2.5,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K04430056-236-02-1,7-NITROINDAZOLE,7-NITROINDAZOLE
REP.PRIMARY,2.5,"GPBAR1, NR1H4, NR1I2, VDR","FXR ANTAGONIST, VITAMIN D RECEPTOR AGONIST",BRD:BRD-K04497194-001-02-1,LITHOCHOLIC-ACID,LITHOCHOLIC-ACID
REP.PRIMARY,2.5,"CHD1, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K04548931-003-16-5,EPIRUBICIN,EPIRUBICIN
REP.PRIMARY,5,,,BRD:BRD-K04552268-001-02-4,4-PYRIMIDINECARBONITRILE,4-PYRIMIDINECARBONITRILE
REP.PRIMARY,2.5,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K04568635-300-01-4,OCTENIDINE,OCTENIDINE
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K04622161-001-02-3,YO-01027,YO-01027
REP.PRIMARY,2.5,TERT,TELOMERASE INHIBITOR,BRD:BRD-K04623885-001-07-5,BIBR-1532,BIBR-1532
REP.PRIMARY,2.5,,,BRD:BRD-K04657451-001-01-0,D-DELTA-TOCOPHEROL,D-DELTA-TOCOPHEROL
REP.PRIMARY,2.5,IDH2,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K04691817-001-01-8,AGI-6780,AGI-6780
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K04704168-003-14-3,CLEMIZOLE,CLEMIZOLE
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K04804440-001-09-5,CIPROFLOXACIN,CIPROFLOXACIN
REP.PRIMARY,2.5,"IGF1R, INSR","IGF-1 INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR, INSULIN RECEPTOR LIGAND",BRD:BRD-K04833372-001-06-2,GSK1904529A,GSK1904529A
REP.PRIMARY,2.5,CASP8,ANTICANCER AGENT,BRD:BRD-K04851519-001-06-8,ALOE-EMODIN,ALOE-EMODIN
REP.PRIMARY,2.5,"GSK3A, GSK3B","GLYCOGEN SYNTHASE KINASE INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-K04923131-001-15-4,GSK-3-INHIBITOR-IX,GSK-3-INHIBITOR-IX
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K04956647-003-02-5,NEBIVOLOL,NEBIVOLOL
REP.PRIMARY,2.5,,"ANTITUMOR AGENT, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-K04993719-001-01-7,LY2334737,LY2334737
REP.PRIMARY,1.57,,,BRD:BRD-K05048137-001-03-9,PHYTOSPHINGOSINE,PHYTOSPHINGOSINE
REP.PRIMARY,2.5,"MAP2K1, MAP3K1, MAP3K2",MEK INHIBITOR,BRD:BRD-K05104363-001-10-0,PD-184352,PD-184352
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K05151076-001-02-6,ZK-164015,ZK-164015
REP.PRIMARY,2.5,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K05181084-003-03-7,NGB-2904,NGB-2904
REP.PRIMARY,2.5,TOP1,GLUCOSIDASE INHIBITOR,BRD:BRD-K05236810-001-19-0,LUTEOLIN,LUTEOLIN
REP.PRIMARY,2.5,PRKCA,PROTEIN KINASE ACTIVATOR,BRD:BRD-K05361803-001-03-9,SC-10,SC-10
REP.PRIMARY,2.5,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K05395900-322-05-4,NICOTINE,NICOTINE
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K05434375-001-06-5,HA-1004,HA-1004
REP.PRIMARY,2.5,"PARP1, PARP2, TNKS, TNKS2",PARP INHIBITOR,BRD:BRD-K05444225-001-01-7,E7449,E7449
REP.PRIMARY,2.5,STAT3,STAT INHIBITOR,BRD:BRD-K05445342-001-05-3,WP1066,WP1066
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K05446112-001-01-8,LEDIPASVIR,LEDIPASVIR
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K05464208-001-05-7,JX-401,JX-401
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K05524748-003-04-4,DRONEDARONE,DRONEDARONE
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K05528470-305-02-2,L-745870,L-745870
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K05619559-001-12-7,TOBRAMYCIN,TOBRAMYCIN
REP.PRIMARY,2.5,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K05638300-001-01-2,SEVOFLURANE,SEVOFLURANE
REP.PRIMARY,2.5,,HIV INTEGRASE INHIBITOR,BRD:BRD-K05658747-001-02-9,RALTEGRAVIR,RALTEGRAVIR
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K05673000-236-12-1,DICLOXACILLIN,DICLOXACILLIN
REP.PRIMARY,2.5,,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",BRD:BRD-K05674516-001-01-7,SOFOSBUVIR,"PSI-7976, SOFOSBUVIR"
REP.PRIMARY,2.5,,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",BRD:BRD-K05674516-001-02-5,SOFOSBUVIR,"PSI-7976, SOFOSBUVIR"
REP.PRIMARY,2.5,PLA2G4A,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K05677083-001-05-4,PACOCF3,PACOCF3
REP.PRIMARY,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-06-0,AZ-628,"AZ 628, AZ-628"
REP.PRIMARY,2.5,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K05850076-001-01-5,SOTAGLIFLOZIN,SOTAGLIFLOZIN
REP.PRIMARY,2.5,"BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8",HDAC INHIBITOR,BRD:BRD-K05878375-236-05-7,SODIUM-BUTYRATE,SODIUM-BUTYRATE
REP.PRIMARY,2.5,"ATP4A, ATP4B",ATPASE INHIBITOR,BRD:BRD-K05900209-001-03-4,DEXLANSOPRAZOLE,DEXLANSOPRAZOLE
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-K05906022-001-05-1,LIMONIN,LIMONIN
REP.PRIMARY,2.5,TRPV1,TRPV AGONIST,BRD:BRD-K05907307-001-07-1,NONIVAMIDE,NONIVAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K05919151-001-01-6,DIXANTHOGEN,DIXANTHOGEN
REP.PRIMARY,2.5,CYP51A1,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K05977355-001-19-0,FLUCONAZOLE,FLUCONAZOLE
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K06147391-300-06-8,TELENZEPINE,TELENZEPINE
REP.PRIMARY,2.5,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1",MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-K06152156-001-01-8,METHOXYFLURANE,METHOXYFLURANE
REP.PRIMARY,2.5,CHRM2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K06181161-048-15-1,CARBETAPENTANE,CARBETAPENTANE
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K06208435-003-08-2,YS-035,YS-035
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K06221026-001-06-8,DUP-697,DUP-697
REP.PRIMARY,2.5,CYP3A4,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K06222852-001-03-2,POSACONAZOLE,POSACONAZOLE
REP.PRIMARY,2.5,TGFBR1,"P38 MAPK INHIBITOR, TGF BETA RECEPTOR INHIBITOR",BRD:BRD-K06234293-001-04-2,LY364947,LY364947
REP.PRIMARY,2.5,"NR1I2, SCN10A",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K06240250-001-01-6,RILPIVIRINE,RILPIVIRINE
REP.PRIMARY,2.5,BMP1,"PROCOLLAGEN C-ENDOPEPTIDASE INHIBITOR, PROCOLLAGEN C-ENDOPEPTIDASE INHIBITORS",BRD:BRD-K06294530-001-01-5,UK-383367,UK-383367
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, NISCH",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K06335600-003-20-7,TIZANIDINE,TIZANIDINE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K06388322-312-02-6,PRAMIPEXOLE,PRAMIPEXOLE
REP.PRIMARY,2.5,"AR, NR3C1, NR3C2",,BRD:BRD-K06408664-001-03-5,FLUDROCORTISONE-ACETATE,FLUDROCORTISONE-ACETATE
REP.PRIMARY,2.5,"CDK2, CDK4",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K06426971-001-02-7,RYUVIDINE,RYUVIDINE
REP.PRIMARY,2.5,ALK,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K06542892-001-01-9,ASP3026,ASP3026
REP.PRIMARY,2.5,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1",PKC INHIBITOR,BRD:BRD-K06543683-066-02-1,BISINDOLYLMALEIMIDE-IX,BISINDOLYLMALEIMIDE-IX
REP.PRIMARY,2.5,"CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1",CYTOCHROME P450 INHIBITOR,BRD:BRD-K06557128-001-07-0,VORICONAZOLE,VORICONAZOLE
REP.PRIMARY,2.5,RARB,RETINOID RECEPTOR AGONIST,BRD:BRD-K06593056-001-04-8,LE-135,LE-135
REP.PRIMARY,2.5,"HTR7, PLA2G2A",CANNABINOID RECEPTOR AGONIST,BRD:BRD-K06644925-001-03-0,OLEAMIDE,OLEAMIDE
REP.PRIMARY,2.5,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7",SERINE PROTEASE INHIBITOR,BRD:BRD-K06674495-334-03-2,NAFAMOSTAT,NAFAMOSTAT
REP.PRIMARY,2.5,"ALK, IGF1R, INSR, RPS6KA1",INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K06749501-001-02-1,GSK1838705A,GSK1838705A
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-K06753942-001-14-5,NOBILETIN,NOBILETIN
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K06762493-001-08-1,ISBUFYLLINE,ISBUFYLLINE
REP.PRIMARY,2.5,CDH5,"TUBULIN POLYMERIZATION INHIBITOR, VE-CADHERIN ANTAGONIST",BRD:BRD-K06814349-304-01-9,FOSBRETABULIN,FOSBRETABULIN
REP.PRIMARY,2.5,RARA,RETINOID RECEPTOR AGONIST,BRD:BRD-K06854232-001-19-9,AM-580,AM-580
REP.PRIMARY,2.5,"TUBA4A, TUBB, TUBB1",MICROTUBULE INHIBITOR,BRD:BRD-K06858286-001-01-3,CABAZITAXEL,CABAZITAXEL
REP.PRIMARY,2.5,UGT1A6,CHELATING AGENT,BRD:BRD-K06878038-001-18-6,DEFERIPRONE,DEFERIPRONE
REP.PRIMARY,2.5,CNR1,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K06900071-001-01-2,TEBIPENEM,TEBIPENEM
REP.PRIMARY,2.5,"ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1","KATP ACTIVATOR, KIR6 CHANNEL (KATP) ACTIVATOR, VASODILATOR",BRD:BRD-K06902185-003-01-7,MINOXIDIL,MINOXIDIL
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K06980535-003-25-9,PROMAZINE,PROMAZINE
REP.PRIMARY,2.5,"EGFR, ERBB2, ERBB4","EGFR INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",BRD:BRD-K07106112-003-03-8,BMS-599626,BMS-599626
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K07160047-001-01-3,FIACITABINE,FIACITABINE
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K07166362-330-02-8,STREPTOMYCIN,STREPTOMYCIN
REP.PRIMARY,2.5,,IMMUNOSUPPRESSANT,BRD:BRD-K07202345-001-19-4,FRENTIZOLE,FRENTIZOLE
REP.PRIMARY,2.5,"DHFR, TYMS",DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K07208025-001-29-7,TRIMETHOPRIM,TRIMETHOPRIM
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K07220430-001-18-4,CINNARAZINE,CINNARAZINE
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K07220430-001-19-2,CINNARAZINE,CINNARAZINE
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K07237224-001-19-6,MOCLOBEMIDE,MOCLOBEMIDE
REP.PRIMARY,2.5,"TOP2A, TOP2B","CHELATING AGENT, TOPOISOMERASE INHIBITOR",BRD:BRD-K07265709-003-05-6,DEXRAZOXANE,DEXRAZOXANE
REP.PRIMARY,2.5,,,BRD:BRD-K07283971-001-01-3,OXYCLOZANIDE,OXYCLOZANIDE
REP.PRIMARY,2.5,"MTOR, PIK3CA","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K07310275-001-02-5,PF-04691502,PF-04691502
REP.PRIMARY,2.5,AGER,ANTIOXIDANT,BRD:BRD-K07359318-001-03-9,BENFOTIAMINE,BENFOTIAMINE
REP.PRIMARY,2.5,,GONADOTROPIN INHIBITOR,BRD:BRD-K07441213-001-18-9,PAROXYPROPIONE,PAROXYPROPIONE
REP.PRIMARY,2.5,BAX,BAX ACTIVATOR,BRD:BRD-K07442505-001-03-6,BAM7,BAM7
REP.PRIMARY,2.5,"EGFR, JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K07487750-001-03-3,WHI-P154,WHI-P154
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K07507905-236-02-6,BRL-37344,BRL-37344
REP.PRIMARY,2.5,"APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CHRM3, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH","CYCLOOXYGENASE INHIBITOR, HISTONE ACETYLTRANSFERASE INHIBITOR, LIPOXYGENASE INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-K07572174-001-39-4,CURCUMIN,CURCUMIN
REP.PRIMARY,2.5,CCKAR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K07609981-001-01-7,DEXLOXIGLUMIDE,DEXLOXIGLUMIDE
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K07612980-001-05-3,SPARFLOXACIN,SPARFLOXACIN
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K07612980-001-07-9,SPARFLOXACIN,SPARFLOXACIN
REP.PRIMARY,2.5,"CDK2, CDK9",CDK INHIBITOR,BRD:BRD-K07691486-001-15-5,ROSCOVITINE,ROSCOVITINE
REP.PRIMARY,2.5,"IL1B, IL6, MAPK11, MAPK12, MAPK14, TNF",P38 MAPK INHIBITOR,BRD:BRD-K07736136-001-04-6,VX-702,VX-702
REP.PRIMARY,2.5,SCN5A,POLARIZATION INHIBITOR,BRD:BRD-K07753030-003-17-6,ACECAINIDE,ACECAINIDE
REP.PRIMARY,2.5,"CDK1, CDK2, CDK5, CDK6","CDK INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K07762753-001-04-4,AMINOPURVALANOL-A,AMINOPURVALANOL-A
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K07798980-001-01-9,PSI-6130,PSI-6130
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K07857022-002-01-1,ALVIMOPAN,ALVIMOPAN
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK","AURORA KINASE INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K07881437-001-03-8,DANUSERTIB,DANUSERTIB
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK","AURORA KINASE INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K07881437-001-04-6,DANUSERTIB,DANUSERTIB
REP.PRIMARY,2.5,"GP9, KCNB2, KCNN4, SLC29A4",HEMOZOIN BIOCRYSTALLIZATION INHIBITOR,BRD:BRD-K07940445-310-02-9,QUININE,QUININE
REP.PRIMARY,2.5,"NOS1, NOS2",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K07954936-001-01-3,2-IMINOBIOTIN,2-IMINOBIOTIN
REP.PRIMARY,2.5,"MTOR, PIK3CA","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K07955840-001-02-3,PF-05212384,PF-05212384
REP.PRIMARY,2.5,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K07972848-001-02-0,GSK2126458,GSK2126458
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K08033334-003-04-3,LINCOMYCIN,LINCOMYCIN
REP.PRIMARY,2.5,TYR,MELANIN INHIBITOR,BRD:BRD-K08037784-001-12-6,ARBUTIN,ARBUTIN
REP.PRIMARY,2.5,SLC6A3,CALCIUM CHANNEL BLOCKER,BRD:BRD-K08078237-001-19-8,TETRANDRINE,TETRANDRINE
REP.PRIMARY,2.5,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K08109215-001-06-4,I-BET-762,I-BET-762
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K08109516-001-07-8,L-701324,L-701324
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K08111240-001-02-8,DANOPREVIR,DANOPREVIR
REP.PRIMARY,2.5,CD55,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K08111712-001-16-7,CHLORAMPHENICOL,CHLORAMPHENICOL
REP.PRIMARY,2.5,,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT",BRD:BRD-K08188887-001-02-4,ASTRAGALOSIDE-A,ASTRAGALOSIDE-A
REP.PRIMARY,2.5,,"DNA REPLICATION INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K08206212-002-01-0,ENTECAVIR,ENTECAVIR
REP.PRIMARY,2.5,"ERBB2, ERBB3, ERBB4, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K08223200-001-01-1,WAY-200070,WAY-200070
REP.PRIMARY,2.5,,,BRD:BRD-K08231299-001-08-1,PROPOXUR,PROPOXUR
REP.PRIMARY,2.5,"BIRC2, XIAP",XIAP INHIBITOR,BRD:BRD-K08248804-001-01-8,LCL-161,LCL-161
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K08251020-001-01-0,FALECALCITRIOL,FALECALCITRIOL
REP.PRIMARY,2.5,"AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K08252256-236-33-8,DICLOFENAC,DICLOFENAC
REP.PRIMARY,2.5,KRT12,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K08273968-001-19-0,GRISEOFULVIN,GRISEOFULVIN
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K08287586-001-14-3,BUTYL-PARABEN,BUTYL-PARABEN
REP.PRIMARY,2.5,,TRANSDERMAL ABSORPTION-ENHANCING COMPOUND,BRD:BRD-K08288352-001-03-6,1-ETHYL-2-PYRROLIDONE,1-ETHYL-2-PYRROLIDONE
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K08303368-001-10-0,CHLORPYRIFOS,CHLORPYRIFOS
REP.PRIMARY,2.5,IGF1R,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K08310154-001-03-8,AG-1024,AG-1024
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K08356259-003-24-7,XYLOMETAZOLINE,XYLOMETAZOLINE
REP.PRIMARY,2.5,,,BRD:BRD-K08493205-001-04-9,SALICYL-ALCOHOL,SALICYL-ALCOHOL
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K08525451-003-05-2,SARAFLOXACIN,SARAFLOXACIN
REP.PRIMARY,0.8,BCL2,CASPASE ACTIVATOR,BRD:BRD-K08542803-001-03-1,GAMBOGIC-ACID,GAMBOGIC-ACID
REP.PRIMARY,2.5,"TOP1, TOP1MT",TOPOISOMERASE INHIBITOR,BRD:BRD-K08547377-394-03-5,IRINOTECAN,IRINOTECAN
REP.PRIMARY,2.5,"PTGDR2, TBXA2R",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K08586861-001-01-1,RAMATROBAN,RAMATROBAN
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K08619574-334-05-4,THIOPROPERAZINE,THIOPROPERAZINE
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K08619838-300-05-7,TREMORINE,TREMORINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K08640512-003-02-3,RS-100329,RS-100329
REP.PRIMARY,2.5,FDPS,BONE RESORPTION INHIBITOR,BRD:BRD-K08681769-323-03-7,IBANDRONATE,IBANDRONATE
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K08703257-001-12-1,3-AMINO-BENZAMIDE,3-AMINO-BENZAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K08791496-001-01-0,FENACLON,FENACLON
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K08799216-001-05-3,PELITINIB,PELITINIB
REP.PRIMARY,2.5,"CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1","AROMATASE INHIBITOR, TRPV ANTAGONIST",BRD:BRD-K08832567-001-11-5,NARINGENIN,NARINGENIN
REP.PRIMARY,2.5,,,BRD:BRD-K08837089-236-01-6,ACTINOQUINOL,ACTINOQUINOL
REP.PRIMARY,2.5,"ITGA2B, ITGB3",STRUCTURAL GLYCOPROTEIN ANTAGONIST,BRD:BRD-K08859203-001-01-9,DU-728,DU-728
REP.PRIMARY,2.5,NR1H4,FXR AGONIST,BRD:BRD-K08864679-001-02-2,FEXARAMINE,FEXARAMINE
REP.PRIMARY,2.5,"RGS4, RGS8",G PROTEIN SIGNALING INHIBITOR,BRD:BRD-K08893438-001-04-9,CCG-50014,CCG-50014
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K08924299-003-06-1,PALONOSETRON,PALONOSETRON
REP.PRIMARY,2.5,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K08953028-001-09-6,U-0521,U-0521
REP.PRIMARY,2.5,"AKR1D1, SRD5A2, TYR",TYROSINASE INHIBITOR,BRD:BRD-K08976401-001-18-5,AZELAIC-ACID,AZELAIC-ACID
REP.PRIMARY,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K08996725-332-01-7,ZOLANTIDINE,ZOLANTIDINE
REP.PRIMARY,2.5,HTR2A,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K08998509-001-02-4,FANANSERIN,FANANSERIN
REP.PRIMARY,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K08999871-213-01-5,PIPEMIDIC-ACID,PIPEMIDIC-ACID
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K09090523-001-02-1,FIROCOXIB,FIROCOXIB
REP.PRIMARY,2.5,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K09090949-001-01-9,"CP-945,598","CP-945,598"
REP.PRIMARY,2.5,DBH,DOPAMINE BETA HYDROXYLASE INHIBITOR,BRD:BRD-K09126848-003-01-9,NEPICASTAT,NEPICASTAT
REP.PRIMARY,2.5,"CSNK1A1, CSNK1D, TGFB1",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K09132007-001-07-5,D-4476,D-4476
REP.PRIMARY,2.5,OPRK1,CHELATING AGENT,BRD:BRD-K09255212-001-16-6,CLIOQUINOL,CLIOQUINOL
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA6, CA9",,BRD:BRD-K09295674-001-09-8,CARZENIDE,CARZENIDE
REP.PRIMARY,2.5,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1",,BRD:BRD-K09338665-001-07-1,1-OCTANOL,1-OCTANOL
REP.PRIMARY,2.5,ABCB1,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K09353376-001-03-9,TARIQUIDAR,TARIQUIDAR
REP.PRIMARY,2.5,IMPDH1,INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,BRD:BRD-K09372874-001-01-0,MERIMEPODIB,MERIMEPODIB
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K09397065-003-06-1,SR-57227A,SR-57227A
REP.PRIMARY,2.5,"HDAC2, HMGCR, ITGAL, NR1I2",HMGCR INHIBITOR,BRD:BRD-K09416995-001-39-9,LOVASTATIN,LOVASTATIN
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K09426783-300-01-0,TAS-103,TAS-103
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K09443272-001-03-3,PHA-680632,PHA-680632
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K09471561-001-18-2,LEVOFLOXACIN,LEVOFLOXACIN
REP.PRIMARY,2.5,PRKDC,"DNA DEPENDENT PROTEIN KINASE INHIBITOR, MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K09537769-001-04-0,NU-7026,NU-7026
REP.PRIMARY,2.5,"ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4",T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K09549677-300-03-4,MIBEFRADIL,MIBEFRADIL
REP.PRIMARY,2.5,"ADCY2, ADCY5, GNAS",ADENYLYL CYCLASE ACTIVATOR,BRD:BRD-K09602097-001-13-6,FORSKOLIN,FORSKOLIN
REP.PRIMARY,2.5,RARG,RETINOID RECEPTOR AGONIST,BRD:BRD-K09619322-001-03-8,CD-1530,CD-1530
REP.PRIMARY,2.5,,,BRD:BRD-K09619578-001-01-3,DS2-(806622),DS2-(806622)
REP.PRIMARY,2.5,"PLCB2, PLCB3, PLCD1, PLCG1, PLCG2",PHOSPHOLIPASE ACTIVATOR,BRD:BRD-K09635314-001-03-4,M-3M3FBS,M-3M3FBS
REP.PRIMARY,2.5,"GABRB2, GABRB3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K09659835-003-01-4,LORECLEZOLE,LORECLEZOLE
REP.PRIMARY,2.5,PLA2G2A,SECRETORY PHOSPHOLIPASE INHIBITOR,BRD:BRD-K09711437-001-04-3,VARESPLADIB,VARESPLADIB
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-K09757388-065-04-0,ATAZANAVIR,ATAZANAVIR
REP.PRIMARY,2.5,TSPO,INOSITOL MONOPHOSPHATASE INHIBITOR,BRD:BRD-K09778810-001-10-6,FGIN-1-27,FGIN-1-27
REP.PRIMARY,2.5,HIF1A,DNA POLYMERASE INHIBITOR,BRD:BRD-K09785578-001-01-2,BAKUCHIOL,BAKUCHIOL
REP.PRIMARY,2.5,,FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K09877029-001-01-2,VS-4718,VS-4718
REP.PRIMARY,2.5,"ALOX5, MIF","HIV INTEGRASE INHIBITOR, LIPOXYGENASE INHIBITOR, NITRIC OXIDE PRODUCTION INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-K09900591-001-26-7,CAFFEIC-ACID,CAFFEIC-ACID
REP.PRIMARY,2.5,"BRAF, LIMK1, NEK11, RAF1, SIK1",RAF INHIBITOR,BRD:BRD-K09951645-001-06-8,DABRAFENIB,DABRAFENIB
REP.PRIMARY,2.5,,,BRD:BRD-K10029415-005-06-9,ENISAMIUM-IODIDE,ENISAMIUM-IODIDE
REP.PRIMARY,2.5,,LAXATIVE,BRD:BRD-K10065684-001-07-4,DANTRON,DANTRON
REP.PRIMARY,2.5,SLC5A2,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K10071630-001-01-0,ERTUGLIFLOZIN,ERTUGLIFLOZIN
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K10176267-001-03-3,L-701252,L-701252
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K10177585-003-02-4,PSB-11,PSB-11
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K10196357-003-02-0,BESIFLOXACIN,BESIFLOXACIN
REP.PRIMARY,2.5,,NOOTROPIC AGENT,BRD:BRD-K10314788-003-12-7,MECLOFENOXATE,MECLOFENOXATE
REP.PRIMARY,2.5,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K10362825-001-03-4,TENIPOSIDE,TENIPOSIDE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K10575656-034-01-0,MRS3777,"MRS-3777, MRS3777"
REP.PRIMARY,2.5,"CHRNA2, CHRNA3, CHRNA4, CHRNA6",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K10598093-303-06-1,HEXAMETHONIUM,HEXAMETHONIUM
REP.PRIMARY,2.5,"ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K10670311-001-15-5,SULFASALAZINE,SULFASALAZINE
REP.PRIMARY,2.5,DHPS,DIHYDROPTEROATE SYNTHETASE INHIBITOR,BRD:BRD-K10671814-001-14-8,SULFAPHENAZOLE,SULFAPHENAZOLE
REP.PRIMARY,2.5,NOS3,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K10673031-004-02-0,S-ISOPROPYLISOTHIOUREA,S-ISOPROPYLISOTHIOUREA
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K10705233-001-02-2,GW-405833,GW-405833
REP.PRIMARY,2.5,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K10706131-046-03-6,RIVASTIGMINE,RIVASTIGMINE
REP.PRIMARY,2.5,,,BRD:BRD-K10759144-001-04-3,XYLOSE,XYLOSE
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K10784860-003-02-3,TEMOCAPRIL,TEMOCAPRIL
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K10799896-001-26-2,CLOBETASOL-PROPIONATE,CLOBETASOL-PROPIONATE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K10836013-001-01-3,SITAFLOXACIN,SITAFLOXACIN
REP.PRIMARY,2.5,"PTGIS, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K10843433-001-22-7,PHENYLBUTAZONE,PHENYLBUTAZONE
REP.PRIMARY,2.5,"PTGIS, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K10843433-001-23-5,PHENYLBUTAZONE,PHENYLBUTAZONE
REP.PRIMARY,2.5,"ATP6V1A, MMP2, PTPN1","BONE RESORPTION INHIBITOR, OSTEOCLAST INHIBITOR",BRD:BRD-K10845183-304-01-6,TILUDRONATE,TILUDRONATE
REP.PRIMARY,2.5,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K10852020-001-04-5,TOLCAPONE,TOLCAPONE
REP.PRIMARY,2.5,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K10852020-001-05-2,TOLCAPONE,TOLCAPONE
REP.PRIMARY,2.5,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K10859802-001-01-0,APD668,APD668
REP.PRIMARY,2.5,,OCT ACTIVATOR,BRD:BRD-K10878147-001-02-2,OAC1,OAC1
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K10906636-001-02-9,SILODOSIN,SILODOSIN
REP.PRIMARY,2.5,PTGFR,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K10961822-001-05-1,LATANOPROST,LATANOPROST
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K10974103-001-21-1,DILOXANIDE,DILOXANIDE
REP.PRIMARY,2.5,,,BRD:BRD-K10990317-001-04-5,CLOTIAPINE,CLOTIAPINE
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K11046126-001-02-0,VUF10166,VUF10166
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K11071038-001-01-7,ICI-162846,ICI-162846
REP.PRIMARY,2.5,TNF,TUMOR NECROSIS FACTOR RELEASE INHIBITOR,BRD:BRD-K11073688-001-01-6,CPI-1189,CPI-1189
REP.PRIMARY,2.5,,HYDROGEN PEROXIDE DECOMPOSITION INHIBITOR,BRD:BRD-K11094367-001-10-1,ACETANILIDE,ACETANILIDE
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-K11099631-001-07-6,GADOTERATE-MEGLUMINE,GADOTERATE-MEGLUMINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K11124378-001-04-6,CEFTIBUTEN,CEFTIBUTEN
REP.PRIMARY,2.5,"LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1",LIPOPROTEIN LIPASE ACTIVATOR,BRD:BRD-K11129031-001-27-5,GEMFIBROZIL,GEMFIBROZIL
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K11153516-001-05-5,INIPARIB,INIPARIB
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K11196887-001-21-2,NORFLOXACIN,NORFLOXACIN
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K11196887-001-22-0,NORFLOXACIN,NORFLOXACIN
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K11215326-001-03-7,TAZEMETOSTAT,TAZEMETOSTAT
REP.PRIMARY,2.5,,DNA DAMAGE INDUCER,BRD:BRD-K11244467-001-08-5,AMBAZONE,AMBAZONE
REP.PRIMARY,2.5,"ALK, MET",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K11267252-001-04-4,ALECTINIB,ALECTINIB
REP.PRIMARY,2.5,ACHE,CHOLINESTERASE INHIBITOR,BRD:BRD-K11292736-300-02-8,AMBENONIUM,AMBENONIUM
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K11373525-003-02-1,ZD-7155,ZD-7155
REP.PRIMARY,2.5,"KCNJ8, PRKAA1",AMPK ACTIVATOR,BRD:BRD-K11399644-003-11-3,PHENFORMIN,PHENFORMIN
REP.PRIMARY,2.5,"GSR, GSTM2",,BRD:BRD-K11411329-001-01-3,NOV-002,NOV-002
REP.PRIMARY,2.5,"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K11433652-001-17-0,ASPIRIN,ASPIRIN
REP.PRIMARY,2.5,,MUCUS PROTECTING AGENT,BRD:BRD-K11510141-001-01-8,TEPRENONE,TEPRENONE
REP.PRIMARY,2.5,"HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K11558771-001-13-9,DROXINOSTAT,DROXINOSTAT
REP.PRIMARY,2.5,"ADORA2A, ESR2, FASN, MCL1, SLC22A12",CYTOCHROME P450 INHIBITOR,BRD:BRD-K11590034-002-03-4,MORIN,MORIN
REP.PRIMARY,2.5,,,BRD:BRD-K11595419-001-01-4,DIPEPTAMIN,DIPEPTAMIN
REP.PRIMARY,2.5,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K11630072-001-13-2,CARMOFUR,CARMOFUR
REP.PRIMARY,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-K11631773-001-10-8,SESAMIN,SESAMIN
REP.PRIMARY,2.5,"AURKA, AURKB, CDK1, CDK2",CDK INHIBITOR,BRD:BRD-K11636097-001-03-1,JNJ-7706621,JNJ-7706621
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K11640013-001-15-8,SULFAMETHAZINE,SULFAMETHAZINE
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K11640013-236-10-1,SULFAMETHAZINE,SULFAMETHAZINE
REP.PRIMARY,2.5,HDAC1,HDAC INHIBITOR,BRD:BRD-K11663430-001-02-3,PYROXAMIDE,PYROXAMIDE
REP.PRIMARY,2.5,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K11672787-001-01-5,ROSTAFUROXINE,ROSTAFUROXINE
REP.PRIMARY,2.5,,"IMIDAZOLINE RECEPTOR AGONIST, IMIDAZOLINE RECEPTOR LIGAND",BRD:BRD-K11696279-003-02-3,BU-239,BU-239
REP.PRIMARY,2.5,ABCC1,CHLORIDE CHANNEL BLOCKER,BRD:BRD-K11717138-001-30-3,BENZBROMARONE,BENZBROMARONE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K11742128-003-23-4,TRIPROLIDINE,TRIPROLIDINE
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K11756522-001-09-9,FURAZOLIDONE,FURAZOLIDONE
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K11796549-001-04-5,NBQX,NBQX
REP.PRIMARY,2.5,"EEF2, PARP1, PARP15, PARP3",PARP INHIBITOR,BRD:BRD-K11853856-001-01-7,PJ-34,PJ-34
REP.PRIMARY,2.5,,,BRD:BRD-K11900042-001-14-4,METHYLTHIOURACIL,METHYLTHIOURACIL
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K11911061-003-11-9,GR-127935,GR-127935
REP.PRIMARY,2.5,SYK,"MEDIATOR RELEASE INHIBITOR, SYK INHIBITOR",BRD:BRD-K11927976-050-02-9,ER-27319,ER-27319
REP.PRIMARY,2.5,TYMP,THYMIDINE PHOSPHORYLASE INHIBITOR,BRD:BRD-K11973162-003-01-8,TIPIRACIL,TIPIRACIL
REP.PRIMARY,2.5,,NITRIC OXIDE DONOR,BRD:BRD-K12014493-001-02-2,BETAINE,BETAINE
REP.PRIMARY,2.5,"AKT2, GSK3B, PKIA, PRKACA",AKT INHIBITOR,BRD:BRD-K12040459-001-06-0,AT7867,AT7867
REP.PRIMARY,2.5,,DNA ALKYLATING AGENT,BRD:BRD-K12047401-001-01-5,PALIFOSFAMIDE,PALIFOSFAMIDE
REP.PRIMARY,2.5,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K12068470-001-02-5,LY2608204,LY2608204
REP.PRIMARY,2.5,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K12068470-001-04-1,LY2608204,LY2608204
REP.PRIMARY,2.5,NPY1R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K12079898-001-02-6,PD-160170,PD-160170
REP.PRIMARY,2.5,"COMT, MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K12102668-001-25-5,NIALAMIDE,NIALAMIDE
REP.PRIMARY,2.5,"ITGA2B, ITGB3",INTEGRIN ANTAGONIST,BRD:BRD-K12120659-305-02-2,GR-144053,GR-144053
REP.PRIMARY,2.5,"ATR, MTOR, PIK3CA, PIK3CD, PIK3CG","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K12184916-001-15-4,NVP-BEZ235,NVP-BEZ235
REP.PRIMARY,2.5,"ABCC8, KCNJ10, KCNJ11, PPARG",SULFONYLUREA,BRD:BRD-K12219985-001-26-1,GLIPIZIDE,GLIPIZIDE
REP.PRIMARY,2.5,MAP2K2,MEK INHIBITOR,BRD:BRD-K12244279-001-05-8,MEK1-2-INHIBITOR,MEK1-2-INHIBITOR
REP.PRIMARY,2.5,"TUBA4A, TUBB",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K12251893-065-04-7,VINCRISTINE,VINCRISTINE
REP.PRIMARY,2.5,,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K12329651-001-18-8,ANDROSTERONE,ANDROSTERONE
REP.PRIMARY,2.5,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K12343256-001-08-9,TRAMETINIB,TRAMETINIB
REP.PRIMARY,2.5,"BRD4, JAK1, JAK2, JAK3, TYK2","FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K12502280-001-08-0,TG-101348,"FEDRATINIB, TG-101348"
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K12513978-001-24-1,FENBUFEN,FENBUFEN
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K12539416-001-01-4,SULBUTIAMINE,SULBUTIAMINE
REP.PRIMARY,2.5,HPGDS,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K12539581-001-23-7,NOCODAZOLE,NOCODAZOLE
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K12568846-001-14-6,AMIDOPYRINE,AMIDOPYRINE
REP.PRIMARY,2.5,,MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-K12609457-001-03-1,EXALAMIDE,EXALAMIDE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K12614344-003-01-8,CGS-21680,CGS-21680
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K12630395-001-14-9,HARMANE,HARMANE
REP.PRIMARY,2.5,"CSK, FGFR1, FLT1, FLT4, KDR, SRC","SRC INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K12735121-001-01-4,TG-100801,TG-100801
REP.PRIMARY,2.5,"PARP1, PARP2",PARP INHIBITOR,BRD:BRD-K12737986-001-01-4,VELIPARIB,VELIPARIB
REP.PRIMARY,2.5,"TNKS, TNKS2",TANKYRASE INHIBITOR,BRD:BRD-K12762134-001-06-2,XAV-939,XAV-939
REP.PRIMARY,2.5,,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K12769093-003-01-3,PNU-37883,PNU-37883
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K12787259-001-04-3,CX-5461,CX-5461
REP.PRIMARY,2.5,"AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1","BONE RESORPTION INHIBITOR, ESTROGEN-RELATED RECEPTOR INVERSE AGONIST",BRD:BRD-K12807006-001-18-5,KAEMPFEROL,KAEMPFEROL
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K12829205-003-02-8,MECHLORETHAMINE,MECHLORETHAMINE
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC6",HDAC INHIBITOR,BRD:BRD-K12867552-001-04-7,PCI-24781,PCI-24781
REP.PRIMARY,2.5,"CYP3A4, CYP3A5",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K12885236-001-02-7,DAPIVIRINE,DAPIVIRINE
REP.PRIMARY,2.5,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K12932420-001-02-3,YM-976,YM-976
REP.PRIMARY,2.5,,,BRD:BRD-K12968785-001-13-3,BERGAPTEN,BERGAPTEN
REP.PRIMARY,2.5,"CA12, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K12994359-001-18-4,VALDECOXIB,VALDECOXIB
REP.PRIMARY,2.5,ATP1A1,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K13044802-213-20-7,CICLOPIROX,CICLOPIROX
REP.PRIMARY,2.5,"AKT1, IGF1R",IGF-1 INHIBITOR,BRD:BRD-K13049116-001-05-7,BMS-754807,BMS-754807
REP.PRIMARY,2.5,"LSM6, TYMP",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K13050303-001-17-3,URIDINE,URIDINE
REP.PRIMARY,2.5,"LSM6, TYMP",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K13050303-001-18-1,URIDINE,URIDINE
REP.PRIMARY,2.5,CTPS1,"GAMMA GLUTAMYLTRANSFERASE INHIBITOR, GAMMA GLUTAMYLTRANSFERASE INHIBITORS",BRD:BRD-K13050541-001-01-9,ACIVICIN,ACIVICIN
REP.PRIMARY,2.5,"CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3",THIAZIDE DIURETIC,BRD:BRD-K13078532-001-28-4,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K13087974-001-02-5,CGP-52411,CGP-52411
REP.PRIMARY,2.5,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-K13094524-001-07-5,PFI-1,PFI-1
REP.PRIMARY,2.5,CYP2B6,DNA SYNTHESIS INHIBITOR,BRD:BRD-K13112821-001-17-4,ARTEMISININ,ARTEMISININ
REP.PRIMARY,2.5,HDAC1,HDAC INHIBITOR,BRD:BRD-K13167095-001-02-9,AR-42,AR-42
REP.PRIMARY,2.5,HDAC1,HDAC INHIBITOR,BRD:BRD-K13169950-001-14-4,NSC-3852,NSC-3852
REP.PRIMARY,2.5,TRDMT1,ANTI-PNEUMOCYSTIS AGENT,BRD:BRD-K13183738-317-10-2,PENTAMIDINE,PENTAMIDINE
REP.PRIMARY,2.5,"DRD3, DRD4, SCN1A, SCN3A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K13211965-003-02-8,L-741742,L-741742
REP.PRIMARY,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K13238168-001-02-0,HALOPROGIN,HALOPROGIN
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K13238618-001-05-9,CARSALAM,CARSALAM
REP.PRIMARY,2.5,GABRB3,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K13249881-001-02-3,PIPERAZINE,PIPERAZINE
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K13261168-300-01-0,QUINELORANE,QUINELORANE
REP.PRIMARY,2.5,"CNR1, GPR55",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K13296708-001-05-8,RIMONABANT,RIMONABANT
REP.PRIMARY,2.5,DKK1,WNT PATHWAY INHIBITOR,BRD:BRD-K13302470-001-02-7,KY02111,KY02111
REP.PRIMARY,2.5,"CYP3A4, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K13314656-001-01-0,EBASTINE,EBASTINE
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K13356952-001-25-1,METHAZOLAMIDE,METHAZOLAMIDE
REP.PRIMARY,2.5,,ATPASE INHIBITOR,BRD:BRD-K13387373-004-14-5,THONZONIUM,THONZONIUM
REP.PRIMARY,2.5,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9",CDK INHIBITOR,BRD:BRD-K13390322-001-06-3,AT-7519,AT-7519
REP.PRIMARY,2.5,,,BRD:BRD-K13409143-001-01-9,ISOPROPYL-MYRISTATE,ISOPROPYL-MYRISTATE
REP.PRIMARY,2.5,NOS2,CYCLIN D INHIBITOR,BRD:BRD-K13421763-001-06-2,AMINOTHIAZOLE,AMINOTHIAZOLE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5, GABRG2",GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K13474508-001-01-2,"L-655,708","L-655,708"
REP.PRIMARY,2.5,,,BRD:BRD-K13486660-001-01-0,SULFACARBAMIDE,SULFACARBAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K13495773-001-11-4,CREATININE,CREATININE
REP.PRIMARY,2.5,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K13511380-001-01-4,NARINGIN-DIHYDROCHALCONE,NARINGIN-DIHYDROCHALCONE
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K13514097-001-05-3,EVEROLIMUS,EVEROLIMUS
REP.PRIMARY,2.5,"CHUK, IKBKB",IKK INHIBITOR,BRD:BRD-K13566078-001-02-3,BMS-345541,BMS-345541
REP.PRIMARY,2.5,"CTSB, CTSD, CTSL, REN",ASPARTIC PROTEASE INHIBITOR,BRD:BRD-K13571841-001-14-4,PEPSTATIN,PEPSTATIN
REP.PRIMARY,2.5,USP7,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K13606314-001-01-3,P5091,P5091
REP.PRIMARY,2.5,,,BRD:BRD-K13619941-213-01-8,ACEGLUTAMIDE,ACEGLUTAMIDE
REP.PRIMARY,2.5,"FLT3, PRKCG","FLT3 INHIBITOR, KIT INHIBITOR, PKC INHIBITOR",BRD:BRD-K13646352-001-03-8,MIDOSTAURIN,MIDOSTAURIN
REP.PRIMARY,2.5,"CDK1, CDK2, CDK5, CDK9",CDK INHIBITOR,BRD:BRD-K13662825-001-07-5,DINACICLIB,DINACICLIB
REP.PRIMARY,2.5,"SLC6A5, SLC6A9","GLYCINE TRANSPORTER INHIBITOR, GLYT-1 INHIBITOR",BRD:BRD-K13756951-001-01-4,BITOPERTIN,BITOPERTIN
REP.PRIMARY,2.5,LTF,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K13800121-001-01-5,PARECOXIB,PARECOXIB
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K13810148-311-03-2,GIVINOSTAT,GIVINOSTAT
REP.PRIMARY,2.5,ACHE,"ACETYLCHOLINESTERASE INHIBITOR, MONOAMINE OXIDASE INHIBITOR",BRD:BRD-K13819402-003-10-2,DESOXYPEGANINE,DESOXYPEGANINE
REP.PRIMARY,2.5,GRIA2,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K13829090-303-02-9,IEM1460,IEM1460
REP.PRIMARY,2.5,SLC6A9,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",BRD:BRD-K13888115-003-02-2,LY2365109,LY2365109
REP.PRIMARY,2.5,"PDE5A, PDE6G, PDE6H",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K13926615-003-03-3,VARDENAFIL,VARDENAFIL
REP.PRIMARY,2.5,"SIRT1, SIRT2, SIRT3",SIRT INHIBITOR,BRD:BRD-K13949769-001-01-7,TENOVIN-6,TENOVIN-6
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K13994703-003-15-8,PROPRANOLOL-(S),PROPRANOLOL-(S)
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K14003026-003-09-0,RITODRINE,RITODRINE
REP.PRIMARY,2.5,CHEK1,CHK INHIBITOR,BRD:BRD-K14109347-001-03-4,LY2603618,LY2603618
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K14116214-001-09-6,SULFAMONOMETHOXINE,SULFAMONOMETHOXINE
REP.PRIMARY,2.5,"CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K14127446-005-22-7,ISOPROPAMIDE-IODIDE,ISOPROPAMIDE-IODIDE
REP.PRIMARY,2.5,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K14175878-001-01-6,MK-0812,MK-0812
REP.PRIMARY,2.5,CHRNA7,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K14235254-001-01-2,GTS21,GTS21
REP.PRIMARY,2.5,CACNA1C,L-TYPE CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K14329163-001-03-9,BAY-K-8644-(S)-(-),BAY-K-8644-(S)-(-)
REP.PRIMARY,2.5,"DDC, PDXK",VITAMIN B,BRD:BRD-K14349461-003-13-1,PYRIDOXINE,PYRIDOXINE
REP.PRIMARY,2.5,"EGLN1, EGLN2, EGLN3",HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K14385366-001-04-4,FG-4592,FG-4592
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K14395568-001-16-3,NECA,NECA
REP.PRIMARY,2.5,TYR,"TOPICAL SUNSCREEN AGENT, UV BLOCKER",BRD:BRD-K14401183-001-10-7,AVOBENZONE,AVOBENZONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K14496212-066-04-8,BROMOCRIPTINE,BROMOCRIPTINE
REP.PRIMARY,2.5,STAT3,STAT INHIBITOR,BRD:BRD-K14529030-001-01-9,MEISOINDIGO,MEISOINDIGO
REP.PRIMARY,2.5,"CDK1, CDK2, CDK7, CDK9, FLT3, JAK2","CDK INHIBITOR, FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K14560436-001-01-4,TG-02,TG-02
REP.PRIMARY,2.5,IKBKB,IKK INHIBITOR,BRD:BRD-K14618467-001-04-6,IKK-16,IKK-16
REP.PRIMARY,2.5,PGR,PROGESTOGEN HORMONE,BRD:BRD-K14619660-001-01-5,ALTRENOGEST,ALTRENOGEST
REP.PRIMARY,2.5,HDAC4,"ANGIOGENESIS INHIBITOR, S100A9 INHIBITOR",BRD:BRD-K14653796-001-01-1,TASQUINIMOD,TASQUINIMOD
REP.PRIMARY,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K14704277-001-22-6,CINOXACIN,CINOXACIN
REP.PRIMARY,2.5,,DIHYDROPTEROATE SYNTHASE INHIBITOR,BRD:BRD-K14705039-001-16-4,SULFATHIAZOLE,SULFATHIAZOLE
REP.PRIMARY,2.5,RPS6KB1,RIBOSOMAL PROTEIN INHIBITOR,BRD:BRD-K14711741-001-02-1,PF-4708671,PF-4708671
REP.PRIMARY,2.5,,,BRD:BRD-K14762862-001-01-9,I-BZA,I-BZA
REP.PRIMARY,2.5,,,BRD:BRD-K14763542-001-02-3,FLUROTHYL,FLUROTHYL
REP.PRIMARY,2.5,SLC18A3,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K14765469-003-12-2,VESAMICOL,VESAMICOL
REP.PRIMARY,2.5,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K14767410-001-02-3,SC-560,SC-560
REP.PRIMARY,2.5,LDLR,LDL RECEPTOR ACTIVATOR,BRD:BRD-K14796088-003-26-8,BERBERINE,BERBERINE
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K14807180-001-02-5,SB-221284,SB-221284
REP.PRIMARY,2.5,AXL,AXL KINASE INHIBITOR,BRD:BRD-K14870255-001-02-3,R-428,R-428
REP.PRIMARY,2.5,"PPARA, PPARD",PPAR RECEPTOR AGONIST,BRD:BRD-K14880289-001-02-2,GW-501516,GW-501516
REP.PRIMARY,2.5,,COLORING AGENT,BRD:BRD-K14920963-304-02-7,ERYTHROSINE,ERYTHROSINE
REP.PRIMARY,2.5,"ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K14965640-001-12-4,IBUPROFEN-(S),IBUPROFEN-(S)
REP.PRIMARY,2.5,"SGK1, SGK2",SERUM/GLUCOCORTICOID REGULATED KINASE INHIBITOR,BRD:BRD-K14991967-001-02-6,GSK650394,GSK650394
REP.PRIMARY,2.5,GABRA1,CHEMORECEPTOR AGONIST,BRD:BRD-K14993104-001-05-9,BEMEGRIDE,BEMEGRIDE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K15010214-364-02-7,EMEDASTINE,EMEDASTINE
REP.PRIMARY,2.5,RELA,NFKB PATHWAY INHIBITOR,BRD:BRD-K15025317-001-15-1,BAY-11-7082,BAY-11-7082
REP.PRIMARY,2.5,,,BRD:BRD-K15045219-001-01-8,SALAZODINE,SALAZODINE
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K15071410-001-01-1,TIOTIDINE,TIOTIDINE
REP.PRIMARY,2.5,HRH4,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K15086322-050-01-3,JNJ-10191584,JNJ-10191584
REP.PRIMARY,2.5,"CMPK1, RRM1, RRM2, TYMS",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K15108141-001-06-6,GEMCITABINE,GEMCITABINE
REP.PRIMARY,2.5,"BCHE, CES1",CARBOXYLESTERASE INHIBITOR,BRD:BRD-K15164005-001-05-6,APOPTOSIS-ACTIVATOR-II,APOPTOSIS-ACTIVATOR-II
REP.PRIMARY,2.5,MAN2A1,ALPHA MANNOSIDASE INHIBITOR,BRD:BRD-K15170068-001-03-2,SWAINSONINE,SWAINSONINE
REP.PRIMARY,2.5,IGF1R,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K15179513-001-03-4,NVP-ADW742,NVP-ADW742
REP.PRIMARY,2.5,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9",PROTEASOME INHIBITOR,BRD:BRD-K15179879-001-03-2,CARFILZOMIB,CARFILZOMIB
REP.PRIMARY,2.5,HCAR3,HYDROXYCARBOXYLIC ACID RECEPTOR AGONIST,BRD:BRD-K15196155-001-02-3,IBC-293,IBC-293
REP.PRIMARY,2.5,PPARG,,BRD:BRD-K15231341-001-01-5,HEMOMEX-S,HEMOMEX-S
REP.PRIMARY,2.5,"HSD11B1, HSD11B2, SLCO1B1, SLCO1B3",THROMBIN INHIBITOR,BRD:BRD-K15318383-201-01-5,AMMONIUM-GLYCYRRHIZINATE,AMMONIUM-GLYCYRRHIZINATE
REP.PRIMARY,2.5,ACHE,TP53 INHIBITOR,BRD:BRD-K15318909-001-10-5,PRIMA1,PRIMA1
REP.PRIMARY,2.5,,,BRD:BRD-K15337272-001-01-3,C-751,C-751
REP.PRIMARY,2.5,CACNA1G,T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K15409150-001-05-8,PENFLURIDOL,PENFLURIDOL
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K15424032-001-03-6,SB-228357,SB-228357
REP.PRIMARY,2.5,PTGS2,"CYCLOOXYGENASE INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-K15426076-001-01-2,IGURATIMOD,IGURATIMOD
REP.PRIMARY,2.5,"CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K15502390-001-20-9,NEVIRAPINE,NEVIRAPINE
REP.PRIMARY,2.5,"PPARA, PPARG","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-K15507868-001-03-7,TESAGLITAZAR,TESAGLITAZAR
REP.PRIMARY,2.5,SLC6A3,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K15519488-050-01-3,CS-110266,CS-110266
REP.PRIMARY,2.5,"AQP9, CLCN3, SLC23A1",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K15563106-001-18-0,PHLORETIN,PHLORETIN
REP.PRIMARY,2.5,"PDE10A, PDE4B, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K15567136-003-27-2,PAPAVERINE,PAPAVERINE
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K15588452-003-02-7,R-96544,R-96544
REP.PRIMARY,2.5,BCL2,BCL INHIBITOR,BRD:BRD-K15600710-066-04-1,OBATOCLAX,OBATOCLAX
REP.PRIMARY,2.5,S1PR1,LYSOPHOSPHOLIPID RECEPTOR AGONIST,BRD:BRD-K15601958-001-03-9,SEW-2871,SEW-2871
REP.PRIMARY,2.5,"AKR1C2, NR1H4","LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K15697815-001-16-2,URSODIOL,URSODIOL
REP.PRIMARY,2.5,MPO,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K15766189-001-09-8,CEFDINIR,CEFDINIR
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K15791587-003-02-5,L-733060,L-733060
REP.PRIMARY,2.5,,ANTHELMINTIC AGENT,BRD:BRD-K15834839-001-02-3,LOBENDAZOLE,LOBENDAZOLE
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K15868788-003-07-7,SDZ-205-557,SDZ-205-557
REP.PRIMARY,2.5,,"HIV INTEGRASE INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K15891719-001-05-1,TENOFOVIR,TENOFOVIR
REP.PRIMARY,2.5,,,BRD:BRD-K15898725-001-01-7,MAYTANSINOL-ISOBUTYRATE,MAYTANSINOL-ISOBUTYRATE
REP.PRIMARY,2.5,"CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8","CYTOCHROME P450 INHIBITOR, IMIDAZOLINE RECEPTOR LIGAND",BRD:BRD-K15916496-001-27-9,CLOTRIMAZOLE,CLOTRIMAZOLE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K15933101-003-06-1,ROPINIROLE,ROPINIROLE
REP.PRIMARY,2.5,TK2,DNA POLYMERASE INHIBITOR,BRD:BRD-K15976406-001-03-3,TELBIVUDINE,TELBIVUDINE
REP.PRIMARY,2.5,CACNA2D1,N-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K16037980-001-01-1,Z160,Z160
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K16077845-001-06-1,FENTIAZAC,FENTIAZAC
REP.PRIMARY,2.5,"KCNQ1, KCNQ2, KCNQ4, KCNQ5",ATP SYNTHASE INHIBITOR,BRD:BRD-K16136380-001-01-7,PYRITHIONE-ZINC,PYRITHIONE-ZINC
REP.PRIMARY,2.5,"CDK1, GSK3A, GSK3B, MAPK1",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K16189898-003-03-3,CHIR-99021,CHIR-99021
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K16195444-003-26-0,OXYMETAZOLINE,OXYMETAZOLINE
REP.PRIMARY,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K16277217-001-10-9,PIPERACETAZINE,PIPERACETAZINE
REP.PRIMARY,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K16295392-003-01-3,ATRASENTAN,ATRASENTAN
REP.PRIMARY,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K16338837-001-02-6,CCMI,CCMI
REP.PRIMARY,2.5,"IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A","LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K16444452-001-09-1,IBUDILAST,IBUDILAST
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K16474819-001-09-6,METACETAMOL,METACETAMOL
REP.PRIMARY,2.5,"BRAF, KDR",RAF INHIBITOR,BRD:BRD-K16478699-001-09-2,PLX4720,"PLX-4720, PLX4720"
REP.PRIMARY,2.5,"CHRM2, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K16484091-001-01-1,METOCURINE,METOCURINE
REP.PRIMARY,2.5,"HDAC1, HDAC11, HDAC2, HDAC3",HDAC INHIBITOR,BRD:BRD-K16485616-001-08-9,MOCETINOSTAT,MOCETINOSTAT
REP.PRIMARY,2.5,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K16508793-001-05-9,DIAZEPAM,DIAZEPAM
REP.PRIMARY,2.5,"GPR35, PDE1A, PDE4D, PDE5A, PDE9A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K16542329-001-13-5,ZAPRINAST,ZAPRINAST
REP.PRIMARY,2.5,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K16551357-001-03-2,EVACETRAPIB,EVACETRAPIB
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C, MAOA, MAOB",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K16551401-003-03-4,PNU-22394,PNU-22394
REP.PRIMARY,2.5,"CSF1R, FLT3, KIT, PDGFRB","FLT3 INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K16664969-001-03-3,GTP-14564,GTP-14564
REP.PRIMARY,2.5,"ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK","FGFR INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAF INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K16730910-001-07-3,REGORAFENIB,REGORAFENIB
REP.PRIMARY,2.5,GCGR,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K16732600-001-01-7,MK-0893,MK-0893
REP.PRIMARY,2.5,HTR2B,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K16757695-050-02-5,PRX-08066,PRX-08066
REP.PRIMARY,2.5,,,BRD:BRD-K16758059-001-01-8,PERFLUAMINE,PERFLUAMINE
REP.PRIMARY,2.5,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ",PKC INHIBITOR,BRD:BRD-K16761703-001-03-8,SOTRASTAURIN,SOTRASTAURIN
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K16803204-001-01-6,FILGOTINIB,FILGOTINIB
REP.PRIMARY,2.5,PORCN,PORCUPINE INHIBITOR,BRD:BRD-K16810791-001-01-0,LGK-974,LGK-974
REP.PRIMARY,2.5,,HIV CAPSID ASSEMBLY INHIBITOR,BRD:BRD-K16898998-001-01-6,BEVIRIMAT-DIMEGLUMINE,BEVIRIMAT-DIMEGLUMINE
REP.PRIMARY,2.5,,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K17008822-303-02-1,BD-1008,BD-1008
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K17016787-001-16-7,ESTRIOL,ESTRIOL
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K17026858-001-01-2,PIBENZIMOL,PIBENZIMOL
REP.PRIMARY,2.5,,,BRD:BRD-K17061841-001-03-5,STATTIC,STATTIC
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K17068645-003-04-2,BENDAMUSTINE,BENDAMUSTINE
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K17075857-001-17-6,CHLOROXINE,CHLOROXINE
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K17075857-001-18-4,CHLOROXINE,CHLOROXINE
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FGFR4, KDR",FGFR ANTAGONIST,BRD:BRD-K17203476-001-01-9,LY2874455,LY2874455
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K17205817-001-06-1,SULFAMETOPYRAZINE,SULFAMETOPYRAZINE
REP.PRIMARY,2.5,,ATP SYNTHASE INHIBITOR,BRD:BRD-K17223896-001-10-0,CHLOROXYLENOL,CHLOROXYLENOL
REP.PRIMARY,2.5,"ACHE, DRD2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K17294426-050-12-3,CLEBOPRIDE,CLEBOPRIDE
REP.PRIMARY,2.5,"HSD11B1, HSD11B2",11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K17368287-001-18-3,ADRENOSTERONE,ADRENOSTERONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K17378184-300-05-9,BP-897,BP-897
REP.PRIMARY,2.5,EGFR,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K17415526-001-03-5,TYRPHOSTIN-AG-835,TYRPHOSTIN-AG-835
REP.PRIMARY,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K17443395-065-02-2,ABACAVIR,ABACAVIR
REP.PRIMARY,2.5,ACE,"EGFR INHIBITOR, SRC INHIBITOR",BRD:BRD-K17497770-001-03-6,BUTEIN,BUTEIN
REP.PRIMARY,2.5,"ADRB1, ADRB2, CHRNA2","ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR ANTAGONIST",BRD:BRD-K17498618-344-02-6,CISATRACURIUM,"BETAXOLOL, CISATRACURIUM"
REP.PRIMARY,2.5,,INTERFERON INDUCER,BRD:BRD-K17500877-001-02-1,BROPIRIMINE,BROPIRIMINE
REP.PRIMARY,2.5,ITGA4,INTEGRIN ANTAGONIST,BRD:BRD-K17513304-001-01-9,FIRATEGRAST,FIRATEGRAST
REP.PRIMARY,2.5,,CHELATING AGENT,BRD:BRD-K17518951-001-03-0,PENICILLAMINE-(D),PENICILLAMINE-(D)
REP.PRIMARY,2.5,"IL1B, MAPK11, MAPK14, MT-CO2, TNF",P38 MAPK INHIBITOR,BRD:BRD-K17555800-003-01-5,TALMAPIMOD,TALMAPIMOD
REP.PRIMARY,2.5,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K17561142-003-32-5,AMIODARONE,AMIODARONE
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-K17565903-066-23-1,PRIDINOL,PRIDINOL
REP.PRIMARY,2.5,"EGFR, ERBB2, SRC",EGFR INHIBITOR,BRD:BRD-K17702546-001-03-2,PD-168393,PD-168393
REP.PRIMARY,2.5,OPRL1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K17705806-003-04-4,JTC-801,JTC-801
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K17743125-001-08-4,BELINOSTAT,BELINOSTAT
REP.PRIMARY,2.5,"SLC8A1, TRPC3, TRPC5, TRPC6",SODIUM/CALCIUM EXCHANGE INHIBITOR,BRD:BRD-K17743697-066-03-6,KB-R7943,KB-R7943
REP.PRIMARY,2.5,HRH4,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K17774839-001-02-9,JNJ-7777120,JNJ-7777120
REP.PRIMARY,2.5,"HPGDS, HRH1",ANGIOGENESIS INHIBITOR,BRD:BRD-K17849083-001-31-1,TRANILAST,TRANILAST
REP.PRIMARY,2.5,"HPGDS, HRH1",ANGIOGENESIS INHIBITOR,BRD:BRD-K17849083-001-32-9,TRANILAST,TRANILAST
REP.PRIMARY,2.5,"PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R",PROSTAGLANDIN RECEPTOR AGONIST,BRD:BRD-K17850764-236-11-9,CLOPROSTENOL-(+/-),CLOPROSTENOL-(+/-)
REP.PRIMARY,2.5,"HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K17868609-001-05-0,BRL-54443,BRL-54443
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K17874705-300-03-2,2-PYRIDYLETHYLAMINE,2-PYRIDYLETHYLAMINE
REP.PRIMARY,2.5,"CDK1, CDK5, GSK3A","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K17894950-001-14-3,INDIRUBIN,INDIRUBIN
REP.PRIMARY,2.5,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K17953908-001-01-7,LY2886721,LY2886721
REP.PRIMARY,2.5,,ANTITUSSIVE,BRD:BRD-K17977438-048-02-4,OXELAIDIN,OXELAIDIN
REP.PRIMARY,2.5,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K17979676-001-01-2,EPROBEMIDE,EPROBEMIDE
REP.PRIMARY,2.5,GCGR,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K18036262-001-02-8,L-168049,L-168049
REP.PRIMARY,0.25,"PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR AGONIST",BRD:BRD-K18059238-001-10-4,GAMMA-LINOLENIC-ACID,GAMMA-LINOLENIC-ACID
REP.PRIMARY,2.5,"CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K18131774-001-17-6,ETHOXZOLAMIDE,ETHOXZOLAMIDE
REP.PRIMARY,2.5,"HSD11B1, NR1H4","11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR, FXR AGONIST",BRD:BRD-K18135438-001-16-7,CHENODEOXYCHOLIC-ACID,CHENODEOXYCHOLIC-ACID
REP.PRIMARY,2.5,,DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K18157228-001-01-7,FDCYD,FDCYD
REP.PRIMARY,2.5,BCL2,BCL INHIBITOR,BRD:BRD-K18163608-001-05-6,HA14-1,HA14-1
REP.PRIMARY,2.5,"GABRA1, GABRB2, GABRG2",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K18172896-001-02-5,ELTANOLONE,ELTANOLONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K18194590-065-08-0,MEPHENTERMINE,MEPHENTERMINE
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K18250272-003-11-0,PROPOXYCAINE,PROPOXYCAINE
REP.PRIMARY,2.5,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K18316707-001-02-7,O-1918,O-1918
REP.PRIMARY,2.5,,,BRD:BRD-K18323388-001-01-1,URIDINE-TRIACETATE,URIDINE-TRIACETATE
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K18324993-001-01-6,BUDIPINE,BUDIPINE
REP.PRIMARY,2.5,"CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5",,BRD:BRD-K18375018-376-02-3,SPERMINE,SPERMINE
REP.PRIMARY,2.5,"KDR, SRC","SRC INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K18424115-003-01-3,TG-100572,TG-100572
REP.PRIMARY,2.5,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K18518344-001-15-9,DIGITOXIGENIN,DIGITOXIGENIN
REP.PRIMARY,2.5,"CYP1A2, CYP3A4, SLC22A6",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K18574842-236-17-7,NAFCILLIN,NAFCILLIN
REP.PRIMARY,2.5,"CYP1A2, CYP3A4, SLC22A6",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K18574842-323-10-8,NAFCILLIN,NAFCILLIN
REP.PRIMARY,2.5,,,BRD:BRD-K18613660-001-05-5,MEXENEONE,MEXENEONE
REP.PRIMARY,2.5,,STEROID,BRD:BRD-K18619710-001-14-4,DIGOXIGENIN,DIGOXIGENIN
REP.PRIMARY,2.5,"FOLR2, FOLR3, SLC19A1, SLC46A1",FOLATE RECEPTOR LIGAND,BRD:BRD-K18673820-001-15-5,FOLIC-ACID,FOLIC-ACID
REP.PRIMARY,2.5,"HCN1, HCN2, HCN3, HCN4",HCN CHANNEL BLOCKER,BRD:BRD-K18678457-003-02-8,ZD-7288,ZD-7288
REP.PRIMARY,2.5,CHRNA1,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K18772613-303-02-4,BENZOQUINONIUM-DIBROMIDE,BENZOQUINONIUM-DIBROMIDE
REP.PRIMARY,2.5,"MAOA, MAOB",ACETYLCHOLINE RELEASE ENHANCER,BRD:BRD-K18779551-003-07-8,BIFEMELANE,BIFEMELANE
REP.PRIMARY,2.5,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1",MEK INHIBITOR,BRD:BRD-K18787491-001-08-6,U-0126,U-0126
REP.PRIMARY,2.5,,FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K18834913-001-01-1,LB42708,LB42708
REP.PRIMARY,2.5,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K18849474-001-04-4,DALCETRAPIB,DALCETRAPIB
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K18850819-001-04-6,MK-0752,MK-0752
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K18895904-001-16-1,OLANZAPINE,OLANZAPINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K18905250-003-02-4,ST-91,ST-91
REP.PRIMARY,2.5,"ESR1, ESR2, GPER1, KCNMA1, NR1I2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K18910433-001-36-6,ESTRADIOL,ESTRADIOL
REP.PRIMARY,2.5,"ESR1, ESR2, GPER1, KCNMA1, NR1I2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K18910433-001-43-2,ESTRADIOL,ESTRADIOL
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K18922609-004-23-1,NEOSTIGMINE,NEOSTIGMINE
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K18948558-001-01-9,CLEVUDINE,CLEVUDINE
REP.PRIMARY,2.5,MET,MET INHIBITOR,BRD:BRD-K18961567-001-01-1,LY2801653,LY2801653
REP.PRIMARY,2.5,"FLT3, JAK1, JAK2, JAK3","FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K19034817-001-01-4,PACRITINIB,PACRITINIB
REP.PRIMARY,2.5,"EGFR, ERBB2",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K19061412-001-02-4,MUBRITINIB,MUBRITINIB
REP.PRIMARY,2.5,PLA2G7,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K19085898-001-01-8,DARAPLADIB,DARAPLADIB
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K19111024-001-20-9,CLOFIBRIC-ACID,CLOFIBRIC-ACID
REP.PRIMARY,2.5,"CDK1, CDK2, CDK5, CDK5R1, GSK3B","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K19136521-001-08-9,INDIRUBIN-3-MONOXIME,INDIRUBIN-3-MONOXIME
REP.PRIMARY,2.5,PYGL,GLYCOGEN PHOSPHORYLASE INHIBITOR,BRD:BRD-K19171642-001-02-3,CP-91149,CP-91149
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",,BRD:BRD-K19180152-001-02-6,MEPROBAMATE,MEPROBAMATE
REP.PRIMARY,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K19203487-001-01-4,SPP301,SPP301
REP.PRIMARY,2.5,UGT1A9,INDICATOR DYE,BRD:BRD-K19227686-001-18-6,PHENOLPHTHALEIN,PHENOLPHTHALEIN
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K19284129-001-02-6,SALVINORIN-A,SALVINORIN-A
REP.PRIMARY,2.5,BCL2,"BCL INHIBITOR, MCL1 INHIBITOR",BRD:BRD-K19295594-015-14-3,GOSSYPOL,GOSSYPOL
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K19309090-300-05-5,SR-95639A,SR-95639A
REP.PRIMARY,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K19318328-001-01-3,FR-139317,FR-139317
REP.PRIMARY,2.5,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K19333160-001-01-3,RKI-1447,RKI-1447
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K19352500-070-12-4,PROCHLORPERAZINE,PROCHLORPERAZINE
REP.PRIMARY,2.5,,ADENYLYL CYCLASE ACTIVATOR,BRD:BRD-K19388745-003-01-7,COLFORSIN-DAPROATE,COLFORSIN-DAPROATE
REP.PRIMARY,2.5,"HSPB1, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K19412355-001-01-0,SB-242235,SB-242235
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K19416115-001-05-3,SITAGLIPTIN,SITAGLIPTIN
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K19438463-001-05-5,CNQX,CNQX
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K19456237-001-27-6,PIRACETAM,PIRACETAM
REP.PRIMARY,2.5,ADRA1A,"ADRENERGIC RECEPTOR ANTAGONIST, CALCIUM CHANNEL BLOCKER",BRD:BRD-K19462402-003-24-6,BUFLOMEDIL,BUFLOMEDIL
REP.PRIMARY,2.5,MET,HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K19477839-001-07-6,SGX523,SGX523
REP.PRIMARY,2.5,"NR3C1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K19507340-001-22-1,MEGESTROL-ACETATE,MEGESTROL-ACETATE
REP.PRIMARY,2.5,"ABL1, LCK, SRC, YES1",SRC INHIBITOR,BRD:BRD-K19540840-001-09-4,SARACATINIB,SARACATINIB
REP.PRIMARY,2.5,"JAK1, JAK2",JAK INHIBITOR,BRD:BRD-K19601669-001-03-5,RUXOLITINIB-(S),RUXOLITINIB-(S)
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K19605405-001-02-7,ZM-241385,ZM-241385
REP.PRIMARY,2.5,"CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8",,BRD:BRD-K19615002-001-02-3,CREATINE,CREATINE
REP.PRIMARY,2.5,"MTOR, PRKDC",DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K19655798-001-01-9,COMPOUND-401,COMPOUND-401
REP.PRIMARY,2.5,CDKN1A,GGTASE INHIBITOR,BRD:BRD-K19669037-001-01-1,GGTI-298,GGTI-298
REP.PRIMARY,2.5,,,BRD:BRD-K19672466-001-02-3,ETHIMIZOL,ETHIMIZOL
REP.PRIMARY,2.5,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K19687926-379-07-4,LAPATINIB,LAPATINIB
REP.PRIMARY,2.5,KCNA5,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K19741547-003-01-7,VERNAKALANT,VERNAKALANT
REP.PRIMARY,2.5,NR3C2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K19761926-001-02-8,EPLERENONE,EPLERENONE
REP.PRIMARY,2.5,NR3C2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K19761926-001-03-6,EPLERENONE,EPLERENONE
REP.PRIMARY,2.5,SMO,SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K19796430-001-05-6,SONIDEGIB,SONIDEGIB
REP.PRIMARY,2.5,"AKT1, MAPK1","AKT INHIBITOR, TRAIL MODULATOR",BRD:BRD-K19939891-001-05-4,TIC10,TIC10
REP.PRIMARY,2.5,,,BRD:BRD-K19972289-001-01-4,OCTINOXATE,OCTINOXATE
REP.PRIMARY,2.5,BRD3,APOLIPOPROTEIN EXPRESSION ENHANCER,BRD:BRD-K20001883-001-02-7,APABETALONE,APABETALONE
REP.PRIMARY,2.5,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K20008181-001-01-3,LCQ908,LCQ908
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K20013301-001-02-6,LY411575,LY411575
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K20075662-300-04-0,BETAZOLE,BETAZOLE
REP.PRIMARY,2.5,"GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K20079257-001-09-6,RUFINAMIDE,RUFINAMIDE
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4",NOREPINEPHRINE TRANSPORTER INHIBITOR,BRD:BRD-K20141153-003-13-7,ATOMOXETINE,ATOMOXETINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K20152659-001-04-6,DIHOMO-GAMMA-LINOLENIC-ACID,DIHOMO-GAMMA-LINOLENIC-ACID
REP.PRIMARY,2.5,CHRNA2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K20168442-004-06-3,VECURONIUM,VECURONIUM
REP.PRIMARY,2.5,"RET, SYK",SYK INHIBITOR,BRD:BRD-K20285085-001-07-1,R406,R406
REP.PRIMARY,2.5,"RET, SYK",SYK INHIBITOR,BRD:BRD-K20285085-074-04-5,R406,R406
REP.PRIMARY,2.5,MAP2K5,MEK INHIBITOR,BRD:BRD-K20290250-001-01-3,BIX-02188,BIX-02188
REP.PRIMARY,2.5,MAP2K5,MEK INHIBITOR,BRD:BRD-K20290250-001-02-1,BIX-02188,BIX-02188
REP.PRIMARY,2.5,"MCL1, TYR",GABA TRANSAMINASE INHIBITOR,BRD:BRD-K20313525-001-04-6,ROSMARINIC-ACID,ROSMARINIC-ACID
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K20338176-001-17-7,CEFACLOR,CEFACLOR
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH",NOREPINEPHRINE PRECURSOR,BRD:BRD-K20372197-001-03-1,DROXIDOPA,DROXIDOPA
REP.PRIMARY,2.5,,,BRD:BRD-K20417253-001-01-9,OXINIACIC-ACID,OXINIACIC-ACID
REP.PRIMARY,2.5,,,BRD:BRD-K20431737-001-08-1,BENZOYLPAS,BENZOYLPAS
REP.PRIMARY,2.5,AKR1C3,"ANTIOXIDANT, CAPILLARY STABILIZING AGENT, NITRIC OXIDE SCAVENGER",BRD:BRD-K20482099-001-09-4,RUTIN,RUTIN
REP.PRIMARY,2.5,AKR1C3,"ANTIOXIDANT, CAPILLARY STABILIZING AGENT, NITRIC OXIDE SCAVENGER",BRD:BRD-K20482099-001-11-0,RUTIN,RUTIN
REP.PRIMARY,2.5,"NOS2, PPARG","LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K20545304-001-01-6,BARDOXOLONE,BARDOXOLONE
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K20548681-001-01-3,SCP-1,SCP-1
REP.PRIMARY,2.5,UBE2N,UBIQUITIN-CONJUGATING ENZYME INHIBITOR,BRD:BRD-K20605374-001-05-4,NSC-697923,NSC-697923
REP.PRIMARY,2.5,,PSYCHOACTIVE DRUG,BRD:BRD-K20655524-003-12-0,MEFEXAMIDE,MEFEXAMIDE
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K20714604-003-02-9,RS-56812,RS-56812
REP.PRIMARY,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K20722021-001-02-1,CEP-32496,CEP-32496
REP.PRIMARY,2.5,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K20738689-001-01-2,DAZMEGREL,DAZMEGREL
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K20742498-003-02-9,RS-39604,RS-39604
REP.PRIMARY,2.5,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K20745393-003-01-0,OLPRINONE,OLPRINONE
REP.PRIMARY,2.5,SPHK1,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-K20755323-001-05-9,SKI-II,SKI-II
REP.PRIMARY,2.5,"GAA, GBA",GLUCOSIDASE INHIBITOR,BRD:BRD-K20897876-001-10-0,CASTANOSPERMINE,CASTANOSPERMINE
REP.PRIMARY,2.5,"KCNMA1, S100P",IMMUNOSUPPRESSANT,BRD:BRD-K20920669-304-09-1,CROMOGLICIC-ACID,CROMOGLICIC-ACID
REP.PRIMARY,2.5,,DNA ALKYLATING AGENT,BRD:BRD-K20958582-001-01-4,TH-302,TH-302
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K20995441-001-02-5,U-54494A,U-54494A
REP.PRIMARY,2.5,PTK2,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K21025364-001-04-9,NVP-TAE226,NVP-TAE226
REP.PRIMARY,2.5,PTK2,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K21025364-001-05-6,NVP-TAE226,NVP-TAE226
REP.PRIMARY,2.5,"PLA2G2E, SLC36A1",BETA AMYLOID ANTAGONIST,BRD:BRD-K21071223-001-02-8,VP-20629,VP-20629
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K21123171-001-02-9,PRAMIRACETAM,PRAMIRACETAM
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K21160401-065-01-0,DEXTROAMPHETAMINE,DEXTROAMPHETAMINE
REP.PRIMARY,2.5,,,BRD:BRD-K21164796-001-02-8,BETA-NAPHTHOL,BETA-NAPHTHOL
REP.PRIMARY,2.5,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11",GLUTAMATE INHIBITOR,BRD:BRD-K21283037-001-21-5,RILUZOLE,RILUZOLE
REP.PRIMARY,2.5,KCNN4,INTERMEDIATE CONDUCTANCE POTASSIUM CHANNEL BLOCKER,BRD:BRD-K21295289-001-01-6,SENICAPOC,SENICAPOC
REP.PRIMARY,2.5,XPO1,EXPORTIN ANTAGONIST,BRD:BRD-K21361524-001-01-1,SELINEXOR,SELINEXOR
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K21372554-003-01-7,CEFETAMET-PIVOXIL,CEFETAMET-PIVOXIL
REP.PRIMARY,2.5,"MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K21396683-001-04-8,MARIMASTAT,MARIMASTAT
REP.PRIMARY,2.5,"CA1, CA12, CA2, CA4, CA9, SLC12A3",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K21450440-001-14-6,BENZTHIAZIDE,BENZTHIAZIDE
REP.PRIMARY,2.5,,,BRD:BRD-K21452876-003-01-8,CHLORAZANIL,CHLORAZANIL
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K21520694-236-02-6,SULFACETAMIDE,SULFACETAMIDE
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K21528677-001-02-8,DESONIDE,DESONIDE
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K21528677-001-03-6,DESONIDE,DESONIDE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR MODULATOR,BRD:BRD-K21547160-001-01-4,SUFENTANIL,SUFENTANIL
REP.PRIMARY,2.5,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K21548250-003-19-1,MORACIZINE,MORACIZINE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K21565985-001-22-5,XYLAZINE,XYLAZINE
REP.PRIMARY,2.5,MMP12,UREASE INHIBITOR,BRD:BRD-K21615095-001-08-4,ACETOHYDROXAMIC-ACID,ACETOHYDROXAMIC-ACID
REP.PRIMARY,2.5,SLC9A1,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K21670884-001-01-9,CARIPORIDE,CARIPORIDE
REP.PRIMARY,2.5,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K21672174-001-03-0,RO-28-1675,RO-28-1675
REP.PRIMARY,2.5,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K21673112-003-01-3,PITOLISANT,"BF2.649, PITOLISANT"
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K21680192-300-14-4,MITOXANTRONE,MITOXANTRONE
REP.PRIMARY,2.5,"ABL1, AURKA, AURKB, FLT3","ABL KINASE INHIBITOR, AURORA KINASE INHIBITOR, FLT3 INHIBITOR",BRD:BRD-K21718444-001-06-8,KW-2449,KW-2449
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K21728777-001-02-3,AMG900,AMG900
REP.PRIMARY,2.5,"ELN, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K21733600-001-14-1,ROFECOXIB,ROFECOXIB
REP.PRIMARY,2.5,,ANTISEPTIC,BRD:BRD-K21771665-304-04-2,MERBROMIN,MERBROMIN
REP.PRIMARY,2.5,MET,MET INHIBITOR,BRD:BRD-K21782625-001-02-4,AMG458,AMG458
REP.PRIMARY,2.5,MET,MET INHIBITOR,BRD:BRD-K21782625-001-03-2,AMG458,AMG458
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K21867462-001-02-9,GSK2816126,GSK2816126
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K21884483-001-03-7,MIZOLASTINE,MIZOLASTINE
REP.PRIMARY,2.5,L3MBTL1,L3MBTL ANTAGONIST,BRD:BRD-K21906513-001-04-0,UNC669,UNC669
REP.PRIMARY,2.5,"PIM1, PIM2, PIM3",PIM KINASE INHIBITOR,BRD:BRD-K21908111-001-01-8,AZD1208,AZD1208
REP.PRIMARY,2.5,APP,ATP SYNTHASE INHIBITOR,BRD:BRD-K21910317-001-12-3,"2,4-DINITROPHENOL","2,4-DINITROPHENOL"
REP.PRIMARY,2.5,SLC22A6,,BRD:BRD-K21913543-001-02-4,FLUORESCEIN,FLUORESCEIN
REP.PRIMARY,2.5,CTSB,CYSTEINE PEPTIDASE INHIBITOR,BRD:BRD-K21937671-001-09-2,LOXISTATIN-ACID,LOXISTATIN-ACID
REP.PRIMARY,2.5,CTSB,CYSTEINE PEPTIDASE INHIBITOR,BRD:BRD-K21937671-001-10-0,LOXISTATIN-ACID,LOXISTATIN-ACID
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-K22009844-001-12-5,PHENPROBAMATE,PHENPROBAMATE
REP.PRIMARY,2.5,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K22024824-001-03-7,RG4733,RG4733
REP.PRIMARY,2.5,,OXIDOSQUALENE CYCLASE INHIBITOR,BRD:BRD-K22025381-003-01-9,U-18666A,U-18666A
REP.PRIMARY,2.5,"PTGS1, PTGS2",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K22031190-001-23-6,DIFLUNISAL,DIFLUNISAL
REP.PRIMARY,2.5,,CHOLESTEROL INHIBITOR,BRD:BRD-K22097830-001-01-9,OCO-1112,OCO-1112
REP.PRIMARY,2.5,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB",PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K22127577-001-03-7,CRENOLANIB,CRENOLANIB
REP.PRIMARY,2.5,"HMGCR, ITGB2",HMGCR INHIBITOR,BRD:BRD-K22134346-001-22-3,SIMVASTATIN,SIMVASTATIN
REP.PRIMARY,2.5,"HMGCR, ITGB2",HMGCR INHIBITOR,BRD:BRD-K22134346-001-24-9,SIMVASTATIN,SIMVASTATIN
REP.PRIMARY,2.5,,TOPICAL SUNSCREEN AGENT,BRD:BRD-K22193694-001-13-6,DIOXYBENZONE,DIOXYBENZONE
REP.PRIMARY,2.5,,,BRD:BRD-K22261391-001-01-2,PIRODAVIR,PIRODAVIR
REP.PRIMARY,2.5,AHR,ARYL HYDROCARBON RECEPTOR ANTAGONIST,BRD:BRD-K22314899-001-02-4,CH223191,CH223191
REP.PRIMARY,2.5,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K22356203-001-01-8,IDO5L,IDO5L
REP.PRIMARY,2.5,"BRD2, BRD3, BRD4","CASEIN KINASE INHIBITOR, MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K22385716-001-02-5,LY303511,LY303511
REP.PRIMARY,2.5,"KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K22482860-001-21-4,DALFAMPRIDINE,DALFAMPRIDINE
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K22503835-001-11-0,SCRIPTAID,SCRIPTAID
REP.PRIMARY,2.5,,,BRD:BRD-K22520627-001-01-7,DVD-111,DVD-111
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K22662435-001-18-3,GANCICLOVIR,GANCICLOVIR
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K22662435-001-19-1,GANCICLOVIR,GANCICLOVIR
REP.PRIMARY,2.5,BDKRB2,BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K22662557-300-01-7,WIN-64338,WIN-64338
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K22685337-001-13-4,ROXARSONE,ROXARSONE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB",IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-K22745370-003-02-3,2-BFI,2-BFI
REP.PRIMARY,2.5,"HRH1, HRH2, HRH3",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K22749967-046-02-3,ABT-239,ABT-239
REP.PRIMARY,2.5,CTSK,CATHEPSIN INHIBITOR,BRD:BRD-K22822991-001-02-3,ODANACATIB,ODANACATIB
REP.PRIMARY,2.5,CDC42,CDC INHIBITOR,BRD:BRD-K22829793-001-01-0,ZCL-278,ZCL-278
REP.PRIMARY,2.5,"AKR1B1, CDK6, CYP19A1, CYP1B1",BREAST CANCER RESISTANCE PROTEIN INHIBITOR,BRD:BRD-K22861715-001-17-4,CHRYSIN,CHRYSIN
REP.PRIMARY,2.5,"HRH1, SLC6A3","DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K22936972-003-23-6,DIPHENYLPYRALINE,DIPHENYLPYRALINE
REP.PRIMARY,2.5,NEU2,NEURAMINIDASE INHIBITOR,BRD:BRD-K23067689-001-02-1,ZANAMIVIR,ZANAMIVIR
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K23082237-003-01-5,BUTACLAMOL,BUTACLAMOL
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K23163214-050-15-1,DIZOCILPINE-(-),DIZOCILPINE-(-)
REP.PRIMARY,2.5,"EGFR, ERBB2",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K23190681-001-01-1,AV-412,AV-412
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K23204545-001-16-4,BUSULFAN,BUSULFAN
REP.PRIMARY,2.5,"FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K23228615-001-02-8,GDC-0980,GDC-0980
REP.PRIMARY,2.5,MLNR,MOTILIN RECEPTOR AGONIST,BRD:BRD-K23248433-001-01-8,CAMICINAL,CAMICINAL
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K23301018-001-11-7,BROXYQUINOLINE,BROXYQUINOLINE
REP.PRIMARY,2.5,GRM7,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K23335153-300-02-5,AMN-082,AMN-082
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K23363278-001-02-1,CYT-997,CYT-997
REP.PRIMARY,2.5,"NCOA1, NCOA2, NR1H2, NR1H3, NR1I2, RXRB",LXR AGONIST,BRD:BRD-K23383398-001-09-9,T-0901317,T-0901317
REP.PRIMARY,2.5,,CATIONIC SURFACTANT,BRD:BRD-K23403298-003-01-9,BENZYLDIMETHYLHEXADECYLAMMONIUM,BENZYLDIMETHYLHEXADECYLAMMONIUM
REP.PRIMARY,2.5,"HRH2, HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K23541596-300-07-2,DIMAPRIT,DIMAPRIT
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K23566484-001-15-1,NILUTAMIDE,NILUTAMIDE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K23586533-001-03-6,CLINDAMYCIN,CLINDAMYCIN
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C, KCNH2",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K23647661-001-02-2,VOLINANSERIN,VOLINANSERIN
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K23672206-001-01-4,BCI-540,BCI-540
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K23677682-003-01-2,VORELOXIN,VORELOXIN
REP.PRIMARY,2.5,TTR,TRANSTHYRETIN AMYLOID INHIBITOR,BRD:BRD-K23728141-001-01-2,TAFAMIDIS-MEGLUMINE,TAFAMIDIS-MEGLUMINE
REP.PRIMARY,2.5,,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K23779958-001-05-8,DICHLORVOS,DICHLORVOS
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6",VITAMIN K ANTAGONIST,BRD:BRD-K23913458-001-20-7,COUMARIN,COUMARIN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K23922020-075-02-9,ARECAIDINE-PROPARGYL-ESTER,ARECAIDINE-PROPARGYL-ESTER
REP.PRIMARY,2.5,BCL2,BCL INHIBITOR,BRD:BRD-K23925186-001-01-0,ORIDONIN,ORIDONIN
REP.PRIMARY,2.5,BCL2,BCL INHIBITOR,BRD:BRD-K23925186-001-02-8,ORIDONIN,ORIDONIN
REP.PRIMARY,2.5,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K23952234-236-01-8,BMS-986020,"AM095, BMS-986020"
REP.PRIMARY,2.5,PTGFR,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K23976833-001-01-0,TRAVOPROST,TRAVOPROST
REP.PRIMARY,2.5,"BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAF INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K23984367-075-15-2,SORAFENIB,SORAFENIB
REP.PRIMARY,2.5,CYP17A1,ANDROGEN BIOSYNTHESIS INHIBITOR,BRD:BRD-K24048528-001-01-7,ABIRATERONE-ACETATE,ABIRATERONE-ACETATE
REP.PRIMARY,2.5,CYP17A1,ANDROGEN BIOSYNTHESIS INHIBITOR,BRD:BRD-K24048528-001-02-5,ABIRATERONE-ACETATE,ABIRATERONE-ACETATE
REP.PRIMARY,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K24084088-001-11-3,PARAXANTHINE,PARAXANTHINE
REP.PRIMARY,2.5,LYZ,,BRD:BRD-K24179883-001-16-7,ARSANILIC-ACID,ARSANILIC-ACID
REP.PRIMARY,2.5,CHRM5,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K24187789-001-01-7,VU0238429,VU0238429
REP.PRIMARY,2.5,HTR7,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K24201553-003-11-5,SB-269970,SB-269970
REP.PRIMARY,2.5,"SLC6A2, SLC6A4",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K24219278-001-01-6,AMINEPTINE,AMINEPTINE
REP.PRIMARY,2.5,CHRNA4,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K24227647-364-01-5,TC2559,TC2559
REP.PRIMARY,2.5,CSF1R,CFMS KINASE INHIBITOR,BRD:BRD-K24242599-001-02-8,GW-2580,GW-2580
REP.PRIMARY,2.5,"AR, ESR1, NR3C1, PRLR",ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K24255045-001-05-3,FLUOXYMESTERONE,FLUOXYMESTERONE
REP.PRIMARY,2.5,"ABAT, ALDH5A1",,BRD:BRD-K24258499-001-05-8,VANILLIN,VANILLIN
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K24297741-001-05-2,URETHANE,URETHANE
REP.PRIMARY,2.5,,ORTHOPOXVIRUS EGRESS INHIBITOR,BRD:BRD-K24312986-001-01-2,TECOVIRIMAT,TECOVIRIMAT
REP.PRIMARY,2.5,,URICOSURIC BLOCKER,BRD:BRD-K24443618-001-10-2,ETEBENECID,ETEBENECID
REP.PRIMARY,2.5,,,BRD:BRD-K24507548-001-01-8,CINTRIAMIDE,CINTRIAMIDE
REP.PRIMARY,2.5,"GRIA1, PTPN1",GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K24548560-342-02-1,EVANS-BLUE,EVANS-BLUE
REP.PRIMARY,2.5,NR3C2,PROGESTOGEN HORMONE,BRD:BRD-K24556098-001-16-7,DEOXYCORTICOSTERONE-ACETATE,DEOXYCORTICOSTERONE-ACETATE
REP.PRIMARY,2.5,NR3C2,PROGESTOGEN HORMONE,BRD:BRD-K24556098-001-19-1,DEOXYCORTICOSTERONE-ACETATE,DEOXYCORTICOSTERONE-ACETATE
REP.PRIMARY,2.5,,ATR KINASE INHIBITOR,BRD:BRD-K24556407-001-02-3,ETP-46464,ETP-46464
REP.PRIMARY,2.5,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K24566386-001-01-9,SD-208,SD-208
REP.PRIMARY,2.5,"AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A","AURORA KINASE INHIBITOR, JAK INHIBITOR",BRD:BRD-K24576554-001-04-8,AT-9283,AT-9283
REP.PRIMARY,2.5,"ALK, IGF1R","ALK TYROSINE KINASE RECEPTOR INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K24593301-001-02-3,AZD3463,AZD3463
REP.PRIMARY,2.5,"SLC5A1, SLC5A11, SLC5A2, SLC5A3",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K24601397-001-01-1,PHLORIZIN,PHLORIZIN
REP.PRIMARY,2.5,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K24603946-001-02-1,5-HYDROXYMETHYL-TOLTERODINE,5-HYDROXYMETHYL-TOLTERODINE
REP.PRIMARY,2.5,"CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3",HMGCR INHIBITOR,BRD:BRD-K24616672-003-20-1,PROCAINE,PROCAINE
REP.PRIMARY,2.5,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K24689407-001-06-3,3-BROMO-7-NITROINDAZOLE,3-BROMO-7-NITROINDAZOLE
REP.PRIMARY,2.5,"IGF1R, INSR",IGF-1 INHIBITOR,BRD:BRD-K24696047-001-02-3,NVP-AEW541,NVP-AEW541
REP.PRIMARY,2.5,,IMMUNOSUPPRESSANT,BRD:BRD-K24697665-001-01-4,BUCILLAMINE,BUCILLAMINE
REP.PRIMARY,2.5,,DNA INTERCALATING AGENT,BRD:BRD-K24715592-406-02-1,ETHACRIDINE-LACTATE-MONOHYDRATE,ETHACRIDINE-LACTATE-MONOHYDRATE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K24723746-036-02-5,SOLIFENACIN-SUCCINATE,SOLIFENACIN-SUCCINATE
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K24771047-001-01-6,AMPALEX,AMPALEX
REP.PRIMARY,2.5,,,BRD:BRD-K24790130-001-07-1,TRICAPRYLIN,TRICAPRYLIN
REP.PRIMARY,2.5,,,BRD:BRD-K24820488-001-01-7,CH-170,CH-170
REP.PRIMARY,2.5,"CREBBP, EP300",BROMODOMAIN INHIBITOR,BRD:BRD-K24821794-001-01-4,SGC-CBP30,SGC-CBP30
REP.PRIMARY,2.5,"DPYD, TYMS",THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K24844714-001-24-5,5-FLUOROURACIL,5-FLUOROURACIL
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K24869513-001-02-1,CNX-2006,CNX-2006
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K24943235-001-01-3,GRAZOPREVIR,GRAZOPREVIR
REP.PRIMARY,2.5,"ITGA4, ITGAV, ITGB1, ITGB7",INTEGRIN ANTAGONIST,BRD:BRD-K24968862-001-01-0,SB-683698,SB-683698
REP.PRIMARY,2.5,PTGER1,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K25015158-001-01-2,LIMAPROST-ALFADEX,LIMAPROST-ALFADEX
REP.PRIMARY,2.5,"AKR1B1, NOS2, TIMP3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K25114078-003-08-1,AMINOGUANIDINE,AMINOGUANIDINE
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K25140590-001-03-0,CX-516,CX-516
REP.PRIMARY,2.5,,CELL CYCLE INHIBITOR,BRD:BRD-K25186396-001-09-6,TANGERITIN,TANGERITIN
REP.PRIMARY,2.5,,HELICASE PRIMASE INHIBITOR,BRD:BRD-K25204779-001-01-1,PRITELIVIR,PRITELIVIR
REP.PRIMARY,2.5,"HTR2A, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K25224017-001-25-0,PIRENPERONE,PIRENPERONE
REP.PRIMARY,2.5,"CSK, KDR, KIT, RET",RET TYROSINE KINASE INHIBITOR,BRD:BRD-K25244359-066-03-4,APATINIB,APATINIB
REP.PRIMARY,2.5,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K25279140-001-01-5,MK-8745,MK-8745
REP.PRIMARY,2.5,"ATM, PRKDC",ATM KINASE INHIBITOR,BRD:BRD-K25311561-001-10-7,KU-55933,KU-55933
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K25312248-001-01-5,MATRINE,MATRINE
REP.PRIMARY,2.5,,,BRD:BRD-K25317177-065-01-4,MODALINE,MODALINE
REP.PRIMARY,2.5,"FLT1, KDR, KIT","KIT INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K25340465-001-11-1,OSI-930,OSI-930
REP.PRIMARY,2.5,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K25359048-001-02-6,WZ811,WZ811
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K25394294-001-14-9,OXAPROZIN,OXAPROZIN
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K25412176-001-01-9,GSK2110183,GSK2110183
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2","NOREPINEPHRINE REPUTAKE INHIBITOR, TRICYCLIC ANTIDEPRESSANT",BRD:BRD-K25433859-003-25-4,MAPROTILINE,MAPROTILINE
REP.PRIMARY,2.5,CSNK1A1,CDK INHIBITOR,BRD:BRD-K25486274-300-01-0,DRF053-(R),DRF053-(R)
REP.PRIMARY,2.5,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K25596805-001-01-8,JNJ-16259685,JNJ-16259685
REP.PRIMARY,2.5,"JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K25630527-001-03-8,LY2784544,LY2784544
REP.PRIMARY,2.5,"MTNR1A, MTNR1B, NQO2",MELATONIN RECEPTOR AGONIST,BRD:BRD-K25649279-001-02-0,2-IODOMELATONIN,2-IODOMELATONIN
REP.PRIMARY,2.5,"ACHE, BCHE","ACETYLCHOLINESTERASE INHIBITOR, CHOLINESTERASE INHIBITOR",BRD:BRD-K25650355-065-02-0,PHYSOSTIGMINE,PHYSOSTIGMINE
REP.PRIMARY,2.5,MIF,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,BRD:BRD-K25690923-001-02-4,4-IODO-6-PHENYLPYRIMIDINE,4-IODO-6-PHENYLPYRIMIDINE
REP.PRIMARY,2.5,,,BRD:BRD-K25691735-001-09-5,CHUANXIONGZINE,CHUANXIONGZINE
REP.PRIMARY,2.5,"HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4",OPIOID RECEPTOR AGONIST,BRD:BRD-K25699529-003-01-1,TAPENTADOL,TAPENTADOL
REP.PRIMARY,2.5,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K25723200-001-02-7,AZILSARTAN-MEDOXOMIL,AZILSARTAN-MEDOXOMIL
REP.PRIMARY,2.5,SYK,"JAK INHIBITOR, SYK INHIBITOR",BRD:BRD-K25835157-001-01-4,PRT062070,PRT062070
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K25837718-001-03-8,JOSAMYCIN,JOSAMYCIN
REP.PRIMARY,2.5,PRKCA,PROTEIN TYROSINE KINASE ACTIVATOR,BRD:BRD-K25875056-001-02-0,SC-9,SC-9
REP.PRIMARY,2.5,"HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K25906698-303-02-7,IMMEPIP,IMMEPIP
REP.PRIMARY,2.5,"DRD2, HTR2A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K25943794-001-02-3,BLONANSERIN,BLONANSERIN
REP.PRIMARY,2.5,RXRA,RETINOID RECEPTOR AGONIST,BRD:BRD-K25991633-001-01-9,BMS-649,BMS-649
REP.PRIMARY,2.5,,NOREPINEPHRINE REPUTAKE INHIBITOR,BRD:BRD-K26005076-001-12-8,GRAMINE,GRAMINE
REP.PRIMARY,2.5,PTPN1,TOPOISOMERASE INHIBITOR,BRD:BRD-K26011976-001-01-0,LICOCHALCONE-A,LICOCHALCONE-A
REP.PRIMARY,2.5,"ACACB, ACP1, APRT, MTAP, PECR, SRPK2",PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K26060080-065-05-6,ADENINE,ADENINE
REP.PRIMARY,2.5,,IMIDAZOLINE RECEPTOR AGONIST,BRD:BRD-K26160755-003-02-6,RS-45041-190,RS-45041-190
REP.PRIMARY,2.5,"GABRA1, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K26168087-001-09-7,MAGNOLOL,MAGNOLOL
REP.PRIMARY,2.5,,,BRD:BRD-K26222048-001-01-7,"TRANS-10,CIS-12-CONJUGATED-LINOLEIC-ACID","TRANS-10,CIS-12-CONJUGATED-LINOLEIC-ACID"
REP.PRIMARY,2.5,VCP,ATPASE INHIBITOR,BRD:BRD-K26253904-001-01-5,NMS-873,NMS-873
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K26262077-238-01-5,ACAMPROSATE,ACAMPROSATE
REP.PRIMARY,2.5,,K-RAS INHIBITOR,BRD:BRD-K26305185-001-02-1,K-RAS(G12C)-INHIBITOR-6,K-RAS(G12C)-INHIBITOR-6
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K26325692-003-01-3,API-001,API-001
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K26341917-001-01-3,L-ERGOTHIONEINE,L-ERGOTHIONEINE
REP.PRIMARY,2.5,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K26349472-001-01-3,OG-L002,OG-L002
REP.PRIMARY,2.5,IKBKB,"IKK INHIBITOR, SYK INHIBITOR",BRD:BRD-K26373640-001-05-1,IKK-2-INHIBITOR,IKK-2-INHIBITOR
REP.PRIMARY,2.5,,,BRD:BRD-K26502378-001-07-9,VANITIOLIDE,VANITIOLIDE
REP.PRIMARY,2.5,DOT1L,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26531771-001-01-4,EPZ-5676,EPZ-5676
REP.PRIMARY,2.5,DOT1L,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26531771-001-02-2,EPZ-5676,EPZ-5676
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K26548821-003-10-5,QUINPIROL-(-),QUINPIROL-(-)
REP.PRIMARY,2.5,CHRNA7,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K26573499-300-02-1,DMAB-ANABASEINE,DMAB-ANABASEINE
REP.PRIMARY,2.5,,,BRD:BRD-K26581543-001-01-6,BIFENDATE,BIFENDATE
REP.PRIMARY,2.5,"EGFR, KDR",EGFR INHIBITOR,BRD:BRD-K26603252-003-04-9,PD-153035,PD-153035
REP.PRIMARY,2.5,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB",GABA RECEPTOR ANTAGONIST,BRD:BRD-K26619122-001-02-1,THIOCOLCHICOSIDE,THIOCOLCHICOSIDE
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K26634012-001-04-9,TILMICOSIN,TILMICOSIN
REP.PRIMARY,2.5,"TLR7, TLR8","INTERFERON INDUCER, TOLL-LIKE RECEPTOR AGONIST",BRD:BRD-K26657438-001-15-2,IMIQUIMOD,IMIQUIMOD
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-K26667523-001-02-5,TAK-733,TAK-733
REP.PRIMARY,2.5,,"HCV INHIBITOR, PROTEASE INHIBITOR",BRD:BRD-K26701552-001-01-8,TEGOBUVIR,TEGOBUVIR
REP.PRIMARY,2.5,CASP1,CASPASE INHIBITOR,BRD:BRD-K26712974-001-01-5,VX-765,VX-765
REP.PRIMARY,2.5,,BRONCHODILATOR,BRD:BRD-K26739552-003-15-4,FENSPIRIDE,FENSPIRIDE
REP.PRIMARY,2.5,ATR,ATR KINASE INHIBITOR,BRD:BRD-K26756394-001-02-2,VE-821,VE-821
REP.PRIMARY,2.5,"DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K26801045-001-02-9,PIPAMPERONE,PIPAMPERONE
REP.PRIMARY,2.5,,,BRD:BRD-K26807903-001-04-3,AKLOMIDE,AKLOMIDE
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26818574-305-04-3,BIX-01294,BIX-01294
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K26823213-001-02-9,GW-842166,GW-842166
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K26824830-001-02-0,AZOMYCIN-(2-NITROIMIDAZOLE),AZOMYCIN-(2-NITROIMIDAZOLE)
REP.PRIMARY,2.5,,TELOMERASE INHIBITOR,BRD:BRD-K26833429-001-02-8,COSTUNOLIDE,COSTUNOLIDE
REP.PRIMARY,2.5,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K26838195-075-04-9,AST-1306,AST-1306
REP.PRIMARY,2.5,CYP1B1,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K26862302-001-05-2,DIOSMETIN,DIOSMETIN
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K26901728-001-06-2,LUMIRACOXIB,LUMIRACOXIB
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26989966-001-03-5,UNC1999,UNC1999
REP.PRIMARY,2.5,TUBB,MICROTUBULE INHIBITOR,BRD:BRD-K26997899-001-02-2,D-64131,D-64131
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGENIC HORMONE,BRD:BRD-K27062708-001-23-1,CHLOROTRIANISENE,CHLOROTRIANISENE
REP.PRIMARY,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K27135764-001-08-7,XANTHONE,XANTHONE
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K27141178-003-07-3,SB-203186,SB-203186
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K27168049-001-02-8,SDZ-220-581,SDZ-220-581
REP.PRIMARY,2.5,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K27182532-001-02-3,METATINIB,METATINIB
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K27184429-300-01-3,LEVOCETIRIZINE,LEVOCETIRIZINE
REP.PRIMARY,2.5,CTSK,CATHEPSIN INHIBITOR,BRD:BRD-K27204852-001-01-9,BALICATIB,BALICATIB
REP.PRIMARY,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K27217864-001-22-3,BUTAMBEN,BUTAMBEN
REP.PRIMARY,2.5,"AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIM1, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1","DNA DEPENDENT PROTEIN KINASE INHIBITOR, MTOR INHIBITOR, PHOSPHODIESTERASE INHIBITOR, PI3K INHIBITOR, PLK INHIBITOR",BRD:BRD-K27305650-001-16-6,LY294002,LY294002
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K27316855-001-13-3,CALCITRIOL,CALCITRIOL
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K27316855-001-19-0,CALCITRIOL,CALCITRIOL
REP.PRIMARY,2.5,HSP90AA1,,BRD:BRD-K27335680-001-10-0,RHEIN,RHEIN
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K27351809-001-09-5,NOMEGESTROL-ACETATE,NOMEGESTROL-ACETATE
REP.PRIMARY,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K27382019-418-01-9,PIPERAQUINE-PHOSPHATE,PIPERAQUINE-PHOSPHATE
REP.PRIMARY,2.5,SLC12A3,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K27393415-001-01-0,XIPAMIDE,XIPAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K27406233-001-07-7,ACETYL-L-LEUCINE,ACETYL-L-LEUCINE
REP.PRIMARY,2.5,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K27721098-065-08-6,CLOPIDOGREL,CLOPIDOGREL
REP.PRIMARY,2.5,"GSG2, PKIA, PRKACA",PKA INHIBITOR,BRD:BRD-K27737647-300-03-0,H-89,H-89
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K27771035-001-02-5,CLINDAMYCIN-PHOSPHATE,CLINDAMYCIN-PHOSPHATE
REP.PRIMARY,2.5,,CALCIUM CHANNEL MODULATOR,BRD:BRD-K27799744-001-02-8,CYCLOVIROBUXIN-D,CYCLOVIROBUXIN-D
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRB1, ADRB2, DRD1",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K27853494-003-04-7,"1S,2R-PHENYLPROPANOLAMINE","1S,2R-PHENYLPROPANOLAMINE"
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K27871792-001-01-8,FLUCLOXACILLIN,FLUCLOXACILLIN
REP.PRIMARY,2.5,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K27911943-001-02-8,"CHROMANOL-293B-(-)-[3R,4S]","CHROMANOL-293B-(-)-[3R,4S]"
REP.PRIMARY,2.5,,ANGIOGENESIS INHIBITOR,BRD:BRD-K27938825-001-02-4,ASA-404,ASA-404
REP.PRIMARY,2.5,MGMT,O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR,BRD:BRD-K27955832-001-02-9,LOMEGUATRIB,LOMEGUATRIB
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K28007504-051-01-2,RO-60-0175,RO-60-0175
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K28029915-001-02-2,DOLASETRON,DOLASETRON
REP.PRIMARY,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K28059174-334-01-2,INCB-003284,INCB-003284
REP.PRIMARY,2.5,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K28115081-001-02-7,APAFANT,APAFANT
REP.PRIMARY,2.5,"IKBKB, RELA",NFKB PATHWAY INHIBITOR,BRD:BRD-K28120222-001-08-4,PARTHENOLIDE-(ALTERNATE-STEREO),PARTHENOLIDE-(ALTERNATE-STEREO)
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K28121004-001-01-1,N-ACETYLGLYCYL-D-GLUTAMIC-ACID,N-ACETYLGLYCYL-D-GLUTAMIC-ACID
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28143534-001-02-2,CYPROHEPTADINE,CYPROHEPTADINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28143534-003-25-9,CYPROHEPTADINE,CYPROHEPTADINE
REP.PRIMARY,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K28183345-003-11-4,PROGUANIL,PROGUANIL
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K28192623-066-08-1,SPIRADOLINE,SPIRADOLINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K28210218-236-08-1,CEPHALOTHIN,CEPHALOTHIN
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6",GABA RECEPTOR MODULATOR,BRD:BRD-K28217197-001-01-4,GANAXOLONE,GANAXOLONE
REP.PRIMARY,2.5,"AHR, AR",ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K28307902-001-21-7,FLUTAMIDE,FLUTAMIDE
REP.PRIMARY,2.5,HRH3,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K28308851-303-01-8,ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(S)-(+),ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(S)-(+)
REP.PRIMARY,2.5,,ECDYSONE RECEPTOR MODULATOR,BRD:BRD-K28343777-001-01-6,20-HYDROXYECDYSONE,20-HYDROXYECDYSONE
REP.PRIMARY,2.5,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K28352084-001-02-3,CH5132799,CH5132799
REP.PRIMARY,2.5,"BCL2, BCL2L1, MCL1",BCL INHIBITOR,BRD:BRD-K28360340-001-08-3,TW-37,TW-37
REP.PRIMARY,2.5,MTOR,,BRD:BRD-K28383148-001-01-4,AP1903,AP1903
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR",FGFR INHIBITOR,BRD:BRD-K28392481-001-05-1,AZD4547,AZD4547
REP.PRIMARY,2.5,,,BRD:BRD-K28405228-001-06-7,MECARBINATE,MECARBINATE
REP.PRIMARY,2.5,"CYP3A4, FGFR1, FLT1, KCNH2, KDR","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K28428262-001-04-1,BRIVANIB,BRIVANIB
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K28442028-001-01-3,R-1479,R-1479
REP.PRIMARY,2.5,CHRM1,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K28453807-003-11-2,NITROCARAMIPHEN,NITROCARAMIPHEN
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K28456624-001-01-1,SEOCALCITOL,SEOCALCITOL
REP.PRIMARY,2.5,,,BRD:BRD-K28492574-001-01-6,PICONOL,PICONOL
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K28494619-001-28-2,SULFAMETHOXAZOLE,SULFAMETHOXAZOLE
REP.PRIMARY,2.5,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K28542495-003-13-5,BENZYDAMINE,BENZYDAMINE
REP.PRIMARY,2.5,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K28570407-001-02-0,A-803467,A-803467
REP.PRIMARY,2.5,"PDE3A, PDE3B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K28578425-001-07-0,CILOSTAMIDE,CILOSTAMIDE
REP.PRIMARY,2.5,,EXCIPIENT,BRD:BRD-K28595280-001-04-5,MEGLUMINE,MEGLUMINE
REP.PRIMARY,2.5,FASN,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K28667793-001-28-1,PYRAZINAMIDE,PYRAZINAMIDE
REP.PRIMARY,2.5,,STEROID,BRD:BRD-K28690501-001-02-1,DIOSGENIN,DIOSGENIN
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28761384-300-01-0,ZUCLOPENTHIXOL,ZUCLOPENTHIXOL
REP.PRIMARY,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K28761891-001-10-1,RAMELTEON,RAMELTEON
REP.PRIMARY,2.5,"HDAC1, HDAC3, HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K28822270-001-01-1,RESMINOSTAT,RESMINOSTAT
REP.PRIMARY,2.5,,CHOLERETIC AGENT,BRD:BRD-K28824103-001-02-8,GENIPIN,GENIPIN
REP.PRIMARY,2.5,,CHOLERETIC AGENT,BRD:BRD-K28824103-001-04-4,GENIPIN,GENIPIN
REP.PRIMARY,2.5,"ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K28849549-001-13-4,MESALAZINE,MESALAZINE
REP.PRIMARY,2.5,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K28861668-001-01-9,A922500,A922500
REP.PRIMARY,2.5,CHRNA7,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K28863208-001-02-0,PNU-282987,PNU-282987
REP.PRIMARY,2.5,RARG,RETINOID RECEPTOR AGONIST,BRD:BRD-K28907958-001-04-3,CD-437,CD-437
REP.PRIMARY,2.5,"BST1, LDHA, PARP1, SIRT5",PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K28912512-001-23-2,NICOTINAMIDE,NICOTINAMIDE
REP.PRIMARY,2.5,"HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD","HISTAMINE RECEPTOR AGONIST, LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K28936863-051-33-0,KETOTIFEN (FUMARATE),"KETOTIFEN, KETOTIFEN (FUMARATE)"
REP.PRIMARY,2.5,,MAP KINASE INHIBITOR,BRD:BRD-K28965160-001-01-1,BVD-523,BVD-523
REP.PRIMARY,2.5,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K28971625-003-01-4,ZD-7114,ZD-7114
REP.PRIMARY,2.5,,,BRD:BRD-K28982731-001-01-6,EMOXIPIN,EMOXIPIN
REP.PRIMARY,2.5,,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K29133151-001-03-2,"ICI-185,282","ICI-185,282"
REP.PRIMARY,2.5,NR3C1,,BRD:BRD-K29173907-001-09-2,ISOFLUPREDONE-ACETATE,ISOFLUPREDONE-ACETATE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K29220403-001-10-8,ESZOPICLONE,ESZOPICLONE
REP.PRIMARY,2.5,JAK2,,BRD:BRD-K29254801-001-14-7,THIRAM,THIRAM
REP.PRIMARY,2.5,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K29322660-001-01-9,EDOXABAN,EDOXABAN
REP.PRIMARY,2.5,ALB,"CYCLOOXYGENASE INHIBITOR, GLUTATHIONE PEROXIDASE AGONIST, H+/K+-ATPASE INHIBITOR, NITRIC OXIDE SYNTHASE INHIBITOR",BRD:BRD-K29359156-001-30-1,EBSELEN,EBSELEN
REP.PRIMARY,2.5,,COENZYME A PRECURSOR,BRD:BRD-K29392254-001-02-2,PANTOTHENIC-ACID,PANTOTHENIC-ACID
REP.PRIMARY,2.5,"PI4KB, PIK3C3, PIK3CG",PI3K INHIBITOR,BRD:BRD-K29395450-001-06-8,PIK-93,PIK-93
REP.PRIMARY,2.5,"MTOR, PIK3CA, PIK3CB, PIK3CG",PI3K INHIBITOR,BRD:BRD-K29415052-050-04-8,BGT226,BGT226
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K29458283-001-29-9,CHLORAMBUCIL,CHLORAMBUCIL
REP.PRIMARY,2.5,"ACE, SLC18A2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K29462201-001-01-9,DESERPIDINE,DESERPIDINE
REP.PRIMARY,2.5,"FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13",HISTAMINE RECEPTOR MODULATOR,BRD:BRD-K29530284-001-06-2,AMLEXANOX,AMLEXANOX
REP.PRIMARY,2.5,SRC,SRC INHIBITOR,BRD:BRD-K29542628-001-03-9,1-NAPHTHYL-PP1,1-NAPHTHYL-PP1
REP.PRIMARY,2.5,OPRD1,,BRD:BRD-K29546239-001-02-3,SNC-80,SNC-80
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K29582115-066-01-2,ZIPRASIDONE,ZIPRASIDONE
REP.PRIMARY,2.5,"CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1",CALCIUM CHANNEL BLOCKER,BRD:BRD-K29582677-300-10-6,FLUNARIZINE,FLUNARIZINE
REP.PRIMARY,2.5,"CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","CARBONIC ANHYDRASE INHIBITOR, GLUTAMATE RECEPTOR ANTAGONIST, KAINATE RECEPTOR ANTAGONIST",BRD:BRD-K29653726-001-13-4,TOPIRAMATE,TOPIRAMATE
REP.PRIMARY,2.5,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K29656036-001-02-5,MK-8245,MK-8245
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K29668683-300-02-2,BD-1063,BD-1063
REP.PRIMARY,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K29673530-001-05-4,HYPERICIN,HYPERICIN
REP.PRIMARY,2.5,,ANTIHISTAMINE,BRD:BRD-K29713308-001-01-7,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE","MEBHYDROLIN, MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE"
REP.PRIMARY,2.5,,ANTIHISTAMINE,BRD:BRD-K29713308-077-04-1,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE","MEBHYDROLIN, MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE"
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K29735307-001-02-9,OSTARINE,OSTARINE
REP.PRIMARY,2.5,"NOS1, PRKCA",PKC INHIBITOR,BRD:BRD-K29834313-001-01-4,MYRICITRIN,MYRICITRIN
REP.PRIMARY,2.5,KDR,VEGFR INHIBITOR,BRD:BRD-K29895144-001-01-0,SKLB1002,SKLB1002
REP.PRIMARY,2.5,"CSF1, FLT1, FLT4, KDR, PLK4","PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K29905972-001-06-3,AXITINIB,AXITINIB
REP.PRIMARY,2.5,"IFNG, IL1B, MMP9, NFKB2, TNF",GLYCOSYLATED PROTEIN PRECURSOR,BRD:BRD-K29918010-003-04-1,GLUCOSAMINE,GLUCOSAMINE
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K29950728-048-17-4,CLOMIFENE,CLOMIFENE
REP.PRIMARY,2.5,SRC,"SRC INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K29968218-001-03-2,KX2-391,KX2-391
REP.PRIMARY,2.5,"CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K30019776-003-01-5,DEXFOSFOSERINE,DEXFOSFOSERINE
REP.PRIMARY,2.5,REN,RENIN INHIBITOR,BRD:BRD-K30020243-051-02-5,ALISKIREN-HEMIFUMARATE,ALISKIREN-HEMIFUMARATE
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K30114692-001-15-9,METHENAMINE,METHENAMINE
REP.PRIMARY,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K30126819-304-02-7,DIMESNA,DIMESNA
REP.PRIMARY,2.5,"CLCN1, PPARA",CYTOCHROME P450 INHIBITOR,BRD:BRD-K30213273-001-01-6,FENOFIBRIC-ACID,FENOFIBRIC-ACID
REP.PRIMARY,2.5,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K30237152-300-02-5,1400W,1400W
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K30240666-051-15-9,CLEMASTINE,CLEMASTINE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ENHANCER,BRD:BRD-K30331124-001-01-7,ASC-J9,ASC-J9
REP.PRIMARY,2.5,"SRD5A1, SRD5A2, SRD5A3",5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K30373883-001-02-8,DUTASTERIDE,DUTASTERIDE
REP.PRIMARY,2.5,,DIURETIC,BRD:BRD-K30374899-001-09-3,MANNITOL-D,MANNITOL-D
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K30421593-050-04-9,TIMOLOL,TIMOLOL
REP.PRIMARY,2.5,,,BRD:BRD-K30431096-004-01-3,DOMIPHEN,DOMIPHEN
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK","GLUTATHIONE TRANSFERASE INHIBITOR, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K30466858-001-09-6,ELLAGIC-ACID,ELLAGIC-ACID
REP.PRIMARY,2.5,SLC12A1,"ELECTROLYTE REABSORPTION INHIBITOR, THROMBOXANE RECEPTOR ANTAGONIST",BRD:BRD-K30480208-001-18-5,TORASEMIDE,TORASEMIDE
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K30519779-001-03-1,HOMOQUINOLINIC-ACID,HOMOQUINOLINIC-ACID
REP.PRIMARY,2.5,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K30550578-001-01-3,PF-04620110,PF-04620110
REP.PRIMARY,2.5,"DGAT1, MTTP, SOAT1, SOAT2",ACAT INHIBITOR,BRD:BRD-K30553453-001-13-2,HESPERETIN,HESPERETIN
REP.PRIMARY,2.5,"HSP90AA1, HSP90B1",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K30563334-001-02-9,RIFABUTIN,RIFABUTIN
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K30572193-001-02-0,CTEP,CTEP
REP.PRIMARY,2.5,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K30577245-001-04-3,DOCETAXEL,DOCETAXEL
REP.PRIMARY,2.5,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K30577245-341-01-9,DOCETAXEL,DOCETAXEL
REP.PRIMARY,2.5,"CHRNA2, OPRM1","OPIOID ANTAGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K30634073-046-01-0,LEVALLORPHAN,LEVALLORPHAN
REP.PRIMARY,2.5,"CA12, CA14, CA2, CA4, CA6, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K30649484-003-13-7,MAFENIDE,MAFENIDE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K30652337-004-02-1,ELETRIPTAN,ELETRIPTAN
REP.PRIMARY,2.5,"THRA, THRB",THYROID HORMONE STIMULANT,BRD:BRD-K30685142-001-15-4,LEVOTHYROXINE,LEVOTHYROXINE
REP.PRIMARY,2.5,"CTNNB1, TCF4",BETA-CATENIN INHIBITOR,BRD:BRD-K30707190-001-04-1,PNU-74654,PNU-74654
REP.PRIMARY,2.5,,COSMETIC MOISTURIZER,BRD:BRD-K30758549-001-01-8,ISOPROPYL-PALMITATE,ISOPROPYL-PALMITATE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K30867024-003-03-3,SB-216641,SB-216641
REP.PRIMARY,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K30933884-001-01-0,UNBS-5162,UNBS-5162
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K30977212-001-02-8,PIK-293,PIK-293
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K30990140-003-02-4,FR-122047,FR-122047
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, HTR1A","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K31054881-300-04-7,BMY-7378,BMY-7378
REP.PRIMARY,2.5,,EUKARYOTIC TRANSLATION ELONGATION FACTOR 2 INHIBITOR,BRD:BRD-K31086665-005-04-6,NH125,NH125
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K31092604-003-03-5,DONITRIPTAN,DONITRIPTAN
REP.PRIMARY,2.5,KEAP1,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K31111078-001-04-2,DIMETHYL-FUMARATE,DIMETHYL-FUMARATE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K31135544-001-07-0,IB-MECA,IB-MECA
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K31283835-048-04-4,TOFACITINIB,TOFACITINIB
REP.PRIMARY,2.5,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K31309378-001-01-5,LUCITANIB,LUCITANIB
REP.PRIMARY,2.5,CDK7,CDK INHIBITOR,BRD:BRD-K31313613-003-04-2,BS-181,BS-181
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K31339321-001-03-6,LIRIMILAST,LIRIMILAST
REP.PRIMARY,2.5,"HCN1, HCN3, HCN4","HCN CHANNEL ANTAGONIST, POTASSIUM CHANNEL BLOCKER, SODIUM CHANNEL BLOCKER",BRD:BRD-K31385749-003-01-3,IVABRADINE,IVABRADINE
REP.PRIMARY,2.5,,URICASE INHIBITOR,BRD:BRD-K31468676-237-01-8,OXONIC-ACID,OXONIC-ACID
REP.PRIMARY,2.5,ELANE,ELASTASE INHIBITOR,BRD:BRD-K31476763-001-01-5,AZD9668,AZD9668
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K31491153-003-05-9,1-PHENYLBIGUANIDE,1-PHENYLBIGUANIDE
REP.PRIMARY,2.5,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K31495718-001-01-1,AZD7687,AZD7687
REP.PRIMARY,2.5,PDE10A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K31519811-001-02-2,PF-02545920,PF-02545920
REP.PRIMARY,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K31553034-001-03-0,ZIBOTENTAN,ZIBOTENTAN
REP.PRIMARY,2.5,"CNR1, GPR119, TRPV1",TRPV AGONIST,BRD:BRD-K31560319-001-01-5,OLVANIL,OLVANIL
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K31627533-001-09-5,RIMEXOLONE,RIMEXOLONE
REP.PRIMARY,2.5,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K31633810-003-02-8,DAU-5884,DAU-5884
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K31682896-001-24-0,SULFAMETHIZOLE,SULFAMETHIZOLE
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K31698212-001-02-9,ICOTINIB,ICOTINIB
REP.PRIMARY,2.5,HRH1,MEDIATOR RELEASE INHIBITOR,BRD:BRD-K31731454-237-02-5,PEMIROLAST,PEMIROLAST
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K31812033-003-11-0,LEVOBUNOLOL,LEVOBUNOLOL
REP.PRIMARY,2.5,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K31841515-001-07-8,OXYPURINOL,OXYPURINOL
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K31843556-001-04-1,T-0070907,T-0070907
REP.PRIMARY,2.5,BRAF,RAF INHIBITOR,BRD:BRD-K31866293-001-01-6,TAK-632,TAK-632
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K31920458-001-23-6,MESTRANOL,MESTRANOL
REP.PRIMARY,2.5,"AURKA, AURKB",AURORA KINASE INHIBITOR,BRD:BRD-K31928526-001-02-1,BARASERTIB,BARASERTIB
REP.PRIMARY,3.16,"CMPK1, RRM1, TYMS",DNA SYNTHESIS INHIBITOR,BRD:BRD-K32007074-001-02-9,ENOCITABINE,ENOCITABINE
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K32021043-001-14-3,SULFACHLORPYRIDAZINE,SULFACHLORPYRIDAZINE
REP.PRIMARY,2.5,TPH1,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K32101625-001-01-6,LX1031,LX1031
REP.PRIMARY,2.5,MGMT,DNA ALKYLATING AGENT,BRD:BRD-K32107296-001-16-9,TEMOZOLOMIDE,TEMOZOLOMIDE
REP.PRIMARY,2.5,"ABCC8, KCNJ1, KCNJ10, KCNJ11",ATP CHANNEL BLOCKER,BRD:BRD-K32164935-001-30-8,TOLAZAMIDE,TOLAZAMIDE
REP.PRIMARY,2.5,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K32218650-001-01-6,MBX-2982,MBX-2982
REP.PRIMARY,2.5,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",GABA RECEPTOR ANTAGONIST,BRD:BRD-K32247306-001-29-4,PRIMIDONE,PRIMIDONE
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K32273377-001-17-9,SULFADIAZINE,SULFADIAZINE
REP.PRIMARY,2.5,MET,TYROSINE KINASE INHIBITOR,BRD:BRD-K32285926-001-02-1,AMG-208,AMG-208
REP.PRIMARY,2.5,"RAC1, RAC3",RAS GTPASE INHIBITOR,BRD:BRD-K32289541-001-01-0,EHOP-016,EHOP-016
REP.PRIMARY,2.5,"EGFR, PRKCB","EGFR INHIBITOR, PKC INHIBITOR",BRD:BRD-K32292990-001-03-6,CGP-53353,CGP-53353
REP.PRIMARY,2.5,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K32311154-001-01-0,NIFEKALANT,NIFEKALANT
REP.PRIMARY,2.5,PNP,DNA POLYMERASE INHIBITOR,BRD:BRD-K32318651-001-23-7,ACYCLOVIR,ACYCLOVIR
REP.PRIMARY,2.5,PNP,DNA POLYMERASE INHIBITOR,BRD:BRD-K32318651-001-24-5,ACYCLOVIR,ACYCLOVIR
REP.PRIMARY,2.5,,,BRD:BRD-K32372024-001-01-0,D-7193,D-7193
REP.PRIMARY,2.5,CPT1A,CARNITINE PALMITOYLTRANSFERASE INHIBITOR,BRD:BRD-K32405725-001-02-8,ETOMOXIR,ETOMOXIR
REP.PRIMARY,2.5,SLC6A3,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K32501161-300-06-2,VANOXERINE,VANOXERINE
REP.PRIMARY,2.5,DHODH,,BRD:BRD-K32572029-001-04-4,OROTIC-ACID,OROTIC-ACID
REP.PRIMARY,2.5,"CA12, CA14, CA2, CA6, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K32681104-001-11-6,2-AMINOBENZENESULFONAMIDE,2-AMINOBENZENESULFONAMIDE
REP.PRIMARY,2.5,MAPK8,JNK INHIBITOR,BRD:BRD-K32730239-001-01-0,SU3327,SU3327
REP.PRIMARY,2.5,"ALDH2, DBH","ALDEHYDE DEHYDROGENASE INHIBITOR, DNA METHYLTRANSFERASE INHIBITOR, TRPV AGONIST",BRD:BRD-K32744045-001-31-2,DISULFIRAM,DISULFIRAM
REP.PRIMARY,2.5,ATP4A,POTASSIUM-COMPETITIVE ACID ANTAGONIST,BRD:BRD-K32768103-051-02-6,VONOPRAZAN,VONOPRAZAN
REP.PRIMARY,2.5,"HPRT1, IMPDH1, PPAT",DEHYDROGENASE INHIBITOR,BRD:BRD-K32821942-001-21-3,AZATHIOPRINE,AZATHIOPRINE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K32830106-001-02-6,GUANFACINE,GUANFACINE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K32830106-003-20-4,GUANFACINE,GUANFACINE
REP.PRIMARY,2.5,,,BRD:BRD-K32847234-065-04-6,SPARTEINE-SULFATE,SPARTEINE-SULFATE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K32977963-001-05-0,EUGENOL,EUGENOL
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K33082088-001-03-3,RETAPAMULIN,RETAPAMULIN
REP.PRIMARY,2.5,"RARA, RARB, RARG, RXRA, RXRB, RXRG",RETINOID RECEPTOR AGONIST,BRD:BRD-K33127281-001-05-6,ADAPALENE,ADAPALENE
REP.PRIMARY,2.5,NOS3,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K33141550-003-05-7,L-NAME,L-NAME
REP.PRIMARY,2.5,"ADRA1A, DRD1, DRD2","ADRENERGIC RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",BRD:BRD-K33151569-003-09-7,DEOXYEPINEPHRINE,DEOXYEPINEPHRINE
REP.PRIMARY,2.5,"HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K33183200-303-02-4,IMETIT,IMETIT
REP.PRIMARY,2.5,"CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4","GLUTAMATE RECEPTOR ANTAGONIST, SIGMA RECEPTOR AGONIST",BRD:BRD-K33211335-004-01-7,DEXTROMETHORPHAN,DEXTROMETHORPHAN
REP.PRIMARY,2.5,TRPA1,TRPV AGONIST,BRD:BRD-K33219225-001-01-9,ALLYLISOTHIOCYANATE,ALLYLISOTHIOCYANATE
REP.PRIMARY,2.5,"CYP3A4, CYP3A5, CYP3A7",HIV PROTEASE INHIBITOR,BRD:BRD-K33226500-001-01-0,INDINAVIR,INDINAVIR
REP.PRIMARY,2.5,UGCG,GLYCOSYL TRANSFERASE INHIBITOR,BRD:BRD-K33251802-001-01-3,MIGLUSTAT,MIGLUSTAT
REP.PRIMARY,2.5,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K33277808-331-01-3,OUABAIN,OUABAIN
REP.PRIMARY,2.5,MET,TYROSINE KINASE INHIBITOR,BRD:BRD-K33379087-001-07-5,TIVANTINIB,TIVANTINIB
REP.PRIMARY,0.25,"ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1",OMEGA 3 FATTY ACID STIMULANT,BRD:BRD-K33396764-001-08-7,ALPHA-LINOLENIC-ACID,ALPHA-LINOLENIC-ACID
REP.PRIMARY,2.5,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K33425534-001-12-5,EXEMESTANE,EXEMESTANE
REP.PRIMARY,2.5,"HRH1, NTSR2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K33453211-003-11-5,LEVOCABASTINE,LEVOCABASTINE
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, SIGMAR1",SIGMA RECEPTOR AGONIST,BRD:BRD-K33459542-001-07-4,DITOLYLGUANIDINE,DITOLYLGUANIDINE
REP.PRIMARY,2.5,,INTERLEUKIN RECEPTOR AGONIST,BRD:BRD-K33483813-001-10-0,ACTARIT,ACTARIT
REP.PRIMARY,2.5,,,BRD:BRD-K33510429-001-03-1,VANILLYLACETONE,VANILLYLACETONE
REP.PRIMARY,2.5,GABBR1,GUANYLATE CYCLASE ACTIVATOR,BRD:BRD-K33583600-001-16-1,ISOLIQUIRITIGENIN,ISOLIQUIRITIGENIN
REP.PRIMARY,2.5,ACHE,CHOLINESTERASE REACTIVATOR,BRD:BRD-K33588785-001-01-9,OBIDOXIME,OBIDOXIME
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K33610132-001-02-9,ROCILETINIB,ROCILETINIB
REP.PRIMARY,2.5,"CDK4, CDK6",CDK INHIBITOR,BRD:BRD-K33622447-066-01-9,ABEMACICLIB,ABEMACICLIB
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K33681278-036-01-2,PRUCALOPRIDE,PRUCALOPRIDE
REP.PRIMARY,2.5,P2RX4,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K33690734-001-01-5,5-BDBD,5-BDBD
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K33720171-001-01-0,DIFLUPREDNATE,DIFLUPREDNATE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K33732501-004-01-0,METHYLNALTREXONE,METHYLNALTREXONE
REP.PRIMARY,2.5,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K33743361-003-02-6,ML133,ML133
REP.PRIMARY,2.5,GSTP1,MUCOLYTIC AGENT,BRD:BRD-K33809398-001-01-8,SCMC-LYS,SCMC-LYS
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K33813875-003-01-8,VALNEMULIN,VALNEMULIN
REP.PRIMARY,2.5,CLCN2,CHLORIDE CHANNEL ACTIVATOR,BRD:BRD-K33814251-001-01-4,LUBIPROSTONE,LUBIPROSTONE
REP.PRIMARY,2.5,CLCN2,CHLORIDE CHANNEL ACTIVATOR,BRD:BRD-K33814251-001-02-2,LUBIPROSTONE,LUBIPROSTONE
REP.PRIMARY,2.5,"NR1H2, NR1H3",LXR AGONIST,BRD:BRD-K33818169-003-04-6,GW-3965,GW-3965
REP.PRIMARY,2.5,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K33852358-001-09-9,AROFYLLINE,AROFYLLINE
REP.PRIMARY,2.5,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K33864865-001-02-5,LY225910,LY225910
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K33882852-003-02-8,ZK-93423,ZK-93423
REP.PRIMARY,2.5,"ACVR1, ACVRL1, BMPR1A",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K33892651-001-02-4,ML347,ML347
REP.PRIMARY,2.5,"POLA1, POLD1, POLE, RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K34022604-001-06-6,CLOFARABINE,CLOFARABINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K34032314-001-04-1,BETAMETHASONE-VALERATE,BETAMETHASONE-VALERATE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K34058848-304-03-1,CEFONICID,CEFONICID
REP.PRIMARY,2.5,IFNG,AP INHIBITOR,BRD:BRD-K34073885-001-09-3,TANSHINONE-I,TANSHINONE-I
REP.PRIMARY,2.5,,,BRD:BRD-K34122555-057-11-5,DENATONIUM-BENZOATE,DENATONIUM-BENZOATE
REP.PRIMARY,2.5,GABRA1,GABA RECEPTOR MODULATOR,BRD:BRD-K34154330-003-06-4,TRACAZOLATE,TRACAZOLATE
REP.PRIMARY,2.5,"HRH2, SLC29A4, SLC47A1, SLC47A2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K34157611-001-16-0,CIMETIDINE,CIMETIDINE
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K34185671-001-02-8,AMG-517,AMG-517
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K34313798-001-01-6,LY215490,LY215490
REP.PRIMARY,2.5,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K34321528-003-01-2,CGP-71683,CGP-71683
REP.PRIMARY,2.5,"CYP19A1, XDH",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K34328244-001-01-4,MF-101,MF-101
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K34332569-001-01-3,IMIDAPRIL,IMIDAPRIL
REP.PRIMARY,2.5,SMO,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K34341643-001-01-4,GLASDEGIB,GLASDEGIB
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K34388247-236-08-2,METHICILLIN,METHICILLIN
REP.PRIMARY,2.5,SLC2A2,DNA ALKYLATING AGENT,BRD:BRD-K34411947-001-12-5,STREPTOZOTOCIN,STREPTOZOTOCIN
REP.PRIMARY,2.5,DRD2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K34415467-003-13-0,TRIMETHOBENZAMIDE,TRIMETHOBENZAMIDE
REP.PRIMARY,2.5,"ACE, ACE2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K34441861-003-07-0,MOEXIPRIL,MOEXIPRIL
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K34469523-003-03-0,LEVALBUTEROL,LEVALBUTEROL
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K34533029-001-08-5,TYRPHOSTIN-AG-494,TYRPHOSTIN-AG-494
REP.PRIMARY,2.5,,INTERFERON INDUCER,BRD:BRD-K34568562-001-04-3,TILORONE,TILORONE
REP.PRIMARY,2.5,,,BRD:BRD-K34591242-001-04-3,METHOPRENE-(S),METHOPRENE-(S)
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K34608650-001-02-4,GP2A,GP2A
REP.PRIMARY,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K34663752-001-09-1,6-CHLOROMELATONIN,6-CHLOROMELATONIN
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K34672903-001-01-7,HEMADO,HEMADO
REP.PRIMARY,2.5,"DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K34685430-050-12-5,METHYLERGOMETRINE,METHYLERGOMETRINE
REP.PRIMARY,2.5,AGTR2,ANGIOTENSIN ANTAGONIST,BRD:BRD-K34713073-001-01-3,PD-123319,PD-123319
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, DRD4, DRD5, GPR143",DOPAMINE PRECURSOR,BRD:BRD-K34730807-001-17-6,LEVODOPA,LEVODOPA
REP.PRIMARY,2.5,"ABCC8, KCNJ1, KCNJ11",INSULIN SECRETAGOGUE,BRD:BRD-K34776109-001-16-6,GLIMEPIRIDE,GLIMEPIRIDE
REP.PRIMARY,2.5,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K34801930-001-01-9,SRT3190,"AZD5069, SRT3190"
REP.PRIMARY,2.5,HDAC1,NFKB PATHWAY INHIBITOR,BRD:BRD-K34851558-001-02-3,PARTHENOLIDE-(-),PARTHENOLIDE-(-)
REP.PRIMARY,2.5,"DRD2, HTR1A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-K34870043-001-01-8,ADOPRAZINE,ADOPRAZINE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, PDE4B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K34888156-213-01-4,THEOBROMINE,THEOBROMINE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K35007173-001-07-5,ENPROFYLLINE,ENPROFYLLINE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K35034482-001-01-8,BUNAZOSIN,BUNAZOSIN
REP.PRIMARY,2.5,PYGM,APOPTOSIS STIMULANT,BRD:BRD-K35079116-001-02-5,ASIATIC-ACID,ASIATIC-ACID
REP.PRIMARY,2.5,PYGM,APOPTOSIS STIMULANT,BRD:BRD-K35079116-001-03-3,ASIATIC-ACID,ASIATIC-ACID
REP.PRIMARY,2.5,CNR1,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K35169477-001-01-9,TARANABANT,TARANABANT
REP.PRIMARY,2.5,,,BRD:BRD-K35170555-001-09-5,CAPRYLIC-ACID,CAPRYLIC-ACID
REP.PRIMARY,2.5,"AR, ESR1, PGR, SRD5A1","ESTROGEN RECEPTOR AGONIST, GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR AGONIST, PROGESTERONE RECEPTOR ANTAGONIST",BRD:BRD-K35189033-001-26-1,LEVONORGESTREL,LEVONORGESTREL
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K35240538-001-26-2,METHYLPREDNISOLONE,METHYLPREDNISOLONE
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K35245662-001-01-2,CICLESONIDE,CICLESONIDE
REP.PRIMARY,2.5,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K35329391-334-01-7,GZD824,GZD824
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K35430135-003-02-3,SR-59230A,SR-59230A
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K35498378-001-06-1,ALRESTATIN,ALRESTATIN
REP.PRIMARY,2.5,"PGD, POLA2",DNA ALKYLATING AGENT,BRD:BRD-K35520305-001-17-7,DACARBAZINE,DACARBAZINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K35559145-050-08-5,LEVOMEPROMAZINE,LEVOMEPROMAZINE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K35586044-003-15-4,YOHIMBINE,YOHIMBINE
REP.PRIMARY,2.5,,GAP JUNCTION MODULATOR,BRD:BRD-K35589454-003-01-1,DANEGAPTIDE,DANEGAPTIDE
REP.PRIMARY,2.5,FBP1,FRUCTOSE BIPHOSPHATE INHIBITOR,BRD:BRD-K35601925-001-01-9,CS-917,CS-917
REP.PRIMARY,2.5,CCKAR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K35629949-001-02-0,SR-27897,SR-27897
REP.PRIMARY,2.5,DPYD,DIHYDROPYRIMIDINE DEHYDROGENASE INHIBITOR,BRD:BRD-K35687421-001-02-5,GIMERACIL,GIMERACIL
REP.PRIMARY,2.5,,,BRD:BRD-K35698076-001-01-2,LAUROCAPRAM,LAUROCAPRAM
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, HTR1A",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K35719256-001-02-6,ROTUNDINE,ROTUNDINE
REP.PRIMARY,2.5,,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K35775715-001-03-1,LIRANAFTATE,LIRANAFTATE
REP.PRIMARY,2.5,"SHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K35781423-001-01-6,SANT-2,SANT-2
REP.PRIMARY,2.5,,,BRD:BRD-K35952844-236-01-6,SODIUM-GLUCOHEPTONATE,"CALCIUM-GLUCEPTATE, SODIUM-GLUCOHEPTONATE"
REP.PRIMARY,2.5,,,BRD:BRD-K35952844-238-01-2,SODIUM-GLUCOHEPTONATE,"CALCIUM-GLUCEPTATE, SODIUM-GLUCOHEPTONATE"
REP.PRIMARY,2.5,STAT3,"DNA REPLICATION INHIBITOR, STAT INHIBITOR",BRD:BRD-K35960502-001-20-0,NICLOSAMIDE,NICLOSAMIDE
REP.PRIMARY,2.5,ATM,ATM KINASE INHIBITOR,BRD:BRD-K36016295-001-04-5,KU-60019,KU-60019
REP.PRIMARY,2.5,ADK,ADENOSINE KINASE INHIBITOR,BRD:BRD-K36021395-300-02-4,ABT-702,ABT-702
REP.PRIMARY,2.5,,ANGIOTENSIN RECEPTOR AGONIST,BRD:BRD-K36040345-001-01-1,TXA127,TXA127
REP.PRIMARY,2.5,RPL3,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K36055864-001-19-2,CYCLOHEXIMIDE,CYCLOHEXIMIDE
REP.PRIMARY,2.5,,PSYCHOACTIVE DRUG,BRD:BRD-K36116267-001-15-3,PYRITHYLDIONE,PYRITHYLDIONE
REP.PRIMARY,2.5,MMP13,METALLOPROTEINASE INHIBITOR,BRD:BRD-K36198571-001-02-0,WAY-170523,WAY-170523
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K36207157-001-07-0,CHLORPROTHIXENE,CHLORPROTHIXENE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K36207157-001-09-6,CHLORPROTHIXENE,CHLORPROTHIXENE
REP.PRIMARY,2.5,,,BRD:BRD-K36222532-001-01-8,BROXALDINE,BROXALDINE
REP.PRIMARY,2.5,GSR,"DNA ALKYLATING AGENT, DNA INHIBITOR",BRD:BRD-K36234266-001-09-8,CARMUSTINE,CARMUSTINE
REP.PRIMARY,2.5,CASP3,CASPASE INHIBITOR,BRD:BRD-K36258877-001-03-1,AZ-10417808,AZ-10417808
REP.PRIMARY,2.5,"AZGP1, CES1, MBL2, REG1A, SELE, SELP, SIGLEC1",,BRD:BRD-K36262466-001-06-3,ACENEURAMIC-ACID,ACENEURAMIC-ACID
REP.PRIMARY,2.5,"NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K36269323-300-02-6,ASYMMETRICAL-DIMETHYLARGININE,ASYMMETRICAL-DIMETHYLARGININE
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K36270037-001-01-7,ESCULIN,ESCULIN
REP.PRIMARY,2.5,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K36363294-001-04-2,I-BET151,I-BET151
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K36381762-300-02-7,NOR-BINALTORPHIMINE-DIHYDROCHLORIDE,"NOR-BINALTORPHIMINE, NOR-BINALTORPHIMINE-DIHYDROCHLORIDE"
REP.PRIMARY,2.5,"CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1",HIV INTEGRASE INHIBITOR,BRD:BRD-K36386086-001-01-1,DOLUTEGRAVIR,DOLUTEGRAVIR
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K36395411-003-02-2,SB-206553,SB-206553
REP.PRIMARY,2.5,"HAL, HARS, HDC, SLC15A3, SLC15A4, SLC38A3, SLC38A5",,BRD:BRD-K36449075-001-01-0,COPPER-HISTIDINE,COPPER-HISTIDINE
REP.PRIMARY,2.5,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B",GABA RECEPTOR ANTAGONIST,BRD:BRD-K36461289-001-05-8,PICROTOXININ,PICROTOXININ
REP.PRIMARY,2.5,"CCL2, CCL7, CCL8",NFKB PATHWAY INHIBITOR,BRD:BRD-K36467523-001-02-8,BINDARIT,BINDARIT
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K36529613-001-02-6,PU-H71,PU-H71
REP.PRIMARY,2.5,"RARA, RARB",RETINOID RECEPTOR AGONIST,BRD:BRD-K36627727-001-05-4,TAMIBAROTENE,TAMIBAROTENE
REP.PRIMARY,2.5,"HDAC10, HDAC6",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K36660044-001-24-2,BUFEXAMAC,BUFEXAMAC
REP.PRIMARY,2.5,MYBPC3,CARDIAC MYOSIN ACTIVATOR,BRD:BRD-K36680103-001-01-6,OMECAMTIV-MECARBIL,OMECAMTIV-MECARBIL
REP.PRIMARY,2.5,,,BRD:BRD-K36711084-001-02-0,CYROMAZINE,CYROMAZINE
REP.PRIMARY,2.5,"HRH1, HTR2A, HTR2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K36732695-001-01-9,SETIPTILINE,SETIPTILINE
REP.PRIMARY,2.5,AHR,ARYL HYDROCARBON RECEPTOR ANTAGONIST,BRD:BRD-K36739687-001-03-0,STEMREGENIN-1,STEMREGENIN-1
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC, CYP2D6, CYP3A4",AURORA KINASE INHIBITOR,BRD:BRD-K36740062-001-06-6,GSK1070916,GSK1070916
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K36756879-003-08-7,ETHAVERINE,ETHAVERINE
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K36775483-001-01-4,DMEOB,DMEOB
REP.PRIMARY,2.5,"CDK4, CDK6",CDK INHIBITOR,BRD:BRD-K36788280-001-01-2,RIBOCICLIB,RIBOCICLIB
REP.PRIMARY,2.5,"NOS3, PAH, TH, TPH1",PHENYLALANINE 4-HYDROXYLASE STIMULANT,BRD:BRD-K36859431-300-02-3,SAPROPTERIN,SAPROPTERIN
REP.PRIMARY,2.5,"ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3",SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,BRD:BRD-K36862742-001-25-6,HYDROFLUMETHIAZIDE,HYDROFLUMETHIAZIDE
REP.PRIMARY,2.5,SIGMAR1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K36864847-303-02-5,BD-1047,BD-1047
REP.PRIMARY,2.5,,,BRD:BRD-K36889451-001-01-1,TETRAMETHYLTHIURAM-MONOSULFIDE,TETRAMETHYLTHIURAM-MONOSULFIDE
REP.PRIMARY,2.5,"ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1","ATP CHANNEL BLOCKER, INSULIN SECRETAGOGUE, SULFONYLUREA",BRD:BRD-K36927236-001-32-6,GLYBURIDE,GLYBURIDE
REP.PRIMARY,2.5,"HTR3A, HTR3B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K36965586-003-08-8,M-CHLOROPHENYLBIGUANIDE,M-CHLOROPHENYLBIGUANIDE
REP.PRIMARY,2.5,,"GAP JUNCTION MODULATOR, NITRIC OXIDE PRODUCTION INHIBITOR",BRD:BRD-K36970462-001-01-6,TONABERSAT,TONABERSAT
REP.PRIMARY,2.5,"PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ",PROTEIN KINASE INHIBITOR,BRD:BRD-K36984403-001-02-7,GO-6983,GO-6983
REP.PRIMARY,2.5,,,BRD:BRD-K37069697-001-01-3,FEXINIDAZOLE,FEXINIDAZOLE
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K37083340-001-02-3,LYCOPENE,LYCOPENE
REP.PRIMARY,2.5,CA14,CHELATING AGENT,BRD:BRD-K37111771-300-02-6,TRIENTINE,TRIENTINE
REP.PRIMARY,2.5,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K37130656-001-04-6,RIVAROXABAN,RIVAROXABAN
REP.PRIMARY,2.5,,,BRD:BRD-K37203094-001-02-5,1-HEXADECANOL,1-HEXADECANOL
REP.PRIMARY,2.5,JAK2,JAK INHIBITOR,BRD:BRD-K37237504-001-02-7,CEP-33779,CEP-33779
REP.PRIMARY,2.5,"HRH1, KCNH1, KCNH2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K37249724-001-25-7,ASTEMIZOLE,ASTEMIZOLE
REP.PRIMARY,2.5,"AR, NR1I2, NR3C1, PGR","GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR ANTAGONIST",BRD:BRD-K37270826-001-27-6,MIFEPRISTONE,MIFEPRISTONE
REP.PRIMARY,2.5,"AR, NR1I2, NR3C1, PGR","GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR ANTAGONIST",BRD:BRD-K37270826-001-31-8,MIFEPRISTONE,MIFEPRISTONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K37289225-001-36-4,CLOZAPINE,CLOZAPINE
REP.PRIMARY,2.5,"CCNB1, CDK1, CDK5, GSK3B","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K37312348-001-15-0,KENPAULLONE,KENPAULLONE
REP.PRIMARY,2.5,"HBA1, HBB","HAEMOGLOBIN OXYGEN RELEASE STIMULANT, HEMOGLOBIN OXYGEN RELEASE STIMULANT",BRD:BRD-K37355418-236-01-6,EFAPROXIRAL,EFAPROXIRAL
REP.PRIMARY,2.5,KIF11,"KINESIN INHIBITOR, KINESIN-LIKE SPINDLE PROTEIN INHIBITOR",BRD:BRD-K37379014-001-01-2,FILANESIB,FILANESIB
REP.PRIMARY,2.5,"AVPR1A, AVPR2",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K37385792-003-02-1,CONIVAPTAN,CONIVAPTAN
REP.PRIMARY,2.5,,CALCIUM CHANNEL MODULATOR,BRD:BRD-K37516142-001-10-5,IDEBENONE,IDEBENONE
REP.PRIMARY,2.5,PDE4D,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K37561857-001-15-5,ZARDAVERINE,ZARDAVERINE
REP.PRIMARY,2.5,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K37590257-001-02-8,GSK256066,GSK256066
REP.PRIMARY,2.5,"ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K37618799-001-03-0,MRS-1220,MRS-1220
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K37682401-001-09-3,PIROMIDIC-ACID,PIROMIDIC-ACID
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K37682401-213-01-1,PIROMIDIC-ACID,PIROMIDIC-ACID
REP.PRIMARY,2.5,MAP3K1,MEK INHIBITOR,BRD:BRD-K37687095-001-06-9,AZD8330,AZD8330
REP.PRIMARY,2.5,NR3C2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K37687387-237-01-7,RU-28318,RU-28318
REP.PRIMARY,2.5,,PSYCHOACTIVE DRUG,BRD:BRD-K37688416-003-13-1,FIPEXIDE,FIPEXIDE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K37694030-003-12-7,DOXEPIN,DOXEPIN
REP.PRIMARY,2.5,DRD4,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K37714784-305-02-1,ABT-724,ABT-724
REP.PRIMARY,2.5,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K37720887-001-07-8,SB-525334,SB-525334
REP.PRIMARY,2.5,CXCR3,APOPTOSIS STIMULANT,BRD:BRD-K37723606-001-01-5,DIOSCIN,DIOSCIN
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K37753391-046-03-2,TYLOSIN,TYLOSIN
REP.PRIMARY,2.5,PAK4,P21 ACTIVATED KINASE INHIBITOR,BRD:BRD-K37764012-001-04-1,PF-03758309,PF-03758309
REP.PRIMARY,2.5,,ANXIOLYTIC,BRD:BRD-K37793595-003-01-7,AFOBAZOLE,AFOBAZOLE
REP.PRIMARY,2.5,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K37798499-001-27-2,ETOPOSIDE,ETOPOSIDE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K37814297-050-09-6,ACEPROMAZINE,ACEPROMAZINE
REP.PRIMARY,0.25,"AR, HIF1A, IFNG, PI3","CHK INHIBITOR, CYTOCHROME P450 ACTIVATOR, INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K37846922-001-09-4,"3,3'-DIINDOLYLMETHANE","3,3'-DIINDOLYLMETHANE"
REP.PRIMARY,2.5,FAAH,"FAAH INHIBITOR, FAAH REUPTAKE INHIBITOR",BRD:BRD-K37865504-001-04-1,LY2183240,LY2183240
REP.PRIMARY,2.5,"ITGA2B, ITGB3","PLATELET AGGREGATION INHIBITOR, STRUCTURAL GLYCOPROTEIN ANTAGONIST",BRD:BRD-K37872686-003-01-9,TIROFIBAN,TIROFIBAN
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K37890730-001-15-1,CAMPTOTHECIN,CAMPTOTHECIN
REP.PRIMARY,2.5,"ATP6V1A, PTPRS",BONE RESORPTION INHIBITOR,BRD:BRD-K37949327-001-06-3,ETIDRONIC-ACID,ETIDRONIC-ACID
REP.PRIMARY,2.5,"TACR1, TACR2",TACHYKININ ANTAGONIST,BRD:BRD-K37952347-001-01-4,"L-732,138","L-732,138"
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K37991163-003-13-4,PAROXETINE,PAROXETINE
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",STEROID,BRD:BRD-K38003476-001-09-1,CLOCORTOLONE-PIVALATE,CLOCORTOLONE-PIVALATE
REP.PRIMARY,2.5,,RESPIRATORY STIMULANT,BRD:BRD-K38055836-001-21-1,ETHAMIVAN,ETHAMIVAN
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-K38140108-002-01-2,GADODIAMIDE,GADODIAMIDE
REP.PRIMARY,2.5,GRIN2B,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K38158531-001-02-1,TRAXOPRODIL,TRAXOPRODIL
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K38183498-001-02-0,CLONAZEPAM,CLONAZEPAM
REP.PRIMARY,2.5,"CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5",SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K38197229-001-29-9,BUMETANIDE,BUMETANIDE
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K38287497-001-01-2,NARLAPREVIR,NARLAPREVIR
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K38305202-001-17-4,DOMPERIDONE,DOMPERIDONE
REP.PRIMARY,2.5,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K38323065-001-19-9,PHENACETIN,PHENACETIN
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K38332599-001-01-3,UPROSERTIB,UPROSERTIB
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K38350380-001-01-8,FK-3311,FK-3311
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K38370968-050-01-3,3-AQC,3-AQC
REP.PRIMARY,2.5,MGEA5,GLCNAC PHOSPHOTRANSFERASE INHIBITOR,BRD:BRD-K38380126-001-01-4,THIAMET-G,THIAMET-G
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4","NOREPINEPHRINE REPUTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K38436528-003-26-1,IMIPRAMINE,IMIPRAMINE
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K38458514-001-01-8,DIAZOOXONORLEUCINE,DIAZOOXONORLEUCINE
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K38473998-001-02-0,CILOMILAST,CILOMILAST
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K38548312-001-01-0,VER-49009,VER-49009
REP.PRIMARY,2.5,"DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1",GROWTH FACTOR RECEPTOR ACTIVATOR,BRD:BRD-K38580127-003-15-4,SEROTONIN,SEROTONIN
REP.PRIMARY,2.5,,,BRD:BRD-K38602774-001-03-2,SULISOBENZONE,SULISOBENZONE
REP.PRIMARY,2.5,"ABCB1, MLNR",BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K38684403-001-05-4,ROXITHROMYCIN,ROXITHROMYCIN
REP.PRIMARY,2.5,APP,BETA AMYLOID SYNTHESIS INHIBITOR,BRD:BRD-K38687824-001-02-5,BETA-AMYLOID-SYNTHESIS-INHIBITOR,BETA-AMYLOID-SYNTHESIS-INHIBITOR
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K38797369-003-01-1,PD-128907,PD-128907
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K38852836-001-02-1,GANETESPIB,GANETESPIB
REP.PRIMARY,2.5,,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K38860038-001-01-2,JK-184,JK-184
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K38868394-001-01-3,MK-0773,MK-0773
REP.PRIMARY,2.5,"AURKB, CACNA1B",FLAVANONE GLYCOSIDE,BRD:BRD-K38903228-001-13-5,HESPERIDIN,HESPERIDIN
REP.PRIMARY,2.5,FLT4,VEGFR INHIBITOR,BRD:BRD-K38904395-001-02-3,SAR131675,SAR131675
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K38911213-003-01-6,APRACLONIDINE,APRACLONIDINE
REP.PRIMARY,2.5,"KCNA5, KCNE1, KCNH2, KCNQ1",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K38913877-300-01-9,AZIMILIDE,AZIMILIDE
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K38938675-001-01-4,MORNIFLUMATE,MORNIFLUMATE
REP.PRIMARY,2.5,,,BRD:BRD-K39023557-001-01-7,OCTOCRYLENE,OCTOCRYLENE
REP.PRIMARY,2.5,,,BRD:BRD-K39061174-001-01-0,BETA-GLYCEROPHOSPHORIC-ACID,BETA-GLYCEROPHOSPHORIC-ACID
REP.PRIMARY,2.5,,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K39079086-001-07-6,CINCHONIDINE,CINCHONIDINE
REP.PRIMARY,2.5,"ESR1, ESR2, MCL1",AUTOTAXIN INHIBITOR,BRD:BRD-K39120595-304-04-7,BITHIONOL,BITHIONOL
REP.PRIMARY,2.5,PLAUR,UROKINASE INHIBITOR,BRD:BRD-K39160765-003-02-9,4-CHLOROPHENYLGUANIDINE,4-CHLOROPHENYLGUANIDINE
REP.PRIMARY,2.5,,,BRD:BRD-K39166528-001-01-0,ID-8,ID-8
REP.PRIMARY,2.5,NAMPT,NAMPT INHIBITOR,BRD:BRD-K39171998-001-01-1,STF-118804,STF-118804
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K39252998-003-01-5,ATIPAMEZOLE,ATIPAMEZOLE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K39339537-001-21-0,EPIRIZOLE,EPIRIZOLE
REP.PRIMARY,2.5,,,BRD:BRD-K39371216-001-01-3,CYACETACIDE,CYACETACIDE
REP.PRIMARY,2.5,ACVR1,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K39381259-001-01-0,DMH1,DMH1
REP.PRIMARY,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K39462424-050-09-8,DEXCHLORPHENIRAMINE,DEXCHLORPHENIRAMINE
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K39467894-001-05-9,NITHIAMIDE,NITHIAMIDE
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K39467894-001-06-7,NITHIAMIDE,NITHIAMIDE
REP.PRIMARY,2.5,RELA,RNA POLYMERASE INHIBITOR,BRD:BRD-K39484304-001-16-5,TRIPTOLIDE,TRIPTOLIDE
REP.PRIMARY,2.5,,,BRD:BRD-K39495750-001-01-2,CHLOROBUTANOL,CHLOROBUTANOL
REP.PRIMARY,2.5,"ALOX5, ALOX5AP",LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K39503511-001-03-9,QUIFLAPON,QUIFLAPON
REP.PRIMARY,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K39558284-001-01-2,SDZ-WAG-994,SDZ-WAG-994
REP.PRIMARY,2.5,OPRD1,OPIOID RECEPTOR AGONIST,BRD:BRD-K39624409-003-02-6,ADL5859,ADL5859
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K39670393-303-02-1,AMTHAMINE,AMTHAMINE
REP.PRIMARY,2.5,,RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K39693230-001-01-2,N-SALICOYLAMINOPHENOL,N-SALICOYLAMINOPHENOL
REP.PRIMARY,2.5,PTGER4,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K39733634-001-02-6,L-161982,L-161982
REP.PRIMARY,2.5,,,BRD:BRD-K39805756-001-01-6,TPPS4,TPPS4
REP.PRIMARY,2.5,"JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K39841531-001-02-1,TG-101209,TG-101209
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K39915878-036-24-4,LOXAPINE,LOXAPINE
REP.PRIMARY,2.5,"FLT4, KDR","FGFR INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K39974922-001-04-3,LENVATINIB,LENVATINIB
REP.PRIMARY,2.5,NR3C1,"GLUCOCORTICOID RECEPTOR AGONIST, PHOSPHOLIPASE INHIBITOR",BRD:BRD-K39983086-001-06-1,LOTEPREDNOL,LOTEPREDNOL
REP.PRIMARY,2.5,,LAXATIVE,BRD:BRD-K39987650-001-24-1,BISACODYL,BISACODYL
REP.PRIMARY,2.5,TGFBR1,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K40109029-001-02-9,SB-505124,SB-505124
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K40175214-001-11-6,TORIN-1,TORIN-1
REP.PRIMARY,1.7000000000000002,"CHRM1, CHRM2, CHRM3, CHRM4",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K40227168-001-12-9,VINBURNINE,VINBURNINE
REP.PRIMARY,2.5,,"PROTEIN TYROSINE KINASE INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K40255344-001-17-6,TYRPHOSTIN-A9,TYRPHOSTIN-A9
REP.PRIMARY,2.5,"CTSB, CTSL, CTSV",CATHEPSIN INHIBITOR,BRD:BRD-K40269473-001-02-2,CATHEPSIN-INHIBITOR-1,CATHEPSIN-INHIBITOR-1
REP.PRIMARY,2.5,SMO,SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K40302533-001-02-9,PF-5274857,PF-5274857
REP.PRIMARY,2.5,NUDT1,MTH1 INHIBITOR,BRD:BRD-K40308497-001-01-2,CRIZOTINIB-(S),CRIZOTINIB-(S)
REP.PRIMARY,2.5,NUDT1,MTH1 INHIBITOR,BRD:BRD-K40308497-001-02-0,CRIZOTINIB-(S),CRIZOTINIB-(S)
REP.PRIMARY,2.5,CCNA2,CDK INHIBITOR,BRD:BRD-K40331046-305-01-5,CR8-(R),CR8-(R)
REP.PRIMARY,2.5,PIK3CG,PI3K INHIBITOR,BRD:BRD-K40366680-001-03-3,CAY10505,CAY10505
REP.PRIMARY,2.5,"KCNJ4, TXNRD1",GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K40438880-305-06-6,SPERMIDINE,SPERMIDINE
REP.PRIMARY,2.5,MPL,THROMBOPOIETIN RECEPTOR AGONIST,BRD:BRD-K40496271-396-01-1,ELTROMBOPAG,ELTROMBOPAG
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K40530731-001-11-6,HYOSCYAMINE,HYOSCYAMINE
REP.PRIMARY,2.5,"ADORA1, ADORA2A",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K40578143-001-02-6,GR-79236,GR-79236
REP.PRIMARY,2.5,PGD,CHELATING AGENT,BRD:BRD-K40621224-001-06-7,PENTETIC-ACID,PENTETIC-ACID
REP.PRIMARY,2.5,"CA1, CA2, CA4",IMMUNOSTIMULANT,BRD:BRD-K40654626-236-01-5,DITIOCARB-SODIUM-TRIHYDRATE,DITIOCARB-SODIUM-TRIHYDRATE
REP.PRIMARY,2.5,,,BRD:BRD-K40715924-001-01-1,MEDORINONE,MEDORINONE
REP.PRIMARY,2.5,"EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K40718343-001-02-6,AEE788,AEE788
REP.PRIMARY,2.5,"AXL, MERTK, MET, MST1R, TYRO3","AXL KINASE INHIBITOR, C-MET INHIBITOR, FLT3 INHIBITOR, HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K40738845-001-05-0,BMS-777607,BMS-777607
REP.PRIMARY,2.5,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4",HIV PROTEASE INHIBITOR,BRD:BRD-K40758068-001-08-2,EFAVIRENZ,EFAVIRENZ
REP.PRIMARY,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K40782193-003-02-9,QX-222,QX-222
REP.PRIMARY,2.5,,"LAXATIVE, OSMOSIS STIMULANT",BRD:BRD-K40787673-001-02-1,LACITOL,LACITOL
REP.PRIMARY,2.5,IL17A,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K40797222-001-01-8,SC-12267,SC-12267
REP.PRIMARY,2.5,ITGA4,INTEGRIN ANTAGONIST,BRD:BRD-K40870905-001-01-7,CT-7758,CT-7758
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K40887525-001-21-9,RITANSERIN,RITANSERIN
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K40901640-003-01-6,CINANSERIN,CINANSERIN
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K40905133-001-04-9,PHENACEMIDE,PHENACEMIDE
REP.PRIMARY,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K40992116-001-09-7,PARACHLOROPHENOL,PARACHLOROPHENOL
REP.PRIMARY,2.5,,,BRD:BRD-K41024817-325-01-0,4-PHENOLSULFONIC-ACID,4-PHENOLSULFONIC-ACID
REP.PRIMARY,2.5,,PERK INHIBITOR,BRD:BRD-K41104902-001-01-3,GSK2656157,GSK2656157
REP.PRIMARY,2.5,"ADORA1, AR",ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K41141507-001-16-2,CYPROTERONE-ACETATE,CYPROTERONE-ACETATE
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41143549-003-02-4,N20C,N20C
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41160163-001-06-8,FENOBAM,FENOBAM
REP.PRIMARY,2.5,"EFTUD1, FPR1, GPBAR1","BILIVERDIN REDUCTASE A ACTIVATOR, G PROTEIN-COUPLED RECEPTOR AGONIST",BRD:BRD-K41170226-001-13-8,DEOXYCHOLIC-ACID,DEOXYCHOLIC-ACID
REP.PRIMARY,2.5,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K41185545-001-02-3,AMBRISENTAN,AMBRISENTAN
REP.PRIMARY,2.5,,HSP INHIBITOR,BRD:BRD-K41213548-001-02-0,KW-2478,KW-2478
REP.PRIMARY,0.03,LTB4R2,MUCIN PRODUCTION ENHANCER,BRD:BRD-K41234004-001-03-1,ICOMUCRET,ICOMUCRET
REP.PRIMARY,2.5,"ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1",PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K41256143-001-12-7,DEHYDROEPIANDROSTERONE,DEHYDROEPIANDROSTERONE
REP.PRIMARY,2.5,"ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A","BENZODIAZEPINE RECEPTOR AGONIST, HDAC INHIBITOR",BRD:BRD-K41260949-236-16-8,VALPROIC-ACID,VALPROIC-ACID
REP.PRIMARY,2.5,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K41278234-001-03-0,CUDC-101,CUDC-101
REP.PRIMARY,2.5,"SOD1, SOD2",SUPEROXIDE DISMUTASE INHIBITOR,BRD:BRD-K41298358-395-03-4,TETRAETHYLENEPENTAMINE,TETRAETHYLENEPENTAMINE
REP.PRIMARY,2.5,GRIA1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41304947-001-03-2,HA-966-(S)-(-),HA-966-(S)-(-)
REP.PRIMARY,2.5,NTRK1,GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K41312087-001-02-7,GW-441756,GW-441756
REP.PRIMARY,2.5,"EGFR, FLT1, FLT4, KDR","ABL KINASE INHIBITOR, SRC INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K41337261-001-03-0,ZM-306416,ZM-306416
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K41406082-001-16-2,SULFAPYRIDINE,SULFAPYRIDINE
REP.PRIMARY,2.5,"ALOX5, PPARG, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K41410256-304-02-2,BALSALAZIDE,BALSALAZIDE
REP.PRIMARY,2.5,ADRA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K41434598-003-01-9,ORG-9768,ORG-9768
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41438959-001-01-7,PERAMPANEL,PERAMPANEL
REP.PRIMARY,2.5,GABBR1,"BENZODIAZEPINE RECEPTOR AGONIST, CHLORIDE CHANNEL AGONIST",BRD:BRD-K41445866-001-18-8,ALFAXALONE,ALFAXALONE
REP.PRIMARY,2.5,"FAAH, PTGS1, PTGS2, TRPV1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K41524689-001-23-5,PARACETAMOL,PARACETAMOL
REP.PRIMARY,2.5,"CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2",TYROSINE KINASE INHIBITOR,BRD:BRD-K41564320-001-02-0,PURVALANOL-B,PURVALANOL-B
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K41567364-001-04-6,SB-334867,SB-334867
REP.PRIMARY,2.5,,CHOLINESTERASE INHIBITOR,BRD:BRD-K41567533-001-08-3,COUMOPHOS,COUMOPHOS
REP.PRIMARY,2.5,"FNTA, HRAS, KRAS, NRAS",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K41599323-001-02-3,LONAFARNIB,LONAFARNIB
REP.PRIMARY,2.5,,"PHOSPHOENOLPYRUVATE CARBOXYLASE ACTIVATOR, SERINE/THREONINE PROTEIN PHOSPHATASE ACTIVATOR",BRD:BRD-K41707108-001-05-6,CERAMIDE,CERAMIDE
REP.PRIMARY,2.5,"KCNH1, KCNH2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K41713976-300-02-6,E-4031,E-4031
REP.PRIMARY,2.5,DNMT1,ANTIBACTERIAL AGENT,BRD:BRD-K41731458-001-15-1,TRICLOSAN,TRICLOSAN
REP.PRIMARY,2.5,"LYN, SRC",SRC ACTIVATOR,BRD:BRD-K41772907-001-01-2,TOLIMIDONE,TOLIMIDONE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K41779183-001-01-2,CB-03-01,CB-03-01
REP.PRIMARY,2.5,IL12A,INTERLEUKIN SYNTHESIS INHIBITOR,BRD:BRD-K41783120-001-02-8,STA-5326,STA-5326
REP.PRIMARY,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K41853443-001-02-9,"1,3-DIPROPYL-8-PHENYLXANTHINE","1,3-DIPROPYL-8-PHENYLXANTHINE"
REP.PRIMARY,2.5,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K41859756-001-06-8,NVP-AUY922,NVP-AUY922
REP.PRIMARY,2.5,,,BRD:BRD-K41866823-001-01-3,2-HYDROXYETHYL-SALICYLATE,2-HYDROXYETHYL-SALICYLATE
REP.PRIMARY,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K41869275-001-02-8,2-PHENYLMELATONIN,2-PHENYLMELATONIN
REP.PRIMARY,2.5,CA2,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K41876534-001-13-7,TIOXOLONE,TIOXOLONE
REP.PRIMARY,2.5,,AMPK ACTIVATOR,BRD:BRD-K41918892-001-05-9,A-769662,A-769662
REP.PRIMARY,2.5,,,BRD:BRD-K42090719-001-06-5,TRICHLOROACETIC-ACID,TRICHLOROACETIC-ACID
REP.PRIMARY,2.5,"ESRRA, ESRRB, ESRRG, TRPC5",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K42095107-001-17-1,DAIDZEIN,DAIDZEIN
REP.PRIMARY,2.5,"SLC6A2, SLC6A4",TRICYCLIC ANTIDEPRESSANT,BRD:BRD-K42098891-003-20-5,PROTRIPTYLINE,PROTRIPTYLINE
REP.PRIMARY,2.5,"PIK3CA, PIK3CG",PI3K INHIBITOR,BRD:BRD-K42191735-001-05-3,BUPARLISIB,BUPARLISIB
REP.PRIMARY,2.5,"SRC, SYK","SRC INHIBITOR, SYK INHIBITOR",BRD:BRD-K42205652-001-02-7,"MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)","3,4-METHYLENEDIOXY-BETA-NITROSTYRENE, MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)"
REP.PRIMARY,2.5,"SIGMAR1, SLC6A1",GABA UPTAKE INHIBITOR,BRD:BRD-K42221274-003-07-7,NNC-711,NNC-711
REP.PRIMARY,2.5,"ANPEP, NPC1L1, SOAT1","CHOLESTEROL INHIBITOR, NIEMANN-PICK C1-LIKE 1 PROTEIN ANTAGONIST",BRD:BRD-K42260897-001-07-6,EZETIMIBE,EZETIMIBE
REP.PRIMARY,2.5,"ANPEP, NPC1L1, SOAT1","CHOLESTEROL INHIBITOR, NIEMANN-PICK C1-LIKE 1 PROTEIN ANTAGONIST",BRD:BRD-K42260897-001-09-2,EZETIMIBE,EZETIMIBE
REP.PRIMARY,2.5,HTR2A,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-K42348709-003-13-1,CYCLOBENZAPRINE,CYCLOBENZAPRINE
REP.PRIMARY,2.5,"CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1",CANNABINOID RECEPTOR AGONIST,BRD:BRD-K42352790-001-05-3,ANANDAMIDE,ANANDAMIDE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1","OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K42417338-045-01-9,BUTORPHANOL-(+)-TARTRATE,BUTORPHANOL-(+)-TARTRATE
REP.PRIMARY,2.5,"ATR, MTOR",ATR KINASE INHIBITOR,BRD:BRD-K42436189-001-01-2,AZ20,AZ20
REP.PRIMARY,2.5,"MAPK11, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K42452249-001-02-5,EO-1428,EO-1428
REP.PRIMARY,2.5,,APOPTOSIS STIMULANT,BRD:BRD-K42495768-001-01-7,TASISULAM,TASISULAM
REP.PRIMARY,2.5,,DNA ALKYLATING AGENT,BRD:BRD-K42497885-001-01-1,SATRAPLATIN,SATRAPLATIN
REP.PRIMARY,2.5,"AURKB, LCK, MKNK1, MKNK2, SGK1",MAP KINASE INHIBITOR,BRD:BRD-K42500029-001-03-5,CGP-57380,CGP-57380
REP.PRIMARY,2.5,"TRPC3, TRPC5, TRPM4",CALCIUM CHANNEL BLOCKER,BRD:BRD-K42563464-001-01-9,YM-58483,YM-58483
REP.PRIMARY,2.5,KCNJ8,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K42679050-001-02-1,Y-27152,Y-27152
REP.PRIMARY,2.5,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K42748308-300-02-0,XE-991,XE-991
REP.PRIMARY,2.5,G6PD,STEROID,BRD:BRD-K42756753-001-01-9,EPIANDROSTERONE,EPIANDROSTERONE
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K42805893-001-04-9,OSIMERTINIB,OSIMERTINIB
REP.PRIMARY,2.5,"CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K42828737-044-09-0,SUNITINIB,SUNITINIB
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K42859542-001-03-3,CFM-2,CFM-2
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K42898655-001-01-8,TEMSIROLIMUS,TEMSIROLIMUS
REP.PRIMARY,2.5,"DRD1, DRD2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K42938903-332-01-1,ACETOPHENAZINE,ACETOPHENAZINE
REP.PRIMARY,2.5,"CCR5, CXCR4",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K42948882-305-01-1,AMD11070,AMD11070
REP.PRIMARY,2.5,,,BRD:BRD-K42959922-001-01-5,TRANS-2-UNDECENOIC-ACID,TRANS-2-UNDECENOIC-ACID
REP.PRIMARY,2.5,"GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K42973005-001-04-0,CHIR-98014,CHIR-98014
REP.PRIMARY,2.5,GRIA1,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K42981054-001-01-9,MIBAMPATOR,MIBAMPATOR
REP.PRIMARY,2.5,,,BRD:BRD-K42991124-001-03-0,CREATINOL-PHOSPHATE,CREATINOL-PHOSPHATE
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K43002771-034-01-6,SR-33805,SR-33805
REP.PRIMARY,2.5,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K43055376-001-01-2,IMEPITOIN,"ADD-233089, IMEPITOIN"
REP.PRIMARY,2.5,"ACHE, CHRM2, CHRNA1, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K43106192-320-11-8,GALLAMINE-TRIETHIODIDE,GALLAMINE-TRIETHIODIDE
REP.PRIMARY,2.5,PIK3CG,"ANDROGEN RECEPTOR AGONIST, CYTOCHROME P450 INHIBITOR",BRD:BRD-K43149758-001-22-7,MYRICETIN,MYRICETIN
REP.PRIMARY,2.5,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B",BILE ACID,BRD:BRD-K43164539-001-11-5,CHOLIC-ACID,CHOLIC-ACID
REP.PRIMARY,2.5,PIK3CA,PIM KINASE INHIBITOR,BRD:BRD-K43187018-001-03-3,GDC-0349,GDC-0349
REP.PRIMARY,2.5,"B2M, HLA-A, TRAC, TRBC1",,BRD:BRD-K43187796-001-02-3,3-INDOLEBUTYRIC-ACID,3-INDOLEBUTYRIC-ACID
REP.PRIMARY,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K43192255-048-03-6,METHYLLYCACONITINE,METHYLLYCACONITINE
REP.PRIMARY,2.5,ICAM1,ICAM1 EXPRESSION INHIBITOR,BRD:BRD-K43236057-001-07-1,POLYDATIN,POLYDATIN
REP.PRIMARY,2.5,"CHRM2, CHRNA2, HTR3A",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K43305603-004-02-8,ROCURONIUM,ROCURONIUM
REP.PRIMARY,2.5,,ADIPOSE TRIGLYCERIDE LIPASE INHIBITOR,BRD:BRD-K43363084-001-01-3,ATGLISTATIN,ATGLISTATIN
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K43383936-001-05-2,FLOPROPIONE,FLOPROPIONE
REP.PRIMARY,2.5,"TOP2A, TOP2B","RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR",BRD:BRD-K43389675-003-16-7,DAUNORUBICIN,DAUNORUBICIN
REP.PRIMARY,2.5,"TOP2A, TOP2B","RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR",BRD:BRD-K43389675-003-20-9,DAUNORUBICIN,DAUNORUBICIN
REP.PRIMARY,2.5,"CDK2, CDK7, CDK9","CDK INHIBITOR, CELL CYCLE INHIBITOR, MCL1 INHIBITOR",BRD:BRD-K43389698-001-09-9,BMS-387032,BMS-387032
REP.PRIMARY,2.5,,RAF INHIBITOR,BRD:BRD-K43410529-001-02-3,MLN2480,MLN2480
REP.PRIMARY,2.5,,APOPTOSIS STIMULANT,BRD:BRD-K43449605-001-01-0,ONCRASIN-1,ONCRASIN-1
REP.PRIMARY,2.5,"AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K43457670-001-27-8,ACETAZOLAMIDE,ACETAZOLAMIDE
REP.PRIMARY,2.5,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K43471985-001-03-0,OTX015,OTX015
REP.PRIMARY,2.5,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K43471985-001-05-5,OTX015,OTX015
REP.PRIMARY,2.5,PTK2,FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K43578482-001-01-4,DEFACTINIB,DEFACTINIB
REP.PRIMARY,2.5,CACNA1C,CALCIUM CHANNEL BLOCKER,BRD:BRD-K43586850-001-02-9,LACIDIPINE,LACIDIPINE
REP.PRIMARY,2.5,"KIT, PDGFRA, PDGFRB",PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K43621685-001-02-5,CP-673451,CP-673451
REP.PRIMARY,2.5,"JAK2, UCHL5, USP14, USP9X",DEUBIQUITINASE INHIBITOR,BRD:BRD-K43644456-001-04-0,WP1130,WP1130
REP.PRIMARY,2.5,,SIGMA RECEPTOR AGONIST,BRD:BRD-K43786866-300-02-3,OPIPRAMOL,OPIPRAMOL
REP.PRIMARY,2.5,"CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5",TYROSINE KINASE INHIBITOR,BRD:BRD-K43797669-001-30-4,GENISTEIN,GENISTEIN
REP.PRIMARY,2.5,FFAR1,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K43802723-340-01-9,AMG-837,AMG-837
REP.PRIMARY,2.5,PRSS1,PROTEASE INHIBITOR,BRD:BRD-K43806473-066-02-1,CAMOSTAT-MESILATE,CAMOSTAT-MESILATE
REP.PRIMARY,2.5,,ANTINEOPLASTIC AGENT,BRD:BRD-K43860855-065-11-9,IOBENGUANE,IOBENGUANE
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-K43873574-001-01-8,ILEPCIMIDE,ILEPCIMIDE
REP.PRIMARY,2.5,"CYP17A1, SULT2B1",GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K43880410-001-14-4,PREGNENOLONE,PREGNENOLONE
REP.PRIMARY,2.5,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K43887077-003-26-3,DOPAMINE,DOPAMINE
REP.PRIMARY,2.5,PTGER3,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K43905307-001-01-2,L-798106,"L-798,106, L-798106"
REP.PRIMARY,2.5,"CALCA, CALCRL, RAMP1",CALCITONIN ANTAGONIST,BRD:BRD-K43927145-001-01-2,BIBN4096,BIBN4096
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K43966364-237-04-8,PENICILLIN-V-POTASSIUM,PENICILLIN-V-POTASSIUM
REP.PRIMARY,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K44004064-001-07-3,ACEFYLLINE,ACEFYLLINE
REP.PRIMARY,2.5,,ATHEROSCLEROSIS FORMATION INHIBITOR,BRD:BRD-K44009692-001-02-3,HYODEOXYCHOLIC-ACID,HYODEOXYCHOLIC-ACID
REP.PRIMARY,2.5,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5",CHLORIDE CHANNEL BLOCKER,BRD:BRD-K44067360-001-30-3,FLUFENAMIC-ACID,FLUFENAMIC-ACID
REP.PRIMARY,2.5,"PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K44084986-300-08-4,Y-27632,Y-27632
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-K44133266-001-10-0,SULBACTAM,SULBACTAM
REP.PRIMARY,2.5,"ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK","BCR-ABL KINASE INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K44227013-001-06-4,PONATINIB,PONATINIB
REP.PRIMARY,2.5,,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K44273375-001-25-0,TOLNAFTATE,TOLNAFTATE
REP.PRIMARY,2.5,"AMY2A, GAA, MGAM, SI",GLUCOSIDASE INHIBITOR,BRD:BRD-K44276885-001-07-4,ACARBOSE,ACARBOSE
REP.PRIMARY,2.5,ADORA3,CALMODULIN ANTAGONIST,BRD:BRD-K44309363-003-02-1,DEXNIGULDIPINE,DEXNIGULDIPINE
REP.PRIMARY,2.5,"ABCC8, KCNJ10, KCNJ11, PPARG",INSULIN SECRETAGOGUE,BRD:BRD-K44353683-001-08-3,NATEGLINIDE,NATEGLINIDE
REP.PRIMARY,2.5,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K44366189-001-01-9,ANACETRAPIB,ANACETRAPIB
REP.PRIMARY,2.5,"COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB",HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K44408410-001-17-6,2-METHOXYESTRADIOL,2-METHOXYESTRADIOL
REP.PRIMARY,2.5,,"INTERFERON RECEPTOR AGONIST, INTERLEUKIN RECEPTOR AGONIST",BRD:BRD-K44442813-001-12-9,PIDOTIMOD,PIDOTIMOD
REP.PRIMARY,2.5,,,BRD:BRD-K44590731-001-01-7,TU-2100,TU-2100
REP.PRIMARY,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K44665581-001-01-8,BROMOSPORINE,BROMOSPORINE
REP.PRIMARY,2.5,"GHR, GHSR",GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K44771174-066-01-0,IBUTAMOREN,IBUTAMOREN
REP.PRIMARY,2.5,,HEPATOCYTE FUNCTION ENHANCER,BRD:BRD-K44777625-001-03-5,FH1,FH1
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-K44824027-001-02-1,BECLAMIDE,BECLAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K44825564-065-01-4,ZAPA,ZAPA
REP.PRIMARY,2.5,SMO,"HEDGEHOG PATHWAY INHIBITOR, SMOOTHENED RECEPTOR ANTAGONIST",BRD:BRD-K44827188-001-06-0,VISMODEGIB,VISMODEGIB
REP.PRIMARY,2.5,PIK3CA,PI3K INHIBITOR,BRD:BRD-K44844162-001-01-6,TASELISIB,TASELISIB
REP.PRIMARY,2.5,"TRPV1, TRPV4",TRPV AGONIST,BRD:BRD-K44849676-001-10-5,CAPSAZEPINE,CAPSAZEPINE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K44876623-001-03-7,ZOLPIDEM,ZOLPIDEM
REP.PRIMARY,2.5,,VOLTAGE-GATED SODIUM CHANNEL MODULATOR,BRD:BRD-K44942188-001-09-1,FOMOCAINE,FOMOCAINE
REP.PRIMARY,2.5,"CHRNA10, CHRNA3, CHRNA4, CHRNB4",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K44942604-346-05-4,PENTOLINIUM,PENTOLINIUM
REP.PRIMARY,2.5,,,BRD:BRD-K44963273-001-06-9,HQK-1001,HQK-1001
REP.PRIMARY,2.5,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K44974079-001-01-3,TICAGRELOR,TICAGRELOR
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K44993696-001-12-3,ATENOLOL-(-),ATENOLOL-(-)
REP.PRIMARY,2.5,"ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K45014108-003-01-8,EPHEDRINE,EPHEDRINE
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K45033733-001-12-2,FAMCICLOVIR,FAMCICLOVIR
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K45071273-003-25-6,TETRACAINE,TETRACAINE
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K45086103-001-15-5,SULFAGUANIDINE,SULFAGUANIDINE
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K45086103-001-16-3,SULFAGUANIDINE,SULFAGUANIDINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K45114938-236-01-8,MEZLOCILLIN,MEZLOCILLIN
REP.PRIMARY,2.5,KCNJ8,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K45117373-001-02-9,Y-26763,Y-26763
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K45152786-001-08-4,MERBARONE,MERBARONE
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K45158365-001-11-4,VALSARTAN,VALSARTAN
REP.PRIMARY,2.5,"GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K45163704-001-01-5,MIDAFOTEL,MIDAFOTEL
REP.PRIMARY,2.5,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K45168550-001-01-9,SB-756050,SB-756050
REP.PRIMARY,2.5,TYR,,BRD:BRD-K45216060-001-10-0,MEQUINOL,MEQUINOL
REP.PRIMARY,2.5,TYR,,BRD:BRD-K45216060-001-11-8,MEQUINOL,MEQUINOL
REP.PRIMARY,2.5,"ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE",,BRD:BRD-K45238818-001-02-6,SUCCINIC-ACID,SUCCINIC-ACID
REP.PRIMARY,2.5,,CHOLESTEROL INHIBITOR,BRD:BRD-K45245728-335-01-4,URSODEOXYCHOLYLTAURINE,URSODEOXYCHOLYLTAURINE
REP.PRIMARY,2.5,"LPL, PPARA",PPAR RECEPTOR AGONIST,BRD:BRD-K45252063-001-13-6,CLOFIBRATE,CLOFIBRATE
REP.PRIMARY,2.5,KCNH2,COAGULATION FACTOR INHIBITOR,BRD:BRD-K45275534-001-01-3,BETRIXABAN,BETRIXABAN
REP.PRIMARY,2.5,"CDK1, CHEK1, CHEK2, GSK3B, LCK, MAPK14, MARK1, MARK3, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG","CDK INHIBITOR, CHK INHIBITOR, PKC INHIBITOR",BRD:BRD-K45293975-001-02-0,7-HYDROXYSTAUROSPORINE,7-HYDROXYSTAUROSPORINE
REP.PRIMARY,2.5,"ESR1, ESR2, ESRRB, ESRRG",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K45330754-001-21-7,DIETHYLSTILBESTROL,DIETHYLSTILBESTROL
REP.PRIMARY,2.5,MAPK14,MAP KINASE INHIBITOR,BRD:BRD-K45385835-001-02-4,SX-011,SX-011
REP.PRIMARY,2.5,GPBAR1,"APOPTOSIS STIMULANT, NFKB PATHWAY INHIBITOR",BRD:BRD-K45401373-001-20-9,BETULINIC-ACID,BETULINIC-ACID
REP.PRIMARY,2.5,GPBAR1,"APOPTOSIS STIMULANT, NFKB PATHWAY INHIBITOR",BRD:BRD-K45401373-001-22-5,BETULINIC-ACID,BETULINIC-ACID
REP.PRIMARY,2.5,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K45435259-003-11-1,SCH-23390,SCH-23390
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K45437867-005-03-3,5-METHYLFURMETHIODIDE,5-METHYLFURMETHIODIDE
REP.PRIMARY,2.5,MGLL,MONOACYLGLUCEROL LIPASE INHIBITOR,BRD:BRD-K45446451-001-05-0,JZL-184,JZL-184
REP.PRIMARY,2.5,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K45462423-001-03-7,VU0361737,VU0361737
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K45479396-050-01-5,BP-554,BP-554
REP.PRIMARY,2.5,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR AGONIST,BRD:BRD-K45503887-001-01-1,DELIVERT,DELIVERT
REP.PRIMARY,2.5,TRPV4,TRPV AGONIST,BRD:BRD-K45519571-001-01-8,RN-1747,RN-1747
REP.PRIMARY,2.5,HDAC8,HDAC INHIBITOR,BRD:BRD-K45528773-001-06-4,M-344,M-344
REP.PRIMARY,2.5,HDAC8,HDAC INHIBITOR,BRD:BRD-K45528773-001-07-2,M-344,M-344
REP.PRIMARY,2.5,"ALOX5, PTGS1",LIPOXYGENASE INHIBITOR,BRD:BRD-K45542189-048-22-1,DIETHYLCARBAMAZINE,DIETHYLCARBAMAZINE
REP.PRIMARY,2.5,TTK,MITOTIC KINASE INHIBITOR,BRD:BRD-K45551181-001-02-1,MPI-0479605,MPI-0479605
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR LIGAND,BRD:BRD-K45662124-050-01-5,3'-FLUOROBENZYLSPIPERONE,3'-FLUOROBENZYLSPIPERONE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K45664306-001-19-6,PREDNISOLONE-ACETATE,PREDNISOLONE-ACETATE
REP.PRIMARY,1.36,SLC5A1,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K45724504-001-01-6,ANGUIDINE,ANGUIDINE
REP.PRIMARY,2.5,MAPK8,JNK INHIBITOR,BRD:BRD-K45746021-003-01-9,CC-401,CC-401
REP.PRIMARY,2.5,USP14,UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR,BRD:BRD-K45841694-001-11-7,IU1,IU1
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K45861246-001-13-4,AZAPERONE,AZAPERONE
REP.PRIMARY,2.5,TSPO,BENZODIAZEPINE RECEPTOR LIGAND,BRD:BRD-K45875383-001-01-2,XBD173,XBD173
REP.PRIMARY,2.5,"NUAK1, NUAK2",AMPK INHIBITOR,BRD:BRD-K45909031-001-01-5,WZ4003,WZ4003
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K45916615-066-02-5,DANOFLOXACIN,DANOFLOXACIN
REP.PRIMARY,2.5,"PDE3A, PDE3B, PDE4B, TNF",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K45924332-001-16-8,AMRINONE,AMRINONE
REP.PRIMARY,2.5,"PPARA, PPARD, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K46018455-001-27-6,BEZAFIBRATE,BEZAFIBRATE
REP.PRIMARY,2.5,"ESR1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K46061689-001-01-9,DESOGESTREL,DESOGESTREL
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K46133855-304-03-8,NXY-059,NXY-059
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K46142322-003-02-4,RS-67333,RS-67333
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K46211610-003-26-7,TOLAZOLINE,TOLAZOLINE
REP.PRIMARY,0.25,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K46254452-001-01-5,GABA-LINOLEAMIDE,GABA-LINOLEAMIDE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K46290096-001-01-1,PRELADENANT,PRELADENANT
REP.PRIMARY,2.5,NOS1,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K46317332-003-17-8,PROADIFEN,PROADIFEN
REP.PRIMARY,2.5,"ESR1, PGR",,BRD:BRD-K46331928-001-05-8,ETHYNODIOL-DIACETATE,ETHYNODIOL-DIACETATE
REP.PRIMARY,2.5,"ESR1, PGR",,BRD:BRD-K46331928-001-06-6,ETHYNODIOL-DIACETATE,ETHYNODIOL-DIACETATE
REP.PRIMARY,2.5,,PHOSPHOLIPASE ACTIVATOR,BRD:BRD-K46384212-001-02-9,O-3M3FBS,O-3M3FBS
REP.PRIMARY,2.5,ERBB2,EGFR INHIBITOR,BRD:BRD-K46386702-001-02-1,ARRY-334543,ARRY-334543
REP.PRIMARY,2.5,,PI3K INHIBITOR,BRD:BRD-K46392623-001-02-5,TG-100713,TG-100713
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K46424862-001-14-1,HYMECROMONE,HYMECROMONE
REP.PRIMARY,2.5,,,BRD:BRD-K46428823-001-02-5,LIOTHYRONINE-(ISOMER),LIOTHYRONINE-(ISOMER)
REP.PRIMARY,2.5,,,BRD:BRD-K46435528-001-04-4,TRICHLOROETHYLENE,TRICHLOROETHYLENE
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K46435977-003-11-1,VALACICLOVIR,VALACICLOVIR
REP.PRIMARY,2.5,"CA1, CA12, CA2, CA9",DNA POLYMERASE INHIBITOR,BRD:BRD-K46493214-001-06-7,SACCHARIN,SACCHARIN
REP.PRIMARY,2.5,,TOPICAL ANESTHETIC,BRD:BRD-K46523383-003-22-9,PRAMOXINE,PRAMOXINE
REP.PRIMARY,2.5,NR3C2,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K46556543-001-01-4,POTASSIUM-CANRENOATE,POTASSIUM-CANRENOATE
REP.PRIMARY,2.5,NR3C2,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K46556543-237-10-5,POTASSIUM-CANRENOATE,POTASSIUM-CANRENOATE
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K46585355-001-14-3,ACETYLSALICYLSALICYLIC-ACID,ACETYLSALICYLSALICYLIC-ACID
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K46654563-238-01-0,ZOFENOPRIL-CALCIUM,ZOFENOPRIL-CALCIUM
REP.PRIMARY,2.5,,,BRD:BRD-K46690591-001-01-2,KP-1212,KP-1212
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K46692793-004-01-8,UMECLIDINIUM,UMECLIDINIUM
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K46731503-050-01-8,FESOTERODINE,FESOTERODINE
REP.PRIMARY,1.58,,PREGNANE X RECEPTOR AGONIST,BRD:BRD-K46741531-001-02-4,CAFESTOL,CAFESTOL
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K46742498-003-11-0,ALOSETRON,ALOSETRON
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K46766488-003-02-0,S-14506,S-14506
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K46791647-001-01-2,STANOZOLOL,STANOZOLOL
REP.PRIMARY,2.5,,CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K46839850-050-04-2,CINEPAZIDE,CINEPAZIDE
REP.PRIMARY,2.5,,,BRD:BRD-K46863940-001-06-2,DIBENZOTHIOPHENE,DIBENZOTHIOPHENE
REP.PRIMARY,2.5,"MAOA, MAOB, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K46914825-300-01-0,ZIMELIDINE,ZIMELIDINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K46937689-001-15-0,PHENAZONE,PHENAZONE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K46970505-003-01-9,CEFOZOPRAN,CEFOZOPRAN
REP.PRIMARY,2.5,KCNK18,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K46982791-001-09-4,CLOXYQUIN,CLOXYQUIN
REP.PRIMARY,1.04,ACTB,MICROTUBULE INHIBITOR,BRD:BRD-K47000838-001-01-6,CYTOCHALASIN-B,CYTOCHALASIN-B
REP.PRIMARY,2.5,"KDM1A, MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K47029922-003-10-9,TRANYLCYPROMINE,TRANYLCYPROMINE
REP.PRIMARY,2.5,,MUCUS PROTECTING AGENT,BRD:BRD-K47031502-001-01-6,EUPATILIN,EUPATILIN
REP.PRIMARY,2.5,OPRL1,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,BRD:BRD-K47049295-300-01-5,BAN-ORL-24,BAN-ORL-24
REP.PRIMARY,2.5,,,BRD:BRD-K47079459-004-04-6,CETRIMONIUM,CETRIMONIUM
REP.PRIMARY,2.5,"TACR2, TACR3",TACHYKININ ANTAGONIST,BRD:BRD-K47095176-001-01-6,TALNETANT,TALNETANT
REP.PRIMARY,2.5,"EGFR, JAK2, JAK3","EGFR INHIBITOR, JAK INHIBITOR",BRD:BRD-K47105409-001-14-5,AG-490,AG-490
REP.PRIMARY,2.5,SLC37A4,ANTIOXIDANT,BRD:BRD-K47114202-001-14-6,CHLOROGENIC-ACID,CHLOROGENIC-ACID
REP.PRIMARY,2.5,KDR,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K47150025-001-05-3,KI-8751,KI-8751
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K47177710-001-03-1,DAPT,DAPT
REP.PRIMARY,0.25,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1",PLATELET AGGREGATION INHIBITOR,BRD:BRD-K47192521-001-05-4,ICOSAPENT,ICOSAPENT
REP.PRIMARY,2.5,,,BRD:BRD-K47195926-001-06-6,ACEDOBEN,ACEDOBEN
REP.PRIMARY,2.5,"MAOA, MAOB",,BRD:BRD-K47264279-001-08-9,PSORALEN,PSORALEN
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K47278471-003-26-3,DIPHENHYDRAMINE,DIPHENHYDRAMINE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K47323024-003-24-4,METHAPYRILENE,METHAPYRILENE
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K47337578-034-02-5,4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)-PIPERIDINE,4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)-PIPERIDINE
REP.PRIMARY,2.5,,,BRD:BRD-K47371940-001-01-6,ECABAPIDE,ECABAPIDE
REP.PRIMARY,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K47376733-001-08-1,JNJ-1661010,JNJ-1661010
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K47407372-001-17-1,NIFENAZONE,NIFENAZONE
REP.PRIMARY,2.5,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K47539947-001-03-7,TETRADECYLTHIOACETIC-ACID,TETRADECYLTHIOACETIC-ACID
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K47554101-001-01-2,EPEREZOLID,EPEREZOLID
REP.PRIMARY,2.5,"TGFBR1, TGFBR2",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K47557313-001-02-7,LY2109761,LY2109761
REP.PRIMARY,2.5,"HCK, RET",SRC INHIBITOR,BRD:BRD-K47598052-001-15-8,PP-1,PP-1
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-K47631482-003-06-2,BROMHEXINE,BROMHEXINE
REP.PRIMARY,2.5,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K47635719-001-21-1,DEXAMETHASONE-ACETATE,DEXAMETHASONE-ACETATE
REP.PRIMARY,2.5,"CHRM1, CHRM2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K47639036-003-06-6,FLAVOXATE,FLAVOXATE
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K47642186-001-01-3,PICLAMILAST,PICLAMILAST
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K47659338-003-02-8,EMD-386088,EMD-386088
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K47679368-236-01-7,BROMFENAC,BROMFENAC
REP.PRIMARY,2.5,,DNA DIRECTED DNA POLYMERASE INHIBITOR,BRD:BRD-K47780086-001-07-9,PENCICLOVIR,PENCICLOVIR
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-K47827687-001-02-2,AMPRENAVIR,AMPRENAVIR
REP.PRIMARY,2.5,TYMS,DNA SYNTHESIS INHIBITOR,BRD:BRD-K47832606-001-30-1,FLOXURIDINE,FLOXURIDINE
REP.PRIMARY,2.5,"IGF1R, TOP2A, TUBA4A, TUBB","MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K47869605-001-32-0,PODOPHYLLOTOXIN,PODOPHYLLOTOXIN
REP.PRIMARY,2.5,,ANTHELMINTIC AGENT,BRD:BRD-K47878171-086-06-0,BEPHENIUM-HYDROXYNAPHTHOATE,BEPHENIUM-HYDROXYNAPHTHOATE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K47886988-001-21-4,NALIDIXIC-ACID,NALIDIXIC-ACID
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR2B",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K47936004-003-11-4,PIRIBEDIL,PIRIBEDIL
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K47949423-001-03-1,MIRABEGRON,MIRABEGRON
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K47976015-001-01-2,BALAPIRAVIR,BALAPIRAVIR
REP.PRIMARY,2.5,"AMD1, CANT1, DCN, NEIL1, VEGFA",,BRD:BRD-K47978074-001-02-4,TROMETAMOL,TROMETAMOL
REP.PRIMARY,2.5,"CHRM1, HRH1, SLC6A3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K48061146-066-01-7,BENZTROPINE-MESYLATE,BENZTROPINE-MESYLATE
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K48068743-001-01-6,TENELIGLIPTIN,TENELIGLIPTIN
REP.PRIMARY,2.5,"OPRL1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K48141473-001-01-7,CEBRANOPADOL,CEBRANOPADOL
REP.PRIMARY,2.5,"DIO1, TPO",THYROID PEROXIDASE INHIBITOR,BRD:BRD-K48168960-001-19-2,PROPYLTHIOURACIL,PROPYLTHIOURACIL
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-K48173020-001-01-8,AMELTOLIDE,AMELTOLIDE
REP.PRIMARY,2.5,"ESR1, ESR2, NR1I2","ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",BRD:BRD-K48195008-001-19-9,ETHINYL-ESTRADIOL,ETHINYL-ESTRADIOL
REP.PRIMARY,2.5,KCNH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K48195801-001-01-6,TECASTEMIZOLE,TECASTEMIZOLE
REP.PRIMARY,2.5,,JNK INHIBITOR,BRD:BRD-K48213016-001-01-8,CC-930,CC-930
REP.PRIMARY,2.5,,,BRD:BRD-K48247567-001-01-9,DIATRIZOIC-ACID,DIATRIZOIC-ACID
REP.PRIMARY,2.5,"CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A","SODIUM CHANNEL BLOCKER, T-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-K48300629-001-14-5,ZONISAMIDE,ZONISAMIDE
REP.PRIMARY,2.5,,STEROIDAL PROGESTIN,BRD:BRD-K48329353-001-01-3,"6,7-DEHYDRO-17-ACETOXY-PROGESTERONE","6,_7-DEHYDRO-17-ACETOXY-PROGESTERONE, 6,7-DEHYDRO-17-ACETOXY-PROGESTERONE"
REP.PRIMARY,2.5,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K48367671-001-05-9,FEBUXOSTAT,FEBUXOSTAT
REP.PRIMARY,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K48443249-001-01-0,CNX-774,CNX-774
REP.PRIMARY,2.5,,PI3K INHIBITOR,BRD:BRD-K48488978-001-05-3,YM-201636,YM-201636
REP.PRIMARY,2.5,PLD1,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K48535733-003-01-2,VU0155069,VU0155069
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, DDC",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K48578705-001-16-8,METHYLDOPA,METHYLDOPA
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, DDC",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K48578705-001-17-6,METHYLDOPA,METHYLDOPA
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K48619321-004-16-8,METHSCOPOLAMINE,METHSCOPOLAMINE
REP.PRIMARY,2.5,NFKBIA,NFKB PATHWAY INHIBITOR,BRD:BRD-K48684885-001-04-2,BAY-11-7085,BAY-11-7085
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K48692744-001-02-0,NU-1025,NU-1025
REP.PRIMARY,2.5,SLC29A1,ADENOSINE REUPTAKE INHIBITOR,BRD:BRD-K48722258-300-10-2,DILAZEP,DILAZEP
REP.PRIMARY,2.5,"ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K48722833-001-07-6,ILOPERIDONE,ILOPERIDONE
REP.PRIMARY,2.5,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K48812570-001-02-3,MACITENTAN,MACITENTAN
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-K48826825-001-01-8,S26948,S26948
REP.PRIMARY,2.5,GPR119,FAAH INHIBITOR,BRD:BRD-K48830578-001-01-9,OMDM-2,OMDM-2
REP.PRIMARY,2.5,,FABI INHIBITOR,BRD:BRD-K48888725-001-01-9,CG-400549,CG-400549
REP.PRIMARY,2.5,"PTGS1, PTGS2",NFKB PATHWAY INHIBITOR,BRD:BRD-K48892307-001-04-1,SASAPYRINE,SASAPYRINE
REP.PRIMARY,2.5,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K48894757-001-01-8,LAROPIPRANT,LAROPIPRANT
REP.PRIMARY,2.5,,,BRD:BRD-K48988407-001-01-2,CYTOCHLOR,CYTOCHLOR
REP.PRIMARY,2.5,,,BRD:BRD-K48996094-001-01-3,PENTACOSANOIC-ACID,PENTACOSANOIC-ACID
REP.PRIMARY,2.5,"ADORA1, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K49027941-001-01-1,PSB-1115,PSB-1115
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K49049886-001-08-7,CGS-15943,CGS-15943
REP.PRIMARY,2.5,PIK3CA,PI3K INHIBITOR,BRD:BRD-K49055432-001-04-2,A66,A66
REP.PRIMARY,2.5,GABRA1,"GABA RECEPTOR ANTAGONIST, TP53 ACTIVATOR",BRD:BRD-K49071277-001-04-7,SECURININE,SECURININE
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","FGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K49075727-001-08-5,NINTEDANIB,NINTEDANIB
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K49111258-003-29-7,PRAZOSIN,PRAZOSIN
REP.PRIMARY,2.5,,,BRD:BRD-K49119234-003-02-6,TMPH,TMPH
REP.PRIMARY,2.5,ADORA2A,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K49197823-001-09-8,CV-1808,CV-1808
REP.PRIMARY,2.5,PIK3CB,PI3K INHIBITOR,BRD:BRD-K49215523-001-04-2,GSK2636771,GSK2636771
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K49236613-001-02-3,6-IODO-NORDIHYDROCAPSAICIN,6-IODO-NORDIHYDROCAPSAICIN
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K49294207-300-03-8,BIBU-1361,BIBU-1361
REP.PRIMARY,2.5,,,BRD:BRD-K49313711-001-05-4,RIBITOL,RIBITOL
REP.PRIMARY,2.5,"ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1","BCR-ABL KINASE INHIBITOR, EPHRIN INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K49328571-001-15-0,DASATINIB,DASATINIB
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K49338325-001-03-4,ETOFIBRATE,ETOFIBRATE
REP.PRIMARY,2.5,"IMPDH1, IMPDH2",PURINE ANTAGONIST,BRD:BRD-K49350383-001-13-7,THIOGUANINE,THIOGUANINE
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC","DNA PROTEIN KINASE INHIBITOR, PI3K INHIBITOR",BRD:BRD-K49371609-003-03-8,PIK-75,PIK-75
REP.PRIMARY,2.5,"CACNA1B, SCN1A, SV2A",CALCIUM CHANNEL BLOCKER,BRD:BRD-K49404994-001-10-9,LEVETIRACETAM,LEVETIRACETAM
REP.PRIMARY,2.5,,PI3K INHIBITOR,BRD:BRD-K49456274-001-01-9,PILARALISIB,PILARALISIB
REP.PRIMARY,2.5,,C-MYC INHIBITOR,BRD:BRD-K49460120-001-02-5,10058-F4,10058-F4
REP.PRIMARY,2.5,"ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K49481516-004-18-3,GALANTAMINE,GALANTAMINE
REP.PRIMARY,2.5,DAO,D-AMINO ACID OXIDASE INHIBITOR,BRD:BRD-K49504902-001-01-6,SEP-227900,SEP-227900
REP.PRIMARY,2.5,GRM3,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K49519144-001-04-6,LY2140023,LY2140023
REP.PRIMARY,2.5,"CYP27B1, VDR",VITAMIN D RECEPTOR AGONIST,BRD:BRD-K49522529-001-02-9,ALFACALCIDOL,ALFACALCIDOL
REP.PRIMARY,2.5,"CYP27B1, VDR",VITAMIN D RECEPTOR AGONIST,BRD:BRD-K49522529-001-03-7,ALFACALCIDOL,ALFACALCIDOL
REP.PRIMARY,2.5,,M2 CHANNEL BLOCKER,BRD:BRD-K49545903-003-01-4,"4,4-PENTAMETHYLENEPIPERIDINE","4,4-PENTAMETHYLENEPIPERIDINE"
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K49554218-001-01-0,CAREBASTINE,CAREBASTINE
REP.PRIMARY,2.5,,HIV INTEGRASE INHIBITOR,BRD:BRD-K49555808-001-03-9,BMS-707035,BMS-707035
REP.PRIMARY,2.5,EGFR,"EGFR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K49657628-001-14-8,TYRPHOSTIN-AG-18,TYRPHOSTIN-AG-18
REP.PRIMARY,2.5,CYP3A4,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K49668410-001-18-8,CLARITHROMYCIN,CLARITHROMYCIN
REP.PRIMARY,2.5,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1",PYRUVATE DEHYDROGENASE KINASE INHIBITOR,BRD:BRD-K49669041-001-08-4,BX-912,BX-912
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K49671696-045-08-5,KETANSERIN,KETANSERIN
REP.PRIMARY,2.5,"RARA, RARB, RARG",RETINOID RECEPTOR AGONIST,BRD:BRD-K49685476-001-15-9,TTNPB,TTNPB
REP.PRIMARY,2.5,"ADRA1A, DRD2",,BRD:BRD-K49702221-003-01-6,SNAP-94847,SNAP-94847
REP.PRIMARY,2.5,"ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K49738308-065-04-9,AGMATINE,AGMATINE
REP.PRIMARY,2.5,,,BRD:BRD-K49759007-001-11-9,4-HYDROXY-PHENAZONE,4-HYDROXY-PHENAZONE
REP.PRIMARY,2.5,"ACHE, CHRNA2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K49783248-303-08-4,DECAMETHONIUM,DECAMETHONIUM
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K49807096-003-15-5,BENAZEPRIL,BENAZEPRIL
REP.PRIMARY,2.5,"CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K49811169-004-06-6,NSC-9965,NSC-9965
REP.PRIMARY,2.5,PPARA,PLATELET AGGREGATION INHIBITOR,BRD:BRD-K49840922-001-05-1,ETOFYLLINE-CLOFIBRATE,ETOFYLLINE-CLOFIBRATE
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-K49865102-001-08-4,PD-0325901,PD-0325901
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K49880111-236-09-2,CEPHAPIRIN,CEPHAPIRIN
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K49945136-001-10-0,GR-113808,GR-113808
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K49954789-001-02-9,MESNA,MESNA
REP.PRIMARY,2.5,PREP,BETA GLUCURONIDASE INHIBITOR,BRD:BRD-K49962337-001-01-1,BAICALIN,BAICALIN
REP.PRIMARY,2.5,PREP,BETA GLUCURONIDASE INHIBITOR,BRD:BRD-K49962337-001-02-9,BAICALIN,BAICALIN
REP.PRIMARY,2.5,"CDK1, RPS6KB1",CDC INHIBITOR,BRD:BRD-K50000283-001-04-4,PHA-767491,PHA-767491
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K50018155-003-02-1,RS-67506,RS-67506
REP.PRIMARY,2.5,PDE9A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K50031829-001-01-6,PF-04447943,PF-04447943
REP.PRIMARY,2.5,TLR7,LIPASE CLEARING FACTOR INHIBITOR,BRD:BRD-K50050533-001-02-1,DOCOSANOL,DOCOSANOL
REP.PRIMARY,2.5,"CYP11B1, CYP17A1",ANDROGEN BIOSYNTHESIS INHIBITOR,BRD:BRD-K50071428-001-03-3,ABIRATERONE,ABIRATERONE
REP.PRIMARY,2.5,,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K50133271-001-18-7,TOLFENAMIC-ACID,TOLFENAMIC-ACID
REP.PRIMARY,2.5,"AGTR1, SLC6A3","DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K50135270-300-02-3,GBR-12935,GBR-12935
REP.PRIMARY,2.5,"ALK, INSR",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K50140147-001-10-1,NVP-TAE684,NVP-TAE684
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K50163129-001-01-4,ACRIVASTINE,ACRIVASTINE
REP.PRIMARY,2.5,"AKT1, EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K50168500-001-07-9,CANERTINIB,CANERTINIB
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K50293352-300-02-1,MM77,MM77
REP.PRIMARY,2.5,,SLOW AFTERHYPERPOLARIZATION CHANNEL BLOCKER,BRD:BRD-K50325075-001-02-1,UCL-2077,UCL-2077
REP.PRIMARY,2.5,"MMP25, PPARA",PPAR RECEPTOR AGONIST,BRD:BRD-K50388907-001-30-4,FENOFIBRATE,FENOFIBRATE
REP.PRIMARY,2.5,"ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K50398167-236-22-7,MECLOFENAMIC-ACID,MECLOFENAMIC-ACID
REP.PRIMARY,2.5,,RNA SYNTHESIS INHIBITOR,BRD:BRD-K50406511-001-26-0,HYCANTHONE,HYCANTHONE
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K50417881-003-17-4,ETICLOPRIDE,ETICLOPRIDE
REP.PRIMARY,2.5,GABRA1,"GABA RECEPTOR ANTAGONIST, GABA RECEPTOR MODULATOR",BRD:BRD-K50422030-001-05-3,CLOMETHIAZOLE,CLOMETHIAZOLE
REP.PRIMARY,2.5,"CSK, LCK, RIPK2",SRC INHIBITOR,BRD:BRD-K50495309-001-02-0,SRC-KINASE-INHIBITOR-I,SRC-KINASE-INHIBITOR-I
REP.PRIMARY,2.5,"DHH, IHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K50498985-001-03-3,TALADEGIB,TALADEGIB
REP.PRIMARY,2.5,"APH1A, APH1B, PSENEN",GAMMA SECRETASE MODULATOR,BRD:BRD-K50564936-001-01-6,E-2012,E-2012
REP.PRIMARY,2.5,"CFTR, TRPV1",TRPV AGONIST,BRD:BRD-K50590187-001-19-9,CAPSAICIN,CAPSAICIN
REP.PRIMARY,2.5,"PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K50631926-001-02-3,PIK-294,PIK-294
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K50677762-001-01-5,OXIRACETAM,OXIRACETAM
REP.PRIMARY,2.5,,,BRD:BRD-K50785021-001-02-1,CYCLAMIC-ACID,CYCLAMIC-ACID
REP.PRIMARY,2.5,"CHRM2, CHRM3, CHRNA1, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K50817623-303-05-7,PANCURONIUM,PANCURONIUM
REP.PRIMARY,2.5,"CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC",CDK INHIBITOR,BRD:BRD-K50836978-001-02-5,PURVALANOL-A,PURVALANOL-A
REP.PRIMARY,2.5,,,BRD:BRD-K50850824-237-04-8,ACESULFAME-POTASSIUM,ACESULFAME-POTASSIUM
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K50853363-001-02-3,DIENOGEST,DIENOGEST
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K50859149-001-19-5,SULFAFURAZOLE,SULFAFURAZOLE
REP.PRIMARY,2.5,"GLRA1, GLRA2, GLRB, HTR3A, HTR4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K50866992-003-09-5,TROPISETRON,TROPISETRON
REP.PRIMARY,2.5,"GLRA1, GLRA2, GLRB, HTR3A, HTR4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K50866992-003-10-3,TROPISETRON,TROPISETRON
REP.PRIMARY,2.5,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K50891186-001-04-4,GR-103691,GR-103691
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K50938287-036-13-8,SUMATRIPTAN,SUMATRIPTAN
REP.PRIMARY,2.5,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K50938786-003-11-8,ROPIVACAINE,ROPIVACAINE
REP.PRIMARY,2.5,"CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","NOREPINEPHRINE REPUTAKE INHIBITOR, OPIOID RECEPTOR AGONIST, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K51033547-003-02-6,TRAMADOL,TRAMADOL
REP.PRIMARY,2.5,"CYP3A4, CYP3A43, CYP3A5, CYP3A7",CYTOCHROME P450 INHIBITOR,BRD:BRD-K51040301-001-02-1,COBICISTAT,COBICISTAT
REP.PRIMARY,2.5,,TROPONIN ACTIVATOR,BRD:BRD-K51087630-001-01-6,TIRASEMTIV,TIRASEMTIV
REP.PRIMARY,2.5,"ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K51143828-003-03-1,LURASIDONE,LURASIDONE
REP.PRIMARY,2.5,,,BRD:BRD-K51199656-003-01-4,FLUOROMETHYLCHOLINE,FLUOROMETHYLCHOLINE
REP.PRIMARY,2.5,,MYCOLIC SYNTHESIS INHIBITOR,BRD:BRD-K51207550-001-23-0,ETHIONAMIDE,ETHIONAMIDE
REP.PRIMARY,2.5,SLC5A2,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K51247865-001-01-2,IPRAGLIFLOZIN-L-PROLINE,IPRAGLIFLOZIN-L-PROLINE
REP.PRIMARY,2.5,SLC6A9,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",BRD:BRD-K51263939-001-08-6,SARCOSINE,SARCOSINE
REP.PRIMARY,2.5,"CDK4, CDK6",CDK INHIBITOR,BRD:BRD-K51313569-003-03-3,PALBOCICLIB,PALBOCICLIB
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K51318897-001-15-3,FENBENDAZOLE,FENBENDAZOLE
REP.PRIMARY,2.5,CCR2,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K51324732-001-01-0,MEGLITINIDE,MEGLITINIDE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K51333959-003-01-3,SIRAMESINE,SIRAMESINE
REP.PRIMARY,2.5,ESR1,"ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",BRD:BRD-K51350053-048-16-5,TOREMIFENE,TOREMIFENE
REP.PRIMARY,2.5,,,BRD:BRD-K51431759-001-02-9,DEXTROSE,DEXTROSE
REP.PRIMARY,2.5,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K51471001-303-04-7,DEMECARIUM,DEMECARIUM
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K51474575-001-10-4,TAURINE,TAURINE
REP.PRIMARY,2.5,"CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7",HIV PROTEASE INHIBITOR,BRD:BRD-K51485625-001-08-4,RITONAVIR,RITONAVIR
REP.PRIMARY,2.5,MAOB,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K51486818-003-02-8,LAZABEMIDE,LAZABEMIDE
REP.PRIMARY,2.5,GRIN2B,"GLUTAMATE RECEPTOR ANTAGONIST, MONAMINE TRANSPORTER MODULATOR",BRD:BRD-K51541829-050-01-0,RO-25-6981,RO-25-6981
REP.PRIMARY,2.5,"KDR, MET, RET","RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K51544265-001-04-2,CABOZANTINIB,CABOZANTINIB
REP.PRIMARY,2.5,IKBKB,IKK INHIBITOR,BRD:BRD-K51575138-001-13-2,TPCA-1,TPCA-1
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR2C, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K51579475-003-02-4,DAPOXETINE,DAPOXETINE
REP.PRIMARY,2.5,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K51662849-001-05-4,ILOMASTAT,ILOMASTAT
REP.PRIMARY,2.5,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K51662849-001-08-8,ILOMASTAT,ILOMASTAT
REP.PRIMARY,2.5,"CA1, CA12, CA7, DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K51671335-001-10-6,LEVOSULPIRIDE,LEVOSULPIRIDE
REP.PRIMARY,2.5,"ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1","CYTOCHROME P450 INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",BRD:BRD-K51677086-001-12-0,ERYTHROMYCIN-ETHYLSUCCINATE,ERYTHROMYCIN-ETHYLSUCCINATE
REP.PRIMARY,2.5,"RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K51747290-001-12-3,HYDROXYUREA,HYDROXYUREA
REP.PRIMARY,2.5,"RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K51747290-001-13-1,HYDROXYUREA,HYDROXYUREA
REP.PRIMARY,2.5,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K51751936-001-09-1,ALFADOLONE-ACETATE,ALFADOLONE-ACETATE
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K51770398-001-01-9,JNJ-17203212,JNJ-17203212
REP.PRIMARY,2.5,"CDK1, CDK4, CDK9",CDK INHIBITOR,BRD:BRD-K51791723-003-01-7,P276-00,P276-00
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K51885093-001-11-2,QUINOLINIC-ACID,QUINOLINIC-ACID
REP.PRIMARY,2.5,"TOP1, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K51911221-001-01-2,NEMORUBICIN,NEMORUBICIN
REP.PRIMARY,2.5,"HRH3, HRH4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K51918615-303-02-9,IODOPHENPROPIT,IODOPHENPROPIT
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K51937257-001-01-4,BILASTINE,BILASTINE
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K51967704-001-03-6,BIIB021,BIIB021
REP.PRIMARY,2.5,"CYP2C9, CYP3A4",DNA INHIBITOR,BRD:BRD-K52020312-001-26-8,METRONIDAZOLE,METRONIDAZOLE
REP.PRIMARY,5.6000000000000005,FASN,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K52075040-001-09-7,CERULENIN,CERULENIN
REP.PRIMARY,2.5,"TUBB, TUBB4B",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K52075715-001-06-7,OXIBENDAZOLE,OXIBENDAZOLE
REP.PRIMARY,2.5,"AR, CYP19A1, MAOA, MAOB",IMIDAZOLINE RECEPTOR AGONIST,BRD:BRD-K52080565-001-09-2,NANDROLONE,NANDROLONE
REP.PRIMARY,2.5,KCNA3,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K52113681-003-02-1,CP-339818,CP-339818
REP.PRIMARY,2.5,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K52172416-001-11-4,ANASTROZOLE,ANASTROZOLE
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K52219182-001-02-4,ICI-63197,ICI-63197
REP.PRIMARY,2.5,"CDK1, CDK2, CDK4, CDK7",CDK INHIBITOR,BRD:BRD-K52233191-001-02-4,R547,R547
REP.PRIMARY,2.5,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K52256627-300-06-6,CHLORHEXIDINE,CHLORHEXIDINE
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K52284881-236-02-4,CHINIOFON,CHINIOFON
REP.PRIMARY,2.5,HDAC1,HDAC INHIBITOR,BRD:BRD-K52313696-001-12-3,TACEDINALINE,TACEDINALINE
REP.PRIMARY,2.5,"TAC1, TACR2",TACHYKININ ANTAGONIST,BRD:BRD-K52394958-001-02-7,GR-159897,GR-159897
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K52396582-001-06-7,CF102,CF102
REP.PRIMARY,2.5,"FAAH, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K52397688-003-06-4,AMPEROZIDE,AMPEROZIDE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K52408781-001-02-8,CLOBAZAM,CLOBAZAM
REP.PRIMARY,2.5,"GRIA1, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5",KAINATE RECEPTOR AGONIST,BRD:BRD-K52459018-001-09-1,KAINIC-ACID,KAINIC-ACID
REP.PRIMARY,2.5,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K52459643-001-17-7,ALPROSTADIL,ALPROSTADIL
REP.PRIMARY,2.5,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K52487250-003-01-2,"ICI-215,001","ICI-215,001"
REP.PRIMARY,2.5,PTGER1,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K52512893-001-08-9,SC-19220,SC-19220
REP.PRIMARY,2.5,,,BRD:BRD-K52523550-001-01-5,N-ACETYLCARNOSINE,N-ACETYLCARNOSINE
REP.PRIMARY,2.5,,,BRD:BRD-K52559566-001-02-9,MONOSODIUM-ALPHA-LUMINOL,MONOSODIUM-ALPHA-LUMINOL
REP.PRIMARY,2.5,"CDIPT, GBA",INSULIN SENSITIZER,BRD:BRD-K52618540-001-09-9,INOSITOL,INOSITOL
REP.PRIMARY,2.5,"EGFR, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K52662033-003-21-2,LIDOCAINE,LIDOCAINE
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K52670952-003-01-4,CIS-UROCANIC-ACID,CIS-UROCANIC-ACID
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K52751261-001-06-1,TAK-715,TAK-715
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K52756523-001-24-7,DIRITHROMYCIN,DIRITHROMYCIN
REP.PRIMARY,2.5,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B","MICROTUBULE STABILIZING AGENT, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K52762805-001-01-2,EPOTHILONE-D,EPOTHILONE-D
REP.PRIMARY,2.5,CFTR,CFTR CHANNEL POTENTIATOR,BRD:BRD-K52818472-001-02-2,IVACAFTOR,IVACAFTOR
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K52911425-001-09-8,GDC-0941,GDC-0941
REP.PRIMARY,2.5,"ABCC8, KCNJ10, PPARG",INSULIN SECRETAGOGUE,BRD:BRD-K52959329-238-01-9,MITIGLINIDE,MITIGLINIDE
REP.PRIMARY,2.5,"GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4",SEROTONIN TRANSPORTER (SERT) INHIBITOR,BRD:BRD-K52989797-003-26-4,CLOMIPRAMINE,CLOMIPRAMINE
REP.PRIMARY,2.5,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K53061490-003-13-9,OZAGREL,OZAGREL
REP.PRIMARY,2.5,,,BRD:BRD-K53083666-001-01-0,"1,5-DICAFFEOYLQUINIC-ACID","1,5-DICAFFEOYLQUINIC-ACID"
REP.PRIMARY,2.5,PTGS2,"CYCLOOXYGENASE INHIBITOR, PPAR RECEPTOR AGONIST",BRD:BRD-K53097745-001-01-5,PTEROSTILBENE,PTEROSTILBENE
REP.PRIMARY,2.5,,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K53123955-001-10-5,NIRIDAZOLE,NIRIDAZOLE
REP.PRIMARY,0.03,"LTB4R, LTB4R2",LEUKOCYTE ACTIVATOR,BRD:BRD-K53124401-001-03-8,LTB4,LTB4
REP.PRIMARY,2.5,CA2,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K53153417-001-10-4,BUTYLATED-HYDROXYTOLUENE,BUTYLATED-HYDROXYTOLUENE
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K53205568-001-02-6,AFALANINE,AFALANINE
REP.PRIMARY,2.5,,SEDATIVE,BRD:BRD-K53220666-001-02-6,TRIMETOZINE,TRIMETOZINE
REP.PRIMARY,2.5,PORCN,PORCUPINE INHIBITOR,BRD:BRD-K53234107-001-01-6,IWP-L6,IWP-L6
REP.PRIMARY,2.5,NR1I3,CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) AGONIST,BRD:BRD-K53263234-001-05-2,CITCO,CITCO
REP.PRIMARY,2.5,"PDE1A, PDE1C","PHOSPHODIESTERASE INHIBITOR, SODIUM CHANNEL BLOCKER",BRD:BRD-K53318339-001-24-9,VINPOCETINE,VINPOCETINE
REP.PRIMARY,2.5,"DAO, HRSP12, PRDX5, RAB9A",FOOD PRESERVATIVE,BRD:BRD-K53397409-001-12-3,BENZOIC-ACID,BENZOIC-ACID
REP.PRIMARY,2.5,"FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB",VEGFR INHIBITOR,BRD:BRD-K53414658-001-08-2,TIVOZANIB,TIVOZANIB
REP.PRIMARY,2.5,MELK,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE INHIBITOR,BRD:BRD-K53417444-003-03-1,OTS167,OTS167
REP.PRIMARY,2.5,,AMPK ACTIVATOR,BRD:BRD-K53448858-001-07-0,ACADESINE,ACADESINE
REP.PRIMARY,2.5,"MMP1, MMP13, MMP2, MMP3, MMP9",METALLOPROTEINASE INHIBITOR,BRD:BRD-K53508936-001-01-0,CTS-1027,CTS-1027
REP.PRIMARY,2.5,SLC6A4,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K53517854-051-01-4,FLUVOXAMINE,FLUVOXAMINE
REP.PRIMARY,2.5,"CHUK, MAP2K1",MEK INHIBITOR,BRD:BRD-K53523901-001-04-4,ARCTIGENIN,ARCTIGENIN
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K53532120-003-09-5,U-50488-(-),U-50488-(-)
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K53532120-003-11-1,U-50488-(-),U-50488-(-)
REP.PRIMARY,2.5,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K53561341-001-07-5,AURORA-A-INHIBITOR-I,AURORA-A-INHIBITOR-I
REP.PRIMARY,2.5,"JAK1, JAK2",JAK INHIBITOR,BRD:BRD-K53581288-001-02-9,BARICITINIB,BARICITINIB
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K53665955-001-03-0,MK-5108,MK-5108
REP.PRIMARY,2.5,CYSLTR1,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K53720352-001-03-2,CINALUKAST,CINALUKAST
REP.PRIMARY,2.5,"FGR, MAP3K9, SYK",SYK INHIBITOR,BRD:BRD-K53734668-003-02-0,PRT062607,PRT062607
REP.PRIMARY,2.5,"FGR, MAP3K9, SYK",SYK INHIBITOR,BRD:BRD-K53734668-003-04-6,PRT062607,PRT062607
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4","NOREPINEPHRINE INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINâNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",BRD:BRD-K53737926-003-27-8,AMITRIPTYLINE,AMITRIPTYLINE
REP.PRIMARY,2.5,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K53765467-001-02-1,EMPAGLIFLOZIN,EMPAGLIFLOZIN
REP.PRIMARY,2.5,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K53814070-310-01-3,RIPASUDIL,RIPASUDIL
REP.PRIMARY,2.5,,,BRD:BRD-K53852914-001-01-8,MENBUTONE,MENBUTONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K53857191-001-22-7,RISPERIDONE,RISPERIDONE
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K53913732-001-05-9,SB-408124,SB-408124
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4","SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K53963539-004-02-0,VORTIOXETINE,VORTIOXETINE
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K53972329-001-07-0,RUXOLITINIB,RUXOLITINIB
REP.PRIMARY,2.5,SLC6A9,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",BRD:BRD-K53979406-003-02-8,ALX-5407,ALX-5407
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K54006094-051-01-7,FORMOTEROL,FORMOTEROL
REP.PRIMARY,2.5,,PHARMACOLOGICAL CHAPERONE,BRD:BRD-K54028654-001-02-6,CABALETTA,CABALETTA
REP.PRIMARY,2.5,"HBE1, HBG1",GENE EXPRESSION STIMULANT,BRD:BRD-K54057105-001-01-2,ISOBUTYRAMIDE,ISOBUTYRAMIDE
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4, HTR2A, SIGMAR1",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K54094468-003-11-1,REMOXIPRIDE,REMOXIPRIDE
REP.PRIMARY,2.5,"GNRHR, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K54095730-001-03-1,CMPD-1,CMPD-1
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K54142781-003-11-8,CIRAZOLINE,CIRAZOLINE
REP.PRIMARY,2.5,,,BRD:BRD-K54187111-001-08-4,DICHLORISONE-ACETATE,DICHLORISONE-ACETATE
REP.PRIMARY,2.5,,,BRD:BRD-K54187111-001-09-2,DICHLORISONE-ACETATE,DICHLORISONE-ACETATE
REP.PRIMARY,2.5,"COL1A1, MMP2",COLLAGENASE INHIBITOR,BRD:BRD-K54247840-004-01-3,HALOFUGINONE,HALOFUGINONE
REP.PRIMARY,2.5,WEE1,WEE1 KINASE INHIBITOR,BRD:BRD-K54256913-001-08-7,MK-1775,MK-1775
REP.PRIMARY,2.5,TYR,MELANIN INHIBITOR,BRD:BRD-K54262262-001-09-0,MONOBENZONE,MONOBENZONE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K54314721-001-10-2,ZOLMITRIPTAN,ZOLMITRIPTAN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K54316499-046-04-5,TOLTERODINE,TOLTERODINE
REP.PRIMARY,2.5,"AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1",P38 MAPK INHIBITOR,BRD:BRD-K54330070-001-15-4,SB-202190,SB-202190
REP.PRIMARY,2.5,,DUB INHIBITOR,BRD:BRD-K54395039-001-01-7,PR-619,PR-619
REP.PRIMARY,2.5,TPO,ANTITHYROID AGENT,BRD:BRD-K54416256-001-19-9,METHIMAZOLE,METHIMAZOLE
REP.PRIMARY,2.5,,HIV INTEGRASE INHIBITOR,BRD:BRD-K54472332-001-03-4,ELVITEGRAVIR,ELVITEGRAVIR
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K54496168-003-01-2,PROPACETAMOL,PROPACETAMOL
REP.PRIMARY,2.5,"AR, NR1H2, NR1H3, NR1I2, NR3C1",LXR AGONIST,BRD:BRD-K54520417-001-01-2,LXR-623,LXR-623
REP.PRIMARY,2.5,,,BRD:BRD-K54521836-001-02-1,THIODIGLYCOL,THIODIGLYCOL
REP.PRIMARY,2.5,"ACE, LTA4H, MMP2, MMP9",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K54529596-001-26-3,CAPTOPRIL,CAPTOPRIL
REP.PRIMARY,2.5,"BRD4, BRDT",BROMODOMAIN INHIBITOR,BRD:BRD-K54606188-001-13-1,JQ1-(+),JQ1-(+)
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K54634444-001-05-9,ARTESUNATE,ARTESUNATE
REP.PRIMARY,2.5,NR1H4,FXR AGONIST,BRD:BRD-K54640016-001-04-7,WAY-362450,WAY-362450
REP.PRIMARY,2.5,DGKA,"DIACYLGLYCEROL KINASE INHIBITOR, PROTEIN KINASE INHIBITOR",BRD:BRD-K54665485-001-07-9,R-59022,R-59022
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-K54708045-001-02-1,NTZDPA,NTZDPA
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4","NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINâNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), TRICYCLIC ANTIDEPRESSANT",BRD:BRD-K54759182-003-08-0,DOSULEPIN,DOSULEPIN
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K54770957-001-04-3,ETORICOXIB,ETORICOXIB
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K54790157-001-15-5,TRIOXSALEN,TRIOXSALEN
REP.PRIMARY,2.5,,IMMUNOSTIMULANT,BRD:BRD-K54824716-001-04-0,PROCODAZOLE,PROCODAZOLE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-K54838207-001-02-0,FUDOSTEINE,FUDOSTEINE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-K54838207-001-03-8,FUDOSTEINE,FUDOSTEINE
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K54847683-001-03-2,EQUOL,EQUOL
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K54847683-001-04-0,EQUOL,EQUOL
REP.PRIMARY,2.5,MPO,ELASTASE INHIBITOR,BRD:BRD-K54936858-001-01-6,DMP-777,DMP-777
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K54997624-001-06-0,ALPELISIB,ALPELISIB
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K55013654-003-02-3,LORCASERIN,LORCASERIN
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K55034111-066-17-1,PEFLOXACIN,PEFLOXACIN
REP.PRIMARY,2.5,"CYP2C19, SLC15A1, SLC15A2, SLC22A6",PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K55044200-001-14-6,AMOXICILLIN,AMOXICILLIN
REP.PRIMARY,2.5,"CYP2C19, SLC15A1, SLC15A2, SLC22A6",PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K55044200-001-15-3,AMOXICILLIN,AMOXICILLIN
REP.PRIMARY,2.5,"ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",GABA RECEPTOR MODULATOR,BRD:BRD-K55055802-001-10-2,ETOMIDATE,ETOMIDATE
REP.PRIMARY,2.5,"CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K55127134-300-11-2,FLUPHENAZINE,FLUPHENAZINE
REP.PRIMARY,2.5,,,BRD:BRD-K55160477-001-04-7,BENZO[D]THIAZOLE-2(3H)-THIONE,BENZO[D]THIAZOLE-2(3H)-THIONE
REP.PRIMARY,2.5,,VASODILATOR,BRD:BRD-K55166090-001-09-0,EFLOXATE,EFLOXATE
REP.PRIMARY,2.5,PLK1,"CELL CYCLE INHIBITOR, PLK INHIBITOR",BRD:BRD-K55187425-236-05-2,RIGOSERTIB,RIGOSERTIB
REP.PRIMARY,2.5,,PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K55191674-237-18-3,BENZYLPENICILLIN,BENZYLPENICILLIN
REP.PRIMARY,2.5,,DIHYDROPTEROATE SYNTHASE INHIBITOR,BRD:BRD-K55250441-001-13-0,SULFADOXINE,SULFADOXINE
REP.PRIMARY,2.5,,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K55305701-001-01-2,SC-144,SC-144
REP.PRIMARY,2.5,"MAOA, MAOB",IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-K55344148-003-02-6,BU-224,BU-224
REP.PRIMARY,2.5,HTR1B,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K55424922-003-02-8,ANPIRTOLINE,ANPIRTOLINE
REP.PRIMARY,2.5,"CNR1, CNR2, FAAH, TRPV1","CYCLOOXYGENASE INHIBITOR, FAAH INHIBITOR, TRPV ANTAGONIST",BRD:BRD-K55462201-001-07-3,AM-404,AM-404
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K55468218-001-26-1,SPIPERONE,SPIPERONE
REP.PRIMARY,2.5,MET,C-MET INHIBITOR,BRD:BRD-K55512740-001-01-6,MK-8033,MK-8033
REP.PRIMARY,2.5,"ADH1C, SLC5A2",ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K55567017-001-12-3,FORMONONETIN,FORMONONETIN
REP.PRIMARY,2.5,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K55675242-001-03-0,TORCETRAPIB,TORCETRAPIB
REP.PRIMARY,2.5,GRIN2B,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K55677650-003-02-9,CO-101244,CO-101244
REP.PRIMARY,2.5,"HRH1, HTR6",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K55703048-001-07-7,LATREPIRDINE,LATREPIRDINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, HTR1A, HTR1B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K55705469-065-01-0,PENBUTOLOL,PENBUTOLOL
REP.PRIMARY,2.5,ATP4A,ATPASE INHIBITOR,BRD:BRD-K55748775-001-02-2,SCH-28080,SCH-28080
REP.PRIMARY,2.5,,HIV ATTACHMENT INHIBITOR,BRD:BRD-K55773932-001-02-0,BMS-806,BMS-806
REP.PRIMARY,2.5,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-K55781385-001-01-7,RIMEGEPANT,"BMS-927711, RIMEGEPANT"
REP.PRIMARY,2.5,,IMMUNOSUPPRESSANT,BRD:BRD-K55847762-304-01-7,LOBENZARIT,LOBENZARIT
REP.PRIMARY,2.5,,,BRD:BRD-K55892330-001-01-8,SORBIC-ACID,SORBIC-ACID
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HYDANTOIN ANTIEPILEPTIC,BRD:BRD-K55930204-236-24-3,PHENYTOIN,PHENYTOIN
REP.PRIMARY,2.5,"AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB","FGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K55966568-001-05-4,ORANTINIB,ORANTINIB
REP.PRIMARY,2.5,"ALK, EGFR",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K56032964-001-02-1,AP26113,AP26113
REP.PRIMARY,2.5,,,BRD:BRD-K56033645-001-07-5,5-METHYLHYDANTOIN-(L),5-METHYLHYDANTOIN-(L)
REP.PRIMARY,2.5,"DAGLA, DAGLB",TRIACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K56047318-001-06-3,RHC-80267,RHC-80267
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K56077740-001-09-2,MMPX,MMPX
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K56104152-008-04-1,OXICONAZOLE,OXICONAZOLE
REP.PRIMARY,2.5,,IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-K56115039-003-02-1,BU226,BU226
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K56156805-001-09-6,BENZNIDAZOLE,BENZNIDAZOLE
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K56195681-001-01-0,LOSMAPIMOD,LOSMAPIMOD
REP.PRIMARY,2.5,"AXL, MET",VEGFR INHIBITOR,BRD:BRD-K56277358-001-07-5,MGCD-265,MGCD-265
REP.PRIMARY,2.5,"MTOR, PIK3CA","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K56291712-001-01-0,VOXTALISIB,VOXTALISIB
REP.PRIMARY,2.5,"BCL2, BCL2L1, BCL2L2",BCL INHIBITOR,BRD:BRD-K56301217-001-07-4,ABT-737,ABT-737
REP.PRIMARY,2.5,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K56334280-001-05-1,AMONAFIDE,AMONAFIDE
REP.PRIMARY,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K56343971-001-10-6,VEMURAFENIB,VEMURAFENIB
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K56405753-001-02-4,MK-2461,MK-2461
REP.PRIMARY,2.5,MIF,"GLUTAMATE INHIBITOR, MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR",BRD:BRD-K56483981-342-06-4,CHICAGO-SKY-BLUE-6B,CHICAGO-SKY-BLUE-6B
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K56515112-001-21-6,MEDRYSONE,MEDRYSONE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K56542719-065-01-4,CEFPIROME,CEFPIROME
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K56543881-001-02-7,ADX-47273,ADX-47273
REP.PRIMARY,2.5,CYP3A4,SODIUM CHANNEL BLOCKER,BRD:BRD-K56558538-003-11-9,AMBROXOL,AMBROXOL
REP.PRIMARY,2.5,"MAPK14, TGFBR1",SODIUM CHANNEL BLOCKER,BRD:BRD-K56596464-004-10-7,QX-314,QX-314
REP.PRIMARY,2.5,,GK0582 INHIBITOR,BRD:BRD-K56614220-001-19-0,CLOFAZIMINE,CLOFAZIMINE
REP.PRIMARY,2.5,,,BRD:BRD-K56691760-001-01-2,PIKAMILONE,PIKAMILONE
REP.PRIMARY,2.5,,,BRD:BRD-K56707426-001-02-0,NITARSONE,NITARSONE
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K56735750-001-06-8,CARBADOX,CARBADOX
REP.PRIMARY,2.5,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K56751279-300-01-4,Y-39983,Y-39983
REP.PRIMARY,2.5,"ADH1A, ADH1B, ADH1C, AKR1A1, CAT",ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K56810756-001-03-0,FOMEPIZOLE,FOMEPIZOLE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K56851771-001-06-8,ENZALUTAMIDE,ENZALUTAMIDE
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K56908511-001-01-2,FLUROXENE,FLUROXENE
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K56940463-001-13-8,OXETHAZAINE,OXETHAZAINE
REP.PRIMARY,2.5,,,BRD:BRD-K56940914-001-04-2,CRESOL,CRESOL
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K56957086-001-06-3,DACINOSTAT,DACINOSTAT
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K57033106-003-19-7,TRIPELENNAMINE,TRIPELENNAMINE
REP.PRIMARY,2.5,F2,THROMBIN INHIBITOR,BRD:BRD-K57041787-001-02-6,DABIGATRAN-ETEXILATE,DABIGATRAN-ETEXILATE
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-K57080016-001-15-9,SELUMETINIB,SELUMETINIB
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K57136142-001-02-4,CCT129202,CCT129202
REP.PRIMARY,2.5,"EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K57169635-001-04-5,DACOMITINIB,DACOMITINIB
REP.PRIMARY,2.5,,ANTIPRURITIC,BRD:BRD-K57179821-001-15-4,CROTAMITON,CROTAMITON
REP.PRIMARY,2.5,"GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K57222227-001-30-1,INDOMETHACIN,INDOMETHACIN
REP.PRIMARY,2.5,"ITGAV, ITGB3",INTEGRIN ANTAGONIST,BRD:BRD-K57252450-001-02-5,CILENGITIDE,CILENGITIDE
REP.PRIMARY,2.5,GLP1R,GLP RECEPTOR AGONIST,BRD:BRD-K57275767-001-02-4,GENIPOSIDE,GENIPOSIDE
REP.PRIMARY,2.5,GLP1R,GLP RECEPTOR AGONIST,BRD:BRD-K57275767-001-03-2,GENIPOSIDE,GENIPOSIDE
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K57284066-001-01-6,RO-9187,RO-9187
REP.PRIMARY,2.5,,ANTIVIRAL,BRD:BRD-K57291914-003-09-4,MOROXYDINE,MOROXYDINE
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K57304726-003-06-9,PRE-084,PRE-084
REP.PRIMARY,2.5,"ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA",,BRD:BRD-K57313110-001-06-8,PIDOLIC-ACID,PIDOLIC-ACID
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K57371763-001-01-7,FIDAXOMICIN,FIDAXOMICIN
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K57432881-003-21-8,TIAPRIDE,TIAPRIDE
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K57545991-050-23-1,ENALAPRIL,ENALAPRIL
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K57569181-001-27-5,PENTOXIFYLLINE,PENTOXIFYLLINE
REP.PRIMARY,2.5,CNR1,CANNABINOID RECEPTOR MODULATOR,BRD:BRD-K57597776-001-01-2,ORG-27569,ORG-27569
REP.PRIMARY,2.5,ALAD,OXIDIZING AGENT,BRD:BRD-K57631554-003-06-2,5-AMINOLEVULINIC-ACID,5-AMINOLEVULINIC-ACID
REP.PRIMARY,2.5,,GABA RECEPTOR ANTAGONIST,BRD:BRD-K57718010-001-11-9,PENTYLENETETRAZOL,PENTYLENETETRAZOL
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K57754230-001-02-7,EPZ005687,EPZ005687
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K57764956-001-02-8,CARIPRAZINE,CARIPRAZINE
REP.PRIMARY,2.5,"IFNG, TPMT",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K57853941-304-02-5,OLSALAZINE,OLSALAZINE
REP.PRIMARY,2.5,"OPRD1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K57927309-001-01-7,BW-180C,BW-180C
REP.PRIMARY,2.5,"DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4",SEROTONIN REUPTAKE INHIBITOR,BRD:BRD-K58010567-003-02-2,VILAZODONE,VILAZODONE
REP.PRIMARY,2.5,GRIA1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K58046914-001-03-8,HA-966-(R)-(+),HA-966-(R)-(+)
REP.PRIMARY,2.5,FOXM1,"FOXM1 INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",BRD:BRD-K58049875-001-04-7,THIOSTREPTON,THIOSTREPTON
REP.PRIMARY,2.5,"BCL2, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K58114536-001-01-6,RASAGILINE,RASAGILINE
REP.PRIMARY,2.5,AURKB,AURORA KINASE INHIBITOR,BRD:BRD-K58122457-001-02-2,HESPERADIN,HESPERADIN
REP.PRIMARY,2.5,NR3C1,ANTI-INFLAMMATORY AGENT,BRD:BRD-K58148589-001-03-6,BETAMETHASONE-DIPROPIONATE,BETAMETHASONE-DIPROPIONATE
REP.PRIMARY,2.5,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K58160573-001-05-4,DAPAGLIFLOZIN,DAPAGLIFLOZIN
REP.PRIMARY,2.5,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K58262659-001-09-7,DOXIFLURIDINE,DOXIFLURIDINE
REP.PRIMARY,2.5,,DIURETIC,BRD:BRD-K58265391-001-12-7,METICRANE,METICRANE
REP.PRIMARY,2.5,APP,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,BRD:BRD-K58299615-001-03-5,RO-90-7501,RO-90-7501
REP.PRIMARY,2.5,"ESRRB, ESRRG",ESTROGEN-RELATED RECEPTOR AGONIST,BRD:BRD-K58343622-001-01-6,DY131,DY131
REP.PRIMARY,2.5,HSP90AA1,"HSP ANTAGONIST, HSP INHIBITOR",BRD:BRD-K58435339-001-03-0,AT13387,AT13387
REP.PRIMARY,2.5,CYP3A4,DOPAMINE SYNTHESIS INHIBITOR,BRD:BRD-K58466253-003-14-0,PALMATINE-CHLORIDE,PALMATINE-CHLORIDE
REP.PRIMARY,2.5,"CXCR1, CXCR2",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K58486055-001-02-7,REPARIXIN,REPARIXIN
REP.PRIMARY,2.5,,,BRD:BRD-K58497451-237-10-7,POTASSIUM-P-AMINOBENZOATE,POTASSIUM-P-AMINOBENZOATE
REP.PRIMARY,2.5,FFAR1,INSULIN SECRETAGOGUE,BRD:BRD-K58501140-002-01-0,TAK-875,TAK-875
REP.PRIMARY,2.5,FDPS,BONE RESORPTION INHIBITOR,BRD:BRD-K58513245-304-02-7,PAMIDRONATE,PAMIDRONATE
REP.PRIMARY,2.5,NAMPT,NIACINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITOR,BRD:BRD-K58550667-001-08-7,FK-866,FK-866
REP.PRIMARY,2.5,BMP1,BONE MORPHOGENIC PROTEIN INHIBITOR,BRD:BRD-K58568447-001-01-1,K02288,K02288
REP.PRIMARY,2.5,"HTR2C, SLC6A4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K58626373-003-07-8,DEXFENFLURAMINE,DEXFENFLURAMINE
REP.PRIMARY,2.5,,,BRD:BRD-K58648841-001-04-7,CRESOPIRINE,CRESOPIRINE
REP.PRIMARY,2.5,CSNK2A1,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K58685305-001-20-4,EMODIN,EMODIN
REP.PRIMARY,2.5,PTGS1,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K58736316-001-09-5,CIANIDANOL,CIANIDANOL
REP.PRIMARY,2.5,,HSP INHIBITOR,BRD:BRD-K58770988-001-01-8,NMS-E973,NMS-E973
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K58772419-001-07-0,AZD6482,AZD6482
REP.PRIMARY,2.5,HPN,,BRD:BRD-K58794715-001-01-8,BENTIROMIDE,BENTIROMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K58819470-001-05-9,2-THIOURACIL,2-THIOURACIL
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K58930050-050-15-8,DIZOCILPINE-(+),DIZOCILPINE-(+)
REP.PRIMARY,2.5,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K58937086-001-01-4,GLUTATHIONE-MONOISOPROPYL-ESTER,GLUTATHIONE-MONOISOPROPYL-ESTER
REP.PRIMARY,2.5,,,BRD:BRD-K58968598-001-03-6,SUCRALOSE,SUCRALOSE
REP.PRIMARY,2.5,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-K59013864-001-01-1,AM-24,AM-24
REP.PRIMARY,2.5,,PROTEASE-ACTIVATED RECEPTOR INHIBITOR,BRD:BRD-K59036917-001-16-7,ML161,ML161
REP.PRIMARY,2.5,LIPE,LIPASE INHIBITOR,BRD:BRD-K59037100-001-14-7,OXYBENZONE,OXYBENZONE
REP.PRIMARY,2.5,,LACTAMASE INHIBITOR,BRD:BRD-K59045783-001-01-1,FAROPENEM-MEDOXOMIL,FAROPENEM-MEDOXOMIL
REP.PRIMARY,2.5,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11",MUCOLYTIC AGENT,BRD:BRD-K59058747-001-18-3,ACETYLCYSTEINE,ACETYLCYSTEINE
REP.PRIMARY,2.5,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11",MUCOLYTIC AGENT,BRD:BRD-K59058747-001-20-9,ACETYLCYSTEINE,ACETYLCYSTEINE
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-K59110290-238-01-7,FOSAMPRENAVIR,FOSAMPRENAVIR
REP.PRIMARY,2.5,,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K59146805-001-03-7,AZ3146,AZ3146
REP.PRIMARY,2.5,"CCNA2, CDK2, GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K59184148-001-21-6,SB-216763,SB-216763
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K59197931-001-04-5,NAPROXEN,NAPROXEN
REP.PRIMARY,2.5,CASP3,ATPASE INHIBITOR,BRD:BRD-K59204667-001-03-1,DBEQ,DBEQ
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K59227464-334-02-4,LY2228820,LY2228820
REP.PRIMARY,2.5,PDE1A,"ADENOSINE REUPTAKE INHIBITOR, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K59273480-001-10-6,PROPENTOFYLLINE,PROPENTOFYLLINE
REP.PRIMARY,2.5,"EGFR, MTOR",EGFR INHIBITOR,BRD:BRD-K59284035-001-07-9,CHRYSOPHANIC-ACID,CHRYSOPHANIC-ACID
REP.PRIMARY,2.5,"MTOR, PIK3CA, PIK3CD, PIK3CG",MTOR INHIBITOR,BRD:BRD-K59317601-001-05-5,MLN0128,MLN0128
REP.PRIMARY,2.5,"CMA1, CTSG, CYP3A4, ELANE",PROTEASOME INHIBITOR,BRD:BRD-K59325863-001-02-8,DELANZOMIB,DELANZOMIB
REP.PRIMARY,2.5,"CMA1, CTSG, CYP3A4, ELANE",PROTEASOME INHIBITOR,BRD:BRD-K59325863-001-03-6,DELANZOMIB,DELANZOMIB
REP.PRIMARY,2.5,"KCNQ2, KCNQ3, KCNQ4, KCNQ5",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K59332007-300-02-7,LINOPIRDINE,LINOPIRDINE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K59333713-003-02-0,NIGULDIPINE-(S)-(+),NIGULDIPINE-(S)-(+)
REP.PRIMARY,2.5,"PTGDR, PTGER1, PTGER2, PTGER3",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K59339270-001-02-6,AH6809,AH6809
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC, LCK","AURORA KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR, FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K59369769-001-20-3,TOZASERTIB,TOZASERTIB
REP.PRIMARY,2.5,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K59390331-045-01-5,TARAFENACIN,TARAFENACIN
REP.PRIMARY,2.5,"CNR1, CNR2, GPR55",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K59419204-001-02-7,AM-281,AM-281
REP.PRIMARY,2.5,"BCAT1, PCCB, VARS",,BRD:BRD-K59424860-001-01-4,VAL,"L-VALINE, VAL"
REP.PRIMARY,2.5,TBXA2R,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K59433843-001-01-7,ICI-192605,ICI-192605
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K59436580-001-01-7,TEDIZOLID,TEDIZOLID
REP.PRIMARY,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K59456551-001-22-6,METHOTREXATE,METHOTREXATE
REP.PRIMARY,2.5,"ERBB2, KDR, NTRK1",TYROSINE KINASE INHIBITOR,BRD:BRD-K59469039-001-08-0,TYRPHOSTIN-AG-879,TYRPHOSTIN-AG-879
REP.PRIMARY,2.5,NOS3,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K59506194-015-04-9,TARGININE,TARGININE
REP.PRIMARY,2.5,"MAOA, MAOB, TRPV1",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K59522102-001-14-6,PIPERINE,PIPERINE
REP.PRIMARY,2.5,"MAOA, MAOB, TRPV1",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K59522102-001-15-3,PIPERINE,PIPERINE
REP.PRIMARY,2.5,PYGM,"CYTOMEGALOVIRUS INHIBITOR, PROTEIN KINASE INHIBITOR",BRD:BRD-K59524082-001-01-3,MARIBAVIR,MARIBAVIR
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K59527975-236-01-8,S-SULFO-L-CYSTEINE-SODIUM-SALT,"S-SULFO-L-CYSTEINE, S-SULFO-L-CYSTEINE-SODIUM-SALT"
REP.PRIMARY,2.5,"LTA4H, RNPEP",LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K59574735-001-11-8,UBENIMEX,UBENIMEX
REP.PRIMARY,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K59597909-001-17-6,PHENOTHIAZINE,PHENOTHIAZINE
REP.PRIMARY,2.5,"KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4",SODIUM CHANNEL BLOCKER,BRD:BRD-K59632282-052-03-1,QUINIDINE,QUINIDINE
REP.PRIMARY,2.5,"CRAT, CROT",,BRD:BRD-K59647213-001-10-5,LEVOCARNITINE,LEVOCARNITINE
REP.PRIMARY,2.5,"SSTR1, SSTR2, SSTR3, SSTR5",SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-K59715032-362-01-4,PASIREOTIDE,PASIREOTIDE
REP.PRIMARY,2.5,"AKT2, PDPK1","AKT INHIBITOR, PYRUVATE DEHYDROGENASE INHIBITOR",BRD:BRD-K59745944-001-02-0,PHT-427,PHT-427
REP.PRIMARY,2.5,"ABL1, ACVR1, RIPK2",BONE MORPHOGENIC PROTEIN INHIBITOR,BRD:BRD-K59831625-001-01-6,LDN-212854,LDN-212854
REP.PRIMARY,2.5,,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-K59875992-001-01-8,FPL-62064,FPL-62064
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K59929863-001-01-9,CB-10-277,CB-10-277
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K59983611-001-21-9,SULFABENZAMIDE,SULFABENZAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K59998349-003-01-4,AMINOLEVULINIC-ACID-BENZYL-ESTER,AMINOLEVULINIC-ACID-BENZYL-ESTER
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K60005752-001-01-9,S-111,S-111
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K60025295-003-06-6,CRYSTAL-VIOLET,CRYSTAL-VIOLET
REP.PRIMARY,2.5,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K60036103-003-01-6,L-NIL,L-NIL
REP.PRIMARY,2.5,"AGTR1, JUN, SLC10A1",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K60038276-001-09-0,IRBESARTAN,IRBESARTAN
REP.PRIMARY,2.5,,ANTIARRHYTHMIC MEDICATION,BRD:BRD-K60060639-005-02-2,N-METHYLLIDOCAINE-IODIDE,N-METHYLLIDOCAINE-IODIDE
REP.PRIMARY,2.5,,ANTISPASMODIC,BRD:BRD-K60102752-001-02-2,ALIBENDOL,ALIBENDOL
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K60150510-001-15-6,N6-CYCLOPENTYLADENOSINE,N6-CYCLOPENTYLADENOSINE
REP.PRIMARY,2.5,SLC6A1,GABA UPTAKE INHIBITOR,BRD:BRD-K60160658-003-11-2,TIAGABINE,TIAGABINE
REP.PRIMARY,2.5,EGFR,TYROSINE KINASE INHIBITOR,BRD:BRD-K60184833-001-05-6,TYRPHOSTIN-AG-99,TYRPHOSTIN-AG-99
REP.PRIMARY,2.5,FDPS,BONE RESORPTION INHIBITOR,BRD:BRD-K60212747-236-01-1,NERIDRONIC-ACID,NERIDRONIC-ACID
REP.PRIMARY,2.5,PSMB1,PROTEASOME INHIBITOR,BRD:BRD-K60230970-001-17-5,MG-132,MG-132
REP.PRIMARY,2.5,"DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT","NAD PRECURSOR, VITAMIN B",BRD:BRD-K60237333-001-27-1,NIACIN,NIACIN
REP.PRIMARY,2.5,CPS1,CARBAMOYL PHOSPHATE SYNTHASE ACTIVATOR,BRD:BRD-K60240222-001-01-4,CARGLUMIC-ACID,CARGLUMIC-ACID
REP.PRIMARY,2.5,"GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K60287130-001-05-7,"5,7-DICHLOROKYNURENIC-ACID","5,7-DICHLOROKYNURENIC-ACID"
REP.PRIMARY,2.5,GRPR,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K60341624-001-02-2,GSK1292263,GSK1292263
REP.PRIMARY,2.5,,,BRD:BRD-K60348325-065-09-9,BRILLIANT-GREEN,BRILLIANT-GREEN
REP.PRIMARY,2.5,"ADK, ENPP1, IMPDH1, IMPDH2, NT5C2",ANTIVIRAL,BRD:BRD-K60369935-001-18-3,RIBAVIRIN,RIBAVIRIN
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K60441002-001-04-8,MUSCIMOL,MUSCIMOL
REP.PRIMARY,2.5,,FUNGAL LANOSTEROL DEMETHYLASE INHIBITOR,BRD:BRD-K60443845-001-08-6,CHLORMIDAZOLE,CHLORMIDAZOLE
REP.PRIMARY,2.5,,PROTEASOME INHIBITOR,BRD:BRD-K60446698-001-01-2,ONX-0914,ONX-0914
REP.PRIMARY,2.5,"HMGCR, SLCO1B1",HMGCR INHIBITOR,BRD:BRD-K60511616-236-08-9,PRAVASTATIN,PRAVASTATIN
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K60567437-001-10-2,DIMPYLATE,DIMPYLATE
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K60585088-001-01-5,PARICALCITOL,PARICALCITOL
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K60640630-001-11-0,MOMETASONE-FUROATE,MOMETASONE-FUROATE
REP.PRIMARY,2.5,"GRM1, GRM4, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K60690191-001-03-3,MPEP,MPEP
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K60770992-066-25-0,PERGOLIDE,PERGOLIDE
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K60866521-001-07-1,IDELALISIB,IDELALISIB
REP.PRIMARY,2.5,CHRNA1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K60907894-003-23-5,ADIPHENINE,ADIPHENINE
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K60914966-001-01-4,ETOSALAMIDE,ETOSALAMIDE
REP.PRIMARY,2.5,CXCL2,IMMUNOSUPPRESSANT,BRD:BRD-K60918217-001-03-8,LAQUINIMOD,LAQUINIMOD
REP.PRIMARY,2.5,"MMP13, MMP2, MMP3","COLLAGENASE INHIBITOR, METALLOPROTEINASE INHIBITOR",BRD:BRD-K60984070-001-01-0,PD-166793,PD-166793
REP.PRIMARY,2.5,"CDK2, CDK4, CDK7, NTRK1","CDK INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K60997853-001-02-3,PHA-848125,PHA-848125
REP.PRIMARY,2.5,,,BRD:BRD-K61032563-001-02-9,NEOHESPERIDIN-DIHYDROCHALCONE,NEOHESPERIDIN-DIHYDROCHALCONE
REP.PRIMARY,2.5,TYR,TYROSINASE INHIBITOR,BRD:BRD-K61036791-001-01-6,RUCINOL,RUCINOL
REP.PRIMARY,2.5,TACR3,TACHYKININ ANTAGONIST,BRD:BRD-K61097567-001-08-5,SB-218795,SB-218795
REP.PRIMARY,2.5,DNM1,DYNAMIN INHIBITOR,BRD:BRD-K61128465-001-09-9,MDIVI-1,MDIVI-1
REP.PRIMARY,2.5,CRHR1,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K61177364-003-02-9,NBI-27914,NBI-27914
REP.PRIMARY,2.5,TYMS,"DNA SYNTHESIS INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K61192372-001-05-5,CAPECITABINE,CAPECITABINE
REP.PRIMARY,2.5,TYMS,"DNA SYNTHESIS INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K61192372-001-08-9,CAPECITABINE,CAPECITABINE
REP.PRIMARY,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K61195623-001-01-4,COMBRETASTATIN-A-4,COMBRETASTATIN-A-4
REP.PRIMARY,2.5,"DNMT1, DNMT3A, DNMT3B",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K61228301-001-01-2,SGI-1027,SGI-1027
REP.PRIMARY,2.5,"THRA, THRB",THYROID HORMONE STIMULANT,BRD:BRD-K61236135-001-08-2,TIRATRICOL,TIRATRICOL
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K61237927-001-01-7,ESLICARBAZEPINE-ACETATE,ESLICARBAZEPINE-ACETATE
REP.PRIMARY,2.5,,HEPATOCYTE FUNCTION ENHANCER,BRD:BRD-K61250484-001-02-3,FPH1-(BRD-6125),FPH1-(BRD-6125)
REP.PRIMARY,2.5,"CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC",OPIOID RECEPTOR AGONIST,BRD:BRD-K61250553-003-32-2,LOPERAMIDE,LOPERAMIDE
REP.PRIMARY,2.5,,PROTEIN KINASE INHIBITOR,BRD:BRD-K61269089-001-05-5,DAPHNETIN,DAPHNETIN
REP.PRIMARY,2.5,"CS, SPR",GLUTAMATE RELEASE INHIBITOR,BRD:BRD-K61279411-001-02-0,OXALOACETATE,OXALOACETATE
REP.PRIMARY,2.5,,ATPASE INHIBITOR,BRD:BRD-K61295575-001-03-6,BLEBBISTATIN-(-),BLEBBISTATIN-(-)
REP.PRIMARY,2.5,"TNKS, TNKS2",PARP INHIBITOR,BRD:BRD-K61314889-001-04-4,ENDO-IWR-1,ENDO-IWR-1
REP.PRIMARY,2.5,"TNKS, TNKS2",PARP INHIBITOR,BRD:BRD-K61314889-001-05-1,ENDO-IWR-1,ENDO-IWR-1
REP.PRIMARY,2.5,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K61323504-001-04-0,SB-225002,SB-225002
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K61337602-003-02-1,NARATRIPTAN,NARATRIPTAN
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K61397605-001-03-4,ROMIDEPSIN,ROMIDEPSIN
REP.PRIMARY,2.5,ATP4A,ATPASE INHIBITOR,BRD:BRD-K61443506-239-01-6,ESOMEPRAZOLE,ESOMEPRAZOLE
REP.PRIMARY,2.5,OXCT1,OTHER ANTIBIOTIC,BRD:BRD-K61443650-236-13-1,THIOMERSAL,THIOMERSAL
REP.PRIMARY,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K61452026-001-04-6,EMTRICITABINE,EMTRICITABINE
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K61496577-001-20-2,FLUMETHASONE,FLUMETHASONE
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K61536336-001-01-7,SB-366791,SB-366791
REP.PRIMARY,2.5,TLR4,"TOLL-LIKE RECEPTOR ANTAGONIST, TOLL-LIKE RECEPTOR INHIBITOR",BRD:BRD-K61567297-001-01-9,RESATORVID,RESATORVID
REP.PRIMARY,2.5,"GRM1, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K61585876-001-01-0,3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(S),3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(S)
REP.PRIMARY,2.5,ERBB2,EGFR INHIBITOR,BRD:BRD-K61642990-001-01-0,FERB-033,FERB-033
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K61665160-001-01-5,BYK-204165,BYK-204165
REP.PRIMARY,2.5,HDAC3,HDAC INHIBITOR,BRD:BRD-K61688984-001-02-9,RGFP966,RGFP966
REP.PRIMARY,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K61691541-001-01-1,PF-03084014,PF-03084014
REP.PRIMARY,2.5,,DIURETIC,BRD:BRD-K61693562-300-01-7,PYRAZINOYLGUANIDINE,PYRAZINOYLGUANIDINE
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K61717546-001-04-3,FLEROXACIN,FLEROXACIN
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K61717546-001-05-0,FLEROXACIN,FLEROXACIN
REP.PRIMARY,2.5,BCL2L1,BCL-XL DOWNREGULATOR,BRD:BRD-K61734568-003-02-1,"2,3-DCPE","2,3-DCPE"
REP.PRIMARY,2.5,,,BRD:BRD-K61802864-001-08-8,CHLORINDIONE,CHLORINDIONE
REP.PRIMARY,2.5,CYP1A2,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K61868322-050-01-7,TENOFOVIR-DISOPROXIL,TENOFOVIR-DISOPROXIL
REP.PRIMARY,2.5,INPP5D,SHIP2 PHOSPHATASE INHIBITOR,BRD:BRD-K61936403-001-01-7,AS-1949490,AS-1949490
REP.PRIMARY,2.5,,OMEGA 3 FATTY ACID STIMULANT,BRD:BRD-K61937613-001-01-1,DOCONEXENT-ETHYL-ESTER,DOCONEXENT-ETHYL-ESTER
REP.PRIMARY,2.5,,GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,BRD:BRD-K61951118-001-07-9,FG-7142,FG-7142
REP.PRIMARY,2.5,,CHLORIDE CHANNEL ANTAGONIST,BRD:BRD-K61988078-001-01-2,MOXIDECTIN,MOXIDECTIN
REP.PRIMARY,2.5,"BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K62008436-001-22-1,PACLITAXEL,PACLITAXEL
REP.PRIMARY,2.5,"RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3",RETINOID RECEPTOR AGONIST,BRD:BRD-K62012036-001-14-4,ACITRETIN,ACITRETIN
REP.PRIMARY,2.5,"HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K62056274-332-01-8,N-METHYLQUIPAZINE,N-METHYLQUIPAZINE
REP.PRIMARY,2.5,,,BRD:BRD-K62186992-334-02-8,HYDROXYSTILBAMIDINE,HYDROXYSTILBAMIDINE
REP.PRIMARY,2.5,"IMPDH1, IMPDH2",INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,BRD:BRD-K62196610-001-01-6,AVN-944,AVN-944
REP.PRIMARY,2.5,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K62200014-003-10-5,ANAGRELIDE,ANAGRELIDE
REP.PRIMARY,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K62213621-001-01-6,DIHYDROARTEMISININ,DIHYDROARTEMISININ
REP.PRIMARY,1.2000000000000002,,NEUROTROPHIC AGENT,BRD:BRD-K62277907-001-01-6,PYM50028,PYM50028
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K62304154-001-04-2,DEFOROLIMUS,DEFOROLIMUS
REP.PRIMARY,2.5,"NR3C1, NR3C2, PGR, PLA2G4A",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K62310379-001-10-5,FLUTICASONE-PROPIONATE,FLUTICASONE-PROPIONATE
REP.PRIMARY,2.5,,ANTICESTODAL AGENT,BRD:BRD-K62326629-001-19-0,DICHLOROPHEN,DICHLOROPHEN
REP.PRIMARY,2.5,"GABBR1, GABBR2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K62353271-001-04-7,BACLOFEN-(R),"(R)-BACLOFEN, BACLOFEN-(R)"
REP.PRIMARY,2.5,DHFR,BACTERIAL ANTIFOLATE,BRD:BRD-K62363391-001-24-9,DAPSONE,DAPSONE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K62374253-001-07-8,RUFLOXACIN,RUFLOXACIN
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K62387885-001-01-9,BASIMGLURANT,BASIMGLURANT
REP.PRIMARY,2.5,BCL2,BCL INHIBITOR,BRD:BRD-K62391742-001-03-0,VENETOCLAX,VENETOCLAX
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K62398570-300-01-2,LERISETRON,LERISETRON
REP.PRIMARY,2.5,"CA12, CA2, CA6, CA9",,BRD:BRD-K62412084-001-07-1,PARA-TOLUENESULFONAMIDE,PARA-TOLUENESULFONAMIDE
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K62414032-001-12-0,NMDA,NMDA
REP.PRIMARY,2.5,"KCNA3, KCNA5, KCNN4",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K62427771-001-01-0,AS-77,AS-77
REP.PRIMARY,2.5,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K62456038-003-07-1,PD-128907,PD-128907
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K62537556-001-02-5,4-IBP,4-IBP
REP.PRIMARY,2.5,CYSLTR1,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K62562723-003-02-7,SR-2640,SR-2640
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR LIGAND,BRD:BRD-K62581435-001-03-8,3-MPPI,3-MPPI
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K62594868-082-08-6,GR125487,GR125487
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K62607865-001-09-7,AZTREONAM,AZTREONAM
REP.PRIMARY,2.5,"SRPK1, SRPK2",SERINE ARGININE PROTEIN KINASE INHIBITOR,BRD:BRD-K62621335-001-01-7,SRPIN340,SRPIN340
REP.PRIMARY,2.5,"MDM2, TP53",MDM INHIBITOR,BRD:BRD-K62627508-001-01-5,IDASANUTLIN,IDASANUTLIN
REP.PRIMARY,2.5,SLC6A2,ADRENERGIC INHIBITOR,BRD:BRD-K62676709-065-05-5,GUANETHIDINE,GUANETHIDINE
REP.PRIMARY,2.5,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K62685538-001-01-7,TRIPTORELIN,TRIPTORELIN
REP.PRIMARY,2.5,GPER1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K62696033-001-01-4,G-1,G-1
REP.PRIMARY,2.5,"FNTA, NFKB1",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K62734952-001-01-0,ARGLABIN,ARGLABIN
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K62736196-015-11-0,GUANABEN-ACETATE,GUANABEN-ACETATE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K62736196-015-13-6,GUANABEN-ACETATE,GUANABEN-ACETATE
REP.PRIMARY,2.5,"ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",CALCIUM CHANNEL BLOCKER,BRD:BRD-K62737565-003-02-6,GABAPENTIN,GABAPENTIN
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K62762455-001-01-3,RU-58841,RU-58841
REP.PRIMARY,2.5,VDR,,BRD:BRD-K62779383-001-05-5,CHOLECALCIFEROL,CHOLECALCIFEROL
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K62782754-337-02-5,TIOTROPIUM,TIOTROPIUM
REP.PRIMARY,2.5,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1",MEK INHIBITOR,BRD:BRD-K62810658-001-12-2,PD-98059,PD-98059
REP.PRIMARY,2.5,"CDK1, CDK2",CDK INHIBITOR,BRD:BRD-K62814476-001-03-3,BMS-265246,BMS-265246
REP.PRIMARY,2.5,"CACNA1B, SCN5A",CALCIUM CHANNEL BLOCKER,BRD:BRD-K62858456-001-01-8,LOMERIZINE,LOMERIZINE
REP.PRIMARY,2.5,,PURINERGIC RECEPTOR ACTIVATOR,BRD:BRD-K62929068-001-16-5,6-BENZYLAMINOPURINE,6-BENZYLAMINOPURINE
REP.PRIMARY,2.5,"FNTA, FNTB",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K62965247-001-04-9,TIPIFARNIB,TIPIFARNIB
REP.PRIMARY,2.5,"SCN1A, SCN3A, SLC29A1",CALCIUM CHANNEL BLOCKER,BRD:BRD-K62996583-001-10-3,LIDOFLAZINE,LIDOFLAZINE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K63001556-001-08-8,ORBIFLOXACIN,ORBIFLOXACIN
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K63001556-001-09-6,ORBIFLOXACIN,ORBIFLOXACIN
REP.PRIMARY,2.5,"PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K63068307-001-08-9,ZSTK-474,ZSTK-474
REP.PRIMARY,2.5,"CTSD, MGMT",,BRD:BRD-K63123526-001-01-2,S-METHYLCYSTEINE,S-METHYLCYSTEINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF","ADRENERGIC RECEPTOR AGONIST, CARBONIC ANHYDRASE ACTIVATOR, NEUROTRANSMITTER",BRD:BRD-K63126190-003-01-6,EPINEPHRINE,EPINEPHRINE
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K63150726-001-02-1,JTE-907,JTE-907
REP.PRIMARY,2.5,,LYMPHOCYTE INHIBITOR,BRD:BRD-K63151507-001-02-4,MNITMT,MNITMT
REP.PRIMARY,2.5,,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K63165456-001-10-8,NORCYCLOBENZAPRINE,NORCYCLOBENZAPRINE
REP.PRIMARY,2.5,,MEK INHIBITOR,BRD:BRD-K63169195-001-01-5,U-0124,U-0124
REP.PRIMARY,2.5,TPH1,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K63178091-001-01-1,TELOTRISTAT,TELOTRISTAT
REP.PRIMARY,2.5,"CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP",LIPASE INHIBITOR,BRD:BRD-K63343048-001-12-2,ORLISTAT,ORLISTAT
REP.PRIMARY,2.5,"CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4",DNA SYNTHESIS INHIBITOR,BRD:BRD-K63430059-001-17-2,METHOXSALEN,METHOXSALEN
REP.PRIMARY,2.5,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET",VEGFR INHIBITOR,BRD:BRD-K63504947-001-15-4,SEMAXANIB,SEMAXANIB
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K63516691-003-02-0,T-0156,T-0156
REP.PRIMARY,2.5,"CNR1, CNR2",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K63533170-001-02-9,AM-630,AM-630
REP.PRIMARY,2.5,MLNR,NFKB PATHWAY INHIBITOR,BRD:BRD-K63550407-001-12-7,ERYTHROMYCIN,ERYTHROMYCIN
REP.PRIMARY,2.5,MLNR,NFKB PATHWAY INHIBITOR,BRD:BRD-K63550407-001-13-5,ERYTHROMYCIN,ERYTHROMYCIN
REP.PRIMARY,2.5,"ATP1A1, SLC12A1",SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,BRD:BRD-K63630713-001-25-8,ETACRYNIC-ACID,ETACRYNIC-ACID
REP.PRIMARY,2.5,"CHRM1, CHRM2, DRD1, DRD2, HTR2B",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K63675182-003-23-6,TRIFLUPROMAZINE,TRIFLUPROMAZINE
REP.PRIMARY,2.5,,RADICAL FORMATION STIMULANT,BRD:BRD-K63712959-001-01-8,TEMOPORFIN,TEMOPORFIN
REP.PRIMARY,2.5,HCAR2,CHOLESTEROL INHIBITOR,BRD:BRD-K63736853-001-04-8,ACIPIMOX,ACIPIMOX
REP.PRIMARY,2.5,"IMPDH1, IMPDH2","DEHYDROGENASE INHIBITOR, INOSITOL MONOPHOSPHATASE INHIBITOR",BRD:BRD-K63750851-001-20-7,MYCOPHENOLIC-ACID,MYCOPHENOLIC-ACID
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K63784565-001-06-2,10-HYDROXYCAMPTOTHECIN,10-HYDROXYCAMPTOTHECIN
REP.PRIMARY,2.5,CHRM2,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K63792901-075-02-1,ARECAIDINE-BUT-2-YNYL-ESTER,ARECAIDINE-BUT-2-YNYL-ESTER
REP.PRIMARY,2.5,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K63806092-236-02-6,SITAXENTAN,SITAXENTAN
REP.PRIMARY,2.5,"ESR1, ESR2","ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",BRD:BRD-K63828191-003-32-1,RALOXIFENE,RALOXIFENE
REP.PRIMARY,2.5,GUCY1A3,GUANYLATE CYCLASE STIMULANT,BRD:BRD-K63861289-001-19-6,MOLSIDOMINE,MOLSIDOMINE
REP.PRIMARY,2.5,"HRH3, HRH4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K63874012-001-02-9,THIOPERAMIDE,THIOPERAMIDE
REP.PRIMARY,2.5,"PIK3CA, PIK3CG",PI3K INHIBITOR,BRD:BRD-K63915849-001-03-7,AS-604850,AS-604850
REP.PRIMARY,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K63919159-003-07-0,APTIGANEL,APTIGANEL
REP.PRIMARY,2.5,AURKB,AURORA KINASE INHIBITOR,BRD:BRD-K63923597-001-10-0,BARASERTIB-HQPA,BARASERTIB-HQPA
REP.PRIMARY,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K63932022-001-01-5,2'-MECCPA,2'-MECCPA
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K64052750-001-17-5,GEFITINIB,GEFITINIB
REP.PRIMARY,0.25,"P2RY12, PTGER1, PTGER4, PTGIR, PTGIS",PROSTACYCLIN ANALOG,BRD:BRD-K64054020-001-03-5,EPOPROSTENOL,EPOPROSTENOL
REP.PRIMARY,2.5,"HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K64137799-003-02-5,2-METHYL-5-HYDROXYTRYPTAMINE,2-METHYL-5-HYDROXYTRYPTAMINE
REP.PRIMARY,2.5,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K64157027-003-02-7,ZD-2079,ZD-2079
REP.PRIMARY,2.5,,,BRD:BRD-K64178227-001-09-0,BTS,BTS
REP.PRIMARY,2.5,,,BRD:BRD-K64191834-001-03-1,N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE,"CBS,-N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE, N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE"
REP.PRIMARY,2.5,MAOB,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K64338723-001-01-6,MILACEMIDE,MILACEMIDE
REP.PRIMARY,2.5,,GUANYLATE CYCLASE ACTIVATOR,BRD:BRD-K64341947-003-02-4,CFM-1571,CFM-1571
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K64381438-001-03-8,ULIPRISTAL,ULIPRISTAL
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K64400208-001-08-3,DNQX,DNQX
REP.PRIMARY,2.5,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K64422603-300-02-7,N-ALPHA-METHYLHISTAMINE-DIHYDROCHLORIDE,N-ALPHA-METHYLHISTAMINE-DIHYDROCHLORIDE
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K64514229-001-05-2,TOLTRAZURIL,TOLTRAZURIL
REP.PRIMARY,2.5,MAP2K1,MEK INHIBITOR,BRD:BRD-K64538373-001-01-4,RO-4987655,RO-4987655
REP.PRIMARY,2.5,"ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K64557645-001-02-4,ZOTEPINE,ZOTEPINE
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K64614248-001-12-3,SALICIN,SALICIN
REP.PRIMARY,2.5,,,BRD:BRD-K64636206-001-02-7,D-ALPHA-TOCOPHERYL-SUCCINATE,D-ALPHA-TOCOPHERYL-SUCCINATE
REP.PRIMARY,2.5,,DIHYDROPTEROATE SYNTHETASE INHIBITOR,BRD:BRD-K64659768-001-12-8,PHTHALYLSULFATHIAZOLE,PHTHALYLSULFATHIAZOLE
REP.PRIMARY,2.5,"CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K64716392-001-01-3,NEDOCROMIL,NEDOCROMIL
REP.PRIMARY,2.5,"GABRB3, PDE4A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K64755930-003-03-2,ETAZOLATE,ETAZOLATE
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K64785675-001-04-0,TG100-115,TG100-115
REP.PRIMARY,2.5,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9",CDK INHIBITOR,BRD:BRD-K64800655-001-07-4,PHA-793887,PHA-793887
REP.PRIMARY,2.5,"CLK4, DYRK1B","CLK INHIBITOR, DYRK INHIBITOR",BRD:BRD-K64835161-001-02-8,ML167,ML167
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K64838454-001-01-0,DIPRAGLURANT,DIPRAGLURANT
REP.PRIMARY,2.5,"AURKA, AURKB, KDR",AURORA KINASE INHIBITOR,BRD:BRD-K64866502-001-03-9,CYC116,CYC116
REP.PRIMARY,1.13,PYGM,"ACAT INHIBITOR, STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR",BRD:BRD-K64874225-001-04-7,NSC-4644,NSC-4644
REP.PRIMARY,2.5,KIF11,KINESIN INHIBITOR,BRD:BRD-K64881305-001-03-7,ISPINESIB,ISPINESIB
REP.PRIMARY,2.5,JAK2,JAK INHIBITOR,BRD:BRD-K64888243-001-03-7,AZ960,AZ960
REP.PRIMARY,2.5,"BRD4, PLK1, PLK2, PLK3",PLK INHIBITOR,BRD:BRD-K64890080-001-13-8,BI-2536,BI-2536
REP.PRIMARY,2.5,MDM2,MDM INHIBITOR,BRD:BRD-K64925568-001-01-8,AMG-232,AMG-232
REP.PRIMARY,2.5,"LPA, PLAT, PLG",PLASMINOGEN ACTIVATOR INHIBITOR,BRD:BRD-K64931368-003-01-4,AMINOCAPROIC-ACID,AMINOCAPROIC-ACID
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K64990126-004-01-1,SCOPOLAMINE,SCOPOLAMINE
REP.PRIMARY,2.5,NOX4,NADPH OXIDASE INHIBITOR,BRD:BRD-K64990520-001-08-4,APOCYNIN,APOCYNIN
REP.PRIMARY,2.5,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K64994968-001-32-5,PROGESTERONE,PROGESTERONE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K65146499-001-27-9,NABUMETONE,NABUMETONE
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K65170927-001-01-6,APREPITANT,APREPITANT
REP.PRIMARY,2.5,PPARG,ICAM1 ANTAGONIST,BRD:BRD-K65275554-001-04-7,NPC-15199,NPC-15199
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K65285700-001-02-3,GP1A,GP1A
REP.PRIMARY,2.5,"GRM2, GRM3, GRM6, GRM8",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K65359424-001-01-3,EGLUMETAD,EGLUMETAD
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-K65377893-001-07-4,7-AMINOCEPHALOSPORANIC-ACID,7-AMINOCEPHALOSPORANIC-ACID
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K65417056-003-10-1,MEPRYLCAINE,MEPRYLCAINE
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K65428967-001-08-4,CORDYCEPIN,CORDYCEPIN
REP.PRIMARY,2.5,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K65503129-001-06-3,CCT018159,CCT018159
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K65518078-002-01-1,CILAZAPRIL,CILAZAPRIL
REP.PRIMARY,2.5,SLC22A6,,BRD:BRD-K65544384-001-15-8,4-AMINOHIPPURIC-ACID,4-AMINOHIPPURIC-ACID
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65639003-001-09-0,ICARIIN,ICARIIN
REP.PRIMARY,2.5,,CELL DIVISION INDUCER,BRD:BRD-K65667145-001-14-0,KINETIN,KINETIN
REP.PRIMARY,2.5,CHRM1,"ACETYLCHOLINE RECEPTOR AGONIST, BENZODIAZEPINE RECEPTOR AGONIST",BRD:BRD-K65678996-001-05-5,NEFIRACETAM,NEFIRACETAM
REP.PRIMARY,2.5,TYR,NOOTROPIC AGENT,BRD:BRD-K65716359-001-02-1,EXIFONE,EXIFONE
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65781196-001-03-0,AVANAFIL,AVANAFIL
REP.PRIMARY,2.5,GABBR1,GABA RECEPTOR MODULATOR,BRD:BRD-K65786282-001-07-5,CGP-7930,CGP-7930
REP.PRIMARY,2.5,"NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K65814004-003-02-9,DIPHENYLENEIODONIUM,DIPHENYLENEIODONIUM
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K65820248-001-01-8,SDZ-NKT-343,SDZ-NKT-343
REP.PRIMARY,2.5,"PDE4B, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65856711-001-04-4,ROLIPRAM-S(+),"(S)-(+)-ROLIPRAM, ROLIPRAM-S(+)"
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K65877271-001-01-8,HALOBETASOL-PROPIONATE,HALOBETASOL-PROPIONATE
REP.PRIMARY,2.5,,,BRD:BRD-K65890018-236-01-1,SSR128129E,SSR128129E
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K65904673-001-01-4,TANDOSPIRONE,TANDOSPIRONE
REP.PRIMARY,2.5,MDM2,MDM INHIBITOR,BRD:BRD-K65924316-001-03-1,SERDEMETAN,SERDEMETAN
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K65928735-001-04-3,AZD1480,AZD1480
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K65991129-001-02-9,SB-705498,SB-705498
REP.PRIMARY,2.5,,AGE INHIBITOR,BRD:BRD-K65992024-001-01-5,PIRENOXINE,PIRENOXINE
REP.PRIMARY,2.5,APP,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,BRD:BRD-K66030860-001-03-6,SALIDROSIDE,SALIDROSIDE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-K66035042-001-10-1,SORBITOL,SORBITOL
REP.PRIMARY,2.5,TSPO,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K66093087-001-03-1,FGIN-1-43,FGIN-1-43
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K66094457-001-01-5,CPP,CPP
REP.PRIMARY,2.5,,RSV FUSION INHIBITOR,BRD:BRD-K66097663-001-01-8,TMC-353121,TMC-353121
REP.PRIMARY,2.5,"EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K66175015-001-09-0,AFATINIB,AFATINIB
REP.PRIMARY,2.5,,,BRD:BRD-K66241279-001-01-8,CINROMIDE,CINROMIDE
REP.PRIMARY,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K66296774-236-11-3,FLUVASTATIN,FLUVASTATIN
REP.PRIMARY,2.5,,MYORELAXANT,BRD:BRD-K66353228-001-14-6,ZOXAZOLAMINE,ZOXAZOLAMINE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1","OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K66404838-310-01-1,NALBUPHINE,NALBUPHINE
REP.PRIMARY,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K66412701-066-01-6,PAZUFLOXACIN,PAZUFLOXACIN
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K66465025-001-05-1,ACPC,ACPC
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K66480997-003-10-0,ISOGUVACINE,ISOGUVACINE
REP.PRIMARY,2.5,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K66527818-001-02-6,VU0364770,VU0364770
REP.PRIMARY,2.5,"KIT, MET","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAD51 INHIBITOR, RET TYROSINE KINASE INHIBITOR",BRD:BRD-K66538826-001-07-2,AMUVATINIB,AMUVATINIB
REP.PRIMARY,2.5,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K66615216-003-14-8,MOXIFLOXACIN,MOXIFLOXACIN
REP.PRIMARY,2.5,DPP4,,BRD:BRD-K66664625-001-01-2,4-IODO-L-PHENYLALANINE,4-IODO-L-PHENYLALANINE
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4, HTR1A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K66715657-050-01-0,UH-232-(+),UH-232-(+)
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K66766661-001-19-2,ESTRADIOL-VALERATE,ESTRADIOL-VALERATE
REP.PRIMARY,2.5,"ADA, DCK, POLA1, RRM1, RRM2",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K66788707-001-14-3,FLUDARABINE,FLUDARABINE
REP.PRIMARY,2.5,METAP2,CHELATING AGENT,BRD:BRD-K66808046-065-03-7,OXYQUINOLINE,OXYQUINOLINE
REP.PRIMARY,2.5,MGAM,GLUCOSIDASE INHIBITOR,BRD:BRD-K66850609-001-07-4,VOGLIBOSE,VOGLIBOSE
REP.PRIMARY,2.5,"MAOA, MAOB",BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K66876909-001-12-6,LINEZOLID,LINEZOLID
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K66896231-001-08-1,IPIDACRINE,IPIDACRINE
REP.PRIMARY,2.5,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-K66911501-003-01-2,MK-3207,MK-3207
REP.PRIMARY,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K66937583-001-01-2,LODOXAMIDE,LODOXAMIDE
REP.PRIMARY,2.5,"CNR1, GPR119, GPR55, PPARA","CANNABINOID RECEPTOR AGONIST, GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST, POTASSIUM CHANNEL BLOCKER, PPAR RECEPTOR AGONIST",BRD:BRD-K66956375-001-11-3,OLEOYLETHANOLAMIDE,OLEOYLETHANOLAMIDE
REP.PRIMARY,2.5,"PDE3A, PDE3B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K67017579-001-28-1,CILOSTAZOL,CILOSTAZOL
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K67043667-001-26-4,ALTRETAMINE,ALTRETAMINE
REP.PRIMARY,2.5,ACE2,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K67068943-001-01-0,ORE1001,ORE1001
REP.PRIMARY,2.5,"PDE2A, PDE3A, PDE3B, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K67080878-001-15-4,MILRINONE,MILRINONE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K67100011-003-06-3,PIVMECILLINAM,PIVMECILLINAM
REP.PRIMARY,2.5,HDAC1,HDAC INHIBITOR,BRD:BRD-K67102207-236-07-7,PHENYLBUTYRATE,PHENYLBUTYRATE
REP.PRIMARY,2.5,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K67121414-001-03-3,APIXABAN,APIXABAN
REP.PRIMARY,2.5,"EIF4E, EIF4G1",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K67173685-001-06-9,4E1RCAT,4E1RCAT
REP.PRIMARY,2.5,,CHOLINESTERASE INHIBITOR,BRD:BRD-K67217586-001-08-0,FENTHION,FENTHION
REP.PRIMARY,2.5,ALB,RADIOPAQUE MEDIUM,BRD:BRD-K67261995-001-11-7,IODIPAMIDE,IODIPAMIDE
REP.PRIMARY,2.5,TBXA2R,"THROMBOXANE RECEPTOR ANTAGONIST, THROMBOXANE SYNTHASE INHIBITOR",BRD:BRD-K67277431-002-10-5,PICOTAMIDE,PICOTAMIDE
REP.PRIMARY,2.5,"ACVR1C, TGFBR1",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K67298865-001-09-0,SB-431542,SB-431542
REP.PRIMARY,2.5,KCNN4,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K67304264-001-08-5,SKA-31,SKA-31
REP.PRIMARY,2.5,"CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K67511046-001-02-3,NALOXONE,NALOXONE
REP.PRIMARY,2.5,,KAINATE RECEPTOR ANTAGONIST,BRD:BRD-K67525671-001-02-5,ZK-200775,ZK-200775
REP.PRIMARY,2.5,,"DNA SYNTHESIS INHIBITOR, RNA SYNTHESIS INHIBITOR",BRD:BRD-K67536197-003-11-4,CYCLOCYTIDINE,CYCLOCYTIDINE
REP.PRIMARY,2.5,IGF1R,IGF-1 INHIBITOR,BRD:BRD-K67537649-001-04-5,PQ-401,PQ-401
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K67563174-001-17-6,ACEMETACIN,ACEMETACIN
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K67566344-001-07-5,KU-0063794,KU-0063794
REP.PRIMARY,2.5,BRAF,RAF INHIBITOR,BRD:BRD-K67578145-001-09-7,GDC-0879,GDC-0879
REP.PRIMARY,2.5,BRAF,RAF INHIBITOR,BRD:BRD-K67578145-001-12-1,GDC-0879,GDC-0879
REP.PRIMARY,2.5,"HTR1B, HTR1D",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K67601717-037-02-4,ALMOTRIPTAN,ALMOTRIPTAN
REP.PRIMARY,2.5,"HRH1, S100A1, S100A12, S100A13, S100A2, S100B",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K67637637-003-12-6,OLOPATADINE,OLOPATADINE
REP.PRIMARY,2.5,SLC6A1,GAT INHIBITOR,BRD:BRD-K67680372-003-02-6,CI-966,CI-966
REP.PRIMARY,2.5,PTPN1,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K67772619-001-05-1,RHEOCHRYSIDIN,RHEOCHRYSIDIN
REP.PRIMARY,2.5,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K67783091-001-26-1,HALOPERIDOL,HALOPERIDOL
REP.PRIMARY,2.5,"HTR1A, HTR2A","SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K67789209-001-01-0,ADATANSERIN,ADATANSERIN
REP.PRIMARY,2.5,KDR,VEGFR INHIBITOR,BRD:BRD-K67831364-003-03-3,ZM-323881,ZM-323881
REP.PRIMARY,2.5,"NAE1, UBA3",NEDD ACTIVATING ENZYME INHIBITOR,BRD:BRD-K67844266-003-01-9,PEVONEDISTAT,PEVONEDISTAT
REP.PRIMARY,2.5,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K67860401-001-05-6,AR-A014418,AR-A014418
REP.PRIMARY,2.5,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K67868012-001-07-6,PI-103,PI-103
REP.PRIMARY,2.5,CES1,ACAT INHIBITOR,BRD:BRD-K67901620-001-02-0,AVASIMIBE,AVASIMIBE
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K67943528-050-01-4,LISURIDE,LISURIDE
REP.PRIMARY,2.5,"ACE, ACE2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K67966701-001-11-6,LISINOPRIL,LISINOPRIL
REP.PRIMARY,2.5,"ACE, ACE2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K67966701-001-12-4,LISINOPRIL,LISINOPRIL
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K67977190-066-02-3,EPROSARTAN,EPROSARTAN
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K68065987-300-09-1,MK-2206,MK-2206
REP.PRIMARY,2.5,"CNR2, GPR119, GPR55",CANNABINOID RECEPTOR AGONIST,BRD:BRD-K68095457-001-10-1,PALMITOYLETHANOLAMIDE,PALMITOYLETHANOLAMIDE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6","BENZODIAZEPINE RECEPTOR AGONIST, GABA BENZODIAZEPINE SITE RECEPTOR PARTIAL AGONIST",BRD:BRD-K68103045-001-02-9,CGS-20625,CGS-20625
REP.PRIMARY,2.5,SQLE,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K68132782-003-13-8,TERBINAFINE,TERBINAFINE
REP.PRIMARY,2.5,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B","MICROTUBULE STABILIZING AGENT, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K68164687-001-01-6,EPOTHILONE-B,EPOTHILONE-B
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K68174511-001-06-6,TORIN-2,TORIN-2
REP.PRIMARY,2.5,"HSD11B1, PLA2G1B, PTPN1, PYGM","ATPASE INHIBITOR, NFKB PATHWAY INHIBITOR, STAT INHIBITOR",BRD:BRD-K68185022-001-14-8,URSOLIC-ACID,URSOLIC-ACID
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K68188368-001-09-4,NIFUROXAZIDE,NIFUROXAZIDE
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K68202742-001-16-5,TRICHOSTATIN-A,TRICHOSTATIN-A
REP.PRIMARY,2.5,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K68232413-001-01-2,ETIZOLAM,ETIZOLAM
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","COLLAPSIN RESPONSE MEDIATOR PROTEIN INHIBITOR, COLLAPSIN RESPONSE MEDIATOR PROTEIN STIMULANT, SODIUM CHANNEL BLOCKER",BRD:BRD-K68232650-001-02-2,LACOSAMIDE,LACOSAMIDE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K68264559-045-02-4,BRIMONIDINE,BRIMONIDINE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K68264559-045-04-0,BRIMONIDINE,BRIMONIDINE
REP.PRIMARY,2.5,"EGFR, MAPK14",EGFR INHIBITOR,BRD:BRD-K68336408-001-10-9,TYRPHOSTIN-AG-1478,TYRPHOSTIN-AG-1478
REP.PRIMARY,2.5,"KCNH2, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K68346641-001-01-4,AMSACRINE,AMSACRINE
REP.PRIMARY,2.5,"KCNH2, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K68346641-001-02-2,AMSACRINE,AMSACRINE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",BENZODIAZEPINE RECEPTOR ANTAGONIST,BRD:BRD-K68392338-003-02-0,ZK-93426,ZK-93426
REP.PRIMARY,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-K68395654-001-03-1,EVP4593,EVP4593
REP.PRIMARY,2.5,TRPC6,MYOSIN LIGHT CHAIN KINASE INHIBITOR,BRD:BRD-K68402494-003-03-5,ML9,"ML-9, ML9"
REP.PRIMARY,2.5,GRM3,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K68405354-001-06-4,SPAGLUMIC-ACID,SPAGLUMIC-ACID
REP.PRIMARY,2.5,GRM3,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K68405354-001-07-2,SPAGLUMIC-ACID,SPAGLUMIC-ACID
REP.PRIMARY,2.5,F2,TOPICAL ANESTHETIC,BRD:BRD-K68408467-065-01-8,PROFLAVINE-HEMISULFATE,PROFLAVINE-HEMISULFATE
REP.PRIMARY,2.5,,WDR5/MLL INTERACTION INHIBITOR,BRD:BRD-K68474068-001-01-8,MM-102,MM-102
REP.PRIMARY,2.5,"AURKA, FLT3, KDR, PDGFRA, PTK2, SRC","AURORA KINASE INHIBITOR, FLT3 INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K68488863-001-04-9,ENMD-2076,ENMD-2076
REP.PRIMARY,2.5,,DNA ALKYLATING AGENT,BRD:BRD-K68502831-001-01-2,DIANHYDROGALACTITOL,DIANHYDROGALACTITOL
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K68507560-003-24-6,DICYCLOVERINE,DICYCLOVERINE
REP.PRIMARY,2.5,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-K68532323-003-02-8,SB-743921,SB-743921
REP.PRIMARY,2.5,PTGS2,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K68538666-001-12-3,ACECLOFENAC,ACECLOFENAC
REP.PRIMARY,2.03,"KCNT2, TRPV4",PKC ACTIVATOR,BRD:BRD-K68552125-001-05-3,12-O-TETRADECANOYLPHORBOL-13-ACETATE,12-O-TETRADECANOYLPHORBOL-13-ACETATE
REP.PRIMARY,2.5,,ANTIHYPERTENSIVE AGENT,BRD:BRD-K68553471-003-12-3,TODRALAZINE,TODRALAZINE
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K68558722-001-04-0,DERACOXIB,DERACOXIB
REP.PRIMARY,2.5,"PTPN1, PTPN11, PTPN2",TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-K68567222-001-01-2,BVT-948,BVT-948
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K68620903-001-11-4,DYDROGESTERONE,DYDROGESTERONE
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K68633617-003-02-9,ACDPP,ACDPP
REP.PRIMARY,2.5,,,BRD:BRD-K68653965-001-01-1,PICOLAMINE,PICOLAMINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K68693535-001-03-4,LIDAMIDINE,LIDAMIDINE
REP.PRIMARY,2.5,"AURKA, AURKB",AURORA KINASE INHIBITOR,BRD:BRD-K68747584-001-02-0,PF-03814735,PF-03814735
REP.PRIMARY,2.5,"MAPK1, MAPK3",MAP KINASE INHIBITOR,BRD:BRD-K68756823-001-07-1,FR-180204,FR-180204
REP.PRIMARY,2.5,"SLC12A1, SLC12A2",ELECTROLYTE REABSORPTION INHIBITOR,BRD:BRD-K68770713-001-01-8,AZOSEMIDE,AZOSEMIDE
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K68805147-001-01-8,PAFURAMIDINE,PAFURAMIDINE
REP.PRIMARY,2.5,"ADIPOR1, ADIPOR2",ADIPONECTIN RECEPTOR AGONIST,BRD:BRD-K68810443-001-01-9,ADIPORON,ADIPORON
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K68867920-051-11-5,QUETIAPINE,QUETIAPINE
REP.PRIMARY,2.5,"ABL1, PDGFRB",BCR-ABL KINASE INHIBITOR,BRD:BRD-K68870568-066-01-5,FLUMATINIB,FLUMATINIB
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K68904758-001-03-5,CEPHALOMANNINE,CEPHALOMANNINE
REP.PRIMARY,2.5,"BIRC2, BIRC3, BIRC7, XIAP",XIAP INHIBITOR,BRD:BRD-K68938568-001-01-7,GDC-0152,GDC-0152
REP.PRIMARY,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K68997413-001-05-1,PF-3845,PF-3845
REP.PRIMARY,2.5,"KDR, MET",VEGFR INHIBITOR,BRD:BRD-K69001009-001-02-8,GOLVATINIB,GOLVATINIB
REP.PRIMARY,2.5,,ATPASE INHIBITOR,BRD:BRD-K69035426-001-01-3,OMEPRAZOLE-SULFIDE,OMEPRAZOLE-SULFIDE
REP.PRIMARY,2.5,DOT1L,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K69070623-003-01-7,EPZ004777,EPZ004777
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K69116396-001-04-1,SERTINDOLE,SERTINDOLE
REP.PRIMARY,2.5,IL1B,INTERLEUKIN INHIBITOR,BRD:BRD-K69122748-001-10-1,DIACEREIN,DIACEREIN
REP.PRIMARY,2.5,XIAP,"DNA ALKYLATING AGENT, DNA SYNTHESIS INHIBITOR",BRD:BRD-K69172251-001-08-9,CISPLATIN,CISPLATIN
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K69195780-004-08-4,NAN-190,NAN-190
REP.PRIMARY,2.5,,,BRD:BRD-K69216798-001-01-9,IODOANTIPYRINE,IODOANTIPYRINE
REP.PRIMARY,2.5,,,BRD:BRD-K69231085-003-05-7,TRIGONELLINE,TRIGONELLINE
REP.PRIMARY,2.5,CFTR,CFTR CHANNEL AGONIST,BRD:BRD-K69236721-001-02-7,LUMACAFTOR,LUMACAFTOR
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K69247067-001-01-8,AFLOQUALONE,AFLOQUALONE
REP.PRIMARY,2.5,"AKR1C1, ESR1, ESR2",SYNTHETIC ESTROGEN,BRD:BRD-K69253806-001-02-0,HEXESTROL,HEXESTROL
REP.PRIMARY,2.5,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K69280563-001-01-8,VINORELBINE,VINORELBINE
REP.PRIMARY,2.5,"ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12",ANTIOXIDANT,BRD:BRD-K69346723-001-04-8,GLUTATHIONE,GLUTATHIONE
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K69469734-003-02-5,TROSPIUM,TROSPIUM
REP.PRIMARY,2.5,"ALOX5, CYSLTR1",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K69470111-236-08-9,MONTELUKAST,MONTELUKAST
REP.PRIMARY,2.5,,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K69577666-001-01-3,SGC-0946,SGC-0946
REP.PRIMARY,2.5,"DRD1, DRD2, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K69600043-328-05-5,THIETHYLPERAZINE,THIETHYLPERAZINE
REP.PRIMARY,2.5,FKBP1A,CALCINEURIN INHIBITOR,BRD:BRD-K69608737-001-10-2,TACROLIMUS,TACROLIMUS
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K69650333-003-13-2,IDARUBICIN,IDARUBICIN
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K69650333-003-14-0,IDARUBICIN,IDARUBICIN
REP.PRIMARY,2.5,"ACHE, BCHE",CHOLINESTERASE INHIBITOR,BRD:BRD-K69688083-004-23-1,MESTINON,MESTINON
REP.PRIMARY,2.5,"PPARG, STAT3","LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K69694239-001-02-2,BARDOXOLONE-METHYL,BARDOXOLONE-METHYL
REP.PRIMARY,2.5,"AHR, DPP4, HMGCR",HMGCR INHIBITOR,BRD:BRD-K69726342-238-02-4,ATORVASTATIN,ATORVASTATIN
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K69726595-001-01-2,MERICITABINE,MERICITABINE
REP.PRIMARY,2.5,PLK1,PLK INHIBITOR,BRD:BRD-K69776681-001-03-8,VOLASERTIB,VOLASERTIB
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K69812556-305-02-0,WAY-100635,WAY-100635
REP.PRIMARY,2.5,OPRL1,"NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K69837166-003-02-0,TRAP-101,TRAP-101
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K69907333-001-10-6,FLURBIPROFEN-(S)-(+),FLURBIPROFEN-(S)-(+)
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K69932463-001-10-6,AZD8055,AZD8055
REP.PRIMARY,2.5,,,BRD:BRD-K70053378-001-01-1,SM-108,SM-108
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K70088346-001-01-6,2-CHLORO-N6-CYCLOPENTYLADENOSINE,2-CHLORO-N6-CYCLOPENTYLADENOSINE
REP.PRIMARY,2.5,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K70159787-001-01-1,SMI-4A,SMI-4A
REP.PRIMARY,2.5,"EGFR, FLT1, FLT4, KDR, PDGFRB","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K70163715-300-05-7,VATALANIB,VATALANIB
REP.PRIMARY,2.5,NDC80,HEC1 INHIBITOR,BRD:BRD-K70177501-003-01-4,INH1,INH1
REP.PRIMARY,2.5,"BLVRB, RFK",VITAMIN B2,BRD:BRD-K70246307-001-04-1,RIBOFLAVIN,RIBOFLAVIN
REP.PRIMARY,2.5,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K70281171-050-08-9,U-99194,U-99194
REP.PRIMARY,2.5,"BLK, BMX, BTK",BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K70301465-001-02-6,IBRUTINIB,IBRUTINIB
REP.PRIMARY,2.5,"ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K70301876-034-13-7,ESCITALOPRAM,ESCITALOPRAM
REP.PRIMARY,2.5,"F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5",DNA SYNTHESIS INHIBITOR,BRD:BRD-K70327167-348-13-4,SURAMIN,SURAMIN
REP.PRIMARY,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K70327191-001-02-2,BENZOXIQUINE,BENZOXIQUINE
REP.PRIMARY,2.5,"DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K70330367-003-07-9,AMANTADINE,AMANTADINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7","SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K70358946-001-15-7,ARIPIPRAZOLE,ARIPIPRAZOLE
REP.PRIMARY,2.5,"EGFR, NR1I2",EGFR INHIBITOR,BRD:BRD-K70401845-003-09-6,ERLOTINIB,ERLOTINIB
REP.PRIMARY,2.5,"HDAC1, HDAC6",HDAC INHIBITOR,BRD:BRD-K70402238-001-02-8,NEXTURASTAT-A,NEXTURASTAT-A
REP.PRIMARY,2.5,HIF1A,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K70463136-001-01-5,BAY-87-2243,BAY-87-2243
REP.PRIMARY,2.5,"ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K70487031-001-02-8,FLUPENTIXOL,FLUPENTIXOL
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K70490179-300-01-2,RIMCAZOLE,RIMCAZOLE
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K70505054-003-12-4,RANITIDINE,RANITIDINE
REP.PRIMARY,2.5,"ADORA1, PDE4A, PDE4B, PDE4C, PDE4D",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K70507123-001-09-7,DOXOFYLLINE,DOXOFYLLINE
REP.PRIMARY,2.5,PLK1,PLK INHIBITOR,BRD:BRD-K70511574-001-06-9,HMN-214,HMN-214
REP.PRIMARY,2.5,"ABCB1, ABCB4",P GLYCOPROTEIN INHIBITOR,BRD:BRD-K70557564-305-03-6,ZOSUQUIDAR,ZOSUQUIDAR
REP.PRIMARY,2.5,"KCNN1, KCNN2, KCNN3, KCNN4",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K70586315-001-02-4,1-EBIO,1-EBIO
REP.PRIMARY,2.5,,"DNA METHYLASE INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",BRD:BRD-K70592483-001-01-0,PHENYLACETYLGLUTAMINE,PHENYLACETYLGLUTAMINE
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K70610771-001-02-9,VX-222,VX-222
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K70778732-003-26-7,TRAZODONE,TRAZODONE
REP.PRIMARY,2.5,PIM1,AKT INHIBITOR,BRD:BRD-K70792160-003-04-6,10-DEBC,10-DEBC
REP.PRIMARY,2.5,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K70821460-300-02-4,4-METHYLHISTAMINE,4-METHYLHISTAMINE
REP.PRIMARY,2.5,"OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K70898774-001-03-5,NALOXONE-BENZOYLHYDRAZONE,NALOXONE-BENZOYLHYDRAZONE
REP.PRIMARY,2.5,"SCN4A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K70912147-001-01-8,CO-102862,CO-102862
REP.PRIMARY,2.5,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K70914287-300-02-8,BIBX-1382,BIBX-1382
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K70924353-001-01-2,AMTOLMETIN-GUACIL,AMTOLMETIN-GUACIL
REP.PRIMARY,2.5,"FGFR3, KIT, PDGFRA, PDGFRB","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR",BRD:BRD-K71035033-001-07-1,MASITINIB,MASITINIB
REP.PRIMARY,2.5,,"HAEMOSTATIC AGENT, HEMOSTATIC AGENT",BRD:BRD-K71055333-224-05-8,ETAMSYLATE,ETAMSYLATE
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K71058253-001-01-9,LULICONAZOLE,LULICONAZOLE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K71059170-001-11-6,CEFIXIME,CEFIXIME
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K71075609-003-01-0,DORZOLAMIDE,DORZOLAMIDE
REP.PRIMARY,2.5,"HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4","NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINâNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",BRD:BRD-K71103788-003-12-0,DULOXETINE,DULOXETINE
REP.PRIMARY,2.5,"DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K71106091-001-06-1,FLUDARABINE-PHOSPHATE,FLUDARABINE-PHOSPHATE
REP.PRIMARY,2.5,,DIHYDROPTEROATE SYNTHETASE INHIBITOR,BRD:BRD-K71125014-001-27-1,SULPHADIMETHOXINE,SULPHADIMETHOXINE
REP.PRIMARY,2.5,"ACACA, ACACB",ACAT INHIBITOR,BRD:BRD-K71164191-001-01-0,KD-023,KD-023
REP.PRIMARY,2.5,"BIRC2, XIAP",XIAP INHIBITOR,BRD:BRD-K71221037-001-01-6,BIRINAPANT,BIRINAPANT
REP.PRIMARY,2.5,ENTPD3,NTPDASE INHIBITOR,BRD:BRD-K71266197-236-02-7,PSB-06126,PSB-06126
REP.PRIMARY,2.5,,HSP INHIBITOR,BRD:BRD-K71281111-001-04-3,SNX-2112,SNX-2112
REP.PRIMARY,2.5,"CYSLTR1, CYSLTR2",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K71289571-001-11-4,ZAFIRLUKAST,ZAFIRLUKAST
REP.PRIMARY,2.5,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K71350836-001-02-4,BUTALBITAL,BUTALBITAL
REP.PRIMARY,2.5,"HRH1, HRH2, HRH3, HRH4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K71430621-303-02-3,CLOBENPROPIT,CLOBENPROPIT
REP.PRIMARY,2.5,XPO1,EXPORTIN ANTAGONIST,BRD:BRD-K71467466-001-02-3,KPT-185,KPT-185
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3, PRKG1",AKT INHIBITOR,BRD:BRD-K71480163-001-01-4,GDC-0068,GDC-0068
REP.PRIMARY,2.5,"CA1, CA12, CA2, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K71499074-001-12-9,DICLOFENAMIDE,DICLOFENAMIDE
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K71512533-066-02-8,SNS-314,SNS-314
REP.PRIMARY,2.5,"FFAR1, FFAR4","FREE FATTY ACID RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST",BRD:BRD-K71534238-001-10-0,GW-9508,GW-9508
REP.PRIMARY,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K71603915-003-01-8,EVP-6124,EVP-6124
REP.PRIMARY,2.5,,,BRD:BRD-K71698503-003-01-6,I-BZA2,I-BZA2
REP.PRIMARY,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K71731651-001-04-3,PNU-120596,PNU-120596
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",CARBOXAMIDE ANTIEPILEPTIC,BRD:BRD-K71799949-001-36-4,CARBAMAZEPINE,CARBAMAZEPINE
REP.PRIMARY,2.5,"GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K71822263-001-03-2,D-SERINE,D-SERINE
REP.PRIMARY,2.5,,MICROTUBULE STABILIZING AGENT,BRD:BRD-K71823332-001-03-7,EPOTHILONE-A,EPOTHILONE-A
REP.PRIMARY,2.5,"POLA1, POLB, POLD1, POLE",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K71847383-001-12-5,CYTIDINE,"CYTARABINE, CYTIDINE"
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K71926323-001-13-8,MARBOFLOXACIN,MARBOFLOXACIN
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K71926323-001-14-6,MARBOFLOXACIN,MARBOFLOXACIN
REP.PRIMARY,2.5,CFTR,CHLORIDE CHANNEL BLOCKER,BRD:BRD-K72004355-001-01-9,CFTRINH-172,CFTRINH-172
REP.PRIMARY,2.5,CYP17A1,CYTOCHROME P450 INHIBITOR,BRD:BRD-K72005722-001-01-2,VT-464,VT-464
REP.PRIMARY,2.5,"ABCA1, ABCB11, CES1",ATHEROGENESIS INHIBITOR,BRD:BRD-K72029282-001-22-0,PROBUCOL,PROBUCOL
REP.PRIMARY,2.5,ADA,ANTIVIRAL,BRD:BRD-K72093121-001-16-3,VIDARABINE,VIDARABINE
REP.PRIMARY,2.5,,,BRD:BRD-K72093555-001-01-0,PROCYANIDIN-B-2,PROCYANIDIN-B-2
REP.PRIMARY,2.5,"GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2",KAINATE RECEPTOR ANTAGONIST,BRD:BRD-K72106461-001-02-1,SYM-2081,SYM-2081
REP.PRIMARY,2.5,"ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K72166146-066-05-4,DIHYDROERGOTAMINE,DIHYDROERGOTAMINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72167406-001-02-1,CEFDITOREN-PIVOXIL,CEFDITOREN-PIVOXIL
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72167406-001-03-9,CEFDITOREN-PIVOXIL,CEFDITOREN-PIVOXIL
REP.PRIMARY,2.5,GAST,5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K72215350-001-06-5,ACEXAMIC-ACID,ACEXAMIC-ACID
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K72222507-003-16-8,QUINAPRIL,QUINAPRIL
REP.PRIMARY,2.5,,,BRD:BRD-K72231366-001-02-3,TAME,TAME
REP.PRIMARY,2.5,"ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH",LIPOXYGENASE INHIBITOR,BRD:BRD-K72327355-001-14-7,BAICALEIN,BAICALEIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72339976-065-02-1,CEFOSELIS,CEFOSELIS
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72339976-065-03-9,CEFOSELIS,CEFOSELIS
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72339976-065-04-7,CEFOSELIS,CEFOSELIS
REP.PRIMARY,2.5,"AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K72369578-001-04-1,AZD4282,AZD4282
REP.PRIMARY,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K72384124-001-08-0,SULBENTINE,SULBENTINE
REP.PRIMARY,2.5,KCNH2,CDK INHIBITOR,BRD:BRD-K72414522-001-06-7,AZD5438,AZD5438
REP.PRIMARY,2.5,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K72420232-001-12-3,WZ-4002,WZ-4002
REP.PRIMARY,2.5,PRKCA,PROTEIN KINASE INHIBITOR,BRD:BRD-K72462751-001-02-7,C-1,C-1
REP.PRIMARY,2.5,"SLC25A4, SLC25A5, SLC25A6",BONE RESORPTION INHIBITOR,BRD:BRD-K72542090-304-02-4,CLODRONIC-ACID,CLODRONIC-ACID
REP.PRIMARY,2.5,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K72687424-001-02-6,VU0364439,VU0364439
REP.PRIMARY,2.5,"AURKA, AURKB",AURORA KINASE INHIBITOR,BRD:BRD-K72703948-001-10-1,ZM-447439,ZM-447439
REP.PRIMARY,2.5,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K72723676-003-17-8,BENZETHONIUM,BENZETHONIUM
REP.PRIMARY,2.5,"CCND1, CDK4",CDK INHIBITOR,BRD:BRD-K72726508-001-02-1,ARCYRIAFLAVIN-A,ARCYRIAFLAVIN-A
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K72728560-001-01-4,DIMETRIDAZOLE,DIMETRIDAZOLE
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K72815923-034-01-2,XANOMELINE,XANOMELINE
REP.PRIMARY,2.5,ALK,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K72827473-001-01-0,CEP-37440,CEP-37440
REP.PRIMARY,2.5,OPRL1,OPIOID RECEPTOR AGONIST,BRD:BRD-K72904818-001-01-1,NNC-63-0532,NNC-63-0532
REP.PRIMARY,2.5,"CTSA, PGR",HCV INHIBITOR,BRD:BRD-K72912098-001-02-3,TELAPREVIR,TELAPREVIR
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K72915123-001-18-1,CINCHOPHEN,CINCHOPHEN
REP.PRIMARY,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K72925150-001-11-1,SCLAREOLIDE,SCLAREOLIDE
REP.PRIMARY,2.5,TOP2A,"DNA INHIBITOR, TOPOISOMERASE INHIBITOR",BRD:BRD-K72951360-001-01-4,VALRUBICIN,VALRUBICIN
REP.PRIMARY,2.5,,,BRD:BRD-K73073971-001-01-7,ZLN005,ZLN005
REP.PRIMARY,2.5,"ALPL, ALPPL2, CHRNA3",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K73107279-003-12-5,LEVAMISOLE,LEVAMISOLE
REP.PRIMARY,2.5,"ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K73109821-001-20-1,DIAZOXIDE,DIAZOXIDE
REP.PRIMARY,2.5,,,BRD:BRD-K73157543-001-04-1,PHENYL-AMINOSALICYLATE,PHENYL-AMINOSALICYLATE
REP.PRIMARY,2.5,,,BRD:BRD-K73191876-001-11-2,ALIZARIN,ALIZARIN
REP.PRIMARY,2.5,HTR1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K73196317-003-14-8,URAPIDIL,URAPIDIL
REP.PRIMARY,2.5,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K73197500-001-02-2,SNX-5422,SNX-5422
REP.PRIMARY,2.5,FAH,,BRD:BRD-K73234506-235-02-1,LITHIUM-ACETOACETATE,LITHIUM-ACETOACETATE
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K73237276-001-01-0,TACALCITOL,TACALCITOL
REP.PRIMARY,2.5,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K73251053-003-22-2,CLORGILINE,CLORGILINE
REP.PRIMARY,2.5,"CYP2D6, OPRD1, OPRK1, OPRM1, UTS2R",OPIOID RECEPTOR AGONIST,BRD:BRD-K73290745-003-02-6,ICI-199441,ICI-199441
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K73293050-001-03-1,WZ-3146,WZ-3146
REP.PRIMARY,2.5,"CYP19A1, ESRRA, ESRRB, ESRRG, FASN",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K73303757-001-21-6,4-METHYLGENISTEIN,4-METHYLGENISTEIN
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K73309154-003-02-8,OSI-420,OSI-420
REP.PRIMARY,2.5,MET,C-MET INHIBITOR,BRD:BRD-K73319509-001-08-0,PF-04217903,PF-04217903
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K73323637-003-10-9,LEVOBUNOLOL-(+),LEVOBUNOLOL-(+)
REP.PRIMARY,2.5,"MAP2K5, MAPK7",MEK INHIBITOR,BRD:BRD-K73368362-001-07-5,BIX-02189,BIX-02189
REP.PRIMARY,2.5,,,BRD:BRD-K73381198-001-01-1,5-FLUORO-3-PYRIDYL-METHANOL,5-FLUORO-3-PYRIDYL-METHANOL
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K73381542-003-23-4,PHENYLEPHRINE,PHENYLEPHRINE
REP.PRIMARY,2.5,EP300,HISTONE ACETYLTRANSFERASE INHIBITOR,BRD:BRD-K73383190-001-02-3,C646,C646
REP.PRIMARY,2.5,EP300,HISTONE ACETYLTRANSFERASE INHIBITOR,BRD:BRD-K73383190-001-03-1,C646,C646
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K73391359-003-10-2,DIMETHISOQUIN,DIMETHISOQUIN
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K73394555-237-01-1,OXOLINIC-ACID,OXOLINIC-ACID
REP.PRIMARY,2.5,SMO,SMOOTHENED RECEPTOR AGONIST,BRD:BRD-K73397362-001-06-6,PURMORPHAMINE,PURMORPHAMINE
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K73425385-065-04-8,BEKANAMYCIN,BEKANAMYCIN
REP.PRIMARY,2.5,"GUCY1A3, GUCY1B3",GUANYLATE CYCLASE ACTIVATOR,BRD:BRD-K73440166-001-01-3,CINACIGUAT,CINACIGUAT
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K73469236-001-01-8,NEDAPLATIN,NEDAPLATIN
REP.PRIMARY,2.5,TRPA1,,BRD:BRD-K73477617-001-08-5,DIBUTYL-PHTHALATE,DIBUTYL-PHTHALATE
REP.PRIMARY,2.5,,ANTIAMYLOIDOGENIC AGENT,BRD:BRD-K73524797-001-01-1,ST-1859,ST-1859
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K73529671-001-02-9,TROXERUTIN,TROXERUTIN
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K73529671-001-04-5,TROXERUTIN,TROXERUTIN
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K73541271-001-03-6,ETOFENAMATE,ETOFENAMATE
REP.PRIMARY,2.5,"HSD11B1, NCOA1, NR3C2",MINERALOCORTICOID RECEPTOR AGONIST,BRD:BRD-K73589401-001-23-6,CORTICOSTERONE,CORTICOSTERONE
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K73589491-001-11-2,NIZATIDINE,NIZATIDINE
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K73642618-001-13-3,BROMOPRIDE,BROMOPRIDE
REP.PRIMARY,2.5,,MELATONIN RECEPTOR AGONIST,BRD:BRD-K73700643-001-11-2,N-ACETYLTRYPTAMINE,N-ACETYLTRYPTAMINE
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K73771095-001-02-5,GENIPOSIDIC-ACID,GENIPOSIDIC-ACID
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K73771095-001-03-3,GENIPOSIDIC-ACID,GENIPOSIDIC-ACID
REP.PRIMARY,2.5,"BRAF, LCK, MAPK14, RAF1",RAF INHIBITOR,BRD:BRD-K73789395-001-10-7,ZM-336372,ZM-336372
REP.PRIMARY,2.5,TRPA1,TRPA1 CHANNEL BLOCKER,BRD:BRD-K73815512-001-02-5,HC-030031,HC-030031
REP.PRIMARY,2.5,CASR,CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K73838513-003-05-5,CINACALCET,CINACALCET
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K73923631-003-02-9,DIFLOXACIN,DIFLOXACIN
REP.PRIMARY,2.5,MAPK8,JNK INHIBITOR,BRD:BRD-K73982490-001-02-9,BI-78D3,BI-78D3
REP.PRIMARY,2.5,"AGTR1, PPARG",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K73999723-001-11-3,TELMISARTAN,TELMISARTAN
REP.PRIMARY,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K74057757-001-01-9,INDIBULIN,INDIBULIN
REP.PRIMARY,2.5,"MAPK11, MAPK12, MAPK13, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K74065929-001-07-2,DORAMAPIMOD,DORAMAPIMOD
REP.PRIMARY,2.5,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7",HIV PROTEASE INHIBITOR,BRD:BRD-K74117820-066-10-8,NELFINAVIR,NELFINAVIR
REP.PRIMARY,2.5,SQLE,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K74141488-003-11-2,NAFTIFINE,NAFTIFINE
REP.PRIMARY,2.5,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K74186897-001-12-4,CYTISINE,CYTISINE
REP.PRIMARY,2.5,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K74186897-001-13-2,CYTISINE,CYTISINE
REP.PRIMARY,2.5,"CA12, CA14, CA2, PTGS1",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K74190368-001-04-3,RESORCINOL,RESORCINOL
REP.PRIMARY,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K74193284-001-04-8,PHENYLMERCURIC-ACETATE,PHENYLMERCURIC-ACETATE
REP.PRIMARY,2.5,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K74195153-050-12-1,IRSOGLADINE,IRSOGLADINE
REP.PRIMARY,2.5,,,BRD:BRD-K74227499-001-01-1,SE-METHYLSELENOCYSTEINE,SE-METHYLSELENOCYSTEINE
REP.PRIMARY,2.5,,MEDIATOR RELEASE INHIBITOR,BRD:BRD-K74236708-001-01-9,ACITAZANOLAST,ACITAZANOLAST
REP.PRIMARY,2.5,IKBKB,"IKK INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-K74305673-001-06-2,IKK-2-INHIBITOR-V,IKK-2-INHIBITOR-V
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K74339692-001-01-9,TAMSULOSIN,TAMSULOSIN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K74363950-004-01-0,ACLIDINIUM,ACLIDINIUM
REP.PRIMARY,2.5,,NEUROTROPHIC AGENT,BRD:BRD-K74371986-001-01-7,NSI-189,NSI-189
REP.PRIMARY,2.5,MLNR,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K74501079-001-18-1,AZITHROMYCIN,AZITHROMYCIN
REP.PRIMARY,2.5,"CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K74514084-001-03-9,PAZOPANIB,PAZOPANIB
REP.PRIMARY,2.5,"ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K74603273-003-01-1,"ICI-118,551","ICI-118,551"
REP.PRIMARY,2.5,,,BRD:BRD-K74664543-213-01-2,SELENOMETHIONINE,SELENOMETHIONINE
REP.PRIMARY,2.5,"CYP2C19, CYP2C9, CYP3A4",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K74717603-001-02-2,ETRAVIRINE,ETRAVIRINE
REP.PRIMARY,2.5,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K74763371-002-04-0,BOSENTAN,BOSENTAN
REP.PRIMARY,0.25,CYSLTR1,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K74765201-001-16-7,TOMELUKAST,TOMELUKAST
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K74913225-001-12-4,BRINZOLAMIDE,BRINZOLAMIDE
REP.PRIMARY,2.5,OPRD1,OPIOID RECEPTOR AGONIST,BRD:BRD-K74990253-001-02-8,BW-373U86,BW-373U86
REP.PRIMARY,2.5,"CDK2, CHEK1",CHK INHIBITOR,BRD:BRD-K75009076-001-02-1,SCH-900776,SCH-900776
REP.PRIMARY,2.5,SLC22A12,URIC ACID DIURETIC,BRD:BRD-K75024268-001-01-0,LESINURAD,LESINURAD
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K75037734-003-13-9,CARBACHOL,CARBACHOL
REP.PRIMARY,2.5,,,BRD:BRD-K75080769-001-01-6,"TRANS-4-[8-(3-FLUOROPHENYL)-1,7-NAPHTHYRIDIN-6-YL]CYCLOHEXANECARBOXYLIC-ACID","TRANS-4-[8-(3-FLUOROPHENYL)-1,7-NAPHTHYRIDIN-6-YL]CYCLOHEXANECARBOXYLIC-ACID"
REP.PRIMARY,2.5,"DNMT1, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K75089421-003-24-5,PROCAINAMIDE,PROCAINAMIDE
REP.PRIMARY,2.5,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K75250001-001-01-3,TIRACIZINE,TIRACIZINE
REP.PRIMARY,2.5,,HYPERCALCAEMIC AGENT,BRD:BRD-K75282704-001-02-4,BL-5583,BL-5583
REP.PRIMARY,2.5,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K75295174-001-05-0,ALISERTIB,ALISERTIB
REP.PRIMARY,2.5,"MTOR, PIK3CG",PI3K INHIBITOR,BRD:BRD-K75308783-001-07-0,SAR-245409,SAR-245409
REP.PRIMARY,2.5,XPO1,EXPORTIN ANTAGONIST,BRD:BRD-K75352575-001-01-3,KPT-276,KPT-276
REP.PRIMARY,2.5,,,BRD:BRD-K75360161-001-18-0,PROTIONAMIDE,PROTIONAMIDE
REP.PRIMARY,2.5,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K75466013-001-14-4,BENZOCAINE,BENZOCAINE
REP.PRIMARY,2.5,GABBR1,GABA RECEPTOR MODULATOR,BRD:BRD-K75478907-001-02-3,GS-39783,GS-39783
REP.PRIMARY,2.5,CASR,CALCIUM RECEPTOR ANTAGONIST,BRD:BRD-K75506300-001-01-6,NPS-2143,NPS-2143
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K75516118-001-03-3,ROLIPRAM-R(-),"(R)-(-)-ROLIPRAM, ROLIPRAM-R(-)"
REP.PRIMARY,2.5,"ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS",BONE RESORPTION INHIBITOR,BRD:BRD-K75527158-360-04-9,ALENDRONATE,ALENDRONATE
REP.PRIMARY,2.5,,,BRD:BRD-K75608666-001-08-3,HYDROXYTOLUIC-ACID,HYDROXYTOLUIC-ACID
REP.PRIMARY,2.5,"ADRA2A, DRD2, HTR3A","ADRENERGIC RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",BRD:BRD-K75615183-300-03-9,TALIPEXOLE,TALIPEXOLE
REP.PRIMARY,2.5,"CHRM1, DRD2, HTR3A, HTR3B, HTR4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K75641298-003-25-0,METOCLOPRAMIDE,METOCLOPRAMIDE
REP.PRIMARY,2.5,,PURINE ANTAGONIST,BRD:BRD-K75649340-001-13-1,TIOGUANINE,TIOGUANINE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K75699339-057-08-1,RIZATRIPTAN,RIZATRIPTAN
REP.PRIMARY,2.5,"HTR1A, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K75844781-003-08-0,MCPP,MCPP
REP.PRIMARY,2.5,,ANTISEPTIC,BRD:BRD-K75855670-001-14-2,IODOQUINOL,IODOQUINOL
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-K75868704-001-05-3,IOPAMIDOL,IOPAMIDOL
REP.PRIMARY,2.5,KDR,"PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K75911534-001-01-6,SU014813,SU014813
REP.PRIMARY,2.5,,,BRD:BRD-K75923785-003-02-1,SCOPINE,SCOPINE
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K75956464-237-01-5,VCH-916,VCH-916
REP.PRIMARY,2.5,"HTR1A, HTR2A, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K75958195-037-09-4,PIZOTIFEN,PIZOTIFEN
REP.PRIMARY,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K75958547-238-01-0,PITAVASTATIN,PITAVASTATIN
REP.PRIMARY,2.5,"CES1, NEU1, NEU2",NEURAMINIDASE INHIBITOR,BRD:BRD-K76011241-001-01-8,OSELTAMIVIR-PHOSPHATE,OSELTAMIVIR-PHOSPHATE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C, CALY, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K76022557-003-02-7,R(-)-APOMORPHINE,"(R)-(-)-APOMORPHINE, R(-)-APOMORPHINE"
REP.PRIMARY,2.5,"ALDH2, DLG4, GAMT, RNASE1",HSP INHIBITOR,BRD:BRD-K76037122-001-02-5,GUANIDINE,GUANIDINE
REP.PRIMARY,2.5,FLT3,FLT3 INHIBITOR,BRD:BRD-K76064317-001-07-3,TYRPHOSTIN-AG-1296,TYRPHOSTIN-AG-1296
REP.PRIMARY,2.5,KDM4E,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K76180386-001-01-6,JIB04,JIB04
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K76205745-237-16-5,LOSARTAN,LOSARTAN
REP.PRIMARY,2.5,"TLR7, TLR8",TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K76210423-001-01-6,RESIQUIMOD,RESIQUIMOD
REP.PRIMARY,2.5,"EGFR, ERBB2, FLT3, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K76239644-001-01-8,BMS-690514,BMS-690514
REP.PRIMARY,2.5,SCN1A,LOCAL ANESTHETIC,BRD:BRD-K76304753-003-20-3,PHENAZOPYRIDINE,PHENAZOPYRIDINE
REP.PRIMARY,2.5,SCN1A,LOCAL ANESTHETIC,BRD:BRD-K76304753-003-21-1,PHENAZOPYRIDINE,PHENAZOPYRIDINE
REP.PRIMARY,2.5,,,BRD:BRD-K76381435-001-08-6,NITROMIDE,NITROMIDE
REP.PRIMARY,2.5,"PKIA, PRKACA",AKT INHIBITOR,BRD:BRD-K76406695-001-02-9,CCT128930,CCT128930
REP.PRIMARY,2.5,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K76452401-001-03-6,PIPERONYL-BUTOXIDE,PIPERONYL-BUTOXIDE
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K76534306-001-22-7,ENROFLOXACIN,ENROFLOXACIN
REP.PRIMARY,2.5,ESR2,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K76568384-001-02-2,PHTPP,PHTPP
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K76592088-001-02-1,3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(R),3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(R)
REP.PRIMARY,2.5,,,BRD:BRD-K76600340-045-04-9,NICOTINYL-ALCOHOL-TARTRATE,NICOTINYL-ALCOHOL-TARTRATE
REP.PRIMARY,2.5,,ANXIOLYTIC,BRD:BRD-K76606751-001-01-7,MEBICAR,MEBICAR
REP.PRIMARY,2.5,CHRFAM7A,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K76609936-001-08-4,IMIDACLOPRID,IMIDACLOPRID
REP.PRIMARY,2.5,"PKIA, PRKACA, ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K76617868-003-11-9,FASUDIL,FASUDIL
REP.PRIMARY,2.5,,"DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K76634210-001-14-7,IDOXURIDINE,IDOXURIDINE
REP.PRIMARY,2.5,RPL3,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K76674262-001-03-3,HOMOHARRINGTONINE,HOMOHARRINGTONINE
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K76677554-003-02-1,AJ76-(+),AJ76-(+)
REP.PRIMARY,2.5,BIRC5,SURVIVIN INHIBITOR,BRD:BRD-K76703230-004-03-3,YM-155,YM-155
REP.PRIMARY,2.5,BIRC5,SURVIVIN INHIBITOR,BRD:BRD-K76703230-004-04-1,YM-155,YM-155
REP.PRIMARY,2.5,"LTF, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K76775527-001-30-2,NIMESULIDE,NIMESULIDE
REP.PRIMARY,2.5,"GSK3A, GSK3B, RPS6KB1",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K76805682-001-15-9,SB-415286,SB-415286
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76810206-001-07-3,NICERGOLINE,NICERGOLINE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76810206-001-08-1,NICERGOLINE,NICERGOLINE
REP.PRIMARY,2.5,"ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4",NITRIC OXIDE PRECURSOR,BRD:BRD-K76811153-003-01-3,L-ARGININE,L-ARGININE
REP.PRIMARY,2.5,PTGS1,"CYCLOOXYGENASE INHIBITOR, OPIOID RECEPTOR AGONIST",BRD:BRD-K76812510-236-14-8,METAMIZOLE,METAMIZOLE
REP.PRIMARY,2.5,"ADRA1A, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76840893-003-02-5,RS-17053,RS-17053
REP.PRIMARY,2.5,"RARA, RARB, RARG, RXRB",RETINOID RECEPTOR AGONIST,BRD:BRD-K76841105-001-04-7,TAZAROTENE,TAZAROTENE
REP.PRIMARY,2.5,,,BRD:BRD-K76845197-001-05-4,SULFANITRAN,SULFANITRAN
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K76890464-001-02-3,TRIAZOLAM,TRIAZOLAM
REP.PRIMARY,2.5,ERBB2,"EGFR INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",BRD:BRD-K76908866-001-07-6,CP-724714,CP-724714
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76953762-001-08-5,INDORAMIN,INDORAMIN
REP.PRIMARY,2.01,IDO1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K76973696-001-12-6,TRYPTANTHRIN,TRYPTANTHRIN
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K77008974-001-03-2,WYE-354,WYE-354
REP.PRIMARY,2.5,,HEDGEHOG PATHWAY MODULATOR,BRD:BRD-K77012840-300-01-6,AY-9944,AY-9944
REP.PRIMARY,2.5,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K77060810-001-01-5,AZD1283,AZD1283
REP.PRIMARY,2.5,,,BRD:BRD-K77115421-001-02-6,PHTHALYLSULFACETAMIDE,PHTHALYLSULFACETAMIDE
REP.PRIMARY,2.5,HRH3,HISTAMINE RECEPTOR MODULATOR,BRD:BRD-K77171813-034-01-8,PROXYFAN,PROXYFAN
REP.PRIMARY,2.5,"GABBR1, GABBR2, GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2, GATM, KCTD12, KCTD16, KCTD8, SLC6A1",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K77245796-003-01-6,GAMMA-AMINOBUTYRIC-ACID,GAMMA-AMINOBUTYRIC-ACID
REP.PRIMARY,2.5,,,BRD:BRD-K77251551-304-02-9,SODIUM-PICOSULFATE,SODIUM-PICOSULFATE
REP.PRIMARY,2.5,,LAXATIVE,BRD:BRD-K77258318-001-04-6,LACTULOSE,LACTULOSE
REP.PRIMARY,2.5,"ACHE, BCHE, CHRNA2, PCYT1A, PCYT1B, PHOSPHO1, PLD1, PLD2",ACETYLCHOLINE PRECURSOR,BRD:BRD-K77300776-001-02-5,CHOLINE,CHOLINE
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP","BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR, PPAR RECEPTOR AGONIST",BRD:BRD-K77345217-001-05-0,GALLIC-ACID,GALLIC-ACID
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K77396579-300-01-0,NVP-DPP728,NVP-DPP728
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K77484724-001-02-0,ADEFOVIR,ADEFOVIR
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K77552740-004-01-0,TIQUIZIUM,TIQUIZIUM
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K77554836-001-11-6,TRIAMCINOLONE,TRIAMCINOLONE
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K77554836-001-14-0,TRIAMCINOLONE,TRIAMCINOLONE
REP.PRIMARY,2.5,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K77561571-001-01-1,TOPIROXOSTAT,TOPIROXOSTAT
REP.PRIMARY,2.5,ADRA2A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K77597856-003-02-5,DETOMIDINE,DETOMIDINE
REP.PRIMARY,2.5,"EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA","EGFR INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K77625799-001-07-7,VANDETANIB,VANDETANIB
REP.PRIMARY,2.5,"ICAM1, SELE",ICAM1 EXPRESSION INHIBITOR,BRD:BRD-K77627880-001-04-0,A205804,A205804
REP.PRIMARY,2.5,,HSP INDUCER,BRD:BRD-K77634909-001-03-5,AEG3482,AEG3482
REP.PRIMARY,2.5,"HDAC2, PIK3R1",PI3K INHIBITOR,BRD:BRD-K77638923-001-02-0,CUDC-907,CUDC-907
REP.PRIMARY,2.5,"ADRA1A, ADRA2A",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K77641333-003-27-1,NAPHAZOLINE,NAPHAZOLINE
REP.PRIMARY,2.5,"HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K77677632-003-02-6,SB-200646,SB-200646
REP.PRIMARY,2.5,"KCNN1, KCNN3",PKC INHIBITOR,BRD:BRD-K77685957-300-09-1,DEQUALINIUM,DEQUALINIUM
REP.PRIMARY,2.5,,ANGIOGENESIS INHIBITOR,BRD:BRD-K77695569-001-30-0,TIABENDAZOLE,TIABENDAZOLE
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",IMIDAZOLINE RECEPTOR AGONIST,BRD:BRD-K77771411-003-10-7,MOXONIDINE,MOXONIDINE
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77791657-001-01-1,3-DEAZANEPLANOCIN-A,3-DEAZANEPLANOCIN-A
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77791657-003-01-7,3-DEAZANEPLANOCIN-A,3-DEAZANEPLANOCIN-A
REP.PRIMARY,2.5,"PKIA, PRKACA, ROCK1",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K77793136-003-03-0,HYDROXYFASUDIL,HYDROXYFASUDIL
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K77821588-364-01-2,AZATADINE,AZATADINE
REP.PRIMARY,2.5,"ARF1, CYTH2",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K77841042-001-14-1,BREFELDIN-A,BREFELDIN-A
REP.PRIMARY,2.5,"CA1, CA12, CA2, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K77867004-001-02-7,U-104,U-104
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC9",HDAC INHIBITOR,BRD:BRD-K77908580-001-09-6,ENTINOSTAT,ENTINOSTAT
REP.PRIMARY,2.5,"HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K77925998-050-14-3,QUIPAZINE,QUIPAZINE
REP.PRIMARY,2.5,MET,MET INHIBITOR,BRD:BRD-K77943374-001-02-8,NVP-BVU972,NVP-BVU972
REP.PRIMARY,2.5,"CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K77947974-001-16-3,FLUSPIRILENE,FLUSPIRILENE
REP.PRIMARY,2.5,PARP2,PARP INHIBITOR,BRD:BRD-K77950083-001-03-3,UPF-1069,UPF-1069
REP.PRIMARY,2.5,"TUBA1A, TUBB, TUBB4B",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K77987382-001-13-2,MEBENDAZOLE,MEBENDAZOLE
REP.PRIMARY,2.5,"CA2, GPR35, SLC12A1, SLC12A2",DIURETIC,BRD:BRD-K78010432-001-21-5,FUROSEMIDE,FUROSEMIDE
REP.PRIMARY,2.5,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K78055238-001-01-8,LY2090314,LY2090314
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR LIGAND,BRD:BRD-K78061844-050-01-9,4-PPBP,4-PPBP
REP.PRIMARY,2.5,"LCK, MAPK14, TGFBR1",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K78086729-001-02-7,GW-788388,GW-788388
REP.PRIMARY,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K78096648-001-05-7,OXIPEROMIDE,OXIPEROMIDE
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K78113049-001-16-2,ENOXACIN,ENOXACIN
REP.PRIMARY,2.5,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K78118466-001-03-3,LY2157299,LY2157299
REP.PRIMARY,2.5,"CATSPER1, CATSPER2, CATSPER3, CATSPER4",T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K78122587-300-02-7,NNC-55-0396,NNC-55-0396
REP.PRIMARY,2.5,"AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1","MITOCHONDRIAL DNA POLYMERASE INHIBITOR, PHOSPHATASE INHIBITOR",BRD:BRD-K78126613-001-28-5,MENADIONE,MENADIONE
REP.PRIMARY,2.5,"AKT1, PKIA, PRKACA",AKT INHIBITOR,BRD:BRD-K78177893-001-02-4,A-674563,A-674563
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K78294846-001-12-4,OSTHOL,OSTHOL
REP.PRIMARY,2.5,,,BRD:BRD-K78299798-001-02-2,MEPIROXOL,MEPIROXOL
REP.PRIMARY,2.5,TNF,TUMOR NECROSIS FACTOR RELEASE INHIBITOR,BRD:BRD-K78303961-001-02-3,GLYCITEIN,GLYCITEIN
REP.PRIMARY,2.5,CYP3A4,CYTOCHROME P450 INHIBITOR,BRD:BRD-K78318619-001-02-7,PF-4981517,PF-4981517
REP.PRIMARY,2.5,,,BRD:BRD-K78342372-001-02-4,HEMATOXYLIN,HEMATOXYLIN
REP.PRIMARY,2.5,"ALK, MET",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K78431006-001-10-2,CRIZOTINIB,CRIZOTINIB
REP.PRIMARY,2.5,PORCN,PORCUPINE INHIBITOR,BRD:BRD-K78455053-001-01-2,WNT-C59,WNT-C59
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K78485176-001-07-8,OLMESARTAN-MEDOXOMIL,OLMESARTAN-MEDOXOMIL
REP.PRIMARY,2.5,,,BRD:BRD-K78496197-001-03-9,SCS,SCS
REP.PRIMARY,2.5,GCK,GLUCOKINASE INHIBITOR,BRD:BRD-K78513633-001-15-7,LONIDAMINE,LONIDAMINE
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K78567475-001-01-4,DOLASTATIN-10,DOLASTATIN-10
REP.PRIMARY,2.5,,ARF INHIBITOR,BRD:BRD-K78633253-001-10-3,EXO-1,EXO-1
REP.PRIMARY,2.5,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K78637815-001-02-2,LY320135,LY320135
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K78643075-001-11-6,BROMPERIDOL,BROMPERIDOL
REP.PRIMARY,2.5,,PROTEASOME INHIBITOR,BRD:BRD-K78659596-001-03-9,IXAZOMIB,IXAZOMIB
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K78666826-003-01-6,PROCATEROL,PROCATEROL
REP.PRIMARY,2.5,"AHR, DHODH, PTK2B","DIHYDROOROTATE DEHYDROGENASE INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K78692225-001-24-5,LEFLUNOMIDE,LEFLUNOMIDE
REP.PRIMARY,2.5,,CCR ANTAGONIST,BRD:BRD-K78720403-001-01-6,SB-328437,SB-328437
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K78781788-003-01-9,BARNIDIPINE,BARNIDIPINE
REP.PRIMARY,2.5,CCKBR,CCK RECEPTOR AGONIST,BRD:BRD-K78789465-001-01-6,PENTAGASTRIN,PENTAGASTRIN
REP.PRIMARY,2.5,CCKBR,CCK RECEPTOR AGONIST,BRD:BRD-K78789465-001-02-4,PENTAGASTRIN,PENTAGASTRIN
REP.PRIMARY,2.5,BRAF,RAF INHIBITOR,BRD:BRD-K78809024-001-05-7,SB-590885,SB-590885
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K78815826-001-14-6,SUXIBUZONE,SUXIBUZONE
REP.PRIMARY,2.5,,SIGMA RECEPTOR LIGAND,BRD:BRD-K78844995-001-02-6,N-[2-(PIPERIDINYLAMINO)ETHYL]-4-IODOBENZAMIDE,N-[2-(PIPERIDINYLAMINO)ETHYL]-4-IODOBENZAMIDE
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K78941306-001-02-4,SB-742457,SB-742457
REP.PRIMARY,2.5,"CACNA1C, CACNA1S",CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K78959463-001-13-2,FPL-64176,FPL-64176
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K78960041-001-03-2,OXALIPLATIN,OXALIPLATIN
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K78960041-001-05-7,OXALIPLATIN,OXALIPLATIN
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K79092138-001-11-0,NITROFURAZONE,NITROFURAZONE
REP.PRIMARY,2.5,,ANTIMETABOLITE,BRD:BRD-K79095980-001-09-6,BROXURIDINE,BROXURIDINE
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K79102359-003-01-6,IDALOPIRDINE,IDALOPIRDINE
REP.PRIMARY,2.5,"SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K79116891-003-15-1,PROXYMETACAINE,PROXYMETACAINE
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-K79124250-001-08-9,IOXAGLIC-ACID,IOXAGLIC-ACID
REP.PRIMARY,2.5,"TUBA1A, TUBB, TUBB4B",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K79131256-001-17-9,ALBENDAZOLE,ALBENDAZOLE
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K79132813-001-09-0,PIBENZIMOL,PIBENZIMOL
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K79145628-001-05-5,NIMORAZOLE,NIMORAZOLE
REP.PRIMARY,2.5,,NOREPINEPHRINE REPUTAKE INHIBITOR,BRD:BRD-K79145749-003-02-2,DIBENZEPINE,DIBENZEPINE
REP.PRIMARY,2.5,"CDK1, CDK2, CDK7, GSK3B, IKBKB",FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K79239947-001-06-8,PF-573228,PF-573228
REP.PRIMARY,2.5,"DNMT1, DNMT3A",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K79254416-001-22-6,DECITABINE,DECITABINE
REP.PRIMARY,2.5,EPHB4,EPHRIN INHIBITOR,BRD:BRD-K79259477-001-04-9,NVP-BHG712,NVP-BHG712
REP.PRIMARY,2.5,APEX1,DNA REPAIR ENZYME INHIBITOR,BRD:BRD-K79277568-003-04-7,METHOXYAMINE,METHOXYAMINE
REP.PRIMARY,2.5,,,BRD:BRD-K79315489-001-07-8,ERYTHRITOL,ERYTHRITOL
REP.PRIMARY,2.5,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG",PKC INHIBITOR,BRD:BRD-K79404599-001-09-3,ENZASTAURIN,ENZASTAURIN
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K79425933-001-09-3,BENPERIDOL,BENPERIDOL
REP.PRIMARY,2.5,PPARG,METHYLTRANSFERASE INHIBITOR,BRD:BRD-K79437791-001-05-7,ACETYL-FARNESYL-CYSTEINE,ACETYL-FARNESYL-CYSTEINE
REP.PRIMARY,2.5,"HRH1, SULT1E1",HISTAMINE RECEPTOR MODULATOR,BRD:BRD-K79501723-001-04-6,CYCLIZINE,CYCLIZINE
REP.PRIMARY,2.5,RAD51,,BRD:BRD-K79555887-001-01-0,RI-1,RI-1
REP.PRIMARY,2.5,MDM2,MDM INHIBITOR,BRD:BRD-K79584249-001-01-3,CGM097,CGM097
REP.PRIMARY,2.5,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K79595931-312-01-3,BAVISANT,BAVISANT
REP.PRIMARY,2.5,"ACACB, PRKAB1",INSULIN SENSITIZER,BRD:BRD-K79602928-003-19-9,METFORMIN,METFORMIN
REP.PRIMARY,2.5,"PARP1, PNP",NEUROTROPHIC AGENT,BRD:BRD-K79612754-001-19-1,INOSINE,INOSINE
REP.PRIMARY,2.5,"PARP1, PNP",NEUROTROPHIC AGENT,BRD:BRD-K79612754-001-21-7,INOSINE,INOSINE
REP.PRIMARY,2.5,,,BRD:BRD-K79633074-001-01-8,XILOBAM,XILOBAM
REP.PRIMARY,2.5,DRD4,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K79684402-300-02-8,RO-10-5824,RO-10-5824
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K79711234-001-18-3,THIAMPHENICOL,THIAMPHENICOL
REP.PRIMARY,2.5,GRIK1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K79753741-001-01-7,UBP-302,UBP-302
REP.PRIMARY,2.5,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K79759585-048-04-8,SILDENAFIL,SILDENAFIL
REP.PRIMARY,2.5,,,BRD:BRD-K79884267-001-01-4,RETINALDEHYDE,RETINALDEHYDE
REP.PRIMARY,2.5,,,BRD:BRD-K79892937-001-02-5,PHENOLSULFONPHTHALEIN,PHENOLSULFONPHTHALEIN
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K79905821-004-03-6,GABAZINE,GABAZINE
REP.PRIMARY,2.5,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K79930101-300-03-7,GW-583340,GW-583340
REP.PRIMARY,2.5,"CHRNA4, CHRNB2, CXCL8",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K79966802-034-01-2,RIVANICLINE,RIVANICLINE
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K79989959-001-01-4,NESBUVIR,NESBUVIR
REP.PRIMARY,2.5,,,BRD:BRD-K80025777-001-01-4,"CIS-9,TRANS-11-CONJUGATED-LINOLEIC-ACID","CIS-9,TRANS-11-CONJUGATED-LINOLEIC-ACID"
REP.PRIMARY,2.5,HRH3,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K80028314-303-02-6,ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(R)-(-),ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(R)-(-)
REP.PRIMARY,2.5,,,BRD:BRD-K80036624-001-04-0,CLOPIDOL,CLOPIDOL
REP.PRIMARY,2.5,,ANTACID,BRD:BRD-K80043866-236-01-1,SODIUM-GUALENATE,SODIUM-GUALENATE
REP.PRIMARY,2.5,GRIA1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K80060353-303-03-9,IEM1754,IEM1754
REP.PRIMARY,2.5,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K80082640-001-01-0,OTAMIXABAN,OTAMIXABAN
REP.PRIMARY,2.5,"DPYD, UCKL1",,BRD:BRD-K80129304-001-08-1,URACIL,URACIL
REP.PRIMARY,2.5,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K80262108-001-07-0,AMIFAMPRIDINE,AMIFAMPRIDINE
REP.PRIMARY,2.5,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80267133-001-17-7,AMINOSALICYLATE,AMINOSALICYLATE
REP.PRIMARY,2.5,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80267133-001-19-3,AMINOSALICYLATE,AMINOSALICYLATE
REP.PRIMARY,2.5,"ABCB1, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K80315159-051-02-0,DPPE,DPPE
REP.PRIMARY,2.5,ERBB2,EGFR INHIBITOR,BRD:BRD-K80343549-001-02-6,TAK-285,TAK-285
REP.PRIMARY,2.5,ALOX5,CYTOCHROME P450 INHIBITOR,BRD:BRD-K80353138-001-12-1,SILIBININ,SILIBININ
REP.PRIMARY,2.5,"ABCC8, KCNJ10, KCNJ8",SULFONYLUREA,BRD:BRD-K80396088-001-12-0,GLIQUIDONE,GLIQUIDONE
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K80431395-001-07-3,TRICIRIBINE,TRICIRIBINE
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K80431395-001-09-9,TRICIRIBINE,TRICIRIBINE
REP.PRIMARY,2.5,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K80451230-051-02-6,ZAMIFENACIN,ZAMIFENACIN
REP.PRIMARY,2.5,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K80480517-001-02-4,REPSOX,REPSOX
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K80608265-001-01-6,ERTEBEREL,ERTEBEREL
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K80639402-003-02-9,SB-258585,SB-258585
REP.PRIMARY,2.5,"B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP",,BRD:BRD-K80653534-001-01-7,N-ACETYL-D-GLUCOSAMINE,N-ACETYL-D-GLUCOSAMINE
REP.PRIMARY,2.5,"FLT3, PIM1, PIM2, PIM3",PIM KINASE INHIBITOR,BRD:BRD-K80700417-001-04-2,SGI-1776,SGI-1776
REP.PRIMARY,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K80725821-300-02-9,RS-16566,RS-16566
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,BRD:BRD-K80778372-001-02-5,RO-19-4605,RO-19-4605
REP.PRIMARY,2.5,DYRK1B,DYRK INHIBITOR,BRD:BRD-K80935598-001-01-1,AZ191,AZ191
REP.PRIMARY,2.5,MET,C-MET INHIBITOR,BRD:BRD-K81016934-001-02-0,INC-280,INC-280
REP.PRIMARY,2.5,"CEL, FABP6, SLCO1C1",G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K81062487-001-05-8,TAUROCHOLATE,TAUROCHOLATE
REP.PRIMARY,2.5,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K81074237-001-02-3,AZILSARTAN,AZILSARTAN
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K81092066-311-01-6,PHENACAINE,PHENACAINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K81101512-234-01-9,FOSFOMYCIN,FOSFOMYCIN
REP.PRIMARY,2.5,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K81128206-003-24-4,EDROPHONIUM,EDROPHONIUM
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K81130846-001-17-4,SALICYLAMIDE,SALICYLAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K81136890-003-01-6,LEUCYLLEUCINE-METHYL-ESTER,LEUCYLLEUCINE-METHYL-ESTER
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K81144366-003-19-7,MOXISYLYTE,MOXISYLYTE
REP.PRIMARY,2.5,"SENP2, USP1, USP2, USP7",UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K81197548-003-01-4,NSC-632839,NSC-632839
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K81225797-001-02-3,SCH-58261,SCH-58261
REP.PRIMARY,2.5,"RYR1, RYR3",CALCIUM CHANNEL BLOCKER,BRD:BRD-K81272440-236-13-5,DANTROLENE,DANTROLENE
REP.PRIMARY,2.5,ERN1,IRE1 INHIBITOR,BRD:BRD-K81316007-001-01-8,4-MU-8C,4-MU-8C
REP.PRIMARY,2.5,PTGDR2,PROSTAGLANDIN SYNTHESIS INHIBITOR,BRD:BRD-K81326768-001-04-0,ZOMEPIRAC,ZOMEPIRAC
REP.PRIMARY,2.5,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K81330143-001-04-8,TIDEGLUSIB,TIDEGLUSIB
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K81332461-001-01-4,MAXACALCITOL,MAXACALCITOL
REP.PRIMARY,2.5,FLT3,FLT3 INHIBITOR,BRD:BRD-K81376179-001-04-8,TCS-359,TCS-359
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K81418486-001-47-5,VORINOSTAT,VORINOSTAT
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K81447180-003-21-4,LINCOMYCIN,LINCOMYCIN
REP.PRIMARY,2.5,"CSNK2A1, CSNK2A2, DAPK3, HIPK3",CASEIN KINASE INHIBITOR,BRD:BRD-K81458380-001-04-9,CX-4945,CX-4945
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K81473043-001-14-6,TANESPIMYCIN,TANESPIMYCIN
REP.PRIMARY,2.5,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K81473089-003-26-1,TACRINE,TACRINE
REP.PRIMARY,2.5,"ABL1, KIT","ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR",BRD:BRD-K81528515-001-13-8,NILOTINIB,NILOTINIB
REP.PRIMARY,2.5,F2RL1,PAR AGONIST,BRD:BRD-K81548480-001-01-2,AC-264613,AC-264613
REP.PRIMARY,2.5,"ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5",ACTIN RELATED PROTEIN INHIBITOR,BRD:BRD-K81572616-001-01-9,CK-636,CK-636
REP.PRIMARY,2.5,,,BRD:BRD-K81613478-001-01-8,GASTRODIN,GASTRODIN
REP.PRIMARY,2.5,"NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K81623406-004-08-3,EIT-HYDROBROMIDE,EIT-HYDROBROMIDE
REP.PRIMARY,2.5,,HSP INHIBITOR,BRD:BRD-K81645297-236-01-1,NKP-1339,NKP-1339
REP.PRIMARY,2.5,,,BRD:BRD-K81645907-001-01-1,CAPTAMINE,CAPTAMINE
REP.PRIMARY,2.5,PI3,PI3K INHIBITOR,BRD:BRD-K81647657-001-04-3,3-METHYLADENINE,3-METHYLADENINE
REP.PRIMARY,2.5,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R",PROSTACYCLIN ANALOG,BRD:BRD-K81672972-001-03-1,DINOPROST,DINOPROST
REP.PRIMARY,2.5,REN,RENIN INHIBITOR,BRD:BRD-K81694556-003-01-9,VTP-27999,VTP-27999
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K81728688-001-04-4,WZ8040,WZ8040
REP.PRIMARY,2.5,CHRM2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K81729199-001-02-8,AQ-RA741,AQ-RA741
REP.PRIMARY,2.5,CDH2,CADHERIN ANTAGONIST,BRD:BRD-K81795818-019-01-4,EXHERIN,EXHERIN
REP.PRIMARY,2.5,"ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K81801188-001-02-8,PP-121,PP-121
REP.PRIMARY,2.5,,,BRD:BRD-K81807412-001-10-6,N6-METHYLADENOSINE,N6-METHYLADENOSINE
REP.PRIMARY,2.5,"ESR1, ESR2","ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",BRD:BRD-K81839095-001-25-1,ESTRONE,ESTRONE
REP.PRIMARY,2.5,"ESR1, ESR2","ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",BRD:BRD-K81839095-001-30-1,ESTRONE,ESTRONE
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K81855038-003-13-9,ROXATIDINE-ACETATE,ROXATIDINE-ACETATE
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K81876028-300-02-0,CP-93129,CP-93129
REP.PRIMARY,2.5,DNMT1,MICROTUBULE INHIBITOR,BRD:BRD-K81916719-001-13-9,TRICLABENDAZOLE,TRICLABENDAZOLE
REP.PRIMARY,2.5,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K81957469-001-01-0,SEMAGACESTAT,SEMAGACESTAT
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K82002057-001-01-2,DFB,DFB
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K82027074-001-07-5,2-HYDROXYFLUTAMIDE,2-HYDROXYFLUTAMIDE
REP.PRIMARY,2.5,"ADORA1, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K82028950-300-02-9,CGH2466,CGH2466
REP.PRIMARY,2.5,"SLC6A3, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K82036761-003-20-3,SERTRALINE,SERTRALINE
REP.PRIMARY,2.5,"MAPK11, MAPK14, PTGS2",P38 MAPK INHIBITOR,BRD:BRD-K82091397-001-03-0,SB-239063,SB-239063
REP.PRIMARY,2.5,,,BRD:BRD-K82104468-001-05-0,ETHYL-VANILLIN,ETHYL-VANILLIN
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K82122102-323-01-1,AMFENAC,AMFENAC
REP.PRIMARY,2.5,HSPA1A,OXIDATIVE STRESS INDUCER,BRD:BRD-K82135108-001-04-3,ELESCLOMOL,ELESCLOMOL
REP.PRIMARY,2.5,,PANIPENEM UPTAKE INHIBITOR,BRD:BRD-K82142815-001-19-1,BETAMIPRON,BETAMIPRON
REP.PRIMARY,2.5,DNMT1,OTHER ANTIFUNGAL,BRD:BRD-K82143716-001-19-9,FLUCYTOSINE,FLUCYTOSINE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K82164249-001-03-5,ANDARINE,ANDARINE
REP.PRIMARY,2.5,"GABRB1, HCAR1, SLC52A2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K82166906-236-02-8,SODIUM-OXYBATE,SODIUM-OXYBATE
REP.PRIMARY,2.5,,,BRD:BRD-K82181219-001-04-3,PYRITINOL,PYRITINOL
REP.PRIMARY,2.5,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3",NITRIC OXIDE STIMULANT,BRD:BRD-K82225283-001-03-1,ISOSORBIDE-MONONITRATE,ISOSORBIDE-MONONITRATE
REP.PRIMARY,2.5,APP,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,BRD:BRD-K82234479-001-09-4,TRAMIPROSATE,TRAMIPROSATE
REP.PRIMARY,2.5,,,BRD:BRD-K82236108-001-04-9,"N-METHYL-(-)EPHEDRINE-[1R,2S]","N-METHYL-(-)EPHEDRINE-[1R,2S]"
REP.PRIMARY,2.5,"CRYZ, NQO1, VKORC1",NADPH INHIBITOR,BRD:BRD-K82236179-213-01-0,DICOUMAROL,DICOUMAROL
REP.PRIMARY,2.5,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K82244583-001-01-3,MEK162,"BINIMETINIB, MEK162"
REP.PRIMARY,2.5,"FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K82255054-001-15-9,PROPOFOL,PROPOFOL
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K82343404-003-02-4,ADRENALONE,ADRENALONE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K82357231-001-17-5,DESLORATADINE,DESLORATADINE
REP.PRIMARY,2.5,"ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K82381502-003-23-1,ACETYLCHOLINE,ACETYLCHOLINE
REP.PRIMARY,2.5,,,BRD:BRD-K82421491-001-02-6,IPAG,IPAG
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K82467063-001-02-7,SB-271046,SB-271046
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K82484965-003-03-5,CARMOXIROLE,CARMOXIROLE
REP.PRIMARY,2.5,ADH5,ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K82522873-001-01-1,N6022,N6022
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K82562631-236-04-6,TOLMETIN,TOLMETIN
REP.PRIMARY,2.5,,PKC INHIBITOR,BRD:BRD-K82603084-408-01-1,ETHYLENEDIAMINETETRAACETIC-ACID,ETHYLENEDIAMINETETRAACETIC-ACID
REP.PRIMARY,2.5,ATP1A1,NEUROTRANSMITTER AGONIST,BRD:BRD-K82677201-001-01-6,ALMITRINE,ALMITRINE
REP.PRIMARY,2.5,"CDK1, CDK2, CDK5, MAPK1",CDK INHIBITOR,BRD:BRD-K82731415-001-07-0,OLOMOUCINE,OLOMOUCINE
REP.PRIMARY,2.5,"BCL2, BCL2L1, BCL2L2",BCL INHIBITOR,BRD:BRD-K82746043-001-15-1,NAVITOCLAX,NAVITOCLAX
REP.PRIMARY,2.5,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K82767007-001-01-1,DAZOXIBEN,DAZOXIBEN
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K82795137-001-26-2,LORATADINE,LORATADINE
REP.PRIMARY,2.5,,,BRD:BRD-K82800842-001-01-9,INOSITOL-HEXANICOTINATE,INOSITOL-HEXANICOTINATE
REP.PRIMARY,2.5,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K82818427-001-02-2,BATIMASTAT,BATIMASTAT
REP.PRIMARY,2.5,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K82818427-001-04-8,BATIMASTAT,BATIMASTAT
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2",GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,BRD:BRD-K82823076-001-02-6,RO-15-4513,RO-15-4513
REP.PRIMARY,2.5,WEE1,PKC INHIBITOR,BRD:BRD-K82823804-001-04-1,PD-407824,PD-407824
REP.PRIMARY,2.5,"ABCC8, KCNJ11, PPARG",INSULIN SECRETAGOGUE,BRD:BRD-K82846253-001-15-4,REPAGLINIDE,REPAGLINIDE
REP.PRIMARY,2.5,"CXCR1, CXCR2",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K82850175-001-01-1,NAVARIXIN,NAVARIXIN
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K82861010-001-02-5,DACLATASVIR,DACLATASVIR
REP.PRIMARY,2.5,GRM5,"GLUTAMATE RECEPTOR ALLOSTERIC LIGAND, GLUTAMATE RECEPTOR MODULATOR",BRD:BRD-K82903013-001-01-4,"3,3'-DICHLOROBENZALDAZINE","3,3'-DICHLOROBENZALDAZINE"
REP.PRIMARY,2.5,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K82928847-001-04-7,ACY-1215,ACY-1215
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K82928892-001-02-5,DOXERCALCIFEROL,DOXERCALCIFEROL
REP.PRIMARY,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K82941592-238-04-5,ROSUVASTATIN,ROSUVASTATIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K82960980-003-01-9,CEFTIOFUR,CEFTIOFUR
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K82960980-003-02-7,CEFTIOFUR,CEFTIOFUR
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K82967685-300-01-2,MIRODENAFIL,MIRODENAFIL
REP.PRIMARY,2.5,PPARD,PPAR RECEPTOR AGONIST,BRD:BRD-K82983861-001-04-3,GW-0742,GW-0742
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K83003151-057-02-4,ALOGLIPTIN,ALOGLIPTIN
REP.PRIMARY,2.5,,,BRD:BRD-K83022601-001-01-0,CI-844,CI-844
REP.PRIMARY,2.5,,MELATONIN RECEPTOR AGONIST,BRD:BRD-K83023055-001-02-7,GR-135531,GR-135531
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K83036479-001-09-2,SALICYLANILIDE,SALICYLANILIDE
REP.PRIMARY,2.5,CCR2,CCR ANTAGONIST,BRD:BRD-K83063356-003-02-5,RS-102895,RS-102895
REP.PRIMARY,2.5,ADORA1,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K83064458-001-23-0,ETOFYLLINE,ETOFYLLINE
REP.PRIMARY,2.5,PTGDR2,CRTH RECEPTOR ANTAGONIST,BRD:BRD-K83186168-001-01-8,AZD1981,AZD1981
REP.PRIMARY,2.5,L3MBTL3,L3MBTL ANTAGONIST,BRD:BRD-K83189926-001-03-1,UNC1215,UNC1215
REP.PRIMARY,2.5,HRH1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K83192048-050-02-7,DIMETHINDENE-(S)-(+),DIMETHINDENE-(S)-(+)
REP.PRIMARY,2.5,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K83245588-001-01-4,PILSICAINIDE,PILSICAINIDE
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K83257731-003-23-5,CHLOROPYRAMINE,CHLOROPYRAMINE
REP.PRIMARY,2.5,"DRD2, SIGMAR1","SIGMA RECEPTOR AGONIST, SIGMA RECEPTOR ANTAGONIST",BRD:BRD-K83322645-050-01-9,L-693403,L-693403
REP.PRIMARY,2.5,,,BRD:BRD-K83335125-001-07-0,CHLOROXOQUINOLINE,CHLOROXOQUINOLINE
REP.PRIMARY,2.5,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2",SEDATIVE,BRD:BRD-K83359602-001-02-3,BARBITAL,BARBITAL
REP.PRIMARY,2.5,"DRD2, HTR2A",SEROTONIN RECEPTOR INVERSE AGONIST,BRD:BRD-K83405785-001-01-5,PIMAVANSERIN,PIMAVANSERIN
REP.PRIMARY,2.5,,ANGIOGENESIS INHIBITOR,BRD:BRD-K83459933-001-05-4,SINOMENINE,SINOMENINE
REP.PRIMARY,2.5,"TACR1, TACR2",TACHYKININ ANTAGONIST,BRD:BRD-K83508485-001-02-7,FK-888,FK-888
REP.PRIMARY,2.5,,ANTITUSSIVE,BRD:BRD-K83551379-001-01-8,LEVODROPROPIZINE,LEVODROPROPIZINE
REP.PRIMARY,2.5,,ANTITUSSIVE,BRD:BRD-K83551379-001-02-6,LEVODROPROPIZINE,LEVODROPROPIZINE
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K83597974-003-22-2,PARGYLINE,PARGYLINE
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K83607951-001-02-2,SKEPINONE-L,SKEPINONE-L
REP.PRIMARY,2.5,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K83636919-001-04-8,ENTACAPONE,ENTACAPONE
REP.PRIMARY,2.5,"FLT3, PLK1, PLK2, PLK3",PLK INHIBITOR,BRD:BRD-K83699324-001-01-1,NMS-1286937,NMS-1286937
REP.PRIMARY,2.5,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K83720053-001-03-8,AVAGACESTAT,AVAGACESTAT
REP.PRIMARY,2.5,TH,TYROSINE HYDROXYLASE INHIBITOR,BRD:BRD-K83766205-001-03-8,METIROSINE,METIROSINE
REP.PRIMARY,2.5,RARG,RETINOID RECEPTOR AGONIST,BRD:BRD-K83794243-001-01-8,PALOVAROTENE,PALOVAROTENE
REP.PRIMARY,2.5,,BMI-1 INHIBITOR,BRD:BRD-K83834509-001-01-1,PTC-209,PTC-209
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2",HDAC INHIBITOR,BRD:BRD-K83837640-001-04-8,JNJ-26481585,JNJ-26481585
REP.PRIMARY,2.5,"CTPS1, GLUL, GPRC6A, PPAT",,BRD:BRD-K83896451-001-06-7,L-GLUTAMINE,"GLUTAMINE-(L), L-GLUTAMINE"
REP.PRIMARY,2.5,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K83963101-001-06-9,MLN8054,"MLN-8054, MLN8054"
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K83988098-001-02-0,ALVESPIMYCIN,ALVESPIMYCIN
REP.PRIMARY,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K83988098-003-03-4,ALVESPIMYCIN,ALVESPIMYCIN
REP.PRIMARY,2.5,,ION CHANNEL ANTAGONIST,BRD:BRD-K84011460-051-01-7,NIZOFENONE,NIZOFENONE
REP.PRIMARY,2.5,,,BRD:BRD-K84075000-001-05-5,2-CHLOROPYRAZINE,2-CHLOROPYRAZINE
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K84091759-001-07-1,CANDESARTAN,CANDESARTAN
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K84163249-001-01-9,ERCALCITRIOL,ERCALCITRIOL
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K84214706-001-05-7,7-CHLOROKYNURENIC-ACID,7-CHLOROKYNURENIC-ACID
REP.PRIMARY,2.5,"PDE7A, PDE7B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K84266862-001-03-2,BRL-50481,BRL-50481
REP.PRIMARY,2.5,POLA1,"DNA SYNTHESIS INHIBITOR, T CELL INHIBITOR",BRD:BRD-K84466663-001-05-4,NELARABINE,NELARABINE
REP.PRIMARY,2.5,"PROC, PROS1",,BRD:BRD-K84544951-236-01-0,SODIUM-TETRADECYL-SULFATE,SODIUM-TETRADECYL-SULFATE
REP.PRIMARY,2.5,KDR,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K84564571-001-02-4,TELATINIB,TELATINIB
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K84663978-003-02-9,TREQUINSIN,TREQUINSIN
REP.PRIMARY,2.5,,"BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR, BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR",BRD:BRD-K84683831-001-01-0,RADEZOLID,RADEZOLID
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B","MELATONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K84698278-001-03-4,AGOMELATINE,AGOMELATINE
REP.PRIMARY,2.5,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K84748119-050-01-1,VICRIVIROC,VICRIVIROC
REP.PRIMARY,2.5,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3",GUANYLATE CYCLASE STIMULANT,BRD:BRD-K84783599-001-01-0,RIOCIGUAT,RIOCIGUAT
REP.PRIMARY,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K84794093-001-07-5,DIDEOXYADENOSINE,DIDEOXYADENOSINE
REP.PRIMARY,2.5,,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K84798689-236-02-9,SODIUM-TANSHINONE-II-A-SULFONATE,SODIUM-TANSHINONE-II-A-SULFONATE
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K84810405-003-01-1,ALMOREXANT,ALMOREXANT
REP.PRIMARY,2.5,CFTR,CFTR CHANNEL ANTAGONIST,BRD:BRD-K84892605-001-01-1,IOWH032,IOWH032
REP.PRIMARY,2.5,PTGIR,IP1 PROSTACYCLIN RECEPTOR AGONIST,BRD:BRD-K84895041-001-02-4,BMY-45778,BMY-45778
REP.PRIMARY,2.5,JUN,AP INHIBITOR,BRD:BRD-K84925803-001-01-9,T-5224,T-5224
REP.PRIMARY,2.5,"FGF2, FKBP1A, MTOR",MTOR INHIBITOR,BRD:BRD-K84937637-001-09-9,SIROLIMUS,SIROLIMUS
REP.PRIMARY,2.5,CYP3A4,HIV PROTEASE INHIBITOR,BRD:BRD-K84986517-001-01-8,DARUNAVIR,DARUNAVIR
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K84996356-001-01-1,AZD3514,AZD3514
REP.PRIMARY,2.5,,PARP INHIBITOR,BRD:BRD-K85014146-001-02-5,AZD2461,AZD2461
REP.PRIMARY,2.5,SLC6A12,"GABA UPTAKE INHIBITOR, GAT INHIBITOR",BRD:BRD-K85015012-003-02-9,NNC-05-2090,NNC-05-2090
REP.PRIMARY,2.5,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K85046107-003-01-2,RAMOSETRON,RAMOSETRON
REP.PRIMARY,2.5,,,BRD:BRD-K85066592-001-01-6,GLY-GLN,GLY-GLN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K85090592-008-22-7,PILOCARPINE,PILOCARPINE
REP.PRIMARY,2.5,"ABCC8, KCNJ1, KCNJ11, KCNJ8",ATP CHANNEL BLOCKER,BRD:BRD-K85119730-001-28-9,TOLBUTAMIDE,TOLBUTAMIDE
REP.PRIMARY,2.5,,RNA SYNTHESIS INHIBITOR,BRD:BRD-K85140930-001-12-7,APHIDICOLIN,APHIDICOLIN
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K85146014-314-05-4,FOSCARNET,FOSCARNET
REP.PRIMARY,2.5,SYK,SYK INHIBITOR,BRD:BRD-K85178109-001-02-3,FOSTAMATINIB,FOSTAMATINIB
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K85307935-236-09-5,NOVOBIOCIN,NOVOBIOCIN
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K85307935-236-10-3,NOVOBIOCIN,NOVOBIOCIN
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K85333151-003-13-4,RAMIFENAZONE,RAMIFENAZONE
REP.PRIMARY,2.5,CACNA1C,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K85337334-004-02-6,OTILONIUM,OTILONIUM
REP.PRIMARY,2.5,"CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB","EGFR INHIBITOR, FGFR INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K85402309-001-06-6,DOVITINIB,DOVITINIB
REP.PRIMARY,2.5,"CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB","EGFR INHIBITOR, FGFR INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K85402309-389-03-2,DOVITINIB,DOVITINIB
REP.PRIMARY,2.5,"THRA, THRB",THYROID HORMONE RECEPTOR AGONIST,BRD:BRD-K85406984-001-01-0,SOBETIROME,SOBETIROME
REP.PRIMARY,2.5,,AUTOPHAGY INDUCER,BRD:BRD-K85479953-001-11-3,STF-62247,STF-62247
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K85503079-001-02-8,PEROSPIRONE,PEROSPIRONE
REP.PRIMARY,2.5,"CHRNA7, GABRB3, GLRA3, P2RX7",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K85554912-001-06-3,IVERMECTIN,IVERMECTIN
REP.PRIMARY,2.5,"CHRNA7, GABRB3, GLRA3, P2RX7",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K85554912-001-08-9,IVERMECTIN,IVERMECTIN
REP.PRIMARY,2.5,"EGFR, ERBB2, KDR",EGFR INHIBITOR,BRD:BRD-K85606544-001-09-1,NERATINIB,NERATINIB
REP.PRIMARY,2.5,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K85751432-001-03-3,REFAMETINIB,REFAMETINIB
REP.PRIMARY,2.5,,BACTERIAL DNA INHIBITOR,BRD:BRD-K85757157-001-01-7,NIFURSOL,NIFURSOL
REP.PRIMARY,2.5,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K85849709-001-01-5,AZD2858,AZD2858
REP.PRIMARY,2.5,"GPR35, GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K85872723-001-15-9,KYNURENIC-ACID,KYNURENIC-ACID
REP.PRIMARY,2.5,"HSD11B1, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K85883481-001-25-7,PREDNISONE,PREDNISONE
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K85920262-001-02-1,WAY-600,WAY-600
REP.PRIMARY,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K85925969-001-17-4,ZALCITABINE,ZALCITABINE
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K86003836-001-10-5,FLUBENDAZOLE,FLUBENDAZOLE
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K86109159-001-02-6,VU0357121,VU0357121
REP.PRIMARY,2.5,"IGF1R, INSR, INSRR",IGF-1 INHIBITOR,BRD:BRD-K86118762-001-01-8,LINSITINIB,LINSITINIB
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K86161929-001-11-7,CORTISONE-ACETATE,CORTISONE-ACETATE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K86161929-001-13-3,CORTISONE-ACETATE,CORTISONE-ACETATE
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K86204871-001-16-2,TERCONAZOLE,TERCONAZOLE
REP.PRIMARY,2.5,ATR,ANTIOXIDANT,BRD:BRD-K86294588-001-01-9,SCHISANDRIN-B,SCHISANDRIN-B
REP.PRIMARY,2.5,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K86301799-001-34-8,DIPYRIDAMOLE,DIPYRIDAMOLE
REP.PRIMARY,2.5,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K86307448-001-17-5,ALLOPURINOL,ALLOPURINOL
REP.PRIMARY,2.5,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K86307448-001-19-1,ALLOPURINOL,ALLOPURINOL
REP.PRIMARY,2.5,,NITRIC OXIDE DONOR,BRD:BRD-K86344238-003-04-6,LINSIDOMINE,LINSIDOMINE
REP.PRIMARY,2.5,,,BRD:BRD-K86435560-001-01-0,PERCHLOZONE,PERCHLOZONE
REP.PRIMARY,2.5,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K86436199-003-01-3,LANDIOLOL,LANDIOLOL
REP.PRIMARY,2.5,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K86525559-001-04-5,AZD7762,AZD7762
REP.PRIMARY,2.5,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K86525559-001-07-8,AZD7762,AZD7762
REP.PRIMARY,2.5,ADRA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K86600316-003-02-0,RS-79948,RS-79948
REP.PRIMARY,2.5,,HDAC INHIBITOR,BRD:BRD-K86687746-001-01-3,R306465,R306465
REP.PRIMARY,2.5,XIAP,"HCV INHIBITOR, XIAP INHIBITOR",BRD:BRD-K86727142-001-12-4,EMBELIN,EMBELIN
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9",HDAC INHIBITOR,BRD:BRD-K86797399-001-04-4,SB-939,SB-939
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9",HDAC INHIBITOR,BRD:BRD-K86797399-001-05-1,SB-939,SB-939
REP.PRIMARY,2.5,,,BRD:BRD-K86799112-001-02-0,5-HMF,5-HMF
REP.PRIMARY,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K86816506-001-01-8,PF-04457845,PF-04457845
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K86882815-001-03-2,CABERGOLINE,CABERGOLINE
REP.PRIMARY,2.5,"KCNH1, KCNH2, KCNJ12, KCNK2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K86887724-001-10-6,DOFETILIDE,DOFETILIDE
REP.PRIMARY,2.5,,DNA DIRECTED DNA POLYMERASE INHIBITOR,BRD:BRD-K86892782-001-17-0,EDOXUDINE,EDOXUDINE
REP.PRIMARY,2.5,"CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB","KIT INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K86930074-001-05-0,CEDIRANIB,CEDIRANIB
REP.PRIMARY,2.5,ANG,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K86972824-001-01-4,OLTIPRAZ,OLTIPRAZ
REP.PRIMARY,2.5,ANG,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K86972824-001-02-2,OLTIPRAZ,OLTIPRAZ
REP.PRIMARY,2.5,"ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K87024524-065-17-7,PHENELZINE,PHENELZINE
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K87028197-001-01-3,ASUNAPREVIR,ASUNAPREVIR
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K87036601-001-01-6,AZODICARBONAMIDE,AZODICARBONAMIDE
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K87048468-003-02-7,RS-102221,RS-102221
REP.PRIMARY,2.5,"MTOR, PASK",MTOR INHIBITOR,BRD:BRD-K87112191-001-04-5,PP242,PP242
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K87124298-001-03-4,OSI-027,OSI-027
REP.PRIMARY,2.5,TPO,ANTITHYROID AGENT,BRD:BRD-K87156652-001-12-7,CARBIMAZOLE,CARBIMAZOLE
REP.PRIMARY,2.5,"ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1",SODIUM CHANNEL BLOCKER,BRD:BRD-K87158025-001-01-6,BENZAMIL,BENZAMIL
REP.PRIMARY,2.5,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","CYCLOOXYGENASE INHIBITOR, FABI INHIBITOR",BRD:BRD-K87202646-001-32-6,PASINIAZID,"ISONIAZID, PASINIAZID"
REP.PRIMARY,2.5,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","CYCLOOXYGENASE INHIBITOR, FABI INHIBITOR",BRD:BRD-K87202646-061-04-9,PASINIAZID,"ISONIAZID, PASINIAZID"
REP.PRIMARY,2.5,SLC6A3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K87278688-001-01-0,ARMODAFINIL,ARMODAFINIL
REP.PRIMARY,2.5,"GABRA1, GABRG2",BENZODIAZEPINE RECEPTOR LIGAND,BRD:BRD-K87349602-001-03-8,BETA-CCB,BETA-CCB
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K87349682-347-03-8,NOREPINEPHRINE,NOREPINEPHRINE
REP.PRIMARY,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K87492696-001-16-5,SULFAMETER,SULFAMETER
REP.PRIMARY,2.5,"CCL2, CCR2",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K87510569-001-02-8,RS-504393,RS-504393
REP.PRIMARY,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K87512222-019-01-7,TALTOBULIN,TALTOBULIN
REP.PRIMARY,2.5,TLR7,,BRD:BRD-K87535339-001-01-6,"5-AMINO-3-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIMIDIN-2,7(3H,6H)-DIONE","5-AMINO-3-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIMIDIN-2,7(3H,6H)-DIONE"
REP.PRIMARY,2.5,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K87696786-003-04-4,LY456236,LY456236
REP.PRIMARY,2.5,,,BRD:BRD-K87700323-003-05-1,CETYLPYRIDINIUM,CETYLPYRIDINIUM
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K87737963-001-06-0,CYT387,CYT387
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K87774949-001-03-9,ISTRADEFYLLINE,ISTRADEFYLLINE
REP.PRIMARY,2.5,"BTK, YES1",BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K87782578-001-01-4,AVL-292,AVL-292
REP.PRIMARY,2.5,,"DNA ALKYLATING AGENT, DNA INHIBITOR",BRD:BRD-K87827419-001-16-8,MELPHALAN,MELPHALAN
REP.PRIMARY,2.5,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM",CDK INHIBITOR,BRD:BRD-K87909389-003-03-4,ALVOCIDIB,ALVOCIDIB
REP.PRIMARY,2.5,"CDK1, CDK5, GSK3B","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K87932577-001-02-4,CDK1-5-INHIBITOR,CDK1-5-INHIBITOR
REP.PRIMARY,2.5,"SLC12A1, SLC12A2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K87990216-001-10-2,PIRETANIDE,PIRETANIDE
REP.PRIMARY,2.5,"S1PR1, S1PR5","IMMUNOSUPPRESSANT, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K88025533-003-03-3,FINGOLIMOD,FINGOLIMOD
REP.PRIMARY,2.5,"ARG1, CA2, CTNNB1",HYDROXY RADICAL FORMATION STIMULANT,BRD:BRD-K88052444-001-08-8,UREA,UREA
REP.PRIMARY,2.5,IMPDH1,"IMMUNOSUPPRESSANT, INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR",BRD:BRD-K88061624-001-21-4,MIZORIBINE,MIZORIBINE
REP.PRIMARY,2.5,,ANTIHISTAMINE,BRD:BRD-K88090157-050-10-8,PIMETHIXENE,PIMETHIXENE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1, SIGMAR1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K88172511-003-20-3,NALTREXONE,NALTREXONE
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1, SIGMAR1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K88172511-003-21-1,NALTREXONE,NALTREXONE
REP.PRIMARY,2.5,NR1H4,FXR AGONIST,BRD:BRD-K88186167-001-04-8,GW-4064,GW-4064
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K88219015-001-10-8,ASARALDEHYDE,ASARALDEHYDE
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K88308881-001-06-8,ETHENZAMIDE,ETHENZAMIDE
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K88358234-003-04-8,XALIPRODEN,XALIPRODEN
REP.PRIMARY,2.5,ACAA2,3-KETOACYL COA THIOLASE INHIBITOR,BRD:BRD-K88366685-300-06-0,TRIMETAZIDINE,TRIMETAZIDINE
REP.PRIMARY,2.5,,ANTIHISTAMINE,BRD:BRD-K88405679-003-03-1,THONZYLAMINE,THONZYLAMINE
REP.PRIMARY,2.5,"DHFR, SLC47A1",DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K88429204-001-35-1,PYRIMETHAMINE,PYRIMETHAMINE
REP.PRIMARY,2.5,ROCK2,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K88506063-001-01-8,KD025,KD025
REP.PRIMARY,2.5,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA","NFKB PATHWAY INHIBITOR, PROTEASOME INHIBITOR",BRD:BRD-K88510285-001-11-1,BORTEZOMIB,BORTEZOMIB
REP.PRIMARY,2.5,"ACAT1, CES1",ACAT INHIBITOR,BRD:BRD-K88544581-001-06-1,CI-976,CI-976
REP.PRIMARY,2.5,,UREASE INHIBITOR,BRD:BRD-K88553858-001-02-7,BENURESTAT,BENURESTAT
REP.PRIMARY,2.5,"PARP1, PARP2",PARP INHIBITOR,BRD:BRD-K88560311-011-06-3,RUCAPARIB,RUCAPARIB
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K88568253-011-19-9,IPRONIAZID,IPRONIAZID
REP.PRIMARY,2.5,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K88611939-001-22-4,ANIRACETAM,ANIRACETAM
REP.PRIMARY,2.5,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K88625236-001-04-2,NONOXYNOL-9,NONOXYNOL-9
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K88646909-004-16-2,ARECOLINE,ARECOLINE
REP.PRIMARY,2.5,"MAP2K1, MAP2K2","MAP KINASE INHIBITOR, MEK INHIBITOR",BRD:BRD-K88677950-001-03-9,PD-198306,PD-198306
REP.PRIMARY,2.5,"CA1, CA2, CA4, SLC12A3",DIURETIC,BRD:BRD-K88682005-001-15-8,CHLOROTHIAZIDE,CHLOROTHIAZIDE
REP.PRIMARY,2.5,DNMT1,CHELATING AGENT,BRD:BRD-K88701661-001-02-9,DIMERCAPTOSUCCINIC-ACID,DIMERCAPTOSUCCINIC-ACID
REP.PRIMARY,2.5,"HDAC1, HDAC10, HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K88742110-001-07-9,PCI-34051,PCI-34051
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K88759641-003-02-8,EMD-66684,EMD-66684
REP.PRIMARY,2.5,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K88789588-001-14-9,LETROZOLE,LETROZOLE
REP.PRIMARY,2.5,ABCB1,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K88807631-001-01-3,ELACRIDAR,ELACRIDAR
REP.PRIMARY,2.5,,,BRD:BRD-K88956297-003-01-9,"1-((Z)-3-CHLOROALLYL)-1,3,5,7-TETRAAZAADAMANTAN-1-IUM","1-((Z)-3-CHLOROALLYL)-1,3,5,7-TETRAAZAADAMANTAN-1-IUM"
REP.PRIMARY,2.5,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K89014967-001-04-3,AS-703026,AS-703026
REP.PRIMARY,2.5,CENPE,CENTROMERE ASSOCIATED PROTEIN INHIBITOR,BRD:BRD-K89015388-001-01-7,GSK923295,GSK923295
REP.PRIMARY,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K89048337-001-06-9,PUERARIN,PUERARIN
REP.PRIMARY,2.5,"TP53, USP14","ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR",BRD:BRD-K89053832-001-01-0,VLX600,VLX600
REP.PRIMARY,2.5,HTR1A,MUSCLE RELAXANT,BRD:BRD-K89055274-048-22-7,ALVERINE,ALVERINE
REP.PRIMARY,2.5,,RYANODINE RECEPTOR ACTIVATOR,BRD:BRD-K89056082-001-07-7,CHLOROCRESOL,CHLOROCRESOL
REP.PRIMARY,0.25,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K89071957-001-01-1,CTS21166,CTS21166
REP.PRIMARY,2.5,ALOX12,LIPOXYGENASE INHIBITOR,BRD:BRD-K89072800-001-01-8,2-TEDC,2-TEDC
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K89104321-003-14-8,GABOXADOL,GABOXADOL
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K89125793-001-26-0,TINIDAZOLE,TINIDAZOLE
REP.PRIMARY,2.5,"THRA, THRB",THYROID HORMONE STIMULANT,BRD:BRD-K89152108-236-07-6,LIOTHYRONINE,LIOTHYRONINE
REP.PRIMARY,2.5,"CSF1R, FLT3, KIT, PDGFD, PDGFRB","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K89162000-001-06-4,TANDUTINIB,TANDUTINIB
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K89208535-051-01-5,INDACATEROL,INDACATEROL
REP.PRIMARY,2.5,"ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6",VITAMIN B,BRD:BRD-K89210380-001-13-7,BIOTIN,BIOTIN
REP.PRIMARY,2.5,"ANO1, CLCN2, CLCN7, TRPA1",CHLORIDE CHANNEL BLOCKER,BRD:BRD-K89272762-001-12-7,NPPB,NPPB
REP.PRIMARY,2.5,,ACETYLCHOLINE RELEASE ENHANCER,BRD:BRD-K89274813-001-02-3,DMP-543,DMP-543
REP.PRIMARY,2.5,"KCNN2, KCNN3, KCNN4",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K89299012-001-06-0,DCEBIO,DCEBIO
REP.PRIMARY,2.5,,NOD1 INHIBITOR,BRD:BRD-K89306950-001-12-5,ML130,ML130
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K89348303-001-14-7,RAMIPRIL,RAMIPRIL
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K89375097-300-08-8,PIRENZEPINE,PIRENZEPINE
REP.PRIMARY,2.5,"DNMT1, DNMT3B",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K89391146-001-08-0,RG108,RG108
REP.PRIMARY,2.5,PTGES,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K89402695-001-02-3,L-655240,L-655240
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K89561498-001-01-7,SN-38,SN-38
REP.PRIMARY,2.5,PYGL,PHOSPHORYLASE INHIBITOR,BRD:BRD-K89588135-001-01-9,TAGATOSE,TAGATOSE
REP.PRIMARY,2.5,,NITRIFICATION INHIBITOR,BRD:BRD-K89634775-001-09-9,ALLYLTHIOUREA,ALLYLTHIOUREA
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K89657519-001-01-8,TESTOSTERONE-ENANTHATE,TESTOSTERONE-ENANTHATE
REP.PRIMARY,2.5,MAN2A1,ALPHA MANNOSIDASE INHIBITOR,BRD:BRD-K89665618-003-02-5,1-DEOXYMANNOJIRIMYCIN,1-DEOXYMANNOJIRIMYCIN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K89704198-001-12-3,VINCAMINE,VINCAMINE
REP.PRIMARY,2.5,OXGR1,,BRD:BRD-K89712525-001-02-1,2-OXOGLUTARIC-ACID,2-OXOGLUTARIC-ACID
REP.PRIMARY,2.5,ALOX5,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-K89714990-001-01-5,TEPOXALIN,TEPOXALIN
REP.PRIMARY,2.5,"ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K89732114-300-14-7,TRIFLUOPERAZINE,TRIFLUOPERAZINE
REP.PRIMARY,2.5,"FPGS, TYMS",THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K89839824-001-05-3,RALTITREXED,RALTITREXED
REP.PRIMARY,2.5,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K89917372-001-01-2,RETIGABINE,RETIGABINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K89997465-003-43-0,CHLORPROMAZINE,CHLORPROMAZINE
REP.PRIMARY,2.5,,THIAMINE UPTAKE BLOCKER,BRD:BRD-K90027121-003-01-7,AMPROLIUM,AMPROLIUM
REP.PRIMARY,2.5,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K90027355-001-13-3,SPIRONOLACTONE,SPIRONOLACTONE
REP.PRIMARY,2.5,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K90027355-001-19-0,SPIRONOLACTONE,SPIRONOLACTONE
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K90065682-300-02-6,5-IODO-A-85380,5-IODO-A-85380
REP.PRIMARY,2.5,,,BRD:BRD-K90168339-001-08-6,THIOPHANATE,THIOPHANATE
REP.PRIMARY,2.5,"ESR1, ESR2",SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K90195324-003-02-5,BAZEDOXIFENE,BAZEDOXIFENE
REP.PRIMARY,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K90239174-001-01-8,AMG-487,AMG-487
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K90333595-003-21-4,PHENTOLAMINE,PHENTOLAMINE
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K90374350-001-09-2,CHLORQUINALDOL,CHLORQUINALDOL
REP.PRIMARY,2.5,"PLK1, PLK3",PLK INHIBITOR,BRD:BRD-K90382497-001-10-7,GW-843682X,GW-843682X
REP.PRIMARY,2.5,PDPK1,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K90497590-001-04-2,AR-12,AR-12
REP.PRIMARY,2.5,PDE5A,"PHOSPHODIESTERASE INHIBITOR, PLATELET AGGREGATION INHIBITOR",BRD:BRD-K90524085-001-07-8,MY-5445,MY-5445
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K90574421-001-03-5,IPSAPIRONE,IPSAPIRONE
REP.PRIMARY,2.5,SQLE,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K90630139-003-05-9,BUTENAFINE,BUTENAFINE
REP.PRIMARY,2.5,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K90647725-001-06-5,OLEANOLIC-ACID,OLEANOLIC-ACID
REP.PRIMARY,2.5,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K90647725-001-07-3,OLEANOLIC-ACID,OLEANOLIC-ACID
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K90777969-300-01-2,CUTAMESINE,CUTAMESINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4","ADRENERGIC INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K90789829-001-07-8,NEFAZODONE,NEFAZODONE
REP.PRIMARY,2.5,,ATPASE INHIBITOR,BRD:BRD-K90817094-001-02-6,BEDAQUILINE,BEDAQUILINE
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K90825648-001-02-0,RS-127445,RS-127445
REP.PRIMARY,2.5,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K90868879-001-03-8,CANAGLIFLOZIN,CANAGLIFLOZIN
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K90885812-004-24-2,PROPANTHELINE,PROPANTHELINE
REP.PRIMARY,2.5,,"DNA ALKYLATING AGENT, DNA INHIBITOR",BRD:BRD-K90947825-001-02-7,CARBOPLATIN,CARBOPLATIN
REP.PRIMARY,2.5,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K90948141-001-01-4,INDIPLON,INDIPLON
REP.PRIMARY,2.5,"FLT1, FLT4, KDR",VEGFR INHIBITOR,BRD:BRD-K90993449-001-02-7,KRN-633,KRN-633
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K91065602-003-05-5,VANCOMYCIN,VANCOMYCIN
REP.PRIMARY,2.5,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K91111634-001-01-2,ROTIGOTINE,ROTIGOTINE
REP.PRIMARY,2.5,,,BRD:BRD-K91147684-001-01-5,M-THP,M-THP
REP.PRIMARY,2.5,"CALCRL, RAMP1",CALCITONIN ANTAGONIST,BRD:BRD-K91159026-001-01-7,TELCAGEPANT,TELCAGEPANT
REP.PRIMARY,2.5,CTSG,PROTEASE INHIBITOR,BRD:BRD-K91188791-001-18-3,ALOXISTATIN,ALOXISTATIN
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4",TRICYCLIC ANTIDEPRESSANT,BRD:BRD-K91263825-003-21-4,NORTRIPTYLINE,NORTRIPTYLINE
REP.PRIMARY,2.5,HNMT,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K91290917-300-01-8,AMODIAQUINE,AMODIAQUINE
REP.PRIMARY,2.5,SIGMAR1,"BRADYKININ RECEPTOR ANTAGONIST, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K91301684-003-05-5,NOSCAPINE,NOSCAPINE
REP.PRIMARY,2.5,,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K91308639-001-02-7,APALUTAMIDE,APALUTAMIDE
REP.PRIMARY,2.5,"HRH1, HRH3","HISTAMINE RECEPTOR AGONIST, HISTAMINE RECEPTOR ANTAGONIST",BRD:BRD-K91315211-300-05-7,BETAHISTINE,BETAHISTINE
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K91336023-003-01-0,MESULERGINE,MESULERGINE
REP.PRIMARY,2.5,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1",DNA SYNTHESIS INHIBITOR,BRD:BRD-K91370081-001-25-1,ANISOMYCIN,ANISOMYCIN
REP.PRIMARY,2.5,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K91422571-001-01-8,TROMARIL,TROMARIL
REP.PRIMARY,2.5,MME,NEPRILYSIN INHIBITOR,BRD:BRD-K91456750-238-01-7,SACUBITRIL,SACUBITRIL
REP.PRIMARY,2.5,,MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-K91495480-001-02-2,AGP-103,AGP-103
REP.PRIMARY,2.5,"ATP5A1, ATP5B, ATP5C1, IRF3",SYK INHIBITOR,BRD:BRD-K91509126-001-23-6,PICEATANNOL,PICEATANNOL
REP.PRIMARY,2.5,,IMMUNOSTIMULANT,BRD:BRD-K91544578-001-03-8,NIKETHAMIDE,NIKETHAMIDE
REP.PRIMARY,2.5,"HPRT1, IMPDH1, IMPDH2, PPAT","IMMUNOSUPPRESSANT, PROTEIN SYNTHESIS INHIBITOR, PURINE ANTAGONIST",BRD:BRD-K91601245-001-12-0,MERCAPTOPURINE,MERCAPTOPURINE
REP.PRIMARY,2.5,,GAMMA HYDROXYBUTYRIC ACID LIGAND,BRD:BRD-K91614056-001-02-2,TRANS-4-HYDROXYCROTONIC-ACID,TRANS-4-HYDROXYCROTONIC-ACID
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K91623615-001-05-0,ABT-751,ABT-751
REP.PRIMARY,2.5,SCN5A,LOCAL ANESTHETIC,BRD:BRD-K91699951-001-10-2,BENZONATATE,BENZONATATE
REP.PRIMARY,2.5,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1",MEK INHIBITOR,BRD:BRD-K91701654-001-03-1,U-0126,U-0126
REP.PRIMARY,2.5,CTSL,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K91740057-001-19-8,FELBINAC,FELBINAC
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K91758890-001-10-0,4-HQN,4-HQN
REP.PRIMARY,2.5,"DCK, TK2",DNA POLYMERASE INHIBITOR,BRD:BRD-K91822704-003-07-2,TORCITABINE,TORCITABINE
REP.PRIMARY,2.5,CCR1,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K91825936-001-01-2,ZK811752,"ZK-811752, ZK811752"
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K91868854-001-03-6,2-[1-(4-PIPERONYL)PIPERAZINYL]BENZOTHIAZOLE,2-[1-(4-PIPERONYL)PIPERAZINYL]BENZOTHIAZOLE
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K91904471-001-02-4,SD-169,SD-169
REP.PRIMARY,2.5,"CNR1, GPR18, GPR55",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K92000912-001-12-6,AM-251,AM-251
REP.PRIMARY,2.5,,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K92015269-300-01-2,GBR-12783,GBR-12783
REP.PRIMARY,2.5,MGMT,O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR,BRD:BRD-K92041145-001-09-5,O6-BENZYLGUANINE,O6-BENZYLGUANINE
REP.PRIMARY,2.5,"SCNN1A, SCNN1B, SCNN1D, SCNN1G",SODIUM CHANNEL BLOCKER,BRD:BRD-K92049597-001-20-8,TRIAMTERENE,TRIAMTERENE
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K92073408-001-16-5,NORETHINDRONE,NORETHINDRONE
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K92093830-003-30-8,DOXORUBICIN,DOXORUBICIN
REP.PRIMARY,2.5,"FKBP1A, MTOR",CALCINEURIN INHIBITOR,BRD:BRD-K92107055-001-01-9,PIMECROLIMUS,PIMECROLIMUS
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K92116564-001-01-4,ISOXEPAC,ISOXEPAC
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K92150287-066-01-2,EXATECAN-MESYLATE,EXATECAN-MESYLATE
REP.PRIMARY,2.5,MTTP,MICROSOMAL TRIGYLCERIDE TRANSFER PROTEIN INHIBITOR,BRD:BRD-K92213669-001-01-3,LOMITAPIDE,LOMITAPIDE
REP.PRIMARY,2.5,"ANPEP, LAP3, NPEPPS",PEPTIDASE INHIBITOR,BRD:BRD-K92241597-001-06-0,TOSEDOSTAT,TOSEDOSTAT
REP.PRIMARY,0.25,HPGD,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K92301463-001-05-5,"16,16-DIMETHYLPROSTAGLANDIN-E2","16,16-DIMETHYLPROSTAGLANDIN-E2"
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K92303087-001-01-6,OGLEMILAST,OGLEMILAST
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K92382976-050-01-1,5-CARBOXAMIDOTRYPTAMINE,5-CARBOXAMIDOTRYPTAMINE
REP.PRIMARY,2.5,"FOLH1, GRIA2, GRIK1, GRIK2, GRM1, GRM2, GRM3, GRM5, GRM7, GRM8",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K92404805-001-07-0,L-QUISQUALIC-ACID,L-QUISQUALIC-ACID
REP.PRIMARY,2.5,"IMPDH1, IMPDH2","DEHYDROGENASE INHIBITOR, INOSITOL MONOPHOSPHATASE INHIBITOR",BRD:BRD-K92428153-001-04-4,MYCOPHENOLATE-MOFETIL,MYCOPHENOLATE-MOFETIL
REP.PRIMARY,2.5,PLK1,PLK INHIBITOR,BRD:BRD-K92428232-001-10-6,GSK461364,GSK461364
REP.PRIMARY,2.5,"RXRA, RXRB, RXRG",RETINOID RECEPTOR AGONIST,BRD:BRD-K92441787-001-04-1,BEXAROTENE,BEXAROTENE
REP.PRIMARY,2.5,"HCN1, HCN2, HCN3, HCN4",HCN CHANNEL BLOCKER,BRD:BRD-K92446736-003-02-2,ZATEBRADINE,ZATEBRADINE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K92467929-001-01-1,OXANDROLONE,OXANDROLONE
REP.PRIMARY,2.5,"LTB4R, LTB4R2",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K92492521-001-02-9,LY255283,LY255283
REP.PRIMARY,2.5,"GRIA2, GRIN1",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K92493880-001-03-0,AMPA-(S),AMPA-(S)
REP.PRIMARY,2.5,SLC6A3,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K92577649-300-01-2,GBR-13069,GBR-13069
REP.PRIMARY,2.5,"DRD2, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K92588747-051-02-7,2-CMDO,2-CMDO
REP.PRIMARY,2.5,MAOB,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, GLUTAMATE INHIBITOR, MONOAMINE OXIDASE INHIBITOR",BRD:BRD-K92613113-066-02-7,SAFINAMIDE,SAFINAMIDE
REP.PRIMARY,2.5,"GABRA1, GABRB1, GABRG2, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K92657060-001-05-7,ZALEPLON,ZALEPLON
REP.PRIMARY,2.5,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-06-7,IMATINIB,IMATINIB
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K92731339-227-04-9,PERINDOPRIL,PERINDOPRIL
REP.PRIMARY,1.44,AADACL2,NFKB PATHWAY INHIBITOR,BRD:BRD-K92758126-001-18-8,MD-920,MD-920
REP.PRIMARY,2.5,"BLVRB, RFK","VITAMIN B, VITAMIN B2",BRD:BRD-K92760278-001-07-3,RIBOFLAVIN,RIBOFLAVIN
REP.PRIMARY,2.5,"KCNQ1, PTGS1, PTGS2, TRPM3",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K92778217-001-32-7,MEFENAMIC-ACID,MEFENAMIC-ACID
REP.PRIMARY,2.5,"ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K92830582-003-10-5,PROPRANOLOL-(R),PROPRANOLOL-(R)
REP.PRIMARY,2.5,NR1I2,RNA SYNTHESIS INHIBITOR,BRD:BRD-K92838188-001-01-9,RIFAXIMIN,RIFAXIMIN
REP.PRIMARY,2.5,,,BRD:BRD-K92844263-001-09-8,TRIACETIN,TRIACETIN
REP.PRIMARY,2.5,"AOC1, PRDX5, PRSS1",ANGIOTENSIN CONVERTING ENZYME ACTIVATOR,BRD:BRD-K92848252-001-01-9,DIMINAZENE-ACETURATE,DIMINAZENE-ACETURATE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K92872987-001-02-9,CEFPIRAMIDE,CEFPIRAMIDE
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K92968657-001-01-6,TIRAPAZAMINE,TIRAPAZAMINE
REP.PRIMARY,2.5,PNP,,BRD:BRD-K92976206-001-01-5,GUANOSINE,GUANOSINE
REP.PRIMARY,2.5,HK2,HEXOKINASE INHIBITOR,BRD:BRD-K92980438-001-03-3,3-BROMOPYRUVATE,3-BROMOPYRUVATE
REP.PRIMARY,2.5,"DRD2, HTR2A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K92984783-003-05-7,MELPERONE,MELPERONE
REP.PRIMARY,2.5,,CONTRAST AGENT,BRD:BRD-K92988025-001-01-9,PERFLUBRON,PERFLUBRON
REP.PRIMARY,2.5,CASP3,CASPASE ACTIVATOR,BRD:BRD-K92991072-001-04-9,PAC-1,PAC-1
REP.PRIMARY,2.5,"ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B","ADENOSINE DEAMINASE INHIBITOR, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-K93034159-001-25-8,CLADRIBINE,CLADRIBINE
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K93035859-001-07-6,BUTYLATED-HYDROXYANISOLE,BUTYLATED-HYDROXYANISOLE
REP.PRIMARY,2.5,ADORA2A,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K93045741-001-01-0,TOZADENANT,TOZADENANT
REP.PRIMARY,2.5,BRAF,"RAF INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K93123848-001-04-1,RAF265,RAF265
REP.PRIMARY,2.5,"RARA, RARB",RETINOID RECEPTOR AGONIST,BRD:BRD-K93176058-001-03-6,AC-55649,AC-55649
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K93188295-300-02-2,ARC-239,ARC-239
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K93208532-001-02-5,APREMILAST,APREMILAST
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K93231391-300-05-6,ETHAMBUTOL,ETHAMBUTOL
REP.PRIMARY,2.5,,,BRD:BRD-K93240442-001-08-4,DINITOLMIDE,DINITOLMIDE
REP.PRIMARY,2.5,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K93255255-001-02-1,INDOXIMOD,INDOXIMOD
REP.PRIMARY,2.5,"NCOA2, PPARG, RXRA",PPAR RECEPTOR ANTAGONIST,BRD:BRD-K93258693-001-17-3,GW-9662,GW-9662
REP.PRIMARY,2.5,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K93441486-067-12-8,DIPHEMANIL,DIPHEMANIL
REP.PRIMARY,2.5,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","SEROTONIN RECEPTOR ANTAGONIST, SODIUM CHANNEL BLOCKER",BRD:BRD-K93460210-001-23-7,LAMOTRIGINE,LAMOTRIGINE
REP.PRIMARY,2.5,"DRD2, HTR1A",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K93461745-003-25-0,BUSPIRONE,BUSPIRONE
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K93468883-001-02-0,IPI-145,"DUVELISIB, IPI-145"
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K93502141-001-01-6,AMYLENE-HYDRATE,AMYLENE-HYDRATE
REP.PRIMARY,2.5,,BACTERIAL ANTIFOLATE,BRD:BRD-K93524252-001-24-7,SULFAMERAZINE,SULFAMERAZINE
REP.PRIMARY,2.5,"ANXA1, NOS2, NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K93568044-001-32-0,HYDROCORTISONE,HYDROCORTISONE
REP.PRIMARY,2.5,,,BRD:BRD-K93611241-001-02-2,DIACETAMATE,DIACETAMATE
REP.PRIMARY,2.5,,BONE RESORPTION INHIBITOR,BRD:BRD-K93618743-001-21-0,IPRIFLAVONE,IPRIFLAVONE
REP.PRIMARY,2.5,,,BRD:BRD-K93631643-001-02-4,HORDENINE,HORDENINE
REP.PRIMARY,2.5,"AKR1C1, ASIC3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K93632104-001-17-2,SODIUM-SALICYLATE,"SALICYLIC-ACID, SODIUM-SALICYLATE"
REP.PRIMARY,2.5,"AKR1C1, ASIC3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K93632104-001-18-0,SODIUM-SALICYLATE,"SALICYLIC-ACID, SODIUM-SALICYLATE"
REP.PRIMARY,2.5,"PDE11A, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K93645900-001-11-3,TADALAFIL,TADALAFIL
REP.PRIMARY,2.5,"EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ","ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",BRD:BRD-K93754473-048-20-2,TAMOXIFEN,TAMOXIFEN
REP.PRIMARY,2.5,,NEURAMINIDASE INHIBITOR,BRD:BRD-K93767137-001-01-1,OSELTAMIVIR-CARBOXYLATE,OSELTAMIVIR-CARBOXYLATE
REP.PRIMARY,2.5,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCG",PKC ACTIVATOR,BRD:BRD-K93779381-001-01-9,INGENOL-MEBUTATE,INGENOL-MEBUTATE
REP.PRIMARY,2.5,,OPIOID RECEPTOR AGONIST,BRD:BRD-K93806173-003-01-8,N-MPPP,N-MPPP
REP.PRIMARY,2.5,TRHR,THYROTROPIN RELEASING HORMONE RECEPTOR AGONIST,BRD:BRD-K93869735-001-01-1,TALTIRELIN,TALTIRELIN
REP.PRIMARY,2.5,,"DNA DIRECTED DNA POLYMERASE INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K93880783-001-26-6,STAVUDINE,STAVUDINE
REP.PRIMARY,2.5,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET",FLT3 INHIBITOR,BRD:BRD-K93918653-001-08-9,QUIZARTINIB,QUIZARTINIB
REP.PRIMARY,0.25,TRPM3,PKC INHIBITOR,BRD:BRD-K93944989-001-08-0,SAFINGOL,SAFINGOL
REP.PRIMARY,2.5,,IONOTROPIC RECEPTOR IR40A ACTIVATOR,BRD:BRD-K94080537-001-09-7,DIETHYLTOLUAMIDE,DIETHYLTOLUAMIDE
REP.PRIMARY,2.5,,NICOTINE METABOLITE,BRD:BRD-K94144010-001-13-9,COTININE,COTININE
REP.PRIMARY,2.5,"GSK3B, JUN, MYC",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K94176593-001-09-4,TWS-119,TWS-119
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K94239562-001-05-5,PAEONOL,PAEONOL
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K94266545-001-24-1,RONIDAZOLE,RONIDAZOLE
REP.PRIMARY,2.5,,CMV TERMINASE INHIBITOR,BRD:BRD-K94288301-001-01-7,LETERMOVIR,LETERMOVIR
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K94293891-001-01-3,SUVOREXANT,SUVOREXANT
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K94353609-001-21-6,FLUOCINOLONE-ACETONIDE,FLUOCINOLONE-ACETONIDE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K94358652-001-02-1,DAPTOMYCIN,DAPTOMYCIN
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K94379058-001-06-8,BML-190,BML-190
REP.PRIMARY,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K94420399-001-01-9,PF-04136309,PF-04136309
REP.PRIMARY,2.5,AHR,"ARYL HYDROCARBON RECEPTOR AGONIST, CAPILLARY STABILIZING AGENT",BRD:BRD-K94436377-001-10-2,DIOSMIN,DIOSMIN
REP.PRIMARY,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K94441233-001-13-0,MEVASTATIN,MEVASTATIN
REP.PRIMARY,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K94441233-001-17-1,MEVASTATIN,MEVASTATIN
REP.PRIMARY,2.5,CTNNB1,BETA-CATENIN INHIBITOR,BRD:BRD-K94455792-001-01-8,ICG-001,ICG-001
REP.PRIMARY,2.5,,UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR,BRD:BRD-K94485812-001-02-9,LDN-57444,LDN-57444
REP.PRIMARY,2.5,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K94534639-001-02-5,LY2811376,LY2811376
REP.PRIMARY,2.5,TPH1,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K94559059-091-01-6,TELOTRISTAT-ETHYL,TELOTRISTAT-ETHYL
REP.PRIMARY,2.5,ADIPOR2,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K94649603-001-10-6,TAXIFOLIN,TAXIFOLIN
REP.PRIMARY,1.95,CYP1B1,CYTOCHROME P450 INHIBITOR,BRD:BRD-K94689771-001-09-0,PINOCEMBRIN,PINOCEMBRIN
REP.PRIMARY,2.5,,ANTISPASMODIC,BRD:BRD-K94720315-001-10-4,CHROMOCARB,CHROMOCARB
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K94723713-001-10-6,RUTAECARPINE,RUTAECARPINE
REP.PRIMARY,2.5,PTPN1,NITRIC OXIDE STIMULANT,BRD:BRD-K94780074-001-06-7,S-NITROSOGLUTATHIONE,S-NITROSOGLUTATHIONE
REP.PRIMARY,2.5,DMD,"CFTR CHANNEL AGONIST, DYSTROPHIN STIMULANT",BRD:BRD-K94830329-001-03-0,ATALUREN,ATALUREN
REP.PRIMARY,2.5,"ESR1, ESR2",ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K94832621-001-02-3,Y-134,Y-134
REP.PRIMARY,5,,CATHEPSIN INHIBITOR,BRD:BRD-K95015809-001-02-8,2-CYANOPYRIMIDINE,2-CYANOPYRIMIDINE
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K95053546-001-01-9,TEMPOL,TEMPOL
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K95053546-001-02-7,TEMPOL,TEMPOL
REP.PRIMARY,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K95053546-001-03-5,TEMPOL,TEMPOL
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K95110148-003-01-5,BETA-FUNALTREXAMINE,BETA-FUNALTREXAMINE
REP.PRIMARY,2.5,PARP2,PARP INHIBITOR,BRD:BRD-K95142244-001-01-5,TALAZOPARIB,TALAZOPARIB
REP.PRIMARY,2.5,,,BRD:BRD-K95161686-001-02-8,OCTISALATE,OCTISALATE
REP.PRIMARY,2.5,"PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1",URICOSURIC BLOCKER,BRD:BRD-K95237249-001-26-5,PROBENECID,PROBENECID
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K95260951-050-03-1,ASENAPINE,ASENAPINE
REP.PRIMARY,2.5,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K95292280-001-01-3,SB-657510,SB-657510
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K95309561-001-24-7,DIENESTROL,DIENESTROL
REP.PRIMARY,2.5,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K95412502-003-01-5,ISTAROXIME,ISTAROXIME
REP.PRIMARY,2.5,MET,C-MET INHIBITOR,BRD:BRD-K95435023-001-08-5,PHA-665752,PHA-665752
REP.PRIMARY,2.5,MET,C-MET INHIBITOR,BRD:BRD-K95435023-001-10-1,PHA-665752,PHA-665752
REP.PRIMARY,2.5,GPR119,TRPV AGONIST,BRD:BRD-K95523387-001-09-6,OLDA,OLDA
REP.PRIMARY,2.5,PFKFB3,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K95573441-001-01-2,PFK-015,PFK-015
REP.PRIMARY,2.5,TRPV4,TRPV ANTAGONIST,BRD:BRD-K95581532-001-01-5,RN-1734,RN-1734
REP.PRIMARY,2.5,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K95600043-001-01-5,NPY-5RA972,NPY-5RA972
REP.PRIMARY,2.5,KCNMA1,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K95609758-001-03-7,BMS-191011,BMS-191011
REP.PRIMARY,2.5,"DRD2, SLC18A1, SLC18A2",VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K95739795-001-03-7,TETRABENAZINE,TETRABENAZINE
REP.PRIMARY,2.5,PDGFRA,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K95763993-001-19-3,TRAPIDIL,TRAPIDIL
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K95773607-004-03-8,DARIFENACIN,DARIFENACIN
REP.PRIMARY,2.5,"SLC19A2, SLC19A3, TPK1",VITAMIN B,BRD:BRD-K95785345-300-14-8,THIAMINE,THIAMINE
REP.PRIMARY,2.5,"ABL1, LCK, LYN, RIPK2, SRC",SRC INHIBITOR,BRD:BRD-K95785537-001-23-1,PP-2,PP-2
REP.PRIMARY,2.5,HCRTR2,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K95828359-001-01-0,MK-3697,MK-3697
REP.PRIMARY,2.5,OPRK1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K95837862-300-01-7,JDTIC,JDTIC
REP.PRIMARY,2.5,GABBR1,GABA RECEPTOR MODULATOR,BRD:BRD-K95851186-001-07-8,CGP-13501,CGP-13501
REP.PRIMARY,2.5,"MAPK11, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K95880107-001-02-4,PH-797804,PH-797804
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K95899059-003-02-8,LY344864,LY344864
REP.PRIMARY,2.5,"PIK3CA, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K95901403-001-04-5,XL147,"XL-147, XL147"
REP.PRIMARY,2.5,"SLC18A1, SLC18A2",VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K95921201-001-14-6,RESERPINE,RESERPINE
REP.PRIMARY,2.5,SIRT1,SIRT ACTIVATOR,BRD:BRD-K95926480-003-03-6,SRT1720,SRT1720
REP.PRIMARY,2.5,,NERVE GROWTH FACTOR AGONIST,BRD:BRD-K95957366-001-02-6,ISAXONINE,ISAXONINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K96006502-001-02-6,DEFLAZACORT,DEFLAZACORT
REP.PRIMARY,2.5,,GLYCOSYLATION INHIBITOR,BRD:BRD-K96029467-003-01-9,ALAGEBRIUM,ALAGEBRIUM
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96042922-001-09-8,ETANIDAZOLE,ETANIDAZOLE
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K96055017-003-02-7,1-ACETYL-4-METHYLPIPERAZINE,1-ACETYL-4-METHYLPIPERAZINE
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K96104201-001-01-5,AZALOMYCIN-B,AZALOMYCIN-B
REP.PRIMARY,2.5,DHODH,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K96123349-236-02-8,BREQUINAR,BREQUINAR
REP.PRIMARY,2.5,HSD11B1,GAP JUNCTION MODULATOR,BRD:BRD-K96137854-001-17-1,ENOXOLONE,ENOXOLONE
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K96153583-001-05-1,CIDOFOVIR,CIDOFOVIR
REP.PRIMARY,2.5,,DNA POLYMERASE INHIBITOR,BRD:BRD-K96159438-001-06-3,ADEFOVIR-DIPIVOXIL,ADEFOVIR-DIPIVOXIL
REP.PRIMARY,2.5,RELA,HIV INTEGRASE INHIBITOR,BRD:BRD-K96188950-001-16-9,CAFFEIC-ACID-PHENETHYL-ESTER,CAFFEIC-ACID-PHENETHYL-ESTER
REP.PRIMARY,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-K96194081-001-10-2,CEPHARANTHINE,CEPHARANTHINE
REP.PRIMARY,2.5,,,BRD:BRD-K96233303-001-01-9,TMS,TMS
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K96253961-046-03-1,METARAMINOL,METARAMINOL
REP.PRIMARY,2.5,IL17A,INTERLEUKIN INHIBITOR,BRD:BRD-K96259238-001-01-4,Y-320,Y-320
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K96263742-001-14-8,GW-7647,GW-7647
REP.PRIMARY,2.5,,,BRD:BRD-K96299080-001-02-7,NEOHESPERIDIN,NEOHESPERIDIN
REP.PRIMARY,2.5,"MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4","DOPAMINE UPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K96319534-003-03-9,PHENTERMINE,PHENTERMINE
REP.PRIMARY,0.94,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K96358241-001-01-9,HARRINGTONINE,HARRINGTONINE
REP.PRIMARY,2.5,,,BRD:BRD-K96391852-001-02-8,ALOPERINE,ALOPERINE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K96424892-001-02-9,CHLORAMPHENICOL-PALMITATE,CHLORAMPHENICOL-PALMITATE
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K96436774-001-01-8,PELANSERIN,PELANSERIN
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K96550715-001-02-6,LINAGLIPTIN,LINAGLIPTIN
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K96615647-001-01-2,AV-608,AV-608
REP.PRIMARY,2.5,,ANTITUMOR AGENT,BRD:BRD-K96631475-001-02-4,10-DEACETYLBACCATIN,10-DEACETYLBACCATIN
REP.PRIMARY,2.5,,ANTITUMOR AGENT,BRD:BRD-K96631475-001-04-0,10-DEACETYLBACCATIN,10-DEACETYLBACCATIN
REP.PRIMARY,2.5,FASN,NITRIC OXIDE DONOR,BRD:BRD-K96671969-001-03-1,PRETOMANID,"PA-824, PRETOMANID"
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K96714749-001-01-0,ISOBUTAMBEN,ISOBUTAMBEN
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2, OXTR",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K96720755-001-02-6,RELCOVAPTAN,RELCOVAPTAN
REP.PRIMARY,2.5,"CHRM3, DRD2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K96740444-001-02-1,ITOPRIDE,ITOPRIDE
REP.PRIMARY,2.5,SLC1A2,GLUTAMATE INHIBITOR,BRD:BRD-K96758128-001-01-8,WAY-213613,WAY-213613
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96786677-236-02-4,OXACILLIN,OXACILLIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96786677-323-02-0,OXACILLIN,OXACILLIN
REP.PRIMARY,2.5,"HSPA1A, TP53",HSP INHIBITOR,BRD:BRD-K96799727-001-06-6,PIFITHRIN-MU,PIFITHRIN-MU
REP.PRIMARY,2.5,"ALOX5, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K96809896-300-02-3,SKF-86002,SKF-86002
REP.PRIMARY,2.5,"FURIN, TNF",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K96862998-001-15-5,PIRFENIDONE,PIRFENIDONE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6",GABA BENZODIAZEPINE SITE RECEPTOR PARTIAL AGONIST,BRD:BRD-K96936751-001-01-4,BRETAZENIL,BRETAZENIL
REP.PRIMARY,2.5,,,BRD:BRD-K97009491-238-03-8,CALCIUM-LEVOFOLINATE,CALCIUM-LEVOFOLINATE
REP.PRIMARY,2.5,CYP3A4,CHELATING AGENT,BRD:BRD-K97010173-001-04-1,DEFERASIROX,DEFERASIROX
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K97019106-005-02-9,"4-ACETYL-1,1-DIMETHYLPIPERAZINIUM","4-ACETYL-1,1-DIMETHYLPIPERAZINIUM"
REP.PRIMARY,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K97025174-001-01-4,CAPADENOSON,CAPADENOSON
REP.PRIMARY,2.5,,,BRD:BRD-K97028990-001-04-4,QUININE-ETHYL-CARBONATE,QUININE-ETHYL-CARBONATE
REP.PRIMARY,2.5,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K97045029-001-02-7,PRANLUKAST,PRANLUKAST
REP.PRIMARY,2.5,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K97045029-001-04-3,PRANLUKAST,PRANLUKAST
REP.PRIMARY,2.5,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K97056771-001-13-1,GNF-2,GNF-2
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97061094-001-21-4,AZACYCLONOL,AZACYCLONOL
REP.PRIMARY,2.5,"CLK1, CLK4, DYRK1A, DYRK1B",CLK INHIBITOR,BRD:BRD-K97072811-001-11-4,TG-003,TG-003
REP.PRIMARY,2.5,,CFTR CHANNEL AGONIST,BRD:BRD-K97101532-001-02-8,TEZACAFTOR,TEZACAFTOR
REP.PRIMARY,2.5,"AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1",CASEIN KINASE INHIBITOR,BRD:BRD-K97118047-001-03-8,"4,5,6,7-TETRABROMOBENZOTRIAZOLE","4,5,6,7-TETRABROMOBENZOTRIAZOLE"
REP.PRIMARY,2.5,"ADRA1A, DRD2, DRD3, DRD4, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97158071-001-18-1,DROPERIDOL,DROPERIDOL
REP.PRIMARY,2.5,"ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13",METALLIC RADICAL FORMATION STIMULANT,BRD:BRD-K97163964-001-03-3,L-ASPARTIC-ACID,L-ASPARTIC-ACID
REP.PRIMARY,2.5,"AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2",SODIUM CHANNEL BLOCKER,BRD:BRD-K97181089-003-24-7,AMILORIDE,AMILORIDE
REP.PRIMARY,2.5,"CACNA1C, CACNA1G",CALCIUM CHANNEL BLOCKER,BRD:BRD-K97181463-003-01-1,BENIDIPINE,BENIDIPINE
REP.PRIMARY,2.5,,CONTRACEPTIVE AGENT,BRD:BRD-K97197005-001-03-2,GESTODENE,GESTODENE
REP.PRIMARY,2.5,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K97233161-003-01-5,ABT-491,ABT-491
REP.PRIMARY,2.5,"DRD1, DRD2, HRH1, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97309399-001-09-4,THIOTHIXENE,THIOTHIXENE
REP.PRIMARY,2.5,,PI3K INHIBITOR,BRD:BRD-K97365803-001-02-1,PI-828,PI-828
REP.PRIMARY,2.5,"ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1",POLAR AUXIN TRANSPORT INHIBITOR,BRD:BRD-K97399794-001-15-3,QUERCETIN,QUERCETIN
REP.PRIMARY,2.5,,,BRD:BRD-K97417064-001-02-4,ACEDAPSONE,ACEDAPSONE
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K97428065-001-01-2,NETUPITANT,NETUPITANT
REP.PRIMARY,2.5,"ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7","ADRENERGIC RECEPTOR ANTAGONIST, PROLACTIN INHIBITOR",BRD:BRD-K97440753-066-18-1,DIHYDROERGOCRISTINE,DIHYDROERGOCRISTINE
REP.PRIMARY,2.5,,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K97464279-001-03-5,DIAVERIDINE,DIAVERIDINE
REP.PRIMARY,2.5,"AR, ESR1, PGR",PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K97472745-001-01-8,GESTRINONE,GESTRINONE
REP.PRIMARY,2.5,,GLYCOLYSIS INHIBITOR,BRD:BRD-K97521363-001-16-1,CLORSULON,CLORSULON
REP.PRIMARY,2.5,"ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB","MELATONIN RECEPTOR AGONIST, NITRIC OXIDE SYNTHASE INHIBITOR",BRD:BRD-K97530723-001-20-9,MELATONIN,MELATONIN
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97564742-050-32-7,MEPYRAMINE,MEPYRAMINE
REP.PRIMARY,2.5,,CD ANTAGONIST,BRD:BRD-K97643133-003-09-3,AMIPRILOSE,AMIPRILOSE
REP.PRIMARY,2.5,USP7,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K97714174-001-01-3,P22077,P22077
REP.PRIMARY,2.5,"ABCC8, KCNJ10, KCNJ11",ATP CHANNEL BLOCKER,BRD:BRD-K97746869-001-27-0,CHLORPROPAMIDE,CHLORPROPAMIDE
REP.PRIMARY,2.5,KCNJ11,"NITRIC OXIDE DONOR, POTASSIUM CHANNEL ACTIVATOR",BRD:BRD-K97752965-001-16-4,NICORANDIL,NICORANDIL
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K97764662-001-17-3,PD-173074,PD-173074
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K97799481-001-16-0,THEOPHYLLINE,"AMINOPHYLLINE, THEOPHYLLINE"
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K97799481-230-01-7,THEOPHYLLINE,"AMINOPHYLLINE, THEOPHYLLINE"
REP.PRIMARY,2.5,"SLC2A1, SLC2A2, SLC2A3, SLC2A4",GLYCOLYSIS INHIBITOR,BRD:BRD-K97808269-001-02-7,2-DEOXYGLUCOSE,2-DEOXYGLUCOSE
REP.PRIMARY,2.5,"GPR97, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K97810537-001-12-8,BECLOMETHASONE-DIPROPIONATE,BECLOMETHASONE-DIPROPIONATE
REP.PRIMARY,2.5,"GPR97, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K97810537-001-13-6,BECLOMETHASONE-DIPROPIONATE,BECLOMETHASONE-DIPROPIONATE
REP.PRIMARY,2.5,,HIV ATTACHMENT INHIBITOR,BRD:BRD-K97883416-001-01-4,BMS-626529,BMS-626529
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K97884852-001-05-4,MALOTILATE,MALOTILATE
REP.PRIMARY,2.5,MET,HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K97963946-001-01-3,EMD-1214063,EMD-1214063
REP.PRIMARY,2.5,"HRH1, PTAFR","HISTAMINE RECEPTOR ANTAGONIST, PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K98004573-051-02-8,RUPATADINE,RUPATADINE
REP.PRIMARY,2.5,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K98143539-001-02-2,COMPOUND-W,COMPOUND-W
REP.PRIMARY,2.5,HTR1D,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K98155362-001-07-7,GR46611,GR46611
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K98157055-001-10-9,SIB-1757,SIB-1757
REP.PRIMARY,2.5,"KCNMA1, KCNN4",BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K98174813-001-18-0,CHLORZOXAZONE,CHLORZOXAZONE
REP.PRIMARY,2.5,"KDM6A, KDM6B",HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K98203492-003-04-1,GSK-J4,GSK-J4
REP.PRIMARY,2.5,"EGLN1, KDM2A, KDM5C",HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K98251413-001-04-0,IOX2,IOX2
REP.PRIMARY,2.5,EDNRB,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K98357249-001-02-9,IRL-2500,IRL-2500
REP.PRIMARY,2.5,PPARD,PPAR RECEPTOR AGONIST,BRD:BRD-K98372770-001-08-2,L-165041,L-165041
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K98384930-003-01-5,FINAFLOXACIN,FINAFLOXACIN
REP.PRIMARY,2.5,TRPA1,MTOR INHIBITOR,BRD:BRD-K98453471-001-01-7,SALIRASIB,SALIRASIB
REP.PRIMARY,2.5,"ALOX5, PTGS1, PTGS2",AKT INHIBITOR,BRD:BRD-K98493452-001-14-9,HONOKIOL,HONOKIOL
REP.PRIMARY,2.5,"NR3C1, NR3C2",MINERALOCORTICOID RECEPTOR AGONIST,BRD:BRD-K98521173-001-19-4,DESOXYCORTONE,DESOXYCORTONE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K98530306-003-18-3,CLONIDINE,CLONIDINE
REP.PRIMARY,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-K98548675-001-05-9,PARTHENOLIDE,PARTHENOLIDE
REP.PRIMARY,2.5,"EGFR, ERBB2, ERBB3",EGFR INHIBITOR,BRD:BRD-K98572433-001-02-9,AZD8931,AZD8931
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K98624455-074-02-8,BEPOTASTINE,BEPOTASTINE
REP.PRIMARY,2.5,PPARD,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K98684188-001-02-9,GSK0660,"GSK-0660, GSK0660"
REP.PRIMARY,2.5,"ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K98763141-001-30-8,NIFLUMIC-ACID,NIFLUMIC-ACID
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",BENZODIAZEPINE RECEPTOR ANTAGONIST,BRD:BRD-K98769987-001-23-7,FLUMAZENIL,FLUMAZENIL
REP.PRIMARY,2.5,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K98795921-001-01-7,SB-2343,SB-2343
REP.PRIMARY,2.5,GSTP1,GLUTATHIONE TRANSFERASE INHIBITOR,BRD:BRD-K98963219-001-01-2,EZATIOSTAT,EZATIOSTAT
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K99023089-001-03-7,AZD5363,AZD5363
REP.PRIMARY,2.5,,,BRD:BRD-K99048103-001-18-4,ACETARSOL,ACETARSOL
REP.PRIMARY,2.5,PNP,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K99063460-001-13-1,DIDANOSINE,DIDANOSINE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K99092662-001-01-1,PS178990,PS178990
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K99107520-001-24-1,FELBAMATE,FELBAMATE
REP.PRIMARY,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K99113996-001-02-0,AZD2014,AZD2014
REP.PRIMARY,2.5,"CALM1, SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K99121711-003-19-7,CINCHOCAINE,CINCHOCAINE
REP.PRIMARY,2.5,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K99149715-001-01-6,PLURISIN-1,"PLURISIN-#1, PLURISIN-1"
REP.PRIMARY,2.5,,P53 ACTIVATOR,BRD:BRD-K99170882-001-04-3,NSC-319726,NSC-319726
REP.PRIMARY,2.5,,CARDIOMYOGENESIS INDUCER,BRD:BRD-K99174507-003-02-0,CARDIOGENOL-C,CARDIOGENOL-C
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-K99241550-001-03-5,METRIZOIC-ACID,METRIZOIC-ACID
REP.PRIMARY,2.5,HRH1,ANTIHISTAMINE,BRD:BRD-K99300445-003-21-6,ANTAZOLINE,ANTAZOLINE
REP.PRIMARY,2.5,PYGM,,BRD:BRD-K99308954-304-02-4,SODIUM-MONOFLUOROPHOSPHATE,SODIUM-MONOFLUOROPHOSPHATE
REP.PRIMARY,2.5,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K99383816-001-02-7,FTORAFUR,FTORAFUR
REP.PRIMARY,2.5,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K99383816-001-03-5,FTORAFUR,FTORAFUR
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-K99451608-001-07-3,LOPINAVIR,LOPINAVIR
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K99475619-001-01-2,GENZ-644282,GENZ-644282
REP.PRIMARY,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K99498722-001-02-6,PLINABULIN,PLINABULIN
REP.PRIMARY,2.5,"GNRHR, LHCGR",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K99504665-001-01-2,GOSERELIN-ACETATE,GOSERELIN-ACETATE
REP.PRIMARY,2.5,"PTK2, PTK2B",FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K99545815-001-06-3,PF-562271,PF-562271
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K99604664-001-01-1,TANAPROGET,TANAPROGET
REP.PRIMARY,2.5,"ESR1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K99615199-001-18-5,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE
REP.PRIMARY,2.5,"ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K99621550-300-01-8,TUBOCURARINE,TUBOCURARINE
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K99622919-001-23-0,BUTACAINE,BUTACAINE
REP.PRIMARY,2.5,"SHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K99741577-001-01-7,SANT-1,SANT-1
REP.PRIMARY,2.5,"CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK","PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K99749624-001-07-0,LINIFANIB,LINIFANIB
REP.PRIMARY,2.5,"GLUD1, SDHD",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K99792991-001-34-9,HEXACHLOROPHENE,HEXACHLOROPHENE
REP.PRIMARY,2.5,KCNA5,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K99922388-001-02-0,DPO-1,DPO-1
REP.PRIMARY,2.5,TYR,LOCAL ANESTHETIC,BRD:BRD-K99946902-001-07-5,HEXYLRESORCINOL,HEXYLRESORCINOL
REP.PRIMARY,2.5,"ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK","ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR, SRC INHIBITOR",BRD:BRD-K99964838-001-11-9,BOSUTINIB,BOSUTINIB
REP.PRIMARY,2.5,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K99984802-100-13-5,FLUNIXIN-MEGLUMIN,FLUNIXIN-MEGLUMIN
REP.PRIMARY,2.5,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-M02075109-001-01-1,CHROMANOL-(+/-),CHROMANOL-(+/-)
REP.PRIMARY,2.5,,,BRD:BRD-M02179497-001-01-1,BISMUTH-OXALATE,BISMUTH-OXALATE
REP.PRIMARY,2.5,,,BRD:BRD-M08274809-001-01-7,INDIUM(III)-ISOPROPOXIDE,INDIUM(III)-ISOPROPOXIDE
REP.PRIMARY,2.5,,AKT INHIBITOR,BRD:BRD-M17926088-001-01-3,FPA-124,FPA-124
REP.PRIMARY,2.5,HCAR1,,BRD:BRD-M29182745-001-01-4,AMMONIUM-LACTATE,AMMONIUM-LACTATE
REP.PRIMARY,2.5,"GRM2, GRM3, GRM6, GRM7, GRM8",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-M29936662-001-02-0,CIS-ACPD,CIS-ACPD
REP.PRIMARY,2.5,GPER1,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-M30288325-001-01-4,G-15,G-15
REP.PRIMARY,2.5,SLC6A2,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-M39350793-334-01-1,REBOXETINE,REBOXETINE
REP.PRIMARY,2.5,,,BRD:BRD-M41245765-001-04-2,LITHIUM-CITRATE,LITHIUM-CITRATE
REP.PRIMARY,2.5,,,BRD:BRD-M54096567-001-01-9,SODIUM-GLUCONATE,SODIUM-GLUCONATE
REP.PRIMARY,2.5,,DIRECT SUBSTITUTION CATALYST,BRD:BRD-M56276249-001-01-1,BISMUTH(III)-TRIFLUOROMETHANESULFONATE,BISMUTH(III)-TRIFLUOROMETHANESULFONATE
REP.PRIMARY,2.5,"SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7",EXCITATORY AMINO ACID TRANSPORTER INHIBITOR,BRD:BRD-M77041484-001-01-8,TBOA-(DL),TBOA-(DL)
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-M80207679-001-01-5,NEMONAPRIDE,NEMONAPRIDE
REP.PRIMARY,2.5,KCNJ8,,BRD:BRD-M89827113-001-01-5,CROMAKALIM,CROMAKALIM
REP.PRIMARY,2.5,,,BRD:BRD-M92352362-002-02-3,TALC,TALC
REP.PRIMARY,2.5,"CACNA1C, CACNA1G","L-TYPE CALCIUM CHANNEL BLOCKER, T-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-M92675308-003-07-1,EFONIDIPINE-MONOETHANOLATE,EFONIDIPINE-MONOETHANOLATE
REP.PRIMARY,2.5,PDK1,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,BRD:BRD-M97302542-001-03-6,DICHLOROACETATE,DICHLOROACETATE
REP.PRIMARY,2.5,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-M98279124-300-01-1,CEVIMELINE,CEVIMELINE
REP.PRIMARY,2.5,,,BRD:BRD-U08520523-000-01-0,COLESEVALAM,COLESEVALAM
REP.PRIMARY,2.5,"LPL, NFKB2",NFKB PATHWAY INHIBITOR,BRD:BRD-U25960968-000-01-9,TYLOXAPOL,TYLOXAPOL
REP.PRIMARY,2.5,,PHOSPHATE ANTAGONIST,BRD:BRD-U45393375-000-01-6,SEVELAMER,SEVELAMER
REP.PRIMARY,2.5,"LPL, NFKB2",NFKB PATHWAY INHIBITOR,BRD:BRD-U48018661-000-01-9,TYLOXAPOL,TYLOXAPOL
REP.PRIMARY,2.5,PCTP,,BRD:BRD-U51753822-000-01-1,PHOSPHATIDYLCHOLINE,PHOSPHATIDYLCHOLINE
REP.PRIMARY,2.5,,IMMUNOSTIMULANT,BRD:BRD-A00055058-001-01-0,RS-0481,RS-0481
REP.PRIMARY,2.5,GPER1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A00842753-001-01-9,OLEUROPEIN,OLEUROPEIN
REP.PRIMARY,2.5,"ACADSB, BCAT1, BCAT2, IARS, IARS2",,BRD:BRD-A02232681-001-01-8,ISOLEUCINE,ISOLEUCINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04447196-001-01-8,GEPEFRINE,GEPEFRINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A04971881-003-01-3,CLORANOLOL,CLORANOLOL
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A08316590-001-01-3,BROXATEROL,BROXATEROL
REP.PRIMARY,2.5,FDFT1,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A08772153-001-02-4,SQ-109,SQ-109
REP.PRIMARY,2.5,,MELANOCYTE-STIMULATING HORMONE RELEASE INHIBITOR,BRD:BRD-A09911125-001-01-4,PROLYLLEUCYLGLYCINAMIDE,PROLYLLEUCYLGLYCINAMIDE
REP.PRIMARY,2.5,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A10188456-001-04-9,DEXAMETHASONE,DEXAMETHASONE
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-A10773072-001-03-4,GLYCEROL-MONOLAURATE,GLYCEROL-MONOLAURATE
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A13116749-003-01-6,MABUTEROL,MABUTEROL
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-A14577621-001-01-5,PEFICITINIB,PEFICITINIB
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A15687940-001-05-6,CLOFEDANOL,CLOFEDANOL
REP.PRIMARY,2.5,SLC12A3,SODIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-A15739803-001-01-0,POLYTHIAZIDE,POLYTHIAZIDE
REP.PRIMARY,2.5,,,BRD:BRD-A16263897-001-06-6,MISONIDAZOLE,MISONIDAZOLE
REP.PRIMARY,2.5,CYP3A4,CYTOCHROME P450 INHIBITOR,BRD:BRD-A17009129-001-01-3,ISAVUCONAZOLE,ISAVUCONAZOLE
REP.PRIMARY,2.5,"CACNA2D1, CACNG1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A18992208-003-02-7,LERCANIDIPINE,LERCANIDIPINE
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6","ADRENERGIC RECEPTOR ANTAGONIST, DOPAMINE RECEPTOR ANTAGONIST",BRD:BRD-A19053834-050-09-5,CLOROTEPINE,CLOROTEPINE
REP.PRIMARY,2.5,"GGCX, VKORC1, VKORC1L1",VITAMIN K,BRD:BRD-A19777893-236-01-9,MENADIONE-BISULFITE,MENADIONE-BISULFITE
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A21280314-001-06-8,NIFENALOL,NIFENALOL
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A21446384-001-01-1,XIBENOLOL,XIBENOLOL
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A21474126-001-01-6,METHOXYPHENAMINE,METHOXYPHENAMINE
REP.PRIMARY,2.5,"CHRM2, CHRM3, CHRNA2",NEUROMUSCULAR BLOCKER,BRD:BRD-A21544762-303-01-5,PIPECURONIUM,PIPECURONIUM
REP.PRIMARY,2.5,"ALK, FES, ROS1",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-A23124853-001-01-4,PF-06463922,PF-06463922
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A23418262-001-01-5,FLOCTAFENINE,FLOCTAFENINE
REP.PRIMARY,2.5,,,BRD:BRD-A24857382-001-03-4,N-ACETYL-TYROSINE,N-ACETYL-TYROSINE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A25492003-003-14-1,CHLORTETRACYCLINE,CHLORTETRACYCLINE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A27274504-001-01-6,BUTOFILOLOL,BUTOFILOLOL
REP.PRIMARY,2.5,CYP51A1,LANOSTEROL DEMETHYLASE INHIBITOR,BRD:BRD-A30774155-001-01-2,EFINACONAZOLE,EFINACONAZOLE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A31362467-065-01-3,CAPREOMYCIN,CAPREOMYCIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A33352494-316-01-6,ORITAVANCIN,ORITAVANCIN
REP.PRIMARY,2.5,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A33479817-003-03-7,TERODILINE,TERODILINE
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A33894669-065-01-9,HEXOPRENALINE,HEXOPRENALINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A34603619-001-01-9,TROPESIN,TROPESIN
REP.PRIMARY,2.5,PRNP,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A34788695-003-10-2,TETRACYCLINE,TETRACYCLINE
REP.PRIMARY,2.5,"SLC18A2, TAAR1",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A35667010-001-01-8,PROPYLHEXEDRINE,PROPYLHEXEDRINE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-A38706605-001-01-2,DROMOSTANOLONE-PROPIONATE,DROMOSTANOLONE-PROPIONATE
REP.PRIMARY,2.5,,,BRD:BRD-A40302156-001-01-9,A-33903,A-33903
REP.PRIMARY,2.5,CYP51A1,OTHER ANTIBIOTIC,BRD:BRD-A40546373-001-01-8,MORINIDAZOLE,MORINIDAZOLE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A41698174-003-12-0,BACAMPICILLIN,BACAMPICILLIN
REP.PRIMARY,2.5,SCN5A,ANTITUSSIVE,BRD:BRD-A42423104-001-01-4,BENPROPERINE,BENPROPERINE
REP.PRIMARY,2.5,"HTR1A, HTR2A, HTR2C, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A42881122-001-01-1,CYAMEMAZINE,CYAMEMAZINE
REP.PRIMARY,2.5,,,BRD:BRD-A44181516-001-01-8,FLUMECINOL,FLUMECINOL
REP.PRIMARY,2.5,"CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A44188509-001-01-2,AZD1446,AZD1446
REP.PRIMARY,2.5,KCNH2,"ANGIOGENESIS INHIBITOR, APOPTOSIS STIMULANT",BRD:BRD-A44511856-001-01-4,GINSENOSIDE-RG3,"GINSENOSIDE-RE3, GINSENOSIDE-RG3"
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-A44971162-001-02-7,ODM-201,"DAROLUTAMIDE, ODM-201"
REP.PRIMARY,2.5,"ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A46335897-003-27-8,PROMETHAZINE,PROMETHAZINE
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-A48376327-003-01-5,IGMESINE,IGMESINE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A48420483-001-02-3,BUPRANOLOL,BUPRANOLOL
REP.PRIMARY,2.5,,,BRD:BRD-A48938994-001-14-1,MONOCTANOIN,MONOCTANOIN
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A50675490-001-01-0,CARAZOLOL,CARAZOLOL
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1",SELECTIVE SEROTONIN REUPTAKE ENHANCER (SSRE),BRD:BRD-A53077924-001-01-2,TIANEPTINE,TIANEPTINE
REP.PRIMARY,2.5,"ADCY2, ADCY5",ADENYLYL CYCLASE ACTIVATOR,BRD:BRD-A55416093-001-06-4,COLFORSIN,COLFORSIN
REP.PRIMARY,2.5,"ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A56241705-003-01-2,TRIMETHOQUINOL,TRIMETHOQUINOL
REP.PRIMARY,2.5,"CHRM1, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A56613951-004-01-1,VALETHAMATE,VALETHAMATE
REP.PRIMARY,2.5,"ATP4A, ATP4B",PROTON PUMP INHIBITOR,BRD:BRD-A56892734-001-09-4,OMEPRAZOLE-MAGNESIUM,OMEPRAZOLE-MAGNESIUM
REP.PRIMARY,2.5,PIK3CD,PI3K INHIBITOR,BRD:BRD-A58947127-001-01-6,AMG319,AMG319
REP.PRIMARY,2.5,KCNK2,POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-A59378440-001-01-3,BUTYLPHTHALIDE,BUTYLPHTHALIDE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A59825838-326-01-4,NETILMICIN,NETILMICIN
REP.PRIMARY,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-A59961917-001-01-0,BQ-123,BQ-123
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A60498477-001-01-2,TOLAMOLOL,TOLAMOLOL
REP.PRIMARY,2.5,,,BRD:BRD-A61633223-001-02-8,ULIFLOXACIN,ULIFLOXACIN
REP.PRIMARY,2.5,GABRA1,GABA RECEPTOR MODULATOR,BRD:BRD-A62197763-001-01-1,ENCIPRAZINE,ENCIPRAZINE
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-A63431791-001-01-9,SULBACTAM-PIVOXIL,SULBACTAM-PIVOXIL
REP.PRIMARY,2.5,"SSTR1, SSTR2, SSTR3, SSTR5",SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-A64173453-015-02-3,OCTREOTIDE,OCTREOTIDE
REP.PRIMARY,2.5,,APOPTOSIS INHIBITOR,BRD:BRD-A65562236-001-01-2,SOLAMARGINE,SOLAMARGINE
REP.PRIMARY,2.5,,NORADRENALINE UPTAKE INHIBITOR,BRD:BRD-A65683612-001-07-7,PHENYLPIRACETAM,PHENYLPIRACETAM
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A67182178-001-01-7,TOLOXATONE,TOLOXATONE
REP.PRIMARY,2.5,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A67305656-001-01-5,SPIRAMYCIN,SPIRAMYCIN
REP.PRIMARY,2.5,ATP4A,H+/K+-ATPASE INHIBITOR,BRD:BRD-A71765060-001-01-4,PICARTAMIDE,PICARTAMIDE
REP.PRIMARY,2.5,,DIURETIC,BRD:BRD-A72297358-001-01-8,OZOLINONE,OZOLINONE
REP.PRIMARY,2.5,"PTGER2, PTGER3, PTGER4, PTGIR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-A72351335-001-04-5,MISOPROSTOL,MISOPROSTOL
REP.PRIMARY,2.5,,RADIOPAQUE MEDIUM,BRD:BRD-A72401848-001-02-2,GADOTERIDOL,GADOTERIDOL
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A72988804-001-11-1,TIAPROFENIC-ACID,TIAPROFENIC-ACID
REP.PRIMARY,2.5,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A73385064-001-01-5,BECLOMETHASONE,BECLOMETHASONE
REP.PRIMARY,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A73566563-001-01-6,TIPRENOLOL,TIPRENOLOL
REP.PRIMARY,2.5,"ABCC2, CYSLTR1",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-A73679382-236-01-8,MK-571,MK-571
REP.PRIMARY,2.5,"CES1, CHRM1",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A74975734-004-09-9,HOMATROPINE,HOMATROPINE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A75224450-001-02-4,IBUPROFEN-PICONOL,IBUPROFEN-PICONOL
REP.PRIMARY,2.5,"ABL1, BCR, LYN","BCR-ABL KINASE INHIBITOR, LYN TYROSINE KINASE INHIBITOR",BRD:BRD-A75975749-001-01-4,BAFETINIB,BAFETINIB
REP.PRIMARY,2.5,,TOPICAL SUNSCREEN AGENT,BRD:BRD-A76533773-001-01-9,LISADIMATE,LISADIMATE
REP.PRIMARY,2.5,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A78277353-001-01-9,METAZOSIN,METAZOSIN
REP.PRIMARY,2.5,,ANTIMALARIAL AGENT,BRD:BRD-A78965079-036-01-8,TAFENOQUINE,TAFENOQUINE
REP.PRIMARY,2.5,CHRNB4,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A79052425-003-01-5,SIB-1553A,SIB-1553A
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A80280426-001-03-8,AD-5467,AD-5467
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-A84810646-001-01-6,GINSENOSIDE-RD,GINSENOSIDE-RD
REP.PRIMARY,2.5,,"CHELATING AGENT, REDUCING AGENT",BRD:BRD-A85295731-001-06-4,TIOPRONIN,TIOPRONIN
REP.PRIMARY,2.5,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A86665761-001-01-1,GABAPENTIN-ENACARBIL,GABAPENTIN-ENACARBIL
REP.PRIMARY,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A88254928-001-07-9,ALBUTEROL,ALBUTEROL
REP.PRIMARY,2.5,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-A88562598-001-01-7,DEGARELIX,DEGARELIX
REP.PRIMARY,2.5,AKT1,AKT INHIBITOR,BRD:BRD-A89082344-001-08-7,PERIFOSINE,PERIFOSINE
REP.PRIMARY,2.5,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A89207210-001-01-6,TERGURIDE,TERGURIDE
REP.PRIMARY,2.5,"CHRM1, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A91444184-300-01-9,BUCLIZINE,BUCLIZINE
REP.PRIMARY,2.5,"ACHE, SLC1A2","GLUTATHIONE TRANSFERASE STIMULANT, MEMBRANE PERMEABILITY ENHANCER",BRD:BRD-A91728607-236-11-9,CITICOLINE,CITICOLINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A92177080-001-02-1,BETAMETHASONE-ACETATE,BETAMETHASONE-ACETATE
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-A92262698-001-02-5,CHLORPHENESIN,CHLORPHENESIN
REP.PRIMARY,2.5,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A92341659-001-04-0,PRULIFLOXACIN,PRULIFLOXACIN
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A93683007-001-01-9,MABUPROFEN,MABUPROFEN
REP.PRIMARY,2.5,,IMMUNOSUPPRESSANT,BRD:BRD-A96466199-001-01-4,NUCLOMEDONE,NUCLOMEDONE
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A99899486-004-01-9,CIMETROPIUM,CIMETROPIUM
REP.PRIMARY,2.5,,VASODILATOR,BRD:BRD-K00531707-001-01-3,CINEPAZET,CINEPAZET
REP.PRIMARY,2.5,SV2A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K00634421-001-01-0,BRIVARACETAM,BRIVARACETAM
REP.PRIMARY,2.5,,IMMUNOSUPPRESSANT,BRD:BRD-K00739965-001-01-9,GUACETISAL,GUACETISAL
REP.PRIMARY,2.5,EGLN2,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K01291782-001-01-1,MOLIDUSTAT,MOLIDUSTAT
REP.PRIMARY,2.5,ADRA2A,"ADRENERGIC RECEPTOR AGONIST, IMIDAZOLINE RECEPTOR AGONIST",BRD:BRD-K01638814-011-01-4,RILMENIDINE,RILMENIDINE
REP.PRIMARY,2.5,CACNA1B,SODIUM CHANNEL BLOCKER,BRD:BRD-K01662324-001-01-8,PRIRALFINAMIDE,PRIRALFINAMIDE
REP.PRIMARY,2.5,"EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K01666412-001-02-0,L-PROLINE,L-PROLINE
REP.PRIMARY,2.5,,ANTIVIRAL,BRD:BRD-K01773083-001-01-4,DENOTIVIR,DENOTIVIR
REP.PRIMARY,2.5,"CELA1, ELANE",ELASTASE INHIBITOR,BRD:BRD-K02152879-414-02-1,SIVELESTAT,SIVELESTAT
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K02275692-300-02-6,CEFOTIAM,CEFOTIAM
REP.PRIMARY,2.5,NR3C1,,BRD:BRD-K02528732-001-02-4,FLUOROMETHOLONE-ACETATE,FLUOROMETHOLONE-ACETATE
REP.PRIMARY,2.5,GHSR,GROWTH HORMONE SECRETAGOGUE RECEPTOR INVERSE AGONIST,BRD:BRD-K02554563-001-01-6,PF-05190457,PF-05190457
REP.PRIMARY,2.5,,,BRD:BRD-K02729857-001-01-9,PHENYLBENZIMIDAZOLE-SULFONIC-ACID,PHENYLBENZIMIDAZOLE-SULFONIC-ACID
REP.PRIMARY,2.5,"HTR2B, HTR4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K02750403-001-01-4,PIBOSEROD,PIBOSEROD
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K02988401-001-01-2,UNC0737,UNC0737
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K02995728-003-01-9,QUINAGOLIDE,QUINAGOLIDE
REP.PRIMARY,2.5,"PPARA, PPARD, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K03165895-001-01-9,ELAFIBRANOR,ELAFIBRANOR
REP.PRIMARY,2.5,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K03503561-001-01-4,RAVUCONAZOLE,RAVUCONAZOLE
REP.PRIMARY,2.5,"EGFR, EPHB4, ERBB2, FLT4, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K03765900-001-01-9,XL647,"XL-647, XL647"
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K03894385-001-01-1,MK-6096,MK-6096
REP.PRIMARY,2.5,,POLYAMINE BIOSYNTHESIS INHIBITOR,BRD:BRD-K04603573-376-01-3,"1,12-BESM","1,12-BESM"
REP.PRIMARY,2.5,"GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K04643877-001-03-2,PERZINFOTEL,PERZINFOTEL
REP.PRIMARY,2.5,"ATM, ATR, MTOR, PIK3CG",ATR KINASE INHIBITOR,BRD:BRD-K04701033-001-04-7,VE-822,VE-822
REP.PRIMARY,2.5,AKT1,"AKT INHIBITOR, DIFFERENTIATION INDUCER, NFKB PATHWAY INHIBITOR",BRD:BRD-K04710043-001-17-8,HEXAMETHYLENEBISACETAMIDE,HEXAMETHYLENEBISACETAMIDE
REP.PRIMARY,2.5,SLC10A2,BILE ACID TRANSPORTER INHIBITOR,BRD:BRD-K05858796-001-01-7,GSK2330672,GSK2330672
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K06182768-001-02-3,A-366,A-366
REP.PRIMARY,2.5,CTSS,"CALPAIN INHIBITOR, CYSTEINE PROTEASE INHIBITOR",BRD:BRD-K06273313-001-07-9,E-64,E-64
REP.PRIMARY,2.5,"MC1R, MC2R, MC3R, MC4R, MC5R",MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K06328344-015-01-7,BREMELANOTIDE,BREMELANOTIDE
REP.PRIMARY,2.5,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K06357403-001-01-4,VELNEPERIT,VELNEPERIT
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K06388517-001-01-2,LOFEMIZOLE,LOFEMIZOLE
REP.PRIMARY,2.5,EGLN1,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K06455935-001-01-3,DAPRODUSTAT,DAPRODUSTAT
REP.PRIMARY,2.5,"ADRB3, UCP1, UCP2, UCP3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K06467130-304-02-7,CL316243,CL316243
REP.PRIMARY,2.5,"BHMT, BHMT2, METAP2, MTR, MTRR",VOLTAGE-GATED CALCIUM CHANNEL LIGAND,BRD:BRD-K06502269-001-02-6,L-METHIONINE,L-METHIONINE
REP.PRIMARY,2.5,"JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1","MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K06519765-001-01-1,VINBLASTINE,VINBLASTINE
REP.PRIMARY,2.5,"ADAM17, MMP1, MMP13, MMP9","MATRIX METALLOPROTEASE INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-K06883221-001-01-9,APRATASTAT,APRATASTAT
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K07070922-001-01-4,PF-03049423,PF-03049423
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K07409305-001-01-1,ORG-12962,ORG-12962
REP.PRIMARY,2.5,,CONTRACEPTIVE AGENT,BRD:BRD-K07625016-001-01-2,NORETHISTERONE-ENANTHATE,NORETHISTERONE-ENANTHATE
REP.PRIMARY,2.5,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K07682953-001-01-8,PALOSURAN,PALOSURAN
REP.PRIMARY,2.5,,STEROID,BRD:BRD-K07785030-001-01-6,7-KETO-DHEA,7-KETO-DHEA
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K07790550-001-01-6,MAVOGLURANT,MAVOGLURANT
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K08255599-365-01-1,FROVATRIPTAN,FROVATRIPTAN
REP.PRIMARY,2.5,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K09436144-001-01-7,YM022,"YM-022, YM022"
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K09735259-001-01-3,ELBASVIR,ELBASVIR
REP.PRIMARY,2.5,,CHELATING AGENT,BRD:BRD-K09821361-066-25-8,DEFEROXAMINE-MESYLATE,DEFEROXAMINE-MESYLATE
REP.PRIMARY,2.5,,MUCOLYTIC AGENT,BRD:BRD-K10415035-001-04-4,TASULDINE,TASULDINE
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-K10667240-001-01-7,ETHACIZIN,ETHACIZIN
REP.PRIMARY,2.5,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K10995081-001-27-9,PERPHENAZINE,PERPHENAZINE
REP.PRIMARY,2.5,,NAD PRECURSOR,BRD:BRD-K11256763-001-01-5,NICERITROL,NICERITROL
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K11443721-003-01-6,NE-100,NE-100
REP.PRIMARY,2.5,"PTGER2, PTGER4",PROSTAGLANDIN INHIBITOR,BRD:BRD-K11452913-001-01-9,EVATANEPAG,EVATANEPAG
REP.PRIMARY,2.5,SAA1,"AMYLOID PROTEIN INHIBITOR, ANTIAMYLOIDOGENIC AGENT",BRD:BRD-K11463116-304-03-5,EPRODISATE,EPRODISATE
REP.PRIMARY,2.5,"CACNA1G, CACNA1H, CACNA1I",CALCIUM CHANNEL BLOCKER,BRD:BRD-K11792081-001-01-4,ABT-639,ABT-639
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4, HTR1A, HTR7","DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-K11851476-003-01-7,PARDOPRUNOX,PARDOPRUNOX
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K12261274-001-02-4,ZALTIDINE,ZALTIDINE
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K12742203-003-01-7,MOXAVERINE,MOXAVERINE
REP.PRIMARY,2.5,ALOX5AP,LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K12852738-001-01-2,VELIFLAPON,VELIFLAPON
REP.PRIMARY,2.5,"TP53, TUBB","MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K12906202-001-06-2,CARBENDAZIM,CARBENDAZIM
REP.PRIMARY,2.5,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K13060017-001-02-1,UNC0631,UNC0631
REP.PRIMARY,2.5,,RNA SYNTHESIS INHIBITOR,BRD:BRD-K13277760-001-01-2,RIFAMYCIN-SV,RIFAMYCIN-SV
REP.PRIMARY,2.5,SLC6A3,DOPAMINE-NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-K13394247-003-01-4,RADAFAXINE,RADAFAXINE
REP.PRIMARY,2.5,"KCNH2, PDE3A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K13414800-001-01-3,VESNARINONE,VESNARINONE
REP.PRIMARY,2.5,"ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3",CALCINEURIN INHIBITOR,BRD:BRD-K13533483-001-16-2,CYCLOSPORINE,"CYCLOSPORIN-A, CYCLOSPORINE"
REP.PRIMARY,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K13664493-316-02-5,NAPHTHOQUINE-PHOSPHATE,NAPHTHOQUINE-PHOSPHATE
REP.PRIMARY,2.5,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K13769342-001-01-5,DANIRIXIN,DANIRIXIN
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K14171291-001-01-4,OMARIGLIPTIN,OMARIGLIPTIN
REP.PRIMARY,2.5,,APOPTOSIS STIMULANT,BRD:BRD-K14276241-001-01-2,DAUCOSTEROL,DAUCOSTEROL
REP.PRIMARY,2.5,,,BRD:BRD-K14571191-001-01-6,ZOMETAPINE,ZOMETAPINE
REP.PRIMARY,2.5,"CACNA1C, PDE4A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K14658796-003-01-6,DROTAVERINE,DROTAVERINE
REP.PRIMARY,2.5,"OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5",SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-K14681867-001-01-6,SOMATOSTATIN,SOMATOSTATIN
REP.PRIMARY,2.5,PLG,"ANTIFIBRINOLYTIC, PLASMINOGEN ACTIVATOR INHIBITOR",BRD:BRD-K15014948-001-10-3,TRANEXAMIC-ACID,TRANEXAMIC-ACID
REP.PRIMARY,2.5,,ISOLEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K15262564-001-15-0,MUPIROCIN,MUPIROCIN
REP.PRIMARY,2.5,,PPAR RECEPTOR AGONIST,BRD:BRD-K15327298-001-05-5,FMOC-L-LEUCINE,FMOC-L-LEUCINE
REP.PRIMARY,2.5,"AR, ESR1, ESR2","ANDROGEN RECEPTOR AGONIST, ESTROGEN RECEPTOR AGONIST",BRD:BRD-K15360631-325-01-4,DEHYDROEPIANDROSTERONE-SULFATE,DEHYDROEPIANDROSTERONE-SULFATE
REP.PRIMARY,2.5,ALOX5AP,LIPOXYGENASE INHIBITOR,BRD:BRD-K15691453-236-01-6,GSK2190915,GSK2190915
REP.PRIMARY,2.5,PTPN1,TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-K16180792-001-01-7,BIS(MALTOLATO)OXOVANADIUM(IV),BIS(MALTOLATO)OXOVANADIUM(IV)
REP.PRIMARY,2.5,PNP,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K16505263-003-02-9,FORODESINE,FORODESINE
REP.PRIMARY,2.5,"HSPA1A, HSPB1",NFKB PATHWAY INHIBITOR,BRD:BRD-K16546375-001-01-4,BICYCLOL,BICYCLOL
REP.PRIMARY,2.5,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K17295893-001-01-0,NASTORAZEPIDE,NASTORAZEPIDE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K17480742-001-01-1,DELAMANID,DELAMANID
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA6, CA7, CA9",CDK INHIBITOR,BRD:BRD-K17610631-001-03-3,INDISULAM,INDISULAM
REP.PRIMARY,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K17641316-001-04-8,DECOQUINATE,DECOQUINATE
REP.PRIMARY,2.5,,,BRD:BRD-K17828029-001-01-5,CINOXATE,CINOXATE
REP.PRIMARY,2.5,"HSD11B1, NR1H4","11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR, FXR AGONIST",BRD:BRD-K18135438-001-14-2,CHENODEOXYCHOLIC-ACID,CHENODEOXYCHOLIC-ACID
REP.PRIMARY,2.5,DDC,"DOPAMINE PRECURSOR, DOPAMINE RECEPTOR AGONIST",BRD:BRD-K18749874-003-08-9,MELEVODOPA,MELEVODOPA
REP.PRIMARY,2.5,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K18878288-001-06-4,SCHISANDROL-B,SCHISANDROL-B
REP.PRIMARY,2.5,MMP9,"EGFR INHIBITOR, METALLOPROTEINASE INHIBITOR",BRD:BRD-K18898553-001-01-1,SALVIANOLIC-ACID-B,SALVIANOLIC-ACID-B
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K19515365-001-02-6,BENDAZAC,BENDAZAC
REP.PRIMARY,2.5,"ITGAL, ITGB2",INTEGRIN ANTAGONIST,BRD:BRD-K20093108-001-02-3,BMS-587101,BMS-587101
REP.PRIMARY,2.5,CHEK1,CHK INHIBITOR,BRD:BRD-K20463415-300-01-4,LY2606368,LY2606368
REP.PRIMARY,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K20468903-001-01-6,BNC105,BNC105
REP.PRIMARY,2.5,PIK3CD,PI3K INHIBITOR,BRD:BRD-K21077415-001-01-5,AMG-319,AMG-319
REP.PRIMARY,2.5,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K21152241-001-07-3,ENOXIMONE,ENOXIMONE
REP.PRIMARY,2.5,PTGIR,"IP1 PROSTACYCLIN RECEPTOR AGONIST, PLATELET AGGREGATION INHIBITOR",BRD:BRD-K21191422-001-01-5,SELEXIPAG,SELEXIPAG
REP.PRIMARY,2.5,MAPK14,"CYTOKINE PRODUCTION INHIBITOR, P38 MAPK INHIBITOR",BRD:BRD-K21237892-376-01-3,SEMAPIMOD,SEMAPIMOD
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K21586122-001-01-9,FIMASARTAN,FIMASARTAN
REP.PRIMARY,2.5,,NERVE GROWTH FACTOR AGONIST,BRD:BRD-K21612934-001-01-1,LETEPRINIM,LETEPRINIM
REP.PRIMARY,2.5,STAT3,STAT INHIBITOR,BRD:BRD-K22064724-001-01-8,NAPABUCASIN,NAPABUCASIN
REP.PRIMARY,2.5,"ALK, FLT3, IGF1R, INSR, TSSK1B",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K22149900-001-03-9,CERITINIB,CERITINIB
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K22514639-001-05-7,EGF816,EGF816
REP.PRIMARY,2.5,INS,,BRD:BRD-K22518984-001-01-8,METACRESOL,METACRESOL
REP.PRIMARY,2.5,"AR, HSD17B1",ANDROGEN RECEPTOR AGONIST,BRD:BRD-K22525962-001-05-0,DIHYDROTESTOSTERONE,DIHYDROTESTOSTERONE
REP.PRIMARY,2.5,,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K22588750-001-07-0,GIDAZEPAM,GIDAZEPAM
REP.PRIMARY,2.5,,FABI INHIBITOR,BRD:BRD-K23791635-001-01-3,AFN-1252,AFN-1252
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K23848629-401-03-7,FOSAPREPITANT-DIMEGLUMINE,FOSAPREPITANT-DIMEGLUMINE
REP.PRIMARY,2.5,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K24221957-003-01-6,PRALIDOXIME-CHLORIDE,PRALIDOXIME-CHLORIDE
REP.PRIMARY,2.5,NR3C1,"ANTI-INFLAMMATORY AGENT, GLUCOCORTICOID RECEPTOR AGONIST",BRD:BRD-K24452555-001-01-7,METHYLPREDNISOLONE-ACEPONATE,METHYLPREDNISOLONE-ACEPONATE
REP.PRIMARY,2.5,PDE5A,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K24476327-001-01-3,ICARITIN,ICARITIN
REP.PRIMARY,2.5,PTGDR2,PROSTAGLANDIN INHIBITOR,BRD:BRD-K24497734-001-01-6,SETIPIPRANT,SETIPIPRANT
REP.PRIMARY,2.5,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K24610819-003-01-8,AMIBEGRON,AMIBEGRON
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K24666289-001-04-9,COPANLISIB,COPANLISIB
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-K24864897-001-01-0,JNJ-26990990,JNJ-26990990
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K25029121-001-05-8,TRICLOCARBAN,TRICLOCARBAN
REP.PRIMARY,2.5,HTR2A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K25146005-001-01-0,CIS-UROCANIC-ACID,"CIS-UROCANIC ACID, CIS-UROCANIC-ACID"
REP.PRIMARY,2.5,,MUSCLE RELAXANT,BRD:BRD-K25154476-001-01-4,CINFLUMIDE,CINFLUMIDE
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2, OXTR",OXYTOCIN RECEPTOR AGONIST,BRD:BRD-K25243230-001-01-2,OXYTOCIN,OXYTOCIN
REP.PRIMARY,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K25494650-003-01-8,CHLORPROGUANIL,CHLORPROGUANIL
REP.PRIMARY,2.5,UTRN,UTROPHIN ENHANCER,BRD:BRD-K25570267-001-01-4,EZUTROMID,EZUTROMID
REP.PRIMARY,2.5,,NA/K-ATPASE INHIBITOR,BRD:BRD-K25970317-001-01-6,RESIBUFOGENIN,RESIBUFOGENIN
REP.PRIMARY,2.5,NR3C2,CORTICOSTEROID AGONIST,BRD:BRD-K26024145-001-01-9,DESOXYCORTICOSTERONE-PIVALATE,DESOXYCORTICOSTERONE-PIVALATE
REP.PRIMARY,2.5,ERBB2,EGFR INHIBITOR,BRD:BRD-K26026438-001-01-0,TUCATINIB,TUCATINIB
REP.PRIMARY,2.5,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K26323068-001-01-8,LEUPROLIDE,LEUPROLIDE
REP.PRIMARY,2.5,,,BRD:BRD-K26530649-001-01-6,CARBOXYPYRIDINE-DISULFIDE,CARBOXYPYRIDINE-DISULFIDE
REP.PRIMARY,2.5,TBXA2R,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K26813177-001-03-2,DALTROBAN,DALTROBAN
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26818574-305-07-6,BIX-01294,BIX-01294
REP.PRIMARY,2.5,MET,MET INHIBITOR,BRD:BRD-K27061362-001-01-6,AMG-337,AMG-337
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K27293958-001-01-5,TIARAMIDE,TIARAMIDE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K27515606-003-01-3,CEFCAPENE-PIVOXIL,CEFCAPENE-PIVOXIL
REP.PRIMARY,2.5,,,BRD:BRD-K27625831-001-02-9,PLECONARIL,PLECONARIL
REP.PRIMARY,2.5,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K27755542-001-01-6,PF-04937319,PF-04937319
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K27798832-001-01-5,CEFETAMET,CEFETAMET
REP.PRIMARY,2.5,"HSD11B1, PTPN1","PKC INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",BRD:BRD-K27885593-001-06-8,COROSOLIC-ACID,COROSOLIC-ACID
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K28061410-001-06-6,BETA-LAPACHONE,BETA-LAPACHONE
REP.PRIMARY,2.5,"HDAC10, HDAC3",HDAC INHIBITOR,BRD:BRD-K28537285-001-01-8,CHIDAMIDE,CHIDAMIDE
REP.PRIMARY,2.5,"PTGS1, PTGS2",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K28687144-001-08-7,FOSFOSAL,FOSFOSAL
REP.PRIMARY,2.5,GAST,GASTRIN INHIBITOR,BRD:BRD-K29570907-001-07-3,SULMETOZINE,SULMETOZINE
REP.PRIMARY,2.5,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K29626940-001-01-5,IMIDAFENACIN,IMIDAFENACIN
REP.PRIMARY,2.5,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K29812331-011-01-7,DIMEMORFAN,DIMEMORFAN
REP.PRIMARY,2.5,,RSV REPLICATION INHIBITOR,BRD:BRD-K30159788-001-01-9,RSV604,RSV604
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K30485548-050-01-6,SUMANIROLE,SUMANIROLE
REP.PRIMARY,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K30764557-001-01-5,MIOCAMYCIN,MIOCAMYCIN
REP.PRIMARY,2.5,,FXR AGONIST,BRD:BRD-K30968378-001-01-9,INT-747,INT-747
REP.PRIMARY,2.5,"AVPR1A, OXTR",OXYTOCIN RECEPTOR ANTAGONIST,BRD:BRD-K31417912-001-01-9,PF-3274167,PF-3274167
REP.PRIMARY,2.5,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K31802667-001-01-9,JNJ-37822681,JNJ-37822681
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K32256160-001-01-9,SOLITHROMYCIN,SOLITHROMYCIN
REP.PRIMARY,2.5,,,BRD:BRD-K32804101-001-01-8,VALROCEMIDE,VALROCEMIDE
REP.PRIMARY,2.5,"ATIC, DHFR, GART, TYMS","DIHYDROFOLATE REDUCTASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K32842773-434-01-8,PEMETREXED,PEMETREXED
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K32891457-001-15-5,CORTODOXONE,CORTODOXONE
REP.PRIMARY,2.5,GRIN2B,GLUTAMATE RECEPTOR DOWNREGULATOR,BRD:BRD-K33131085-001-07-2,GENTIOPICRIN,GENTIOPICRIN
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K33133047-001-01-8,DAPIPRAZOLE,DAPIPRAZOLE
REP.PRIMARY,2.5,"ACKR3, CCR4, CXCR4",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K33240821-001-06-2,PLERIXAFOR,PLERIXAFOR
REP.PRIMARY,2.5,SMO,SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K33245965-001-03-4,BMS-833923,BMS-833923
REP.PRIMARY,2.5,"DRD4, HTR1A, HTR2A",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K33637378-001-01-7,FLIBANSERIN,FLIBANSERIN
REP.PRIMARY,2.5,CYP3A4,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K34068325-066-03-7,DELAVIRDINE,DELAVIRDINE
REP.PRIMARY,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K34251960-036-01-6,CIBENZOLINE,CIBENZOLINE
REP.PRIMARY,2.5,"CCKAR, CCKBR, KCNQ1",CCK RECEPTOR ANTAGONIST,BRD:BRD-K34277641-001-01-2,L-365260,L-365260
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K34445261-001-02-2,SLV-320,SLV-320
REP.PRIMARY,2.5,PSEN1,GAMMA SECRETASE MODULATOR,BRD:BRD-K34508702-001-02-4,CHF5074,CHF5074
REP.PRIMARY,2.5,"GHRHR, GHSR",GROWTH HORMONE RELEASING FACTOR AGONIST,BRD:BRD-K35304636-001-01-0,EXAMORELIN,EXAMORELIN
REP.PRIMARY,2.5,LTB4R,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K35367061-001-01-1,LY223982,LY223982
REP.PRIMARY,2.5,OPRM1,OPIOID RECEPTOR AGONIST,BRD:BRD-K35626314-003-01-1,TRV130,TRV130
REP.PRIMARY,2.5,,LOCAL ANESTHETIC,BRD:BRD-K35798650-001-01-4,POLIDOCANOL,POLIDOCANOL
REP.PRIMARY,2.5,VWF,ANTITUMOR AGENT,BRD:BRD-K35882976-001-04-7,MITOFLAXONE,MITOFLAXONE
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K36379990-001-01-1,RIODIPINE,RIODIPINE
REP.PRIMARY,2.5,PTGDR2,CRTH RECEPTOR ANTAGONIST,BRD:BRD-K36463073-001-03-9,OC000459,OC000459
REP.PRIMARY,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K36524108-065-04-0,PAROMOMYCIN,PAROMOMYCIN
REP.PRIMARY,2.5,"NTRK1, NTRK2, NTRK3",TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-K36574127-001-01-3,LOXO-101,"LAROTRECTINIB, LOXO-101"
REP.PRIMARY,2.5,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K36636143-001-01-0,NOLATREXED,NOLATREXED
REP.PRIMARY,2.5,SLC22A12,URATE TRANSPORTER INHIBITOR,BRD:BRD-K36741660-001-01-1,VERINURAD,VERINURAD
REP.PRIMARY,2.5,"CHRM1, CHRM2, CHRM3, CHRM4",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K37543758-001-01-3,TREPIBUTONE,TREPIBUTONE
REP.PRIMARY,2.5,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K37708699-001-01-4,EXISULIND,EXISULIND
REP.PRIMARY,2.5,F2,THROMBIN INHIBITOR,BRD:BRD-K38168441-001-03-7,DABIGATRAN,DABIGATRAN
REP.PRIMARY,2.5,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K38398115-001-01-9,YM-511,YM-511
REP.PRIMARY,2.5,ESR1,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K38477637-001-01-0,DROLOXIFENE,DROLOXIFENE
REP.PRIMARY,2.5,"JAK2, STAT3","JAK INHIBITOR, STAT INHIBITOR",BRD:BRD-K38527262-300-01-0,ATIPRIMOD,ATIPRIMOD
REP.PRIMARY,2.5,,,BRD:BRD-K38564664-001-01-1,ROLZIRACETAM,ROLZIRACETAM
REP.PRIMARY,2.5,"ALK, NTRK1, NTRK2, NTRK3, ROS1","ALK TYROSINE KINASE RECEPTOR INHIBITOR, PROTO-ONCOGENE TYROSINE PROTEIN KINASE INHIBITOR",BRD:BRD-K39009484-001-01-4,ENTRECTINIB,ENTRECTINIB
REP.PRIMARY,2.5,"OPRD1, OPRK1, OPRM1","OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST, OPIOID RECEPTOR MODULATOR",BRD:BRD-K39560679-001-01-1,ELUXADOLINE,ELUXADOLINE
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K40002998-001-01-5,ORG-26576,ORG-26576
REP.PRIMARY,2.5,TGFB1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K41267922-001-01-4,F351,F351
REP.PRIMARY,2.5,OPRM1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K41458421-034-01-6,NALOXEGOL,NALOXEGOL
REP.PRIMARY,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K41592905-001-01-6,7-METHYLXANTHINE,7-METHYLXANTHINE
REP.PRIMARY,2.5,CASR,CALCIUM-SENSING RECEPTOR AGONIST,BRD:BRD-K41662846-003-01-5,TECALCET,TECALCET
REP.PRIMARY,2.5,GABRA1,GABA RECEPTOR MODULATOR,BRD:BRD-K42066335-001-01-0,LOREDIPLON,LOREDIPLON
REP.PRIMARY,2.5,GNRH1,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K42140276-402-01-4,ALARELIN,ALARELIN
REP.PRIMARY,2.5,PGR,,BRD:BRD-K42504537-001-01-6,NORELGESTROMIN,NORELGESTROMIN
REP.PRIMARY,2.5,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K42673188-001-01-1,VERUBULIN,VERUBULIN
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K42816473-001-01-0,ZILPATEROL,ZILPATEROL
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K43230258-001-01-4,CRISABOROLE,CRISABOROLE
REP.PRIMARY,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K43316319-001-01-8,MK-2295,MK-2295
REP.PRIMARY,2.5,,HEMOGLOBIN MODULATOR,BRD:BRD-K43639297-001-01-9,VOXELOTOR,"HEMOGLOBIN-MODULATORS-1, VOXELOTOR"
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K43647122-001-01-3,NERBACADOL,NERBACADOL
REP.PRIMARY,2.5,"HTR2A, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K43837174-003-01-3,PRUVANSERIN,PRUVANSERIN
REP.PRIMARY,2.5,,ANTILIPEMIC,BRD:BRD-K43890836-001-01-6,GEMCADIOL,GEMCADIOL
REP.PRIMARY,2.5,TBXA2R,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K43975632-001-01-1,TERUTROBAN,TERUTROBAN
REP.PRIMARY,2.5,S1PR1,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K44030614-001-01-6,PONESIMOD,PONESIMOD
REP.PRIMARY,2.5,"HTR3A, HTR4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K44164034-003-01-1,PUMOSETRAG,PUMOSETRAG
REP.PRIMARY,2.5,"ESR1, ESR2",SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K44184170-001-01-7,OSPEMIFENE,OSPEMIFENE
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K44471774-001-01-8,BAY-W-9798,BAY-W-9798
REP.PRIMARY,2.5,,MUCUS PROTECTING AGENT,BRD:BRD-K45125084-001-01-4,ZOLIMIDINE,ZOLIMIDINE
REP.PRIMARY,2.5,,RSV FUSION INHIBITOR,BRD:BRD-K45906612-001-01-8,PRESATOVIR,PRESATOVIR
REP.PRIMARY,2.5,"ACHE, BCHE","ACETYLCHOLINESTERASE INHIBITOR, BETA AMYLOID SYNTHESIS INHIBITOR",BRD:BRD-K46580984-001-03-6,PHENSERINE,PHENSERINE
REP.PRIMARY,2.5,S1PR1,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K46625559-001-01-8,OZANIMOD,OZANIMOD
REP.PRIMARY,2.5,FKBP1A,MTOR INHIBITOR,BRD:BRD-K46843573-001-01-9,ZOTAROLIMUS,ZOTAROLIMUS
REP.PRIMARY,2.5,CYP11B1,CYTOCHROME P450 INHIBITOR,BRD:BRD-K46862739-001-14-3,METYRAPONE,METYRAPONE
REP.PRIMARY,2.5,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K47492008-001-02-7,ALCLOFENAC,ALCLOFENAC
REP.PRIMARY,2.5,CTSC,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K47690382-001-03-0,BIPENAMOL,BIPENAMOL
REP.PRIMARY,2.5,,,BRD:BRD-K47887731-001-01-4,NITENPYRAM,NITENPYRAM
REP.PRIMARY,2.5,CCR9,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K47929404-001-01-0,VERCIRNON,VERCIRNON
REP.PRIMARY,2.5,"DRD1, DRD2, HTR1A, HTR2A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K48429278-001-01-3,PIPOTIAZINE-PALMITATE,PIPOTIAZINE-PALMITATE
REP.PRIMARY,2.5,SIRT1,SIRT ACTIVATOR,BRD:BRD-K48452630-001-01-8,SRT2104,SRT2104
REP.PRIMARY,2.5,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K49372556-001-04-1,MOFEZOLAC,MOFEZOLAC
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K49659468-436-01-2,TMC647055,TMC647055
REP.PRIMARY,2.5,,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-K49793107-402-02-6,CASPOFUNGIN-ACETATE,CASPOFUNGIN-ACETATE
REP.PRIMARY,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K49841478-001-01-6,ROSOXACIN,ROSOXACIN
REP.PRIMARY,2.5,"EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K50010139-001-02-3,POZIOTINIB,POZIOTINIB
REP.PRIMARY,2.5,"PLD1, PLD2",PHOSPHOLIPASE INHIBITOR,BRD:BRD-K50055394-001-03-6,HALOPEMIDE,HALOPEMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K50122911-001-01-2,BORONOPHENYLALANINE,BORONOPHENYLALANINE
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K50489389-001-01-8,RANIRESTAT,RANIRESTAT
REP.PRIMARY,2.5,"BACE1, FASN",BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K50660797-001-05-1,EPICATECHIN-GALLATE-(-),EPICATECHIN-GALLATE-(-)
REP.PRIMARY,2.5,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K50813454-001-01-9,AMFLUTIZOLE,AMFLUTIZOLE
REP.PRIMARY,2.5,,IMMUNOSTIMULANT,BRD:BRD-K51730347-001-06-4,DIPHENCYPRONE,DIPHENCYPRONE
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K51784806-001-01-6,ALACEPRIL,ALACEPRIL
REP.PRIMARY,2.5,AGER,RAGE RECEPTOR ANTAGONIST,BRD:BRD-K51899933-001-02-6,AZELIRAGON,AZELIRAGON
REP.PRIMARY,2.5,,,BRD:BRD-K51956333-001-03-8,IOPODIC-ACID,IOPODIC-ACID
REP.PRIMARY,2.5,,PI3K INHIBITOR,BRD:BRD-K52579889-001-01-9,TGR-1202,TGR-1202
REP.PRIMARY,2.5,"CHRNA4, CHRNB2",NICOTINIC RECEPTOR AGONIST,BRD:BRD-K52681925-050-01-6,ALTINICLINE,ALTINICLINE
REP.PRIMARY,2.5,,,BRD:BRD-K52914072-001-01-5,LTA,LTA
REP.PRIMARY,2.5,"ABCC8, KCNJ1, KCNJ10, KCNJ11",ATP CHANNEL BLOCKER,BRD:BRD-K52960356-001-15-5,ACETOHEXAMIDE,ACETOHEXAMIDE
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K53156626-001-01-3,7-METHOXYTACRINE,7-METHOXYTACRINE
REP.PRIMARY,2.5,"CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K53195974-001-01-9,SIPATRIGINE,SIPATRIGINE
REP.PRIMARY,2.5,"CALM1, SCN5A",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K53236343-003-03-7,APRINDINE,APRINDINE
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K53319039-001-01-8,ESTRADIOL-ACETATE,ESTRADIOL-ACETATE
REP.PRIMARY,2.5,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K53809807-304-02-4,FOSPHENYTOIN,FOSPHENYTOIN
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K54339150-001-01-8,PROQUAZONE,PROQUAZONE
REP.PRIMARY,2.5,"CSF1R, FLT3, KIT",TYROSINE KINASE INHIBITOR,BRD:BRD-K54519451-001-02-9,PEXIDARTINIB,PEXIDARTINIB
REP.PRIMARY,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K54863166-001-01-9,DARUSENTAN,DARUSENTAN
REP.PRIMARY,2.5,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-K54907283-001-01-2,AKBA,AKBA
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K54955827-001-02-2,NIRAPARIB,NIRAPARIB
REP.PRIMARY,2.5,GRM2,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K55029398-001-01-6,JNJ-40411813,JNJ-40411813
REP.PRIMARY,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K55172746-001-01-3,APRICITABINE,APRICITABINE
REP.PRIMARY,2.5,"TOP1, TOP1MT",TOPOISOMERASE INHIBITOR,BRD:BRD-K55696337-003-24-4,TOPOTECAN,TOPOTECAN
REP.PRIMARY,2.5,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K55808645-001-01-4,ELAGOLIX,ELAGOLIX
REP.PRIMARY,2.5,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K55991142-001-01-6,ALCAFTADINE,ALCAFTADINE
REP.PRIMARY,2.5,OXTR,OXYTOCIN RECEPTOR AGONIST,BRD:BRD-K56107812-001-01-7,CARBETOCIN,CARBETOCIN
REP.PRIMARY,2.5,VDR,VITAMIN ANALOG,BRD:BRD-K56155962-001-12-1,ERGOCALCIFEROL,ERGOCALCIFEROL
REP.PRIMARY,2.5,NFE2L2,NITRIC OXIDE PRODUCTION INHIBITOR,BRD:BRD-K56211775-001-03-8,RTA-408,RTA-408
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K56429665-001-09-6,CALCIPOTRIOL,CALCIPOTRIOL
REP.PRIMARY,2.5,"KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5",POTASSIUM CHANNEL AGONIST,BRD:BRD-K56740996-001-01-3,FLINDOKALNER,FLINDOKALNER
REP.PRIMARY,2.5,"EGLN1, EGLN2, HIF1A",HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K56807945-001-01-2,FG-2216,FG-2216
REP.PRIMARY,2.5,ROCK1,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K56912469-003-02-0,SAR407899,SAR407899
REP.PRIMARY,2.5,"ALK, EGFR","ALK TYROSINE KINASE RECEPTOR INHIBITOR, EGFR INHIBITOR",BRD:BRD-K56981171-001-01-0,BRIGATINIB,BRIGATINIB
REP.PRIMARY,2.5,PDE10A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K57155378-001-01-1,TAK-063,TAK-063
REP.PRIMARY,2.5,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K57427145-001-01-6,RIPAZEPAM,RIPAZEPAM
REP.PRIMARY,2.5,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K57774929-001-01-3,FOROPAFANT,FOROPAFANT
REP.PRIMARY,2.5,"NR3C1, SERPINA6, SMO",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K57886322-001-16-6,FLUOCINONIDE,FLUOCINONIDE
REP.PRIMARY,2.5,,STEROID,BRD:BRD-K58277159-001-01-7,NPC-01,NPC-01
REP.PRIMARY,2.5,TNFSF10,"AKT INHIBITOR, MAP KINASE INHIBITOR",BRD:BRD-K58529924-001-01-5,ONC201,ONC201
REP.PRIMARY,2.5,NR3C1,CORTICOSTEROID AGONIST,BRD:BRD-K58810291-001-16-2,CLOBETASONE-BUTYRATE,CLOBETASONE-BUTYRATE
REP.PRIMARY,2.5,"PRSS1, TPSAB1",SERINE PROTEASE INHIBITOR,BRD:BRD-K59256312-066-15-7,GABEXATE,GABEXATE
REP.PRIMARY,2.5,AVPR2,VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K59391348-001-01-7,LIXIVAPTAN,LIXIVAPTAN
REP.PRIMARY,2.5,"TUBB, TUBB1",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K59753975-001-02-6,VINDESINE,VINDESINE
REP.PRIMARY,2.5,ABCG2,BREAST CANCER RESISTANCE PROTEIN INHIBITOR,BRD:BRD-K59866480-001-07-3,CYCLOVALONE,CYCLOVALONE
REP.PRIMARY,2.5,"CHRM1, CHRM2",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K59895502-001-01-9,CARAMIPHEN,CARAMIPHEN
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K60130390-001-02-1,UNC0642,UNC0642
REP.PRIMARY,2.5,,ALDEHYDE REDUCTASE INHIBITOR,BRD:BRD-K60241851-001-11-9,ISODIBUT,ISODIBUT
REP.PRIMARY,2.5,,APOPTOSIS STIMULANT,BRD:BRD-K60284353-001-01-3,TITANOCENE-DICHLORIDE,TITANOCENE-DICHLORIDE
REP.PRIMARY,2.5,"BTK, EGFR","BRUTON'S TYROSINE KINASE (BTK) INHIBITOR, EGFR INHIBITOR",BRD:BRD-K60421517-001-01-4,OLMUTINIB,OLMUTINIB
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1",TRICYCLIC ANTIDEPRESSANT,BRD:BRD-K60762818-003-26-0,DESIPRAMINE,DESIPRAMINE
REP.PRIMARY,2.5,,NEUTROPHIL SUPEROXIDE PRODUCTION,BRD:BRD-K60798049-001-03-8,FANETIZOLE,FANETIZOLE
REP.PRIMARY,2.5,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K61496577-001-19-4,FLUMETHASONE,FLUMETHASONE
REP.PRIMARY,2.5,GLB1,GLUCOSIDASE INHIBITOR,BRD:BRD-K61536264-001-01-3,FAGOMINE,FAGOMINE
REP.PRIMARY,2.5,ESR1,SELECTIVE ESTROGEN RECEPTOR DESTABILIZER,BRD:BRD-K61923022-001-02-4,GDC-0810,GDC-0810
REP.PRIMARY,2.5,"FLT1, FLT3, KDR, PDGFRA, PDGFRB",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K62040061-001-01-0,TOCERANIB,TOCERANIB
REP.PRIMARY,2.5,PTGER4,PROSTAGLANDIN INHIBITOR,BRD:BRD-K62050508-001-01-0,GRAPIPRANT,GRAPIPRANT
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K62240499-001-05-9,HUPERZINE-A,HUPERZINE-A
REP.PRIMARY,3.1195349940000003,"AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K62309135-001-05-2,L-GLUTAMIC-ACID,L-GLUTAMIC-ACID
REP.PRIMARY,2.5,,PI3K INHIBITOR,BRD:BRD-K62374002-001-01-5,PI3K-IN-2,PI3K-IN-2
REP.PRIMARY,2.5,S1PR1,"SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, SPHINGOSINE PHOSPHATE RECEPTOR MODULATOR",BRD:BRD-K62384160-001-02-0,SIPONIMOD,SIPONIMOD
REP.PRIMARY,2.5,LPL,LIPOPROTEIN LIPASE ACTIVATOR,BRD:BRD-K62490786-001-01-1,IBROLIPIM,IBROLIPIM
REP.PRIMARY,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K62971431-001-01-9,TASIMELTEON,TASIMELTEON
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-K63018010-001-01-7,RELEBACTAM,RELEBACTAM
REP.PRIMARY,2.5,ACLY,AMPK INHIBITOR,BRD:BRD-K63177377-001-01-8,ETC-1002,"BEMPEDOIC-ACID, ETC-1002"
REP.PRIMARY,2.5,"ANPEP, BDKRB2",BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K63772874-001-02-2,ICATIBANT-ACETATE,ICATIBANT-ACETATE
REP.PRIMARY,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K64034691-001-01-9,ACALABRUTINIB,ACALABRUTINIB
REP.PRIMARY,2.5,,MICROTUBULE INHIBITOR,BRD:BRD-K64120610-001-01-4,VINFLUNINE,VINFLUNINE
REP.PRIMARY,2.5,MMP9,METALLOPROTEINASE INHIBITOR,BRD:BRD-K65498798-001-01-7,ABAMETAPIR,ABAMETAPIR
REP.PRIMARY,2.5,,"CALCIUM CHANNEL BLOCKER, GLUTAMATE RECEPTOR ANTAGONIST",BRD:BRD-K65900713-003-01-0,CAROVERINE,CAROVERINE
REP.PRIMARY,2.5,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K66192203-001-02-2,OPICAPONE,OPICAPONE
REP.PRIMARY,2.5,"CA1, CA12, CA14, CA2, CA4, CA6, CA9",ANTIOXIDANT,BRD:BRD-K66295376-001-13-1,FERULIC-ACID,FERULIC-ACID
REP.PRIMARY,2.5,,URICOSURIC AGENT,BRD:BRD-K66437909-001-01-0,KT-433,KT-433
REP.PRIMARY,2.5,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8",VOLTAGE-GATED CALCIUM CHANNEL LIGAND,BRD:BRD-K66786476-001-01-3,PREGABALIN,PREGABALIN
REP.PRIMARY,2.5,,,BRD:BRD-K66845263-001-03-0,SOPHOCARPINE,SOPHOCARPINE
REP.PRIMARY,2.5,,,BRD:BRD-K67117832-001-01-9,DEXTRAN,DEXTRAN
REP.PRIMARY,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K67186445-001-02-1,DEHYDROCORYDALINE,DEHYDROCORYDALINE
REP.PRIMARY,2.5,JAK1,JAK INHIBITOR,BRD:BRD-K67482377-001-01-8,ITACITINIB,ITACITINIB
REP.PRIMARY,2.5,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K67628093-001-01-9,INCB-3284,INCB-3284
REP.PRIMARY,2.5,CXCL8,CALCIUM CHANNEL BLOCKER,BRD:BRD-K68408772-001-05-4,CARBOXYAMIDOTRIAZOLE,CARBOXYAMIDOTRIAZOLE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K68432770-236-23-1,AMPICILLIN,AMPICILLIN
REP.PRIMARY,2.5,MPL,THROMBOPOIETIN RECEPTOR AGONIST,BRD:BRD-K68544925-001-01-1,AVATROMBOPAG,AVATROMBOPAG
REP.PRIMARY,2.5,,COENZYME A PRECURSOR,BRD:BRD-K68764924-001-03-2,PANTETHINE,PANTETHINE
REP.PRIMARY,2.5,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K69636617-001-01-7,TESTOLACTONE,TESTOLACTONE
REP.PRIMARY,2.5,"HTR1A, HTR1B, HTR1D",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K69669039-001-01-8,GSK163090,GSK163090
REP.PRIMARY,2.5,"RXRA, RXRB, RXRG",RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K70262971-001-01-9,AGN-194310,AGN-194310
REP.PRIMARY,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K70330032-001-01-1,JNJ-42165279,JNJ-42165279
REP.PRIMARY,2.5,KDR,VEGFR INHIBITOR,BRD:BRD-K70504253-001-01-3,FRUQUINTINIB,FRUQUINTINIB
REP.PRIMARY,2.5,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-K70592963-001-31-6,PHENINDIONE,PHENINDIONE
REP.PRIMARY,2.5,IDH1,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K70601687-001-01-3,ENASIDENIB,ENASIDENIB
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K70650177-001-01-7,TESTOSTERONE-UNDECANOATE,TESTOSTERONE-UNDECANOATE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K71026158-304-01-0,CARUMONAM,CARUMONAM
REP.PRIMARY,2.5,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K71977764-001-01-2,PIROXIMONE,PIROXIMONE
REP.PRIMARY,2.5,"SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K72259270-003-25-6,DYCLONINE,DYCLONINE
REP.PRIMARY,2.5,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K72264770-001-03-2,BRD4770,BRD4770
REP.PRIMARY,2.5,FLT3,FLT3 INHIBITOR,BRD:BRD-K72280606-001-01-2,GILTERITINIB,GILTERITINIB
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K72533376-001-01-2,ETOPOSIDE-PHOSPHATE,ETOPOSIDE-PHOSPHATE
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K73027814-003-01-0,OXYFEDRINE,OXYFEDRINE
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2, OXTR",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K73028949-001-02-8,VASOPRESSIN,VASOPRESSIN
REP.PRIMARY,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K73132780-001-01-2,PYRONARIDINE,PYRONARIDINE
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K73451719-001-01-2,TERLIPRESSIN,TERLIPRESSIN
REP.PRIMARY,2.5,F2,THROMBIN INHIBITOR,BRD:BRD-K73504359-001-01-3,BIVALIRUDIN,BIVALIRUDIN
REP.PRIMARY,2.5,TLR7,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K73585091-001-02-3,GS-9620,GS-9620
REP.PRIMARY,2.5,,,BRD:BRD-K73753850-003-01-6,HEXAMINOLEVULINATE,HEXAMINOLEVULINATE
REP.PRIMARY,2.5,CYP3A4,CYTOCHROME P450 INHIBITOR,BRD:BRD-K73881242-003-04-6,ARBIDOL,ARBIDOL
REP.PRIMARY,2.5,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K74236984-001-04-8,UNC0321,UNC0321
REP.PRIMARY,2.5,"ENOX2, SPHK1",XIAP INHIBITOR,BRD:BRD-K74671368-001-01-8,IDRONOXIL,IDRONOXIL
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K74759733-065-01-4,ISEPAMICIN,ISEPAMICIN
REP.PRIMARY,2.5,"HTR1A, HTR2A, HTR2C","DOPAMINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K75385383-001-01-5,DIPT,DIPT
REP.PRIMARY,2.5,ESR1,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K75445017-001-01-1,ESTETROL,ESTETROL
REP.PRIMARY,2.5,PDXK,,BRD:BRD-K76204040-001-03-8,PYRIDOXAL,PYRIDOXAL
REP.PRIMARY,2.5,"GNRHR, LHCGR",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K76315403-015-02-5,CETRORELIX,CETRORELIX
REP.PRIMARY,2.5,TACR1,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K76594255-001-01-6,MAROPITANT,MAROPITANT
REP.PRIMARY,2.5,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K76614248-001-01-2,ATIZORAM,ATIZORAM
REP.PRIMARY,2.5,,"DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K76634210-001-12-1,IDOXURIDINE,IDOXURIDINE
REP.PRIMARY,2.5,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K76713213-001-02-1,TAVABOROLE,TAVABOROLE
REP.PRIMARY,2.5,SYK,SYK INHIBITOR,BRD:BRD-K76719364-001-02-5,GS-9973,GS-9973
REP.PRIMARY,2.5,,DNA INHIBITOR,BRD:BRD-K76927775-001-11-8,NITROFURANTOIN,NITROFURANTOIN
REP.PRIMARY,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K77038618-356-01-3,GARENOXACIN,GARENOXACIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K77073709-435-01-2,CEFMINOX,CEFMINOX
REP.PRIMARY,2.5,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K77175907-001-08-0,CALCIFEDIOL,CALCIFEDIOL
REP.PRIMARY,2.5,,ANTIOXIDANT,BRD:BRD-K77320845-001-01-2,SECOISOLARICIRESINOL-DIGLUCOSIDE,SECOISOLARICIRESINOL-DIGLUCOSIDE
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77428767-001-01-7,UNC0224,UNC0224
REP.PRIMARY,2.5,,STEROL METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77432251-001-01-2,ABAFUNGIN,ABAFUNGIN
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K77564118-001-03-1,FENOVERINE,FENOVERINE
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K78666663-001-01-6,LEMBOREXANT,LEMBOREXANT
REP.PRIMARY,2.5,"TAS1R2, TRPV1",,BRD:BRD-K78841970-001-13-8,ASPARTAME,ASPARTAME
REP.PRIMARY,2.5,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K79450420-001-01-8,INCB-024360,"EPACADOSTAT, INCB-024360"
REP.PRIMARY,2.5,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K79450420-001-02-6,INCB-024360,"EPACADOSTAT, INCB-024360"
REP.PRIMARY,2.5,"NOX1, NOX4",NADPH OXIDASE INHIBITOR,BRD:BRD-K79710622-001-02-9,GKT137831,GKT137831
REP.PRIMARY,2.5,"CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K79803033-300-01-3,POZANICLINE,POZANICLINE
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K79821389-001-03-5,RUBITECAN,RUBITECAN
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80076813-001-08-8,DIFTALONE,DIFTALONE
REP.PRIMARY,2.5,,VASODILATOR,BRD:BRD-K80353807-001-25-3,KHELLIN,KHELLIN
REP.PRIMARY,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K80359953-001-01-3,TALAMPANEL,TALAMPANEL
REP.PRIMARY,2.5,SLC6A2,ADRENERGIC NEURON BLOCKER,BRD:BRD-K80419150-001-02-4,DEBRISOQUIN,DEBRISOQUIN
REP.PRIMARY,2.5,,SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-K80607346-001-01-1,FK-962,FK-962
REP.PRIMARY,2.5,"CSNK2A1, NQO2, PTGS1, PTGS2","CYTOCHROME P450 INHIBITOR, SIRT ACTIVATOR",BRD:BRD-K80738081-001-46-8,RESVERATROL,RESVERATROL
REP.PRIMARY,2.5,SLCO1B1,CONTRAST AGENT,BRD:BRD-K80762071-236-02-5,INDOCYANINE-GREEN,INDOCYANINE-GREEN
REP.PRIMARY,2.5,"DRD2, DRD3, DRD4, HTR2A",PSYCHOACTIVE DRUG,BRD:BRD-K80859331-001-01-5,HALOPERIDOL-DECANOATE,HALOPERIDOL-DECANOATE
REP.PRIMARY,2.5,"IL10, IL1B, IL6, TNF",CYTOKINE PRODUCTION INHIBITOR,BRD:BRD-K81405859-300-01-4,JTE-607,JTE-607
REP.PRIMARY,2.5,HTR1D,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K81616657-001-01-4,PNU-142633,PNU-142633
REP.PRIMARY,2.5,"GLRB, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K81981783-236-02-9,GAVESTINEL,GAVESTINEL
REP.PRIMARY,2.5,"AOC3, P4HA1",VASODILATOR,BRD:BRD-K82103381-003-09-4,HYDRALAZINE,HYDRALAZINE
REP.PRIMARY,2.5,,"ACETYLCHOLINE RECEPTOR AGONIST, NICOTINIC RECEPTOR AGONIST",BRD:BRD-K82118441-001-03-7,PYRANTEL,PYRANTEL
REP.PRIMARY,2.5,ADRA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K82687598-001-01-6,TOLONIDINE,TOLONIDINE
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K82908348-001-01-9,DARGLITAZONE,DARGLITAZONE
REP.PRIMARY,2.5,MTOR,"MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K82967180-001-01-6,LY3023414,LY3023414
REP.PRIMARY,2.5,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-K83029223-001-01-3,LITRONESIB,LITRONESIB
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K83144676-001-09-5,OLMESARTAN,OLMESARTAN
REP.PRIMARY,2.5,"CASR, IDO1, SLC36A1, WARS, WARS2",SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K83776863-001-08-9,TRYPTOPHAN,TRYPTOPHAN
REP.PRIMARY,2.5,AR,AROMATASE INHIBITOR,BRD:BRD-K84036904-001-08-8,17-ALPHA-METHYLTESTOSTERONE,17-ALPHA-METHYLTESTOSTERONE
REP.PRIMARY,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K84173274-001-01-6,UFENAMATE,UFENAMATE
REP.PRIMARY,2.5,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K84281997-003-08-4,PRALIDOXIME,PRALIDOXIME
REP.PRIMARY,2.5,,,BRD:BRD-K84459715-001-01-6,ZOPOLRESTAT,ZOPOLRESTAT
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FGFR4",FGFR INHIBITOR,BRD:BRD-K84868168-001-01-0,ERDAFITINIB,ERDAFITINIB
REP.PRIMARY,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K84971356-001-01-4,ETAFENONE,ETAFENONE
REP.PRIMARY,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-K85882401-323-01-5,AVIBACTAM,AVIBACTAM
REP.PRIMARY,2.5,"HTR1A, HTR1B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K86171477-001-01-3,ELTOPRAZINE,ELTOPRAZINE
REP.PRIMARY,2.5,,"DOPAMINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K86358349-001-02-0,BROMANTAN,BROMANTAN
REP.PRIMARY,2.5,UGCG,GLYCOSYL TRANSFERASE INHIBITOR,BRD:BRD-K86410485-046-01-0,ELIGLUSTAT,ELIGLUSTAT
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K86670086-001-02-5,SUTEZOLID,SUTEZOLID
REP.PRIMARY,2.5,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K86856088-001-06-9,UNC0638,UNC0638
REP.PRIMARY,2.5,"ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3",SODIUM CHANNEL BLOCKER,BRD:BRD-K86864073-001-01-1,CHLOROPROCAINE,CHLOROPROCAINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K86873305-236-14-7,PIPERACILLIN,PIPERACILLIN
REP.PRIMARY,2.5,"ESR2, NCOA1",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K87316765-001-01-4,PRINABEREL,PRINABEREL
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K87386013-001-01-7,DIROXIMEL-FUMARATE,DIROXIMEL-FUMARATE
REP.PRIMARY,2.5,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K87465484-001-02-7,UNC0646,UNC0646
REP.PRIMARY,2.5,,,BRD:BRD-K87573013-001-01-0,CL-225385,CL-225385
REP.PRIMARY,2.5,"CA2, STS",STEROID SULFATASE INHIBITOR,BRD:BRD-K87777313-001-02-2,IROSUSTAT,IROSUSTAT
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K87948281-001-01-9,F-11440,F-11440
REP.PRIMARY,2.5,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2",GABA RECEPTOR MODULATOR,BRD:BRD-K88143662-001-01-5,METHARBITAL,METHARBITAL
REP.PRIMARY,2.5,PTGER2,PROSTAGLANDIN RECEPTOR AGONIST,BRD:BRD-K88854110-001-01-5,TAPRENEPAG,TAPRENEPAG
REP.PRIMARY,2.5,RARA,"APOPTOSIS STIMULANT, RETINOID RECEPTOR AGONIST",BRD:BRD-K89085489-001-23-2,FENRETINIDE,FENRETINIDE
REP.PRIMARY,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K89121095-001-01-7,TEDIZOLID-PHOSPHATE,TEDIZOLID-PHOSPHATE
REP.PRIMARY,2.5,"OPRK1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K89272869-003-01-8,NALFURAFINE,NALFURAFINE
REP.PRIMARY,2.5,GABBR1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K89413285-074-01-5,REMIMAZOLAM,REMIMAZOLAM
REP.PRIMARY,2.5,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K89490285-001-08-1,BENTAZEPAM,BENTAZEPAM
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K89920762-001-01-4,PARITAPREVIR,PARITAPREVIR
REP.PRIMARY,2.5,,ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K90069354-001-03-7,ISOVALERAMIDE,ISOVALERAMIDE
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K90171280-001-01-4,LY2452473,LY2452473
REP.PRIMARY,2.5,,FUNGAL ERGOSTEROL INHIBITOR,BRD:BRD-K90563805-001-02-6,NATAMYCIN,NATAMYCIN
REP.PRIMARY,2.5,,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, CYCLOOXYGENASE INHIBITOR",BRD:BRD-K90629600-001-01-4,EMORFAZONE,EMORFAZONE
REP.PRIMARY,2.5,DRD3,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K90982969-001-01-2,ETILEVODOPA,ETILEVODOPA
REP.PRIMARY,2.5,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K91244729-003-01-3,PROPIVERINE,PROPIVERINE
REP.PRIMARY,2.5,"HCAR2, HCAR3",NIACIN RECEPTOR AGONIST,BRD:BRD-K91405252-001-01-9,MK-0354,MK-0354
REP.PRIMARY,2.5,ADA,"ADENOSINE DEAMINASE INHIBITOR, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-K91543828-001-02-0,PENTOSTATIN,PENTOSTATIN
REP.PRIMARY,2.5,"MAPK11, MAPK12, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K91900765-001-07-6,VX-745,VX-745
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K92073408-001-15-7,NORETHINDRONE,NORETHINDRONE
REP.PRIMARY,2.5,,GLUTATHIONE SYNTHASE STIMULANT,BRD:BRD-K92413528-001-06-9,PROCYSTEINE,PROCYSTEINE
REP.PRIMARY,2.5,,,BRD:BRD-K92426617-001-06-3,ESAPRAZOLE,ESAPRAZOLE
REP.PRIMARY,2.5,,GLUTATHIONE TRANSFERASE STIMULANT,BRD:BRD-K92490248-001-06-6,ANETHOLE-TRITHIONE,ANETHOLE-TRITHIONE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR MODULATOR,BRD:BRD-K92581468-001-01-6,OCINAPLON,OCINAPLON
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K92902018-001-01-9,HYDROXYPROGESTERONE-ACETATE,HYDROXYPROGESTERONE-ACETATE
REP.PRIMARY,2.5,FFAR1,ATP CITRASE LYASE INHIBITOR,BRD:BRD-K92908289-001-01-8,MEDICA-16,MEDICA-16
REP.PRIMARY,2.5,F2R,"THROMBIN INHIBITOR, THROMBIN RECEPTOR ANTAGONIST",BRD:BRD-K93442924-001-03-4,VORAPAXAR,VORAPAXAR
REP.PRIMARY,2.5,,,BRD:BRD-K93900986-001-15-0,STETADERM,STETADERM
REP.PRIMARY,2.5,,BONE RESORPTION INHIBITOR,BRD:BRD-K94072573-001-09-9,MEDRONIC-ACID,MEDRONIC-ACID
REP.PRIMARY,2.5,RRM1,RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K94146583-001-01-6,DIDOX,DIDOX
REP.PRIMARY,2.5,"CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A","CYTOCHROME P450 INHIBITOR, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K94830213-001-01-3,TOFISOPAM,TOFISOPAM
REP.PRIMARY,2.5,"ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9",METALLOPROTEINASE INHIBITOR,BRD:BRD-K95362002-001-01-1,CIPEMASTAT,CIPEMASTAT
REP.PRIMARY,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K95941975-001-01-5,PIPERAZINEDIONE,PIPERAZINEDIONE
REP.PRIMARY,2.5,,"CYCLOOXYGENASE INHIBITOR, PROSTAGLANDIN INHIBITOR",BRD:BRD-K96206066-001-07-9,DIFENPIRAMIDE,DIFENPIRAMIDE
REP.PRIMARY,2.5,GCK,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K96344439-002-02-7,TOFOGLIFLOZIN,TOFOGLIFLOZIN
REP.PRIMARY,2.5,,PYRUVATE FERREDOXIN OXIDOREDUCTASE INHIBITOR,BRD:BRD-K96471533-001-09-0,NITAZOXANIDE,NITAZOXANIDE
REP.PRIMARY,2.5,,AGE INHIBITOR,BRD:BRD-K96669468-300-01-1,PYRIDOXAMINE,PYRIDOXAMINE
REP.PRIMARY,2.5,,,BRD:BRD-K96691275-001-01-2,MEBROFENIN,MEBROFENIN
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96734425-304-01-7,CEFTRIAXONE,CEFTRIAXONE
REP.PRIMARY,2.5,"GNRHR, GNRHR2",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K96874295-015-01-0,GONADORELIN,GONADORELIN
REP.PRIMARY,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K97939847-001-12-0,CRIDANIMOD,CRIDANIMOD
REP.PRIMARY,2.5,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K98054437-001-09-9,EPALRESTAT,EPALRESTAT
REP.PRIMARY,2.5,GABBR1,GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K98557884-001-01-6,SURITOZOLE,SURITOZOLE
REP.PRIMARY,2.5,,,BRD:BRD-K99077012-001-01-9,BEFURALINE,BEFURALINE
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K99199077-001-16-1,HYDROCORTISONE-BUTYRATE,HYDROCORTISONE-BUTYRATE
REP.PRIMARY,2.5,RXRA,RETINOID RECEPTOR AGONIST,BRD:BRD-K99431849-001-01-7,PERETINOIN,PERETINOIN
REP.PRIMARY,2.5,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K99447003-335-04-1,ENALAPRILAT,ENALAPRILAT
REP.PRIMARY,2.5,,,BRD:BRD-K99506538-001-03-8,XENALIPIN,XENALIPIN
REP.PRIMARY,2.5,"FLT1, FLT4, KDR, KIT","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K99616396-001-05-1,MOTESANIB,MOTESANIB
REP.PRIMARY,2.5,ALK,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K99879819-001-02-1,LORLATINIB,LORLATINIB
REP.PRIMARY,2.5,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2",NA/K-ATPASE INHIBITOR,BRD:BRD-K99919177-001-01-3,DESLANOSIDE,DESLANOSIDE
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-M63173034-001-03-6,CLONIXIN-LYSINATE,CLONIXIN-LYSINATE
REP.PRIMARY,2.5,CXCR3,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-A01307728-001-01-4,AMG-487-(+/-),AMG-487-(+/-)
REP.PRIMARY,2.5,TUBB,"MICROTUBULE STIMULANT, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-A02473266-001-01-1,CEVIPABULIN,CEVIPABULIN
REP.PRIMARY,2.5,SLC6A2,ADRENERGIC INHIBITOR,BRD:BRD-A02532772-003-01-7,TALOPRAM,TALOPRAM
REP.PRIMARY,2.5,,,BRD:BRD-A02933148-001-01-8,ISOTIQUIMIDE,ISOTIQUIMIDE
REP.PRIMARY,2.5,,GABA RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A03204438-001-01-2,PREGNANOLONE,PREGNANOLONE
REP.PRIMARY,2.5,NGFR,NEUROTROPHIC AGENT,BRD:BRD-A04649065-001-01-7,LM11A-31,LM11A-31
REP.PRIMARY,2.5,TP53,P53 ACTIVATOR,BRD:BRD-A09004963-001-01-3,APR-246,APR-246
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A09368919-001-01-7,FPL-12495,FPL-12495
REP.PRIMARY,2.5,,,BRD:BRD-A11725667-001-01-8,TERCIPRAZINE,TERCIPRAZINE
REP.PRIMARY,2.5,KCNQ4,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-A12633378-001-07-0,ML-213,ML-213
REP.PRIMARY,2.5,GRM2,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A13293292-001-02-6,BINA,BINA
REP.PRIMARY,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-A13689093-001-01-8,ONO-4059,ONO-4059
REP.PRIMARY,2.5,MDM2,MDM INHIBITOR,BRD:BRD-A16035238-001-01-7,SAR405838,SAR405838
REP.PRIMARY,2.5,TRPA1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-A16560607-001-02-5,TCS-5861528,TCS-5861528
REP.PRIMARY,2.5,NTRK2,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-A19609491-001-01-8,ANA-12,ANA-12
REP.PRIMARY,2.5,"MAPK1, MAPK3",MAP KINASE INHIBITOR,BRD:BRD-A20830788-001-01-9,GDC-0994,GDC-0994
REP.PRIMARY,2.5,"DRD2, SLC6A2, SLC6A4","DOPAMINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A24208517-003-01-8,BICIFADINE,BICIFADINE
REP.PRIMARY,2.5,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A25182582-001-01-8,EDAGLITAZONE,EDAGLITAZONE
REP.PRIMARY,2.5,,CYTIDINE DEAMINASE INHIBITOR,BRD:BRD-A26105646-001-06-1,3-DEAZAURIDINE,3-DEAZAURIDINE
REP.PRIMARY,2.5,"JAK2, STAT1",NFKB PATHWAY INHIBITOR,BRD:BRD-A26458246-004-02-1,CKD-712,CKD-712
REP.PRIMARY,2.5,,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-A26835809-300-01-3,PX-478,PX-478
REP.PRIMARY,2.5,PARP2,PARP INHIBITOR,BRD:BRD-A27911617-001-01-7,AC-55541,AC-55541
REP.PRIMARY,2.5,"CYP3A4, MAPK11, MAPK12, MAPK14",MAP KINASE INHIBITOR,BRD:BRD-A29014990-001-02-3,ML3403,"ML-3403, ML3403"
REP.PRIMARY,2.5,,GLYCOSIDE AGONIST,BRD:BRD-A30370660-001-04-1,SENNOSIDE-A,SENNOSIDE-A
REP.PRIMARY,2.5,"ADRB1, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A31575449-066-07-8,CGP-20712A,CGP-20712A
REP.PRIMARY,2.5,AMY2B,,BRD:BRD-A32796301-001-01-6,4-GALACTOSYLLACTOSE,4-GALACTOSYLLACTOSE
REP.PRIMARY,2.5,"GRIN2C, GRIN2D",GLUTAMATE RECEPTOR POTENTIATOR,BRD:BRD-A35425966-001-02-3,CIQ,CIQ
REP.PRIMARY,2.5,ATR,ATR KINASE INHIBITOR,BRD:BRD-A36013532-001-01-3,AZD6738,AZD6738
REP.PRIMARY,2.5,,,BRD:BRD-A37752546-001-01-9,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME,"1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE OXIME, 1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME"
REP.PRIMARY,2.5,HTR7,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A39794701-003-01-6,DR-4485,DR-4485
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-A42383464-001-06-3,ACTINOMYCIN-D,ACTINOMYCIN-D
REP.PRIMARY,2.5,S1PR1,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-A43005764-003-01-5,CYM-5442,CYM-5442
REP.PRIMARY,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A46136514-001-01-2,BUTIBUFEN,BUTIBUFEN
REP.PRIMARY,2.5,RAPGEF3,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR INHIBITOR,BRD:BRD-A47940219-001-01-4,CE3F4,CE3F4
REP.PRIMARY,2.5,GLP1R,GLP RECEPTOR AGONIST,BRD:BRD-A48274390-001-01-8,LIRAGLUTIDE,LIRAGLUTIDE
REP.PRIMARY,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A50016482-001-01-7,CI-923,CI-923
REP.PRIMARY,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-A53472930-001-01-7,SECLAZONE,SECLAZONE
REP.PRIMARY,2.5,FFAR2,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-A54139254-001-09-2,4-CMTB,4-CMTB
REP.PRIMARY,2.5,"CNR1, DRD2, HTR1A",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-A54228901-001-01-7,SLV-319-(+/-),SLV-319-(+/-)
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A55204514-003-01-2,HIGENAMINE,HIGENAMINE
REP.PRIMARY,2.5,CES1,,BRD:BRD-A55748233-001-08-7,BENZOIN,BENZOIN
REP.PRIMARY,2.5,,,BRD:BRD-A56754222-001-01-2,GEPON,GEPON
REP.PRIMARY,2.5,"CYP19A1, CYP26A1",CYTOCHROME P450 INHIBITOR,BRD:BRD-A57133765-300-01-7,LIAROZOLE,LIAROZOLE
REP.PRIMARY,2.5,LPL,CHOLESTEROL INHIBITOR,BRD:BRD-A57806482-001-01-4,BRL-26314,BRL-26314
REP.PRIMARY,2.5,GPR55,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-A59391172-001-07-7,CID-16020046,CID-16020046
REP.PRIMARY,2.5,,"NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-A59747053-003-01-3,INDELOXAZINE,INDELOXAZINE
REP.PRIMARY,2.5,GLP1R,GLUCAGON-LIKE PEPTIDE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A60153876-001-01-0,BETP,BETP
REP.PRIMARY,2.5,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-A62133859-001-03-7,NLG919,NLG919
REP.PRIMARY,2.5,"EWSR1, FLI1",APOPTOSIS INHIBITOR,BRD:BRD-A62182663-001-03-0,YK-4-279,YK-4-279
REP.PRIMARY,2.5,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A62743154-003-01-5,BIMU-8,BIMU-8
REP.PRIMARY,2.5,NPSR1,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-A63344375-001-01-8,SHA-68,SHA-68
REP.PRIMARY,2.5,HTR2B,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A64004759-003-01-9,LY266097,LY266097
REP.PRIMARY,2.5,MCOLN3,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,BRD:BRD-A64319165-001-07-0,SN-2,SN-2
REP.PRIMARY,2.5,GABBR1,GABA RECEPTOR ANTAGONIST,BRD:BRD-A65793993-001-01-6,BTS-72664,BTS-72664
REP.PRIMARY,2.5,,GABA RECEPTOR MODULATOR,BRD:BRD-A66143912-001-01-1,3-HYDROXY-3-PHENYLPENTANAMIDE,3-HYDROXY-3-PHENYLPENTANAMIDE
REP.PRIMARY,2.5,APP,GAMMA SECRETASE MODULATOR,BRD:BRD-A66521565-001-01-8,TC-E-5006,TC-E-5006
REP.PRIMARY,2.5,FOLH1,GLUTAMATE CARBOXYPEPTIDASE INHIBITOR,BRD:BRD-A66788520-001-01-7,2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID,"2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID, 2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID"
REP.PRIMARY,2.5,"ADSSL1, HPRT1, IMPDH2, PYGM",IMMUNOSTIMULANT,BRD:BRD-A67531813-001-01-6,POLYINOSINE,POLYINOSINE
REP.PRIMARY,2.5,"CPA1, CPA2",CARBOXYPEPTIDASE INHIBITOR,BRD:BRD-A69126730-001-01-3,CPA-INHIBITOR,CPA-INHIBITOR
REP.PRIMARY,2.5,SPHK2,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-A70814879-001-01-2,ABC-294640,ABC-294640
REP.PRIMARY,2.5,,FAAH INHIBITOR,BRD:BRD-A74347210-001-01-7,MINERVAL,MINERVAL
REP.PRIMARY,2.5,MDM2,MDM INHIBITOR,BRD:BRD-A78210457-001-01-5,RG7112,RG7112
REP.PRIMARY,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A79643124-001-01-9,FLOSEQUINAN,FLOSEQUINAN
REP.PRIMARY,2.5,HTR2B,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-A79769222-001-01-3,NORFLUOXETINE,NORFLUOXETINE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A80321291-001-03-2,BIAPENEM,BIAPENEM
REP.PRIMARY,2.5,PTGER4,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-A80567330-001-01-7,ONO-AE3-208,ONO-AE3-208
REP.PRIMARY,2.5,"AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1","CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR, PURINERGIC RECEPTOR ANTAGONIST",BRD:BRD-A81177136-001-12-7,KN-62,KN-62
REP.PRIMARY,2.5,MIF,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,BRD:BRD-A81603255-001-01-0,CPSI-1306-(+/-),CPSI-1306-(+/-)
REP.PRIMARY,2.5,"DRD2, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A82013137-300-01-1,PD-168568,PD-168568
REP.PRIMARY,2.5,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-A83792282-001-01-6,TC-I-2000,TC-I-2000
REP.PRIMARY,2.5,SCN9A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-A84202322-001-01-7,NAV-26,NAV-26
REP.PRIMARY,2.5,CXCR3,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-A86523169-001-01-0,NBI-74330-(+/-),NBI-74330-(+/-)
REP.PRIMARY,2.5,"CPT1A, CPT1B",CARNITINE PALMITOYLTRANSFERASE INHIBITOR,BRD:BRD-A86525947-001-01-4,OXFENICINE,OXFENICINE
REP.PRIMARY,2.5,"CSF1R, KDR, KIT, PDGFRB",C-FMS INHIBITOR,BRD:BRD-A88787317-001-01-0,KI-20227,KI-20227
REP.PRIMARY,2.5,,,BRD:BRD-A90642009-001-03-2,BENAXIBINE,BENAXIBINE
REP.PRIMARY,2.5,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-A91031770-001-01-8,SB-268262,SB-268262
REP.PRIMARY,2.5,,,BRD:BRD-A92448440-001-01-3,SARI-59-801,SARI-59-801
REP.PRIMARY,2.5,ACKR3,CC CHEMOKINE RECEPTOR AGONIST,BRD:BRD-A93717708-051-01-2,VUF11207,VUF11207
REP.PRIMARY,2.5,"CRY1, CRY2",PROTEASOME INHIBITOR,BRD:BRD-A94580299-001-10-4,KL-001,KL-001
REP.PRIMARY,2.5,ENPP2,AUTOTAXIN INHIBITOR,BRD:BRD-A94640958-001-01-7,AUTOTAXIN-MODULATOR-1,AUTOTAXIN-MODULATOR-1
REP.PRIMARY,2.5,JAK3,JAK INHIBITOR,BRD:BRD-A95300432-001-01-3,DECERNOTINIB,DECERNOTINIB
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A95683721-001-03-8,KW-3902,KW-3902
REP.PRIMARY,2.5,"IL1B, NR1I2, TNF","ANTI-INFLAMMATORY AGENT, INTERLEUKIN INHIBITOR",BRD:BRD-K00141480-001-15-4,TANSHINONE-IIA,TANSHINONE-IIA
REP.PRIMARY,2.5,P2RX3,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00354853-001-01-2,RO-3,RO-3
REP.PRIMARY,2.5,PIK3CG,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K00652956-001-01-5,BAG-956,BAG-956
REP.PRIMARY,2.5,PTPN11,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00818915-003-01-8,SHP099,SHP099
REP.PRIMARY,2.5,,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K00989047-001-01-2,TROVIRDINE,TROVIRDINE
REP.PRIMARY,2.5,PDK2,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K01036220-001-01-0,JNJ-42041935,JNJ-42041935
REP.PRIMARY,2.5,NUDT1,MTH1 INHIBITOR,BRD:BRD-K01054709-001-01-3,TH588,"TH-588, TH588"
REP.PRIMARY,2.5,TSPO,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K01080633-001-01-9,DAA-1106,DAA-1106
REP.PRIMARY,2.5,,"KATP ACTIVATOR, POTASSIUM CHANNEL AGONIST",BRD:BRD-K01231377-001-01-8,BMS-191095,BMS-191095
REP.PRIMARY,2.5,CRHR1,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K01363385-003-01-5,ANTALARMIN,ANTALARMIN
REP.PRIMARY,2.5,LRRK2,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K01436366-001-22-2,LRRK2-IN-1,LRRK2-IN-1
REP.PRIMARY,2.5,"ITGA2, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K01492390-001-01-9,BTT-3033,BTT-3033
REP.PRIMARY,2.5,CERK,CERAMIDASE INHIBITOR,BRD:BRD-K01573278-001-02-1,NVP-231,NVP-231
REP.PRIMARY,2.5,HSD17B1,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K01742705-001-01-7,BVT-2733,BVT-2733
REP.PRIMARY,2.5,PTGS2,"NFKB PATHWAY INHIBITOR, NITRIC OXIDE SYNTHASE INHIBITOR",BRD:BRD-K01942833-001-01-8,GINSENOSIDE-C-K,GINSENOSIDE-C-K
REP.PRIMARY,2.5,CDK7,CDK INHIBITOR,BRD:BRD-K02135007-001-01-8,THZ1-R,THZ1-R
REP.PRIMARY,2.5,"KCNK3, KCNK9",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K02160913-001-02-7,ML365,"ML-365, ML365"
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K02213468-001-02-3,CDPPB,CDPPB
REP.PRIMARY,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K02782351-003-01-5,SSR-180711,SSR-180711
REP.PRIMARY,2.5,"BRD1, BRPF1, BRPF3",BROMODOMAIN INHIBITOR,BRD:BRD-K03042257-001-01-2,NI-57,NI-57
REP.PRIMARY,2.5,"SCN1A, SCN3A",SODIUM CHANNEL BLOCKER,BRD:BRD-K03149601-001-02-6,ICA-121431,ICA-121431
REP.PRIMARY,2.5,"ITGA4, ITGB1",INTEGRIN ANTAGONIST,BRD:BRD-K03399463-001-01-6,BIO-1211,BIO-1211
REP.PRIMARY,2.5,,,BRD:BRD-K03871161-001-01-9,5-HYDROXYECTOINE,5-HYDROXYECTOINE
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K03988082-001-01-7,SB-399885,SB-399885
REP.PRIMARY,2.5,CD274,PROGRAMMED DEATH LIGAND INHIBITOR,BRD:BRD-K04032780-001-01-8,PD1-PDL-INHIBITOR-1,PD1-PDL-INHIBITOR-1
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K04266228-001-03-8,XL019,XL019
REP.PRIMARY,2.5,EIF2AK4,PERK INHIBITOR,BRD:BRD-K04374714-003-01-1,AMG-PERK-44,AMG-PERK-44
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K04643927-001-01-6,GLPG0492-R-ENANTIOMER,GLPG0492-R-ENANTIOMER
REP.PRIMARY,2.5,,ANALGESIC AGENT,BRD:BRD-K04843302-001-02-5,2-ETHOXYBENZOIC-ACID,2-ETHOXYBENZOIC-ACID
REP.PRIMARY,2.5,BRD9,BROMODOMAIN INHIBITOR,BRD:BRD-K04972057-001-01-1,I-BRD9,I-BRD9
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K05419687-001-01-0,PSB-603,PSB-603
REP.PRIMARY,2.5,CCND1,CYCLIN D INHIBITOR,BRD:BRD-K05531427-001-01-7,BRICICLIB,BRICICLIB
REP.PRIMARY,2.5,DHH,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K05973499-300-01-0,AZ-12080282,AZ-12080282
REP.PRIMARY,2.5,SIRT1,"SIRT INHIBITOR, TP53 ACTIVATOR",BRD:BRD-K05977823-001-05-3,TENOVIN-1,TENOVIN-1
REP.PRIMARY,2.5,PIK3CG,PI3K INHIBITOR,BRD:BRD-K06750613-001-07-3,GSK1059615,GSK1059615
REP.PRIMARY,2.5,ALDH2,ALDEHYDE DEHYDROGENASE ACTIVATOR,BRD:BRD-K06890060-001-09-1,ALDA-1,ALDA-1
REP.PRIMARY,2.5,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K07061232-001-01-8,BW-616U,BW-616U
REP.PRIMARY,2.5,"MAPK14, PTGS2",MAP KINASE INHIBITOR,BRD:BRD-K07074923-001-01-5,RWJ-67657,RWJ-67657
REP.PRIMARY,2.5,SLC6A9,GLYCINE TRANSPORTER INHIBITOR,BRD:BRD-K07150325-001-01-7,ASP-2535,ASP-2535
REP.PRIMARY,2.5,AR,"ANDROGEN RECEPTOR ANTAGONIST, ANTI-INFLAMMATORY AGENT",BRD:BRD-K07449869-001-01-5,APC-100,APC-100
REP.PRIMARY,2.5,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K07656463-001-01-5,AS-1269574,AS-1269574
REP.PRIMARY,2.5,,HIV GAG INHIBITOR,BRD:BRD-K08398903-001-01-1,GSK2838232,GSK2838232
REP.PRIMARY,2.5,SNCA,AUTOPHAGY INDUCER,BRD:BRD-K08478539-001-13-8,SMER-28,SMER-28
REP.PRIMARY,2.5,SMN1,SURVIVAL MOTOR NEURON PROTEIN MODULATOR,BRD:BRD-K08532119-001-01-5,LMI070,LMI070
REP.PRIMARY,2.5,"GNRHR, HRH2, TACR2",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K08657056-300-01-1,WAY-207024,WAY-207024
REP.PRIMARY,2.5,NQO2,DNA REPLICATION INHIBITOR,BRD:BRD-K08748705-001-08-2,TRETAZICAR,TRETAZICAR
REP.PRIMARY,2.5,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K08902330-001-01-3,TCS-PIM-1-1,TCS-PIM-1-1
REP.PRIMARY,2.5,,,BRD:BRD-K09118247-001-03-3,TRIBOMSALAN,TRIBOMSALAN
REP.PRIMARY,2.5,SIRT2,SIRT INHIBITOR,BRD:BRD-K09143580-001-01-0,AK-7,AK-7
REP.PRIMARY,2.5,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K09223495-001-01-4,GSK2879552,GSK2879552
REP.PRIMARY,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K09291936-001-13-3,9-AMINOCAMPTOTHECIN,9-AMINOCAMPTOTHECIN
REP.PRIMARY,2.5,PTK2,FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K09317629-004-01-7,Y-11,Y-11
REP.PRIMARY,2.5,"CMPK1, RRM1, TYMS","APOPTOSIS INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K09456915-001-01-2,GEMCITABINE-ELAIDATE,GEMCITABINE-ELAIDATE
REP.PRIMARY,2.5,GRIN2A,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K09787262-001-01-9,TCN201,TCN201
REP.PRIMARY,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K09946180-300-01-6,CP-99994,CP-99994
REP.PRIMARY,2.5,"DRD2, HTR2A","DOPAMINE RECEPTOR MODULATOR, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K10031916-075-01-3,LUMATEPERONE,LUMATEPERONE
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K10115470-001-01-8,PKI-166,PKI-166
REP.PRIMARY,2.5,,,BRD:BRD-K10226125-245-01-5,AC1NDSS5,AC1NDSS5
REP.PRIMARY,2.5,SLC22A6,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K10656395-001-02-1,ADIPIC-ACID,ADIPIC-ACID
REP.PRIMARY,2.5,FFAR4,FREE FATTY ACID RECEPTOR ANTAGONIST,BRD:BRD-K10852420-001-02-5,AH-7614,AH-7614
REP.PRIMARY,2.5,"FNTA, FNTB, PGGT1B",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K10958118-003-01-5,L-778123,L-778123
REP.PRIMARY,2.5,RXRA,RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K11428250-001-01-0,PA-452,PA-452
REP.PRIMARY,2.5,,,BRD:BRD-K11548689-001-01-6,LAURIC-DIETHANOLAMIDE,LAURIC-DIETHANOLAMIDE
REP.PRIMARY,2.5,,,BRD:BRD-K11576103-003-01-1,BENZYLDIMETHYLOCTYLAMMONIUM,BENZYLDIMETHYLOCTYLAMMONIUM
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3",FIBROBLAST GROWTH FACTOR INHIBITOR,BRD:BRD-K11683436-001-01-7,CH-5183284,CH-5183284
REP.PRIMARY,2.5,HDAC1,HDAC INHIBITOR,BRD:BRD-K11773281-075-02-4,4SC-202,4SC-202
REP.PRIMARY,2.5,TLR8,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K11785681-001-01-2,MOTOLIMOD,MOTOLIMOD
REP.PRIMARY,2.5,"TNKS, TNKS2",TANKYRASE INHIBITOR,BRD:BRD-K12198961-001-01-8,G007-LK,G007-LK
REP.PRIMARY,2.5,"CDC7, PIM1",CDC INHIBITOR,BRD:BRD-K12511835-003-02-0,BMS-863233,BMS-863233
REP.PRIMARY,2.5,KMO,KYNURENINE 3-MONOOXYGENASE INHIBITOR,BRD:BRD-K12639498-001-01-3,RO-61-8048,RO-61-8048
REP.PRIMARY,2.5,WNT5A,WNT5A PEPTIDE MIMETIC,BRD:BRD-K13005598-001-02-3,FOXY-5,FOXY-5
REP.PRIMARY,2.5,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K13039700-066-01-2,GW-438014A,GW-438014A
REP.PRIMARY,2.5,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K13142315-004-01-2,A-61603,A-61603
REP.PRIMARY,2.5,,,BRD:BRD-K13473780-001-02-1,BENETHAMINE,BENETHAMINE
REP.PRIMARY,2.5,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K13843533-001-01-7,AMRUBICIN,AMRUBICIN
REP.PRIMARY,2.5,"IGF1R, SRC","ABL KINASE INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR, SRC INHIBITOR",BRD:BRD-K14274271-001-02-8,XL228,XL228
REP.PRIMARY,2.5,,CREATINE KINASE SUBSTRATE,BRD:BRD-K14379200-001-04-7,CYCLOCREATINE,CYCLOCREATINE
REP.PRIMARY,2.5,HRAS,RAS GTPASE INHIBITOR,BRD:BRD-K14590126-001-01-6,FARNESYL-THIOSALICYLIC-ACID-AMIDE,FARNESYL-THIOSALICYLIC-ACID-AMIDE
REP.PRIMARY,2.5,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K15119094-001-01-1,BMS-CCR2-22,BMS-CCR2-22
REP.PRIMARY,2.5,"KDM2A, KDM4A, KDM4C, KDM5A, KDM6A, KDM7A, PHF8",HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K15256258-001-01-3,TC-E-5002,TC-E-5002
REP.PRIMARY,2.5,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-K15811707-001-02-0,CPI-203,CPI-203
REP.PRIMARY,2.5,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB",PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K15819326-001-01-6,AC-710,AC-710
REP.PRIMARY,2.5,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K15858023-001-01-0,ETP-45658,ETP-45658
REP.PRIMARY,2.5,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K15893360-001-01-8,GLPG0492,GLPG0492
REP.PRIMARY,2.5,TNKS,TANKYRASE INHIBITOR,BRD:BRD-K16183658-001-01-4,MN-64,MN-64
REP.PRIMARY,2.5,SIRT2,SIRT INHIBITOR,BRD:BRD-K16472653-001-01-6,SIRREAL-2,SIRREAL-2
REP.PRIMARY,2.5,FPR2,FORMYL PEPTIDE RECEPTOR AGONIST,BRD:BRD-K16497916-001-01-6,TC-FPR-43,TC-FPR-43
REP.PRIMARY,2.5,MTOR,"DNA PROTEIN KINASE INHIBITOR, MTOR INHIBITOR",BRD:BRD-K16755045-003-01-7,CC-115,CC-115
REP.PRIMARY,2.5,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K17617556-001-01-3,NIDA-41020,NIDA-41020
REP.PRIMARY,2.5,"ITGA2, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K17621556-001-01-5,TC-I-15,TC-I-15
REP.PRIMARY,2.5,,,BRD:BRD-K18280217-001-01-0,NAMPT-IN-1,NAMPT-IN-1
REP.PRIMARY,2.5,HSD11B1,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K18289362-001-02-2,PF-915275,PF-915275
REP.PRIMARY,2.5,POU5F1,OCT ACTIVATOR,BRD:BRD-K18305454-001-07-4,OAC2,OAC2
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K18319422-001-01-7,CPI-360,CPI-360
REP.PRIMARY,2.5,OXER1,OXOEICOSANOID RECEPTOR MODULATOR,BRD:BRD-K18745919-001-01-3,GUE-1654,GUE-1654
REP.PRIMARY,2.5,EED,POLYCOMB PROTEIN INHIBITOR,BRD:BRD-K19002914-001-01-3,EED226,EED226
REP.PRIMARY,2.5,TNKS2,"TANKYRASE INHIBITOR, WNT PATHWAY INHIBITOR",BRD:BRD-K19316653-001-02-0,WIKI4,WIKI4
REP.PRIMARY,2.5,FFAR4,G PROTEIN-COUPLED RECEPTOR MODULATOR,BRD:BRD-K19409553-001-01-6,GPR120-MODULATOR-1,GPR120-MODULATOR-1
REP.PRIMARY,2.5,"AVPR1A, AVPR2, OXTR",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K19426040-001-01-1,OPC-21268,OPC-21268
REP.PRIMARY,2.5,GPR139,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K19482962-001-01-8,JNJ-63533054,JNJ-63533054
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K19742012-001-02-3,SULFAMOXOLE,SULFAMOXOLE
REP.PRIMARY,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K19781342-001-01-4,ACT-462206,ACT-462206
REP.PRIMARY,2.5,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-K19871656-001-01-3,CPI-0610,CPI-0610
REP.PRIMARY,2.5,"ABCC8, KCNJ11",ATP-SENSITIVE POTASSIUM CHANNEL AGONIST,BRD:BRD-K20568871-001-01-1,TIFENAZOXIDE,TIFENAZOXIDE
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K20828910-001-02-0,GW-6471,GW-6471
REP.PRIMARY,2.5,EPAS1,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K20850787-001-01-6,PT-2385,PT-2385
REP.PRIMARY,2.5,"CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9",CDK INHIBITOR,BRD:BRD-K20986415-001-01-8,RGB-286638,RGB-286638
REP.PRIMARY,2.5,"LIMK2, ROCK1, ROCK2","LIM KINASE INHIBITOR, RHO ASSOCIATED KINASE INHIBITOR",BRD:BRD-K21038058-001-01-9,LX7101,LX7101
REP.PRIMARY,2.5,CTSS,CATHEPSIN INHIBITOR,BRD:BRD-K21070437-001-01-4,LY3000328,LY3000328
REP.PRIMARY,2.5,"ITGA4, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K21318844-001-01-4,BIO-5192,BIO-5192
REP.PRIMARY,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K21415491-001-01-4,ALS-8176,"ALS-8112, ALS-8176"
REP.PRIMARY,2.5,RPS6KB1,RIBOSOMAL PROTEIN INHIBITOR,BRD:BRD-K21833260-075-01-1,LY2584702,LY2584702
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K21865955-003-01-5,NS-018,NS-018
REP.PRIMARY,2.5,EPAS1,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K21894922-001-01-9,TC-S-7009,TC-S-7009
REP.PRIMARY,2.5,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K21920947-001-02-1,AN2718,AN2718
REP.PRIMARY,2.5,L3MBTL1,MBT INHIBITOR,BRD:BRD-K22229656-003-01-5,UNC926,"UNC-926, UNC926"
REP.PRIMARY,2.5,,NOTCH SIGNALING INHIBITOR,BRD:BRD-K22316123-001-01-9,BMS-983970,BMS-983970
REP.PRIMARY,2.5,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K22421059-001-02-3,EBROTIDINE,EBROTIDINE
REP.PRIMARY,2.5,"NAMPT, SLC2A1",NAMPT INHIBITOR,BRD:BRD-K22477529-001-02-7,STF-31,STF-31
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K22641081-304-01-8,CEFODIZIME,CEFODIZIME
REP.PRIMARY,2.5,,,BRD:BRD-K23005288-001-01-8,SP-420,SP-420
REP.PRIMARY,2.5,"TACR1, TACR2, TACR3",NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K23106423-001-01-0,SUBSTANCE-P,SUBSTANCE-P
REP.PRIMARY,2.5,AGTR1,ANGIOTENSIN ANTAGONIST,BRD:BRD-K23533833-001-01-9,CARBOXYLOSARTAN,CARBOXYLOSARTAN
REP.PRIMARY,2.5,FFAR4,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K24282351-001-01-4,TUG-891,TUG-891
REP.PRIMARY,2.5,PARP3,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K24283677-001-01-9,ME-0328,ME-0328
REP.PRIMARY,2.5,"APC, AXIN1, GSK3B",WNT PATHWAY INHIBITOR,BRD:BRD-K24554037-001-08-3,JW-67,JW-67
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K24871708-002-04-6,CEFPROZIL,CEFPROZIL
REP.PRIMARY,2.5,"NTSR1, NTSR2",NEUROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K25075681-001-02-0,MECLINERTANT,MECLINERTANT
REP.PRIMARY,2.5,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K25143390-001-01-0,MSX-122,MSX-122
REP.PRIMARY,2.5,SLC16A1,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K25210703-001-01-9,AZD3965,AZD3965
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3, PAK4, PAK6, PAK7, PRKCQ, PRKG1, PRKX",AKT INHIBITOR,BRD:BRD-K25325018-001-05-6,GSK690693,GSK690693
REP.PRIMARY,2.5,MAPK8,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K25863791-001-01-8,ANTAGONIST-G,ANTAGONIST-G
REP.PRIMARY,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K26041695-001-02-5,TC-F-2,TC-F-2
REP.PRIMARY,2.5,"TP53, USP14","ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR",BRD:BRD-K26122255-001-01-7,VLX600,"VLX-600, VLX600"
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K26169680-003-01-9,ROBALZOTAN,ROBALZOTAN
REP.PRIMARY,2.5,,,BRD:BRD-K26273521-001-07-3,TRANS-4-METHOXYCINNAMIC-ACID,TRANS-4-METHOXYCINNAMIC-ACID
REP.PRIMARY,2.5,FAAH,FAAH ACTIVATOR,BRD:BRD-K26358347-001-01-7,PDP-EA,PDP-EA
REP.PRIMARY,2.5,ERN1,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K26420709-001-01-7,TOYOCAMYCIN,TOYOCAMYCIN
REP.PRIMARY,2.5,"LPAR1, LPAR3",LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K26439554-001-01-3,H2L-5765834,H2L-5765834
REP.PRIMARY,2.5,FFAR4,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K26514105-001-01-7,GSK37647,"GSK-37647, GSK37647"
REP.PRIMARY,2.5,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, TBXA2R",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K26521938-001-09-8,DINOPROSTONE,DINOPROSTONE
REP.PRIMARY,2.5,,,BRD:BRD-K26556907-001-01-8,BENZOFENAC,BENZOFENAC
REP.PRIMARY,2.5,ROCK1,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K27051047-001-01-0,AS-1892802,AS-1892802
REP.PRIMARY,2.5,SLC12A5,POTASSIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-K27074404-001-08-4,VU0240551,"VU-0240551, VU0240551"
REP.PRIMARY,2.5,,MEMBRANE PERMEABILITY ENHANCER,BRD:BRD-K27352494-001-03-6,AMPHOTERICIN-B,AMPHOTERICIN-B
REP.PRIMARY,2.5,GPR55,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K27539181-001-08-5,ML193,"ML-193, ML193"
REP.PRIMARY,2.5,NPBWR1,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K27732927-001-03-6,CYM-50769,CYM-50769
REP.PRIMARY,2.5,PFKFB3,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K28010364-001-01-0,PFK-158,PFK-158
REP.PRIMARY,2.5,,,BRD:BRD-K28030264-001-02-7,N-HYDROXYNICOTINAMIDE,N-HYDROXYNICOTINAMIDE
REP.PRIMARY,2.5,PAK1,P21 ACTIVATED KINASE INHIBITOR,BRD:BRD-K28132190-001-02-0,NVS-PAK1-1,NVS-PAK1-1
REP.PRIMARY,2.5,"CYP2C8, CYP2C9, CYP3A4",RNA POLYMERASE INHIBITOR,BRD:BRD-K28346421-001-06-8,RIFAPENTINE,RIFAPENTINE
REP.PRIMARY,2.5,MDM2,UBIQUITIN LIGASE INHIBITOR,BRD:BRD-K28571773-001-01-6,SP-141,SP-141
REP.PRIMARY,2.5,DRD4,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28639661-001-01-6,NGD-94-1,NGD-94-1
REP.PRIMARY,2.5,S1PR2,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K29151923-001-01-5,CYM-5520,CYM-5520
REP.PRIMARY,2.5,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K29328421-001-01-6,GSK9027,GSK9027
REP.PRIMARY,2.5,"MAP3K5, MAP3K6",MAP KINASE INHIBITOR,BRD:BRD-K29660062-300-01-2,TC-ASK-10,TC-ASK-10
REP.PRIMARY,2.5,LRRK2,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K30185465-001-03-0,GSK2578215A,GSK2578215A
REP.PRIMARY,2.5,SERPINE1,PLASMINOGEN ACTIVATOR INHIBITOR,BRD:BRD-K30882994-001-01-6,TIPLAXTININ,TIPLAXTININ
REP.PRIMARY,2.5,ALDH1A2,ALDEHYDE DEHYDROGENASE INHIBITOR,BRD:BRD-K30930903-001-01-3,WIN-18446,WIN-18446
REP.PRIMARY,2.5,,CHOLESTEROL INHIBITOR,BRD:BRD-K31139048-001-03-2,OMEGA-3-ACID-ESTERS,OMEGA-3-ACID-ESTERS
REP.PRIMARY,2.5,ADORA2A,"A1 ADENOSINE RECEPTOR ANTAGONIST, ADENOSINE RECEPTOR ANTAGONIST",BRD:BRD-K31170746-001-01-6,ANR-94,ANR-94
REP.PRIMARY,2.5,,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K31329721-001-08-2,CENTAZOLONE,CENTAZOLONE
REP.PRIMARY,2.5,CRHR1,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K31394475-001-01-9,CP-376395,CP-376395
REP.PRIMARY,2.5,TP53,TP53 INHIBITOR,BRD:BRD-K31792052-004-02-7,PIFITHRIN-CYCLIC,PIFITHRIN-CYCLIC
REP.PRIMARY,2.5,LPAR5,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K32031961-001-01-7,TC-LPA5-4,TC-LPA5-4
REP.PRIMARY,2.5,"GUCY1A3, GUCY1B3",GUANYLYL CYCLASE ACTIVATOR,BRD:BRD-K32033120-001-01-1,BAY-41-2272,BAY-41-2272
REP.PRIMARY,2.5,"AKT1, AKT2, AKT3, ROCK1, ROCK2, SGK3",PROTEIN KINASE INHIBITOR,BRD:BRD-K32127727-001-04-2,AT13148,AT13148
REP.PRIMARY,2.5,LPAR2,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K32322923-001-01-7,LPA2-ANTAGONIST-1,LPA2-ANTAGONIST-1
REP.PRIMARY,2.5,RARA,RETINOID RECEPTOR AGONIST,BRD:BRD-K32533226-001-01-3,AGN-195183,AGN-195183
REP.PRIMARY,2.5,KDM6B,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K32847255-001-01-1,GSK-J1,GSK-J1
REP.PRIMARY,2.5,"GLRB, SLC6A5",GLYCINE TRANSPORTER INHIBITOR,BRD:BRD-K32853922-003-01-8,ORG-25543,ORG-25543
REP.PRIMARY,2.5,"CHRNA3, CHRNA4, CHRNA7",ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K33059059-001-01-0,A-867744,A-867744
REP.PRIMARY,2.5,GPBAR1,FXR AGONIST,BRD:BRD-K33067152-236-01-1,INT-767,INT-767
REP.PRIMARY,2.5,"CYP1A1, CYP1A2, CYP2B6, CYP3A4, ESR1, MMP1, SULT2A1, UGT1A1",,BRD:BRD-K33903083-001-03-5,BENFLURALIN,BENFLURALIN
REP.PRIMARY,2.5,"CYP2C9, SLC12A1","CYTOCHROME P450 INHIBITOR, SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR",BRD:BRD-K34098590-001-02-1,TIENILIC-ACID,TIENILIC-ACID
REP.PRIMARY,2.5,RAPGEF4,GTPASE INHIBITOR,BRD:BRD-K34411045-001-01-9,HJC-0350,HJC-0350
REP.PRIMARY,2.5,"KCNN1, KCNN2, KCNN3",CALCIUM-ACTIVATED POTASSIUM CHANNEL MODULATOR,BRD:BRD-K34624869-003-01-6,NS-8593,NS-8593
REP.PRIMARY,2.5,GRM2,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K34675210-003-01-4,CBIPES,CBIPES
REP.PRIMARY,2.5,"AKT1, CAMK2A, CAMK4, MYLK",CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K35772771-001-02-1,CAMKII-IN-1,CAMKII-IN-1
REP.PRIMARY,2.5,"KDR, TEK","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K35936936-001-01-6,ACTB-1003,ACTB-1003
REP.PRIMARY,2.5,,COLORING AGENT,BRD:BRD-K36163066-304-02-4,ROSE-BENGAL-LACTONE,ROSE-BENGAL-LACTONE
REP.PRIMARY,2.5,,"NFKB PATHWAY INHIBITOR, PKC INHIBITOR",BRD:BRD-K36201510-001-06-7,VERBASCOSIDE,VERBASCOSIDE
REP.PRIMARY,2.5,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K36611520-001-01-6,CP-532623,CP-532623
REP.PRIMARY,2.5,NEDD4,UBIQUITIN LIGASE TRANSPORT PROMOTER,BRD:BRD-K36804890-001-01-9,NAB-2,NAB-2
REP.PRIMARY,2.5,"KDR, PDGFRB","PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K36949735-001-01-1,ANLOTINIB,ANLOTINIB
REP.PRIMARY,2.5,,,BRD:BRD-K36998189-001-03-5,O-MERCAPTO-BENZOIC-ACID,O-MERCAPTO-BENZOIC-ACID
REP.PRIMARY,2.5,,HIV PROTEASE INHIBITOR,BRD:BRD-K37087535-001-01-1,DPC-681,DPC-681
REP.PRIMARY,2.5,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K37151368-001-01-7,ADAPTAVIR,ADAPTAVIR
REP.PRIMARY,2.5,"AURKA, AURKB, AURKC, MAP2K1, MAP2K2","AURORA KINASE INHIBITOR, MEK INHIBITOR",BRD:BRD-K37492701-001-02-9,BI-847325,BI-847325
REP.PRIMARY,2.5,,,BRD:BRD-K37747025-001-08-2,SANAZOLE,SANAZOLE
REP.PRIMARY,2.5,,PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K37848908-001-05-6,CEFORANIDE,CEFORANIDE
REP.PRIMARY,2.5,ELANE,"ELASTASE INHIBITOR, LEUKOCYTE ELASTASE INHIBITOR",BRD:BRD-K37864785-001-01-0,GW-311616,GW-311616
REP.PRIMARY,2.5,P2RX3,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K38019854-323-01-4,A-317491,A-317491
REP.PRIMARY,2.5,PDE10A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K38145871-001-01-8,PDE10-IN-1,PDE10-IN-1
REP.PRIMARY,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K38385169-001-04-5,LY3009120,LY3009120
REP.PRIMARY,2.5,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K38775274-001-22-1,DEXAMETHASONE,DEXAMETHASONE
REP.PRIMARY,2.5,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K38793468-001-01-4,TAK-220,TAK-220
REP.PRIMARY,2.5,"FAAH, MGLL","FAAH INHIBITOR, MONOACYLGLYCEROL LIPASE INHIBITOR",BRD:BRD-K38875233-001-03-9,JZL-195,JZL-195
REP.PRIMARY,2.5,CHRNA4,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K40176866-001-01-6,NS-9283,NS-9283
REP.PRIMARY,2.5,KDR,VEGFR INHIBITOR,BRD:BRD-K40575944-001-01-5,DMH4,DMH4
REP.PRIMARY,2.5,HTR1D,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K41194171-003-09-7,LY310762,LY310762
REP.PRIMARY,2.5,"AR, ESR1, ESR2, ESRRG, PPARG",SYNTHETIC ESTROGEN,BRD:BRD-K41494493-001-13-8,BISPHENOL-A,BISPHENOL-A
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K41626799-001-01-1,AZD3759,AZD3759
REP.PRIMARY,2.5,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K41705163-001-01-1,EC-144,EC-144
REP.PRIMARY,2.5,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K41933240-001-02-4,CURCUMOL,CURCUMOL
REP.PRIMARY,2.5,"AVPR1A, OXTR",OXYTOCIN RECEPTOR ANTAGONIST,BRD:BRD-K42009284-001-01-1,OT-R-ANTAGONIST-1,OT-R-ANTAGONIST-1
REP.PRIMARY,2.5,,APOPTOSIS STIMULANT,BRD:BRD-K42019693-001-01-5,PYRIDOXAL-ISONICOTINOYL-HYDRAZONE,PYRIDOXAL-ISONICOTINOYL-HYDRAZONE
REP.PRIMARY,2.5,TAAR1,TRACE AMINE ASSOCIATED RECEPTOR ANTAGONIST,BRD:BRD-K42536037-001-01-3,EPPTB,EPPTB
REP.PRIMARY,2.5,,WNT AGONIST,BRD:BRD-K42624714-001-04-1,BML-284,BML-284
REP.PRIMARY,2.5,"FGFR1, FGFR2, FGFR3, FGFR4, KDR",FGFR INHIBITOR,BRD:BRD-K42728290-001-09-1,NVP-BGJ398,NVP-BGJ398
REP.PRIMARY,2.5,TLR4,TOLL-LIKE RECEPTOR INHIBITOR,BRD:BRD-K43167535-001-01-3,C34,C34
REP.PRIMARY,2.5,,HISTAMINE RELEASE INHIBITOR,BRD:BRD-K43419711-001-01-4,WY-16922,WY-16922
REP.PRIMARY,2.5,"CSNK1D, CSNK1E",CASEIN KINASE INHIBITOR,BRD:BRD-K43428468-003-04-0,PF-4800567,PF-4800567
REP.PRIMARY,2.5,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-K43436647-001-01-7,ARQ-621,ARQ-621
REP.PRIMARY,2.5,CDK9,CDK INHIBITOR,BRD:BRD-K43914553-001-01-5,CDK9-IN-6,CDK9-IN-6
REP.PRIMARY,2.5,SLC9A1,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K43992824-300-01-0,ZONIPORIDE,ZONIPORIDE
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K44022883-001-01-7,MRK-016,MRK-016
REP.PRIMARY,2.5,KCNK9,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K44043890-001-01-4,PK-THPP,PK-THPP
REP.PRIMARY,2.5,"HTR1A, HTR1B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K44091134-001-01-9,FLUPRAZINE,FLUPRAZINE
REP.PRIMARY,2.5,HIF1A,HYPOXIA INDUCIBLE FACTOR ACTIVATOR,BRD:BRD-K44432556-001-05-5,ML228,"ML-228, ML228"
REP.PRIMARY,2.5,"AXL, MERTK, TYRO3",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K44715996-001-01-0,LDC1267,LDC1267
REP.PRIMARY,2.5,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K44731351-001-01-6,AL-8697,AL-8697
REP.PRIMARY,2.5,FKBP1A,FKBP INHIBITOR,BRD:BRD-K44869961-001-01-6,GPI-1046,GPI-1046
REP.PRIMARY,2.5,TYMS,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K45973863-001-01-4,WR99210,WR99210
REP.PRIMARY,2.5,"IKBKB, PRDX5, TRPA1",NFKB PATHWAY INHIBITOR,BRD:BRD-K45995181-001-04-6,AURANOFIN,AURANOFIN
REP.PRIMARY,2.5,"CNR1, CNR2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K46209126-001-06-4,PRAVADOLINE,PRAVADOLINE
REP.PRIMARY,2.5,PIP5K1C,PHOSPHATIDYL-INOSITOL ACTIVATOR,BRD:BRD-K46344388-001-01-3,UNC3230,"UNC-3230, UNC3230"
REP.PRIMARY,2.5,,,BRD:BRD-K46416130-001-07-7,ACETRIAZOIC-ACID,ACETRIAZOIC-ACID
REP.PRIMARY,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR PARTIAL AGONIST,BRD:BRD-K46647427-001-02-0,L-838417,L-838417
REP.PRIMARY,2.5,MGLL,MONOACYLGLUCEROL LIPASE INHIBITOR,BRD:BRD-K46734292-001-03-6,KML29,KML29
REP.PRIMARY,2.5,,MEK INHIBITOR,BRD:BRD-K46908090-001-02-2,GDC-0623,GDC-0623
REP.PRIMARY,2.5,,,BRD:BRD-K47169076-003-01-6,RHODAMINE-123,RHODAMINE-123
REP.PRIMARY,2.5,"PIK3CB, PIK3CD",PI3K INHIBITOR,BRD:BRD-K47289408-001-01-5,AZD8186,AZD8186
REP.PRIMARY,2.5,CSNK1D,CASEIN KINASE INHIBITOR,BRD:BRD-K47409078-001-02-6,LH846,LH846
REP.PRIMARY,2.5,GGCX,VITAMIN K ANTAGONIST,BRD:BRD-K47458712-001-20-7,ANISINDIONE,ANISINDIONE
REP.PRIMARY,2.5,WDR5,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K47726410-001-01-2,WDR5-0103,WDR5-0103
REP.PRIMARY,2.5,SORT1,SORTILIN INHIBITOR,BRD:BRD-K47816470-001-01-8,AF38469,AF38469
REP.PRIMARY,2.5,PLK1,PLK INHIBITOR,BRD:BRD-K48059512-003-01-0,TAK-960,TAK-960
REP.PRIMARY,2.5,"BAZ2A, BAZ2B",BROMODOMAIN INHIBITOR,BRD:BRD-K48062199-001-01-8,GSK2801,GSK2801
REP.PRIMARY,2.5,STK33,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K48188942-001-03-7,ML281,"ML-281, ML281"
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K48371964-001-06-5,VU1545,VU1545
REP.PRIMARY,2.5,MAPK7,MAP KINASE INHIBITOR,BRD:BRD-K48449981-001-02-7,XMD17-109,XMD17-109
REP.PRIMARY,2.5,VCP,VALOSIN-CONTAINING PROTEIN INHIBITOR,BRD:BRD-K49048664-001-01-2,CB-5083,CB-5083
REP.PRIMARY,2.5,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K49110935-300-01-9,SB-772077B,SB-772077B
REP.PRIMARY,2.5,"KIT, PDGFRA","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K49246350-001-01-1,DCC-2618,DCC-2618
REP.PRIMARY,2.5,CES3,CARBOXYLESTERASE INHIBITOR,BRD:BRD-K49389158-001-01-3,WWL-113,WWL-113
REP.PRIMARY,2.5,HRH3,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K49519092-303-03-0,IMMETHRIDINE,IMMETHRIDINE
REP.PRIMARY,2.5,"AKT1, AKT3, ROCK1, RPS6KA5, RPS6KB1",KINASE INHIBITOR,BRD:BRD-K49597925-300-01-9,SB-747651A,SB-747651A
REP.PRIMARY,2.5,PTGER4,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K50005760-001-01-1,GW-627368,GW-627368
REP.PRIMARY,2.5,MAPK10,JNK INHIBITOR,BRD:BRD-K50378376-001-01-8,SR-3576,SR-3576
REP.PRIMARY,2.5,NRP1,NEUROPILIN RECEPTOR ANTAGONIST,BRD:BRD-K50653584-001-01-2,EG00229,EG00229
REP.PRIMARY,2.5,BDKRB1,BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K50699835-001-01-2,ELN-441958,ELN-441958
REP.PRIMARY,2.5,"ADRA2A, KCNQ1, KCNQ2",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K50720187-051-03-1,FLUPIRTINE,FLUPIRTINE
REP.PRIMARY,2.5,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K51041191-001-01-4,PF-03882845,PF-03882845
REP.PRIMARY,2.5,"DHH, IHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K51265828-001-01-0,M-25,M-25
REP.PRIMARY,2.5,CD38,RIBOSYL CYCLASE INHIBITOR,BRD:BRD-K51337109-003-01-3,KUROMANIN,KUROMANIN
REP.PRIMARY,2.5,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K51387999-067-01-6,AMEZINIUM,AMEZINIUM
REP.PRIMARY,2.5,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K51528698-003-01-4,TEIJIN-COMPOUND-1,TEIJIN-COMPOUND-1
REP.PRIMARY,2.5,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K51700582-001-01-2,BUPICOMIDE,BUPICOMIDE
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K52598503-003-01-1,MOFEGILINE,MOFEGILINE
REP.PRIMARY,2.5,ANO1,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,BRD:BRD-K53030960-001-01-4,EACT,EACT
REP.PRIMARY,2.5,"TNKS, TNKS2",TANKYRASE INHIBITOR,BRD:BRD-K53328210-001-04-4,JW-55,JW-55
REP.PRIMARY,2.5,"MAPK14, TEK","MAP KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR",BRD:BRD-K53405000-001-02-8,PEXMETINIB,PEXMETINIB
REP.PRIMARY,2.5,,HIV INTEGRASE INHIBITOR,BRD:BRD-K53422148-001-01-8,BI-224436,BI-224436
REP.PRIMARY,2.5,"MIF, PFKFB3",PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K53438416-001-01-9,YZ9,YZ9
REP.PRIMARY,2.5,METAP2,METHIONINE AMINOPEPTIDASE INHIBITOR,BRD:BRD-K53597484-001-02-7,TNP-470,TNP-470
REP.PRIMARY,2.5,GHSR,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K53600683-051-01-5,TABIMORELIN,TABIMORELIN
REP.PRIMARY,2.5,,CHOLESTEROL INHIBITOR,BRD:BRD-K53605365-001-01-4,PROACIPIMOX,PROACIPIMOX
REP.PRIMARY,2.5,BRAF,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K53723268-001-01-3,PLX8394,PLX8394
REP.PRIMARY,2.5,ESR2,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K53788420-001-01-1,AC-186,AC-186
REP.PRIMARY,2.5,PYGL,GLYCOGEN PHOSPHORYLASE INHIBITOR,BRD:BRD-K53913008-001-01-5,CP-316819,CP-316819
REP.PRIMARY,2.5,"GABRA1, GABRB2, GABRG2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K54093161-001-01-8,CGS-9896,CGS-9896
REP.PRIMARY,2.5,,PROTEIN KINASE INHIBITOR,BRD:BRD-K54170555-001-01-8,NMS-P715,NMS-P715
REP.PRIMARY,2.5,PORCN,"BETA CATENIN INHIBITOR, PORCUPINE INHIBITOR",BRD:BRD-K54264768-001-01-2,ETC-159,ETC-159
REP.PRIMARY,2.5,,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K54538117-001-01-7,LY450108,LY450108
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR POTENTIATOR,BRD:BRD-K54783522-001-01-8,VU29,VU29
REP.PRIMARY,2.5,PTGER2,PROSTAGLANDIN INHIBITOR,BRD:BRD-K54871792-001-02-2,PF-04418948,PF-04418948
REP.PRIMARY,2.5,"AVPR1A, OXT","OXYTOCIN RECEPTOR AGONIST, VASOPRESSIN RECEPTOR AGONIST",BRD:BRD-K55013981-001-01-3,TC-OT-39,TC-OT-39
REP.PRIMARY,2.5,P4HB,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K55188888-065-01-2,RIBOSTAMYCIN,RIBOSTAMYCIN
REP.PRIMARY,2.5,LSS,OXIDOSQUALENE CYCLASE INHIBITOR,BRD:BRD-K55192287-051-01-1,RO-48-8071,RO-48-8071
REP.PRIMARY,2.5,"ITGA4, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K55216666-001-01-4,TCS-2314,TCS-2314
REP.PRIMARY,2.5,,HISTONE DEMETHYLASE CONTROL,BRD:BRD-K55438324-001-01-8,GSK-J5,GSK-J5
REP.PRIMARY,2.5,,SRC INHIBITOR,BRD:BRD-K55487946-001-01-3,WEHI-345-ANALOG,WEHI-345-ANALOG
REP.PRIMARY,2.5,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K55529781-236-03-8,FUREGRELATE,FUREGRELATE
REP.PRIMARY,2.5,"ELANE, EP300, FASN, KAT2B, MMP14, MMP2",BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K55591206-001-20-7,EPIGALLOCATECHIN-GALLATE-(-),EPIGALLOCATECHIN-GALLATE-(-)
REP.PRIMARY,2.5,,GLUCONEOGENESIS INHIBITOR,BRD:BRD-K55822903-003-01-8,IMEGLIMIN,IMEGLIMIN
REP.PRIMARY,2.5,FFAR1,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K56086081-001-01-7,TUG-770,TUG-770
REP.PRIMARY,2.5,CDK1,CDK INHIBITOR,BRD:BRD-K56239177-300-01-3,CGP-74514,CGP-74514
REP.PRIMARY,2.5,,,BRD:BRD-K56405978-001-01-5,TBA-354,TBA-354
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K56565215-001-01-9,VIPADENANT,VIPADENANT
REP.PRIMARY,2.5,,,BRD:BRD-K56634222-001-03-0,2-IODOHIPPURIC-ACID,2-IODOHIPPURIC-ACID
REP.PRIMARY,2.5,,,BRD:BRD-K57091285-001-07-7,DICYCLOHEXYLAMINE,DICYCLOHEXYLAMINE
REP.PRIMARY,2.5,FGFR3,"FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K57187269-001-02-4,BRIVANIB-ALANINATE,BRIVANIB-ALANINATE
REP.PRIMARY,2.5,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K57416838-001-01-1,MRK-409,MRK-409
REP.PRIMARY,2.5,HPGDS,PROSTAGLANDIN INHIBITOR,BRD:BRD-K57708067-001-01-3,TFC-007,TFC-007
REP.PRIMARY,2.5,GLS,GLUTAMINASE INHIBITOR,BRD:BRD-K58070273-001-03-3,CB-839,CB-839
REP.PRIMARY,2.5,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K58319700-001-01-1,BEGACESTAT,BEGACESTAT
REP.PRIMARY,2.5,EGFR,EGFR INHIBITOR,BRD:BRD-K58811567-001-01-9,HKI-357,HKI-357
REP.PRIMARY,2.5,MMP8,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K58894520-001-01-1,ONO-4817,ONO-4817
REP.PRIMARY,2.5,,ANTIVIRAL,BRD:BRD-K59590127-001-04-5,CHLORPROPHAM,CHLORPROPHAM
REP.PRIMARY,2.5,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K59711701-300-02-1,ORY-1001,ORY-1001
REP.PRIMARY,2.5,FBP1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K59753853-001-02-3,MDL-29951,MDL-29951
REP.PRIMARY,2.5,,ATP SYNTHASE INHIBITOR,BRD:BRD-K59853741-001-01-9,Q-203,Q-203
REP.PRIMARY,2.5,KCNQ1,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K60020910-001-02-5,ML277,"ML-277, ML277"
REP.PRIMARY,2.5,AKT2,AKT INHIBITOR,BRD:BRD-K60171656-001-01-6,ARQ-092,ARQ-092
REP.PRIMARY,2.5,AHR,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K60298136-001-03-3,ITE,ITE
REP.PRIMARY,2.5,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K60371362-001-01-7,OSEMOZOTAN,OSEMOZOTAN
REP.PRIMARY,2.5,PRMT3,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K60635008-001-01-5,UNC2327,"UNC-2327, UNC2327"
REP.PRIMARY,2.5,ALDH2,ALDEHYDE DEHYDROGENASE INHIBITOR,BRD:BRD-K60659193-001-02-8,CVT-10216,CVT-10216
REP.PRIMARY,2.5,,,BRD:BRD-K60902958-001-01-9,ECTOINE-ZWITTERION,ECTOINE-ZWITTERION
REP.PRIMARY,2.5,TACR1,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K60931454-003-01-3,SR-140333,SR-140333
REP.PRIMARY,2.5,"MAPK10, MAPK8, MAPK9",JNK INHIBITOR,BRD:BRD-K60952143-001-01-0,SR-3306,SR-3306
REP.PRIMARY,2.5,"GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K61041538-001-03-0,AZD1080,AZD1080
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K61043483-001-01-5,AZD9272,AZD9272
REP.PRIMARY,2.5,,P53 ACTIVATOR,BRD:BRD-K61339991-003-01-8,KEVETRIN,KEVETRIN
REP.PRIMARY,2.5,"PLD1, PLD2",PHOSPHOLIPASE INHIBITOR,BRD:BRD-K61560897-003-01-4,FIPI,FIPI
REP.PRIMARY,2.5,CASP3,CASPASE INHIBITOR,BRD:BRD-K61918008-001-07-1,NQDI-1,NQDI-1
REP.PRIMARY,2.5,DRD4,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K62066682-300-01-0,A-412997,A-412997
REP.PRIMARY,2.5,EPHX2,EPOXIDE HYDOLASE INHIBITOR,BRD:BRD-K62738477-001-01-7,GSK2256294A,GSK2256294A
REP.PRIMARY,2.5,,,BRD:BRD-K62914667-001-13-9,HIPPURIC-ACID,HIPPURIC-ACID
REP.PRIMARY,2.5,PTGS1,,BRD:BRD-K63247785-001-01-5,O-ACETYL-L-SERINE,O-ACETYL-L-SERINE
REP.PRIMARY,2.5,RET,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K63253858-001-01-5,SPP86,"SPP-86, SPP86"
REP.PRIMARY,2.5,"DRD2, HTR2A, HTR2C, HTR6, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K63483542-300-01-6,WAY-208466,WAY-208466
REP.PRIMARY,2.5,"PDE3A, PDE3B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K63631219-001-01-6,QUAZINONE,QUAZINONE
REP.PRIMARY,2.5,,HISTAMINE RELEASE INHIBITOR,BRD:BRD-K63651590-001-01-3,PIRQUINOZOL,PIRQUINOZOL
REP.PRIMARY,2.5,,MICROTUBULE INHIBITOR,BRD:BRD-K64120610-046-01-9,VINFLUNINE,VINFLUNINE
REP.PRIMARY,2.5,GLI1,GLI ANTAGONIST,BRD:BRD-K64451768-001-05-4,GANT-58,GANT-58
REP.PRIMARY,2.5,"ABCB1, ABCC1",BCRP INHIBITOR,BRD:BRD-K64642496-001-04-0,KO143,KO143
REP.PRIMARY,2.5,,ANTICONVULSANT,BRD:BRD-K64834129-001-19-6,ETEROBARB,ETEROBARB
REP.PRIMARY,2.5,CSNK2A1,CASEIN KINASE INHIBITOR,BRD:BRD-K64852730-001-01-7,TTP-22,TTP-22
REP.PRIMARY,2.5,ICAM1,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,BRD:BRD-K64880136-001-02-6,BIRT-377,BIRT-377
REP.PRIMARY,2.5,SLC6A4,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K64973364-001-01-4,INDALPINE,INDALPINE
REP.PRIMARY,2.5,"KCNH2, MCHR1",MELANIN INHIBITOR,BRD:BRD-K65576800-001-01-6,GW-803430,GW-803430
REP.PRIMARY,2.5,"CDK2, DNMT1","CDK INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K66213167-001-01-2,RX-3117,RX-3117
REP.PRIMARY,2.5,CDK7,CDK INHIBITOR,BRD:BRD-K66401437-001-03-3,THZ1,THZ1
REP.PRIMARY,2.5,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K66896751-001-02-4,ALPIDEM,ALPIDEM
REP.PRIMARY,2.5,CASP3,APOPTOSIS STIMULANT,BRD:BRD-K66898851-003-03-3,SANGUINARIUM-CHLORIDE,SANGUINARIUM-CHLORIDE
REP.PRIMARY,2.5,PARP1,PARP INHIBITOR,BRD:BRD-K66998413-300-01-6,EB-47,EB-47
REP.PRIMARY,2.5,"ADORA2A, ADORA2B",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K67079690-001-01-2,LUF-5834,LUF-5834
REP.PRIMARY,2.5,PDGFRA,VEGFR INHIBITOR,BRD:BRD-K67262033-001-01-0,TAK-593,TAK-593
REP.PRIMARY,2.5,GPBAR1,"G PROTEIN COUPLED RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST",BRD:BRD-K67397687-001-01-3,GPBAR-A,GPBAR-A
REP.PRIMARY,2.5,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K67915505-001-01-2,NVP-HSP990,NVP-HSP990
REP.PRIMARY,2.5,KLF4,"KR""""""""UPPEL-LIKE FACTOR EXPRESSION ENHANCER, KRÃPPEL-LIKE FACTOR EXPRESSION ENHANCER",BRD:BRD-K68003372-001-01-6,APTO-253,APTO-253
REP.PRIMARY,2.5,GRM2,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K68220839-413-02-8,LY2979165,LY2979165
REP.PRIMARY,2.5,HDAC6,HDAC INHIBITOR,BRD:BRD-K68358632-001-01-0,TCS-HDAC6-20B,TCS-HDAC6-20B
REP.PRIMARY,2.5,,PABA ANTAGONIST,BRD:BRD-K68379918-001-01-1,SILVER-SULFADIAZINE,SILVER-SULFADIAZINE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K68453341-001-01-1,GS-6201,GS-6201
REP.PRIMARY,2.5,MYD88,MYELOID DIFFERENTIATION PRIMARY RESPONSE INHIBITOR,BRD:BRD-K68470841-001-01-0,ST-2825,ST-2825
REP.PRIMARY,2.5,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K68633027-001-01-9,SB-706375,SB-706375
REP.PRIMARY,2.5,GRM3,"GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR, GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR",BRD:BRD-K68674163-001-01-7,VU0422288,"VU-0422288, VU0422288"
REP.PRIMARY,2.5,RIPK2,"NECROPTOSIS INHIBITOR, RIPK INHIBITOR",BRD:BRD-K68851986-001-01-6,NECROSTATIN-2,NECROSTATIN-2
REP.PRIMARY,2.5,JAK1,JAK INHIBITOR,BRD:BRD-K69215269-001-01-1,SOLCITINIB,SOLCITINIB
REP.PRIMARY,2.5,XIAP,APOPTOSIS INHIBITOR,BRD:BRD-K69351586-001-01-0,CUDC-427,CUDC-427
REP.PRIMARY,2.5,"DHH, IHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K69624312-001-01-1,CUR-61414,CUR-61414
REP.PRIMARY,2.5,NAMPT,NAMPT INHIBITOR,BRD:BRD-K69832040-001-01-9,GMX1778,GMX1778
REP.PRIMARY,2.5,S1PR4,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K69877120-001-01-7,CYM-50260,CYM-50260
REP.PRIMARY,2.5,"GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K70329400-001-02-5,A-1070722,A-1070722
REP.PRIMARY,2.5,NTRK2,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-K70404782-001-01-6,LM-22A4,LM-22A4
REP.PRIMARY,2.5,PRMT5,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K70446295-001-01-7,EPZ015666,EPZ015666
REP.PRIMARY,2.5,POLR2A,RNA POLYMERASE INHIBITOR,BRD:BRD-K70578146-001-06-7,DACTINOMYCIN,DACTINOMYCIN
REP.PRIMARY,2.5,APP,BETA AMYLOID INHIBITOR,BRD:BRD-K70614402-001-01-0,SEN-1269,SEN-1269
REP.PRIMARY,2.5,TRPA1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K70744942-001-01-2,A-967079,A-967079
REP.PRIMARY,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K70759443-001-01-4,IDAZOXANE,IDAZOXANE
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K70976396-236-26-0,CEFOXITIN,CEFOXITIN
REP.PRIMARY,2.5,,VITAMIN K ANTAGONIST,BRD:BRD-K71133585-236-14-4,SULFAQUINOXALINE,SULFAQUINOXALINE
REP.PRIMARY,2.5,PLK1,PLK INHIBITOR,BRD:BRD-K71667152-003-09-8,SBE-13,SBE-13
REP.PRIMARY,2.5,"NFKB1, NOS2, PDE10A, PTGS1","CYCLOOXYGENASE INHIBITOR, PLATELET AGGREGATION INHIBITOR, THROMBOXANE SYNTHASE INHIBITOR",BRD:BRD-K71696703-001-07-9,TRIFLUSAL,TRIFLUSAL
REP.PRIMARY,2.5,,FABI INHIBITOR,BRD:BRD-K72078047-001-01-7,MUT056399,MUT056399
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K72293620-001-01-7,GSK503,GSK503
REP.PRIMARY,2.5,"ABL1, BCR",ABL KINASE INHIBITOR,BRD:BRD-K72514671-001-01-4,PPY-A,PPY-A
REP.PRIMARY,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K72735080-001-01-0,BET-BAY-002,BET-BAY-002
REP.PRIMARY,2.5,"KIT, STAT3",KIT INHIBITOR,BRD:BRD-K72748448-001-01-0,APCK-110,APCK-110
REP.PRIMARY,2.5,PIK3C3,PI3K INHIBITOR,BRD:BRD-K72868067-001-02-4,SAR405,SAR405
REP.PRIMARY,2.5,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K73235735-001-02-7,AZD9496,AZD9496
REP.PRIMARY,2.5,OPRL1,"NOCICEPTIN/ORPHANIN FQ (NOP) RECEPTOR AGONIST, NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST",BRD:BRD-K73276278-305-01-1,MCOPPB,MCOPPB
REP.PRIMARY,2.5,PRMT5,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K73746696-003-01-8,HLCL-61,HLCL-61
REP.PRIMARY,2.5,CCR1,CC CHEMOKINE RECEPTOR AGONIST,BRD:BRD-K73799155-001-01-5,NSC5844,"NSC-5844, NSC5844"
REP.PRIMARY,2.5,PIK3CA,PI3K INHIBITOR,BRD:BRD-K73877023-001-01-9,MLN1117,MLN1117
REP.PRIMARY,2.5,DGAT1,DIACYLGLYCEROL KINASE INHIBITOR,BRD:BRD-K73984371-001-01-1,AZD3988,AZD3988
REP.PRIMARY,2.5,"AMY2B, MGAM",,BRD:BRD-K74377520-001-01-7,D-(+)-MALTOSE,D-(+)-MALTOSE
REP.PRIMARY,2.5,"ACVR1B, TGFBR1",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K74396648-001-01-4,EW-7197,EW-7197
REP.PRIMARY,2.5,AHR,ARYL HYDROCARBON RECEPTOR LIGAND,BRD:BRD-K74558903-300-01-5,PHORTRESS,PHORTRESS
REP.PRIMARY,2.5,CNR2,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K74965187-001-01-3,COR-170,COR-170
REP.PRIMARY,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K75052463-001-01-4,V-51,V-51
REP.PRIMARY,2.5,,,BRD:BRD-K75167327-001-01-6,ANTHRANILIC-ACID,"2-(1-ADAMANTYLAMINO)BENZOIC-ACID, ANTHRANILIC-ACID"
REP.PRIMARY,2.5,FFAR1,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K75254015-001-01-9,AS-2034178,AS-2034178
REP.PRIMARY,2.5,LIMK1,LIM KINASE INHIBITOR,BRD:BRD-K75373031-001-01-7,LIMKI-3,LIMKI-3
REP.PRIMARY,2.5,"APH1B, BACE1, IKBKG, PSEN1, PSEN2, PTGS1, PTGS2",GAMMA SECRETASE INHIBITOR,BRD:BRD-K75410565-001-02-9,FLURIZAN,FLURIZAN
REP.PRIMARY,2.5,PI4K2B,PI4K INHIBITOR,BRD:BRD-K75528696-001-01-2,PI4KIII-BETA-INHIBITOR-1,PI4KIII-BETA-INHIBITOR-1
REP.PRIMARY,2.5,"TNKS, TNKS2","TANKYRASE INHIBITOR, WNT SIGNALING INHIBITOR",BRD:BRD-K75664313-001-02-6,JW-74,JW-74
REP.PRIMARY,2.5,,,BRD:BRD-K76139886-003-01-3,COMPOUND-58112,COMPOUND-58112
REP.PRIMARY,2.5,SMYD2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K76244476-362-02-5,AZ505,AZ505
REP.PRIMARY,2.5,GSG2,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K76259716-019-01-1,CHR-6494,CHR-6494
REP.PRIMARY,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K76365178-001-01-5,SC-236,SC-236
REP.PRIMARY,2.5,"ABL1, BCR, FGR, FLT3, HCK, LYN, SRC","BCR-ABL KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K76694128-001-05-0,REBASTINIB,REBASTINIB
REP.PRIMARY,2.5,"BIRC5, CDK1",LIPOXYGENASE INHIBITOR,BRD:BRD-K76788410-001-01-6,TERAMEPROCOL,TERAMEPROCOL
REP.PRIMARY,2.5,TTK,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K76792630-001-01-2,TC-MPS1-12,TC-MPS1-12
REP.PRIMARY,2.5,,HIV INTEGRASE INHIBITOR,BRD:BRD-K76819217-001-02-2,CABOTEGRAVIR,CABOTEGRAVIR
REP.PRIMARY,2.5,GHSR,GROWTH HORMONE RELEASING FACTOR AGONIST,BRD:BRD-K77070363-001-01-5,U-75799E,U-75799E
REP.PRIMARY,2.5,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR LIGAND,BRD:BRD-K77087341-001-02-4,2-OLEOYLGLYCEROL,2-OLEOYLGLYCEROL
REP.PRIMARY,2.5,"RAPGEF3, RAPGEF4",EPAC INHIBITOR,BRD:BRD-K77139516-001-02-2,ESI-09,ESI-09
REP.PRIMARY,2.5,PTGIR,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K77220725-003-01-5,RO-1138452,RO-1138452
REP.PRIMARY,2.5,NR5A2,LIVER RECEPTOR HOMOLOG INVERSE AGONIST,BRD:BRD-K77547509-001-03-3,ML179,"ML-179, ML179"
REP.PRIMARY,2.5,,,BRD:BRD-K77756533-001-01-4,"7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE","7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE"
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K77911775-003-01-8,ADX-10059,ADX-10059
REP.PRIMARY,2.5,PDE1A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K77987496-011-01-9,ITI214,ITI214
REP.PRIMARY,2.5,,HCV INHIBITOR,BRD:BRD-K78092779-001-01-6,2'-C-METHYLGUANOSINE,2'-C-METHYLGUANOSINE
REP.PRIMARY,2.5,SCN9A,SODIUM CHANNEL BLOCKER,BRD:BRD-K78161388-001-01-2,TC-N-1752,TC-N-1752
REP.PRIMARY,2.5,AR,ANDROGENIC STEROID,BRD:BRD-K78352627-001-01-8,NANDROLONE-DECANOATE,NANDROLONE-DECANOATE
REP.PRIMARY,2.5,CDK1,CDK INHIBITOR,BRD:BRD-K78373679-001-03-7,RO-3306,RO-3306
REP.PRIMARY,2.5,"KDR, MET, TEK","MET INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K78627070-001-01-5,ALTIRATINIB,ALTIRATINIB
REP.PRIMARY,2.5,TACC3,NEURAL STEM CELL INDUCER,BRD:BRD-K78978711-003-01-3,KHS-101,KHS-101
REP.PRIMARY,2.5,"CDK1, CDK2",CDK INHIBITOR,BRD:BRD-K79090631-001-22-3,CGP-60474,CGP-60474
REP.PRIMARY,2.5,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K79337272-001-01-6,LSN-2463359,LSN-2463359
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K79511609-001-20-0,2-CHLOROADENOSINE,2-CHLOROADENOSINE
REP.PRIMARY,2.5,NTSR1,NEUROTENSIN AGONIST,BRD:BRD-K79608170-001-02-1,TC-NTR1-17,TC-NTR1-17
REP.PRIMARY,2.5,ABCC1,MRP INHIBITOR,BRD:BRD-K79700588-001-09-7,REVERSAN,REVERSAN
REP.PRIMARY,2.5,"CSNK1D, CSNK1E, MAPK14","CASEIN KINASE INHIBITOR, MAP KINASE INHIBITOR",BRD:BRD-K79856806-001-01-0,TA-01,TA-01
REP.PRIMARY,2.5,"TRPC4, TRPC5",TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K80021413-001-08-8,ML204,ML204
REP.PRIMARY,2.5,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-K80194255-001-01-9,BW-A4C,BW-A4C
REP.PRIMARY,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K80403280-001-02-1,ALAFOSFALIN,ALAFOSFALIN
REP.PRIMARY,2.5,S1PR4,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,BRD:BRD-K80666802-003-01-0,CYM-50358,CYM-50358
REP.PRIMARY,2.5,"RARA, RARB, RARG",RETINOID RECEPTOR AGONIST,BRD:BRD-K81004638-001-01-7,EC-23,EC-23
REP.PRIMARY,2.5,"KDR, MET","C-MET INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K81026553-234-01-8,BMS-817378,BMS-817378
REP.PRIMARY,2.5,LYPLA1,LYSOPHOSPHOLIPASE INHIBITOR,BRD:BRD-K81044214-001-06-4,ML348,"ML-348, ML348"
REP.PRIMARY,2.5,ABCG2,BCRP INHIBITOR,BRD:BRD-K81053848-001-01-0,KS-176,KS-176
REP.PRIMARY,2.5,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K81614372-001-02-1,A-922500,A-922500
REP.PRIMARY,2.5,,,BRD:BRD-K82178523-001-01-6,L-ASPARAGINE-N-HYDROXY,L-ASPARAGINE-N-HYDROXY
REP.PRIMARY,2.5,,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K82484347-001-01-2,GSK-J2,GSK-J2
REP.PRIMARY,2.5,"BRAF, MAP2K1, MAP2K2, RAF1","MEK INHIBITOR, RAF INHIBITOR",BRD:BRD-K82804538-001-01-0,RO-5126766,RO-5126766
REP.PRIMARY,2.5,"PIK3CA, PIK3CD",PI3K INHIBITOR,BRD:BRD-K82894950-001-01-0,AZD8835,AZD8835
REP.PRIMARY,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K83020231-001-01-2,DBPR108,DBPR108
REP.PRIMARY,2.5,LRRK2,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K83114366-001-02-8,PF-06447475,PF-06447475
REP.PRIMARY,2.5,ABHD6,MONOACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K83176916-001-01-4,WWL-123,WWL-123
REP.PRIMARY,2.5,NAMPT,NAMPT INHIBITOR,BRD:BRD-K83289131-003-01-0,GPP-78,GPP-78
REP.PRIMARY,2.5,LIMK2,LIM KINASE INHIBITOR,BRD:BRD-K83492904-001-01-9,T-5601640,T-5601640
REP.PRIMARY,2.5,ADORA2A,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K83970940-001-01-0,LU-AA-47070,LU-AA-47070
REP.PRIMARY,2.5,AXL,AXL KINASE INHIBITOR,BRD:BRD-K84034737-001-01-1,TP-0903,TP-0903
REP.PRIMARY,2.5,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K84883208-001-01-1,MR-948,MR-948
REP.PRIMARY,2.5,TNK2,TYROSINE KINASE INHIBITOR,BRD:BRD-K85139301-001-01-3,AIM-100,AIM-100
REP.PRIMARY,2.5,ICAM1,"ICAM1 ANTAGONIST, LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN RECEPTOR ANTAGONIST",BRD:BRD-K85649978-001-02-1,BMS-688521,BMS-688521
REP.PRIMARY,2.5,"AKR1A1, AKR1B1, AKR1B10",ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K85693895-001-02-9,TOLRESTAT,TOLRESTAT
REP.PRIMARY,2.5,,ANTIVIRAL,BRD:BRD-K85764479-003-01-0,SOMANTADINE,SOMANTADINE
REP.PRIMARY,2.5,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K86226872-001-01-6,APD597,APD597
REP.PRIMARY,2.5,"MAPK1, MAPK3",ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,BRD:BRD-K86309810-001-01-5,RAVOXERTINIB,RAVOXERTINIB
REP.PRIMARY,2.5,"MAPK11, MAPK12, MAPK13, MAPK14",MAP KINASE INHIBITOR,BRD:BRD-K86673452-001-01-7,AMG-548,AMG-548
REP.PRIMARY,2.5,LRRK2,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K87021635-003-02-2,CZC-54252,CZC-54252
REP.PRIMARY,2.5,"HCAR2, PTGR1",,BRD:BRD-K87122641-001-10-7,NARINGENINIC-ACID,NARINGENINIC-ACID
REP.PRIMARY,2.5,GPR39,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K87199310-001-01-4,TC-G-1008,TC-G-1008
REP.PRIMARY,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K87468701-001-01-0,EPZ011989,EPZ011989
REP.PRIMARY,2.5,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K87632963-001-03-0,GNF-5,GNF-5
REP.PRIMARY,2.5,AGER,RAGE RECEPTOR ANTAGONIST,BRD:BRD-K87691185-001-01-2,FPS-ZM1,FPS-ZM1
REP.PRIMARY,2.5,FABP4,FATTY ACID BINDING PROTEIN INHIBITOR,BRD:BRD-K87956243-001-01-9,BMS-309403,BMS-309403
REP.PRIMARY,2.5,SRC,SRC INHIBITOR,BRD:BRD-K88154110-001-01-0,KB-SRC-4,KB-SRC-4
REP.PRIMARY,2.5,"ITGAV, ITGB6",INTEGRIN ANTAGONIST,BRD:BRD-K88165431-003-01-4,INTEGRIN-ANTAGONIST-1,INTEGRIN-ANTAGONIST-1
REP.PRIMARY,2.5,"ALOX5AP, CNR1, CNR2","CANNABINOID RECEPTOR AGONIST, LIPOXYGENASE INHIBITOR",BRD:BRD-K88443722-001-01-7,AM679,AM679
REP.PRIMARY,2.5,PIEZO1,PIEZO CHANNEL ACTIVATOR,BRD:BRD-K88570498-001-01-9,YODA-1,YODA-1
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C, HTR4",SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K88743730-050-04-1,TEGASEROD,TEGASEROD
REP.PRIMARY,2.5,KIF18A,MITOTIC KINESIN INHIBITOR,BRD:BRD-K89000287-001-01-1,BTB1,BTB1
REP.PRIMARY,2.5,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K89223384-001-05-2,NG-NITRO-ARGININE,NG-NITRO-ARGININE
REP.PRIMARY,2.5,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K89464729-001-03-1,GSK269962,GSK269962
REP.PRIMARY,2.5,"DYRK1A, DYRK1B",DYRK INHIBITOR,BRD:BRD-K89517477-001-01-4,TC-S-7004,TC-S-7004
REP.PRIMARY,2.5,PLK2,PLK INHIBITOR,BRD:BRD-K89584803-001-01-9,TC-S-7005,TC-S-7005
REP.PRIMARY,2.5,,,BRD:BRD-K90033078-001-08-7,ZEATIN,ZEATIN
REP.PRIMARY,2.5,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K90082312-001-01-5,VUF10460,VUF10460
REP.PRIMARY,2.5,INS,INSULIN SENSITIZER,BRD:BRD-K90305467-001-01-3,ID-1101,ID-1101
REP.PRIMARY,2.5,CFD,"COMPLEMENT INHIBITOR, SERINE PROTEASE INHIBITOR",BRD:BRD-K90472149-066-01-0,BCX-1470,BCX-1470
REP.PRIMARY,2.5,,ANTIARRHYTHMIC,BRD:BRD-K90727284-001-05-0,PINCAINIDE,PINCAINIDE
REP.PRIMARY,2.5,"BRAF, FLT3, KIT, PDGFRB",RAF INHIBITOR,BRD:BRD-K90747162-001-01-4,KG-5,KG-5
REP.PRIMARY,2.5,KRAS,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K90830492-305-01-4,DELTARASIN,DELTARASIN
REP.PRIMARY,2.5,,IMMUNOSUPPRESSANT,BRD:BRD-K91234829-001-01-7,NAPIRIMUS,NAPIRIMUS
REP.PRIMARY,2.5,"FLT3, MERTK","FLT3 INHIBITOR, MER TYROSINE KINASE INHIBITOR",BRD:BRD-K91283740-003-01-6,UNC2025,UNC2025
REP.PRIMARY,2.5,,,BRD:BRD-K91356052-001-04-0,PALMITOLEIC-ACID,PALMITOLEIC-ACID
REP.PRIMARY,2.5,SOAT1,ACAT INHIBITOR,BRD:BRD-K91716465-001-01-2,YM-750,YM-750
REP.PRIMARY,2.5,,,BRD:BRD-K91733562-001-05-0,SECOISOLARICIRESINOL-(-),SECOISOLARICIRESINOL-(-)
REP.PRIMARY,2.5,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K92129045-001-01-6,CAROXAZONE,CAROXAZONE
REP.PRIMARY,2.5,"FAAH, FAAH2, TRPA1",FAAH INHIBITOR,BRD:BRD-K92169341-001-11-2,URB597,URB597
REP.PRIMARY,2.5,"PIK3CB, PIK3CD",PI3K INHIBITOR,BRD:BRD-K92517771-001-01-2,ACALISIB,ACALISIB
REP.PRIMARY,2.5,NTSR1,NEUROTENSIN AGONIST,BRD:BRD-K92606079-001-02-0,ML314,ML314
REP.PRIMARY,2.5,PKD1,PROTEIN KINASE INHIBITOR,BRD:BRD-K92781136-001-08-9,CID-2011756,CID-2011756
REP.PRIMARY,2.5,IDH1,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K93073858-001-01-1,IVOSIDENIB,IVOSIDENIB
REP.PRIMARY,2.5,PLD2,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K93317811-003-02-2,VU0364739,"VU-0364739, VU0364739"
REP.PRIMARY,2.5,"AVPR1A, AVPR1B, AVPR2",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K93331255-001-02-0,LYPRESSIN,LYPRESSIN
REP.PRIMARY,2.5,CAMK2A,CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K93480852-003-01-0,KN-93,KN-93
REP.PRIMARY,2.5,MAPK1,MAP KINASE INHIBITOR,BRD:BRD-K93725829-001-03-8,VX-11E,VX-11E
REP.PRIMARY,2.5,"PTK2, PTK2B",FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K93788137-001-04-1,PF-431396,PF-431396
REP.PRIMARY,2.5,USP1,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K93942811-001-01-3,ML323,"ML-323, ML323"
REP.PRIMARY,2.5,ICAM1,INTEGRIN INHIBITOR,BRD:BRD-K94623186-001-01-5,RWJ-50271,RWJ-50271
REP.PRIMARY,2.5,,,BRD:BRD-K94934625-001-01-5,SPIZOFURONE,SPIZOFURONE
REP.PRIMARY,2.5,,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, ANTIOXIDANT",BRD:BRD-K94948151-001-07-4,MACELIGNAN,MACELIGNAN
REP.PRIMARY,2.5,"ADORA1, PDE2A, PDE3B, PDE4D, PDE5A, PDE6G, PDE7A, PDE8A, PDE9A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K94979336-001-20-0,IBMX,IBMX
REP.PRIMARY,2.5,FASN,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K95123482-001-01-6,GSK2194069,GSK2194069
REP.PRIMARY,2.5,CDK7,CDK INHIBITOR,BRD:BRD-K95902121-001-01-0,THZ2,THZ2
REP.PRIMARY,2.5,"CSNK1D, CSNK1E",CASEIN KINASE INHIBITOR,BRD:BRD-K96295391-300-01-7,PF-670462,PF-670462
REP.PRIMARY,2.5,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K96418224-300-01-8,R-1485,R-1485
REP.PRIMARY,2.5,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K96843359-001-02-6,CP-775146,CP-775146
REP.PRIMARY,2.5,"CDK4, CDK6, FLT3","CDK INHIBITOR, FLT3 INHIBITOR",BRD:BRD-K97452254-001-01-3,AMG-925,AMG-925
REP.PRIMARY,2.5,,NA/K-ATPASE INHIBITOR,BRD:BRD-K98006098-001-01-6,OLEANDRIN,OLEANDRIN
REP.PRIMARY,2.5,CCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K98179423-300-01-3,C-021,C-021
REP.PRIMARY,2.5,RARG,RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K98353094-001-01-6,MM-11253,MM-11253
REP.PRIMARY,2.5,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K98736329-300-01-5,OXA-06,OXA-06
REP.PRIMARY,2.5,"HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR INVERSE AGONIST,BRD:BRD-K99968849-300-01-4,SB-243213,SB-243213
REP.PRIMARY,2.5,MTOR,PROTEIN SYNTHESIS STIMULANT,BRD:BRD-M02899238-238-01-6,BETA-HYDROXY-BETA-METHYLBUTYRATE,BETA-HYDROXY-BETA-METHYLBUTYRATE
REP.PRIMARY,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-M86143595-034-03-4,MRS-3777,MRS-3777
REP.1M,2.5,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-A00047421-001-01-7,ARV-825,ARV-825
REP.1M,2.5,,LAXATIVE,BRD:BRD-A00092689-236-04-9,DOCUSATE,DOCUSATE
REP.1M,2.5,C5AR1,ANAPHYLATOXIN CHEMOTACTIC RECEPTOR ANTAGONIST,BRD:BRD-A00559310-003-01-1,W-54011,W-54011
REP.1M,2.5,GRIN1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A02971356-001-09-9,IBOTENIC-ACID,IBOTENIC-ACID
REP.1M,2.5,ADORA3,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A06784547-001-03-9,MRS-1334,MRS-1334
REP.1M,2.5,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A08641215-065-05-5,POLYMYXIN-B-SULFATE,POLYMYXIN-B-SULFATE
REP.1M,2.5,NAMPT,NAMPT INHIBITOR,BRD:BRD-A09487507-001-03-9,P7C3,P7C3
REP.1M,2.5,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-A12147465-003-02-9,TC-A-2317,TC-A-2317
REP.1M,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A14757586-001-04-9,TETRAZOL-5-YL-GLYCINE-(RS),TETRAZOL-5-YL-GLYCINE-(RS)
REP.1M,2.5,WASL,"ACTIN RELATED PROTEIN INHIBITOR, NEURAL WISKOTT-ALDRICH SYNDROME PROTEIN INHIBITOR",BRD:BRD-A18579359-001-05-9,WISKOSTATIN,WISKOSTATIN
REP.1M,2.5,CHRNA7,NICOTINIC RECEPTOR AGONIST,BRD:BRD-A18598741-001-02-9,4BP-TQS,4BP-TQS
REP.1M,2.5,,,BRD:BRD-A19232309-001-08-6,PROPYLENE-GLYCOL,PROPYLENE-GLYCOL
REP.1M,2.5,"GRM1, GRM5",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A20589515-001-03-9,DIHYDROXYPHENYLGLYCINE,DIHYDROXYPHENYLGLYCINE
REP.1M,2.5,,CHELATING AGENT,BRD:BRD-A22971209-001-01-0,DMPS,DMPS
REP.1M,2.5,CDC42,GTPASE INHIBITOR,BRD:BRD-A25043798-001-02-9,CASIN,CASIN
REP.1M,2.5,GGT1,GAMMA GLUTAMYLTRANSFERASE INHIBITOR,BRD:BRD-A25625670-001-02-7,GGSTOP,GGSTOP
REP.1M,2.5,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-A25988899-001-01-6,TENOFOVIR-ALAFENAMIDE,TENOFOVIR-ALAFENAMIDE
REP.1M,2.5,CDC42,GTPASE INHIBITOR,BRD:BRD-A28422330-001-11-9,ML141,ML141
REP.1M,2.5,S1PR1,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,BRD:BRD-A29148886-003-02-9,RP-001,RP-001
REP.1M,2.5,PNKP,POLYNUCLEOTIDE KINASE/PHOSPHATASE INHIBITOR,BRD:BRD-A30000356-001-02-9,A12B4C3,A12B4C3
REP.1M,2.5,"CYP11A1, CYP11B1, ESR1",ANTINEOPLASTIC AGENT,BRD:BRD-A31204924-001-14-2,MITOTANE,MITOTANE
REP.1M,2.5,HHAT,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-A33603104-003-02-9,RU-SKI-43,RU-SKI-43
REP.1M,2.5,,,BRD:BRD-A37752546-001-02-9,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME,"1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE OXIME, 1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME"
REP.1M,2.5,,ANTITUMOR AGENT,BRD:BRD-A37873789-003-02-9,OCTODRINE,OCTODRINE
REP.1M,2.5,"RALA, RALB",RAS GTPASE INHIBITOR,BRD:BRD-A40257118-001-02-0,BQU57,BQU57
REP.1M,2.5,,DOPAMINE RELEASE INHIBITOR,BRD:BRD-A40504327-003-02-9,"4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE","4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE"
REP.1M,2.5,HCAR2,,BRD:BRD-A41387824-001-06-0,BETA-HYDROXYBUTYRATE,BETA-HYDROXYBUTYRATE
REP.1M,2.5,GRIK1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A45499626-001-04-9,UBP-296,UBP-296
REP.1M,2.5,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A50062753-001-02-9,LY404187,LY404187
REP.1M,2.5,PTGER2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A52551912-001-02-9,ATB-346,ATB-346
REP.1M,2.5,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-A55946879-001-04-9,BW-B70C,BW-B70C
REP.1M,2.5,ALOX5,"LEUKOTRIENE SYNTHESIS INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-A56359832-001-16-9,ZILEUTON,ZILEUTON
REP.1M,2.5,TGFBR2,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-A56690687-001-02-9,ITD-1,ITD-1
REP.1M,2.5,"TRPA1, TRPV1",CYTOKINE PRODUCTION INHIBITOR,BRD:BRD-A60402836-001-01-0,ALLICIN,ALLICIN
REP.1M,2.5,TBXA2R,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-A60765580-001-03-4,SERATRODAST,SERATRODAST
REP.1M,2.5,"RALA, RALB",RAL GTPASE INHIBITOR,BRD:BRD-A67036568-001-03-9,RBC8,RBC8
REP.1M,2.5,,,BRD:BRD-A67265925-236-02-6,SODIUM-ASCORBATE,SODIUM-ASCORBATE
REP.1M,2.5,"GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A67976398-001-02-9,DQP-1105,DQP-1105
REP.1M,2.5,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A70182876-001-11-9,AZAPROPAZONE,AZAPROPAZONE
REP.1M,2.5,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-A73891132-001-02-9,OXF-BD-02,OXF-BD-02
REP.1M,2.5,,,BRD:BRD-A74328360-409-02-8,ANTIMONYL,ANTIMONYL
REP.1M,2.5,ADCY5,ADENYLYL CYCLASE INHIBITOR,BRD:BRD-A75015151-001-08-9,NKY-80,NKY-80
REP.1M,2.5,TRPM3,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,BRD:BRD-A75514485-001-02-9,CIM-0216,CIM-0216
REP.1M,2.5,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-A77118605-237-09-5,D609,D609
REP.1M,2.5,"RHOC, SRF",APOPTOSIS STIMULANT,BRD:BRD-A79726147-001-02-9,CCG-1423,CCG-1423
REP.1M,2.5,"CACNA1C, CACNA1D, CACNA1F, CACNA1S",CALCIUM CHANNEL BLOCKER,BRD:BRD-A84465106-001-09-5,NISOLDIPINE,NISOLDIPINE
REP.1M,2.5,ROCK2,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-A86468475-300-02-9,SR-3677,SR-3677
REP.1M,2.5,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A87125127-001-03-9,3-MATIDA,3-MATIDA
REP.1M,2.5,,ANTITUMOR AGENT,BRD:BRD-A88644406-001-02-9,AVADOMIDE,AVADOMIDE
REP.1M,2.5,,GLYCOGEN PHOSPHORYLASE INHIBITOR,BRD:BRD-A90201073-001-02-9,GPI-688,GPI-688
REP.1M,2.5,CLCA1,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,BRD:BRD-A90751343-001-02-9,CACCINH-A01,CACCINH-A01
REP.1M,2.5,,DNA ALKYLATING AGENT,BRD:BRD-A91386192-001-07-9,TROFOSFAMIDE,TROFOSFAMIDE
REP.1M,2.5,,,BRD:BRD-A91448670-001-08-9,MANDELIC-ACID,MANDELIC-ACID
REP.1M,2.5,MIF,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,BRD:BRD-A94055480-001-02-9,ISO-1,ISO-1
REP.1M,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A94965935-001-01-6,CICLOPROFEN,CICLOPROFEN
REP.1M,2.5,METAP2,METHIONINE AMINOPEPTIDASE INHIBITOR,BRD:BRD-A99367815-001-04-9,FUMAGILLIN,FUMAGILLIN
REP.1M,2.5,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00002423-001-02-9,PF-05175157,PF-05175157
REP.1M,2.5,,"BACTERIAL CELL WALL SYNTHESIS INHIBITOR, FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-K00002625-402-02-9,CASPOFUNGIN,CASPOFUNGIN
REP.1M,2.5,,P38 MAPK INHIBITOR,BRD:BRD-K00003093-001-01-9,SD-0006,SD-0006
REP.1M,2.5,,C-MET INHIBITOR,BRD:BRD-K00003094-001-01-9,JNJ-38877618,JNJ-38877618
REP.1M,2.5,,CFTR CHANNEL POTENTIATOR,BRD:BRD-K00003095-001-01-9,GLPG1837,GLPG1837
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003096-001-01-9,FN-1501,FN-1501
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003097-001-01-9,PF-05180999,PF-05180999
REP.1M,2.5,,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K00003098-001-01-9,IDF-11774,IDF-11774
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003099-001-01-9,PLX51107,PLX51107
REP.1M,2.5,,GLUCOCORTICOID RECEPTOR MODULATOR,BRD:BRD-K00003100-001-01-9,AZD7594,AZD7594
REP.1M,2.5,,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K00003101-001-02-9,GDC-0927,GDC-0927
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003102-001-01-9,INCB-057643,INCB-057643
REP.1M,2.5,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K00003103-001-01-9,DESISOBUTYRYL-CICLESONIDE,DESISOBUTYRYL-CICLESONIDE
REP.1M,2.5,,MITOCHONDRIAL COMPLEX I INHIBITOR,BRD:BRD-K00003105-003-01-9,IACS-10759,IACS-10759
REP.1M,2.5,,CDK9 INHIBITOR,BRD:BRD-K00003106-001-01-9,AZD4573,AZD4573
REP.1M,2.5,,RAF INHIBITOR,BRD:BRD-K00003107-001-01-9,LXH254,LXH254
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003108-001-01-9,ABBV-744,ABBV-744
REP.1M,2.5,,HBV CAPSID ASSEMBLY INHIBITOR,BRD:BRD-K00003109-001-01-9,AB-423,AB-423
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003110-001-01-9,BMS-986195,BMS-986195
REP.1M,2.5,,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K00003111-001-01-9,BOS-172722,BOS-172722
REP.1M,2.5,,CHK INHIBITOR,BRD:BRD-K00003112-001-01-9,GDC-0575,GDC-0575
REP.1M,2.5,,AMPK ACTIVATOR,BRD:BRD-K00003113-001-01-9,O-304,O-304
REP.1M,2.5,,STAT INHIBITOR,BRD:BRD-K00003114-001-01-9,C188-9,C188-9
REP.1M,2.5,,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K00003115-001-01-9,ETC-206,ETC-206
REP.1M,2.5,,MAP KINASE INHIBITOR,BRD:BRD-K00003116-001-01-9,CC-90003,CC-90003
REP.1M,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K00003117-001-01-9,CEFTOBIPROLE,CEFTOBIPROLE
REP.1M,2.5,,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K00003118-011-01-9,RETAGLIPTIN,RETAGLIPTIN
REP.1M,2.5,,CYTOCHROME P450 ACTIVATOR,BRD:BRD-K00003119-066-01-9,PRADEFOVIR,PRADEFOVIR
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003120-001-01-9,BI-409306,BI-409306
REP.1M,2.5,,POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K00003121-300-01-9,GSK369796,GSK369796
REP.1M,2.5,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00003122-001-01-9,PRINOMASTAT,PRINOMASTAT
REP.1M,2.5,,THYROID HORMONE RECEPTOR AGONIST,BRD:BRD-K00003123-001-01-9,RESMETIROM,RESMETIROM
REP.1M,2.5,,TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-K00003124-389-01-9,TRODUSQUEMINE,TRODUSQUEMINE
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003125-001-01-9,SULFATINIB,SULFATINIB
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003126-001-01-9,G-749,G-749
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003127-001-01-9,PIMODIVIR,PIMODIVIR
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003128-001-01-9,BECLABUVIR,BECLABUVIR
REP.1M,2.5,,NOTCH SIGNALING INHIBITOR,BRD:BRD-K00003129-001-01-9,CRENIGACESTAT,CRENIGACESTAT
REP.1M,2.5,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K00003130-003-01-9,EPETRABOROLE,EPETRABOROLE
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003131-001-01-9,LY2510924,LY2510924
REP.1M,2.5,,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K00003132-001-01-9,LGD-6972,LGD-6972
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003133-001-01-9,VELPATASVIR,VELPATASVIR
REP.1M,2.5,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K00003134-001-01-9,DESLORELIN,DESLORELIN
REP.1M,2.5,,CYCLOPHILIN INHIBITOR,BRD:BRD-K00003135-001-01-9,ALISPORIVIR,ALISPORIVIR
REP.1M,2.5,,PYRUVATE KINASE ISOZYME ACTIVATOR,BRD:BRD-K00003136-001-01-9,MITAPIVAT,MITAPIVAT
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003137-001-01-9,LOTAMILAST,LOTAMILAST
REP.1M,2.5,,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K00003138-001-01-9,ASIVATREP,ASIVATREP
REP.1M,2.5,,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,BRD:BRD-K00003139-001-01-9,ETRASIMOD,ETRASIMOD
REP.1M,2.5,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003140-001-01-9,HPGDS-IN-1,HPGDS-IN-1
REP.1M,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00003141-003-01-9,VIXOTRIGINE,VIXOTRIGINE
REP.1M,2.5,,DOPAMINE-NOREPINEPHRINE-SEROTONIN REUPTAKE INHIBITOR,BRD:BRD-K00003142-003-01-9,DASOTRALINE,DASOTRALINE
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003143-001-01-9,BAY1217389,BAY1217389
REP.1M,2.5,,CDK9 INHIBITOR,BRD:BRD-K00003144-001-01-9,ATUVECICLIB,ATUVECICLIB
REP.1M,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00003145-001-01-9,PF-05089771,PF-05089771
REP.1M,2.5,,INTERFERON INDUCER,BRD:BRD-K00003146-318-01-9,MIW-815,MIW-815
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003147-001-01-9,S49076,S49076
REP.1M,2.5,,"ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR AGONIST",BRD:BRD-K00003148-001-01-9,BATEFENTEROL,BATEFENTEROL
REP.1M,2.5,,VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K00003149-001-01-9,RO-5028442,RO-5028442
REP.1M,2.5,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K00003150-001-01-9,SEGESTERONE-ACETATE,SEGESTERONE-ACETATE
REP.1M,2.5,,ANGIOTENSIN ANTAGONIST,BRD:BRD-K00003151-001-01-9,OLODANRIGAN,OLODANRIGAN
REP.1M,2.5,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003152-001-01-9,AM211,AM211
REP.1M,2.5,,SUPEROXIDE DISMUTASE MIMETIC,BRD:BRD-K00003154-001-01-9,IMISOPASEM-MANGANESE,IMISOPASEM-MANGANESE
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003155-003-01-9,TAK-779,TAK-779
REP.1M,2.5,,MICROTUBULE INHIBITOR,BRD:BRD-K00003156-066-01-9,ERIBULIN,ERIBULIN
REP.1M,2.5,,HSP INHIBITOR,BRD:BRD-K00003157-001-01-9,DEBIO-0932,DEBIO-0932
REP.1M,2.5,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K00003158-001-01-9,ABARELIX,ABARELIX
REP.1M,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003159-300-01-9,BANOXANTRONE,BANOXANTRONE
REP.1M,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003160-003-01-9,BELOTECAN,BELOTECAN
REP.1M,2.5,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K00003161-015-01-9,BUSERELIN,BUSERELIN
REP.1M,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K00003162-001-01-9,CROLIBULIN,CROLIBULIN
REP.1M,2.5,,VEGF ANTAGONIST,BRD:BRD-K00003164-001-01-9,OGLUFANIDE,OGLUFANIDE
REP.1M,2.5,,S-ADENOSYLMETHIONINE DECARBOXYLASE INHIBITOR,BRD:BRD-K00003165-300-01-9,SARDOMOZIDE,SARDOMOZIDE
REP.1M,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003166-001-01-9,GSK189254,GSK189254
REP.1M,2.5,,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K00003167-001-01-9,MACITENTAN-N-BUTYL-ANALOGUE,MACITENTAN-N-BUTYL-ANALOGUE
REP.1M,2.5,,P38 MAPK INHIBITOR,BRD:BRD-K00003168-003-01-9,BMS-582949,BMS-582949
REP.1M,2.5,,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K00003169-001-01-9,RAD140,RAD140
REP.1M,2.5,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003170-001-01-9,PAVINETANT,PAVINETANT
REP.1M,2.5,,BETA AMYLOID AGGREGATION INHIBITOR,BRD:BRD-K00003171-001-01-9,DWK-1339,DWK-1339
REP.1M,2.5,,ANGIOGENESIS INHIBITOR,BRD:BRD-K00003172-001-01-9,E7820,E7820
REP.1M,2.5,,DNA INTERCALATING AGENT,BRD:BRD-K00003173-001-01-9,SJG-136,SJG-136
REP.1M,2.5,,MICROTUBULE INHIBITOR,BRD:BRD-K00003174-001-01-9,SOBLIDOTIN,SOBLIDOTIN
REP.1M,2.5,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003175-001-01-9,ROLAPITANT,ROLAPITANT
REP.1M,2.5,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003176-001-01-9,KARENITECIN,KARENITECIN
REP.1M,2.5,"NCOA1, PPARA, PPARD, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K00003177-001-01-9,INDEGLITAZAR,INDEGLITAZAR
REP.1M,2.5,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00003178-003-01-9,LASMIDITAN,LASMIDITAN
REP.1M,2.5,,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K00003180-001-01-9,VERUCERFONT,VERUCERFONT
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003181-001-01-9,CENICRIVIROC,CENICRIVIROC
REP.1M,2.5,,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K00003182-001-01-9,GEMIGLIPTIN,GEMIGLIPTIN
REP.1M,2.5,VCAM1,ANTIOXIDANT,BRD:BRD-K00003183-001-01-9,SUCCINOBUCOL,SUCCINOBUCOL
REP.1M,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K00003184-001-01-9,OZENOXACIN,OZENOXACIN
REP.1M,2.5,,KINESIN INHIBITOR,BRD:BRD-K00003185-001-01-9,EMD534085,EMD534085
REP.1M,2.5,,BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003186-003-01-9,SSR240612,SSR240612
REP.1M,2.5,,DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K00003187-236-01-9,GUADECITABINE,GUADECITABINE
REP.1M,2.5,,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K00003188-046-01-9,CAPROMORELIN,CAPROMORELIN
REP.1M,2.5,,JAK INHIBITOR,BRD:BRD-K00003189-001-01-9,BMS-911543,BMS-911543
REP.1M,2.5,,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K00003190-001-01-9,MK-0557,MK-0557
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003191-001-01-9,FOSTEMSAVIR,FOSTEMSAVIR
REP.1M,2.5,,P SELECTIN INHIBITOR,BRD:BRD-K00003192-001-01-9,PSI-697,PSI-697
REP.1M,2.5,,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K00003194-001-01-9,MK-7622,MK-7622
REP.1M,2.5,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K00003195-001-01-9,LY2795050,LY2795050
REP.1M,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003197-001-02-9,ONO-4059,ONO-4059
REP.1M,2.5,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00003198-001-01-9,REVEFENACIN,REVEFENACIN
REP.1M,2.5,,CRTH RECEPTOR ANTAGONIST,BRD:BRD-K00003199-001-01-9,MK-7246,MK-7246
REP.1M,2.5,,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K00003201-001-01-9,TENAPANOR,TENAPANOR
REP.1M,2.5,,HDAC INHIBITOR,BRD:BRD-K00003202-001-01-9,CITARINOSTAT,CITARINOSTAT
REP.1M,2.5,,FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K00003203-001-01-9,BMS-214662,BMS-214662
REP.1M,2.5,,GLUCOSIDASE INHIBITOR,BRD:BRD-K00003204-003-01-9,CELGOSIVIR,CELGOSIVIR
REP.1M,2.5,,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,BRD:BRD-K00003205-003-01-9,D-3263,D-3263
REP.1M,2.5,,ALPHA GLUCOSIDE INHIBITOR,BRD:BRD-K00003206-001-01-9,EMIGLITATE,EMIGLITATE
REP.1M,2.5,,ANTIMETABOLITE,BRD:BRD-K00003207-001-01-9,ETHYNYLCYTIDINE,ETHYNYLCYTIDINE
REP.1M,2.5,,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K00003208-001-01-9,IMIRESTAT,IMIRESTAT
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003209-001-01-9,JI-101,JI-101
REP.1M,2.5,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K00003210-001-01-9,OSILODROSTAT,OSILODROSTAT
REP.1M,2.5,,DNA BINDING AGENT,BRD:BRD-K00003211-001-01-9,LURBINECTEDIN,LURBINECTEDIN
REP.1M,2.5,,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,BRD:BRD-K00003212-001-01-9,OMTRIPTOLIDE,OMTRIPTOLIDE
REP.1M,2.5,,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,BRD:BRD-K00003213-001-01-9,PCI-27483,PCI-27483
REP.1M,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K00003214-001-01-9,SAPACITABINE,SAPACITABINE
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003215-043-01-9,SQUALAMINE,SQUALAMINE
REP.1M,2.5,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K00003216-001-01-9,RELUGOLIX,RELUGOLIX
REP.1M,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00003217-304-01-9,TRANSCROCETINATE,TRANSCROCETINATE
REP.1M,2.5,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00003218-001-01-9,UPAMOSTAT,UPAMOSTAT
REP.1M,2.5,,P38 MAPK INHIBITOR,BRD:BRD-K00003220-001-01-9,ACUMAPIMOD,ACUMAPIMOD
REP.1M,2.5,,GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K00003221-001-01-9,BASMISANIL,BASMISANIL
REP.1M,2.5,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003222-001-01-9,TRADIPITANT,TRADIPITANT
REP.1M,2.5,,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,BRD:BRD-K00003223-003-01-9,AMISELIMOD,AMISELIMOD
REP.1M,2.5,,KALLIKREIN INHIBITOR,BRD:BRD-K00003224-001-01-9,AVORALSTAT,AVORALSTAT
REP.1M,2.5,,LATE SODIUM CURRENT INHIBITOR,BRD:BRD-K00003225-003-01-9,ELECLAZINE,ELECLAZINE
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00003226-001-01-9,EMERAMIDE,EMERAMIDE
REP.1M,2.5,,IP1 PROSTACYCLIN RECEPTOR AGONIST,BRD:BRD-K00003227-001-01-9,RALINEPAG,RALINEPAG
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00003228-001-01-9,SELETALISIB,SELETALISIB
REP.1M,2.5,,BETA SECRETASE INHIBITOR,BRD:BRD-K00003229-001-01-9,VERUBECESTAT,VERUBECESTAT
REP.1M,2.5,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003230-001-01-9,ASAPIPRANT,ASAPIPRANT
REP.1M,2.5,,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K00003231-001-01-9,DORAVIRINE,DORAVIRINE
REP.1M,2.5,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003232-001-01-9,FEVIPIPRANT,FEVIPIPRANT
REP.1M,2.5,,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K00003233-001-01-9,VALBENAZINE,VALBENAZINE
REP.1M,2.5,,GUANYLATE CYCLASE STIMULANT,BRD:BRD-K00003234-001-01-9,VERICIGUAT,VERICIGUAT
REP.1M,2.5,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K00003235-001-01-9,VELEDIMEX,VELEDIMEX
REP.1M,2.5,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00003236-001-01-9,FIRSOCOSTAT,FIRSOCOSTAT
REP.1M,2.5,,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K00003237-001-01-9,MAVATREP,MAVATREP
REP.1M,2.5,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003238-001-01-9,SITRAVATINIB,SITRAVATINIB
REP.1M,2.5,,GABA RECEPTOR ANTAGONIST,BRD:BRD-K00003239-001-01-9,FLURALANER,FLURALANER
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003240-300-01-9,ERAVACYCLINE,ERAVACYCLINE
REP.1M,2.5,,ANTITUMOR AGENT,BRD:BRD-K00003242-001-01-9,SANCYCLINE,SANCYCLINE
REP.1M,2.5,ATP4A,ATPASE INHIBITOR,BRD:BRD-K00003243-236-01-9,PANTOPRAZOLE,PANTOPRAZOLE
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003244-001-01-9,AMCASERTIB,AMCASERTIB
REP.1M,2.5,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003245-001-01-9,BELIZATINIB,BELIZATINIB
REP.1M,2.5,,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K00003246-001-01-9,BEXAGLIFLOZIN,BEXAGLIFLOZIN
REP.1M,2.5,,HIV INTEGRASE INHIBITOR,BRD:BRD-K00003247-001-01-9,BICTEGRAVIR,BICTEGRAVIR
REP.1M,2.5,,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,BRD:BRD-K00003248-001-01-9,CENERIMOD,CENERIMOD
REP.1M,2.5,,"GABA RECEPTOR MODULATOR, VOLTAGE-GATED SODIUM CHANNEL BLOCKER",BRD:BRD-K00003249-001-01-9,CENOBAMATE,CENOBAMATE
REP.1M,2.5,,CALCIUM SENSITIZER,BRD:BRD-K00003250-001-01-9,EVOCALCET,EVOCALCET
REP.1M,2.5,,PPAR RECEPTOR AGONIST,BRD:BRD-K00003251-001-01-9,PEMAFIBRATE,PEMAFIBRATE
REP.1M,2.5,,NEPRILYSIN INHIBITOR,BRD:BRD-K00003252-001-01-9,SACUBITRILAT,SACUBITRILAT
REP.1M,2.5,,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K00003253-001-01-9,SPARSENTAN,SPARSENTAN
REP.1M,2.5,,TYROSINE KINASE PARTIAL AGONIST,BRD:BRD-K00003254-001-01-9,TAVILERMIDE,TAVILERMIDE
REP.1M,2.5,,LEUKOTRIENE INHIBITOR,BRD:BRD-K00003255-001-01-9,ACEBILUSTAT,ACEBILUSTAT
REP.1M,2.5,,COMPLEMENT INHIBITOR,BRD:BRD-K00003256-001-01-9,AVACOPAN,AVACOPAN
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003257-001-01-9,CEFIDEROCOL,CEFIDEROCOL
REP.1M,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-K00003258-001-01-9,EDASALONEXENT,EDASALONEXENT
REP.1M,2.5,,BETA AMYLOID INHIBITOR,BRD:BRD-K00003259-050-01-9,EDONERPIC-MALEATE,EDONERPIC-MALEATE
REP.1M,2.5,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00003260-001-01-9,GLECAPREVIR,GLECAPREVIR
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00003261-001-01-9,LENIOLISIB,LENIOLISIB
REP.1M,2.5,,STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR,BRD:BRD-K00003262-001-01-9,NICODICOSAPENT,NICODICOSAPENT
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00003263-001-01-9,TENALISIB,TENALISIB
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003264-001-01-9,ZOLIFLODACIN,ZOLIFLODACIN
REP.1M,2.5,"ACE, MME",METALLOPROTEINASE INHIBITOR,BRD:BRD-K00003265-001-01-9,OMAPATRILAT,OMAPATRILAT
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003266-001-01-9,UDENAFIL,UDENAFIL
REP.1M,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K00003267-003-01-9,OMBRABULIN,OMBRABULIN
REP.1M,2.5,,G PROTEIN SIGNALING INHIBITOR,BRD:BRD-K00003269-001-01-9,LEQ506,LEQ506
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003270-003-01-9,GALIDESIVIR,GALIDESIVIR
REP.1M,2.5,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K00003271-001-01-9,JD-5037,JD-5037
REP.1M,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K00003272-001-01-9,DEXTROROTATION-NIMORAZOLE-PHOSPHATE-ESTER,DEXTROROTATION-NIMORAZOLE-PHOSPHATE-ESTER
REP.1M,2.5,,HISTONE CHAPERONE INHIBITOR,BRD:BRD-K00003273-003-01-9,CBL0137,CBL0137
REP.1M,2.5,,MAP KINASE ACTIVATOR,BRD:BRD-K00003274-001-01-9,SELONSERTIB,SELONSERTIB
REP.1M,2.5,,RAF INHIBITOR,BRD:BRD-K00003275-001-01-9,LIFIRAFENIB,LIFIRAFENIB
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003276-001-01-9,CCT245737,CCT245737
REP.1M,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00003277-003-01-9,VATINOXAN,VATINOXAN
REP.1M,2.5,,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K00003278-003-01-9,TCV-309,TCV-309
REP.1M,2.5,,MYELOPEROXIDASE INHIBITOR,BRD:BRD-K00003279-001-01-9,PF-06282999,PF-06282999
REP.1M,2.5,,PIM KINASE INHIBITOR,BRD:BRD-K00003280-300-01-9,PIM-447,PIM-447
REP.1M,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K00003281-001-01-9,FERROQUINE,FERROQUINE
REP.1M,2.5,,ANTIRHEUMATIC DRUG,BRD:BRD-K00003282-001-01-9,ESONARIMOD,ESONARIMOD
REP.1M,2.5,,,BRD:BRD-K00003283-001-01-9,ROLUPERIDONE,ROLUPERIDONE
REP.1M,2.5,,PPAR RECEPTOR AGONIST,BRD:BRD-K00003284-236-01-9,SELADELPAR,SELADELPAR
REP.1M,2.5,,,BRD:BRD-K00003285-001-01-9,NEMIRALISIB,NEMIRALISIB
REP.1M,2.5,,JAK INHIBITOR,BRD:BRD-K00003286-001-01-9,UPADACITINIB,UPADACITINIB
REP.1M,2.5,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003287-001-01-9,FEZOLINETANT,FEZOLINETANT
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003288-003-01-9,GLESATINIB,GLESATINIB
REP.1M,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K00003289-001-01-9,TECADENOSON,TECADENOSON
REP.1M,2.5,,RETINOID ISOMEROHYDROLASE INHIBITOR,BRD:BRD-K00003290-003-01-9,EMIXUSTAT,EMIXUSTAT
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00003291-001-01-9,BEBT-908,BEBT-908
REP.1M,2.5,,ROR MODULATOR,BRD:BRD-K00003292-001-01-9,GSK2981278,GSK2981278
REP.1M,2.5,,MICROTUBULE INHIBITOR,BRD:BRD-K00003293-001-01-9,MERTANSINE,MERTANSINE
REP.1M,2.5,,EGFR INHIBITOR,BRD:BRD-K00003294-050-01-9,AVITINIB,AVITINIB
REP.1M,2.5,,ESTROGEN RECEPTOR DEGRADER,BRD:BRD-K00003295-300-01-9,ELACESTRANT,ELACESTRANT
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003296-001-01-9,PF-06650833,PF-06650833
REP.1M,2.5,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003297-001-01-9,AZD5069,AZD5069
REP.1M,2.5,,MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K00003298-001-01-9,SETMELANOTIDE,SETMELANOTIDE
REP.1M,2.5,,,BRD:BRD-K00003299-001-01-9,F-16915,F-16915
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00003300-001-01-9,LTX-315,LTX-315
REP.1M,2.5,,ALDO-KETO REDUCTASE INHIBITOR,BRD:BRD-K00003301-001-01-9,ASP-9521,ASP-9521
REP.1M,2.5,,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K00003302-001-01-9,ADOMEGLIVANT,ADOMEGLIVANT
REP.1M,2.5,,ANTITRYPANOSOMAL,BRD:BRD-K00003303-001-01-9,ACOZIBOROLE,ACOZIBOROLE
REP.1M,2.5,,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K00003304-001-01-9,MK-1064,MK-1064
REP.1M,2.5,,LXR AGONIST,BRD:BRD-K00003305-001-01-9,BMS-779788,BMS-779788
REP.1M,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-K00003306-001-01-9,VABORBACTAM,VABORBACTAM
REP.1M,2.5,,RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K00003307-001-01-9,COH29,COH29
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003308-001-01-9,TD139,TD139
REP.1M,2.5,,"MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K00003309-001-01-9,GDC-0084,GDC-0084
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003310-001-01-9,DERAZANTINIB,DERAZANTINIB
REP.1M,2.5,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003311-001-01-9,PF-06459988,PF-06459988
REP.1M,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003312-003-01-9,SULTOPRIDE,SULTOPRIDE
REP.1M,2.5,,ANTITUMOR AGENT,BRD:BRD-K00003313-001-01-9,TRABECTEDIN,TRABECTEDIN
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003314-001-01-9,FURAGIN,FURAGIN
REP.1M,2.5,,GUANYLATE CYCLASE STIMULANT,BRD:BRD-K00003315-001-01-9,NELOCIGUAT,NELOCIGUAT
REP.1M,2.5,VDR,BONE FORMATION STIMULANT,BRD:BRD-K00003316-001-01-9,ELDECALCITOL,ELDECALCITOL
REP.1M,2.5,,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K00003317-312-01-9,PIPOFEZINE,PIPOFEZINE
REP.1M,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003318-300-01-9,DECLOXIZINE,DECLOXIZINE
REP.1M,2.5,,VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K00003319-001-01-9,FELYPRESSIN,FELYPRESSIN
REP.1M,2.5,CCKAR,CCK RECEPTOR AGONIST,BRD:BRD-K00003320-001-01-9,CERULETIDE,CERULETIDE
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003321-001-01-9,DALFOPRISTIN,DALFOPRISTIN
REP.1M,2.5,,NEUROMUSCULAR BLOCKADE REVERSAL AGENT,BRD:BRD-K00003322-363-01-9,SUGAMMADEX,SUGAMMADEX
REP.1M,2.5,,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K00003325-001-01-9,TOPILUTAMIDE,TOPILUTAMIDE
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003326-001-01-9,GINSENOSIDE-RE,GINSENOSIDE-RE
REP.1M,2.5,,ANTITUMOR AGENT,BRD:BRD-K00003327-001-01-9,HYDROXYSAFFLOR-YELLOW-A,HYDROXYSAFFLOR-YELLOW-A
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003328-001-01-9,MADECASSOSIDE,MADECASSOSIDE
REP.1M,2.5,"PRKCD, PRKCE",PKC ACTIVATOR,BRD:BRD-K00003329-001-01-9,INGENOL,INGENOL
REP.1M,2.5,,MELANOCYTE-STIMULATING HORMONE MIMETIC,BRD:BRD-K00003330-001-01-9,AFAMELANOTIDE,AFAMELANOTIDE
REP.1M,2.5,,MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR,BRD:BRD-K00003331-001-01-9,NIM811,NIM811
REP.1M,2.5,,NEUROTRANSMITTER RELEASE INHIBITOR,BRD:BRD-K00003332-001-01-9,ARGIRELINE,ARGIRELINE
REP.1M,2.5,,VASOCONSTRICTOR,BRD:BRD-K00003333-001-01-9,ORNIPRESSIN,ORNIPRESSIN
REP.1M,2.5,,CHOLECYSTOKININ AGONIST,BRD:BRD-K00003334-001-01-9,SINCALIDE,SINCALIDE
REP.1M,2.5,,INTEGRIN SIGNALING ACTIVATOR,BRD:BRD-K00003335-001-01-9,IRGD-PEPTIDE,IRGD-PEPTIDE
REP.1M,2.5,,MACROPHAGE ACTIVATOR,BRD:BRD-K00003336-001-01-9,TUFTSIN,TUFTSIN
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003337-019-01-9,ALX-40-4C,ALX-40-4C
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003338-001-01-9,TRIAMCINOLONE-HEXACETONIDE,TRIAMCINOLONE-HEXACETONIDE
REP.1M,2.5,,ANTIPSYCHOTIC,BRD:BRD-K00003339-001-01-9,DIXYRAZINE,DIXYRAZINE
REP.1M,2.5,,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K00003340-300-01-9,JPH203,JPH203
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003341-001-01-9,KETOHEXOKINASE-INHIBITOR-1,KETOHEXOKINASE-INHIBITOR-1
REP.1M,2.5,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K00003342-001-01-9,ATICAPRANT,ATICAPRANT
REP.1M,2.5,,DEUBIQUITINASE INHIBITOR,BRD:BRD-K00003343-001-01-9,VLX1570,VLX1570
REP.1M,2.5,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00003344-001-01-9,INCYCLINIDE,INCYCLINIDE
REP.1M,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003346-003-01-9,MINOCYCLINE,MINOCYCLINE
REP.1M,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003347-003-01-9,DEMECLOCYCLINE,DEMECLOCYCLINE
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00003348-001-01-9,COTI-2,COTI-2
REP.1M,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003349-001-01-9,TIGECYCLINE,TIGECYCLINE
REP.1M,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K00003351-003-01-9,METHACYCLINE,METHACYCLINE
REP.1M,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003352-003-01-9,TETRACYCLINE,TETRACYCLINE
REP.1M,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K00003353-003-01-9,CHLORTETRACYCLINE,CHLORTETRACYCLINE
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00003354-001-01-9,CINOBUFOTALIN,CINOBUFOTALIN
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00003355-001-01-9,FUCOXANTHIN,FUCOXANTHIN
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003356-001-01-9,MIVEBRESIB,MIVEBRESIB
REP.1M,2.5,,AKT INHIBITOR,BRD:BRD-K00003357-001-01-9,BAY1125976,BAY1125976
REP.1M,2.5,,FGFR INHIBITOR,BRD:BRD-K00003358-001-01-9,ROGARATINIB,ROGARATINIB
REP.1M,2.5,,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K00003359-001-01-9,BAY-1436032,BAY-1436032
REP.1M,2.5,,EZH2 INHIBITOR,BRD:BRD-K00003360-001-01-9,CPI-1205,CPI-1205
REP.1M,2.5,,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K00003361-001-01-9,TOMIVOSERTIB,TOMIVOSERTIB
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00003362-066-01-9,MITOQUINONE,MITOQUINONE
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003363-001-01-9,DELPAZOLID,DELPAZOLID
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003364-001-01-9,GSK2239633A,GSK2239633A
REP.1M,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K00003365-300-01-9,AQ-13,AQ-13
REP.1M,2.5,,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,BRD:BRD-K00003366-001-01-9,LINAPRAZAN,LINAPRAZAN
REP.1M,2.5,,UROKINASE INHIBITOR,BRD:BRD-K00003367-001-01-9,UKI-1,UKI-1
REP.1M,2.5,,VEGFR INHIBITOR,BRD:BRD-K00003368-001-01-9,BFH772,BFH772
REP.1M,2.5,,EXPORTIN INHIBITOR,BRD:BRD-K00003369-001-01-9,ELTANEXOR,ELTANEXOR
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003370-001-01-9,CADAZOLID,CADAZOLID
REP.1M,2.5,,S100A9 INHIBITOR,BRD:BRD-K00003371-001-01-9,PAQUINIMOD,PAQUINIMOD
REP.1M,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003372-003-01-9,CGP-25454A,CGP-25454A
REP.1M,2.5,,RET TYROSINE KINASE INHIBITOR,BRD:BRD-K00003373-001-01-9,GSK3179106,GSK3179106
REP.1M,2.5,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K00003374-001-01-9,ESAXERENONE,ESAXERENONE
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00003375-004-01-9,VISOMITIN,VISOMITIN
REP.1M,2.5,,UBIQUITIN ACTIVATING ENZYME INHIBITOR,BRD:BRD-K00003376-001-01-9,TAK-243,TAK-243
REP.1M,2.5,,FIBROBLAST GROWTH FACTOR INHIBITOR,BRD:BRD-K00003377-001-01-9,FISOGATINIB,FISOGATINIB
REP.1M,2.5,,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K00003378-001-01-9,FT011,FT011
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003379-001-01-9,GSK2256098,GSK2256098
REP.1M,2.5,,INTEGRIN ANTAGONIST,BRD:BRD-K00003380-001-01-9,GLPG0187,GLPG0187
REP.1M,2.5,,INSULIN SENSITIZER,BRD:BRD-K00003381-001-01-9,MSDC-0160,MSDC-0160
REP.1M,2.5,,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K00003382-001-01-9,NICAINOPROL,NICAINOPROL
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00003383-001-01-9,UROLITHIN-A,UROLITHIN-A
REP.1M,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K00003384-001-01-9,FOSFLUCONAZOLE,FOSFLUCONAZOLE
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00003385-001-01-9,IPI549,IPI549
REP.1M,2.5,,GALANIN RECEPTOR 3 ANTAGONIST,BRD:BRD-K00003386-001-01-9,HT-2157,HT-2157
REP.1M,2.5,,BETA SECRETASE INHIBITOR,BRD:BRD-K00003387-001-01-9,LANABECESTAT,LANABECESTAT
REP.1M,2.5,,HDAC INHIBITOR,BRD:BRD-K00003388-001-01-9,CXD101,CXD101
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00003389-001-01-9,HTHQ,HTHQ
REP.1M,2.5,,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K00003390-003-01-9,YL0919,YL0919
REP.1M,2.5,,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K00003391-236-01-9,PBI-4050,PBI-4050
REP.1M,2.5,,FGFR INHIBITOR,BRD:BRD-K00003392-001-01-9,FUTIBATINIB,FUTIBATINIB
REP.1M,2.5,,PARP INHIBITOR,BRD:BRD-K00003393-300-01-9,BGP-15,BGP-15
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003394-001-01-9,ABX464,ABX464
REP.1M,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003395-001-01-9,BISANTRENE,BISANTRENE
REP.1M,2.5,,AXL KINASE INHIBITOR,BRD:BRD-K00003396-001-01-9,CEP-40783,CEP-40783
REP.1M,2.5,,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K00003397-001-01-9,MK-8617,MK-8617
REP.1M,2.5,,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K00003398-001-01-9,AZD7986,AZD7986
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00003399-001-01-9,OCAPERIDONE,OCAPERIDONE
REP.1M,2.5,,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K00003400-001-01-9,PF-06840003,PF-06840003
REP.1M,2.5,,PET RADIOTRACER,BRD:BRD-K00003401-001-01-9,THK5351,THK5351
REP.1M,2.5,,PET RADIOTRACER,BRD:BRD-K00003402-001-01-9,T-807,T-807
REP.1M,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003403-001-01-9,JNJ-39758979,JNJ-39758979
REP.1M,2.5,,CDK INHIBITOR,BRD:BRD-K00003404-001-01-9,CYC065,CYC065
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003405-001-01-9,EVOBRUTINIB,EVOBRUTINIB
REP.1M,2.5,,MDM INHIBITOR,BRD:BRD-K00003406-001-01-9,MILADEMETAN,MILADEMETAN
REP.1M,2.5,,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K00003407-001-01-9,VADADUSTAT,VADADUSTAT
REP.1M,2.5,,CEREBLON MODULATOR,BRD:BRD-K00003408-001-01-9,IBERDOMIDE,IBERDOMIDE
REP.1M,2.5,,DUAL SPECIFICITY PROTEIN KINASE INHIBITOR,BRD:BRD-K00003409-001-01-9,CFI-402257,CFI-402257
REP.1M,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00003410-001-01-9,GAL-021,GAL-021
REP.1M,2.5,,PROTON PUMP INHIBITOR,BRD:BRD-K00003411-001-01-9,BAMAQUIMAST,BAMAQUIMAST
REP.1M,2.5,,CDK INHIBITOR,BRD:BRD-K00003412-300-01-9,TRILACICLIB,TRILACICLIB
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003413-001-01-9,ZANUBRUTINIB,ZANUBRUTINIB
REP.1M,2.5,,NEMATOCIDE,BRD:BRD-K00003414-001-01-9,EMODEPSIDE,EMODEPSIDE
REP.1M,2.5,,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K00003415-001-01-9,ICLAPRIM,ICLAPRIM
REP.1M,2.5,,ERK INHIBITOR,BRD:BRD-K00003416-001-01-9,LY3214996,LY3214996
REP.1M,2.5,,MER TYROSINE KINASE INHIBITOR,BRD:BRD-K00003417-001-01-9,MRX-2843,MRX-2843
REP.1M,2.5,,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K00003418-001-01-9,BMS-986205,BMS-986205
REP.1M,2.5,,KIT INHIBITOR,BRD:BRD-K00003419-001-01-9,AVAPRITINIB,AVAPRITINIB
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00003420-001-01-9,GDC-0077,GDC-0077
REP.1M,2.5,,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K00003421-001-01-9,GSK3326595,GSK3326595
REP.1M,2.5,,ATR KINASE INHIBITOR,BRD:BRD-K00003422-003-01-9,BAY-1895344,BAY-1895344
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003423-001-01-9,BMS-986158,BMS-986158
REP.1M,2.5,,FGFR INHIBITOR,BRD:BRD-K00003424-001-01-9,ROBLITINIB,ROBLITINIB
REP.1M,2.5,,PKC INHIBITOR,BRD:BRD-K00003425-001-01-9,LXS196,LXS196
REP.1M,2.5,,DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K00003426-001-01-9,PEPOSERTIB,PEPOSERTIB
REP.1M,2.5,,PROTON PUMP INHIBITOR,BRD:BRD-K00003427-001-01-9,ILAPRAZOLE,ILAPRAZOLE
REP.1M,2.5,,GABA RECEPTOR AGONIST,BRD:BRD-K00003428-001-01-9,PAGOCLONE,PAGOCLONE
REP.1M,2.5,,RIPK INHIBITOR,BRD:BRD-K00003429-001-01-9,GSK2982772,GSK2982772
REP.1M,2.5,,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00003430-001-01-9,PRN1371,PRN1371
REP.1M,2.5,,AUTOTAXIN INHIBITOR,BRD:BRD-K00003431-001-01-9,ZIRITAXESTAT,ZIRITAXESTAT
REP.1M,2.5,,HDAC INHIBITOR,BRD:BRD-K00003432-001-01-9,EDO-S101,EDO-S101
REP.1M,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003433-001-01-9,VERALIPRIDE,VERALIPRIDE
REP.1M,2.5,,AMYLOID PROTEIN INHIBITOR,BRD:BRD-K00003434-001-01-9,MIRIDESAP,MIRIDESAP
REP.1M,2.5,,SIGMA RECEPTOR AGONIST,BRD:BRD-K00003435-003-01-9,AVEX-73,AVEX-73
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00003436-001-01-9,AVN-492,AVN-492
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003437-001-01-9,BTK-IN-1,BTK-IN-1
REP.1M,2.5,,CALCIUM RELEASE ACTIVATED CHANNEL MODULATOR,BRD:BRD-K00003438-001-01-9,CM-4620,CM-4620
REP.1M,2.5,,LXR AGONIST,BRD:BRD-K00003439-001-01-9,XL041,XL041
REP.1M,2.5,,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00003441-001-01-9,SELITRECTINIB,SELITRECTINIB
REP.1M,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00003442-001-01-9,CPI-444,CPI-444
REP.1M,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00003443-001-01-9,AZD4635,AZD4635
REP.1M,2.5,,CAMP STIMULANT,BRD:BRD-K00003444-001-01-9,BT-11,BT-11
REP.1M,2.5,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00003445-001-01-9,VANIPREVIR,VANIPREVIR
REP.1M,2.5,,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K00003446-001-01-9,LY3200882,LY3200882
REP.1M,2.5,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003447-001-01-9,REPOTRECTINIB,REPOTRECTINIB
REP.1M,2.5,,GABA RECEPTOR AGONIST,BRD:BRD-K00003448-001-01-9,ZURANOLONE,ZURANOLONE
REP.1M,2.5,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K00003449-001-01-9,E7046,E7046
REP.1M,2.5,,LACTAMASE INHIBITOR,BRD:BRD-K00003450-001-01-9,AAI101,AAI101
REP.1M,2.5,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00003451-001-01-9,LY334370,LY334370
REP.1M,2.5,,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K00003452-001-01-9,DESIDUSTAT,DESIDUSTAT
REP.1M,2.5,,CDK INHIBITOR,BRD:BRD-K00003453-003-01-9,CT7001,CT7001
REP.1M,2.5,,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K00003454-001-01-9,SECLIDEMSTAT,SECLIDEMSTAT
REP.1M,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003455-001-01-9,S-38093,S-38093
REP.1M,2.5,,BCR-ABL KINASE INHIBITOR,BRD:BRD-K00003456-001-01-9,ASCIMINIB,ASCIMINIB
REP.1M,2.5,,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K00003457-001-01-9,IDH-305,IDH-305
REP.1M,2.5,,ROR AGONIST,BRD:BRD-K00003458-001-01-9,CINTIRORGON,CINTIRORGON
REP.1M,2.5,,P38 MAPK INHIBITOR,BRD:BRD-K00003459-001-01-9,DILMAPIMOD,DILMAPIMOD
REP.1M,2.5,,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K00003460-001-01-9,VORASIDENIB,VORASIDENIB
REP.1M,2.5,,PARP INHIBITOR,BRD:BRD-K00003461-001-01-9,PAMIPARIB,PAMIPARIB
REP.1M,2.5,,PPAR RECEPTOR AGONIST,BRD:BRD-K00003462-001-01-9,LANIFIBRANOR,LANIFIBRANOR
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003463-001-01-9,PYROTINIB,PYROTINIB
REP.1M,2.5,,ENTEROVIRUS CAPSID INHIBITOR,BRD:BRD-K00003464-001-01-9,POCAPAVIR,POCAPAVIR
REP.1M,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00003465-001-01-9,FANTOFARONE,FANTOFARONE
REP.1M,2.5,,SEROTONIN RECEPTOR INVERSE AGONIST,BRD:BRD-K00003466-001-01-9,NELOTANSERIN,NELOTANSERIN
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00003467-001-01-9,TEMANOGREL,TEMANOGREL
REP.1M,2.5,,PKC INHIBITOR,BRD:BRD-K00003468-001-01-9,DELCASERTIB,DELCASERTIB
REP.1M,2.5,,TIGHT JUNCTION REGULATOR,BRD:BRD-K00003469-015-01-9,LARAZOTIDE-ACETATE,LARAZOTIDE-ACETATE
REP.1M,2.5,,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00003470-001-01-9,NEU2000,NEU2000
REP.1M,2.5,,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00003471-001-01-9,RISLENEMDAZ,RISLENEMDAZ
REP.1M,2.5,,CALCINEURIN INHIBITOR,BRD:BRD-K00003472-001-01-9,VOCLOSPORIN,VOCLOSPORIN
REP.1M,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003473-001-01-9,PRIDOPIDINE,PRIDOPIDINE
REP.1M,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K00003474-001-01-9,LETRAZURIL,LETRAZURIL
REP.1M,2.5,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00003475-001-01-9,S-3304,S-3304
REP.1M,2.5,,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00003476-075-01-9,NINGETINIB-TOSYLATE,NINGETINIB-TOSYLATE
REP.1M,2.5,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K00003477-001-01-9,ASIMADOLINE,ASIMADOLINE
REP.1M,2.5,,5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K00003478-001-01-9,EPRISTERIDE,EPRISTERIDE
REP.1M,2.5,,CYTOKINE PRODUCTION INHIBITOR,BRD:BRD-K00003479-003-01-9,AX-024,AX-024
REP.1M,2.5,,FXR AGONIST,BRD:BRD-K00003480-001-01-9,TROPIFEXOR,TROPIFEXOR
REP.1M,2.5,,LYSYL OXIDASE INHIBITOR,BRD:BRD-K00003481-001-01-9,PAT-1251,PAT-1251
REP.1M,2.5,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00003482-001-01-9,MK-4074,MK-4074
REP.1M,2.5,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K00003483-003-01-9,GSK656,GSK656
REP.1M,2.5,,CALCIUM CHANNEL ANTAGONIST,BRD:BRD-K00003484-074-01-9,MIROGABALIN-BESYLATE,MIROGABALIN-BESYLATE
REP.1M,2.5,,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K00003485-001-01-9,SB-649868,SB-649868
REP.1M,2.5,,LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K00003486-003-01-9,DG051,DG051
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003487-001-01-9,TOMEGLOVIR,TOMEGLOVIR
REP.1M,2.5,CA2,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K00003488-001-01-9,SULTIAME,SULTIAME
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00003489-001-01-9,GAMITHROMYCIN,GAMITHROMYCIN
REP.1M,2.5,,GAMMA SECRETASE MODULATOR,BRD:BRD-K00003490-001-01-9,NGP555,NGP555
REP.1M,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K00003491-001-01-9,MORPHOTHIADIN,MORPHOTHIADIN
REP.1M,2.5,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K00003492-001-01-9,APARARENONE,APARARENONE
REP.1M,2.5,,ANTIEPILEPTIC,BRD:BRD-K00003493-001-01-9,PADSEVONIL,PADSEVONIL
REP.1M,2.5,,SHIP1 PHOSPHATASE ACTIVATOR,BRD:BRD-K00003494-001-01-9,ROSIPTOR,ROSIPTOR
REP.1M,2.5,,ENDONUCLEASE INHIBITOR,BRD:BRD-K00003495-001-01-9,BALOXAVIR-MARBOXIL,BALOXAVIR-MARBOXIL
REP.1M,2.5,,ENDONUCLEASE INHIBITOR,BRD:BRD-K00003496-001-01-9,BALOXAVIR,BALOXAVIR
REP.1M,2.5,,MYOSIN INHIBITOR,BRD:BRD-K00003497-001-01-9,MAVACAMTEN,MAVACAMTEN
REP.1M,2.5,,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K00003498-001-01-9,TAPINAROF,TAPINAROF
REP.1M,2.5,,WNT PATHWAY INHIBITOR,BRD:BRD-K00003499-001-01-9,ADAVIVINT,ADAVIVINT
REP.1M,2.5,,JAK INHIBITOR,BRD:BRD-K00003500-001-01-9,DELGOCITINIB,DELGOCITINIB
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003501-001-01-9,LAZERTINIB,LAZERTINIB
REP.1M,2.5,,LXR AGONIST,BRD:BRD-K00003502-001-01-9,ROVAZOLAC,ROVAZOLAC
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003503-001-01-9,VECABRUTINIB,VECABRUTINIB
REP.1M,2.5,,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K00003504-001-01-9,LICOGLIFLOZIN,LICOGLIFLOZIN
REP.1M,2.5,,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K00003505-001-01-9,NEMOREXANT,NEMOREXANT
REP.1M,2.5,,RNA SPLICING INHIBITOR,BRD:BRD-K00003506-001-01-9,RISDIPLAM,RISDIPLAM
REP.1M,2.5,,IONOTROPIC GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K00003507-001-01-9,FARAMPATOR,FARAMPATOR
REP.1M,2.5,,APOPTOSIS INHIBITOR,BRD:BRD-K00003508-001-01-9,ASTX660,ASTX660
REP.1M,2.5,,ATM KINASE INHIBITOR,BRD:BRD-K00003509-001-01-9,AZD1390,AZD1390
REP.1M,2.5,,FLT3 INHIBITOR,BRD:BRD-K00003510-001-01-9,FLT3-IN-1,FLT3-IN-1
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00003511-001-01-9,CA-4948,CA-4948
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003512-001-01-9,BMS-813160,BMS-813160
REP.1M,2.5,"F10, SERPINC1",COAGULATION FACTOR INHIBITOR,BRD:BRD-K00003513-363-01-9,FONDAPARINUX,FONDAPARINUX
REP.1M,2.5,,PURINERGIC RECEPTOR ACTIVATOR,BRD:BRD-K00003514-342-01-9,DIQUAFOSOL,DIQUAFOSOL
REP.1M,2.5,,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K00003515-003-01-9,AZ7550,AZ7550
REP.1M,2.5,,GABA RECEPTOR AGONIST,BRD:BRD-K00003516-057-01-9,EMAMECTIN,EMAMECTIN
REP.1M,2.5,,HEMOSTATIC AGENT,BRD:BRD-K00003517-001-01-9,4-(AMINOMETHYL)BENZOIC-ACID,4-(AMINOMETHYL)BENZOIC-ACID
REP.1M,2.5,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00003518-004-01-9,METHYLBENACTYZIUM-BROMIDE,METHYLBENACTYZIUM-BROMIDE
REP.1M,2.5,,SIGMA RECEPTOR LIGAND,BRD:BRD-K00003520-001-01-9,GLYCEROL-PHENYLBUTYRATE,GLYCEROL-PHENYLBUTYRATE
REP.1M,2.5,"APEX1, TOP1, TOP2A",ENDONUCLEASE INHIBITOR,BRD:BRD-K00003521-001-01-9,LUCANTHONE,LUCANTHONE
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003522-001-01-9,BROMISOVAL,BROMISOVAL
REP.1M,2.5,,MEMBRANE PERMEABILITY ENHANCER,BRD:BRD-K00003523-236-01-9,TAUROGLYCOCHOLATE,TAUROGLYCOCHOLATE
REP.1M,2.5,,CYTOCHROME P450 MODULATOR,BRD:BRD-K00003524-001-01-9,APRONAL,APRONAL
REP.1M,2.5,,VITAMIN B,BRD:BRD-K00003525-003-01-9,HYDROXOCOBALAMIN,HYDROXOCOBALAMIN
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003526-001-01-9,UPRIFOSBUVIR,UPRIFOSBUVIR
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003527-001-01-9,SOFOSBUVIR-IMPURITY-M,SOFOSBUVIR-IMPURITY-M
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003528-457-01-9,AZD5153,AZD5153
REP.1M,2.5,,POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K00003529-458-01-9,CLOPERASTINE-FENDIZOATE,CLOPERASTINE-FENDIZOATE
REP.1M,2.5,,ACETYLCHOLINE RECEPTOR INHIBITOR,BRD:BRD-K00003530-003-01-9,PIRMENOL,PIRMENOL
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00003531-001-01-9,ACELARIN,ACELARIN
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00003532-001-01-9,INARIGIVIR,INARIGIVIR
REP.1M,2.5,,CDK9 INHIBITOR,BRD:BRD-K00003533-001-01-9,BAY-1251152,BAY-1251152
REP.1M,2.5,,VITAMIN B,BRD:BRD-K00003534-001-01-9,METHYLCOBALAMIN,METHYLCOBALAMIN
REP.1M,2.5,,CHELATING AGENT,BRD:BRD-K00003535-001-01-9,POLAPREZINC,POLAPREZINC
REP.1M,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003537-001-01-9,CHLORPHENOXAMINE,CHLORPHENOXAMINE
REP.1M,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003569-003-01-9,OMADACYCLINE,OMADACYCLINE
REP.1M,2.5,BRAF,RAF INHIBITOR,BRD:BRD-K00003576-001-01-9,ENCORAFENIB,ENCORAFENIB
REP.1M,2.5,,BRONCHODILATOR,BRD:BRD-K00003598-001-01-9,HOKU-81,HOKU-81
REP.1M,2.5,,NITRIC OXIDE DONOR,BRD:BRD-K00003606-380-01-9,SODIUM-NITROPRUSSIDE,SODIUM-NITROPRUSSIDE
REP.1M,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K00003682-001-01-9,IMIDUREA,IMIDUREA
REP.1M,2.5,,PHOTOSENSITIZING AGENT,BRD:BRD-K00003730-001-01-9,HPPH,HPPH
REP.1M,2.5,,PROTEIN KINASE ACTIVATOR,BRD:BRD-K00003731-001-01-9,PF-06409577,PF-06409577
REP.1M,2.5,,JAK INHIBITOR,BRD:BRD-K00003732-001-01-9,ATRACTYLENOLIDE-I,ATRACTYLENOLIDE-I
REP.1M,2.5,,JAK INHIBITOR,BRD:BRD-K00003733-001-01-9,GANODERIC-ACID-A,GANODERIC-ACID-A
REP.1M,2.5,HTR1B,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004235-334-01-9,NAS-181,NAS-181
REP.1M,2.5,OPRL1,NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST,BRD:BRD-K00004286-001-01-9,SCH-221510,SCH-221510
REP.1M,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00004292-003-02-9,EFONIDIPINE,EFONIDIPINE
REP.1M,2.5,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K00004294-001-01-9,TCS-2002,TCS-2002
REP.1M,2.5,"KCNN1, KCNN2, KCNN3, KCNN4",CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00004295-001-01-9,NS-309,NS-309
REP.1M,2.5,KCNQ4,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00004301-001-01-9,ML213,ML213
REP.1M,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K00004316-003-01-9,SSR180711,SSR180711
REP.1M,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K00004526-001-01-9,ATROPINE-OXIDE,ATROPINE-OXIDE
REP.1M,2.5,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K00004538-001-01-9,ROSAMICIN,ROSAMICIN
REP.1M,2.5,,FREE RADICAL SCAVENGER,BRD:BRD-K00004545-001-01-9,CRISDESALAZINE,CRISDESALAZINE
REP.1M,2.5,,,BRD:BRD-K00004546-001-01-9,PERFLUOROHEXYLOCTANE,PERFLUOROHEXYLOCTANE
REP.1M,2.5,,,BRD:BRD-K00004547-001-01-9,PRISOTINOL,PRISOTINOL
REP.1M,2.5,,GABA RECEPTOR AGONIST,BRD:BRD-K00004548-001-01-9,NS-11394,NS-11394
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00004549-001-01-9,IRGANOX-1010,IRGANOX-1010
REP.1M,2.5,,P38 MAPK INHIBITOR,BRD:BRD-K00004550-001-01-9,BMS-626531,BMS-626531
REP.1M,2.5,,ANTIHISTAMINE,BRD:BRD-K00004551-001-01-9,EFLETIRIZINE,EFLETIRIZINE
REP.1M,2.5,,OPIOID RECEPTOR MODULATOR,BRD:BRD-K00004552-001-01-9,SAMERIDINE,SAMERIDINE
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004553-001-01-9,SAM-315,SAM-315
REP.1M,2.5,,ANTIRETROVIRAL,BRD:BRD-K00004554-001-01-9,LODENOSINE,LODENOSINE
REP.1M,2.5,,CHELATING AGENT,BRD:BRD-K00004555-001-01-9,HBED,HBED
REP.1M,2.5,,PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K00004556-001-01-9,WAY-255348,WAY-255348
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004557-001-01-9,MK-0608,MK-0608
REP.1M,2.5,,CARDIAC GLYCOSIDE,BRD:BRD-K00004559-001-01-9,CONVALLATOXIN,CONVALLATOXIN
REP.1M,2.5,"DRD1, DRD2, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00004560-001-01-9,PIPOTIAZINE,PIPOTIAZINE
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00004561-001-01-9,E-2001,E-2001
REP.1M,2.5,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K00004562-001-01-9,DEAZAGUANINE,DEAZAGUANINE
REP.1M,2.5,,"ADRENERGIC RECEPTOR ANTAGONIST, MONOAMINE REUPTAKE INHIBITOR",BRD:BRD-K00004563-001-01-9,NAPAMEZOLE,NAPAMEZOLE
REP.1M,2.5,PDE4D,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004564-001-01-9,TETOMILAST,TETOMILAST
REP.1M,2.5,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K00004565-001-01-9,LY311727,LY311727
REP.1M,2.5,,CHOLERETIC AGENT,BRD:BRD-K00004566-001-01-9,FEBUPROL,FEBUPROL
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004567-001-01-9,FLORIFENINE,FLORIFENINE
REP.1M,2.5,,SODIUM/HYDROGEN ANTIPORT INHIBITOR,BRD:BRD-K00004568-001-01-9,ENIPORIDE,ENIPORIDE
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004569-001-01-9,ICI-169369,ICI-169369
REP.1M,2.5,,,BRD:BRD-K00004570-001-01-9,DSPC,DSPC
REP.1M,2.5,,GABA RECEPTOR ANTAGONIST,BRD:BRD-K00004571-001-01-9,FASORACETAM,FASORACETAM
REP.1M,2.5,,GABA RECEPTOR MODULATOR,BRD:BRD-K00004572-001-01-9,RO-48-6791,RO-48-6791
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004573-001-01-9,RG7834,RG7834
REP.1M,2.5,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00004574-001-01-9,ARIPIPRAZOLE-LAUROXIL,ARIPIPRAZOLE-LAUROXIL
REP.1M,2.5,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004575-001-01-9,JNJ-54175446,JNJ-54175446
REP.1M,2.5,,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K00004576-001-01-9,CLAMIKALANT,CLAMIKALANT
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004577-001-01-9,VAPENDAVIR,VAPENDAVIR
REP.1M,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K00004578-001-01-9,KAF-156,KAF-156
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00004579-001-01-9,RV1729,RV1729
REP.1M,2.5,,,BRD:BRD-K00004580-001-01-9,VELARESOL,VELARESOL
REP.1M,2.5,,HYPOLIPIDEMIC,BRD:BRD-K00004581-001-01-9,PIROZADIL,PIROZADIL
REP.1M,2.5,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K00004582-001-01-9,SUFUGOLIX,SUFUGOLIX
REP.1M,2.5,,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K00004583-001-01-9,AC260584,AC260584
REP.1M,2.5,,HDAC INHIBITOR,BRD:BRD-K00004584-001-01-9,REMETINOSTAT,REMETINOSTAT
REP.1M,2.5,,PROTON PUMP INHIBITOR,BRD:BRD-K00004585-001-01-9,SORAPRAZAN,SORAPRAZAN
REP.1M,2.5,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K00004586-001-01-9,BMS-986020,BMS-986020
REP.1M,2.5,,CELL DEATH INHIBITOR,BRD:BRD-K00004587-001-01-9,KR-33494,KR-33494
REP.1M,2.5,,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-K00004588-001-01-9,CENTANAFADINE,CENTANAFADINE
REP.1M,2.5,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004589-001-01-9,GEFAPIXANT,GEFAPIXANT
REP.1M,2.5,,RNA SPLICING MODIFIER,BRD:BRD-K00004590-001-01-9,RG7800,RG7800
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00004591-001-01-9,BMS-986142,BMS-986142
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00004592-001-01-9,PI3KD-IN-2,PI3KD-IN-2
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004593-001-01-9,BW-348U87,BW-348U87
REP.1M,2.5,,PI3K INHIBITOR,BRD:BRD-K00004594-001-01-9,PARSACLISIB,PARSACLISIB
REP.1M,2.5,,FXR AGONIST,BRD:BRD-K00004595-001-01-9,CILOFEXOR,CILOFEXOR
REP.1M,2.5,,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K00004596-001-01-9,TELRATOLIMOD,TELRATOLIMOD
REP.1M,2.5,,LXR AGONIST,BRD:BRD-K00004597-001-01-9,RGX-104,RGX-104
REP.1M,2.5,,BETA SECRETASE INHIBITOR,BRD:BRD-K00004598-001-01-9,PF-06751979,PF-06751979
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00004599-001-01-9,PRN1008,PRN1008
REP.1M,2.5,,RSV FUSION INHIBITOR,BRD:BRD-K00004600-001-01-9,JNJ-678,JNJ-678
REP.1M,2.5,,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K00004601-001-01-9,HC-070,HC-070
REP.1M,2.5,,IMMUNE RESPONSE MODULATOR,BRD:BRD-K00004602-001-01-9,THYMALFASIN,THYMALFASIN
REP.1M,2.5,,MONOACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K00004603-001-01-9,ABX-1431,ABX-1431
REP.1M,2.5,,VOLTAGE-DEPENDENT ANION SELECTIVE CHANNEL PROTEIN INHIBITOR,BRD:BRD-K00004604-001-01-9,PRLX-93936,PRLX-93936
REP.1M,2.5,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K00004606-001-01-9,AZD3839,AZD3839
REP.1M,2.5,,MTOR INHIBITOR,BRD:BRD-K00004607-001-01-9,MONEPANTEL,MONEPANTEL
REP.1M,2.5,,GASTRIN INHIBITOR,BRD:BRD-K00004608-001-01-9,SOGRAZEPIDE,SOGRAZEPIDE
REP.1M,2.5,DCK,ANTINEOPLASTIC AGENT,BRD:BRD-K00004609-001-01-9,ELACYTARABINE,ELACYTARABINE
REP.1M,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K00004610-001-01-9,ENTASOBULIN,ENTASOBULIN
REP.1M,2.5,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00004611-001-01-9,OLUMACOSTAT-GLASARETIL,OLUMACOSTAT-GLASARETIL
REP.1M,2.5,,MYELOPEROXIDASE INHIBITOR,BRD:BRD-K00004612-001-01-9,VERDIPERSTAT,VERDIPERSTAT
REP.1M,2.5,FKBP1A,IMMUNOPHILIN LIGAND,BRD:BRD-K00004613-001-01-9,GM-1485,GM-1485
REP.1M,2.5,,HDAC INHIBITOR,BRD:BRD-K00004614-001-01-9,GSK3117391,GSK3117391
REP.1M,2.5,,CHELATING AGENT,BRD:BRD-K00004615-001-01-9,PBT-1033,PBT-1033
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004616-001-01-9,PRX-07034,PRX-07034
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00004617-001-01-9,IMIDAZOACRIDINONE,IMIDAZOACRIDINONE
REP.1M,2.5,,PROLYL ENDOPEPTIDASE INHIBITOR,BRD:BRD-K00004618-001-01-9,S-17092,S-17092
REP.1M,2.5,,ANALGESIC AGENT,BRD:BRD-K00004619-001-01-9,CENTHAQUIN,CENTHAQUIN
REP.1M,2.5,,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00004620-001-01-9,ZD-0947,ZD-0947
REP.1M,2.5,,STAT INHIBITOR,BRD:BRD-K00004622-001-01-9,MM-206,MM-206
REP.1M,2.5,,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,BRD:BRD-K00004623-001-01-9,RO-5263397,RO-5263397
REP.1M,2.5,,LIPOXYGENASE INHIBITOR,BRD:BRD-K00004624-001-01-9,CJ-13610,CJ-13610
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004625-001-01-9,CIPAMFYLLINE,CIPAMFYLLINE
REP.1M,2.5,,NMDA RECEPTOR ANTAGONIST,BRD:BRD-K00004626-001-01-9,CGP-39551,CGP-39551
REP.1M,2.5,,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K00004627-001-01-9,TIPELUKAST,TIPELUKAST
REP.1M,2.5,,GROWTH HORMONE RELEASING PEPTIDE LIGAND AGONIST,BRD:BRD-K00004629-001-01-9,PRALMORELIN,PRALMORELIN
REP.1M,2.5,,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K00004630-001-01-9,VAL-TYR,VAL-TYR
REP.1M,2.5,,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K00004631-001-01-9,T-1095,T-1095
REP.1M,2.5,,PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K00004632-001-01-9,PF-02413873,PF-02413873
REP.1M,2.5,,LIPOXYGENASE INHIBITOR,BRD:BRD-K00004633-001-01-9,PF-4191834,PF-4191834
REP.1M,2.5,,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K00004634-001-01-9,BMS-207940,BMS-207940
REP.1M,2.5,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00004635-001-01-9,PF-04995274,PF-04995274
REP.1M,2.5,,,BRD:BRD-K00004636-001-01-9,DPC,DPC
REP.1M,2.5,,TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K00004638-001-01-9,PF-06273340,PF-06273340
REP.1M,2.5,,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K00004639-001-01-9,ORMELOXIFENE,ORMELOXIFENE
REP.1M,2.5,GBA,GLUCOSIDASE INHIBITOR,BRD:BRD-K00004640-001-01-9,NN-DNJ,NN-DNJ
REP.1M,2.5,,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K00004641-001-01-9,PHA-543613,PHA-543613
REP.1M,2.5,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K00004642-001-01-9,PF-514273,PF-514273
REP.1M,2.5,,CYTOCHROME P450 ACTIVATOR,BRD:BRD-K00004643-001-01-9,EF5,EF5
REP.1M,2.5,,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K00004644-001-01-9,PF-06260414,PF-06260414
REP.1M,2.5,,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K00004645-001-01-9,RIMEPORIDE,RIMEPORIDE
REP.1M,2.5,,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K00004646-001-01-9,ARAMCHOL,ARAMCHOL
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004647-001-01-9,NB-001,NB-001
REP.1M,2.5,,EGFR INHIBITOR,BRD:BRD-K00004648-001-01-9,PF-06747775,PF-06747775
REP.1M,2.5,,NFKB PATHWAY INHIBITOR,BRD:BRD-K00004649-001-01-9,E3330,E3330
REP.1M,2.5,"GABBR1, GABBR2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K00004650-001-01-9,SGS-742,SGS-742
REP.1M,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K00004651-001-01-9,TALSACLIDINE,TALSACLIDINE
REP.1M,2.5,,DOPAMINE RECEPTOR PARTIAL AGONIST,BRD:BRD-K00004652-001-01-9,PF-06412562,PF-06412562
REP.1M,2.5,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00004653-001-01-9,S15535,S15535
REP.1M,2.5,,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K00004654-001-01-9,"CP-105,696","CP-105,696"
REP.1M,2.5,,11-BETA-HSD1 INHIBITOR,BRD:BRD-K00004655-001-01-9,BMS-770767,BMS-770767
REP.1M,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K00004656-001-01-9,DENOPAMINE,DENOPAMINE
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004657-001-01-9,MOTAPIZONE,MOTAPIZONE
REP.1M,2.5,,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K00004658-001-01-9,ETRABAMINE,ETRABAMINE
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004659-001-01-9,DAPANSUTRILE,DAPANSUTRILE
REP.1M,2.5,,NIACIN RECEPTOR AGONIST,BRD:BRD-K00004660-001-01-9,MK-1903,MK-1903
REP.1M,2.5,,CELL CYCLE INHIBITOR,BRD:BRD-K00004661-001-01-9,DECLOPRAMIDE,DECLOPRAMIDE
REP.1M,2.5,,"ADRENERGIC RECEPTOR AGONIST, ADRENERGIC RECEPTOR ANTAGONIST",BRD:BRD-K00004662-001-01-9,NEMAZOLINE,NEMAZOLINE
REP.1M,2.5,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K00004663-001-01-9,TINAZOLINE,TINAZOLINE
REP.1M,2.5,,,BRD:BRD-K00004664-001-01-9,NDD-094,NDD-094
REP.1M,2.5,,,BRD:BRD-K00004665-001-01-9,SY-640,SY-640
REP.1M,2.5,,AKT INHIBITOR,BRD:BRD-K00004666-001-01-9,TRICIRIBINE-PHOSPHATE,TRICIRIBINE-PHOSPHATE
REP.1M,2.5,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00004667-001-01-9,CILUPREVIR,CILUPREVIR
REP.1M,2.5,"CELA1, ELANE",ELASTASE INHIBITOR,BRD:BRD-K00004668-001-01-9,FRESELESTAT,FRESELESTAT
REP.1M,2.5,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004669-001-01-9,CANGRELOR,CANGRELOR
REP.1M,2.5,,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K00004670-001-01-9,NAXAGOLIDE,NAXAGOLIDE
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00004671-001-01-9,PANIPENEM,PANIPENEM
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004672-001-01-9,BRINCIDOFOVIR,BRINCIDOFOVIR
REP.1M,2.5,,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K00004673-001-01-9,LP-533401,LP-533401
REP.1M,2.5,,EXPORTIN ANTAGONIST,BRD:BRD-K00004674-001-01-9,VERDINEXOR,VERDINEXOR
REP.1M,2.5,,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K00004675-001-01-9,LSZ-102,LSZ-102
REP.1M,2.5,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K00004676-001-01-9,RILAPLADIB,RILAPLADIB
REP.1M,2.5,,,BRD:BRD-K00004677-001-01-9,2-FLUOROFUCOSE,2-FLUOROFUCOSE
REP.1M,2.5,,,BRD:BRD-K00004678-001-01-9,DOTMP,DOTMP
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00004679-001-01-9,5-FLUOROPYRIMIDINE,5-FLUOROPYRIMIDINE
REP.1M,2.5,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K00004680-001-01-9,BEVENOPRAN,BEVENOPRAN
REP.1M,2.5,,PROTEIN KINASE ACTIVATOR,BRD:BRD-K00004681-001-01-9,5-OCTANOYLSALICYLIC-ACID,5-OCTANOYLSALICYLIC-ACID
REP.1M,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00004682-001-01-9,TAMINADENANT,TAMINADENANT
REP.1M,2.5,,GLUTAMATE TRANSPORTER MODULATOR,BRD:BRD-K00004683-001-01-9,MS-424,MS-424
REP.1M,2.5,,OXIDATIVE STRESS INDUCER,BRD:BRD-K00004684-001-01-9,SQUARIC-ACID-DIBUTYL-ESTER,SQUARIC-ACID-DIBUTYL-ESTER
REP.1M,2.5,,DELAYED VASOSPASM ANTAGONIST,BRD:BRD-K00004685-001-01-9,TS-011,TS-011
REP.1M,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00004686-001-01-9,NPS-2407,NPS-2407
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004687-001-01-9,PELRINONE,PELRINONE
REP.1M,2.5,,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K00004688-001-01-9,EVENAMIDE,EVENAMIDE
REP.1M,2.5,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00004689-001-01-9,GSK239512,GSK239512
REP.1M,2.5,,"ABL KINASE INHIBITOR, EGFR INHIBITOR, FLT3 INHIBITOR",BRD:BRD-K00004690-001-01-9,SKLB-1028,SKLB-1028
REP.1M,2.5,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K00004691-001-01-9,MEGESTROL,MEGESTROL
REP.1M,2.5,,QUORUM SENSING SIGNALING INHIBITOR,BRD:BRD-K00004693-001-01-9,FURVINA,FURVINA
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00004694-001-01-9,SULTAMICILLIN,SULTAMICILLIN
REP.1M,2.5,,,BRD:BRD-K00004695-001-01-9,MONOMETHYL-FUMARATE,MONOMETHYL-FUMARATE
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004696-001-01-9,LEONURINE,LEONURINE
REP.1M,2.5,,DNA SYNTHESIS MARKER,BRD:BRD-K00004697-001-01-9,ALOVUDINE,ALOVUDINE
REP.1M,2.5,,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K00004698-001-01-9,TRABODENOSON,TRABODENOSON
REP.1M,2.5,,BDNF INDUCER,BRD:BRD-K00004699-001-01-9,J147,J147
REP.1M,2.5,,GLUCOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K00004700-001-01-9,CORT-108297,CORT-108297
REP.1M,2.5,,NAMPT INHIBITOR,BRD:BRD-K00004701-001-01-9,KPT-9274,KPT-9274
REP.1M,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00004702-001-01-9,FUNAPIDE,FUNAPIDE
REP.1M,2.5,,MITOCHONDRIAL PYRUVATE CARRIER MODULATOR,BRD:BRD-K00004703-001-01-9,MSDC-0602K,MSDC-0602K
REP.1M,2.5,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K00004704-001-01-9,DBPR-211,DBPR-211
REP.1M,2.5,,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K00004705-001-01-9,AQW-051,AQW-051
REP.1M,2.5,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00004706-001-01-9,ST-1535,ST-1535
REP.1M,2.5,,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-K00004707-001-01-9,SOLRIAMFETOL,SOLRIAMFETOL
REP.1M,2.5,,BETA LACTAMASE INHIBITOR,BRD:BRD-K00004708-001-01-9,OP-0595,OP-0595
REP.1M,2.5,,BRADYCARDIC EFFECT,BRD:BRD-K00004709-001-01-9,ALINIDINE,ALINIDINE
REP.1M,2.5,,P38 MAPK INHIBITOR,BRD:BRD-K00004710-001-01-9,R-1487,R-1487
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004711-001-01-9,GSK356278,GSK356278
REP.1M,2.5,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00004712-001-01-9,PF-06305591,PF-06305591
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K00004713-001-01-9,SULOPENEM,SULOPENEM
REP.1M,2.5,PTGS2,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004714-001-01-9,VEDAPROFEN,VEDAPROFEN
REP.1M,2.5,,PROSTAGLANDIN RECEPTOR AGONIST,BRD:BRD-K00004715-001-01-9,BUTAPROST,BUTAPROST
REP.1M,2.5,,BCR-ABL KINASE INHIBITOR,BRD:BRD-K00004716-001-01-9,RADOTINIB,RADOTINIB
REP.1M,2.5,,CRF RECEPTOR ANTAGONIST,BRD:BRD-K00004717-001-01-9,R-121919,R-121919
REP.1M,2.5,,ANTIMETABOLITE,BRD:BRD-K00004718-001-01-9,ALANOSINE,ALANOSINE
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00004719-001-01-9,CP-547632,CP-547632
REP.1M,2.5,,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K00004720-001-01-9,ACOLBIFENE,ACOLBIFENE
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00004721-001-01-9,BMS-935177,BMS-935177
REP.1M,2.5,,AURORA KINASE INHIBITOR,BRD:BRD-K00004722-001-01-9,LY3295668,LY3295668
REP.1M,2.5,,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K00004723-001-01-9,HP-228,HP-228
REP.1M,2.5,,ANALGESIC AGENT,BRD:BRD-K00004724-001-01-9,FLURBIPROFEN-AXETIL,FLURBIPROFEN-AXETIL
REP.1M,2.5,,CDK9 INHIBITOR,BRD:BRD-K00004725-001-01-9,VORUCICLIB,VORUCICLIB
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00004726-001-01-9,AMETANTRONE,AMETANTRONE
REP.1M,2.5,,KINASE INHIBITOR,BRD:BRD-K00004727-001-01-9,SIMUROSERTIB,SIMUROSERTIB
REP.1M,2.5,,"ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR",BRD:BRD-K00004728-001-01-9,ALLOPURINOL-RIBOSIDE,ALLOPURINOL-RIBOSIDE
REP.1M,2.5,,DEHYDROGENASE INHIBITOR,BRD:BRD-K00004729-001-01-9,MANITIMUS,MANITIMUS
REP.1M,2.5,,RNA POLYMERASE INHIBITOR,BRD:BRD-K00004730-001-01-9,ABT-072,ABT-072
REP.1M,2.5,,CHOLINESTERASE INHIBITOR,BRD:BRD-K00004731-001-01-9,GLN-1062,GLN-1062
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004732-001-01-9,CAMOBUCOL,CAMOBUCOL
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004733-001-01-9,NSP-805,NSP-805
REP.1M,2.5,,NITRIC OXIDE SYNTHASE STIMULANT,BRD:BRD-K00004734-001-01-9,AVE-3085,AVE-3085
REP.1M,2.5,,FATTY ACID HYDROLASE INHIBITOR,BRD:BRD-K00004735-001-01-9,BIA-10-2474,BIA-10-2474
REP.1M,2.5,,,BRD:BRD-K00004736-001-01-9,BETAMETHASONE-BUTYRATE-PROPIONATE,BETAMETHASONE-BUTYRATE-PROPIONATE
REP.1M,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K00004737-001-01-9,NITROFLURBIPROFEN,NITROFLURBIPROFEN
REP.1M,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K00004738-001-01-9,APYRAMIDE,APYRAMIDE
REP.1M,2.5,,DNA CROSS-LINKING,BRD:BRD-K00004739-001-01-9,HEPSULFAM,HEPSULFAM
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004740-001-01-9,PARCETASAL,PARCETASAL
REP.1M,2.5,,STERYL SULFATASE INHIBITOR,BRD:BRD-K00004741-001-01-9,ESTRADIOL-3-O-SULFAMATE,ESTRADIOL-3-O-SULFAMATE
REP.1M,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004742-001-01-9,LUSAPERIDONE,LUSAPERIDONE
REP.1M,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K00004743-001-01-9,NUVENZEPINE,NUVENZEPINE
REP.1M,2.5,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004744-001-01-9,LINTOPRIDE,LINTOPRIDE
REP.1M,2.5,,ANTIALLERGIC AGENT,BRD:BRD-K00004745-001-01-9,HSR6071,HSR6071
REP.1M,2.5,,CALCIUM RECEPTOR ANTAGONIST,BRD:BRD-K00004746-001-01-9,YS-201,YS-201
REP.1M,2.5,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00004747-001-01-9,KME-4,KME-4
REP.1M,2.5,,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K00004748-001-01-9,CI-953,CI-953
REP.1M,2.5,,INTERLEUKIN SYTHESIS STIMULATOR,BRD:BRD-K00004749-001-01-9,NCX-1015,NCX-1015
REP.1M,2.5,,CDK INHIBITOR,BRD:BRD-K00004750-001-01-9,PF-06873600,PF-06873600
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004751-001-01-9,INARIGIVIR-SOPROXIL,INARIGIVIR-SOPROXIL
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K00004752-001-01-9,INX-08189,INX-08189
REP.1M,2.5,,PHOTOSENSITIZING AGENT,BRD:BRD-K00004965-342-01-9,TALAPORFIN,TALAPORFIN
REP.1M,2.5,,HELICASE PRIMASE INHIBITOR,BRD:BRD-K00004966-001-01-9,AMENAMEVIR,AMENAMEVIR
REP.1M,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K00004968-001-01-9,ACETYLSPIRAMYCIN,ACETYLSPIRAMYCIN
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00005238-001-01-9,ALPHA-GLUCOSYL-HESPERIDIN,ALPHA-GLUCOSYL-HESPERIDIN
REP.1M,2.5,,"1,4,5-TRISPHOSPHATE INHIBITOR",BRD:BRD-K00005239-001-01-9,TP-3654,TP-3654
REP.1M,2.5,,ANTIDEPRESSANT,BRD:BRD-K00005240-001-01-9,TULRAMPATOR,TULRAMPATOR
REP.1M,2.5,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00005241-001-01-9,RIPRETINIB,RIPRETINIB
REP.1M,2.5,,BROMODOMAIN INHIBITOR,BRD:BRD-K00005242-001-01-9,TEN-010,TEN-010
REP.1M,2.5,,GUANYLYL CYCLASE ACTIVATOR,BRD:BRD-K00005243-001-01-9,FK-409,FK-409
REP.1M,2.5,,RAF INHIBITOR,BRD:BRD-K00005244-001-01-9,CCT196969,CCT196969
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00005245-001-01-9,KM-0118,KM-0118
REP.1M,2.5,,EGFR INHIBITOR,BRD:BRD-K00005246-001-01-9,CK-101,CK-101
REP.1M,2.5,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00005247-001-01-9,SALVIANOLIC-ACID-A,SALVIANOLIC-ACID-A
REP.1M,2.5,,,BRD:BRD-K00005248-001-01-9,WP921,WP921
REP.1M,2.5,,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K00005249-001-01-9,LY2828360,LY2828360
REP.1M,2.5,,MCL1 INHIBITOR,BRD:BRD-K00005264-001-02-9,AZD5991,AZD5991
REP.1M,2.5,,CYCLIC GMP-AMP SYNTHASE INHIBITOR,BRD:BRD-K00005326-001-01-9,PF-06928215,PF-06928215
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K00005327-001-01-9,SCABERTOPIN,SCABERTOPIN
REP.1M,2.5,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K00005328-001-01-9,RADIPRODIL,RADIPRODIL
REP.1M,2.5,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00005329-074-01-9,LEVAMLODIPINE,LEVAMLODIPINE
REP.1M,2.5,,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00005330-001-01-9,AUT-1,AUT-1
REP.1M,2.5,,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K00005331-001-01-9,BAY-8002,BAY-8002
REP.1M,2.5,,CALCITONIN AGONIST,BRD:BRD-K00005332-019-01-9,CALCITONIN,CALCITONIN
REP.1M,2.5,,STING ANTAGONIST,BRD:BRD-K00005333-001-01-9,H-151,H-151
REP.1M,2.5,,ANTIHYPERTENSIVE AGENT,BRD:BRD-K00005334-001-01-9,GUANCYDINE,GUANCYDINE
REP.1M,2.5,,,BRD:BRD-K00005335-001-01-9,CYCLUC1,CYCLUC1
REP.1M,2.5,,PANTOTHENATE KINASE ACTIVATOR,BRD:BRD-K00005336-001-01-9,PZ-2891,PZ-2891
REP.1M,2.5,,NUCLEAR RECEPTOR ANTAGONIST,BRD:BRD-K00005337-001-01-9,DIM-C-PPHCO2ME,DIM-C-PPHCO2ME
REP.1M,2.5,,PROTAC,BRD:BRD-K00005338-001-01-9,VL285,VL285
REP.1M,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00005339-001-01-9,A-381393,A-381393
REP.1M,2.5,,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K00005340-001-01-9,SBI-115,SBI-115
REP.1M,2.5,,G PROTEIN-COUPLED RECEPTOR MODULATOR,BRD:BRD-K00005341-001-01-9,OGERIN,OGERIN
REP.1M,2.5,,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,BRD:BRD-K00005342-001-01-9,TRIFLOXYSTROBIN,TRIFLOXYSTROBIN
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K00005343-001-01-9,REYNOUTRIN,REYNOUTRIN
REP.1M,2.5,,PROTEIN KINASE ACTIVATOR,BRD:BRD-K00005344-001-01-9,DCP-LA,DCP-LA
REP.1M,2.5,,ION CHANNEL ANTAGONIST,BRD:BRD-K00005345-001-01-9,20-HETE,20-HETE
REP.1M,2.5,,,BRD:BRD-K00005349-304-01-9,BETAMETHASONE-PHOSPHATE,BETAMETHASONE-PHOSPHATE
REP.1M,2.5,,,BRD:BRD-K00010129-001-01-9,PYRETHRINS,PYRETHRINS
REP.1M,2.5,,K-RAS INHIBITOR,BRD:BRD-K00010385-001-01-9,AMG-510,AMG-510
REP.1M,2.5,,SHIP2 PHOSPHATASE INHIBITOR,BRD:BRD-K00010386-001-01-9,RMC-4550,RMC-4550
REP.1M,2.5,,ATPASE INHIBITOR,BRD:BRD-K00010387-001-01-9,BAFILOMYCIN-A1,BAFILOMYCIN-A1
REP.1M,2.5,,BMI-1 INHIBITOR,BRD:BRD-K00010388-001-01-9,PTC-028,PTC-028
REP.1M,2.5,,RAF INHIBITOR,BRD:BRD-K00010389-001-01-9,RAF709,RAF709
REP.1M,2.5,,,BRD:BRD-K00010938-001-01-9,BTS-71321,BTS-71321
REP.1M,2.5,,PARG INHIBITOR,BRD:BRD-K00021095-001-01-9,PDD-00017273,PDD-00017273
REP.1M,2.5,"CASP1, CASP3, CASP7",CASPASE INHIBITOR,BRD:BRD-K00023644-001-01-9,EMRICASAN,EMRICASAN
REP.1M,2.5,,PROTEIN PHOSPHATASE INHIBITOR,BRD:BRD-K00256256-001-06-1,AMZ30,AMZ30
REP.1M,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K00495673-001-05-2,MEGLUTOL,MEGLUTOL
REP.1M,2.5,,"CHELATING AGENT, INSULIN SENSITIZER",BRD:BRD-K01029106-001-02-9,PICOLINIC-ACID,"CHROMIUM-PICOLINATE, PICOLINIC-ACID"
REP.1M,2.5,,TRANSCRIPTIONAL REGULATORY PROTEIN WALR,BRD:BRD-K01129913-001-01-5,WALRYCIN-B,WALRYCIN-B
REP.1M,2.5,"FCGR1A, FECH",OXIDIZING AGENT,BRD:BRD-K01292611-003-13-7,METHYL-AMINOLEVULINATE,METHYL-AMINOLEVULINATE
REP.1M,2.5,ANO1,PARG INHIBITOR,BRD:BRD-K01584643-001-04-9,TANNIC-ACID,TANNIC-ACID
REP.1M,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K01825677-050-02-9,BRL-44408,BRL-44408
REP.1M,2.5,ABAT,GABA AMINOTRANSFERASE ACTIVATOR,BRD:BRD-K01825682-074-02-9,3-METHYL-GABA,3-METHYL-GABA
REP.1M,2.5,PKM,PYRUVATE KINASE ISOZYME ACTIVATOR,BRD:BRD-K01826017-001-02-9,TEPP-46,TEPP-46
REP.1M,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR MODULATOR,BRD:BRD-K01826330-001-01-9,ETIFOXINE,ETIFOXINE
REP.1M,2.5,"HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K01826806-050-02-9,ALPHA-METHYLSEROTONIN,ALPHA-METHYLSEROTONIN
REP.1M,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K02260986-001-03-9,BUTYLIDENEPHTHALIDE,BUTYLIDENEPHTHALIDE
REP.1M,2.5,NUDT1,MTH1 INHIBITOR,BRD:BRD-K02460719-001-02-9,SCH-51344,SCH-51344
REP.1M,2.5,EDNRB,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K02490038-236-03-8,BQ-788,BQ-788
REP.1M,2.5,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K03019184-439-02-9,AMD-3465,AMD-3465
REP.1M,2.5,CHRNA7,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K03128577-005-08-9,MG-624,MG-624
REP.1M,2.5,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K03336321-001-02-9,AZD8797,AZD8797
REP.1M,2.5,TRPV4,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K03391209-001-02-0,HC-067047,HC-067047
REP.1M,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K03665769-001-02-9,SB-452533,SB-452533
REP.1M,2.5,KCNMA1,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K03808106-001-02-9,NS-19504,NS-19504
REP.1M,2.5,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K03827870-001-02-9,GKA-50,GKA-50
REP.1M,2.5,,,BRD:BRD-K03871161-001-02-9,5-HYDROXYECTOINE,5-HYDROXYECTOINE
REP.1M,2.5,"BRS3, GRPR, NMBR",BOMBESIN RECEPTOR AGONIST,BRD:BRD-K03886848-001-01-8,MK-5046,MK-5046
REP.1M,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K04035716-011-02-9,PK-44,PK-44
REP.1M,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K04301924-236-03-2,CEFTIZOXIM,CEFTIZOXIM
REP.1M,2.5,CACNA1B,CALCIUM CHANNEL BLOCKER,BRD:BRD-K04426574-001-03-9,PD-173212,PD-173212
REP.1M,2.5,"HDAC1, HDAC2",HDAC INHIBITOR,BRD:BRD-K04466929-001-12-9,MERCK60,MERCK60
REP.1M,2.5,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K04635846-003-02-9,PNU-177864,PNU-177864
REP.1M,2.5,"ACVR1, BMPR1A",BONE MORPHOGENIC PROTEIN INHIBITOR,BRD:BRD-K04853698-376-01-4,LDN193189,LDN193189
REP.1M,2.5,FDPS,OSTEOCLAST INHIBITOR,BRD:BRD-K05185389-001-02-6,RISEDRONATE,RISEDRONATE
REP.1M,2.5,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K05262258-001-02-9,TC-I-2014,TC-I-2014
REP.1M,2.5,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K05355328-001-02-9,ANAGLIPTIN,ANAGLIPTIN
REP.1M,2.5,LDHA,LACTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K05653025-001-02-9,NHI-2,NHI-2
REP.1M,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628,"AZ 628, AZ-628"
REP.1M,2.5,MTNR1B,MELATONIN RECEPTOR ANTAGONIST,BRD:BRD-K06014311-001-04-9,DH-97,DH-97
REP.1M,2.5,,HOMOQUINOLINIC ACID BINDING INHIBITOR,BRD:BRD-K06159959-001-03-9,CCMQ,CCMQ
REP.1M,2.5,"BIRC2, BIRC3, XIAP",XIAP INHIBITOR,BRD:BRD-K06191411-001-02-5,SM-164,SM-164
REP.1M,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K06204668-001-03-9,"3,4-DCPG-(R)","3,4-DCPG-(R)"
REP.1M,2.5,GPR35,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K06405316-001-04-9,CID-2745687,CID-2745687
REP.1M,2.5,"AR, NR3C1, NR3C2",,BRD:BRD-K06408664-001-04-9,FLUDROCORTISONE-ACETATE,FLUDROCORTISONE-ACETATE
REP.1M,2.5,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K06496777-003-02-9,AT-1015,AT-1015
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K06520168-001-03-9,PROPYPHENAZONE,PROPYPHENAZONE
REP.1M,2.5,"CSF2RB, IL5RA",IL5 INHIBITOR,BRD:BRD-K06712146-001-04-9,YM-90709,YM-90709
REP.1M,2.5,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K07395323-001-02-9,17-PA,17-PA
REP.1M,2.5,"GABRA1, GABRB2, GABRG2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K07460388-019-02-9,PHP-501,PHP-501
REP.1M,2.5,NTSR2,NEUROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K07788774-001-02-9,NTRC-824,NTRC-824
REP.1M,2.5,OPRL1,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,BRD:BRD-K08333979-003-02-9,SB-612111,SB-612111
REP.1M,2.5,"GLI1, GLI2",GLI ANTAGONIST,BRD:BRD-K09485525-001-03-9,GANT-61,GANT-61
REP.1M,2.5,"GRIK1, GRIK5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K09597601-001-02-9,UBP-310,UBP-310
REP.1M,2.5,"CYP2B6, CYP3A4",CYTOCHROME P450 INHIBITOR,BRD:BRD-K09631521-001-12-3,THIOTEPA,THIOTEPA
REP.1M,2.5,,MITOTIC KINESIN INHIBITOR,BRD:BRD-K09774593-001-02-9,S-TRITYL-L-CYSTEINE,S-TRITYL-L-CYSTEINE
REP.1M,2.5,"CHRM1, HRH2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K09859624-004-11-9,METHANTHELINE,METHANTHELINE
REP.1M,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K09907507-300-02-9,AZ-10606120,AZ-10606120
REP.1M,2.5,FFAR1,FREE FATTY ACID RECEPTOR ANTAGONIST,BRD:BRD-K10596918-001-02-9,DC-260126,DC-260126
REP.1M,2.5,,HCV INHIBITOR,BRD:BRD-K11072003-001-02-4,OMBITASVIR,OMBITASVIR
REP.1M,2.5,RORC,RETINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K11641193-001-03-9,SR-2211,SR-2211
REP.1M,2.5,MBTPS1,SREBP INHIBITOR,BRD:BRD-K11821338-300-02-9,PF-429242,PF-429242
REP.1M,2.5,,UREASE INHIBITOR,BRD:BRD-K11984358-001-01-3,ZAMI-633,ZAMI-633
REP.1M,2.5,SPHK2,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-K12106308-003-01-9,K145,K145
REP.1M,2.5,CHRM4,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K12483104-001-02-9,VU10010,VU10010
REP.1M,2.5,S1PR1,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-K12745498-001-03-4,S1P1-AGONIST-III,S1P1-AGONIST-III
REP.1M,2.5,"EIF2A, EIF2AK3","EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR, PERK INHIBITOR",BRD:BRD-K12826175-001-02-4,ISRIB,ISRIB
REP.1M,2.5,ALDH2,ANTIOXIDANT,BRD:BRD-K12979078-001-02-9,DAIDZIN,DAIDZIN
REP.1M,2.5,BRPF1,BROMODOMAIN INHIBITOR,BRD:BRD-K13106865-001-02-9,PFI-4,PFI-4
REP.1M,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K13223831-003-02-9,A-438079,A-438079
REP.1M,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K13330768-001-02-9,ZINC-UNDECYLENATE,ZINC-UNDECYLENATE
REP.1M,2.5,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K13642819-001-02-9,TRIMETREXATE,TRIMETREXATE
REP.1M,2.5,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K13699028-003-02-9,AZD9056,AZD9056
REP.1M,2.5,,GLUCOSYLCERAMIDASE INHIBITOR,BRD:BRD-K14063023-001-02-9,IBIGLUSTAT,IBIGLUSTAT
REP.1M,2.5,IKBKB,IKK INHIBITOR,BRD:BRD-K14287049-001-01-3,AZD3264,AZD3264
REP.1M,2.5,"GRM4, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K14561059-001-06-9,SIB-1893,SIB-1893
REP.1M,2.5,PLAU,UROKINASE INHIBITOR,BRD:BRD-K14646328-004-02-9,BC-11,BC-11
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K14661019-001-02-9,AZ-7371,AZ-7371
REP.1M,2.5,PIK3CG,PI3K INHIBITOR,BRD:BRD-K14988953-001-04-4,AS-252424,AS-252424
REP.1M,2.5,,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K15241725-001-02-9,NBI-98782,NBI-98782
REP.1M,2.5,CDK9,CDK INHIBITOR,BRD:BRD-K15382985-001-01-7,LY2857785,LY2857785
REP.1M,2.5,,DNA ALKYLATING AGENT,BRD:BRD-K15656090-001-07-3,PIPOBROMAN,PIPOBROMAN
REP.1M,2.5,CDC25B,CDC INHIBITOR,BRD:BRD-K15957397-001-05-9,ANTHRAQUINONE,ANTHRAQUINONE
REP.1M,2.5,CCR3,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K16107558-001-02-9,SB-297006,SB-297006
REP.1M,2.5,,DPRE1 INHIBITOR,BRD:BRD-K16343284-001-02-9,MACOZINONE,MACOZINONE
REP.1M,2.5,,CLK INHIBITOR,BRD:BRD-K16605796-001-01-9,T-025,T-025
REP.1M,2.5,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K16939217-001-02-9,TC-G-1005,TC-G-1005
REP.1M,2.5,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K17295893-238-03-9,NASTORAZEPIDE,NASTORAZEPIDE
REP.1M,2.5,PPM1D,PROTEIN PHOSPHATASE INHIBITOR,BRD:BRD-K17472821-001-01-2,GSK2830371,GSK2830371
REP.1M,2.5,ERN1,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K17511755-001-02-9,APY-29,APY-29
REP.1M,2.5,C5AR1,COMPLEMENT ANTAGONIST,BRD:BRD-K17539220-001-02-9,NDT-9513727,NDT-9513727
REP.1M,2.5,CHRNB2,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K17751100-001-02-9,CC4,CC4
REP.1M,2.5,,"DNA SYNTHESIS INHIBITOR, PURINE ANTAGONIST",BRD:BRD-K17874929-236-02-0,BROMEBRIC-ACID,BROMEBRIC-ACID
REP.1M,2.5,RARA,RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K18347943-001-02-9,ER-50891,ER-50891
REP.1M,2.5,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K18399440-001-11-9,CLONIXIN,CLONIXIN
REP.1M,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K18423410-003-02-5,DEXMEDETOMIDINE,DEXMEDETOMIDINE
REP.1M,2.5,TTK,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K18530250-001-02-9,MPS-BAY-2A,MPS-BAY-2A
REP.1M,2.5,DRD2,DOPAMINE RECEPTOR MODULATOR,BRD:BRD-K18573821-001-03-9,PAOPA,PAOPA
REP.1M,2.5,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K18602506-001-09-9,OR-486,OR-486
REP.1M,2.5,"CTNNB1, TCF4","BETA CATENIN INHIBITOR, WNT SIGNALING INHIBITOR",BRD:BRD-K18634484-001-02-9,ICRT-14,ICRT-14
REP.1M,2.5,,,BRD:BRD-K18637542-001-01-7,DIHYDROXYACETONE,DIHYDROXYACETONE
REP.1M,2.5,"HTR1A, HTR1B, HTR1D",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K18816859-001-06-9,L-694247,L-694247
REP.1M,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K19189338-001-03-2,UNDECYLENIC-ACID,UNDECYLENIC-ACID
REP.1M,2.5,SLC16A1,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K19558579-001-02-9,UK-5099,UK-5099
REP.1M,2.5,"P2RY12, PPARD, PTGIR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K19706299-236-02-9,TREPROSTINIL,TREPROSTINIL
REP.1M,2.5,"APP, SOD2",CATALASE STIMULANT,BRD:BRD-K19741031-001-01-4,EUK-134,EUK-134
REP.1M,2.5,CASR,CALCIUM SENSING RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K19811997-003-02-9,CALHEX-231,CALHEX-231
REP.1M,2.5,,NEURAL STEM CELL INDUCER,BRD:BRD-K19958299-001-02-9,TCS-2210,TCS-2210
REP.1M,2.5,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K20049318-303-03-9,IMPENTAMINE,IMPENTAMINE
REP.1M,2.5,,LIPOXYGENASE INHIBITOR,BRD:BRD-K20168484-001-07-9,MK-886,MK-886
REP.1M,2.5,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K20239555-001-02-9,A-887826,A-887826
REP.1M,2.5,"HDAC1, HDAC2, HDAC3, HDAC8",HDAC INHIBITOR,BRD:BRD-K20480395-001-02-9,UF-010,UF-010
REP.1M,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K20484910-001-16-9,AMPYRONE,AMPYRONE
REP.1M,2.5,,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K20497775-001-06-9,L-KYNURENINE,L-KYNURENINE
REP.1M,2.5,,NEUROMUSCULAR BLOCKER,BRD:BRD-K20672254-046-05-4,PYRANTEL-PAMOATE,PYRANTEL-PAMOATE
REP.1M,2.5,"CCNA2, CDK2",CYCLIN D INHIBITOR,BRD:BRD-K20976221-001-12-0,NU-2058,NU-2058
REP.1M,2.5,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K21306330-001-02-9,CJ-033466,CJ-033466
REP.1M,2.5,MC1R,MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K22000702-300-02-9,BMS-470539,BMS-470539
REP.1M,2.5,"MAN1B1, PLA2G2A, PLA2G2E","BENZODIAZEPINE RECEPTOR AGONIST, GAMMA HYDROXYBUTYRIC ACID AGONIST",BRD:BRD-K22346679-001-06-3,"1,4-BUTANEDIOL","1,4-BUTANEDIOL"
REP.1M,2.5,,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K22379844-001-04-9,BAY-2402234,BAY-2402234
REP.1M,2.5,,NEUROGENESIS OF NON-PLURIPOTENT C2C12 MYOBLAST INDUCER,BRD:BRD-K22631935-001-02-7,NEURODAZINE,NEURODAZINE
REP.1M,2.5,DNM1,DYNAMIN INHIBITOR,BRD:BRD-K23479488-001-02-9,DYNOLE-34-2,DYNOLE-34-2
REP.1M,2.5,FFAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K23614267-001-01-2,GW-1100,GW-1100
REP.1M,2.5,SYK,SYK INHIBITOR,BRD:BRD-K23902832-001-01-7,R112,R112
REP.1M,2.5,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K23952234-236-03-4,BMS-986020,"AM095, BMS-986020"
REP.1M,2.5,HDAC2,HDAC INHIBITOR,BRD:BRD-K24031866-001-02-1,MC1568,MC1568
REP.1M,2.5,KCNH2,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K24434292-001-01-3,NS-3623,NS-3623
REP.1M,2.5,KCNJ5,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K24526313-001-17-7,LEVCROMAKALIM,LEVCROMAKALIM
REP.1M,2.5,PPIA,CYCLOPHILIN INHIBITOR,BRD:BRD-K24527118-001-02-9,TMN-355,TMN-355
REP.1M,2.5,"NR1H4, NR1I3, PPARG",CAR ANTAGONIST,BRD:BRD-K24570280-001-07-9,CINPA-1,CINPA-1
REP.1M,2.5,PLD2,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K24600306-003-02-9,ML298,ML298
REP.1M,2.5,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K24675965-001-06-9,LY288513,LY288513
REP.1M,2.5,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K25290930-001-03-9,FENEBRUTINIB,FENEBRUTINIB
REP.1M,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K25412176-001-04-9,GSK2110183,GSK2110183
REP.1M,2.5,,,BRD:BRD-K25521961-001-06-9,L-PHENYLISOPROPYLADENOSINE,L-PHENYLISOPROPYLADENOSINE
REP.1M,2.5,KDM4A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K25611237-001-02-1,ML324,ML324
REP.1M,2.5,"RORA, RORC",RETINOID RECEPTOR AGONIST,BRD:BRD-K26501486-001-02-9,SR-1078,SR-1078
REP.1M,2.5,,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K26526496-001-03-9,GS-967,GS-967
REP.1M,2.5,PI4KB,PI4K INHIBITOR,BRD:BRD-K26726854-001-02-9,MI-14,MI-14
REP.1M,2.5,TRPA1,"ALDOSE REDUCTASE INHIBITOR, TRPV AGONIST",BRD:BRD-K26875402-001-13-9,CINNAMALDEHYDE,CINNAMALDEHYDE
REP.1M,2.5,"ACACA, ACACB",ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K26921335-003-01-2,CP-640186,CP-640186
REP.1M,2.5,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K27010807-050-02-9,TC-G-1000,TC-G-1000
REP.1M,2.5,,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K27040396-051-02-9,CFI-400945,CFI-400945
REP.1M,2.5,,,BRD:BRD-K27529556-001-04-9,EPIGALLOCATECHIN-(-),EPIGALLOCATECHIN-(-)
REP.1M,2.5,FLNA,CHONDROCYTE DIFFERENTIATION STIMULATOR,BRD:BRD-K27584835-001-02-9,KARTOGENIN,KARTOGENIN
REP.1M,2.5,,PKC INHIBITOR,BRD:BRD-K27677357-003-04-9,RUBOXISTAURIN,RUBOXISTAURIN
REP.1M,2.5,,ANTIMALARIAL AGENT,BRD:BRD-K27811785-001-02-9,CIPARGAMIN,CIPARGAMIN
REP.1M,2.5,PTGER4,PROSTAGLANDIN INHIBITOR,BRD:BRD-K27983781-001-01-4,MK-2894,MK-2894
REP.1M,2.5,"BMP2, LIF",NEURAL STEM CELL INDUCER,BRD:BRD-K28567778-001-02-7,NEUROPATHIAZOL,NEUROPATHIAZOL
REP.1M,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K28935038-002-03-9,LORACARBEF,LORACARBEF
REP.1M,2.5,,DECAPPING SCAVENGER ENZYME INHIBITOR,BRD:BRD-K29066607-001-02-9,D-157495,D-157495
REP.1M,2.5,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K29313239-005-10-9,4-DAMP,4-DAMP
REP.1M,2.5,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K29343434-001-02-9,BMS-906024,BMS-906024
REP.1M,2.5,HCRTR2,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K29424831-003-01-3,TCS-OX2-29,TCS-OX2-29
REP.1M,2.5,"CHRM1, CHRM2, DRD1, DRD2",G PROTEIN-COUPLED RECEPTOR MODULATOR,BRD:BRD-K29562203-004-12-9,SCH-202676,SCH-202676
REP.1M,2.5,PNLIP,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K30177383-001-02-9,DALBAVANCIN,DALBAVANCIN
REP.1M,2.5,,HISTONE ACETYLTRANSFERASE INHIBITOR,BRD:BRD-K30233223-001-04-9,A-485,A-485
REP.1M,2.5,,,BRD:BRD-K30284967-001-02-9,6-AMINOPENICILLANIC-ACID,6-AMINOPENICILLANIC-ACID
REP.1M,2.5,AR,ANDROGEN RECEPTOR ENHANCER,BRD:BRD-K30331124-001-04-9,ASC-J9,ASC-J9
REP.1M,2.5,,ANTIEPILEPTIC,BRD:BRD-K30360804-001-02-9,BURAMATE,BURAMATE
REP.1M,2.5,,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K30421675-001-04-9,JNJ-64619178,JNJ-64619178
REP.1M,2.5,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K30425481-003-02-9,L-760735,L-760735
REP.1M,2.5,RARB,RETINOID RECEPTOR AGONIST,BRD:BRD-K31144453-001-03-9,AC-261066,AC-261066
REP.1M,2.5,,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K31168993-001-03-9,MCN-5652-(+/-),MCN-5652-(+/-)
REP.1M,2.5,,CCK RECEPTOR ANTAGONIST,BRD:BRD-K31238592-001-02-9,DEVAZEPIDE,DEVAZEPIDE
REP.1M,2.5,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K31339597-051-03-9,SDZ-SER-082,SDZ-SER-082
REP.1M,2.5,"PDPK1, PIM1, PRKCI, PRKCZ",PKC INHIBITOR,BRD:BRD-K31342827-001-13-8,GF109203X,GF109203X
REP.1M,2.5,"DRD1, DRD2, DRD3, DRD4, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K31471398-003-06-9,DIHYDREXIDINE,DIHYDREXIDINE
REP.1M,2.5,HRH1,MEDIATOR RELEASE INHIBITOR,BRD:BRD-K31731454-237-04-9,PEMIROLAST,PEMIROLAST
REP.1M,2.5,"CDK6, FASN",AURORA KINASE INHIBITOR,BRD:BRD-K31836715-001-06-8,FISETIN,FISETIN
REP.1M,2.5,TRPA1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K32143970-001-02-9,AP-18,AP-18
REP.1M,2.5,HSPA1A,HSP INHIBITOR,BRD:BRD-K32330832-001-01-0,VER-155008,VER-155008
REP.1M,2.5,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K32531356-001-03-9,AMMONIUM-PERFLUOROCAPRYLATE,AMMONIUM-PERFLUOROCAPRYLATE
REP.1M,2.5,SLC6A3,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-K32892871-003-02-9,JHW-007,JHW-007
REP.1M,2.5,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K32952627-001-02-9,BAY-60-6583,BAY-60-6583
REP.1M,2.5,"MMP1, MMP13, MMP2, MMP3, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K33234937-001-02-9,CP-471474,CP-471474
REP.1M,2.5,,SERINE PROTEASE INHIBITOR,BRD:BRD-K33422401-001-06-4,PHENYLMETHYLSULFONYL-FLUORIDE,PHENYLMETHYLSULFONYL-FLUORIDE
REP.1M,2.5,,,BRD:BRD-K33445938-001-01-8,N-METHYLFORMAMIDE,N-METHYLFORMAMIDE
REP.1M,2.5,,,BRD:BRD-K33457401-001-02-9,BRONOPOL,BRONOPOL
REP.1M,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K33499285-001-02-9,GEPOTIDACIN,GEPOTIDACIN
REP.1M,2.5,CNR1,CANNABINOID RECEPTOR MODULATOR,BRD:BRD-K33502629-001-02-9,PSNCBAM-1,PSNCBAM-1
REP.1M,2.5,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K33521504-300-01-6,GSK-LSD-1,GSK-LSD-1
REP.1M,2.5,PRMT6,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K33586289-003-02-8,EPZ020411,EPZ020411
REP.1M,2.5,HTR1B,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K33860217-003-04-0,CP-94253,CP-94253
REP.1M,2.5,,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K33963447-001-03-9,GNE-7915,GNE-7915
REP.1M,2.5,CSNK1G2,CASEIN KINASE INHIBITOR,BRD:BRD-K34303607-300-01-4,CKI-7,CKI-7
REP.1M,2.5,LCK,SRC INHIBITOR,BRD:BRD-K34362291-001-02-9,TC-S-7003,TC-S-7003
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K34566599-001-03-9,ECTOINE,ECTOINE
REP.1M,2.5,"AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB",IGF-1 INHIBITOR,BRD:BRD-K34581968-001-04-6,BMS-536924,BMS-536924
REP.1M,2.5,KCNH2,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K34657753-001-01-9,PD-118057,PD-118057
REP.1M,2.5,,ATPASE INHIBITOR,BRD:BRD-K34798115-001-02-9,SJ-733,SJ-733
REP.1M,2.5,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K34843150-001-03-0,ACT-132577,ACT-132577
REP.1M,2.5,,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K35498911-001-02-9,DSM265,DSM265
REP.1M,2.5,"HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K35941380-050-28-9,METHYSERGIDE,METHYSERGIDE
REP.1M,2.5,,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K35984734-001-02-9,ZSET1446,ZSET1446
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K36137799-001-06-9,PLUMBAGIN,PLUMBAGIN
REP.1M,2.5,MRGPRX1,ANGIOTENSIN RECEPTOR AGONIST,BRD:BRD-K36154108-001-01-7,AVE-0991,AVE-0991
REP.1M,2.5,"CTSB, CTSL, CTSS",CATHEPSIN INHIBITOR,BRD:BRD-K36338614-001-02-1,VBY-825,VBY-825
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K36474365-001-09-9,TARTARIC-ACID,TARTARIC-ACID
REP.1M,2.5,KCNN1,CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K36485341-001-02-9,GW-542573X,GW-542573X
REP.1M,2.5,TRIO,GEF INHIBITOR,BRD:BRD-K36515744-001-03-5,ITX3,ITX3
REP.1M,2.5,CYP2D6,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K36551084-001-04-9,CINCHONINE,CINCHONINE
REP.1M,2.5,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K36697397-003-02-9,GSK1562590,GSK1562590
REP.1M,2.5,NR1I3,CAR ANTAGONIST,BRD:BRD-K37635256-001-02-9,S-07662,S-07662
REP.1M,2.5,,,BRD:BRD-K37851352-001-02-9,ISOPENTYL-4-METHOXYCINNAMATE,ISOPENTYL-4-METHOXYCINNAMATE
REP.1M,2.5,ATP5F1,ATPASE INHIBITOR,BRD:BRD-K37933329-001-03-9,BTB06584,BTB06584
REP.1M,2.5,,TOPK INHIBITOR,BRD:BRD-K38018935-001-01-1,OTS514,OTS514
REP.1M,2.5,,,BRD:BRD-K38203080-001-01-2,SPARTEINE-(+),SPARTEINE-(+)
REP.1M,2.5,TGM2,TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K38272302-001-02-7,GK921,GK921
REP.1M,2.5,"IL12A, IL12B, PIKFYVE",PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K38627885-001-01-9,APY0201,APY0201
REP.1M,2.5,"SMAD3, TGFBR1",SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K38905597-003-02-9,SIS3,SIS3
REP.1M,2.5,"DPP4, DPP7",DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K38966689-300-02-9,UAMC-00039,UAMC-00039
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K39084158-001-08-9,LIQUIRITIN,LIQUIRITIN
REP.1M,2.5,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K39359968-001-03-9,L-755507,L-755507
REP.1M,2.5,,MICROTUBULE INHIBITOR,BRD:BRD-K39576764-071-01-6,MIVOBULIN,MIVOBULIN
REP.1M,2.5,,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-K40407248-001-04-9,MICAFUNGIN,MICAFUNGIN
REP.1M,2.5,TPP2,TRIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K40581315-034-02-9,BUTABINDIDE,BUTABINDIDE
REP.1M,2.5,ALK,ALK INIHIBITOR,BRD:BRD-K40604024-001-02-9,KRCA-0008,KRCA-0008
REP.1M,2.5,"JAK1, JAK3",JAK INHIBITOR,BRD:BRD-K40624912-003-17-9,ZM-39923,ZM-39923
REP.1M,2.5,STAT3,STAT INHIBITOR,BRD:BRD-K40853697-001-20-5,STAT3-INHIBITOR-VI,STAT3-INHIBITOR-VI
REP.1M,2.5,"ADORA1, AR",ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K41141507-001-18-9,CYPROTERONE-ACETATE,CYPROTERONE-ACETATE
REP.1M,2.5,,RYANODINE RECEPTOR BLOCKER,BRD:BRD-K41262162-303-11-9,DHBP,DHBP
REP.1M,2.5,KDM1A,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K41415459-300-02-9,RN-1,RN-1
REP.1M,2.5,,,BRD:BRD-K41504985-003-02-9,CABAGIN,CABAGIN
REP.1M,2.5,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K41895652-001-02-9,JNJ-27141491,JNJ-27141491
REP.1M,2.5,"SLC16A1, SLC16A7",MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K42325600-001-01-8,AR-C155858,AR-C155858
REP.1M,2.5,"MCOLN3, NPY2R",NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K42629487-001-09-9,SF-11,SF-11
REP.1M,2.5,"P2RY10, S1PR2",LYSOPHOSPHOLIPID RECEPTOR ANTAGONIST,BRD:BRD-K43330982-001-04-9,JTE-013,JTE-013
REP.1M,2.5,HSP90AA1,HSP INHIBITOR,BRD:BRD-K43570081-001-02-4,GELDANAMYCIN,GELDANAMYCIN
REP.1M,2.5,,PROTEIN KINASE INHIBITOR,BRD:BRD-K43812936-001-01-9,MPS1-IN-5,MPS1-IN-5
REP.1M,2.5,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K43883465-003-02-9,LEVOBETAXOLOL,LEVOBETAXOLOL
REP.1M,2.5,,MCL1 INHIBITOR,BRD:BRD-K43900408-001-02-9,AMG-176,AMG-176
REP.1M,2.5,,IMMUNE RESPONSE STIMULATOR,BRD:BRD-K43977121-001-06-9,THYMOPENTIN,THYMOPENTIN
REP.1M,2.5,,ANTISEPTIC,BRD:BRD-K44091963-001-04-9,PHENYL-SALICYLATE,PHENYL-SALICYLATE
REP.1M,2.5,TP53,P53 STABILIZING AGENT,BRD:BRD-K44400149-003-02-9,PHIKAN-083,PHIKAN-083
REP.1M,2.5,,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K44845912-001-02-9,ASTILBIN,ASTILBIN
REP.1M,2.5,"HDAC1, HDAC2, HDAC3, HDAC8",HDAC INHIBITOR,BRD:BRD-K45044657-001-01-4,TC-H-106,TC-H-106
REP.1M,2.5,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K45152786-001-09-9,MERBARONE,MERBARONE
REP.1M,2.5,TLR7,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K46384285-001-02-9,DSR-6434,DSR-6434
REP.1M,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K46531780-003-19-7,METHYLBENZETHONIUM-CHLORIDE,METHYLBENZETHONIUM-CHLORIDE
REP.1M,2.5,,,BRD:BRD-K46648676-001-01-8,GALLIUM-TRIQUINOLIN-8-OLATE,GALLIUM-TRIQUINOLIN-8-OLATE
REP.1M,2.5,,JAK INHIBITOR,BRD:BRD-K47084954-001-02-9,PF-06651600,PF-06651600
REP.1M,2.5,NFE2L2,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K47441935-001-02-9,NK-252,NK-252
REP.1M,2.5,,PURINE ANTAGONIST,BRD:BRD-K47464228-001-14-9,AZASERINE,AZASERINE
REP.1M,2.5,,CHELATING AGENT,BRD:BRD-K47608922-001-05-9,DIPYROCETYL,DIPYROCETYL
REP.1M,2.5,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1",IKK INHIBITOR,BRD:BRD-K47983010-001-15-3,BX-795,BX-795
REP.1M,2.5,CHRNA7,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K48053228-051-02-9,PHA-568487,PHA-568487
REP.1M,2.5,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K48059230-003-03-9,YM-298198-DESMETHYL,YM-298198-DESMETHYL
REP.1M,2.5,"PPARD, PPARG","PPAR RECEPTOR ANTAGONIST, WNT SIGNALING INHIBITOR",BRD:BRD-K48112880-001-04-9,FH-535,FH-535
REP.1M,2.5,MGLL,MONOACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K48424871-001-04-9,JW-642,JW-642
REP.1M,2.5,PREP,PROLYL ENDOPEPTIDASE INHIBITOR,BRD:BRD-K48449073-034-03-9,Y-29794,Y-29794
REP.1M,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K48470486-236-11-6,CEFMETAZOLE,CEFMETAZOLE
REP.1M,2.5,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K48832421-001-03-9,PIM-1-INHIBITOR-2,PIM-1-INHIBITOR-2
REP.1M,2.5,TNF,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,BRD:BRD-K48875051-001-01-0,LIGUSTILIDE,LIGUSTILIDE
REP.1M,2.5,,CELL SPLICING INHIBITOR,BRD:BRD-K48905682-001-11-1,MADRASIN,MADRASIN
REP.1M,2.5,,OTHER ANTIBIOTIC,BRD:BRD-K48963429-001-01-9,RIODOXOL,RIODOXOL
REP.1M,2.5,"RARA, RXRG",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K49076555-001-05-6,ETRETINATE,ETRETINATE
REP.1M,2.5,JAK3,JAK INHIBITOR,BRD:BRD-K49461364-001-01-0,TCS-21311,TCS-21311
REP.1M,2.5,MAP3K8,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K49468759-001-04-2,COT-INHIBITOR-2,COT-INHIBITOR-2
REP.1M,2.5,"NEDD4, SMURF2, WWP1",UBIQUITIN LIGASE INHIBITOR,BRD:BRD-K49788188-001-02-9,HECLIN,HECLIN
REP.1M,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K49900195-300-02-9,WYE-687,WYE-687
REP.1M,2.5,"HDAC4, HDAC5",HDAC INHIBITOR,BRD:BRD-K49921286-001-02-6,LMK-235,LMK-235
REP.1M,2.5,"LCK, SRC",SRC INHIBITOR,BRD:BRD-K50199947-001-07-9,WH-4-023,WH-4-023
REP.1M,2.5,"DCLK2, MAPK7, PLK4, TNK1",MAP KINASE INHIBITOR,BRD:BRD-K50387473-001-11-0,XMD8-92,XMD8-92
REP.1M,2.5,,ANTICOAGULANT,BRD:BRD-K50490982-001-09-9,BROMINDIONE,BROMINDIONE
REP.1M,2.5,LDHA,LACTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K50679358-001-02-9,GSK2837808A,GSK2837808A
REP.1M,2.5,ENPP2,AUTOTAXIN INHIBITOR,BRD:BRD-K50865540-001-02-3,PF-8380,PF-8380
REP.1M,2.5,,GLYCINE RECEPTOR AGONIST,BRD:BRD-K50888640-001-01-6,MDL-27531,MDL-27531
REP.1M,2.5,CTNNB1,WNT SIGNALING INHIBITOR,BRD:BRD-K50905564-001-08-9,CARDIONOGEN-1,CARDIONOGEN-1
REP.1M,2.5,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K51041191-001-02-9,PF-03882845,PF-03882845
REP.1M,2.5,"MMP1, MMP13, MMP2",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K51102532-003-02-9,SD-2590,SD-2590
REP.1M,2.5,SRC,SRC INHIBITOR,BRD:BRD-K51329597-001-02-9,AZM-475271,AZM-475271
REP.1M,2.5,TGM2,TISSUE TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K51485109-001-02-9,LDN-27219,LDN-27219
REP.1M,2.5,MAP3K8,MAP KINASE INHIBITOR,BRD:BRD-K51776215-001-03-9,TC-S-7006,TC-S-7006
REP.1M,2.5,,CHOLINESTERASE INHIBITOR,BRD:BRD-K51805276-001-10-9,TEMEFOS,TEMEFOS
REP.1M,2.5,,SODIUM/CALCIUM EXCHANGE INHIBITOR,BRD:BRD-K52087522-300-02-9,YM-244769,YM-244769
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K52416806-001-05-9,SULFISOMIDIN,SULFISOMIDIN
REP.1M,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K52644305-300-02-9,ML786,ML786
REP.1M,2.5,KCNJ8,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K52721684-001-04-8,PCO-400,PCO-400
REP.1M,2.5,PNP,PURINE ANTAGONIST,BRD:BRD-K53114651-001-12-7,AZAGUANINE-8,AZAGUANINE-8
REP.1M,2.5,SYK,SYK INHIBITOR,BRD:BRD-K53281329-300-01-5,BAY-61-3606,BAY-61-3606
REP.1M,2.5,CCR2,"CCR AGONIST, INTERFERON RECEPTOR AGONIST",BRD:BRD-K53382462-001-02-0,PROPAGERMANIUM,PROPAGERMANIUM
REP.1M,2.5,STAT3,"APOPTOSIS STIMULANT, STAT INHIBITOR",BRD:BRD-K53731810-001-05-9,ALANTOLACTONE,ALANTOLACTONE
REP.1M,2.5,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K53896891-001-01-2,METHANESULFONYL-FLUORIDE,METHANESULFONYL-FLUORIDE
REP.1M,2.5,NEUROD1,NEURAL STEM CELL INDUCER,BRD:BRD-K53903639-001-01-3,ISX-9,ISX-9
REP.1M,2.5,,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K54208592-001-10-9,CARBARIL,CARBARIL
REP.1M,2.5,"ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC",AMPK INHIBITOR,BRD:BRD-K54233340-001-02-2,DORSOMORPHIN,DORSOMORPHIN
REP.1M,2.5,GPR139,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K54297077-001-02-9,TC-O-9311,TC-O-9311
REP.1M,2.5,"HDAC1, HDAC3",HDAC INHIBITOR,BRD:BRD-K54729176-001-03-9,SBHA,SBHA
REP.1M,2.5,,LOCAL ANESTHETIC,BRD:BRD-K54799382-003-08-4,PARETHOXYCAINE,PARETHOXYCAINE
REP.1M,2.5,MRE11A,MRE11A EXONUCLEASE INHIBITOR,BRD:BRD-K55420858-001-01-0,MIRIN,MIRIN
REP.1M,2.5,HTR2C,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K55430733-003-03-9,WAY-629,WAY-629
REP.1M,2.5,,APOPTOSIS STIMULANT,BRD:BRD-K55790047-001-02-9,ON-01500,ON-01500
REP.1M,2.5,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K56509348-003-04-9,BMS-182874,BMS-182874
REP.1M,2.5,"ACHE, BCHE",CHOLINESTERASE INHIBITOR,BRD:BRD-K56575995-001-03-0,ISOFLUROPHATE,ISOFLUROPHATE
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K56792340-001-14-9,ETHOXYQUIN,ETHOXYQUIN
REP.1M,2.5,,,BRD:BRD-K56839624-001-06-9,CQS,CQS
REP.1M,2.5,"IMPDH1, IMPDH2",INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,BRD:BRD-K56932272-001-02-9,BMS-566419,BMS-566419
REP.1M,2.5,"MMP13, MMP14, MMP2, MMP3, MMP9",METALLOPROTEINASE INHIBITOR,BRD:BRD-K57011718-001-01-5,UK-356618,UK-356618
REP.1M,2.5,"CREBBP, EP300",BROMODOMAIN INHIBITOR,BRD:BRD-K57090026-001-04-9,I-CBP-112,I-CBP-112
REP.1M,2.5,"PAK1, PAK2, PAK3, PAK4",SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K57243773-001-01-6,FRAX486,FRAX486
REP.1M,2.5,,CONTRAST AGENT,BRD:BRD-K57365211-314-03-9,MANGAFODIPIR,MANGAFODIPIR
REP.1M,2.5,GRM1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K57796080-001-04-9,"3,5-DHPG-(S)","3,5-DHPG-(S)"
REP.1M,2.5,TLR3,TOLL-LIKE RECEPTOR INHIBITOR,BRD:BRD-K58234744-001-02-9,CU-CPT-4A,CU-CPT-4A
REP.1M,2.5,PFKFB3,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K58413118-001-01-8,3PO,3PO
REP.1M,2.5,NUAK1,PROTEIN KINASE INHIBITOR,BRD:BRD-K58726989-001-02-7,HTH-01-015,HTH-01-015
REP.1M,2.5,,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K58938839-001-06-9,CYCLOPAMINE,CYCLOPAMINE
REP.1M,2.5,RBP4,RETINOID RECEPTOR LIGAND,BRD:BRD-K59060513-001-02-5,A-1120,A-1120
REP.1M,2.5,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K59650319-003-04-9,YM-298198,YM-298198
REP.1M,2.5,"KCNQ2, KCNQ3",VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K59839632-001-02-9,ICA-069673,ICA-069673
REP.1M,2.5,,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,BRD:BRD-K60265345-001-02-9,LIFITEGRAST,LIFITEGRAST
REP.1M,2.5,SLC16A1,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K60302405-001-04-5,CHC,CHC
REP.1M,2.5,,NITRIC OXIDE SYNTHASE STIMULANT,BRD:BRD-K60379054-001-09-9,BENDAZOL,BENDAZOL
REP.1M,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K60427831-001-02-9,A-839977,A-839977
REP.1M,2.5,"GUCY1A2, GUCY1A3, GUCY1B3, HIF1A",GUANYLYL CYCLASE ACTIVATOR,BRD:BRD-K60476892-001-17-9,YC-1,YC-1
REP.1M,2.5,,,BRD:BRD-K60600693-314-03-2,SODIUM-ORTHOVANADATE,SODIUM-ORTHOVANADATE
REP.1M,2.5,,,BRD:BRD-K60783397-001-12-9,PROPYLPARABEN,PROPYLPARABEN
REP.1M,2.5,,ANTIVIRAL,BRD:BRD-K60842365-001-03-9,THEAFLAVIN,THEAFLAVIN
REP.1M,2.5,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K60946979-003-02-9,CGP-78608,CGP-78608
REP.1M,2.5,"KDM4A, KDM4B",HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K61120504-001-01-6,NSC-636819,NSC-636819
REP.1M,2.5,,NITRIC OXIDE DONOR,BRD:BRD-K61230716-236-03-5,SODIUM-NITRITE,SODIUM-NITRITE
REP.1M,2.5,ATP4A,ATPASE INHIBITOR,BRD:BRD-K61443506-239-03-9,ESOMEPRAZOLE,ESOMEPRAZOLE
REP.1M,2.5,"PBRM1, SMARCA4",BROMODOMAIN INHIBITOR,BRD:BRD-K61524559-001-04-7,PFI-3,PFI-3
REP.1M,2.5,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K61721596-001-01-0,JNJ-10397049,JNJ-10397049
REP.1M,2.5,"DDR1, DDR2",DISCOIDIN DOMAIN RECEPTOR INHIBITOR,BRD:BRD-K61845293-300-03-9,DDR1-IN-1,DDR1-IN-1
REP.1M,2.5,SFRP1,SECRETED FRIZZLED RELATED PROTEIN INHIBITOR,BRD:BRD-K61871885-001-01-3,WAY-316606,WAY-316606
REP.1M,2.5,CERS1,,BRD:BRD-K61915943-001-02-9,FUMONISIN-B1,FUMONISIN-B1
REP.1M,2.5,CNR1,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K62289640-003-05-9,LYLAMINE,LYLAMINE
REP.1M,2.5,,ANTICANCER AGENT,BRD:BRD-K62378877-001-05-9,CLANFENUR,CLANFENUR
REP.1M,2.5,"ANO1, CLCN1",,BRD:BRD-K62607075-001-04-9,9-ANTHRACENECARBOXYLIC-ACID,9-ANTHRACENECARBOXYLIC-ACID
REP.1M,2.5,PTGER1,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K62715847-003-02-9,SC-51089,SC-51089
REP.1M,2.5,PPARG,PPAR RECEPTOR LIGAND,BRD:BRD-K62814487-001-03-0,SR-1664,SR-1664
REP.1M,2.5,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K63806092-236-06-9,SITAXENTAN,SITAXENTAN
REP.1M,2.5,,RENAL FUNCTION DIAGNOSTIC AGENT,BRD:BRD-K63979671-001-11-9,ETIFENIN,ETIFENIN
REP.1M,2.5,"PRKAA1, PRKAB1, PRKAG1",AMPK ACTIVATOR,BRD:BRD-K64103579-003-02-9,ZLN024,ZLN024
REP.1M,2.5,,EGFR INHIBITOR,BRD:BRD-K64114733-066-03-9,NAQUOTINIB,NAQUOTINIB
REP.1M,2.5,ENPP2,AUTOTAXIN INHIBITOR,BRD:BRD-K64452997-001-02-9,HA-130,HA-130
REP.1M,2.5,"OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K64748124-300-06-9,GNTI,GNTI
REP.1M,2.5,MAPK7,MAP KINASE INHIBITOR,BRD:BRD-K64857848-001-06-4,ERK5-IN-1,ERK5-IN-1
REP.1M,2.5,PTGFR,PROSTAGLANDIN INHIBITOR,BRD:BRD-K65059905-001-02-9,TAFLUPROST,TAFLUPROST
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K65230684-001-06-9,OXACEPROL,OXACEPROL
REP.1M,2.5,,MDM INHIBITOR,BRD:BRD-K65480835-001-02-9,SIREMADLIN,SIREMADLIN
REP.1M,2.5,,ANTITUMOR AGENT,BRD:BRD-K65508953-001-13-9,MONOCROTALINE,MONOCROTALINE
REP.1M,2.5,,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K65840970-001-02-9,GW274150,GW274150
REP.1M,2.5,TRPV1,TRPV ANTAGONIST,BRD:BRD-K66541497-001-02-9,BCTC,BCTC
REP.1M,2.5,S1PR3,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,BRD:BRD-K66584608-001-03-9,TY-52156,TY-52156
REP.1M,2.5,ZNF215,BROMODOMAIN INHIBITOR,BRD:BRD-K66830666-001-02-7,BAZ2-ICR,BAZ2-ICR
REP.1M,2.5,"CDKL2, DAPK3, FLT3, LRRK2, MAP3K10, MAP3K11, MAP3K2, MAP3K9, SRPK2",MIXED LINEAGE KINASE INHIBITOR,BRD:BRD-K66908976-001-01-8,URMC-099,URMC-099
REP.1M,2.5,"MTNR1A, MTNR1B",MELATONIN RECEPTOR ANTAGONIST,BRD:BRD-K67013324-001-04-9,LUZINDOLE,LUZINDOLE
REP.1M,2.5,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K68075732-001-11-8,ATENOLOL-(+),ATENOLOL-(+)
REP.1M,2.5,,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K68332390-001-04-9,STATIL,STATIL
REP.1M,2.5,,CHOLESTEROL INHIBITOR,BRD:BRD-K68534611-001-07-8,2-METHYLIMIDAZOLE,2-METHYLIMIDAZOLE
REP.1M,2.5,APP,GAMMA SECRETASE INHIBITOR,BRD:BRD-K68795758-001-02-9,MRK-560,MRK-560
REP.1M,2.5,"ADORA1, AVPR1A, CCR1, CHRM1, CHRM2, CHRM3, CHRM4, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR3A, TACR2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K68982262-001-02-9,A-987306,A-987306
REP.1M,2.5,"GCK, TNK2","GLUCOKINASE INHIBITOR, PROTEIN KINASE INHIBITOR",BRD:BRD-K69075588-001-02-9,GNF-7,GNF-7
REP.1M,2.5,NOS2,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K69191882-065-01-6,GUANIDINOETHYLDISULFIDE-BICARBONATE,GUANIDINOETHYLDISULFIDE-BICARBONATE
REP.1M,2.5,"BRD2, BRD3, BRD4, BRDT",BROMODOMAIN INHIBITOR,BRD:BRD-K69211575-001-02-9,XD-14,XD-14
REP.1M,2.5,"HTR3A, HTR3B, HTR4",SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K69343602-003-02-9,ML10302,ML10302
REP.1M,2.5,,ATM KINASE INHIBITOR,BRD:BRD-K69555850-001-02-9,AZD0156,AZD0156
REP.1M,2.5,,ANALGESIC AGENT,BRD:BRD-K69632891-001-02-9,TRIBROMOETHANOL,TRIBROMOETHANOL
REP.1M,2.5,"AHR, DPP4, HMGCR",HMGCR INHIBITOR,BRD:BRD-K69726342-238-05-9,ATORVASTATIN,ATORVASTATIN
REP.1M,2.5,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K69857269-001-03-9,SONEPIPRAZOLE,SONEPIPRAZOLE
REP.1M,2.5,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K70161083-001-06-9,CAROVERIN,CAROVERIN
REP.1M,2.5,"AURKA, AURKB, PDPK1",PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K70642949-001-03-7,GSK2334470,GSK2334470
REP.1M,2.5,UGCG,GLUCOSYLCERAMIDASE INHIBITOR,BRD:BRD-K70693421-001-01-1,GENZ-123346,GENZ-123346
REP.1M,2.5,"EGLN1, KDM3A, KDM4C, KDM6B",HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K70751730-001-10-4,IOX1,IOX1
REP.1M,2.5,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K71223042-001-03-9,PCI-29732,PCI-29732
REP.1M,2.5,FGFR1,FIBROBLAST GROWTH FACTOR MIMETIC,BRD:BRD-K71250460-001-02-9,SUN-11602,SUN-11602
REP.1M,2.5,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K71315565-001-02-9,MJ-15,MJ-15
REP.1M,2.5,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K71454870-046-01-8,MORANTEL,MORANTEL
REP.1M,2.5,"RARA, RARB",RETINOID RECEPTOR BINDER,BRD:BRD-K71487808-001-02-8,CH55,CH55
REP.1M,2.5,,SPLEEN ASSOCIATED TYROSINE KINASE INHIBITOR,BRD:BRD-K71500795-003-02-9,TAK-659,TAK-659
REP.1M,2.5,KCNQ2,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K71686520-001-02-9,ICA-110381,ICA-110381
REP.1M,2.5,ACO2,,BRD:BRD-K71756122-001-02-5,CIS-ACONITIC-ACID,CIS-ACONITIC-ACID
REP.1M,2.5,"ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARG, RARRES1, RORB, RORC, RXRB, RXRG","RETINOID RECEPTOR AGONIST, RETINOID RECEPTOR LIGAND",BRD:BRD-K71879491-001-51-5,TRETINOIN,TRETINOIN
REP.1M,2.5,"JUN, NFKB1",NFKB PATHWAY INHIBITOR,BRD:BRD-K71900389-001-02-9,SP-100030,SP-100030
REP.1M,2.5,KCNJ1,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K72063794-003-02-9,VU591,VU591
REP.1M,2.5,CALY,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K72226571-003-02-9,A77636,A77636
REP.1M,2.5,HMGCR,"CYTOCHROME P450 INHIBITOR, HMGCR INHIBITOR",BRD:BRD-K72536715-001-01-5,ALPHA-ASARONE,ALPHA-ASARONE
REP.1M,2.5,FGFR4,FGFR INHIBITOR,BRD:BRD-K72898849-001-01-8,BLU9931,BLU9931
REP.1M,2.5,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K73499906-300-02-9,IT1T,IT1T
REP.1M,2.5,IRAK4,INTERLEUKIN INHIBITOR,BRD:BRD-K73565918-003-02-9,AS-2444697,AS-2444697
REP.1M,2.5,XIAP,XIAP INHIBITOR,BRD:BRD-K73610817-001-10-9,UC-112,UC-112
REP.1M,2.5,"KCNH2, KCNH6, KCNMA1",VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K73738482-001-01-7,NS-1643,NS-1643
REP.1M,2.5,"ALPPL2, ENPP1",REDUCING AGENT,BRD:BRD-K73947551-001-04-4,AMIFOSTINE,AMIFOSTINE
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K73991644-001-07-9,ISOQUERCITRIN,ISOQUERCITRIN
REP.1M,2.5,,ENZYME INDUCER,BRD:BRD-K74057164-001-01-6,HEMIN,HEMIN
REP.1M,2.5,,ANTIOXIDANT,BRD:BRD-K74227494-001-03-9,RIBOFLAVIN-TETRABUTYRATE,RIBOFLAVIN-TETRABUTYRATE
REP.1M,2.5,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K74284736-001-04-9,L-689560,L-689560
REP.1M,2.5,,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K74319597-001-02-9,HM-30181,HM-30181
REP.1M,2.5,"ACTA1, ATOX1, C22orf28, LYZ",,BRD:BRD-K74724920-001-02-4,SUCROSE,SUCROSE
REP.1M,2.5,ESR1,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K75016267-001-02-9,SNG-1153,SNG-1153
REP.1M,2.5,PRMT1,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K75114721-304-02-6,AMI-1,AMI-1
REP.1M,2.5,"AMD1, KCNJ4, ODC1",TISSUE TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K75282878-300-05-3,PUTRESCINE,PUTRESCINE
REP.1M,2.5,NAT10,TRANSFERASE INHIBITOR,BRD:BRD-K75349868-001-03-9,REMODELIN,REMODELIN
REP.1M,2.5,PPARD,PPAR RECEPTOR INVERSE AGONIST,BRD:BRD-K75748943-300-02-9,DG-172,DG-172
REP.1M,2.5,S1PR3,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,BRD:BRD-K75940276-001-04-9,CYM-5541,CYM-5541
REP.1M,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K75958547-238-04-9,PITAVASTATIN,PITAVASTATIN
REP.1M,2.5,,MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K75989555-001-02-9,MELANOTAN-II,MELANOTAN-II
REP.1M,2.5,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K76205745-237-22-9,LOSARTAN,LOSARTAN
REP.1M,2.5,PTGER1,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K76725781-001-02-9,ONO-8130,ONO-8130
REP.1M,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76894955-001-02-1,A-804598,A-804598
REP.1M,2.5,,SR-BI INHIBITOR,BRD:BRD-K76911699-003-03-9,ITX5061,ITX5061
REP.1M,2.5,ADORA2A,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K76989898-001-02-9,TC-G-1004,TC-G-1004
REP.1M,2.5,"AURKB, INCENP, MAP2K1",AURORA KINASE INHIBITOR,BRD:BRD-K77286328-001-03-7,REVERSINE,REVERSINE
REP.1M,2.5,"ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR1E, HTR2B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K77474816-003-15-9,RAUWOLSCINE,RAUWOLSCINE
REP.1M,2.5,PRMT1,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77758223-300-02-9,FURAMIDINE,FURAMIDINE
REP.1M,2.5,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K77817104-001-02-9,N-(P-AMYLCINNAMOYL)-ANTHRANILIC-ACID,N-(P-AMYLCINNAMOYL)-ANTHRANILIC-ACID
REP.1M,2.5,,ANTIBACTERIAL,BRD:BRD-K77897005-001-02-9,RIDINILAZOLE,RIDINILAZOLE
REP.1M,2.5,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K77915400-001-01-6,TCN238,TCN238
REP.1M,2.5,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K77951111-001-05-9,PD-81723,PD-81723
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K78097265-001-02-9,ADELMIDROL,ADELMIDROL
REP.1M,2.5,,OTHER ANTIFUNGAL,BRD:BRD-K78321730-001-13-9,METHYLPARABEN,METHYLPARABEN
REP.1M,2.5,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K78364995-236-18-3,CEFOTAXIME,CEFOTAXIME
REP.1M,2.5,,PI4K INHIBITOR,BRD:BRD-K78973789-001-02-9,MMV-390048,MMV-390048
REP.1M,2.5,"CSF1R, KIT",RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K79294107-300-02-9,PLX647,PLX647
REP.1M,2.5,CHRNA7,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K79743788-001-02-9,A-582941,A-582941
REP.1M,2.5,"PPARA, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K79878800-239-02-9,SAROGLITAZAR,SAROGLITAZAR
REP.1M,2.5,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80267133-325-22-9,AMINOSALICYLATE,AMINOSALICYLATE
REP.1M,2.5,,ANTACID,BRD:BRD-K80528473-001-03-0,BISMUTH-SUBSALICYLATE,BISMUTH-SUBSALICYLATE
REP.1M,2.5,,TYROSINE KINASE INHIBITOR,BRD:BRD-K81048131-001-03-9,AG-556,AG-556
REP.1M,2.5,KCNN4,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K81341251-001-02-9,TRAM-39,TRAM-39
REP.1M,2.5,"EIF2AK3, MYLK2",PROTEIN KINASE INHIBITOR,BRD:BRD-K81689258-001-04-8,GSK2606414,GSK2606414
REP.1M,2.5,CRHR1,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K81779590-003-02-9,NGD-98-2,NGD-98-2
REP.1M,2.5,,NMDA RECEPTOR ANTAGONIST,BRD:BRD-K81881550-001-03-9,LICOSTINEL,LICOSTINEL
REP.1M,2.5,GPR35,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K81935556-001-02-9,TCS-3035,TCS-3035
REP.1M,2.5,,ANALGESIC AGENT,BRD:BRD-K81993098-003-15-0,MECYSTEINE,MECYSTEINE
REP.1M,2.5,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K82239282-001-02-9,ASP-6537,ASP-6537
REP.1M,2.5,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K82266792-001-03-9,SDZ-220-040,SDZ-220-040
REP.1M,2.5,HMGCR,HMGCR INHIBITOR,BRD:BRD-K82941592-238-07-9,ROSUVASTATIN,ROSUVASTATIN
REP.1M,2.5,,IAP ANTAGONIST,BRD:BRD-K83030136-001-02-9,AT-406,AT-406
REP.1M,2.5,CASR,"BONE FORMATION STIMULANT, BONE RESORPTION INHIBITOR",BRD:BRD-K83146339-001-04-0,STRONTIUM-RANELATE,STRONTIUM-RANELATE
REP.1M,2.5,,CSF1R INHIBITOR,BRD:BRD-K83157152-001-02-9,BLZ945,BLZ945
REP.1M,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K83213911-001-08-9,PF-750,PF-750
REP.1M,2.5,RELA,NFKB PATHWAY INHIBITOR,BRD:BRD-K83354763-001-07-9,NFKB-ACTIVATION-INHIBITOR-II,NFKB-ACTIVATION-INHIBITOR-II
REP.1M,2.5,"KDM2A, KDM7A, PHF8",KDM2A INHIBITOR,BRD:BRD-K83452553-001-07-9,DAMINOZIDE,DAMINOZIDE
REP.1M,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K83547600-001-02-9,JNJ-47965567,JNJ-47965567
REP.1M,2.5,,ANTICONVULSANT,BRD:BRD-K83631119-001-04-9,PAEONIFLORIN,PAEONIFLORIN
REP.1M,2.5,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K83649660-003-04-9,VU0360172,VU0360172
REP.1M,2.5,,BMI-1 INHIBITOR,BRD:BRD-K83834509-001-04-9,PTC-209,PTC-209
REP.1M,2.5,TGFBR1,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K83904070-001-02-9,R-268712,R-268712
REP.1M,2.5,"ABAT, ACE, AKR1C3, CA2, CELA1, ESR2, FFAR2, FFAR3, HPRT1, LTA4H, MMP12, NOS1, NOS3, PLA2G1B, PTPN1, SOD1, TXN",,BRD:BRD-K83914624-415-01-3,C11-ACETATE,C11-ACETATE
REP.1M,2.5,PRKACA,PKA ACTIVATOR,BRD:BRD-K84068331-001-02-9,CW-008,CW-008
REP.1M,2.5,"FDPS, GGPS1",BONE RESORPTION INHIBITOR,BRD:BRD-K84253429-001-06-9,ZOLEDRONIC-ACID,ZOLEDRONIC-ACID
REP.1M,2.5,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K84313779-003-03-9,TINORIDINE,TINORIDINE
REP.1M,2.5,KHK,HEXOKINASE INHIBITOR,BRD:BRD-K84605263-003-01-6,KHK-IN-1,KHK-IN-1
REP.1M,2.5,,"GLUTAMATE RECEPTOR ANTAGONIST, GLUTAMINASE INHIBITOR",BRD:BRD-K84924563-001-04-9,6-DIAZO-5-OXO-L-NORLEUCINE,"6-DIAZO-5-OXO-L-NOR-LEUCINE, 6-DIAZO-5-OXO-L-NORLEUCINE"
REP.1M,2.5,"USP10, USP13",DEUBIQUITINASE INHIBITOR,BRD:BRD-K84964099-001-03-9,SPAUTIN-1,SPAUTIN-1
REP.1M,2.5,,BUTYRYLCHOLINESTERASE INHIBITOR,BRD:BRD-K85030058-003-16-9,BENACTYZINE,BENACTYZINE
REP.1M,2.5,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K85804405-003-01-3,LY231617,LY231617
REP.1M,2.5,,T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K86677390-001-02-9,MK-8998,MK-8998
REP.1M,2.5,PRMT3,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K86718786-001-03-9,SGC-707,SGC-707
REP.1M,2.5,,,BRD:BRD-K86872788-065-01-5,SPARTEINE-(-),SPARTEINE-(-)
REP.1M,2.5,PDE2A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K86932920-001-02-9,BAY-60-7550,BAY-60-7550
REP.1M,2.5,"PI4KA, PI4KB, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PLK1, PRKDC",PI3K INHIBITOR,BRD:BRD-K87343924-001-16-9,WORTMANNIN,WORTMANNIN
REP.1M,2.5,TNKS2,TANKYRASE INHIBITOR,BRD:BRD-K87454346-001-01-1,NVP-TNKS656,NVP-TNKS656
REP.1M,2.5,S1PR1,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,BRD:BRD-K87461578-001-02-9,TC-SP-14,TC-SP-14
REP.1M,2.5,,TOPOISOMERASE INHIBITOR,BRD:BRD-K87595680-001-05-9,SOBUZOXANE,SOBUZOXANE
REP.1M,2.5,TRPV1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K87665527-001-02-9,A-784168,A-784168
REP.1M,2.5,"CDA, DNMT1",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K87714311-001-05-9,ZEBULARINE,ZEBULARINE
REP.1M,2.5,"DNM1, DNM1L, DNM2",DYNAMIN INHIBITOR,BRD:BRD-K87718015-001-04-9,DYNASORE,DYNASORE
REP.1M,2.5,CHRM4,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K87727457-001-02-9,VU152100,VU152100
REP.1M,2.5,ERBB2,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K87919739-001-08-9,TYRPHOSTIN-AG-825,TYRPHOSTIN-AG-825
REP.1M,2.5,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K87941707-001-02-9,TP-003,TP-003
REP.1M,2.5,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K87973152-001-02-9,RQ-00203078,RQ-00203078
REP.1M,2.5,"ADRA2A, ASIC1, PKD2L1","SODIUM/HYDROGEN EXCHANGER INHIBITOR, TRANSIENT RECEPTOR POTENTIAL POLYCYSTIC INHIBITOR",BRD:BRD-K88120876-001-10-9,EIPA,EIPA
REP.1M,2.5,"CDK4, NUAK1, PDGFRB",CDK INHIBITOR,BRD:BRD-K88554883-001-03-2,ON123300,ON123300
REP.1M,2.5,MTOR,MTOR INHIBITOR,BRD:BRD-K88737571-001-02-2,CC-223,CC-223
REP.1M,2.5,"BIRC2, BIRC3, XIAP",XIAP INHIBITOR,BRD:BRD-K88767641-001-01-7,AZD5582,AZD5582
REP.1M,2.5,FKBP1A,CALCINEURIN INHIBITOR,BRD:BRD-K88882192-001-03-3,ASCOMYCIN,ASCOMYCIN
REP.1M,2.5,KIF11,KINESIN INHIBITOR,BRD:BRD-K89329876-001-08-9,BRD9876,BRD9876
REP.1M,2.5,"TLR1, TLR2",TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K89462779-001-02-9,CU-T12-9,CU-T12-9
REP.1M,2.5,,EGFR INHIBITOR,BRD:BRD-K89709433-001-03-9,HER2-INHIBITOR-1,HER2-INHIBITOR-1
REP.1M,2.5,CBFB,CORE BINDING FACTOR INHIBITOR,BRD:BRD-K89899948-001-01-7,AI-10-49,AI-10-49
REP.1M,2.5,MAPKAPK2,MAP KINASE INHIBITOR,BRD:BRD-K90316462-003-01-1,MK2-IN-1,MK2-IN-1
REP.1M,2.5,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K90410034-003-02-9,M8-B,M8-B
REP.1M,2.5,TRPV4,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K90737788-001-02-9,GSK2193874,GSK2193874
REP.1M,2.5,KRAS,K-RAS INHIBITOR,BRD:BRD-K90756851-001-01-1,K-RAS(G12C)-INHIBITOR-12,K-RAS(G12C)-INHIBITOR-12
REP.1M,2.5,,ANTIINFECTIVE DRUG,BRD:BRD-K90991629-100-02-9,DELAFLOXACIN,DELAFLOXACIN
REP.1M,2.5,CTNNB1,WNT SIGNALING INHIBITOR,BRD:BRD-K90999434-004-02-9,CCT-031374,CCT-031374
REP.1M,2.5,CARM1,"DNA METHYLTRANSFERASE INHIBITOR, RNA SYNTHESIS INHIBITOR",BRD:BRD-K91100918-001-03-8,SINEFUNGIN,SINEFUNGIN
REP.1M,2.5,PDGFRB,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K91106808-001-03-9,SU16F,SU16F
REP.1M,2.5,GRM1,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K91333421-001-02-9,RO-67-7476,RO-67-7476
REP.1M,2.5,GHSR,GHRELIN RECEPTOR ANTAGONIST,BRD:BRD-K91403886-003-02-9,YIL-781,YIL-781
REP.1M,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K91535048-001-01-2,EI1,EI1
REP.1M,2.5,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K91644281-311-02-9,KASUGAMYCIN,KASUGAMYCIN
REP.1M,2.5,,MCL1 INHIBITOR,BRD:BRD-K91876515-001-03-9,S63845,S63845
REP.1M,2.5,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K92377961-001-03-7,CATHARANTHINE,CATHARANTHINE
REP.1M,2.5,SCN10A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K92435527-001-03-9,PF-04885614,PF-04885614
REP.1M,2.5,"NPY2R, SST",TISSUE TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K92611362-003-03-9,CYSTEAMINE,CYSTEAMINE
REP.1M,2.5,BRD1,BROMODOMAIN INHIBITOR,BRD:BRD-K92658264-001-02-9,OF-1,OF-1
REP.1M,2.5,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-17-4,IMATINIB,IMATINIB
REP.1M,2.5,"CACNA1G, CACNA1H, CACNA1I",T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K92995792-003-03-9,ML218,ML218
REP.1M,2.5,"EGFR, FGFR1, PDGFRB, PKMYT1, SRC, WEE1",SRC INHIBITOR,BRD:BRD-K93217218-300-03-9,PD-166285,PD-166285
REP.1M,2.5,,THROMBOPOIETIN RECEPTOR AGONIST,BRD:BRD-K93228461-001-02-9,LUSUTROMBOPAG,LUSUTROMBOPAG
REP.1M,2.5,KCND3,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K93314017-001-02-9,NS-5806,NS-5806
REP.1M,2.5,WDR5,WDR5/MLL INTERACTION INHIBITOR,BRD:BRD-K94083718-001-03-9,OICR-9429,OICR-9429
REP.1M,2.5,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K94313941-001-03-9,A-804598,A-804598
REP.1M,2.5,,INTEGRIN SIGNALING ACTIVATOR,BRD:BRD-K94659840-001-02-9,PYRINTEGRIN,PYRINTEGRIN
REP.1M,2.5,,ANTIPROTOZOAL AGENT,BRD:BRD-K94848716-001-12-9,CARBARSONE,CARBARSONE
REP.1M,2.5,TTK,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K94853001-300-04-9,MPS1-IN-1,MPS1-IN-1
REP.1M,2.5,,,BRD:BRD-K94882685-003-10-0,TOLONIUM,TOLONIUM
REP.1M,2.5,"CDK1, CDK2, CDK4, CDK5",CDK INHIBITOR,BRD:BRD-K94883909-001-17-7,SU9516,SU9516
REP.1M,2.5,"PARP1, PARP3",PARP INHIBITOR,BRD:BRD-K94920105-001-05-9,DR-2313,DR-2313
REP.1M,2.5,,HDAC INHIBITOR,BRD:BRD-K95216408-001-02-9,TUCIDINOSTAT,TUCIDINOSTAT
REP.1M,2.5,HTR1A,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K95598440-001-10-9,PINDOLOL-(-),PINDOLOL-(-)
REP.1M,2.5,ATP2A1,ATPASE INHIBITOR,BRD:BRD-K95603879-001-08-9,BHQ,BHQ
REP.1M,2.5,TNKS,WNT SIGNALING INHIBITOR NEGATIVE CONTROL,BRD:BRD-K96155658-001-02-9,EXO-IWR-1,EXO-IWR-1
REP.1M,2.5,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K96298462-001-08-9,IMAZODAN,IMAZODAN
REP.1M,2.5,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3",CALCIUM CHANNEL BLOCKER,BRD:BRD-K96354014-001-29-4,NIFEDIPINE,NIFEDIPINE
REP.1M,2.5,"CA12, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K96798615-001-02-9,S4,S4
REP.1M,2.5,,,BRD:BRD-K97009491-238-05-9,CALCIUM-LEVOFOLINATE,CALCIUM-LEVOFOLINATE
REP.1M,2.5,CYP3A4,CHELATING AGENT,BRD:BRD-K97010173-001-06-9,DEFERASIROX,DEFERASIROX
REP.1M,2.5,FGFR1,FGFR INHIBITOR,BRD:BRD-K97152684-001-03-9,PD-161570,PD-161570
REP.1M,2.5,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K97181972-001-01-9,CPI-169,CPI-169
REP.1M,2.5,,FERROPTOSIS INHIBITOR,BRD:BRD-K97375133-001-04-9,FERROSTATIN-1,FERROSTATIN-1
REP.1M,2.5,,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K97656802-001-02-9,GSK2881078,GSK2881078
REP.1M,2.5,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K97840621-001-02-9,API-1,API-1
REP.1M,2.5,MET,C-MET INHIBITOR,BRD:BRD-K98028353-001-02-8,SAVOLITINIB,SAVOLITINIB
REP.1M,2.5,MAP3K8,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K98710228-001-01-6,COT-INHIBITOR-1,COT-INHIBITOR-1
REP.1M,2.5,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K99308908-001-02-9,A-939572,A-939572
REP.1M,2.5,"SMO, TRPC6",SMOOTHENED RECEPTOR AGONIST,BRD:BRD-K99433989-001-02-9,SAG,SAG
REP.1M,2.5,PON1,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K99750640-236-20-3,CEFAZOLIN,CEFAZOLIN
REP.1M,2.5,FAAH,FAAH INHIBITOR,BRD:BRD-K99819791-001-02-9,SA-47,SA-47
REP.1M,2.5,,MUCUS PROTECTING AGENT,BRD:BRD-M00184283-001-01-1,ACRYLATE,ACRYLATE
REP.1M,2.5,,ISOCITRATE LYASE SUBSTRATE,BRD:BRD-M01344114-348-01-0,THREO-2-METHYLISOCITRATE-(DL),THREO-2-METHYLISOCITRATE-(DL)
REP.1M,2.5,,,BRD:BRD-M55321172-001-03-3,POTASSIUM-IODIDE,POTASSIUM-IODIDE
REP.1M,2.5,ALB,,BRD:BRD-M58433298-001-02-4,SODIUM-DODECYL-SULFATE,SODIUM-DODECYL-SULFATE
REP.1M,2.5,,DIURETIC,BRD:BRD-M67659203-001-02-7,PAMABROM,PAMABROM
REP.1M,2.5,"F12, FABP4, FFAR1, FFAR4, PLD2",IMMUNOSTIMULANT,BRD:BRD-M75061779-001-01-2,ETHANOLAMINE-OLEATE,ETHANOLAMINE-OLEATE
REP.1M,2.5,"ESR1, ESR2",SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-M93148412-001-02-6,LASOFOXIFENE,LASOFOXIFENE
REP.300,2.5,,,BRD:BRD-A04843135-001-09-9,OXAMNIQUINE,OXAMNIQUINE
REP.300,2.5,,,BRD:BRD-A49924714-001-08-9,2-ETHYLHEXYL 4-(DIMETHYLAMINO)BENZOATE,2-ETHYLHEXYL 4-(DIMETHYLAMINO)BENZOATE
REP.300,2.5,,,BRD:BRD-K00003538-001-02-9,ACT-709478,ACT-709478
REP.300,2.5,,,BRD:BRD-K00005263-001-02-9,MIK665,MIK665
REP.300,2.5,,,BRD:BRD-K00010521-300-02-9,KB-0742 (DIHYDROCHLORIDE),KB-0742 (DIHYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00029604-001-02-9,LATANOPROSTENE BUNOD,LATANOPROSTENE BUNOD
REP.300,2.5,,,BRD:BRD-K00029607-334-02-9,NETARSUDIL MESYLATE,NETARSUDIL MESYLATE
REP.300,2.5,,,BRD:BRD-K00068629-001-02-9,CBP/P300-IN-4,CBP/P300-IN-4
REP.300,2.5,,,BRD:BRD-K00069020-001-02-9,MOBOCERTINIB,MOBOCERTINIB
REP.300,2.5,,,BRD:BRD-K00071586-001-01-9,FLUTEMETAMOL,FLUTEMETAMOL
REP.300,2.5,,,BRD:BRD-K00071589-001-01-9,LEFAMULIN,LEFAMULIN
REP.300,2.5,,,BRD:BRD-K00071592-001-01-9,PIBRENTASVIR,PIBRENTASVIR
REP.300,2.5,,,BRD:BRD-K00071596-019-01-9,MACIMORELIN,MACIMORELIN
REP.300,2.5,,,BRD:BRD-K00071599-001-02-9,REMDESIVIR,REMDESIVIR
REP.300,2.5,,,BRD:BRD-K00073038-001-02-9,ENSARTINIB HYDROCHLORIDE,ENSARTINIB HYDROCHLORIDE
REP.300,2.5,,,BRD:BRD-K00073067-001-02-9,ARTELINIC ACID,ARTELINIC ACID
REP.300,2.5,,,BRD:BRD-K00073070-001-02-9,SAR-260301,SAR-260301
REP.300,2.5,,,BRD:BRD-K00073093-001-02-9,ALOFANIB,ALOFANIB
REP.300,2.5,,,BRD:BRD-K00073449-019-02-9,H-VAL-PRO-PRO-OH (TFA),H-VAL-PRO-PRO-OH (TFA)
REP.300,2.5,,,BRD:BRD-K00073457-001-02-9,ALMINOPROFEN,ALMINOPROFEN
REP.300,2.5,,,BRD:BRD-K00073831-019-02-9,DUSQUETIDE,DUSQUETIDE
REP.300,2.5,,,BRD:BRD-K00073864-001-02-9,PEXACERFONT,PEXACERFONT
REP.300,2.5,,,BRD:BRD-K00073880-001-02-9,TILDIPIROSIN,TILDIPIROSIN
REP.300,2.5,,,BRD:BRD-K00073895-001-02-9,GW7604,GW7604
REP.300,2.5,,,BRD:BRD-K00073934-001-02-9,DABUZALGRON,DABUZALGRON
REP.300,2.5,,,BRD:BRD-K00073937-001-02-9,RP-54745,RP-54745
REP.300,2.5,,,BRD:BRD-K00073947-001-02-9,SELTOREXANT,SELTOREXANT
REP.300,2.5,,,BRD:BRD-K00074079-001-02-9,GSK2245035,GSK2245035
REP.300,2.5,,,BRD:BRD-K00074122-001-02-9,TAS-116,TAS-116
REP.300,2.5,,,BRD:BRD-K00074484-001-02-9,MHP,MHP
REP.300,2.5,,,BRD:BRD-K00074531-001-02-9,NETICONAZOLE,NETICONAZOLE
REP.300,2.5,,,BRD:BRD-K00074616-003-02-9,ETIDOCAINE (HYDROCHLORIDE),ETIDOCAINE (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00074641-001-02-9,IMRECOXIB,IMRECOXIB
REP.300,2.5,,,BRD:BRD-K00074712-001-02-9,TEGLICAR,TEGLICAR
REP.300,2.5,,,BRD:BRD-K00074735-014-02-9,OLANEXIDINE,OLANEXIDINE
REP.300,2.5,,,BRD:BRD-K00074789-001-02-9,SPIRAPRIL HYDROCHLORIDE,SPIRAPRIL HYDROCHLORIDE
REP.300,2.5,,,BRD:BRD-K00074831-001-02-9,AZD 4017,AZD 4017
REP.300,2.5,,,BRD:BRD-K00074843-001-02-9,TEPILAMIDE FUMARATE,TEPILAMIDE FUMARATE
REP.300,2.5,,,BRD:BRD-K00074858-003-02-9,SR-31747,SR-31747
REP.300,2.5,,,BRD:BRD-K00075060-001-02-9,RUPINTRIVIR,RUPINTRIVIR
REP.300,2.5,,,BRD:BRD-K00075103-001-02-9,FINERENONE,FINERENONE
REP.300,2.5,,,BRD:BRD-K00075152-001-02-9,AZD1940,AZD1940
REP.300,2.5,,,BRD:BRD-K00075290-001-02-9,PAMICOGREL,PAMICOGREL
REP.300,2.5,,,BRD:BRD-K00075424-001-02-9,RECILISIB,RECILISIB
REP.300,2.5,,,BRD:BRD-K00075537-001-02-9,LY2562175,LY2562175
REP.300,2.5,,,BRD:BRD-K00075584-003-02-9,MELFLUFEN (HYDROCHLORIDE),MELFLUFEN (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00075618-001-03-9,FEDOVAPAGON,FEDOVAPAGON
REP.300,2.5,,,BRD:BRD-K00075632-305-02-9,ADRIFORANT (HYDROCHLORIDE),ADRIFORANT (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00075673-001-02-9,PF-03463275,PF-03463275
REP.300,2.5,,,BRD:BRD-K00075696-001-02-9,IOMAZENIL,IOMAZENIL
REP.300,2.5,,,BRD:BRD-K00075715-003-02-9,ABT-418 (HYDROCHLORIDE),ABT-418 (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00075727-003-02-9,TIPEPIDINE (HYDROCHLORIDE),TIPEPIDINE (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00075754-001-02-9,CENISERTIB,CENISERTIB
REP.300,2.5,,,BRD:BRD-K00075778-003-02-9,ANSOFAXINE HYDROCHLORIDE,ANSOFAXINE HYDROCHLORIDE
REP.300,2.5,,,BRD:BRD-K00076061-001-02-9,ALEGLITAZAR,ALEGLITAZAR
REP.300,2.5,,,BRD:BRD-K00076155-001-02-9,LONAPALENE,LONAPALENE
REP.300,2.5,,,BRD:BRD-K00076260-001-02-9,SR 146131,SR 146131
REP.300,2.5,,,BRD:BRD-K00076315-001-02-9,PIBRENTASVIR,PIBRENTASVIR
REP.300,2.5,,,BRD:BRD-K00076418-001-02-9,AZD5423,AZD5423
REP.300,2.5,,,BRD:BRD-K00076465-001-02-9,ZD-4190,ZD-4190
REP.300,2.5,,,BRD:BRD-K00076468-001-02-9,BROFAROMINE,BROFAROMINE
REP.300,2.5,,,BRD:BRD-K00076493-001-02-9,NRC-2694,NRC-2694
REP.300,2.5,,,BRD:BRD-K00076501-001-02-9,PF 04531083,PF 04531083
REP.300,2.5,,,BRD:BRD-K00076620-001-02-9,CE-245677,CE-245677
REP.300,2.5,,,BRD:BRD-K00076647-001-02-9,MK-0429,MK-0429
REP.300,2.5,,,BRD:BRD-K00076721-001-02-9,SDZ-MKS 492,SDZ-MKS 492
REP.300,2.5,,,BRD:BRD-K00076909-001-02-9,AZD2098,AZD2098
REP.300,2.5,,,BRD:BRD-K00076917-001-02-9,FEBANTEL,FEBANTEL
REP.300,2.5,,,BRD:BRD-K00076940-046-02-9,EVOGLIPTIN (TARTRATE),EVOGLIPTIN (TARTRATE)
REP.300,2.5,,,BRD:BRD-K00076949-001-02-9,RIMACALIB,RIMACALIB
REP.300,2.5,,,BRD:BRD-K00076962-001-02-9,LAFLUNIMUS,LAFLUNIMUS
REP.300,2.5,,,BRD:BRD-K00077013-001-02-9,MAPRACORAT,MAPRACORAT
REP.300,2.5,,,BRD:BRD-K00077023-001-02-9,OTESECONAZOLE,OTESECONAZOLE
REP.300,2.5,,,BRD:BRD-K00077076-019-02-9,FRAKEFAMIDE (TFA),FRAKEFAMIDE (TFA)
REP.300,2.5,,,BRD:BRD-K00077192-001-02-9,"N-(2-BROMO-6-FLUOROPHENYL)-4,5-DIHYDRO-1H-IMIDAZOL","N-(2-BROMO-6-FLUOROPHENYL)-4,5-DIHYDRO-1H-IMIDAZOL"
REP.300,2.5,,,BRD:BRD-K00077266-001-02-9,CCR2 ANTAGONIST 3,CCR2 ANTAGONIST 3
REP.300,2.5,,,BRD:BRD-K00077340-001-02-9,EPI-001,EPI-001
REP.300,2.5,,,BRD:BRD-K00077386-001-02-9,LY2940094,LY2940094
REP.300,2.5,,,BRD:BRD-K00077460-001-02-9,ILORASERTIB,ILORASERTIB
REP.300,2.5,,,BRD:BRD-K00077480-001-02-9,TRIFAROTENE,TRIFAROTENE
REP.300,2.5,,,BRD:BRD-K00077698-001-02-9,BIMOSIAMOSE,BIMOSIAMOSE
REP.300,2.5,,,BRD:BRD-K00077939-001-02-9,GEMCABENE,GEMCABENE
REP.300,2.5,,,BRD:BRD-K00077971-001-02-9,BAY-85-8501,BAY-85-8501
REP.300,2.5,,,BRD:BRD-K00077991-001-02-9,DIFELIKEFALIN,DIFELIKEFALIN
REP.300,2.5,,,BRD:BRD-K00078070-001-02-9,"2,4-DIHYDROXYPYRIMIDINE-5-CARBOXYLIC ACID","2,4-DIHYDROXYPYRIMIDINE-5-CARBOXYLIC ACID"
REP.300,2.5,,,BRD:BRD-K00078154-001-02-9,AR-9281,AR-9281
REP.300,2.5,,,BRD:BRD-K00078209-001-02-9,FULACIMSTAT,FULACIMSTAT
REP.300,2.5,,,BRD:BRD-K00078221-019-02-9,EPITALON (TFA),EPITALON (TFA)
REP.300,2.5,,,BRD:BRD-K00078317-001-02-9,SAR125844,SAR125844
REP.300,2.5,,,BRD:BRD-K00078423-001-02-9,NAVOXIMOD,NAVOXIMOD
REP.300,2.5,,,BRD:BRD-K00078514-003-02-9,ETELCALCETIDE (HYDROCHLORIDE),ETELCALCETIDE (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00078613-001-02-9,GLPG0974,GLPG0974
REP.300,2.5,,,BRD:BRD-K00078614-001-02-9,GEMILUKAST,GEMILUKAST
REP.300,2.5,,,BRD:BRD-K00078770-001-02-9,4-CPA,4-CPA
REP.300,2.5,,,BRD:BRD-K00079018-003-02-9,NEPINALONE (HYDROCHLORIDE),NEPINALONE (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00079087-001-02-9,DECOGLURANT,DECOGLURANT
REP.300,2.5,,,BRD:BRD-K00079205-001-02-9,ISLATRAVIR,ISLATRAVIR
REP.300,2.5,,,BRD:BRD-K00079239-001-02-9,E1210,E1210
REP.300,2.5,,,BRD:BRD-K00079286-003-02-9,CARCAINIUM (CHLORIDE),CARCAINIUM (CHLORIDE)
REP.300,2.5,,,BRD:BRD-K00079290-001-02-9,PCO371,PCO371
REP.300,2.5,,,BRD:BRD-K00079347-066-02-9,MK-0941,MK-0941
REP.300,2.5,,,BRD:BRD-K00079404-001-02-9,LAS101057,LAS101057
REP.300,2.5,,,BRD:BRD-K00079493-001-02-9,WAY-181187,WAY-181187
REP.300,2.5,,,BRD:BRD-K00079505-019-02-9,ELAMIPRETIDE (TFA),ELAMIPRETIDE (TFA)
REP.300,2.5,,,BRD:BRD-K00079520-001-02-9,TECARFARIN,TECARFARIN
REP.300,2.5,,,BRD:BRD-K00079528-001-02-9,AMG 333,AMG 333
REP.300,2.5,,,BRD:BRD-K00079560-001-02-9,TYLVALOSIN,TYLVALOSIN
REP.300,2.5,,,BRD:BRD-K00084836-001-01-9,AFOXOLANER,AFOXOLANER
REP.300,2.5,,,BRD:BRD-K00084839-001-01-9,DINOTEFURAN,DINOTEFURAN
REP.300,2.5,,,BRD:BRD-K00084841-001-01-9,FLUTICASONE FUROATE,FLUTICASONE FUROATE
REP.300,2.5,,,BRD:BRD-K00084842-001-01-9,LOTILANER,LOTILANER
REP.300,2.5,,,BRD:BRD-K00084846-001-01-9,OCLACITINIB,OCLACITINIB
REP.300,2.5,,,BRD:BRD-K00084847-001-01-9,PYRIPROXYFEN,PYRIPROXYFEN
REP.300,2.5,,,BRD:BRD-K00084848-001-01-9,SAROLANER,SAROLANER
REP.300,2.5,,,BRD:BRD-K00087010-001-02-9,CC-92480,CC-92480
REP.300,2.5,,,BRD:BRD-K00089583-001-01-9,INDOXACARB,INDOXACARB
REP.300,2.5,,,BRD:BRD-K00090621-001-02-9,MOLNUPIRAVIR,MOLNUPIRAVIR
REP.300,2.5,,,BRD:BRD-K00090622-001-01-9,AMYLOID P-IN-1,AMYLOID P-IN-1
REP.300,2.5,,,BRD:BRD-K00090624-001-01-9,UBROGEPANT,UBROGEPANT
REP.300,2.5,,,BRD:BRD-K00090625-001-01-9,NP-G2-044,NP-G2-044
REP.300,2.5,,,BRD:BRD-K00090626-001-01-9,PTC596,PTC596
REP.300,2.5,,,BRD:BRD-K00090627-050-01-9,ARIMOCLOMOL (MALEATE),ARIMOCLOMOL (MALEATE)
REP.300,2.5,,,BRD:BRD-K00090628-001-01-9,AB-680,AB-680
REP.300,2.5,,,BRD:BRD-K00090629-001-01-9,RBN-2397,RBN-2397
REP.300,2.5,,,BRD:BRD-K00090631-001-01-9,DEPRODONE PROPIONATE,DEPRODONE PROPIONATE
REP.300,2.5,,,BRD:BRD-K00090633-001-01-9,GSK-626616,GSK-626616
REP.300,2.5,,,BRD:BRD-K00090634-001-01-9,ENARODUSTAT,ENARODUSTAT
REP.300,2.5,,,BRD:BRD-K00090635-001-01-9,DM4,DM4
REP.300,2.5,,,BRD:BRD-K00090636-001-01-9,PT2399,PT2399
REP.300,2.5,,,BRD:BRD-K00090644-001-01-9,DEXAMETHASONE PALMITATE,DEXAMETHASONE PALMITATE
REP.300,2.5,,,BRD:BRD-K00090645-001-01-9,DORZAGLIATIN,DORZAGLIATIN
REP.300,2.5,,,BRD:BRD-K00090646-001-01-9,TK216,TK216
REP.300,2.5,,,BRD:BRD-K00090647-001-01-9,SENAPARIB,SENAPARIB
REP.300,2.5,,,BRD:BRD-K00090648-001-01-9,ZOTATIFIN,ZOTATIFIN
REP.300,2.5,,,BRD:BRD-K00090650-001-01-9,REMOGLIFLOZIN ETABONATE,REMOGLIFLOZIN ETABONATE
REP.300,2.5,,,BRD:BRD-K00090651-001-01-9,SNDX-5613,SNDX-5613
REP.300,2.5,,,BRD:BRD-K00090654-001-01-9,LHF-535,LHF-535
REP.300,2.5,,,BRD:BRD-K00090657-001-01-9,(RAC)-TAVAPADON,(RAC)-TAVAPADON
REP.300,2.5,,,BRD:BRD-K00090658-001-01-9,SIBOFIMLOC,SIBOFIMLOC
REP.300,2.5,,,BRD:BRD-K00090659-001-01-9,ETRIPAMIL,ETRIPAMIL
REP.300,2.5,,,BRD:BRD-K00091066-075-01-9,T-1101 (TOSYLATE),T-1101 (TOSYLATE)
REP.300,2.5,,,BRD:BRD-K00091067-376-01-9,AMXT-1501 TETRAHYDROCHLORIDE,AMXT-1501 TETRAHYDROCHLORIDE
REP.300,2.5,,,BRD:BRD-K00091070-001-01-9,VX-984,VX-984
REP.300,2.5,,,BRD:BRD-K00091071-001-01-9,PF-06952229,PF-06952229
REP.300,2.5,,,BRD:BRD-K00091072-001-01-9,ATR INHIBITOR 2,ATR INHIBITOR 2
REP.300,2.5,,,BRD:BRD-K00091073-001-01-9,ALICAPISTAT,ALICAPISTAT
REP.300,2.5,,,BRD:BRD-K00091074-001-01-9,EC5026,EC5026
REP.300,2.5,,,BRD:BRD-K00091075-001-01-9,E-7386,E-7386
REP.300,2.5,,,BRD:BRD-K00091077-001-01-9,AZD8329,AZD8329
REP.300,2.5,,,BRD:BRD-K00091078-001-01-9,AZD-0364,AZD-0364
REP.300,2.5,,,BRD:BRD-K00091079-001-01-9,MSC2360844,MSC2360844
REP.300,2.5,,,BRD:BRD-K00091080-001-01-9,SSTR5 ANTAGONIST 1,SSTR5 ANTAGONIST 1
REP.300,2.5,,,BRD:BRD-K00091082-001-01-9,LY2922470,LY2922470
REP.300,2.5,,,BRD:BRD-K00091083-015-01-9,IM156,IM156
REP.300,2.5,,,BRD:BRD-K00091085-001-01-9,BAY 2416964,BAY 2416964
REP.300,2.5,,,BRD:BRD-K00091086-001-01-9,ZAMICASTAT,ZAMICASTAT
REP.300,2.5,,,BRD:BRD-K00091088-001-01-9,AZD-7648,AZD-7648
REP.300,2.5,,,BRD:BRD-K00091089-001-01-9,PTI-428,PTI-428
REP.300,2.5,,,BRD:BRD-K00091090-001-01-9,S55746,S55746
REP.300,2.5,,,BRD:BRD-K00091091-003-01-9,NEVANIMIBE HYDROCHLORIDE,NEVANIMIBE HYDROCHLORIDE
REP.300,2.5,,,BRD:BRD-K00091092-001-01-9,OLUTASIDENIB,OLUTASIDENIB
REP.300,2.5,,,BRD:BRD-K00091093-001-01-9,SAR439859,SAR439859
REP.300,2.5,,,BRD:BRD-K00091094-001-01-9,BMS-986165,BMS-986165
REP.300,2.5,,,BRD:BRD-K00091095-001-01-9,SELPERCATINIB,SELPERCATINIB
REP.300,2.5,,,BRD:BRD-K00091099-001-01-9,DIFAMILAST,DIFAMILAST
REP.300,2.5,,,BRD:BRD-K00091100-001-01-9,ANTINEOPLASTON A10,ANTINEOPLASTON A10
REP.300,2.5,,,BRD:BRD-K00091101-001-01-9,ODM-203,ODM-203
REP.300,2.5,,,BRD:BRD-K00091102-001-01-9,GUSACITINIB,GUSACITINIB
REP.300,2.5,,,BRD:BRD-K00091103-001-01-9,SX-682,SX-682
REP.300,2.5,,,BRD:BRD-K00091104-001-01-9,9-ING-41,9-ING-41
REP.300,2.5,,,BRD:BRD-K00091105-001-01-9,N-ACETYLCYSTEINE AMIDE,N-ACETYLCYSTEINE AMIDE
REP.300,2.5,,,BRD:BRD-K00091106-001-01-9,TAK-071,TAK-071
REP.300,2.5,,,BRD:BRD-K00091108-001-01-9,PRI-724,PRI-724
REP.300,2.5,,,BRD:BRD-K00091109-001-01-9,LIGANDROL,LIGANDROL
REP.300,2.5,,,BRD:BRD-K00091110-074-01-9,CC-90011 (BENZENESULFONATE),CC-90011 (BENZENESULFONATE)
REP.300,2.5,,,BRD:BRD-K00091111-001-01-9,AB928,AB928
REP.300,2.5,,,BRD:BRD-K00091113-001-01-9,BIIB068,BIIB068
REP.300,2.5,,,BRD:BRD-K00091116-001-01-9,DCC-3014,DCC-3014
REP.300,2.5,,,BRD:BRD-K00091117-001-01-9,OMACICLOVIR,OMACICLOVIR
REP.300,2.5,,,BRD:BRD-K00091118-001-01-9,TEFINOSTAT,TEFINOSTAT
REP.300,2.5,,,BRD:BRD-K00091120-001-01-9,ALK2-IN-1,ALK2-IN-1
REP.300,2.5,,,BRD:BRD-K00091121-003-01-9,SEL120-34A (MONOHYDROCHLORIDE),SEL120-34A (MONOHYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00091122-001-01-9,BELVARAFENIB,BELVARAFENIB
REP.300,2.5,,,BRD:BRD-K00091126-001-01-9,USL311,USL311
REP.300,2.5,,,BRD:BRD-K00091129-001-01-9,PF 03716556,PF 03716556
REP.300,2.5,,,BRD:BRD-K00091130-325-01-9,TRIAZAVIRIN,TRIAZAVIRIN
REP.300,2.5,,,BRD:BRD-K00091132-001-01-9,LTA4H-IN-1,LTA4H-IN-1
REP.300,2.5,,,BRD:BRD-K00091135-001-01-9,NIDUFEXOR,NIDUFEXOR
REP.300,2.5,,,BRD:BRD-K00091136-303-01-9,BURIXAFOR (HYDROBROMIDE),BURIXAFOR (HYDROBROMIDE)
REP.300,2.5,,,BRD:BRD-K00091264-001-01-9,FILIBUVIR,FILIBUVIR
REP.300,2.5,,,BRD:BRD-K00091265-001-01-9,GSK2983559 (FREE ACID),GSK2983559 (FREE ACID)
REP.300,2.5,,,BRD:BRD-K00091266-001-01-9,IDO1-IN-5,IDO1-IN-5
REP.300,2.5,,,BRD:BRD-K00091267-001-01-9,MDR-652,MDR-652
REP.300,2.5,,,BRD:BRD-K00091270-459-01-9,POLYMYXIN B NONAPEPTIDE (TFA),POLYMYXIN B NONAPEPTIDE (TFA)
REP.300,2.5,,,BRD:BRD-K00091271-001-01-9,6-THIO-2'-DEOXYGUANOSINE,6-THIO-2'-DEOXYGUANOSINE
REP.300,2.5,,,BRD:BRD-K00091272-001-01-9,CCR1 ANTAGONIST 9,CCR1 ANTAGONIST 9
REP.300,2.5,,,BRD:BRD-K00091273-001-01-9,MW-150,MW-150
REP.300,2.5,,,BRD:BRD-K00091274-001-01-9,OLINCIGUAT,OLINCIGUAT
REP.300,2.5,,,BRD:BRD-K00091275-001-01-9,VALNIVUDINE,VALNIVUDINE
REP.300,2.5,,,BRD:BRD-K00091277-001-01-9,PETESICATIB,PETESICATIB
REP.300,2.5,,,BRD:BRD-K00091278-001-01-9,ELENBECESTAT,ELENBECESTAT
REP.300,2.5,,,BRD:BRD-K00091279-001-01-9,BALOVAPTAN,BALOVAPTAN
REP.300,2.5,,,BRD:BRD-K00091280-001-01-9,ASP5878,ASP5878
REP.300,2.5,,,BRD:BRD-K00091281-001-01-9,DS-1971A,DS-1971A
REP.300,2.5,,,BRD:BRD-K00091282-001-01-9,FOSDAGROCORAT,FOSDAGROCORAT
REP.300,2.5,,,BRD:BRD-K00091285-001-01-9,THELIATINIB,THELIATINIB
REP.300,2.5,,,BRD:BRD-K00091286-001-01-9,BATABULIN,BATABULIN
REP.300,2.5,,,BRD:BRD-K00091287-001-01-9,FLESINOXAN,FLESINOXAN
REP.300,2.5,,,BRD:BRD-K00091288-001-01-9,BELZUTIFAN,BELZUTIFAN
REP.300,2.5,,,BRD:BRD-K00091289-300-01-9,TEBANICLINE (DIHYDROCHLORIDE),TEBANICLINE (DIHYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K00091290-001-01-9,TAS4464,TAS4464
REP.300,2.5,,,BRD:BRD-K00091294-001-01-9,FAPI-4,FAPI-4
REP.300,2.5,,,BRD:BRD-K00091297-001-01-9,SAREDUTANT,SAREDUTANT
REP.300,2.5,,,BRD:BRD-K00093437-001-01-9,ELEXACAFTOR,ELEXACAFTOR
REP.300,2.5,,,BRD:BRD-K00093439-001-01-9,ACRIZANIB,ACRIZANIB
REP.300,2.5,,,BRD:BRD-K00093440-001-01-9,ZANDELISIB,ZANDELISIB
REP.300,2.5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628,"AZ 628, AZ-628"
REP.300,2.5,,,BRD:BRD-K11848003-001-17-9,ZEARALANOL,ZEARALANOL
REP.300,2.5,,,BRD:BRD-K12609995-001-02-9,GNE-477,GNE-477
REP.300,2.5,,,BRD:BRD-K15324227-001-02-9,ML355,ML355
REP.300,2.5,,,BRD:BRD-K17754715-036-03-9,DDD107498 (SUCCINATE),DDD107498 (SUCCINATE)
REP.300,2.5,,,BRD:BRD-K20878815-001-06-9,KOJIC ACID,KOJIC ACID
REP.300,2.5,,,BRD:BRD-K24621118-001-04-9,ACTINONIN,ACTINONIN
REP.300,2.5,,,BRD:BRD-K27889527-001-10-9,JNJ-5207852,JNJ-5207852
REP.300,2.5,,,BRD:BRD-K31606909-001-03-9,METARRESTIN,METARRESTIN
REP.300,2.5,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K43055376-001-04-9,IMEPITOIN,"ADD-233089, IMEPITOIN"
REP.300,2.5,,,BRD:BRD-K44518413-066-04-9,TRICAINE (METHANESULFONATE),TRICAINE (METHANESULFONATE)
REP.300,2.5,,,BRD:BRD-K76687997-003-07-9,RANITIDINE (HYDROCHLORIDE),RANITIDINE (HYDROCHLORIDE)
REP.300,2.5,,,BRD:BRD-K77185060-001-08-9,METOPRINE,METOPRINE
REP.300,2.5,,,BRD:BRD-K83982397-001-06-9,2-BENZYL-4-CHLOROPHENOL,2-BENZYL-4-CHLOROPHENOL
REP.300,2.5,,,BRD:BRD-K86283245-001-03-9,OR-1896,OR-1896
REP.300,2.5,,,BRD:BRD-K89669299-001-04-9,PERICYAZINE,PERICYAZINE
REP.300,2.5,,,BRD:BRD-K99108507-001-10-9,CB-103,CB-103
